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Alfred Day Hershey (1908-1997)
Most of the basic facts about the gene and how it functions were learned
through studies of bacteriophages, the viruses of bacteria. Phages came
into biological prominence through experiments done in wartime United
States by the German physicist, Max DelbrOck, and the Italian biologist,
Salvador Luria. They believed that in studying how a single phage particle
multiplies within a host bacterium to form many identical progeny phages,
they were in effect studying naked genes in action. Soon they recruited the
American chemist-turned-biologist Alfred Hershey to their way of thinking,
and in 1943 the "Phage Group" was born. Of this famous trio, who were to
receive in 1969 the Nobel Prize, Hershey was initially the least celebrated.
Al had no trace of DelbrOck's almost evangelical charisma or of Luria's
candid assertiveness and never welcomed the need to travel and expose
his ideas to a wide audience. He framed his experiments to convince him-
self, not others, that he was on the right track. Then he could enjoy what he
called Hershey Heaven, doing experiments that he understood would give
the same answer upon repetition. Although both he and Luria had indepen-
dently demonstrated that phages upon multiplying give rise to stable vari-
ants (mutants), it was Hershey, then in St. Louis, who in 1948 showed that
their genetic determinants (genes) were linearly linked to each other like the
genes along chromosomes of higher organisms.
His most famous experiment, however, occurred soon after he moved to
the Department of Genetics of the Carnegie Institution of Washington in Cold
Spring Harbor on Long Island. There, in 1952, with his assistant, Martha
Chase, he showed that phage DNA, not its protein component, contains the
phage genes. After a tadpole-shaped phage particle attaches to a bacteri-
um, its DNA enters through a tiny hole while its protein coat remains outside.
Key to Hershey's success was showing that viral infection is not affected by
violent agitation in a kitchen blender, which removes the empty viral protein
shells from the bacterial surface.
Although there was already good evidence from the 1944 announcement
of Avery, MacLeod, and McCarty at the Rockefeller Institute that DNA could
genetically alter the surface properties of bacteria, its broader significance
was unknown. The Hershey-Chase experiment had a much stronger impact
than most confirmatory announcements and made me ever more certain that
finding the three-dimensional structure of DNA was biology's next most
important objective. The finding of the double helix by Francis Crick and me
came only 11 months after my receipt of a long Hershey letter describing
his blender experiment results. Soon afterward, I brought it to Oxford to
excitedly read aloud before a large April meeting on viral multiplication.
Hershey's extraordinary experimental acumen was last demonstrated
through his 1965 finding that the DNA molecule (chromosome) of bacterio-
phage X had 20-base-long single-stranded tails at each end. The base
sequences of these tails were complementary, allowing them to find each
other and circular X DNA molecules. This was a bombshell result, because
circular molecules had 2 years before been hypothesized as an intermediate
in the integration of X DNA molecules into bacterial chromosomes.
An abridged version of this essay appeared in the New York Times Magazine on January 4, 1998.
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Key to the esprit of the phage group was its annual late summer meeting at
Cold Spring Harbor. It was not for amateurs, and the intellects then exposed
had no equal in biology then or even now, in the hurly burly rush of genetic
manipulation of today where perhaps a quarter-million individuals think about
DNA in the course of their daily lives. Logic, never emotion or commercial
consideration, set the tone in those days, and it was always with keen expec-
tation that we awaited Al's often hour-long concluding remarks. Tightly con-
structed, his summaries struck those of us aware of his acute taciturnity as
containing more words than he might have spoken to outsiders over the
course of the past year.
By 1970, the base features of A, DNA replication and functioning, both in its
more conventional lytic phase and in its prophage stage, had become known,
and a book was needed for their presentation to a broader biological audi-
ence. Because of his stature and honest impartiality, everyone wanted Al to
be the editor and to see that the 52 different papers said what they should
and no more. Through Al's ruthless cutting of unneeded verbiage, the book's
length was kept in check and the final volume not painful to hold in one's
hands. Working hard to make the changes that Al suggested, the young
Harvard star, Mark Ptashne, noted with pleasure that Al had made no further
changes in his revised manuscript's first ten pages. Then on page 11, Al
wrote, "Start here." Only Al could be so direct and so admired.
This was his last scientific hurrah. Although he was only 63, he soon chose
to retire. It bothered me that a mind so focused and inventive would willingly
stop doing science, but he lived to his own standards, and the pursuit of new
ideas was never easy. New moments of Hershey Heaven never lasted long,
and his long summers sailing on Georgian Bay were out of place as the num-
ber of new scientists seeking gene secrets increased. In retrospect, he did
not get out too soon. Recombinant DNA was but 2 years away, and soon
there would have been competitors on all sides.
Retirement saw him first expanding his garden, and I could exchange
words with him on my walks past his home. Later, when he became absorbed
with computers, he was inside and I never thought I had something important
enough for an excuse to interrupt. I now regret my lack of courage. Al always
appreciated others trying to move ahead. In his last month, now 88 and much
curved over by arthritis, Al drove his wife to my house for a small gathering.
In asking about our daily lives at the lab, Al likely knew that this would be the
last time we saw him. The time to go was at hand, and he stopped eating. No
one among his friends ever expects to see another who so pushed science to
that level of human endurance.
November 10, 1997 J.D. Watson
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PRESIDENT'S
ESSAY
I am close to completing 50 years of association with the Cold Spring Harbor Laboratory.
In mid-June of 1948, I arrived here to spend the summer doing phage experiments under
Salvador Luria, with whom I had just started my Ph.D. thesis research at Indiana
University. It was to be an interval that set the course of my future life. Until then, my
impressions of what high-level science was like had come largely from books, journal
articles, and university lectures. Suddenly I had the opportunity to associate faces and
voices with ideas and experiments. Not discouraged by personalities who did not always
measure up to their science, I was happily finding out that high-level science could be
more than long days in the lab and much mental sweat. It could also encompass a life
that had room for outdoor fun and silly moments that did not always treat gently individ-
uals who thought too well of themselves.
Dominating the intellectual esprit that summer was the German-born theoretical
physicist-turned-phage biologist Max Delbruck. He, with his wife Manny, had been in
Cold Spring Harbor every summer save one since 1941. Born in 1906 in Berlin, Max had
moved in the circle of the great theoreticians when quantum mechanics revolutionized
the world of physics. At that time, Berlin was one of the world's great centers for science,
but its central role vanished as soon as Hitler took over in 1933. Coming from a distin-
guished Protestant academic family, Max did not have to leave, but feeling at odds with
the Nazi-led university scene, he migrated to the United States in early 1937. By then he
had become more interested in the gene than the atom and so used his Rockefeller
Foundation fellowship to go to the California Institute of Technology to work with its strong
contingent of geneticists. There he soon saw the possibility of using the viruses of bac-
teria (bacteriophages or phage for short) as model systems for studying the fundamen-
tal properties of genes.
1
It was after his move to Vanderbilt University in Nashville in early 1940 that he
received an invitation from Milislav Demerec, then the Laboratory's Director, to participate
in the 1941 Cold Spring Harbor Symposium. Even more important, he was asked to stay
on for the remainder of the summer to do experiments in one of the unheated lab build-
ings assigned to summer visitors. Max extended this invitation to his new friend Salvador
Luria, who had done phage experiments in Rome and Paris before fleeing ahead of
advancing German troops to a boat that would take him to New York. He had restarted
phage experiments at the College of Physicians & Surgeons of Columbia University when
he and Max first met in late December of 1940 at an American Association for the
Advancement of Science annual meeting in Philadelphia. After first talking about their
phage work, Max took Salva to dinner with a friend of his from the past, the theoretician
Wolfgang Pauli, legendary for both his ideas and his rudeness.
Six months later, his summer experiments with Salva were going so well that Max,
who had left for Pasadena in late July to get married, brought his new bride Manny (Mary
Bruce) back to Cold Spring Harbor for the remainder of the summer. In no sense was it
a traditional honeymoon. But Manny was then, as throughout her life, never bound by
conventions. She quickly began to share Max's enchantment with Cold Spring Harbor
and eagerly looked forward to returning the following summer.
The collection of scientists that Demerec assembled that summer of '41 was extraor-
dinary. It included the young Drosophila geneticists, Ed Lewis and Jim Neel, as well as
the already revered Hermann J. Muller, arguably the world's best geneticist, just back in
the States after nine years in Berlin, Moscow, and Edinburgh. Sewell Wright, the best
population geneticist in the United States, also was there, as were four leading maize
geneticists including the Cornell University-trained Marcus Rhodes and Barbara
McClintock. Later that year, Barbara, personally incompatible with the University of
Missouri, was appointed to the Cold Spring Harbor staff by Demerec, remaining here for
just over 50 years until her death in 1992. With Bentley Glass and Alexander Hollander
also in residence, this particular cohort of summer visitors represented an intellectual vir-
tuosity never before seen in Cold Spring Harbor's 51 years of existence.
Max and Manny were to spend six years in Nashville before they returned to
Pasadena where they had first met. In 1946, as soon as George Beadle moved from
Stanford back to Caltech as head of its Biology Division, he asked Max to come back as
a tenured professor. Accepting this invitation was easy for Max. He had greatly enjoyed
his earlier stay at Caltech, and Manny's family lived nearby in an affluent San Marino
home. Her father had managed copper mines in Cyprus, and most of Manny's early life
had been spent in the Middle East. She had returned to the United States only when she
reached college age and entered the orange-grove-surrounded Scripps Women's
College in Claremont, some 20 miles to the east of Pasadena.
Although once again based in California, the Delbrucks continued to make the trek
east to Cold Spring Harbor each summer, and 1948 was no exception. Max's firm yet soft
way of speaking mesmerized me that summer of '48. As much as possible I tried to be
near him-when he was eating in Blackford, or writing equations on the Blackford Hall
Fireplace Room blackboard, or hitting tennis balls so much harder than I could, or swim-
ming off the sand spit raft. Then, he was about to turn 42, and at 20 I was almost young
enough to be his son. Others, observing our similar tall, thin shapes and my never sub-
tle attempts to mimic Max's behavior, jokingly began to call me son of Max.
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Manny was constantly finding novel ways to avoid boredom and relished the non-
conformity of many of the personalities then in pursuit of the gene. She could not resist
making fun of snobs enamored of money or possessions and took much pleasure in
telling tales about friends whose character defects led them to embarrassing moments.
When given the chance, she was always outdoors, never hesitating to choose a canoe-
ing adventure to an unknown site over newspapers or magazine reports of events out of
her control. I could not then imagine Max having a more suitable wife and wondered
whether I would ever have such an idyllic companion for life.
That summer I relaxed in Manny's noncompetitive reflective presence, not at all
embarrassed by either my excessive skinniness or my inability to easily make social
remarks that put others at ease. Still necessarily more an observer than a real player in
the phage group, I took pleasure in Max's letting me call him by his first name and in
return soon being known to others as Jim. Although we would eagerly listen to Max's
opinions, no personal penalty was incurred by not adopting his way of thinking. Instead,
the scientific mood was much that of a Socratic dialogue leading toward conclusions that
might someday reveal the deep nature of the gene.
With my thesis research on X-ray-inactivated phage effectively a routine extension of
Luria's prior work on UV-inactivated phage, I had no need to be intellectually clever in
planning the next day's experiments. Nor did they seem so immediately important as to
preclude more fun activities, especially after the Lurias returned to Bloomington in early
August to await the birth of their son Danny. Then Max and Manny persuaded Renato
Dulbecco, whom Luria had brought over the year before from Italy to work in his
Bloomington lab, to drive us up to the Marine Biological Lab at Woods Hole. There we
met the German refugees Hans Gaffron and Victor Hamburger and listened to much gos-
sip about the legendary Berlin biochemist Otto Warburg, whose ideas about photosyn-
thesis and cancer then provoked much controversy. After our return to Cold Spring
Harbor, Renato's family arrived from Italy and soon he was driving off to Bloomington. But
as I was to be with Luria at a mid-September Genetics Society meeting in Washington, I
stayed on in my Blackford Hall room long after virtually all of the other summer visitors
were gone. Max and Manny also lingered on, and after the Blackford Hall dining room
closed on Labor Day, we had meals with those Carnegie staff who lived in the big
Victorian, Jones-built house on Route 25A that today we call Davenport House.
The academic year that followed at Indiana University in 1948-1949 saw me focused
on chemically induced indirect effects of X-rays on phage. For days at a time, I would
think I was on to something big, but then cold reality inevitably arrived. Particularly awk-
ward were my presentations in either Bloomington or Chicago before Max or the
Hungarian-born physicist Leo Szilard, the most famous of the phage course's converts
to the pursuit of the gene. Leo would start interrupting me as soon as I started to speak.
Later I comforted myself by hoping that he wouldn't have been so ferocious if there was
nothing of importance in what I was saying. In retrospect, however, that was the sad truth,
and my Ph.D. period proved primarily a time for learning until eventually, I could intellec-
tually stand on my own feet as opposed to those of Luria. But Salva's help was always
there. Seeing that I could not use the English language effectively, in April 1950, he pared
my unconceptual Ph.D. thesis to 50 pages.
Manny was expecting their second child during the summer of 1949, so many of the
phage group assembled in Pasadena. Like during Cold Spring Harbor summers, token
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weekday experiments alternated with many blackboard discussions as well as tennis.
Weekends were mapped out for camping trips, which frequently did not proceed accord-
ing to plan. One of the most memorable trips occurred early in August, when Gunther
Stent and Wolf Weidel, then postdocs with Max, found themselves stranded over a
Saturday night below treacherous cliffs on Catalina Island. The following March Max
organized a mini-Caltech meeting aimed at extending the phage world's ways of think-
ing to plant and animal viruses. I was then trying to finish my thesis so did not accom-
pany Salva to Pasadena. Later Max was to make my day by asking me to help put togeth-
er a syllabus on the procedures, facts, and interpretations of phage. It appeared at the
end of the little book, Viruses 1950, that emerged from the Caltech conference.
What mattered most then were the phage facts and ideas, not the individuals who
brought them forth. This was Max's biggest impact on the phage group and it allowed us
to take real joy in the discoveries of others instead of being jealous of them for providing
our intellectual excitement of the moment. In retrospect, Max's unchallenged scientific
collectivism was helped by the still so-mysterious nature of the gene. It was not then clear
what types of phage experiments could lead to a real breakthrough, and no two individ-
uals were pursuing the same experimental approaches. Only with the 1952 Hershey-
Chase experiment did the primacy of DNA became clear The discovery a year later of its
double helical structure started us thinking about how genetic information is encoded by
the sequences of base pairs. The ways to pin down how DNA functions in protein syn-
thesis, however, long remained partly clouded. So for the next 15 years, we remained in
the happy situation where there were more important problems to solve than scientists
opting for their challenges.
By then I was on the Harvard faculty, and it was easy to propose potentially impor-
tant thesis topics for my students without worrying whether someone else would be doing
similar experiments. Just one of my students had his thesis work made largely irrelevant
by more incisive findings elsewhere, and only once, when searching for the molecular
nature of nonsense suppressors, did we consciously find ourselves racing against anoth-
er lab. Happily we won that race when, in 1965, Mario Cappechi and Gary Gussin found
mutant tRNAs to be the molecular entities that misread nonsense codons as sense. In
retrospect, the pace of research up through the end of the 1960s was not that hurried,
and summers could still be used as low-key periods for recharging our intellectual bat-
teries. Life at Cold Spring Harbor correspondingly remained much as when I first came
here, with the students taking the summer courses occasionally bringing along wives, if
not families, and regulars like Rollin Hotchkiss coming each year for the occasional sum-
mer experiment in Jones lab.
After I became Director of the Laboratory in February 1968, I brought here for the
coming summer some of the better of the younger scientists working on phage X,. At that
time, my Harvard lab was increasingly focused on this most fascinating lysogenic phage
and I saw great advantage in having my so-oriented students come in long contact with
their peers from elsewhere. Max and Manny were once again regular summer visitors,
with Max, at John Cairns' urging, having started in 1965 a workshop on Phycomyces, the
mold then used as a model system for studying biological responses to light. Each sum-
mer, the DelbrOcks were domiciled in the utilitarian Page Motel. Perfect for outside-ori-
ented visitors, it easily allowed Max and Manny to assemble friends on the lawn outside
for barbecues. I had just married Liz, and Max and Manny, knowing that all too many
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young scientists are not people-oriented, graciously made her welcome in their home-
away-from-home. The DelbrUcks were to return for five more workshops between 1971
and 1976, by which time Max was 70 and saw the need for others to assume leadership
of Phycomyces research.
During the early 1970s, improving Laboratory finances allowed us to install heating
systems and modernize many of our run-down older buildings that were formerly rele-
gated to summer activities. Cold Spring Harbor as a summer-dominated institution began
to vanish as we strove to become one of the world's more exciting sites for tumor virus
research. In particular, by focusing on the small DNA tumor viruses SV40 and aden-
ovirus, we hoped to identify genes that make cells cancerous. Initially, our tumor virus
lab, led by Joe Sambrook, had almost the aura of a tiny frontier mining encampment filled
with upstarts waiting to take big risks. Each was hoping that their next experiment would
lead to a gold strike. In so prospecting, they needed brains and brawn as well as luck.
Those not of strong will and guts knew they were out of place and moved elsewhere. On
Friday nights, our Blackford Hall bar had the swagger of a western saloon awaiting the
inevitable gun fights that would come during our impending tumor virus meetings.
Certain personalities were bound to prove more than others could bear.
These tensions, so ready to explode, were still those of the academics searching pri-
marily for intellectual glory. The academic powers to be won were likely to be marked by
family cars bearing no more cachet than a Chevrolet. No one here then thought he might
soon have facts or ideas about cancer cells that would have commercial applications.
Like most pure academic biologists, we looked more with disdain than envy on those
chemist acquaintances whose industrial contacts let them live in homes almost suitable
for bankers. So with sufficient monies coming from the War on Cancer to support our
experiments, I saw no reason to taint our reputation for academic purity by unnecessar-
ily promoting commercial activities. With no hesitation I turned down Richard Roberts'
request that our Lab help start a company to commercialize the new restriction enzymes
that he was isolating. For several years, he had been providing them gratis to scientist
acquaintances, but now he was receiving more requests than he could handle.
The rough saloon camaraderie of tumor virology research persisted through our 1979
Viral Oncogenes Symposium. Its record-breaking 141 presentations allowed virtually
everyone with a true result to speak up and be heard. Then, as the powerful new proce-
dures of recombinant DNA became available, key objectives became much easier to
reach and our cowboy era was over. Once one mastered the new gene cloning proce-
dures, experimental success was almost foreordained. So oncogenes quickly moved
from being largely hypothetical constructs to definitive DNA sequences.
Correspondingly, which experiments to do next became more obvious, with the road
maps to reach key objectives often available to all. Lab sizes had to grow to keep others
from mining important quarries that in the past were treated as personal possessions.
Summer became no different from any other time of year, and once a tumor virus meet-
ing was over, its participants quickly departed back to their labs.
In the early 1980s, tumor virology moved beyond the concept of oncogenes to
embrace the equally important concept of tumor suppressors. These were genes whose
loss could also lead to the cancerous phenotype. Oncogenes became seen as the accel-
erators of cell growth and division, whereas tumor suppressor genes were perceived as
the corresponding brakes. It was here at Cold Spring Harbor that these two means of
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cancer causation first effectively came together. In our new Sambrook Lab, Ed Harlow
made his seminal 1988 finding that the E1A oncogene of adenoviruses acted by neutral-
izing the key cellular tumor suppressor Rb protein. Through this watershed observation,
we at last knew how to go after the molecular mechanisms by which the various forms of
human cancer arise, either by oncogene acquisitions or by tumor suppressor gene loss-
es. Immediately, we foresaw a rapidly escalating pace of cancer research, since the num-
ber of human oncogenes and human tumor suppressor genes was likely to be large.
In our current search for the vast multiplicity of genetic changes that underlie human
cancer, the social fabric under which we work bears little relation to the cowboy days of
the 1970s. Virtually all of our research objectives have human implications, and we must
increasingly face the fact that our scientific competitors are now located in commercially
based, as well as academic, institutions. In a real sense we should be happy, because
this now means that those financial types who control big sums of money believe that
soon there will be real payoffs from our cancer research. On their horizons are scores of
new diagnostic tests as well as the successful utilization of cancer-gene-derived molec-
ular targets for the generation of powerful new classes of anti-cancer drugs.
Now that commercial, as well as academic, gold lies within our potential grasp, past
ways to achieve socially acceptable balances between competition and cooperation
among scientists will be even harder to maintain. Our scientists will see the need not only
to publish first, but also to be the first to file concomitant patent applications. In the past,
scientific civility was greatly helped by individuals deciding to publish simultaneously
even though one group might have been one to two months ahead in reaching the main
conclusion. Unfortunately, patent law does not forgive being a few days late and the win-
ner gets all.
For the foreseeable future, research sweat, as opposed to research fun, will thus
increasingly dominate the day-to-day atmosphere of cancer research. We should not,
however, moan too long for our past days of academic purity. Instead, we must accept
our frenzied states as manifestations of our increasing scientific optimism that the splen-
did science of the past 30 years will soon lead to reduced feelings of dread when the
physician's verdict is "cancer." But for us as academics to continue as vital forces in can-
cer research, we will necessarily have to act more and more like our more commercial
compatriots. Expensive new genome technologies, for example, must not remain restrict-
ed to big pharmaceutical laboratories or well-capitalized biotech firms. Instead, they
must become available to the academic community. Luckily, this is a year when federal
funding for cancer research may greatly increase. If it is deployed well, academics such
as ourselves can continue to be major players in turning cancer knowledge into cancer
cures.
In so working to remain an important player in cancer research, we must also see to
it that Cold Spring Harbor Laboratory retains its cherished role in the broader world of
biology and medicine. We must remain an institution primarily focused on the generation
and dissemination of ideas as opposed to their commercial exploitation. One way to so
continue is to strengthen even further our advanced teaching programs. Now we offer 25
courses in contrast to just one in 1945, when Max DelbrOck taught the first phage course.
But to keep our courses first-rate, we must constantly improve their laboratory facilities
and equipment. Now, for example, only seven years after completion of our Beckman
Lab, its teaching facilities are inadequate for teaching the new nerve cell imaging tech-
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niques. So we have just started construction of our new Edwin and Nancy Marks Imaging
Building, with its completion anticipated as the new millennium starts.
We will always need warm and wise friends, like the Marks, who come to our aid
when we need to move forward quickly. Manny DelbrOck long helped us in this way. Soon
after I became Director, she provided the funds that allowed us to transform the then-
derelict Wawepex Laboratory into new dormitory space. In this way we were able to
house the students for the new neurobiology courses to be given in newly renovated
teaching space in McClintock Laboratory. Manny's help also made possible the new ten-
nis courts on Bungtown Road on the way to the sand spit. Sadly, upon her death early
this January, we have lost our last close connection to the first heroic period of phage
research. Now, however, we should not weep too long for Manny but instead rejoice that
she was so long a part of our lives. In the same way, we must not dwell too much on our
loss of the former coziness of those Cold Spring Harbor summers that witnessed the
coming of the phage world.
There will always exist those individuals who, like the early pioneers of the phage
world or tumor virology, feel happiest in moving upon uncharted water. Today, the way
precise information is stored in and retrieved from the human brain appears equally, if not
more, mysterious than the necessarily fuzzy way I perceived the storing of genetic infor-
mation during my first Cold Spring Harbor experience some 50 years ago. Small groups
of young scientists, attracted by the prospect of not following their elders' paths, are
bound to assemble again to meet this challenge.
As long as we remain a home for tough risk-takers, not caring too much whether or
not there might be gunslingers among them, we should not worry too much about how
the start of the forthcoming millennium will find us.
March 1998 James D. Watson
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Manny and Max, 1948
Remembering Manny
Manny and Salvador Luria, 1953
Manny personified joie de vivre-the name of her game was Fun. Having relinquished per-
sonal ambition at an early stage, she was free to pursue whatever interest struck her fancy.
And those interests were many, including especially the zoo of characters who passed
through Max's lab and visited Caltech over the years. Manny loved stories about those peo-
ple, of whom I was privileged to be one. "As tired as Seymour at the Grand Canyon" became
a standard of fatigue which Manny and Max took glee in applying to novice campers whom
they had introduced to the first camping trip of their lives. No such trip was complete without
some kind of disaster to recount, later, with enjoyment. Herman Kalckar's broken leg, after he
had deprecated the crumbly desert boulders as "Hollywood rocks," was a trophy. My confi-
dence in rock climbing was shaken when, while dangling helplessly in space at the end of a
rope held by Jean Weigle, I looked down and saw the DelbrOcks slapping their sides with
laughter. Practical jokes were almost de rigeur. But make no mistake: This mischief was com-
bined with unsurpassed warmth, hospitality, generosity and concern. To know Manny and
Max was to love and admire them both.
Seymour Benzer
Niccolo Visconti and Manny, 1953
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Manny and Jim Watson, 1953
Delbriick (1917-1998)
From Max we learned how to do science; from Manny, how to live. As a Californian raised in
the Levant, Manny had an aura of cosmopolitan glamour about her. With her quick mind,
wide cultural interests, and mental rigor, on the one hand, and her casual charm, good will,
and sense of humor, on the other, she was a rare combination of the best personality traits
that the Old and New Worlds have to offer. She made the Delbruck home a kind of intellectual
salon, where we could drop in on her and Max at almost any time, and socialize with them
and with other drop-ins, warming our hearts in the enchanting ambience generated by
Manny's wonderful qualities. The venue of Manny's salon was not restricted to her home. On
many a weekend, we sat around a campfire somewhere in the California desert, on one of the
outings that she had organized. The visits to the DelbrUcks' house and the desert outings
provided for us many of the most precious memories of the formative years we spent at
Caltech, with Manny at their focus.
Manny and friends barbecuing in front of
Page Motel, 1975
Gunther Stent
Agnes Ullmann, Manny, and Peggy Lieb
501h Anniversary of Phage Meeting, 1995
Manny lived a life that I loved. She was a person in her own right, a partner, not simply "Max's
wife." Her ideas and example challenged and expanded the conventions I had been exposed
to previously. It was in 1952, when I was newly married, and new to the culture of international
science, that Manny and Max welcomed Dave and me into their circle, where plots and activi-
ties were hatched spontaneously and carried on with childish enthusiasm. Being part of
Manny's life gave me a sense, an experience, of a life that flowed from people to culture to
play to science to nature to civic life-all on the lubricants of good food, unpretentious spon-
taneity, and seemingly effortless immersion in the flow of life. Manny's gift for friendship was
extraordinary. Although she had friends all over the world, she always remembered her partic-
ular connection with each, picking up the thread from their last time together. And at her
home, friends came, friends stayed, friends left, and returned...
Anne Stadler
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DIRECTOR'S
REPORT
At the time of this writing, we are in the midst of celebrating several significant anniver-
saries for Jim Watson. It was 50 years ago that Jim, as a young graduate student working
with Salvador Luria, first arrived at Cold Spring Harbor to spend the summer with that
year's phage group. Twenty years later, in 1968, Jim, returned to the Laboratory as its new
Director and began the remarkable revitalization of the Laboratory's facilities and research
activities. By choosing to study the cancer-forming DNA tumor viruses, simian virus 40
(SV40) and adenovirus, Jim placed the Laboratory and its scientists in an excellent posi-
tion to make seminal contributions to cancer research and to fundamental aspects of
eukaryotic cell and molecular biology. Jim arrived here with his new bride, Liz, and togeth-
er they have perfected one of the most attractive centers for research in the world, com-
bining historic and architectural taste with an unparalleled love for the beauty and history
of Cold Spring Harbor and its environs. All of us owe a great debt to both Jim and Liz, and
we are happy that they continue to devote much of their time to the continued success of
the Laboratory.
Science has changed profoundly in the past 30 years. The year 1997 marks the 25th
anniversary of the publication by Paul Berg and his colleagues of the first joining togeth-
er of DNAs from different sources; they combined SV40 DNA with either bacteriophage
DNA or Escherichia coli DNA. The next year, Stanley Cohen, Herb Boyer, and their col-
leagues reported the first functional recombinant DNA. Twenty years ago, Fred Sanger
and his colleagues reported the sequence of the complete genome of bacteriophage
(0(174 (5375 nucleotides), and they published the new chain-terminating method for
sequencing DNA. Today, this technique is the basis for sequencing the entire genome of
many organisms, including the human genome, which consists of about 3 billion base
pairs. These accomplishments, together with the innovative use of restriction endonucle-
ases by Kathleen Danna and Dan Nathans to map the SV40 genome in 1971, heralded a
new age in biology. Soon, Cold Spring Harbor Laboratory scientists, quick to master the
new science, made important advances that contributed to the emerging recombinant
DNA age. Biologists were no longer limited by techniques, but only by their imagination.
One of the significant developments to come soon thereafter was the establishment
of the first biotechnology companies, which used the new biology to produce contempo-
rary pharmaceutical products and reagents more effectively. The biotech companies, with
their significant resources provided by venture capital, would soon produce recombinant
human growth hormone, recombinant insulin, blood cell growth factors, and other impor-
tant new drugs. Company scientists realized that they had to be in the business of basic
research to be the first to discover new drug targets and proteins. The initial successes of
the biotech companies attracted collaborations with increasing numbers of academic
researchers because their biotech colleagues often had equipment and facilities that
were the envy of the academic community. Collaborations to sequence proteins and clone
cDNAs that encoded important cell surface receptors and other signaling molecules
became the norm. Often, the biotech companies won the race with academic laboratories
to obtain key genes. But even with all its resources, the biotech industry did not surpass
the quality of research in the universities and institutions like our own, for it was not always
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obvious where the next important and useful discovery would emerge. With few excep-
tions, the great discoveries in biology during the past 20 years emerged from academic
laboratories, including Cold Spring Harbor Laboratory.
The relationship between academic research and biotech research has evolved over
the years, and today, a happy synergy exists that greatly benefits society as a whole.
Publicly funded academic research is still governed by peer review, is published for all
to see, and is focused primarily on the issues that society and individual scientists deem
important. A large percentage of public funds continue to support fundamental, rather
than directed, discovery. For example, many of the dramatic advances in the develop-
ment of combinations of drugs against HIV relied on basic studies of many retroviruses
and their interactions with the cell. Techniques and facilities for protein crystallography
that ultimately played an important role in the development of the HIV pharmaceuticals
were developed to understand the structure of proteins that had little if any medical or
commercial value. And without recombinant DNA technology, it would have been far
more difficult to develop strategies to fight the AIDS epidemic. There remains much to do
in HIV research, but it is already clear that because of the vigorous support of basic aca-
demic research, scientists had the tools to deal with HIV when it surfaced. Basic research
had provided an infrastructure on which to build, and although it was often frustrating that
progress was not faster, the pace of dealing with the disease was relatively rapid when
compared to epidemics of the past.
Biotechnology companies now play an important role in the larger biomedical research
enterprise. In addition to their contributions to basic and applied research programs, they
have become a very effective conduit for translating the basic research discoveries made
in academic laboratories into drug discovery and, ultimately, clinical uses. In the past,
basic research discoveries that might have languished for many years are now rapidly
picked up by the biotech industry and incorporated into their own research programs.
Many biotech companies, in turn, seek collaborations with the much larger pharma-
ceutical companies that have the financial and technical resources to develop promising
leads into the clinic or to the market. In a sense, the pharmaceutical industry can choose
from the large number of projects put forward by the smaller biotech companies and
have greater confidence that a project may go all the way to the clinic. Collaborations
between the biotech and pharmaceutical companies are important because the cost of
developing a new drug that will become an FDA-approved pharmaceutical is extraordi-
narily high, often running into the hundreds of millions of dollars. As a result of the acad-
emic-biotech-pharmaceutical collaborations, completely new approaches for the treat-
ment of cancer are entering clinical trials at unprecedented rates, with real expectations
that significant inroads to treating the disease may occur in the not too distant future.
Collaborations between academic institutions such as Cold Spring Harbor
Laboratory and the biotech industry can also fulfill another need that large pharmaceuti-
cal companies may not address. Many diseases, although devastating to patients and
their families, are not economically feasible for large pharmaceutical companies to pur-
sue, principally because the market will not be large enough to justify the expense.
Biotech companies, particularly the newer enterprises, are more likely to pursue these
targets because they offer an opportunity for a biotech company to achieve its first inde-
pendent clinical success. In some cases, where the clinical need is demonstrable but the
economic incentive is absent, public funds from the National Institutes of Health and
other government agencies might be money well spent. Thus, the relationship between
the biotech industry and public funding might come full circle to yield clinical success.
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The number of biotechnology companies continues to grow at a rapid rate, and I
suspect that we are at the beginning of a significant expansion and further evolution of
this industry and its relationship to academic labs. Public funding for science is increas-
ing because every informed person realizes that extraordinary research opportunities
now exist. We also know from experience that the academic community is best posi-
tioned to make the important advances that are unexpected, primarily because the
goals of basic research are very different from the research conducted in industry. At
the same time, however, industry cannot afford to ignore these basic discoveries and
has equipped itself with the technologies to rapidly take advantage of new develop-
ments. Today, the biotech and pharmaceutical industry laboratories are much more well
equipped for modern biology than are the academic laboratories; they cannot afford not
to be.
The cost of modern biological research in academic laboratories is increasing with the
complexity of the tasks. Unfortunately, public funding for equipping academic laborato-
ries has not kept pace with the cost of the equipment. It is common these days to spend
many hundreds of thousands of dollars on a single item of equipment for a single investi-
gator, and federal funds are not easy to obtain in a timely and efficient manner, if they can
be obtained at all. To ensure that the academic research laboratories do not fall behind
the well-equipped industrial laboratories, the National Institutes of Health and the National
Science Foundation should establish better mechanisms for providing infrastructure sup-
port. It would be very dangerous to create a wide gulf between the academic labs and
the industrial labs because of the lack of equipment support in academia. Such a gap
would eventually lead to a weakening of the process of innovative discovery that is the
hallmark of academic research. One kind of funding mechanism for improved infrastruc-
ture might be to provide competitive, peer-reviewed, multi-year block grants to institutions
that would then have access to these funds immediately. Although Cold Spring Harbor
Laboratory spends a considerable amount of its resources obtained through fund-raising
to equip its labs, we cannot keep pace with the constant demand for new equipment. This
is, in part, because the equipment is more expensive, and also because the techniques
in modern biology are more complex than they were 20-30 years ago.
The existing relationship between biotechnology and academia is a healthy one for
society as a whole, as long as the potential conflicts of interest are declared and under-
stood by the public, research institutions, and scientists. The vast majority of such inter-
actions, and certainly all of those occurring at Cold Spring Harbor Laboratory, benefit
without compromising the goals of publicly funded research. We have in place a very
effective subcommittee of the Board of Trustees that oversees interactions with private
companies and enforces strict guidelines on the nature of the collaborations.
This year saw the completion of an agreement that allows Westvaco, Novatis, and
Monsanto Corporations to provide infrastructure support for our research in plant biolo-
gy and to help us develop a database of gene-trap and enhancer-trap lines of
Arabidopsis, one of our favorite plants for biological investigation. Without the support of
these forward-thinking companies, we would not have the resources to pursue this
research, which will ultimately benefit the entire plant biology community. This year also
saw the completion of agreements with Hoffmann La-Roche Inc., OSIP (formerly
Oncogene Sciences), and Helicon Corporation to study learning and memory and with
Tularik Inc. to identify new cancer gene loci. These arrangements will enable our scien-
tists to pursue their research projects and have access to resources that otherwise would
not have been available.
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Because future interactions between biotech and academic laboratories will be an
integral part of the larger scientific picture, we have taken steps to help establish a
Biotech Park on Long Island near the Laboratory. Centers of modern biological discov-
ery such as Cold Spring Harbor Laboratory often have attracted biotech companies to
locate nearby because the proximity fosters scientific interactions and aids in recruiting
scientists to their companies. The Laboratory has been involved in transferring technolo-
gy to many start-up biotech companies, but most of these are located in places other
than Long Island. Three of these companies, however, exist nearby and we are keen to
see that they remain. To facilitate this, the Laboratory sought advice and help from New
York State, and we were pleased to learn recently that Governor Pataki and the State
Legislature will support the establishment of a Biotech Park adjacent to the nearby State
University of New York, Farmingdale campus, a short distance from the Laboratory.
Although the Biotech Park will be a separate entity from Cold Spring Harbor Laboratory,
we will help guide the facility to become a nationally recognized center of excellence in
biotechnology. It is hoped that a nearby Biotech Park will attract many outstanding com-
panies that will create a broader scientific environment on Long Island and at the same
time benefit the area economically. John Cleary did much to guide us in our support of
this important project; for this, and for many other matters on which he has provided
sound counsel, we are very grateful.
Our own growing technology needs require that we provide an off-grounds facility to
accommodate the increased DNA sequencing and gene-based research that is such an
essential component of modern biological science. As the Laboratory expands its
genome sequencing and related gene technologies, we need space that would best be
provided by a large building located off campus. In addition, the success of our neuro-
biology research program has created new demands for mouse behavior facilities that
cannot be incorporated into our existing infrastructure. As part of a solution for these
urgent needs, we expect in the near future to acquire a sizable building that is located a
short distance from the Laboratory, on the way to the Biotech Park. There, we will estab-
lish a state-of-the-art DNA technology center large enough to accommodate the expand-
ed genome projects that we began 2 years ago, as well as behavior rooms that will do
justice to the exciting neurobiology research.
Another development this year that should broaden the intellectual community on
Long Island and take the Laboratory to new heights was the decision this year by our
Board of Trustees to explore the possibilities of establishing a Graduate School of
Biological Sciences. We already have a very expansive education program at the
Laboratory, including the elementary and high school programs at the DNA Learning
Center, a sizable contingent of graduate students from the State University of New York
(SUNY) at Stony Brook, and our advanced courses and meetings program that constitute
postgraduate training for scientists. We see the possibility of starting our own graduate
school, while maintaining the very valuable programs and interactions we have with SUNY
Stony Brook, as very exciting. It is particularly pleasing that Winship Herr is developing
the new graduate school that will take Cold Spring Harbor Laboratory into a new era.
As the pace of biological discovery evolves, so too, does the Laboratory. Any
research institution must adapt to the sometimes dramatic changes in modern biological
research. The projects and thinking I have outlined are all essential for our research insti-
tution to remain dynamic. At the same time, we must make sure that our scientists are
supported to the fullest extent possible and that the research remains of the highest pos-
sible quality, in the new academic style.
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HIGHLIGHTS OF THE YEAR
Research Highlights
Cancer Genetics and Cell Division
In March, Cold Spring Harbor Laboratory (CSHL) scientists Michael Wig ler and Clifford
Yen with colleague Ramon Parsons, M.D., Ph.D., of the Herbert Irving Comprehensive
Cancer Center and Columbia-Presbyterian Medical Center, announced the discovery of
a tumor suppressor gene, which they named PTEN. The gene appears to be altered in a
large percentage of brain, breast, and prostate cancers, and evidence suggests that loss
of PTEN affects the way a benign tumor becomes malignant. Unlike mutations of genes
such as hMSH2 and BRCA1, which were found in people who have hereditary predispo-
sitions to cancer, PTEN was discovered by analyzing the more common sporadic can-
cers. More than 80% of all cases of cancer are sporadic, meaning that they have no obvi-
ous hereditary contribution.
PTEN received its name because of its similarity to phosphatases and tensin. The
M. Wig ler
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similarity between PTEN and protein phosphatases, which remove phosphates
from proteins, is significant because many oncogenes-genes that help to trans-
form normal cells into cancer cells-encode tyrosine kinases, which add phos-
phates to proteins. Tensin is part of a complex of proteins that sits below the cell
surface and controls cell shape. Thus, PTEN may also be involved in the spread
of tumors, by localizing to the cell surface and removing phosphates from key sig-
naling proteins. In a productive collaboration between the Wig ler laboratory and
Nicholas Tonks' laboratory at CSHL, the two groups quickly confirmed that PTEN
is a phosphatase and have identified proteins with which it interacts. These stud-
ies should point to the pathway in which PTEN functions in normal cells and which
is altered in tumor cells.
Representational difference analysis (RDA), an advanced genetic technology
developed by Mike and Nikolai Lisitsyn, then at CSHL, played a key role in the identifi-
cation of a PTEN tumor suppressor gene. RDA is a procedure used to analyze the differ-
ences between two genomes. (A genome is the entire DNA sequence of an organism.)
By comparing DNA from diseased and normal cells from the same person, scientists can
use RDA to identify DNA sequences that differ between the cancer cells and normal
cells. In the case of PTEN, RDA was used to find unique DNA sequences present in nor-
mal tissue but missing in breast cancer. To date, the Wig ler lab has located about a
dozen genetic loci potentially involved in breast cancer. Each of these discoveries rep-
resents a vital step forward in the path to earlier diagnosis and improved treatment for
breast cancer patients, and it illustrates the growing realization of the genetic complexi-
ty of cancer.
In 1994, to further utilize RDA in the search for cancer-related genes, the Laboratory
and Mike formed Amp licon Corporation. In October 1997, the Laboratory announced the
acquisition of Amplicon by biotech leader Tularik, Inc. Tularik is the largest privately held
biotechnology company in the nation, and its scientists are enthusiastic about continuing
collaborations with CSHL scientists while using RDA in an extensive cancer research pro-
gram. Although Tularik, Inc. is located in California, the oncology division of the compa-
ny will continue to operate on Long Island for at least 5 years and will continue to collab-
orate with CSHL scientists.
There was good news and bad news from Carol Greider's lab in 1997: The good
news was the report of a line of telomerase knock-out mice. The bad news was that Carol
left Cold Spring Harbor after 9 years to accept a position as Associate Professor
in the Department of Molecular Biology and Genetics at Johns Hopkins University
School of medicine in Baltimore, Maryland, to follow her historian husband to his
new faculty position at George Washington University.
In October, Carol's group published a report about mice that lack telomerase,
an enzyme that she discovered in 1985 and has continued to study. Telomerase
is necessary for maintaining chromosome integrity. Several studies have sug-
gested that telomerase also plays a role in cancer and cell senescence. The ends
of chromosomes, called telomeres, shorten each time a cell divides. It is thought
that when telomeres reach a critically short length, the cell division cycle arrests
and cells enter into a senescent state after which they never divide again.
Telomerase appears to sustain telomeres against this shortening.
In collaboration with Ron DePinho's lab at Albert Einstein College of Medicine,
Carol's group bred a line of mice that lacked the telomerase enzyme. The results showed
that mice can survive for six generations without telomerase. The studies also proved
telomerase's role in chromosome stability; mice that lacked telomerase showed telomere
shortening and loss of telomere function, and they eventually developed chromosomal
abnormalities. After five or six generations, telomere loss in mice leads to sterility and
loss of cell viability in certain highly proliferative tissues. The work confirms the suspect-
ed role for this important enzyme in cell proliferation and demonstrates that when telom-
eres reach a critically short length, cell and tissue viability are progressively lost.
Interestingly, cells that lacked telomerase could still form tumors, demonstrating that
telomerase is not essential for tumor formation in mice. As predicted, however, recent
results indicate that the rate of tumor formation is lower in mice that lack telomerase.
Thus, although telomerase is not essential for the development of cancer, it may play an
important role in tumor formation.
Scott Lowe and David Beach made a surprising new discovery about the transfor-
mation of normal cells into cancer cells. Usually, most human cells undergo senescence,
D. Beach, S. Lowe
C. Greider
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or permanent cell cycle arrest, after a restricted number of cell divisions. This, in effect,
limits the cells' life span. Cancer occurs when cells continue dividing beyond the normal
limit or fail to die when they should. In 1981, scientists, including Mike Wig ler at CSHL,
discovered that a gene called ras was involved in some human cancers. This was the first
discovery of a human oncogene that was derived from a tumor. In 1983, Earl Ruley-then
at CSHL, now at Vanderbilt University School of Medicine-showed that ras acts in con-
cert with other oncogenes to cause cancer. It was determined that most of these coop-
erative oncogenes can independently extend the life span of-or even immortalize-
cells. Recently, Scott and David reported the surprising observation that when the onco-
genic form of ras is overexpressed in normal cells, it immediately induces the same sort
of cell senescence that occurs during cell aging. Two other genes, p16 and p53, both
extensively studied at CSHL and elsewhere, are necessary for this type of cell cycle
arrest. When p53 or p16 are absent from the cell, ras now stimulates uncontrolled cell
division, rather than cell division arrest. This research provides important information
about the multistep nature of cancer and suggests that, in the right context, it may be pos-
sible to exploit oncogenes to reverse tumor cell growth.
Neuroscience
In previous reports, CSHL neurobiologist Hollis Cline described the role of the enzyme
CaMKII in neuronal development. In 1997, her lab built on its previous discoveries-that
expression of CaMKII is involved with neuronal maturation and with the stabilization of
synapses, the intricate connections between neurons. Evidence from the Cline lab
showed that CaMKII coordinates the development of the physical structure of neurons
with the development of their synaptic connections. The normal, gradual increase of
CaMKII expression during early brain development correlates with slowed growth rate
and increased stabilization of dendrites-the branches through which neurons receive
their electrochemical signals. These changes signify neuronal maturity. Holly therefore
hypothesized that CaMKII, which is regulated by calcium activity, may represent an activ-
ity-dependent mediator of neuronal maturation. Her lab tested this theory by forcing the
expression of CaMKII in immature neurons and obtained the exciting result that indeed
CaMKII expression suppressed the development of additional, longer dendrites and
prompted the stabilization of the existing branches. Thus, it promoted the maturation of
neurons during brain development.
Conversely, Holly and research investigator El ly Nedivi showed that a novel protein,
CPG15, increases the number of dendritic branches in neurons. El ly isolated the gene for
CPG15, which belongs to a group of genes whose expression is elevated by neuronal
activity. In addition to inducing neuronal branching, they found that CPG15 also controls
the growth of neighboring neurons through an intercellular signaling mechanism. These
studies suggest that CPG15 is capable of translating local neuronal activity into structur-
al changes in the brain. This would represent the discovery of a new class of neuronal
activity regulated growth factors.
Alcino Silva's lab continues to study the molecular and behavioral functions involved
in learning and memory in mice. In 1997, Alcino tied previous results together through an
experiment with collaborator Howard Eichenbaum of Boston University in which he mon-
itored the activity of specific cells in the hippocampus in the brains of living, functioning
mice.
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Alcino has been studying "place cells"-specific, identifiable brain cells that fire only
when an animal is in a precise place in its environment, a place that the animal's brain
recognizes. These place cells are representative of the "place circuits" that are stimulat-
ed as an animal becomes acquainted with a place or area. The establishment of such a
series of circuits is called spatial orientation or learning; the mouse recognizes familiar
things as it travels about. Alcino tested the function of place cells in two types of mutant
mice, each representing a component in learning and memory that Alcino has been
studying-the aCaMKII protein and a CREB protein. Alcino created genetically modified
mice that carry a point mutation in a single amino acid of the aCaMKII protein. Instead of
firing at specific times like wild-type cells, place cells in animals with this aCaMKII muta-
tion fire randomly when they are exposed to familiar and unfamiliar places, which indi-
cates a lack of learning. Mice containing decreased levels of CREB also display this
reduced learning, albeit to a lesser degree. Behavioral studies corroborate this finding,
as the same mutant mice demonstrate a marked lack of spatial orientation.
In a second set of experiments, Alcino's lab successfully reversed the learning deficit
in mice with the NF1 mutation characteristic of neurofibromatosis type 1. These mice
have proven to be a valuable model for the study of this disease. He has confirmed a
mechanism that is defective in NF1 mice and has restored the ability of mice to learn by
breeding in a second mutation that counteracts the effects of the NF1 mutation. These
behavioral studies may suggest targets for the search for treatments of learning defi-
ciencies in children affected by mutations in the neurofibromatosis type 1 gene.
HIV Pathogenesis
Jacek Skowronski's studies of HIV pathogenesis have continued to produce new under-
standing of how the deadly virus commandeers its host cells. Jacek's laboratory has
used genetic techniques to dissect the functions of the Nef protein, the product of
the viral gene nef that is found in human and simian immunodeficiency viruses
(HIV and SIV). Nef is a regulatory protein that is important for efficient viral repli-
cation and essential for the development of AIDS in humans and primates. HIVs
lacking Nef do not cause AIDS, and thus inhibiting the functions of this protein is
a key goal for controlling HIV pathogenesis.
Jacek has shown that Nef possesses multiple independent functions. One
role is to control levels of the CD4 protein on the cell surface of CD4' T lympho-
cytes. CD4 is one component of the cell surface receptor for HIV. A second role
is to control the levels of cell surface MHC molecules, proteins that play a key role
in immune recognition of virus-infected cells. The genetic dissection of the multi-
ple functions of Nef provides a basis for experiments directed toward under-
standing in detail the molecular mechanisms by which Nef affects the develop-
ment of AIDS, and such experiments are currently under way in Jacek's laboratory. In
addition, Jacek and his colleagues are collaborating with scientists who study SIV patho-
genesis using animal models of AIDS with the goal of developing an HIV vaccine.
Cell Death during Development and Cancer Progression
In the study of programmed cell death, or apoptosis, Michael Hengartner's lab has made
significant progress in identifying the genes involved and their roles. Working with post-
J. Skowronski
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doctoral researcher Mona Spector, Michael has continued to gain new information about
this process by studying the tiny worm Caenorhabditis elegans, an ideal model organism
for genetics research. Previously, three genes were known to be essential for properly
controlled programmed cell death to take place in C. elegans, and two of these genes
were known to have counterparts, or homologs, in mammals. Michael and others had
shown that CED-3 and CED-4 work in concert to kill unneeded cells, a necessary process
cells during normal development, and that CED-9 suppresses this action. If the worm car-
ries a mutation in either CED-3 or CED-4, then this necessary mechanism to rid the body
of unwanted cells never takes place, resulting in excess cells in the adult worm. In con-
trast, if there is a mutation in CED-9, programmed cell death is not controlled and cells
die at an abnormally high rate.
Recently, Michael and Mona identified a previously unknown physical interaction
between the suppressor of cell death, CED-9, and the activator of cell death, CED-4.
They discovered that if the interaction between the two proteins is disrupted, there is a
failure to control apoptosis. These and other results suggest that CED-9 works by bind-
ing to CED-4 and regulating its activity. The new information begins to suggest how CED-
3, 4, and 9 interact to control the process of programmed cell death.
Many drugs for treating cancer kill tumor cells by inducing apoptosis, or programmed
cell death, but many tumor cells have mutations that produce resistance to chemothera-
py. Yuri Lazebnik and Scott Lowe have been studying the process of cell death in normal
and tumor cells and they reported this year that unexpectedly, extracts from drug-resis-
tant tumor cells contain the cell death machinery and the ability to trigger this process.
Interestingly, the tumor cells contain an activity that can induce programmed cell death
in normal cells, a factor that Yuri and Scott call oncogene-generated activity (OGA). They
are pursuing the nature of OGA with the hope that they might be able to stimulate its func-
tion in tumor cells that have become resistant to chemotherapy.
Chromosome Structure
In another vital area of our research program, Tatsuya Hirano has made significant strides
in his studies of chromosome structure and function. DNA in chromosomes exists in a
coiled state usually stretched out like a fully extended Slinkey
(the popular children's toy) within the cell nucleus. Immediately
before cell division, the DNA molecules must condense and be
packaged into compact rod-shaped structures, like the Slinkey
retracted into its tightly coiled shape, so that the duplicated chro-
mosomes can be divided evenly into the daughter cells. Unlike
the Slinkey, however, the packaging of DNA into chromosomes is
not a spontaneous process because it requires the assistance of
"packaging" proteins. Tatsuya studies the mechanisms of chro-
mosome packaging (or condensation) via a biochemical
approach using frog egg extracts and was the first to identify
such a "packaging" protein, named condensin (for condensation
protein).
In 1997, Tatsuya and his colleagues purified and characterized condensin. They
found that condensin contains several highly conserved proteins that induce, in a test
tube, remarkable structural changes in DNA called positive supercoiling, which is corn-
T. Hirano
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parable to the retraction and tight coiling of DNA necessary for cell division. This is the
first reported evidence for how this class of proteins actually works. In addition to the
condensin protein complex, Tatsuya has shown that another protein complex containing
condensin-related proteins exists in cells and is involved in chromosome cohesion, the
process by which the two duplicated DNA molecules remain bound to each other prior
to their condensation and separation at mitosis. Further understanding of the proteins'
control of higher-order chromosome structure will likely reveal more surprises.
Plant Biology
In plant genetics, the Laboratory's part of the global Arabidopsis Sequencing Project
continues to go well. Richard McCombie's sequencing expertise and Rob Martienssen's
work with the gene traps that he developed with Venkatesan Sundaresan have proved
an invaluable contribution not only to the sequencing effort, but also to the determination
of gene function. Rob continues to do other plant genetic research as well, and he
recently made an important discovery relating to protein transport. Protein translocation
is a term used to describe the process of moving proteins across cell membranes. Rob's
lab identified a gene, hcf106, which produces a membrane protein that is vital to one of
three known pathways for protein translocation in maize. Two things about this discovery
were especially exciting: (1) This was the first component of the pathway to be identified
and (2) the pathway in which this protein is involved was thought to be unique to high-
er-plant chloroplasts. However, after Rob and his lab cloned and characterized the
hcf106 gene, they found in database searches that homologous genes were present in
bacterial This interesting discovery was made possible by the worldwide bacterial
genome sequencing projects and the accessibility of the data in public databases.
Bioinformatics
The Laboratory's bioinformatics program-the use of computers to analyze, store, and
distribute scientific data, a kind of scientific information technology-has continued to
evolve. Bioinformatics scientist Michael Zhang has been at CSHL since 1991 and stud-
ies DNA sequence pattern recognition. Recently, he was joined by three new computa-
tional biologists: Andy Neuwald, Andy Reiner, and Lincoln Stein. Andy Neuwald brings
expertise in understanding the relationship between protein sequence and structure.
Andy Reiner studies mechanisms for data storage and management, and Lincoln Stein
is an expert in genome research and sequencing. In addition to their own research, all
are providing valuable contributions to Dick McCombie's DNA sequencing efforts. Tom
Marr, a member of the Laboratory's bioinformatics team since 1989, spent 1997 in tran-
sition between the Laboratory and Genomica Corporation in Boulder, Colorado. Tom is
still involved in research projects here at Cold Spring Harbor, but he is now president and
C.E.O. of Genomica.
The goal of the Laboratory's bioinformatics program is to develop and use comput-
erized methods to study biology. As genomic research advances, so too does the need
for efficient analysis, reliable storage, and accessibility of data. Genome scientists make
up one of the most open group of research scientists today, posting programs and results
on searchable Internet sites as soon as they are assembled. The bioinformatics group at
the Laboratory will continue to work on original research and development projects and
to collaborate with other Cold Spring Harbor scientists on a wide range of projects.
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Symposium LXII: Pattern Formation during Development
One of the great scientific accomplishments of the past decade or so is the recognition
that the molecular and cellular mechanisms that guide the patterning of tissues and
organs during embryonic development are remarkably similar among different species.
What works for flies and frogs also serves humans very well as embryos acquire their
form and identity. To celebrate these marvelous discoveries, the 62nd CSH Symposium
focused on pattern formation during development, with a particular emphasis on evolu-
tionarily conserved mechanisms and molecules.
When the CSH Symposium was initiated in 1933, the length of each meeting was five
summer weeks, and the length of presentations was unlimited. In 1941, director Milislav
Demerec saw fit to reduce the duration of the meeting to two weeks; in 1948, he reduced
it to eight days. The length of the symposium remained at a week and a day for almost
half a century, but in today's fast-paced world, with many two-career families, it has
become increasingly difficult for most scientists to be away from home for more than a
week. After much careful consideration, the length of the Symposium was reduced to five
days in 1997.
The 62nd CSH Symposium, Pattern Formation during Development, took place from
May 28 to June 2. On Sunday evening, June 1, Sean Carroll, Professor of Molecular
Biology, Genetics and Medical Genetics at the University of Wisconsin at Madison, pre-
sented the annual Dorcas Cummings lecture for meeting participants and the public. In
it, Dr. Carroll presented an audiovisual short course in the development of body parts
that was extremely interesting to both the lay and scientific audiences.
20 Years of Splicing
On August 23, during the Eukaryotic mRNA Processing meeting, the Laboratory held a
special historic session and champagne toast to honor the 20th anniversary of the dis-
Twenty years of splicing: The Toast
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covery of RNA splicing and split genes. In 1993, the Nobel Prize for Medicine or
Physiology was awarded to Rich Roberts and Phil Sharp for their contributions to the dis-
covery of split genes. The discovery-that some regions of a gene, the exons, are tran-
scribed into messenger RNA (mRNA), whereas other regions, the introns, are spliced
out-led to the creation of a new field of science, known as RNA splicing.
Phil Sharp and his colleagues in the Nobel Prize-winning work, Sue Berget and
Claire Moore, were on hand for the celebration. Thoughtful reflection by James Watson
familiarized the largely younger audience with the Nobel selection process, and remarks
from Phil and Sue provided a candid perspective on winning a Nobel and the research
that contributes to one.
National Medal of Science
On April 30, 1997, President Bill Clinton announced that Jim Watson had been awarded
the National Medal of Science. The presidential honor, administered by the National
Science Foundation, is this nation's highest scientific honor. The award was made in
recognition of Jim's co-discovery of the structure of DNA in 1953 and for his pioneering
role in the establishment of the Human Genome Project, the worldwide effort to map and
sequence the human genome. Jim was appointed Associate Director for Human
Genome Research of the National Institutes of Health in 1988, and in 1989 he became
the first Director of the National Center for Human Genome Research, a position he held
until 1992. On December 16, 1997, he traveled to Washington, DC, to accept the medal
from President Clinton.
1997 National Medal of Science Award Ceremony
James D. Watson and President Clinton
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Executive's Seminar meeting at Banbury
Banbury Conference Center
Executives' Seminar Weekend at Banbury Center
Our close relationship with J.P. Morgan and Co., Inc. continues and has led to their sup-
port of the annual Executives' Seminar meeting, Banbury Center's equivalent of the CSH
Symposium. To be sure, the scales are different-the Banbury Center is about one-tenth
the size of Grace Auditorium-but both meetings, in their different ways, are unique occa-
sions for reviewing the most exciting and interesting biological research. This year, the
topic of the Executives' Seminar was Genetic Engineering. The coverage was broad.
Stanley Cohen (of the famous Cohen-Boyer recombinant DNA discovery) discussed the
origins of his work, Jim Wells described the genetic engineering of molecules, Shirley
Tilghman and Richard Michelmore discussed the genetic engineering of animals and
plants, respectively, and Kay Davies led participants into the world of gene therapy. Of
special note was Alan Colman's presentation on the cloning of Dolly the sheep, and on
the hope of the biotechnology community for the use of cloning to produce genetically
engineered proteins in animals.
Gene Therapy of Duchenne Muscular Dystrophy
An important function of Banbury Center meetings is to promote research by hosting dis-
cussions on important topics. A recent example was the meeting on Up-regulation of
Utrophin Gene Expression. Kay Davies, of the University of Oxford, has devised a
research initiative with the goal of turning on the utrophin protein to take the place of the
critical protein-dystrophin-missing in patients with Duchenne muscular dystrophy. With
funding from the Oxnard Foundation, we are holding a series of expert meetings to
explore the ramifications of this approach, and in February, Banbury Center hosted a
meeting that brought together scientists working on Duchenne muscular dystrophy,
researchers studying the control of gene expression, and clinical scientists who are using
a gene-reactivation strategy for treating the thalassemias. We will hold further meetings
at Banbury so that the expertise and knowledge already gained in other systems can be
brought to bear on this debilitating disorder.
22
The "Post-Genomics" World
In the past two years, a flood of complete genome sequences has been published,
including those of the bacterial "workhorse," E. coli, and of the yeast Saccharomyces
cerevisiae; the genome sequence of the nematode worm C. elegans will be completed
in 1998. Knowledge of complete genome sequences will have a profound impact on the
way biological research is carried out, and two Banbury Center meetings examined what
is to be done in this so-called "post-genomics" world. One meeting-Integrating Genetic,
Biochemical, and Other Data discussed how best to make use of all the data on the
functions of cells and organisms that have been acquired during the past 100 years, in
light of the more recently obtained genome sequences. The goal of this meeting is to pro-
duce a "virtual cell" that can be used as a predictive tool.
Physiologists traditionally have used other techniques to study organisms on more of
a systems level, and the American Physiological Society is keen to use the tools of genet-
ics to further their research. The meeting Genomics to Physiology and Beyond was
designed to introduce physiologists to some of the ways in which genomics and the
analysis of complex genetic traits might be used to answer the kinds of questions that
interest them.
Robertson Research Fund
The Robertson Research Fund has been a continuing source of support for the
Laboratory since 1973. Robertson funds supported labs in each of the Laboratory's pri-
mary fields of research: cancer, neurobiology, and plant genetics. Cancer research
recipients were Xiaodong Cheng, Ryuji Kobayashi, Yuri Lazebnik, Benjamin Lee, W.
Richard McCombie, David Spector, Jacek Skowronski, Nick Tonks, and Rui Ming Xu. In
neurobiology, the Robertson Research Fund supported Hollis Cline, Alcino Silva, Tim
Tully, Jerry Yin, and Yi Zhong-all of whom have made great strides in understanding the
biological basis of learning and memory. In plant research, the fund furthered the stud-
ies of Ueli Grossniklaus and Hong Ma. The Robertson Research Fund also helps to sup-
port postdoctoral researchers, graduate students, and scientific seminars.
In 1975, the Robertson family established an additional fund, designated for neuro-
science, in memory of Marie H. Robertson. In 1997, allocations went to Hollis Cline for
her work on neuronal growth and stabilization and to Grigori Enikolopov for his studies of
the neurobiology and development of the fruit fly Drosophila.
Board of Trustees
Several valued trustees completed their terms in 1997. Scientific trustees GOnter Blobel,
M.D., Ph.D., Gerald Fink, Ph.D., and Eckhard Wimmer, Ph.D. have departed, as have
individual trustees Wendy Russell and Douglas A. (Sandy) Warner III, who is taking the
requisite 1-year interval after two successive 3-year terms.
At the close of the 1997 term (February 1998), John Cleary concluded his term as
President of the CSHL Association and as Trustee. We are most grateful to John for his
outstanding service to the Association and to the Laboratory in general and will continue
to seek his valuable advice and guidance. We look forward to working with Vernon Merrill
who has now assumed the position of CSHL Association President.
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Wendy Russell has been named Honorary Trustee. Wendy began serving on the
Board in 1984, has served four 3-year terms, and was Secretary in 1985-1987 and
1992-1997. She has served on the Development, Executive, Finance & Investment,
Banbury, Building, and DNALC Committees, as well as the CSHL Association.
Wendy is a superstar in raising financial support for the Laboratory and was instru-
mental in starting the Corporate Advisory Board (CAB) for the DNA Learning Center. She
was also a vital and wonderful part of the Laboratory's initiative to establish on-site child
care. Her tireless efforts toward that end, as well as on behalf of the CSHL Association
Annual Fund, are deeply appreciated.
The Laboratory's continuing success is due, in large part, to the outstanding leader-
ship and support of the dedicated people who volunteer their time in support of an excel-
lent cause. We offer heartfelt thanks to each of these individuals for their contributions
and active participation and look forward to continuing our relationship in the future.
Our new scientific trustees, whose terms became effective in 1997, are Edward
Harlow, Ph.D., of Harvard Medical School and Massachusetts General Hospital; John
Kuriyan, Ph.D., a prominent X-ray crystallographer studying signal transduction and
DNA replication among other things as a Howard Hughes Medical Institute Investigator
and Professor at Rockefeller University; and Lorne Mendell, Ph.D, Distinguished
Professor and Chairman of the Department of Neurobiology and Behavior at State
University of New York (SUNY) Stony Brook and President of the American Society for
Neuroscience. Ed Harlow's return to CSHL is particularly meaningful: Ed was on our sci-
entific staff from 1982 to 1991. His demonstration here in 1989 of a relationship between
the retinoblastoma (rb) oncogene and the E1A tumor suppressor have won him much
well-deserved acclaim. Ed studied oncogenes for a decade prior to this important dis-
covery and has had a stellar career in science since. In addition, he is also co-author
with David Lane of our very successful laboratory manual Antibodies. Ed is currently
Professor of Genetics at Harvard Medical School and the Massachusetts General
Hospital and Associate Director for Science Policy at the National Cancer Institute. We
are honored and grateful to have the participation of these and other scientists in chart-
ing the course for continued scientific success at Cold Spring Harbor.
In November, the Board of Trustees voted to approve the Laboratory's plan to estab-
lish a CSHL graduate program. This has allowed us to begin the application process for
becoming a degree-granting institution. Our intention is to initiate a small program of
approximately five Ph.D. students per year to be run in conjunction with our
existing program of graduate education for students of SUNY Stony Brook.
The planning and application process is being handled by Assistant Director
Winship Herr, who will also be the first Dean of the graduate school.
M.J. Harris
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A Friend Lost: Mary Jeanne Harris
In November, we were deeply saddened by the death of a very special
friend, Mary Jeanne Harris. Mary Jeanne and her husband Henry U. Harris,
Jr., have been members of the CSHL Association since 1980, and over the
years, they have been extremely generous in their support of a wide variety
of projects at the Laboratory. In 1982, Mary Jeanne joined the Laboratory's Board of
Trustees, on which she served for six consecutive years. She served on the Building
Committee; the Robertson House Committee, through which she helped to decorate the
guest accommodations at the Laboratory's Banbury Center; the DNA Learning Center
(DNALC) Committee; and as Vice Chairman of the Education Committee. The Harris'
support was instrumental in the establishment of the Laboratory's DNALC in 1988, and in
1991, they funded an architectural study and made the lead gift toward construction of
an addition to the DNALC.
Over several terms as a CSHL Association director (1980-1988, 1991-1994, and for
a short time in 1997), including a period as Vice Chairman, Mary Jeanne demonstrated
a heartfelt interest in education and child care, and a deep concern for the quality of life
of Laboratory scientists and their families. She organized and hosted many events
designed to make the young families more comfortable in their new surroundings.
Mary Jeanne brought a unique warmth to the projects on which she worked and a
determined sensibility to the goals she set. We miss her deeply.
CSHL Association
On February 2, 1997, guest speaker Philip R. Reilly, M.D., Executive Director of the
Shriver Center for Mental Retardation in Waltham, Massachusetts, addressed the mem-
bers of the CSHL Association at their annual meeting. His talk, entitled "Genetics, Ethics,
and You," was a thought-provoking analysis of the impact of genetic information on our
daily lives. He explored various issues faced by the public as advances in genetics are
increasingly applied to health care, including diagnostics and prognostics. Dr. Reilly also
examined the possible effects of genetic information on health insurance, life insurance,
and employment.
The Association held its annual Major Donor Cocktail party on November 16 in the
home of David and Jamie Deming. Association members and scientists shared a relaxed
evening of wonderful food and good conversation in the Demings' warm and comfortable
home.
CSHL Association Annual Meeting
J. Cleary and P. Reilly
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DNA Learning Center
We were very pleased to learn that the DNALC has received a 3-year grant of $820,000
from the Josiah Macy, Jr. Foundation to create an extensive Internet site for public edu-
cation about genetics. The DNALC's newly created multimedia communications group
will first develop DNA from the Beginning, an animated "primer" to provide background
information on classical genetics, molecular biology, and biochemistry. This will be fol-
lowed by a Gene Almanac, designed to function as an animated "encyclopedia" of
genetic disorders featuring detailed information on causative or predisposing genes,
DNA diagnosis, and treatments. A 3-year grant of $335,000 from the Department of
Energy enabled the DNALC staff to continue their tradition of nationwide teacher train-
ing. The Science and Issues of Human DNA Polymorphisms introduces high school biol-
ogy teachers to a laboratory-based unit on human DNA polymorphisms, which provides
a uniquely personal perspective on the science and ELSI aspects of the Human Genome
Project. Finally, the DNALC received a 3-year grant of $600,000 from the National
Science Foundation's Advanced Technological Education (ATE) Program to create and
disseminate advanced technology units on genomic biology. Operating under a direct
congressional mandate, the ATE program aims to ensure U.S. competitiveness in emerg-
ing technologies of the 21st century.
CSHL Press
1997 was a year of extensive change for the Press and it ended with much improvement
in organizational efficiency, technical expertise, and financial performance.
The Cold Spring Harbor journals, Genes & Development, Genome Research, and
Learning & Memory all gained ground in 1997, with record circulation, more published
papers, higher impact factors, booming advertising sales, and increased visibility. There
were new faces among the principal editors of all three journals, and the scope and the
mix of articles in the journals broadened. Most notably, online editions of Genes &
Development and Genome Research were created. These offered the entire contents of
each issue via the Internet in a fully searchable format with links to other electronic
resources such as Med line. Initially, these editions were made available free of charge,
with the intention of providing the electronic subscription only to print subscribers until
the impact of this development on the journals' circulation and revenues could be
assessed. Learning & Memory received a generous grant from the Donaldson Charitable
Trust that will support the development of its electronic edition in 1998.
A total of 18 new books were published in 1997, double the previous year's total.
They included three of the most complex and colorful volumes ever to originate from the
Laboratory: the remarkable laboratory manual Cells, by David Spector, Bob Goldman,
and Leslie Leinwand; Retroviruses, by John Coffin, Steve Hughes, and Harold Varmus, a
textbook for a community of scientists and physicians given dramatic prominence by
HIV-induced disease; and Mutants of Maize, by Gerry Neuffer, Ed Coe, and Sue Wessler,
an encyclopedic account of the extraordinary genetic diversity of corn, which was rec-
ognized as one of the three Best Books of the Year in Biology by the American
Association of Publishers. These and the other new titles, such as the commanding
Symposium volume on nervous system function, combined with the continued strength
of classics such as Molecular Cloning and Antibodies to produce an increase of over
12% in book sales.
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Major Gifts
We have been extremely fortunate over the years in the amount of support the
Laboratory receives from the private sector. As federal support now constitutes less than
approximately 38% of the Laboratory's budget, contributions from individuals, founda-
tions, and businesses are ever more crucial to the Lab's survival and to the continuation
of our scientific mission.
The Laboratory's neuroscience program recently received unparalleled private sup-
port. William and Marjorie Matheson, of Mill Neck, New York, and Hobe Sound, Florida,
have been members and generous supporters of the CSHL Association
since 1989. In 1995, they established the Matheson Fund for Neurosci-
ence with two contributions totaling $300,000. In 1997, Bill and Marjorie
added an unprecedented $2.8 million to this endowment. The fund's value
at year-end was $3,537,952, after an award of $121,659 was made to sup-
port scientist Grisha Enikolopov and his work on the role of nitric oxide in
development. The endowment provides a vital and enduring source of
support for our neuroscience program, as its sizable principal, carefully
invested, will continue to generate income that may be applied directly to
research support without decreasing the balance.
Another very important research project that we likely could not have
undertaken without private support was the Arabidopsis Sequencing
Project. This is an organized, global effort to sequence the entire genome
of a flowering plant for the first time in history. Like the Human Genome
Project, the Arabidopsis Sequencing Project is expected to produce an entire genetic
"toolbox" for plants, providing the basis for vast continued discovery as scientists explore
the function and manipulation of important genes. We could not have geared up for this
project and subsequently qualified for important federal grants without the support of
Westvaco Corporation and of Laboratory Board Chairman David L. Luke III. Westvaco
provided $290,000 for the purchase of sequencing equipment, and then subsequently
and separately, Mr. Luke made two gifts totaling approximately $700,000 for additional
sequencing equipment and plant research. This roughly million dollar combined invest-
ment has enabled CSHL to further secure its place in plant genetics research, a fitting
step forward for the Laboratory in light of its long history of plant genetics research.
George Schull's demonstration of "hybrid vigor" began CSHL's foray into plant genetics
in 1908, and it yielded the sweet corn we eat today, and Barbara McClintock's 1951
description of "transposable elements" in maize, the jumping genes now studied widely
in genetics, earned her the 1983 Nobel Prize in Physiology or Medicine.
For 10 years now, Edna Davenport has given generously to the Annual Fund. Her
contribution of $100,000 in 1997-and each of the previous 3 years-typifies her gen-
erosity toward the Laboratory. These funds help to support young researchers who have
not yet secured federal or other grant support, awards that may elude young scientists
because they are often dependent on a track record in research.
During the past 8 years, Alan and Edith Seligson have fully supported 15 postdoc-
toral fellowships. Again in 1997, they gave a 1-year award of $35,000, this time sup-
porting Howard Fearnhead in Yuri Lazebnik's lab. Howard has done excellent work in his
studies on apoptosis, or programmed cell death, a process involved in a variety of dis-
eases including cancer. We are most grateful for the Seligsons' continuing support of our
promising young researchers.
William and Marjori
Matheson with Liz
Watson
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Plans for the new Advanced Imaging Facility are well under way and we have
received exceptional gifts to that end. Edwin and Nancy Marks gave $2.5 million through
the Marks Family Foundation, and the W.M. Keck Foundation contributed $2 million. Our
good friends George and Mary D. Lindsay gave $250,000 toward the new initiative,
Burroughs Wellcome contributed $470,800 over 5 years in support of Zachary Mainen,
a postdoctoral researcher working with Roberto Malinow and Karel Svoboda on the new
two-photon excitation laser scanning imaging. The two-photon imaging technology
around which the Advanced Imaging Facility will be built is currently being developed in
Karel's temporary lab in the Beckman Neuroscience building.
The capital campaign for the Mary D. Lindsay Child Care Center continued in 1997,
and was completed in excess of its $1 million goal with gifts including $50,000 from Mr.
and Mrs. William R. Miller through the Miller Family Foundation. The DNALC received a
most important 3-year grant of $820,000 from the Josiah Macy, Jr., Foundation to enable
them to develop an extensive educational genetics website. Geri Barish and our special
friends at 1 in 9: The Long Island Breast Cancer Action Coalition presented a check for
$75,000 to Mike Wigler's lab in October at their annual black tie dinner dance fund-
raiser.
In other gifts, the St. Giles Foundation gave $508,000 to Mike Wigler's lab and to vis-
iting scientist Eli Hatchwell of Southampton University, Wessex Genetics Institute in
Southampton, U.K., who came here to apply representational difference analysis to his
studies of human genetics. The Sidney Kimmell Foundation for Cancer Research gave
$400,000 to cancer researchers Linda Van Aelst and Scott Lowe. The William and Maude
Pritchard Charitable Trust gave $243,000 in unrestricted funds, which were applied to the
high-powered beamline at Brookhaven National Laboratory, a vital off-site tool for our X-
ray crystallographers. The Lita Annenberg Hazen Foundation awarded $200,000 to Karel
Svoboda for neuroscience research, and the Pew Charitable Trust gave $200,000 to
research: Recipients included Greg Hannon, Tatsuya Hirano, Yuri Lazebnik, and Yi
Zhong. The Alexander and Margaret Stewart Trust gave $150,000 to support new pro-
jects in cancer research, and we are pleased that they have designated CSHL as one of
the few cancer centers which they will support. The Oxnard Foundation gave $120,000
toward muscular dystrophy research; the Oliver S. and Jenny R. Donaldson Trust con-
tributed $100,000 for sequencing equipment for the McCombie lab; and the V
Foundation gave $100,000 to Linda Van Aelst for her studies on the ras pathway. The
Helen Hay Whitney Foundation gave $87,000 to a postdoctoral fellowship for Peiqing
Sun in David Beach's lab, and Pioneer Hi-Bred International, Inc., gave $70,000 toward
Ueli Grossniklaus' plant research. Henry Wendt gave $56,450 for two postdoctoral fel-
lowships in neuroscience: Frances Hannan in Yi Zhong's lab and Peter Krasnov in Grisha
Enikolopov's lab. The Goldring Family Foundation gave $50,000 toward support of two
postdoctoral researchers: Bill Henry in Nouria Hernandez's lab and Kaetrin Simpson in
my lab. The Perkin Fund gave $50,000 to neurobiologist Alcino Silva in support of his
work on learning and memory in mice.
We also received two very generous gifts of real estate. Jill Hershey of Laurel Hollow
and Bob Garland of Oyster Bay have each gifted their homes to the Laboratory, with
each retaining a life estate. Jill and Al Hershey have been a part of the Laboratory for
many decades, and Al's death in 1997 was a loss that we shared with Jill. Bob Garland,
a good friend to several of our trustees, has been a supporter of the Laboratory since
1990. We are most appreciative of these very generous planned gifts.
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President's Council
The President's Council was formed four years ago in an effort to bring together a small
group of individuals who have a keen interest in science and the work of CSHL. Through
their annual commitment of $25,000, the members provide support for the Cold Spring
Harbor Fellows program. The funding is critical in attracting top-notch young scientists
fresh from their Ph.D. studies. It allows them to embark on an independent research
career, rather than assisting in the laboratory of an established scientist.
A major feature of the President's Council is its annual meeting that brings together
this select group of leaders from business, finance, and science to discuss the latest
developments in genetics research and biotechnology. The Council's 1997 meeting,
held May 16-17, commenced with lunch on Friday at Ballybung and was followed by
thought-provoking lectures by Scott Lowe and Ueli Grossniklaus of CSHL. The keynote
speaker, Matt Ridley, of the Evolution and Behavior Research Group, University of
Newcastle, England, opened the evening session with his talk on Gender Warfare and
Evolution. Saturday's highlights included lectures by Rudi Jaenisch, of the Whitehead
Institute for Biomedical Research, Massachusetts Institute of Technology; Suzanne B.
Cassidy, of the Center for Human Genetics, Case Western Reserve University; and David
Haig, of the Museum of Comparative Zoology, Harvard University. The mix of leaders
from the business field and the scientific community evoked interesting insights as well
as provocative discussions. The meeting ended on Saturday with the guests gathering
once again at Ballybung for a parting luncheon. The following are Members of the
President's Council:
Abraham Appel, Appel Consultants
Peter Bloom, General Atlantic Partners
James Conneen, A.T. Hudson & Co.
Michel David-Weill, Lazard Freres & Co.
Stefan Englehorn
Leo A. Guthart, ADEMCO
Charles E. Harris, Harris & Harris Group, Inc.
Walter B. Kissenger, WBK Associates
Donald A. Pels, Pelsco, Inc.
George B. Rathmann, ICOS Corporation
Hubert J. P. Schoemaker, Centocor, Inc.
James H. Simons, Renaissance Technologies Corp.
Sigi Ziering, Diagnostic Products Corporation.
Gavin Borden Visiting Fellow
On May 17, Leland Hartwell, Ph.D., now President of Fred Hutchinson Cancer Research
Center, delivered the annual Gavin Borden Lecture. Dr. Hartwell discussed the role of
yeast genetics in cancer research as part of the Gavin Borden Visiting Fellowship,
named for the late charismatic publisher of scientific textbooks. The annual event was
initiated in 1995 in honor of Gavin, who died in 1991 of salivary gland cancer, and in an
effort to carry on the mission that was so dear to him: the education of graduate students.
With this goal in mind, the annual lecture by an inspiring scientist is directed toward that
audience, although it is open to all Laboratory staff. During their a 2-day stay at the
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Leland Hartwell and Bruce Stillman
Laboratory, Gavin Borden Fellows spend time talking with the graduate students who are
currently studying at the Laboratory. Discussions typically involve science, life in science
and careers in science.
Major Building Projects
Over the course of 1997, we saw the completion of two very important building projects.
The Mary D. Lindsay Child Care Center, which involved extensive renovation of the old
De Forest Stables, was readied for its young charges in the late spring. The dedication
of the building, which represented the culmination of a decade of effort to secure on-site
child care for our employees, was held on Saturday, June 21. Tributes and thanks to Mary
Lindsay and the Child Care Capital Campaign Committee were offered by the
Child Care Center Dedication
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Laboratory's Director of Public Affairs and Development Susan Cooper, Laboratory
President James Watson, and myself. The children of many lab employees, climbing on
the colorful geometric playground equipment, made the event complete.
On October 19, we celebrated the completion of the Facilities Department's move to
the Richards Building and facilities complex. The Richards Building resulted from the
renovation of the old Kurahara house on the west side of Bungtown Road, supplement-
ed by the construction of barns to the east and west of the building. The building was
named for long-time director of Buildings and Grounds, Jack Richards, who has now
assumed the more focused position of Director of Construction. His projects included
major building renovations on a failing campus in the early 1970s, as well as assorted
other tasks that fell under his loosely defined job, which in the early days included plow-
ing, mowing, and distributing mail. Jack was responsible for developing a skilled and
comprehensive staff of plumbers, carpenters, electricians, and others to serve the
Laboratory's growing needs over the years. He also supervised the construction of
Ballybung, the President's residence, together with Jim and Liz Watson in 1994. Toasts
to Jack were offered by Arthur Brings, Director of Facilities; Raymond Geste land, former
Assistant Director of the Laboratory (1968-1971); contractors Arthur Herman of Herman
Development Corporation and George Feraco, Sr. of Abel Grenier Inc. and Feraco Inc.;
architect James Childress of Centerbrook, and me.
In 1997, we directed extensive effort toward planning of the Marks Building, which
will be home to the new CSHL Advanced Imaging Facility. Centerbrook, the architectur-
al firm recently awarded the American Institute of Architects (AIA) 1998 Architecture Firm
Award, the highest honor conferred by the AIA, has been contracted by the Laboratory
for this project. Lead architect Bill Grover has been involved in the planning and execu-
tion of many building projects the years, including Grace
Auditorium in 1986; Beckman Neuroscience, Dolan Hall, and Hazen Tower in 1991; and
the Watson's residence, Ballybung, in 1994.
The Marks Building will house teaching laboratories, which will further strengthen our
educational initiative, and will expand our research initiatives through sophisticated
imaging studies of the brain.
Undergraduate Research Program (URP)
In 1997, we received 375 applications-a record number-for the Undergraduate
Research Program. The 23 successful candidates, 16 men and 7 women, came from six
countries. The program, known as the URP program, was initiated in 1959. Many former
URPs have gone on to productive careers in the biological sciences, including David
Baltimore, a member of the first class, who went on to share the 1975 Nobel Prize in
Physiology or Medicine. The URP program exposes students to hands-on experimental
approaches to science and helps lead them to a greater understanding of the issues
involved in biochemistry, genetics, and molecular and cellular biology. Participants live
and work at the Laboratory for 10 weeks during the summer, so that they are exposed
not only to science in the lab, but also to life as scientists.
A list of the students, their schools, mentors, and research projects may be found in
the Undergraduate Research Program Section of this Annual Report. Information about
the URP program and its alumni may also be accessed through the Labortory's web site
at: http://www.cshl.org/URPsite/URP.html
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Partners for the Future (PFF)
Each year since 1990, the Laboratory appeals to every Long Island high school science
department chairman for the nomination of one student for participation in CSHL
Partners for the Future program. In 1997, we were pleased to increase the number of
Partners to six, each of whom spends a minimum of 10 hours per week at the Laboratory
in October through March, doing original molecular biology experiments under the guid-
ance of a scientist mentor.
The participants for the 1997-1998 school year (and their scientist mentors) are
Aaron Bronfman of Syosset, Cold Spring Harbor High School (Bruce Stillman); Arti
Anand of Jericho, Jericho High School (Peter Nest ler); Bradley Gottfried of Plainview,
Port ledge School (John Connolly); Elyse Katz of East Setauket, Ward Melville High
School (Hong Ma); Nancy Choi of Woodbury, Syosset High School (Michael Hengartner);
and Chian Chuu of Bayville, Locust Valley High School (Michael Regulski). Arti Anand
was the second Cablevision Scholar under a special Partners for the Future scholarship
offered by Cablevision, the first local business to underwrite a portion of this important
educational program.
Educational Outreach
The Laboratory continues to take great pride in its educational outreach programs. We
remain committed to the philosophy that it is vital to provide positive scientific experi-
ences for young people in order to pave the way to a scientifically literate, and excited,
next generation. The Interschool Exchange program continues to provide tours and
meetings for students and parents of local private and public schools.
In 1997, we hosted four West Side School Science Nights: "How to Teach a Mutant
Fly" (Tim Tully), "Turning Genes On" (Winship Herr), "You Don't Have to Be a Chicken to
Lay an Egg" (Ueli Grossniklaus), and "How to Find a Needle in a Haystack" (Peter
Nest ler). These programs, initiated through West Side School, are now open to all local
elementary students, parents, and teachers.
For high school students, we host a lecture series called Great Moments in Science.
This year's talks were about gene transcription (Nouria Hernandez), the three-dimen-
sional structure of proteins (Leemor Joshua-Tor), and brain development (Holly Cline).
Students from the East Woods School enjoyed a tour and visit with scientist Roberto
Malinow. The Cold Spring Harbor High School brought their Japanese exchange stu-
dents for a tour and luncheon for the third consecutive year.
The Laboratory once again participated in Project WISE-Women in Science and
Engineering. Orchestrated by SUNY Stony Brook and funded by a grant from the
National Science Foundation, the project involves several Long Island institutions-
SUNY Stony Brook, CSHL, Brookhaven National Laboratory, and the American
Association of University Women-each helping to expose bright young women to the
world of science. The program involves female high school students in 9th through 12th
grade, and each year the girls participate in research programs at one of the four insti-
tutions. In 10th grade, they come to CSHL for a research experience in molecular biolo-
gy and genetics under the guidance of scientist mentors.
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Community Outreach
Several initiatives through our Department of Development continue to go well. The Next
Generation Initiative (NGI) is a series of lectures and tours designed to inspire interest in
basic research in people in their 30s and 40s. The Young President's Organization (YPO)
provides similar experiences for young leaders of industry and companies, and the
Harbor Society is a small group of Laboratory supporters who have contributed to the
Laboratory's planned giving program.
For the general public, the Laboratory holds lectures and concerts throughout the
year. Jan Witkowski continues to host Lloyd Harbor Seminars at the Banbury Conference
Center, and periodically, scientists who are attending scientific conferences at Banbury
will deliver a public talk on their area of expertise in Grace Auditorium. In April, Mary-
Claire King did just that with her talk, "Breast Cancer Update." Dr. King, professor in the
Division of Medical Genetics at the University of Washington in Seattle, was responsible
for locating the first breast cancer gene, BRCAl; she gave her lecture while participating
in The Biology of BRCA1 meeting at the Banbury Center.
In October, Dr. Svante Paablo, Professor of General Biology at University of Munich,
presented a lecture entitled "DNA, Neandertals, and Us." In November, we presented the
third Cold Spring Harbor Laboratory Lyme Disease Forum. Moderators of the discussion
were Steven E. Schutzer, M.D., of the New Jersey Medical School Department of
Medicine, and John Dunn, Ph.D., of Brookhaven National Laboratory's Department of
Biology. The speakers, Patricia K. Coyle, M.D., of the University Hospital at Stony Brook
Department of Neurology and Raymond Dattwyler, M.D., of the University Hospital at
Stony Brook Department of Allergy and Lyme, discussed current research and clinical
treatment of the disease and answered questions from the audience.
Concerts
In 1997, we hosted seven concerts, each by one or more outstanding young classical
musicians. Pianists, violinists, cellists, and sopranos played to audiences of scientists,
Benjamin Loeb (piano) and Allison
Charney (soprano)
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Top row: Art Brings, Bruce Stillman, Dave Mick los, James Watson, David Beach, Susan Cooper
Bottom row: Cliff Sutkevich, Patricia Bird, Terri Grodzicker, Elaine Gaveglia, Barbara Terry
staff, and neighbors. These concerts began as cultural refreshment for scientists who
were at the Laboratory for several days or more attending scientific conferences. The
caliber of the musicians has made these concerts an attractive event for our staff and
neighbors as well and we have been delighted to provide great musical performances,
usually for no charge. Performances in 1997 included: April 26, Alexander Velenzon on
violin and Inessa Zaretsky on piano; May 10, pianist Freddy Kempf; May 24, pianist
Wendy Chen; June 13, pianist Misha Dichter; August 30, The Laurel Trio with
SunghaeAnna Lim on violin, Amy Levine Tsang on cello, and Dena Levine on piano;
September 6, pianist Benjamin Loeb and soprano Allison Charney; and on September
20, pianist Jon Klibonoff.
Long-term Service
A pool-side dinner at Robertson House on June 11 marked the anniversaries of several
long-term employees of the Laboratory. Susan Cooper, Director of Public Affairs and
Development, and Terri Grodzicker, Assistant Director of Academic Affairs, both cele-
brated their 25-year anniversaries. Over the years, Susan evolved from librarian, to mar-
keting for the CSHL Press, to Director of the Library, then Director of Public Affairs, and
finally took on Development as well. Her departure to become Director for Institutional
Advancement at the Trudeau Institute in upstate New York (see Changes in
Administrative Staff, below) left many holes to be filled at the Laboratory. Terri Grodzicker,
who came to Cold Spring Harbor as a scientist in Joe Sambrook's James lab, went on to
become a staff scientist and then Assistant Director of Academic Affairs and editor of
Genes & Development.
Celebrating 15-year anniversaries were investigator David Beach, scientific secre-
tary Patricia Bird, Director of Facilities Art Brings, typesetter Elaine Gaveglia, DNALC
Director David Mick los, manager of equipment repair Clifford Sutkevich, and circulation
manager Barbara Terry.
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Changes in Administrative Staff
In January, Nancy Ford concluded 24 years of dedicated service to the CSHL Press.
Nancy was instrumental in developing the publications program, and she worked
extremely well with a wide variety of well-respected scientists to create many landmark
publications in molecular biology. Her professionalism and dedication were of great value
to the Press and the Laboratory for without Nancy many of the distinguished volumes
produced by the Press would not have been as great as they are. Nancy's contributions
to the Press will long be remembered.
Susan Cooper, Director of Public Affairs, Development, and the Library exceeded her
title by a good measure in her role as confidant and friend to many, in particular Jim
Watson. Her decision to accept the position of Director for Institutional Advancement at
the Trudeau Institute came as a great surprise, although it is not difficult to see why
Trudeau would have courted her. Susan worked double-time, with unparalleled dedica-
tion and true devotion. She arrived here in 1972 as head librarian in the Laboratory's
Carnegie Library, and she grew up with the institution, later adding the roles of Director
of Public Affairs and then Director of Development. Susan orchestrated and carried out
the Lab's spectacular centennial celebration nearly a decade ago, as well as planning
ceremonies and booklets for the Lab's many building dedications over the years. She
had a remarkable rapport with our friends, neighbors, and supporters, and she helped
foster the careers of many of our scientists. Susan's vitality and enthusiasm made the
Laboratory an enjoyable and interesting place to work. That she has "left home" to make
her mark elsewhere is saddening to many of us, but we wish her and her husband Bob
the best and much success.
Nancy Ford at her retirement luncheon. Susan Cooper in her CSHL office.
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Changes in Scientific Staff
Departures
Carol Greider moved on to a position as Associate Professor with Johns Hopkins
University School of Medicine, Department of Molecular Biology and Genetics, in
Baltimore. Carol's work with telomeres and telomerase, the enzyme that regulates their
length, earned her much scientific and popular acclaim during her years at Cold Spring
Harbor. Carol came to the Laboratory in 1988 as a Cold Spring Harbor Laboratory Fellow
after completing her Ph.D. with Elizabeth Blackburn at University of California Berkeley,
where Carol discovered telomerase as a graduate student. In 1989, Carol was appoint-
ed to the staff of the Laboratory, eventually being appointed full investigator. The move to
Maryland has worked well for Carol and her family as her husband, Nathaniel Comfort-
former Science Writer at CSHL-simultaneously accepted an assistant professorship at
George Washington University, in Washington DC, after completing his Ph.D. in the his-
tory of science.
X-ray crystallographer Xiaodong Cheng left for a position with Emory University in
Atlanta, Georgia. Xiaodong came to us as a postdoctoral researcher in 1990 and worked
for 2 years in Jim Pflugrath's lab. He became a staff member in 1992 and did much
ground-breaking work with DNA methyltransferases and methylation during his time here,
including the discovery of the phenomenon called "base flipping," whereby a single base
turns outward from the DNA helix-in effect opening the DNA at a given point.
Erich Grotewold, who arrived here as a postdoctoral researcher in 1989, left for a
position at Ohio State University, in Columbus.
Tom Marr, a member of the Laboratory's bioinformatics team since 1989, has com-
pleted the transition from CSHL to president and C.E.O. of Genomica Corporation in
Boulder, Colorado.
Joe Colasanti, research investigator who came to do postdoctoral research with
Venkatesan Sundaresan in 1988, has gone on to The University of California at Berkeley,
Plant Gene Expression Center, as visiting assistant research geneticist.
Masafumi Tanaka, staff investigator who came as a postdoctoral researcher in 1986
and joined the staff in 1988, moved on to Tokai University School of Medicine in Japan.
Arrivals
Neurobiologist Karel Svoboda joined our scientific staff in June. Karel studied physics at
Cornell University and biophysics at Harvard, where he used a technique called laser-
optical tweezers to measure the force generated by individual molecular motors. More
recently, at Bell Laboratories in New Jersey, he used two-photon excitation laser scanning
microscopy to obtain never-before seen images of neurons in living brains. Two-photon
excitation laser scanning microscopy is an emerging imaging technology; it utilizes the
tremendous concentrations of light achievable with pulsed-laser light sources to "excite"
fluorophores by two-photon absorption. Karel is applying his knowledge of this technique
to the establishment and further development of a state-of-the-art neural imaging facility
at CSHL.
David Jackson arrived in September, after doing postdoctoral research in Sarah
Hake's lab at the Plant Gene Expression Center in Berkeley, California. David is a maize
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geneticist; he has been using transposons-Barbara McClintock's jumping genes-to
study such phenomena as development of flowering plants, including the formation of
leaves from a small group of cells called the meristem. In addition, David is studying
intercellular transport, the movement of proteins and other molecules from one plant cell
into another.
Andy Neuwald joined us in November, from the National Institutes of Health, National
Center for Biotechnology in Bethesda, Maryland. Andy is a computational biologist and
is interested in the development and use of statistical and algorithmic methods to clas-
sify and model protein domains and is also working on the development of a compre-
hensive database in which to log the resulting data.
Promotions
Yi Zhong, a staff member with our neurobiology program since 1992, was promoted to
Associate Investigator. Bill Tansey, a postdoctoral researcher in Winship Herr's lab since
1992, was appointed Assistant Investigator in 1997, and he is now combining two active
areas of research, gene transcription and cell cycle control. Doug Conklin, a postdoc-
toral researcher in David Beach's lab since 1993, was promoted to the position of Senior
Fellow. Postdoctoral researchers Nei lay Dedhia from Dick McCombie's lab, Robert Lucito
of Michael Wigler's lab, and El ly Nedivi of Hollis Cline's lab were each appointed
Research Investigator. Graduate student John Connolly completed his Ph.D. from the
Massachusetts Institute of Technology while working in Tim Tully's lab and is now doing
postdoctoral research in the Tully lab.
In addition, two visiting scientists have joined our staff: Clifford Yen and Masaaka
Hamaguchi, both of whom were visiting Michael Wigler's lab, have each been appointed
Research Investigator.
Visiting Scientists
Nine visiting scientists wrapped up their sojourns to CSHL: Aiping Dong, visitor to
Xiaodong Cheng's laboratory, has moved to a position as visiting scientist at Emory
University in Atlanta, Georgia; Konstantin Galaktionov, who came from Leningrad, USSR
in 1988, left David Beach's lab to accept an assistant professorship at Baylor College of
Medicine in Houston Texas; and Roberta Maestro, in David Beach's lab since 1995,
returned to CRO in Aviano, Italy. Eli Hatchwell, a clinician from Wessex Clinical Genetics
Service in Southampton, UK, spent 6 months in Michael Wigler's lab applying RDA to his
research and has since returned to the UK. Liam Dolan returned to the John Innes Center
in Norwich, UK, from Rob Martienssen's lab, and Ross Bicknell concluded his visit with
Ueli Grossniklaus, to return to Crop & Food Research in Christchurch, New Zealand.
Several more visiting scientists have arrived. Jiaxin An, of the China Academy of
Space Technology in Beijing and Zuoping Xie of Tsinghua University, also in Beijing, have
both come to do research in Yi Zhong's lab. Ming Huang of Otsuka America
Pharmaceutical Inc. is visiting Michael Zhang's lab, Nobuhiro Kashige of Fukuoka
University, Department of Pharmacological Science in Kukuoka, Japan, is working in
Ryuji Kobayashi's lab, and Tatyana Michurina from the Institute of Developmental Biology
in Moscow, Russia is visiting Grigori Enikolopov's lab.
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Postdoctoral Departures
Stephen Buck, Siyuan Le, Bong-Kyeong Oh, and Michael Rudd moved with Carol
Greider to Johns Hopkins University in Baltimore, MD, to continue their postdoctoral
studies in her lab, and Maria Blasco, also of Carol's lab, went to a position as Staff
Investigator at the Universidad Autonoma De Madrid.
Weimin Gong and Yu Liu transferred with Xiaodong Cheng to Emory University
School of Medicine, Atlanta, GA, to continue their postdoctoral studies in his lab, while
John Horton went with Xiaodong to Emory to become an Assistant Professor there.
Margaret O'Gara and Xujia Zhang of Xiaodong's lab each moved on as well; Margaret
accepted a position as scientist with Pfizer Ltd., in Sandwich, UK, and Xujia became a
researcher at the Biophysics Institute, in Beijing, China.
From the Stillman lab, Gerhard Cullmann became a Project Leader at Connex, in
Germany; Kim Gavin stayed on to become an Editorial Assistant for the CSHL Press;
Masumi Hidaka accepted a position as Assistant Professor at the National Institute for
Basic Biology in Okazaki, Japan; Masayoshi lizuka became an Assistant Professor at the
National Cancer Center in Tokyo, Japan; and Caroline Mirzayan took a position as
Assistant Professor at the University of Aarhus, in Denmark.
From David Beach's lab, Kang Dai accepted a position as scientist with Chiron
Company, Walnut Creek, CA; Manuel Serrano went on to become Staff Investigator with
Centro Nacional De Biotechnologia in Madrid, Spain; and Amancio Carnero has moved
to David's new laboratory at the Institute for Child Health in London.
From Hollis Cline's lab, James Edwards is continuing his postdoctoral studies at
Virginia Commonwealth University, in Richmond, VA, and Gang-Yi Wu is doing the same
at Stanford University in CA. From Hong Ma's lab, Hai Huang went on to become
Professor at Shanghai Center of Life Science in China, and Hua-Ying Fan is continuing
postdoctoral studies at New York University Medical Center. From Nick Tonks' lab, Salim
Mamajiwalla became a patent agent with Blake, Cassels & Graydon, in Unionville, and
Tony Tiganis is now a research officer with St. Vincent's Institute of Medical Research in
Victoria, Australia.
From Dick McCombie's lab, Arthur Johnson became Sequencing Facility Director at
North Carolina State University, Department of Forest Biology, in Raleigh, NC, while
Muhammad Lodhi accepted a position as senior scientist with Sequana Therapeutics in
La Jolla, CA. From the Krainer lab, Javier Caceres went on to become Group Leader at
the MRC, Western General Hospital in Edinburgh, Scotland, and David Horowitz became
Assistant Professor at the Uniformed Services University of the Health Sciences in
Bethesda, MD.
Derek Gordon left Tom Marr's lab to continue postdoctoral studies at Rockefeller
University, in New York, NY. Bing Guo went from Kim Arndt's lab to continue postdoctor-
al research at the Whitehead Institute in Cambridge, MA. Sui Huang left David Spector's
lab to accept a position as Assistant Professor at Northwestern University Medical
School in Chicago, IL, and Peter Lorenz is continuing postdoctorial research at University
of Rostock, Institute of Immunology in Rostock, Germany. Stephen Brand left Mike
Mathews' lab to accept a Clinical Research Scientist position with Cato Research in
Durham, NC. Thillai Koothan of the Malinow lab is continuing postdoctoral research at
the Mayo Clinic in Jacksonville, FL. Patricia Springer of Rob Martienssen's lab is now an
Assistant Professor at the University of California, Riverside, and Mee-wa Wong of Nouria
38
Hernandez's lab is now at the. University of Texas. Qizhi Wang finished up in Mike
Mathews' lab, and Christopher Jones and Gert Bolwig left Tim Tully's lab: Christopher
accepted a postdoctoral position at the University of Tennessee and Gert became an
Assistant Professor at the Institute of Human Genetics in Denmark.
Graduate Student Departures
Nick Carpino went from Ryuji Kobayashi's lab to do postdoctoral research at St. Jude's
Children's Hospital in Memphis, TN, and Chong Huang graduated from Winship Herr's
lab and accepted a postdoctoral research position at the Molecular Neurogenetics Unit
of Massachusetts General Hospital in Boston, MA.
Two graduate students made the transition to medical school and one joined the
computer world, Benjamin Lee of Winship's lab is now a medical student at SUNY Stony
Brook School of Medicine in NY, and Aneil Shirke of Roberto Malinow's lab is now a med-
ical student at University of Iowa in Iowa City, IA; Jian Sheng of Yi Zhong's lab has
become a student in the Computer Department at SUNY Stony Brook.
Doug Mason went to continue graduate studies with Carol Greider at Johns Hopkins
School of Medicine.
A Busy Agenda
Cold Spring Harbor Laboratory has never rested on its past accomplishments.
Throughout the history of the Laboratory, the introduction of new programs such as the
scientific meetings in the 1930s, the laboratory courses in the 1940s, the Banbury
Conference Center in the 1970s, and the DNA Learning Center in the 1980s has trans-
formed and strengthened the institution. I am pleased that we have a vigorous research
agenda and that the educational programs at the Laboratory continue to go from strength
to strength. We have chosen to undertake several major initiatives this year: expansion
of our research facilities, fostering a local biotechnology industry, and growth of our edu-
cational mission by developing a graduate school of biological sciences. Each of these
objectives presents a great challenge, but they are all necessary to ensure that Cold
Spring Harbor Laboratory remains a vital and exciting place to live and work. We have a
very busy time ahead, but I am confident that we can efficiently incorporate these new
programs into our existing infrastructure while maintaining a high standard of excellence
and a leading role in biology and the biomedical sciences.
April 1998 Bruce Stillman
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ADMINISTRATION
As the century draws to a close, there is a growing sense among the public that biolo-
gists are making real progress in the War on Cancer, the Human Genome Project, and
the great promise of biotech. The renewed public confidence in science is reflected in
Congress, which now seems likely to vote substantial increases in federal funding for
basic research. Here at Cold Spring Harbor Laboratory, it is exciting to know that many
of our research and education programs have been at the heart of the discoveries and
strategies that now seem likely to usher in a new golden age for biology.
From an administrative viewpoint, 1997 was a good year for the Laboratory. Financial
results were positive with operating revenues reaching a new high of nearly $50 million.
There was a surplus from operations of $317,000 after fully allowing for depreciation of
$3,370,000. The operating budget for the year had been conservatively stated and was
bettered by some $870,000. There was a positive cash flow from operations of
$3,688,000. Sustaining a positive cash flow of this magnitude is extremely important if we
are to maintain and modernize facilities, and to purchase the ever more expensive sci-
entific equipment that has become a necessity for any world-class research center.
The better-than-anticipated financial results for the year were driven by the success
of our scientists in obtaining grants, increased corporate sponsorship of our research,
good attendance at meetings and courses, higher income from tech transfer and invest-
ments, and careful departmental control of costs. There were also substantial savings in
electricity costs which are providing a rapid return on the major capital investment made
in energy-saving programs in recent years.
The year 1997 was not without challenges, however. Early in the year, it became clear
that a reorganization of the CSHL Press was needed, which required some painful reduc-
tions in staff. The result has been positive, with a much-improved ability to meet produc-
tion schedules for new books. As in past years, book sales from the back list were very
strong, and journal subscriptions and advertising revenues increased nicely. By year-
end, the Press had published 18 important and beautifully produced new books, most
notably Mutants of Maize, Cells, and Retroviruses, and it had achieved a small surplus
before the reorganization expense.
During 1997, several relatively senior members of the scientific staff made transitions
to other institutions. Such departures are a sad but sometimes unavoidable result of the
efforts of other institutions to recruit from the exceptional scientific talent at the
Laboratory. We have come to realize from experience that such turnover constantly
refreshes our research programs with new young scientists who will make the next series
of unexpected discoveries. On a practical basis, however, the departure of senior scien-
tists also means the departure of grants that must be replaced from scarce internal
Laboratory resources while newly recruited scientists begin the research that will ulti-
mately enable them to compete effectively for federal funding. In addition, the Laboratory
must pay for the expensive redesign and equipping of the new scientists' labs.
A further challenge has been the escalating cost of providing the data-processing
infrastructure that in recent years has become so important to biologists. Gene sequenc-
ing, protein studies, and other new high-tech methodologies are triggering an enormous
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flood of new data that must be managed and analyzed to be useful. The Laboratory has
made major investments to provide a high-speed Internet connection and a campus-
wide, fiber-optic local area network that is supported by a professional Information
Services Department. It will be a continuing challenge to keep up with the growing
demand for these services.
In 1997, The Laboratory's endowment once again achieved handsome gains as a
result of good market returns and new additions. The endowment consists collectively of
the Robertson Research and Cold Spring Harbor Funds and is our primary source of
internal funding for research. At year end, the market value of the endowment was
$144,098,000, a 12-month increase of over $14 million. The funds are invested in a bal-
anced mix of equities, fixed-income securities, and short-term instruments. The endow-
ment is managed by a team of investment professionals-Essex Investment
Management Company, Inc., Miller Anderson & Sherrerd (a subsidiary of Morgan Stanley
Dean Witter), U.S. Trust Company, and the Vanguard Prime Cap Fund. Over the years,
all segments of the funds have achieved very competitive returns when compared with
benchmark indices. The growth of the endowment has been enhanced by a conserva-
tive Laboratory drawdown policy of 4% per annum, based on a 3-year moving average
of previous year-end market value. In very strong markets such as those of recent years,
the drawdown has been held to less than targeted levels. In 1997, it was 3.7%. As a
result, the endowment has more than kept up with inflation and has made it possible to
expand the overall science program and react positively and quickly to opportunities cre-
ated by new discoveries.
A very important component of the endowment is the Science Fund, which was
established by the Board of Trustees in 1992. On December 31, 1997, it totaled
$5,452,000. The fund holds a portion of royalties and all of the equity positions received
by the Laboratory in return for the transfer of intellectual property to various biotech com-
panies based in whole or in part on CSHL technology. There are now 13 such compa-
nies, 4 of which have public markets. The estimated value of these equity positions on
December 31, 1997, was $3,748,000, which is believed to be very conservatively stated.
The Trustees have designated the Science Fund to be used for the support of future sci-
ence, and it is hoped that as some of these ventures mature, their value will become an
important source of funding for the Laboratory research. In this manner, the value of intel-
lectual property created today may be recycled in the years ahead as future support for
science.
The development of a strategy to manage intellectual property at the Laboratory has
been primarily the responsibility of John Maroney, Director of Technology Transfer. John
and his associate Carol Dempster interact with the scientists, patent attorneys, and ven-
ture capitalists to make viable commercial ventures of the Laboratory's discoveries; the
very good results of their efforts speak for themselves. The Laboratory is now thought of
as a leader in the management of intellectual property and its practices are being emu-
lated by many other research centers.
The Buildings and Grounds Department, led by Art Brings, had another very pro-
ductive year marked by the dedications in June and October, respectively, of the Mary
D. Lindsay Child Care Center and the Richards Building and facilities complex. A high
point of the latter was the marvelous music provided by the Corinthians, led by Bill Grover
of Centerbrook Architects, of Essex, Connecticut, who played a mean saxophone. Bill's
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presence reminded us all of the enormous contributions that he, Jim Childress, and so
many of the other Centerbrook architects and technicians have made to the style and
beauty of our campus. So it was with great pleasure that we heard early this year that
Centerbrook had been named the recipient of the 1998 Architecture Firm of the Year
Award by the American Institute of Architects.
Other important Building and Grounds projects included the $1.7 million replace-
ment of the complete HVAC systems in Demerec Laboratory and Bush Auditorium, which
was accomplished, with the help of a cool summer, without shutting down the facilities.
The lighting systems in these buildings and in DelbrOck Laboratory were also upgraded,
and throughout the Laboratory, all high-horsepower variable-speed drives were
replaced. Savings from these renovations and previously completed energy savings pro-
grams should exceed $300,000 on an annual basis. The former Mathews' laboratory in
Demerec was completely rebuilt, and in Beckman Center, a laser lab, wet lab, and office
were created for Karel Svoboda from previous storage areas. In 1999, Karel will move
his new photon laser imaging technology to the Edward and Nancy Marks Imaging
Building, which is now under construction. The new imaging technology makes it possi-
ble for the first time to study individual neurons and circuits in the brain of living and
behaving animals.
Much appreciated by the Laboratory staff are two newly constructed sand volleyball
courts and a state-of-the-art fitness center. Under the very able direction of Dan Miller,
the overall Laboratory grounds have never looked better. There is much new landscap-
ing on the north campus near Ballybung, and Airs lie, and around the new Lindsay Child
Care Center and the Richards Building and facilities complex. Much credit should also
be given to the people who provide the constant internal and external maintenance of our
more than 50 buildings on the main campus, Banbury Center, the DNA Learning Center,
and at Uplands Farm.
During the year, there were significant changes in the leadership of important admin-
istrative areas-development, public affairs, and library services. These were previously
the sole responsibility of Susan Cooper, who has moved on to a new challenge as
Director of Institutional Advancement at the Trudeau Institute in Saranac Lake, New York.
As discussed earlier in the Highlights section of this report, Susan contributed greatly to
a broad spectrum of Laboratory activities and she is sorely missed. Prior to her depar-
ture, it had been decided to separate the departments of Development and Public Affairs
and recruit new leadership for each. After an extensive search, we were successful in
attracting Rick Cosnotti, who joined us in November as Chief Development Officer. Rick
has had many years of professional experience with major gifts and capital campaigns
with the well-known development consulting firm of Ketcham, Inc. Most recently, he was
Director of Development of the Episcopal Theological Seminary of New York. After a short
stay in a Williams House apartment, Rick and his wife Shari, who is the new Curate at St.
John's of Cold Spring Harbor, are now happily moved into the Galehouse residence on
the spectacular waterfront between Airs lie and Ballybung. As our new Chief
Development Officer, Rick will have his hands full with the large and important fund-rais-
ing tasks immediately ahead.
To direct Public Affairs, we have been fortunate in attracting Deborah Barnes, a fre-
quent visitor in the past to Laboratory meetings. Deborah has a Ph.D. in biology from
Georgetown University, was a postdoc at Harvard Medical School, taught biology, wrote
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for the news department of the journal Science, and was Editor of the Journal of NIH
Research. She is now completing several assignments for the National Institutes of
Health and will join the Laboratory on a full-time basis in July. Her primary focus at the
Laboratory will be to increase the visibility of our research and education programs with
the media and to make our community outreach programs even more interesting.
For the Library, the task was relatively easy. We already had the able services of
Margaret Henderson as Head of Library Services, and we confidently appointed her as
the new Director of Libraries. Margaret will undertake a thorough study of our future
library needs, including the implications and fast-growing requirements of electronic
media. With the help of a consultant, she will draw up a plan for improving the organiza-
tion and usefulness of the very important archives of the Laboratory's 108-year history.
As the Laboratory continues to grow, the task of managing its finances has become
more complex. Our long-term Controller, Bill Keen, can be counted on to make all sur-
prises pleasant ones, and he deals most efficiently with the frequently changing stan-
dards for not-for-profit fund accounting. In October, Bill's assistant Kathy Didie, moved to
a position at CMP Media, Inc. We are fortunate to have as her replacement Lari Russo,
who joined the Laboratory in January, in time to be much involved in the year-end clos-
ing, annual audit, and 1998 budget.
The Grants Management, Human Resources, and Purchasing Departments, under
the leadership of Susan Schultz, Cheryl Sinclair, and Phil Lembo, respectively, each year
provide effective and very necessary support across a broad spectrum of Laboratory
activities. Roberta Salant, Administrative Assistant to both John Maroney and me, also
manages the often-complex task of providing for the meeting arrangements and other
needs of our Board of Trustees and its many committees.
As we look forward to the years immediately ahead, there are several important new
projects in various stages of development that would substantially expand the scope of
the Laboratory's activities. In November, the Board of Trustees, subject to the approval
of the N.Y. State Board of Regents, decided to establish a graduate degree-granting pro-
gram at the Laboratory. A graduate school would complement our long-standing pro-
gram with SUNY Stony Brook, which currently involves approximately 50 students. The
new CSHL graduate school would be a unique accelerated program with a matriculating
class of about five students of exceptional caliber each year. As such, it would require
only minor refurbishment of existing facilities on our Laurel Hollow campus.
The Board of Trustees has also authorized the purchase of a 60,000-sq. ft. building
located on 12 acres in Woodbury near the Long Island Expressway. This facility would
be used by the Laboratory as a high-tech center for gene sequencing and DNA chip
technologies and as a home for the editorial and fulfillment activities of our academic
press.
In March, Governor George Pataki came to Long Island and announced his support
for a CSHL-associated Biotechnology Park. The Park would be fully financed by the State
of New York and located on property owned by SUNY at Farmingdale on Route 110,
about 20 minutes driving time from the Laboratory. The Park will be designed to attract
young companies that are commercializing new technologies from the Laboratory, as
well as other companies that are located elsewhere but would value close association
with the Laboratory's research and education programs. The 1998 New York State
Budget, which has now passed, includes approximately $14 million for this project.
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As we consider the challenges and opportunities inherent in these and other pro-
grams, we have decided to increase the depth of administrative management at the
Laboratory. We are very pleased that W. Dil laway Ayres, a resident of Laurel Hollow, has
agreed to join us as Associate Administrative Director. Dill is well known in the commu-
nity and at the Laboratory, where he has served as a Director of the CSHL Association.
He is a graduate of Princeton University and received an MBA from the Columbia
University Graduate School of Business Administration. He has extensive business expe-
rience in the areas of corporate planning and finance.
All in all, it is a very exciting time at the Laboratory. Our science and education pro-
grams are first-rate, and we have both the management and financial strength to be con-
fident of remaining a world center of biology.
G. Morgan Browne
Administrative Director
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TUMOR VIRUSES
A unifying feature of the investigations in the Tumor Viruses Section is the use of viruses to probe
cell function and to understand the processes affected during cell transformation. The viruses
used include adenovirus, human and bovine papillomaviruses, SV40, herpes simplex virus, and
human and simian immunodeficiency viruses. Arne Stenlund and Bruce Stillman study DNA
replication of papillomavirus and SV40, respectively. The Stillman laboratory complements stud-
ies of SV40 DNA replication with studies of cellular DNA replication in human and yeast cells.
Winship Herr and Masafumi Tanaka, Adrian Krainer, and William Tansey study control of gene
expression in human cells, in particular the control of transcription, pre-mRNA splicing, and pro-
tein stability, respectively. Yuri Lazebnik and Scott Lowe study how programmed cell death or
apoptosis is regulated in normal and cancer cells, and how changes in the regulation of apopto-
sis influence the response of cancer cells to chemotherapy. Jacek Skowronski studies virus/host-
cell interactions with human and simian immunodeficiency viruses, probing how the viral protein
Nef disrupts multiple aspects of signal transduction in T cells. The synergy between the study of
cellular processes and the study of how viruses affect those processes is readily apparent from
a reading of the following research descriptions.
DNA SYNTHESIS
B. Stillman S. Waga
J. Chong
G. Cullmann
V. Ellison
M. Hidaka
M. lizuka
C. Liang
J. Mendez
C. Mirzayan
K. Shibahara
K. Simpson H. Yang
A. Verreault L. Zou
M. Weinreich M. Waga
Y.-C. (Nancy) Du P. Wendel
K. Gavin C. Driessens
This year, our studies on the replication of DNA and
chromatin assembly in eukaryotes have progressed
rapidly with advances made in a number of areas.
More details have emerged about the proteins that syn-
thesize DNA at the replication fork and how the cell
cycle regulator protein, p21, controls the function of
the proliferating cell nuclear antigen (PCNA). We have
also found that the papillomavirus transforming pro-
tein, E7, modulates the function of the p21 protein,
reversing its PCNA inhibiting functions.
Our studies on chromatin assembly have focused
on the role of the chromatin assembly factor, CAF-1.
The year saw a major advance with the purification
and characterization of CAF-1 from the budding yeast,
Saccharomyces cerevisiae. Although CAF-1 was not
essential for cell division, the inheritance of epigenet-
ically determined transcription states of chromatin was
compromised. In human cells, we demonstrated that
CAF-1 exists in a complex with newly synthesized
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histones H3 and H4 that are modified by acetylation.
Finally, we have purified the human histone H4 acetyl-
transferase (HAT1) and have demonstrated that it con-
tains an essential histone-binding protein that is high-
ly related to a histone-binding protein subunit of CAF-
1.
In another important development, we have devel-
oped a chromatin-binding assay for DNA replication
proteins from S. cerevisiae and demonstrated that the
cellular initiator protein, ORC, is bound to yeast chro-
mosomes throughout the cell cycle. In contrast, the
mini-chromosome maintenance (MCM) proteins and
the Cdc45 protein (Cdc45p) are associated with chro-
matin in a cell-cycle-regulated manner. Particularly
interesting was the observation that Cdc45p loading
onto chromatin required activation of the S-phase-spe-
cific cyclin-CDKs that are essential for initiation of
DNA replication. Cdc45p loading also required the
assembly of ORC, the MCM proteins, and Cdc6p into
a prereplication complex at origins of DNA replica-
tion. The assembly of these protein complexes nor-
mally occurs only once per cell cycle, and we have
provided convincing evidence that the Cdc6 protein is
the mediator of this control.
As part of our efforts to understand the mecha-
nisms of initiation of DNA replication in mammalian
cells, we have continued to isolate the human ORC
proteins and to characterize the human Cdc6p. Studies
this year have resulted in the cloning of cDNAs encod-
ing human ORC4 and ORC5, and the demonstration
that the human CDC6 gene is regulated by the E2F
transcription factor, a finding that links initiation of
DNA replication to the cell cycle regulatory machin-
ery essential for commitment to cell division.
SV40 DNA Replication
V. Ellison, M. Waga, S. Waga, B. Stillman
This marks the 13th year that we have studied the
mechanisms of DNA replication using simian virus 40
(SV40) as a model system. Three years ago, we report-
ed the reconstitution of complete SV40 DNA replica-
tion with purified proteins, together with a fairly
extensive description of the mechanisms of DNA syn-
thesis at the replication fork. Apart from the virus-
encoded T antigen, all of the proteins were from
human or bovine cells. Some of the interesting mech-
anisms that occur at the replication fork, for synthesis
of both leading (continuously synthesized) and lag-
ging (discontinuously synthesized) strands, are the
steps that require the proliferating cell nuclear antigen
(PCNA) and replication factor C (RFC). This involves
loading of a trimer of PCNA, the clamp that ties the
DNA polymerase to the template DNA, by the RFC
ATPase protein. To facilitate further mechanistic stud-
ies on this step, a better understanding of the regula-
tion of clamp loading and the extensive protein-pro-
tein interactions between PCNA and other proteins
that function at the replication fork, we have expressed
recombinant human RFC in various baculovirus vec-
tors and have purified the recombinant RFC (rRFC).
The five-subunit rRFC has all of the same activities as
the RFC purified from human cells, including DNA-
and PCNA-activated ATPase activity, DNA binding,
and an ability to support SV40 DNA replication in
vitro. The large 140-kD subunit protein is essential for
the PCNA-stimulated ATPase activity, although a
four-subunit complex containing the RFC small sub-
units (40 kD, 38 kD, 37 kD, and 36 kD) and a three-
subunit complex (40 kD, 37 kD, and 36 kD) have
DNA-activated ATPase activity that cannot be stimu-
lated by PCNA. The rRFC expressed from the five
separate baculovirus vectors will enable us to charac-
terize the role of RFC more extensively.
A new PCNA clamp loading assay requiring ATP,
replication protein A (RPA), RFC, and a single-strand-
ed DNA with an annealed primer was developed and
used to demonstrate that RFC remains bound to the
PCNA-DNA complex after it loads PCNA onto the
DNA. We have shown previously that the cell cycle
regulator protein p21 blocks PCNA-dependent DNA
replication, and using the new DNA-binding assay, we
have now shown that p21 becomes part of the
PCNA-DNA complex via its interaction with PCNA.
p21 remains stably bound to the PCNA and stimulates
the dissociation of RFC from the DNA-protein com-
plex. These results suggest that p21 blocks a PCNA-
dependent step during either polymerase loading or
subsequent polymerase activity. Since p21 binds inde-
pendently to cyclin-dependent protein kinases, the
new data suggest the possiblity that the p21-PCNA
complex on the DNA attracts these cell cycle regula-
tors to the DNA. These interactions are currently
being tested.
In a productive collaboration with Denise
Galloway and her colleagues at the Fred Hutchinson
Cancer Center in Seattle, we have shown that the
human papillomavirus (HPV) E7 protein can abrogate
the effect of the p21 protein on PCNA replication
functions. The E7 protein from the highly oncogenic
HPV type 16, but not the nononcogenic HPV type 6,
can block the p21-induced inhibition of PCNA stimu-
lation of the DNA polymerase and can also block the
inhibitory effect of p21 on the human cyclin-depen-
dent protein kinases. Thus, the oncogenic form of the
E7 protein targets the p21 protein, which is regulated
by the tumor suppressor protein p53, by altering
PCNA function in much the same way as the E7 pro-
tein blocks the function of the retinoblastoma (Rb)
tumor suppressor. These results provide further bio-
logical evidence for a role for the p21-PCNA interac-
tion in modulating DNA replication and thereby
effecting genome stability.
As a result of a successful sabbatical visit to Cold
Spring Harbor by Nicholas Muzyczka some years ago,
we have continued to collaborate with Nick and his
colleagues (University of Florida, Gainesville), who
have demonstrated that adeno-associated virus (AAV)
DNA replication can occur in human cell extracts in
the absence of adenovirus proteins. Many of the same
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human cell proteins that support SV40 DNA replica-
tion are also used by AAV to replicate the viral
genome, along with the AAV-encoded Rep78 initiator
protein. These cellular proteins include RPA, PCNA,
RFC, and as yet unidentified proteins that are not
required for SV40 DNA replication.
Replication-dependent
Chromatin Assembly
K. Shibahara, A. Verreault
Concomitant with studies on the mechanism of DNA
replication, we have been studying the replication-
dependent assembly of chromatin, a process that
requires a three-subunit protein called chromatin
assembly factor-1 (CAF-1). Last year we reported
identification of the CAF-1 genes from the yeast S.
cerevisiae and the observation that the CAF genes are
essential for the inheritance of epigenetically deter-
mined transcription states of chromatin, such as
silencing of genes adjacent to telomeres. Others have
extended this observation by demonstrating that CAF-
1 is essential for inheritance of the silent state of mat-
ing-type genes on chromosome III in the budding
yeast. Current studies are aimed at determining
whether other epigenetically determined states are
dependent on CAF-1 and how CAF-1 links the main-
tenance of these transcription states of chromatin to
DNA replication.
The smallest subunit of CAF-1 in human (p48) and
yeast cells (Cac3p) is a member of a family of proteins
called the WD40 repeat proteins because of the pres-
B-type H4
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ence of a repeated amino sequence motif (WD40) in
the protein. Another protein from human cells, called
p46, is highly related to the CAF-1 p48 subunit and is
also similar to a protein in the budding yeast that is a
subunit of the histone H4 acetyltransferase, HAT1. We
have purified the human HAT1 enzyme and shown
that it contains two subunits: one is the p46 WD40
repeat protein and another is an ortholog of the bud-
ding yeast acetyltransferase, HAT1. Like the yeast
counterpart, the human HAT1 enzyme acetylates his-
tone H4 on lysine residues located at positions 5 and
12 from the amino terminus of the protein.
Characterization of the two subunits of human HAT1
shows that the activity of the acetyltransferase catalyt-
ic subunit is greatly stimulated by the p46 subunit.
Both the HAT1 p46 protein and the p48 CAF-1 sub-
unit bind tightly to an a-helix in the amino terminus of
histone H4, and this binding facilitates the acetyltrans-
ferase activity. A summary of the protein complexes
that contain either p46, p48, or their orthologs is
shown in Figure 1.
Interestingly, the p46 or p48 interaction with the
histone cannot occur if the histone is assembled into a
nucleosome, suggesting that the HAT1 enzyme can
only modify histone H4 when the histone amino ter-
minus is free, such as during DNA replication or per-
haps nucleosome remodeling. In this context, it is
interesting that a nucleosome remodeling factor from
Drosophila called NURF and the histone deacetylases
HDAC1 and HDAC2 from human cells contain p48 or
its Drosophila ortholog, as a subunit. We suggest that
acetylation of these residues in histone H4, commonly
associated with silenced transcriptional states of chro-
matin, can only be modified during DNA replication
of locus-specific nucleosome remodeling.
Core histone
t et ramer assembly factor (CAF1)
Nucleosome
Histone deacetylases Remodeling Fact or
(NURF)
H. sapiens S. cerevisiae H. sapiens S. cerevisiae D. melanogaster H. sapiens S. cerevisiae
p150 Cac1 p180/ 105 (Sin3A, B) Sin3
Catalytic
subunits
Histone
binding subunits
Catalytic
subunits
D. melanogaster
FIGURE 1 Protein complexes containing the p48/p46 proteins and their orthologs in S. cerevisiae and Drosophila. (CAF-
1) Chromatin assembly factor 1; (HDA1 and HDA2) histone deacetylases; (HAT) histone acetyltransferase; (NURF)
nucleosome remodeling factor.
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FIGURE 2 Model for the initiation of DNA replication in the yeast S. cerevisiae.
The proteins are ORC, origin recognition complex; MCM, mini-chromosome main-
tenance proteins; APC, anaphase promoting complex, a ubiquitin ligase E3 that
causes degradation of Clb cyclins; Cdc4, Cdc34, Cdc53, Skpl, a ubiquitin lig-
ase E3 that causes degradation of Sicl p, a Clb-Cdc28p kinase inhibitor; Cdc45p
and Cdc6p, proteins that function in initiation; Cdc7p-Dbf4p, a protein kinase
required for initiation.
Initiation of Chromosomal
DNA Replication in Yeast
J. Chong, Y.-C. Du, C. Liang, P. Wendel,
M. Weinreich, L. Zou
Our studies on the mechanism of initiation of chromo-
somal DNA replication have progressed to the stage
where we can obtain the first glimpses of how the cell
cycle machinery controls entry into S phase and how
DNA replication occurs only once per cell division
cycle. Indeed, the progress in this field by a number of
laboratories, since our 1991 discovery of the origin
recognition complex (ORC), the cellular initiator pro-
tein, has been dramatic. In the last year, we have frac-
tionated yeast cells into various biochemically distinct
fractions that enable us to determine whether proteins
are associated with the cellular chromatin and, if so,
during which stages of the cell division cycle.
The majority, if not all, of ORC, which contains
six subunits, is tightly bound to yeast chromatin
throughout the cell division cycle, whereas the Orc 1 p-
related protein, Cdc6p, is only chromatin-associated
during a period from exit from mitosis to late G1. The
six mini-chromosome maintenance (MCM) proteins,
which are known to be required for the initiation of
DNA replication, associate with the chromatin during
G1 and are gradually released during S phase. Only a
subset of the available MCM proteins associate with
chromatin, and a large protein complex containing
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ORC, Cdc6p, and the six MCM proteins, perhaps with
other proteins, forms what John Diffley has termed the
pre-replication complex (pre-RC; Fig. 2).
Last year, we reported the isolation of the gene
encoding Cdc45p, a protein implicated by genetic
means to interact with the MCM proteins. We have
now shown that Cdc45p associates with chromatin
only after activation of the S-phase cyclin-dependent
kinases (Clb5p- Cdc28p and Clb6p- Cdc28p) and
degradation of the CDK inhibitor protein p40 Sic 1 p.
In contrast, Cdc45p was fully loaded onto chromatin
prior to the Cdc7 protein-kinase-dependent step, the
last known regulatory stage prior to entry into S phase.
Thus, the association of Cdc45p with chromatin
defined an S-phase-specific cyclin-dependent assem-
bly of a new complex we have called the pre-initiation
complex (pre-IC).
We have also shown that the Cdc45p binds to the
MCM proteins in a cell-cycle-dependent manner. The
association between Cdc45p and the MCM proteins
most likely occurs concomitant with the association of
Cdc45p with chromatin. Indeed, we have shown that
Cdc45p loading onto chromatin requires functional
Cdc6p and Mcm2p. Recently, Stephen Bell and his
colleagues have shown that Cdc45p associates with
origins of DNA replication in late G1. Although
Cdc45p loading onto chromatin follows binding of the
MCM proteins, the MCM proteins and Cdc45p appear
to dissociate from chromatin by independent mecha-
nisms. A model for some of the events that occur dur-
ing the initiation of DNA replication is shown in
Figure 2.
We have also characterized further the mutants in
the CDC6 gene that cause overreplication of the DNA
in a single cell cycle. In the cdc6-3 mutant cells, initi-
ation at origins of DNA replication is deregulated and
can recur in late G2 of the cell cycle, causing accumu-
lation of more than 2C content of DNA in a haploid
cell, a lethal event. We have now shown that in the
cdc6-3 mutant cells, the MCM proteins are associated
with the chromatin in late S phase and in G2 phase of
the cell cycle, stages when they are normally not chro-
matin-associated in wild-type cells. This argues that
the pre-RC is either stable or can be formed after S
phase, in the presence of the mutant Cdc6p and Clb
cyclin-CDKs. These S-phase and M-phase cyclin-
CDKs normally prevent formation of the pre-RC late
in the cell cycle. Since Cdc6p is a known target of the
cyclin-CDKs, the cdc6-3 results suggest that Cdc6p is
the key target for the control that ensures once -per-
cell -cycle replication.
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Initiation of Chromosomal DNA
Replication in Human Cells
M. lizuka, J. Mendez, K. Simpson, X. H. Yang
The isolation of cDNAs encoding the human Cdc6p
has enabled more detailed analysis of the regulation of
this key protein. In collaboration with R. Sanders
Williams (University of Texas, Southwestern Medical
School) and Joseph Nevins (Duke University) and
their colleagues, we have shown that transcription of
the human CDC6 gene is controlled by the E2F tran-
scription regulatory factor, itself a target of the Rb
tumor suppressor protein. In unpublished studies, we
have demonstrated that the amount of human Cdc6p is
cell-cycle-regulated and is absent or at a low level in
cells in very early G1 phase, arguing that the timing of
establishing competent origins of DNA replication is
different in mammalian cells from that in yeast cells.
As part of our studies to identify proteins that are
involved in the initiation of human chromosome repli-
cation, we have previously identified human Orc 1 p
and Orc2p. During this year, in collaboration with Tim
Hunt and his colleagues (Imperial Cancer Research
Fund, U.K.), we have identified human and Xenopus
Orc4p and human Orc5p and have isolated cDNAs
encoding these proteins.
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MOLECULAR BIOLOGY OF PAPILLOMAVIRUSES
A. Stenlund C. Sanders G. Chen
E. Gillitzer A. Lee
The papillomaviruses infect and transform the basal
epithelium in their hosts, inducing proliferation of the
cells at the site of infection. The resulting tumors are
in most cases benign and will usually regress after
some time, but certain types of human papillo-
maviruses (HPVs) give rise to tumors that are prone to
progress toward malignancy, especially frequently
cervical carcinoma. In total, HPV DNA can now be
found in biopsies from approximately 80% of all cer-
vical carcinomas.
A key impediment to the study of papillomavirus-
es has been the inability to define a simple in vitro cell
culture system for human papillomaviruses, largely
due to the fact that these viruses normally require spe-
cialized differentiating cells that can only with great
difficulty be generated in cell culture. Therefore, a
bovine papillomavirus type 1 (BPV-1) has become the
prototype virus for the papillomavirus group largely
because a convenient cell culture system exists for this
virus. In this cell culture system, viral gene expres-
sion, oncogenic transformation, and viral DNA repli-
cation can be studied. The DNA replication properties
of papillomaviruses show some unique and interesting
characteristics. As a part of their normal life cycle,
these viruses can exist in a state of latency which is
characterized by maintenance of the viral DNA as a
multicopy plasmid in the infected cells. The copy
number of the viral DNA appears to be tightly con-
trolled, and the viral DNA is stably inherited under
these conditions. This system therefore provides a
unique opportunity to study plasmid replication in
mammalian cells.
In previous years, we have reported the character-
ization of the papillomavirus replicon and the identifi-
cation of the viral components that are required for
viral DNA replication. More recently, we have direct-
ed our attention toward detailed biochemical analysis
of the replication process. We are studying the bio-
chemical properties of the virus-encoded El and E2
proteins that are required for viral DNA replication.
We are also studying how these two proteins interact
with the on and with each other to generate initiation
complexes. From these studies, we now have a rela-
tively clear picture of the roles of the El and E2 pro-
teins in replication. El has all the characteristics of an
initiator protein, including on recognition, DNA-
dependent ATPase activity, and DNA helicase activity.
El can also function to unwind a supercoiled plasmid
that contains the on sequence. The E2 polypeptide,
whose function has remained more elusive, appears to
serve largely as a specificity factor for El. Through
physical interactions with both El and the ori, E2 can
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provide sequence specificity in the formation of the
initiation complex.
Our attention has now turned toward elucidation
of the precise biochemical events that precede initia-
tion of replication at the origin of replication, i.e.,
binding of the initiator to the ori, the initial opening of
the DNA helix, and the assembly and loading of the
El replication helicase at the replication fork. Our
studies indicate that initiation of DNA replication is an
ordered multistep process involving the sequential
assembly of El onto the ori to generate different com-
plexes that in turn serve to recognize the ori, destabi-
lize the double helix at the ori, and function as a repli-
cation helicase.
Interactions between the
El and E2 Proteins
G. Chen, M. Berg
In most eukaryotic replicons that have been studied,
binding sites for transcription factors constitute a part
of the cis-acting sequences required for replication
activity. In the majority of cases, including, for exam-
ple, SV40, polyomavirus, and ARS elements from
Saccharomyces cerevisiae, this auxiliary activity can
be supplied by various transcriptional trans-activators
with little apparent specificity. A similar requirement
exists also for papillomavirus replicons; however,
only the virus-encoded transcription factor E2 can
serve as an auxiliary factor for replication. The
involvement of E2 in replication of BPV extends
beyond a mere requirement for E2 bound to the ori: A
physical interaction with El is also required. This
interaction can be detected as cooperative binding of
the two proteins to the ori, when the respective bind-
ing sites are located in the correct position relative to
each other. Because the E2 proteins are well conserved
between different papillomaviruses and have a con-
served overall structure, we tested E2 proteins from
other papillomaviruses for interaction with BPV El
and for replication. E2 from HPV-11 failed to interact
with BPV El in either of these assays. This observa-
tion presented us with an opportunity to map the
regions of E2 that were required for this interaction by
construction of chimeric BPV/HPV-11 E2 proteins.
These chimeras were tested for their ability to interact
physically with BPV El in a biochemical assay and
for the ability to support replication in vivo. The
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results from these experiments have revealed a more
complex situation than we had anticipated. We find
that multiple regions from both the amino-terminal
trans-activation domain of E2 and the carboxy-termi-
nal "hinge" and DNA-binding domain cooperate to
generate a strong interaction with El. The interaction
between the El and E2 proteins appears to take place
in a two-step process where an initial weak physical
interaction between El and the DNA-binding domain
of E2 allows a stronger, productive interaction to
occur between El and the activation domain of E2.
The specificity of the interaction between El and E2
resides in the first step, i.e., in the interaction between
El and the DNA-binding domain of E2, whereas the
activation domains of both BPV E2 and HPV-11 E2
are equally capable of interacting with El. We have
recently used site-directed mutagenesis to identify the
specific residues in the E2 DNA-binding domain that
are required for the interaction with El. These studies
map a small patch of residues in the DNA-binding
domain of E2 that are important for the interaction
with El, verifying the specificity of this interaction
and allowing us to address the importance of this pro-
tein-protein interaction in the viral life cycle.
The DNA-binding Domain of
the Initiator Protein El
G. Chen
The initiator protein El has a poorly characterized
DNA-binding activity which serves to recognize the
papillomavirus origin of DNA replication and thus
determines where DNA replication initiates. We have
previously established that El can form several differ-
ent complexes with ori DNA. To understand how these
forms are generated and how they function in replica-
tion, we are interested in determining the stoichiome-
try of binding as well as defining the sequences that
constitute specific recognition sequences for El. We
have identified and isolated a minimal domain from
El that is capable of binding specifically to the ori.
This domain, which consists of the sequences between
amino acids 142 and 308 in El, can form several dif-
ferent complexes with the ori as judged from gel-shift
analysis and can also bind cooperatively with the E2
protein. To determine the stoichiometry of binding, we
performed mixing experiments using two DNA-bind-
ing domain fragments of different sizes. The results
from these studies demonstrated that the El DNA-
El E2-ori (El )n+-ori
Ori specificity E2-containing Ori distorting complex Helicase
complex intermediates
FIGURE 1 Proposed assembly pathway for initiator complexes on the BPV origin of DNA replication. The ini-
tiator El, together with E2, forms a highly sequence specific-complex on the ori (El E2-ori). This complex can
be converted to the El-on complex by the addition of El molecules and displacement of E2, in a reaction that
requires ATP hydrolysis. The El-ori complex has a low degree of sequence specificity and displays on dis-
torting activity. The conversion of the El-ori complex to the hexameric El helicase as shown at the right in the
figure is hypothetical.
binding domain, which is monomeric in solution, can
bind to the ori as one to four monomers. Interference
analysis in combination with mutational analysis
demonstrated that each monomer of El recognizes a
hexameric sequence which exists in four copies in the
ori sequence. The preferred form of El binding is as
two monomers which is also the form of El that binds
cooperatively with the E2 protein. A very striking and
unexpected finding is that although the DNA-binding
domains of El and SV40 T antigen show no homolo-
gy and the recognition sequences for these two pro-
teins are unrelated, the arrangement of the binding
sites for the two proteins are similar, indicating that
the positions of the binding sites might have function-
al significance in the biochemical activities of these
proteins, possibly in the process of unwinding of the
ori.
El Forms a Hexameric Structure
That Has DNA-dependent ATPase
and DNA Helicase Activities
J. Sedman
The El protein has been demonstrated to have both
DNA-dependent ATPase activity and DNA helicase
activity. All DNA-dependent DNA helicases to date
have been shown to have nucleotide hydrolysis capac-
ity. To identify the form of El that has ATPase activi-
ty, we assembled El under conditions used for ATPase
assays and sedimented the material on a glycerol gra-
dient. When the gradient was assayed for ATPase
activity, interestingly, the activity was found to sedi-
ment as a discrete peak with a relative molecular mass
of 400-450 kD, which is substantially than
either a monomer of El or the trimeric complex of El
that we have previously analyzed. Further molecular
mass analysis of this form of El using gel filtration
has revealed that the molecular weight is consistent
with a hexameric form of El. When isolated from a
glycerol gradient, this complex has DNA helicase
activity, indicating that the hexamer constitutes the
active helicase. A requirement for the formation of the
hexameric El complex is single-stranded DNA which
is stably associated with the hexamer.
Assembly of Initiator Complexes
C. Sanders
An intriguing aspect of viral initiator proteins is their
ability to perform several different, seemingly unrelat-
ed biochemical functions. The El protein is known to
be a sequence-specific DNA-binding protein, but it
can also distort the ori and serve as a DNA helicase.
One model to explain how these activities can reside
in one single polypeptide is that different oligomeric
forms of the protein may have different activities. Our
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previous genetic and biochemical studies have indicat-
ed that both of the two specific El-containing com-
plexes that we can detect on the ori are important for
initiation of DNA replication. These two complexes,
which we have termed the ElE2-ori complex and the
El-ofi complex, differ in that E2 is present in one of
the complexes and also that a larger number of El
molecules are present in the E 1 -ori complex.
However, the complexes are clearly related in that the
El molecules bound in the E1E2-ori complex consti-
tute a subset of the El molecules bound in the El -ofi
complex. To address whether these two complexes
constitute stages in an assembly pathway, we have
analyzed their biochemical properties as well as their
relation to each other. These studies have revealed a
very interesting relationship between the two com-
plexes, consistent with a role for both complexes in
the ordered assembly of an initiator complex on the
BPV on (see Fig. 1). The EIE2 -ori complex binds to
the ori with very high affinity and specificity, whereas
the El-ori complex shows limited sequence specifici-
ty. By using an epitope-tagging technique to follow
the fate of the El molecules from one particular com-
plex, we have been able to demonstrate that the E1E2-
ofi complex is a preferred substrate for the formation
of the El-ori complex. In a reaction that requires
hydrolysis of ATP, the E1E2-ori complex can be con-
verted into the El -ori complex. As a consequence of
this reaction, E2 is displaced from its binding site and
additional El molecules are added to the complex.
TRANSCRIPTIONAL REGULATION
W. Herr D. Aufiero
M. Tanaka R. Babb
R. Freiman
C. Grozinger
C. Hinkley
C. Huang P. Reilly
C. Hunt-Grubbe W. Tansey
Y. Liu T. Tubon
V. Meschan K. Wu
J. Reader X. Zhao
We use human viruses, in particular herpes simplex
virus (HSV), as models to understand how transcrip-
tion is regulated in human cells. Viruses provide sim-
ple regulatory networks in which the cellular tran-
scriptional machinery is altered to achieve the goals of
viral infection. In a cell infected by HSV, the virus can
grow lytically-rapidly killing the host cell-or
remain latent for many years. In the lytic cycle, HSV
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Because the El-ori complex formed from the E1E2-
ori complex appears to be identical to the El-ofi com-
plex formed in the absence of E2, these results identi-
fy a role for the viral transcription factor E2 as a fac-
tor required transiently and catalytically for the
assembly of the initiator complex. One clear implica-
tion of these results is that a crucial function for E2 in
DNA replication is to form a cooperative complex
with El, increasing the specificity and affinity of El
binding. Thus, this pathway identifies a strategy for
depositing a complex with limited sequence specifici-
ty (the El -ori complex) onto a specific site. This is
accomplished through the initial formation of the
sequence-specific ElE2-ori complex which subse-
quently is converted to the less sequence-specific El -
ori complex.
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gene expression is initiated by a viral transcription
factor called VP16, which is carried in the virion.
Before activating transcription, VP16 forms a multi-
protein-DNA complex-the VP16-induced com-
plex-on viral immediate-early promoters with two
cellular proteins: HCF, a protein that regulates cell
proliferation, and Oct-1, a POU-homeodomain tran-
scription factor. Once the VP16-induced complex is
assembled, VP16 initiates viral gene transcription
through a potent transcriptional activation domain.
Our research is focused on three principal issues:
(1) How do transcriptional regulators activate the
basal transcriptional machinery? (2) How do tran-
scription factors, as in the VP16-induced complex,
modify their transcriptional activity through selective
protein-protein and protein-DNA interactions? (3)
What are the natural cellular roles of HCF and Oct-1,
and how do they influence HSV infection?
Transcriptional Activation
C. Hinkley, W. Tansey, T. Tubon, X. Zhao
We use transcriptional activators to study how regula-
tory information is transferred from transcription fac-
tors to the basal transcriptional machinery assembled
at the start site of transcription. In vivo, it is difficult
to study how the basal transcriptional machinery
responds to activators because the basal factors are
highly conserved, ubiquitously expressed, and proba-
bly essential proteins. Thus, there is no direct way to
study basal factors within a cellular context. To over-
come these limitations, we alter the specificity of
interactions between components of the basal machin-
ery by mutagenesis, which permits the activity of
mutant basal factors to be monitored in the presence of
their wild-type counterparts.
Last year, we successfully assembled two altered-
specificity interactions in sequence: an altered TATA
box-TBP interaction developed by K. Struhl (Harvard
University) and an altered TBP-TFIIB interaction that
we developed. This altered TATA-TBP-TFIIB array
allows us to study in human cells the structure and
function of TBP, the TATA box-binding protein, and
TFIIB, another general core promoter transcription
factor that binds to TBP when TBP is bound to the
TATA box. Using this TATA-TBP-TFIIB array, we
showed that different transcriptional activation
domains use the known TBP-TFIIB interaction differ-
ently: Whereas activation domains derived from viral
(e.g., VP16) and some cellular (e.g., p53 and CTF)
transcriptional activators depend on this interaction to
activate transcription in vivo, a transcriptional activa-
tion domain derived from the cellular activator Spl
does not rely on this TBP-TFIIB interaction. This
result suggests that transcriptional activation in vivo
can be achieved through differential reliance on inter-
actions between core components of the basal machin-
ery, a theme we have observed previously in other
studies of TBP.
The sequential altered-specificity TATA-TBP-
TFIIB array also allows us to probe the surfaces of
TFIIB required for transcriptional activators to stimu-
late transcription in vivo. The amino-terminal region
of TFIIB has been implicated in interactions with
RNA polymerase and the basal transcription factor
TFIIF and contains a zinc-binding domain. To study
its role in transcriptional activation in vivo, we have
analyzed the ability of a series of amino-terminal
TFIIB deletions to support activation of transcription
in vivo by the cellular CTF transcriptional activation
domain. Results of these studies indicate that the
TFIIB zinc-binding domain is important to support
activation of transcription by the CTF transcriptional
activation domain in vivo. We now plan to examine
what activity or activities of the zinc-binding domain
are important to support this activated transcription.
Modification of Transcription Factor
Activity Through Selective Protein-
Protein and Protein-DNA Interactions
D. Aufiero, R. Babb, C. Huang
The activity of eukaryotic transcriptional regulators
can be modified by coregulators. For example, Oct-1,
which is broadly expressed in human cells, acquires
cell-specific promoter activation properties through
association with both viral and cellular coregulators.
In HSV-infected cells, Oct-1 activates HSV immedi-
ate-early (IE) gene transcription after associating with
the HSV trans-activator VP16 and HCF on HSV IE
promoters. In B cells, Oct-1 activates immunoglobu-
lin-gene transcription after associating with the B-cell
factor OCA-B on immunoglobulin-gene promoters.
Oct-1 interacts with VP16 and OCA-B through its
POU domain, a bipartite structure consisting of an
amino-terminal POU-specific domain joined by a
flexible linker to a carboxy-terminal POU-home-
odomain. In the absence of VP16 or OCA-B, Oct-1
preferentially activates transcription from small
nuclear RNA (snRNA) promoters, a class of cellular
promoters studied by the Hernandez laboratory here at
CSHL. Previously, we have shown that VP16 associa-
tion with Oct-1 alters the transcriptional activity of
Oct-1 in two ways: It (1) provides a transcriptional
activation domain that activates mRNA promoters,
such as the viral HSV IE promoters, better than
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snRNA promoters, and (2) stabilizes Oct-1 on the
VP16-response elements found in the HSV IE promot-
ers.
To study Oct-1 coregulator interactions more
extensively, we have analyzed the functional proper-
ties of OCA-B. We found that OCA-B functions anal-
ogously to VP16: It contains an activation domain that
preferentially activates mRNA-type promoters and it
stabilizes Oct-1 binding to DNA. OCA-B, however,
interacts with a different surface of the DNA-bound
Oct-1 POU domain than does VP16. VP16 interacts
primarily with the Oct-1 POU-homeodomain, whereas
OCA-B interacts with both the POU-specific and
POU-homeodomains. Indeed, the OCA-B and VP16
interactions with the Oct-1 POU domain are suffi-
ciently different to permit OCA-B and VP16 to bind
the Oct-1 POU domain simultaneously. These results
emphasize the structural versatility of the Oct-1 POU
domain in its interaction with coregulators.
Virus/Host Cell Interactions: The HSV
VP16-induced Complex
R. Freiman, C. Grozinger, C. Hunt-Grubbe,
Y. Liu, P. Reilly, K. Wu
HSV must maintain an intimate relationship with the
host cell to remain latent for many years and yet retain
the ability to grow lytically. Because VP16 associates
with the cellular proteins HCF and Oct-1 to initiate
HSV gene expression during lytic infection, we
hypothesize that HCF and Oct-1 are key regulators of
which mode of infection-latent or lytic-HSV enters.
We are therefore interested in the natural cellular roles
of HCF and Oct-1, and how these roles may influence
HSV infection. We focus primarily on the cellular
functions of HCF because HCF has been highly con-
served during evolution and is involved in cell prolif-
eration.
Human HCF is synthesized as a large approxi-
mately 2000-amino-acid precursor protein, which is
proteolytically cleaved to generate a family of associ-
ated amino- and carboxy-terminal polypeptides. Only
the amino-terminal 380 residues of HCF, however, are
required to associate with VP16 and to stabilize VP16-
induced complex formation. Sequence similarity to
other proteins, including one of known structure, indi-
cates that this amino-terminal region of HCF, which
we refer to as the HCFvic domain, forms a structure
resembling a six-bladed propeller.
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In collaboration with T. Nishimoto and colleagues
(Kyushu University), we have characterized a hamster
cell line that has a temperature-sensitive defect in cell
proliferation caused by a missense mutation in the
HCF gene. This missense mutation lies within the
HCF,L, domain and affects the ability of VP16 to acti-
vate transcription and associate with HCF. These
results indicate that VP16 targets a part of the cell
machinery important for cell proliferation and suggest
that VP16 mimics a cellular cofactor of HCF function
that is involved in cell proliferation.
To identify a cellular factor mimicked by VP16,
we asked what human proteins can associate with the
HCF,ic domain in a yeast two-hybrid screen. Such a
two-hybrid screen revealed a single candidate: a basic
leucine-zipper protein called LZIP. Consistent with
VP16 mimicry of LZIP, VP16 and LZIP share the
same tetrapeptide motif-D/EHXY-to associate with
human HCF. Figure 1 shows how we identified this
shared tetrapeptide HCF-binding motif. We individu-
ally substituted each of nine residues spanning the
tetrapeptide motif in VP16 and LZIP and assayed the
effect of each substitution on association with endoge-
nous HCF in a coimmunoprecipitation assay after
transient expression in human cells. Only substitution
of the three conserved residues in the tetrapeptide
motif (the first, second, and fourth positions) in both
proteins had a severe effect on association with HCF.
The association of LZIP with HCF through this
tetrapeptide HCF-binding motif has apparently been
conserved during evolution because an LZIP-related
protein in Drosophila called BBF-2 or dCREB-A also
contains a related HCF-binding tetrapeptide motif.
These results suggest that to control HSV infection,
VP16 mimics the human basic leucine-zipper protein
LZIP, which through association with HCF may con-
trol cell cycle progression.
A Genetic Analysis of
Transcriptional Synergy
in Yeast
M. Tanaka
Many eukaryotic promoters contain multiple binding
sites for transcriptional activators, which synergize
with one another to activate transcription. For this
synergistic transcriptional activation to occur, the
exact combinations or positions of activator-binding
sites within a promoter do not appear to be generally
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FIGURE 1 LZIP and VP16 share a small HCF-binding motif. Epitope-tagged wild-type or nine sub-
stitution mutants of LZIP (upper panels) and VP16 (lower panels) were transiently expressed in
human 293 cells. The residue mutated in each mutant is indicated above each lane. In LZIP, all
residues were changed to alanine, except for the threonine which was changed toasparagine. In
VP16, all nonalanine residues were changed to alanine, and the alanine was changed to serine.
Expression of each mutant protein is shown by direct immunoblot of the 293-cell extracts (lanes
1-10). To assay HCF association, extracts were precipitated with an HCF antibody (lanes 11-20)
or an irrelevant antibody (lanes 21-30). LZIP and VP16 were subsequently detected by immunoblot
analysis.
important. To elucidate the mechanisms underlying
this promiscuous transcriptional synergy, I isolated
yeast mutants in which the activity of a promoter con-
taining a single activator-binding site is significantly
enhanced, whereas the activity of promoters contain-
ing multiple activator-binding sites is relatively unaf-
fected. In these mutants, activator-binding sites work
additively rather than synergistically, and transcrip-
tional synergy is largely lost in these mutants.
A genetic characterization of these mutants has
revealed that the mutations responsible for the loss of
transcriptional synergy are recessive (i.e., cause a loss
of wild-type function) and are located within either of
two genes, SIN4 or RGRI, both of which encode com-
ponents of a subcomplex that associates with RNA
polymerase II. Thus, in wild-type cells, the SIN4- and
RGR/-encoded proteins Sin4p and Rgrlp have an
activity that specifically represses the single-site pro-
moter but has little effect on multiple-site promoters.
These results indicate that a selective negative func-
tion of Sin4p and Rgrlp on a single-site promoter is
important for producing synergistic effects in tran-
scriptional activation.
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RNA SPLICING
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A. Mayeda
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E. Thomas
T.-L. Tseng
Q. Wu
MECHANISMS OF CONSTITUTIVE AND ALTERNATIVE
PRE-mRNA SPLICING
RNA splicing is a required step in the expression of
most eukaryotic protein-coding genes. The selection
and pairing of authentic splice sites within the spliceo-
some occur with a very high degree of fidelity, which
requires that limited and dispersed sequence informa-
tion present throughout introns and exons be precisely
interpreted. The expression of many cellular and viral
genes occurs via alternative splicing, which involves
substantial flexibility in the choice of splice sites,
allowing the expression of multiple protein isoforms
from individual genes. The choice of alternative splice
sites is commonly regulated to alter gene expression,
either tissue specifically or in response to a develop-
mental program or to extracellular signals: Both con-
stitutive and alternative splicing mechanisms involve
multiple protein components, as well as RNA compo-
nents that are part of small nuclear ribonucleoprotein
(snRNP) particles. Our lab has focused on the identifi-
cation, purification, and molecular characterization of
protein factors that are necessary for the catalysis of
splicing and/or for the regulation of alternative splice-
site selection.
SUBCELLULAR LOCALIZATION,
NUCLEOCYTOPLASMIC SHUTTLING, AND
OTHER PROPERTIES OF SR PROTEINS
The SR proteins constitute a large family of nuclear
phosphoproteins required for constitutive pre-mRNA
splicing. These factors also have global, concentra-
tion-dependent effects on alternative splicing regula-
tion, and this activity is antagonized by members of
the heterogeneous nuclear RNP (hnRNP) A/B family
of proteins. The SR proteins have a modular structure
that consists of one or two RNA-recognition motifs
(RRMs) and a carboxy-terminal RS domain. J.
Caceres completed the characterization of domains
required for proper localization of SR proteins within
nucleoplasmic speckles. Interestingly, the RS domain
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was found to be necessary and sufficient for correct
sublocalization of certain SR proteins, such as SRp20,
but not of others, such as SF2/ASF. In the latter case,
the RS domain is sufficient as a nuclear localization
signal, but not for targeting to the speckles.
J. Caceres then examined whether SR protein
localization is static or dynamic, and again found
unexpected differences between SR proteins. A subset
of SR proteins shuttles rapidly and continuously
between the nucleus and the cytoplasm, although at
steady state only the nuclear population is detected by
immunofluorescence. Upon inhibition of transcrip-
tion, shuttling SR proteins, such as SF2/ASF, accumu-
late in the cytoplasm, whereas nonshuttling SR pro-
teins, such as SC35, remain nuclear. Stronger evidence
for shuttling was obtained by using interspecies het-
erokaryons (Fig. 1A), which showed that shuttling SR
proteins are exported from human nuclei and are reim-
ported into both human and mouse nuclei of a het-
erokaryon (Fig. 1B). The different shuttling properties
of different SR proteins were shown to be attributable
to their RS domains. However, the RS domain of
SF2/ASF is not sufficient for shuttling, and RNA bind-
ing was also shown to be required.
We found that the relative accumulation of shuttling
SR proteins in the nucleus and the cytoplasm can be
modulated by the Clk/Sty kinase, which has been
shown to phosphorylate the RS domains of SR pro-
teins in vitro. Overexpression of catalytically active
kinase resulted in cytoplasmic accumulation of shut-
tling SR proteins (Fig. 1C), which may account for the
previously observed effects of this kinase on alterna-
tive splicing of cotransfected reporter genes. Differ-
ential modulation of hnRNP A/B and SR protein shut-
tling by kinases may thus serve to regulate alternative
splicing in response to signal transduction pathways.
The finding that some but not all SR proteins shuttle
suggests that these proteins may have roles not only in
nuclear pre-mRNA splicing, but also in mRNA trans-
port, in cytoplasmic events, and/or in processes that
involve communication between the nucleus and the
cytoplasm.
We have continued the functional characterization
of SR proteins with respect to their roles in enhancer-
dependent splicing and in alternative splicing regula-
tion. H.-X. Liu developed a randomization and
iterative selection protocol based on biochemical com-
plementation with single SR proteins, to define the
types of sequences that can function as exonic splicing
enhancers in the presence of each of three different SR
proteins. In collaboration with M. Zhang (CSHL),
short consensus sequences corresponding to enhancers
specific for each SR protein were defined. These stud-
ies defined new classes of splicing enhancers, of
which the well-studied purine-rich elements are only a
small subset. A. Mayeda continued to define the cis-
elements within two pre-mRNAs that splice only in
the presence of particular SR proteins. This study
defined two natural SR protein-specific enhancer ele-
ments. L. Cartegni has begun to study the substrate
specificity of SR proteins in alternative splicing in
vivo. T.-L. Tseng has been studying related proteins
with RS domains in fission yeast, focusing on the
genetic characterization of a protein with an amino-
terminal RS domain and three RRMs.
STRUCTURE AND FUNCTION OF HNRNP
A/B PROTEINS
hnRNP A/B proteins, exemplified by hnRNP Al,
antagonize SR proteins to promote exon skipping and
distal alternative 5' splice site use. These proteins con-
sist of two RRMs and a carboxy-terminal glycine-rich
domain. A proteolytic fragment of hnRNP Al lacking
the carboxy-terminal domain is known as UP1. The
crystal structure of human UP1 was determined by R.-
M. Xu (CSHL) in collaboration with our group, and
simultaneously by a team at Yale. This was the first
structure with more than one RRM, which is of inter-
est because numerous eukaryotic proteins contain
multiple RRMs. The structure showed that each RRM
folds independently; but unexpectedly, the two RRMs,
which are antiparallel, are held together rigidly by two
salt bridges. This is unlikely to be due to crystal pack-
ing forces, because the aspartic acid and arginine
residues that form the salt bridges are highly con-
served among the RRMs of the hnRNP A/B family of
proteins. The two n-sheets-one from each RRM-
form an extended RNA-binding surface. The position
of the inter-RRM linker suggests a possible role in
contacting bound RNA, and this is supported by its
phylogenetic length and sequence conservation among
the hnRNP A/B family of proteins.
A. Mayeda, in collaboration with S. Munroe
(Marquette University), continued the characterization
of the structure and function of hnRNP Al with
respect to its role in alternative splice-site selection, as
well as in RNA binding and RNA annealing. Last year,
we made the observation that although both RRMs of
hnRNP Al are required for its splicing function and
are very closely related in sequence, they have distinct
roles. Thus, replacement of RRM1 with a second copy
of RRM2 yielded a highly active protein, whereas
replacement of RRM2 by a second copy of RRM1
resulted in inactive protein. Deletion or point muta-
tions in either RRM inactivated the protein, and swap-
ping the positions of the two RRMs gave a protein
with weak but detectable activity. Shortening of the
linker that separates the two RRMs also inactivated
the protein. The recent UP1 structure determination
has helped us to interpret these findings and to design
follow-up experiments. The symmetry of the structure
and the very similar folding of the two RRMs explain
in part why the RRM2 duplication is active. Regarding
the salt bridges observed in the structure, they appear
to be preserved in the active duplication, whereas only
one of the two salt bridges is maintained in the inac-
tive duplication and in the swap variant. We therefore
repaired the missing salt bridge in the inactive variant,
but this was insufficient to restore function. We are
currently testing whether replacement of specific
residues in the inactive RRM1 duplication variant is
sufficient for gain of function. One attractive model is
that RRM2 is involved in specific contacts with RNA
that are essential for function, whereas RRM1 con-
tributes to the overall free energy of binding through
nonspecific contacts. Further structural characteriza-
tion and mutational analysis will test this and other
models.
A TRIMERIC HPRP3/HPRP4/CYCLOPHILIN COMPLEX
ASSOCIATED WITH U4/U6 sNRNP
D. Horowitz investigated the nature of a 55 -kD protein
that cross-reacts with antibodies against hPrp18.
Analysis of snRNP association by Western blotting of
velocity gradient fractions showed that hPrp18 is not
stably associated with fast-sedimenting complexes,
whereas the cross-reacting 55-kD polypeptide co-sed-
imented with the U4/U6 and 1.14/U6U5 snRNP parti-
cles. The 55-kD protein was purified by chromatogra-
phy under native conditions, using Western blotting to
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follow the protein. This procedure resulted in a highly
purified protein complex consisting of the 55-kD
polypeptide and two additional polypeptides of 90 kD
and 18 kD. This protein complex is stable even in the
absence of RNA. Partial amino acid sequence for all
three polypeptides was obtained by R. Kobayashi
(CSHL), and this information was used to obtain com-
plete cDNA sequences for all three proteins. Sequence
analysis showed that the 55-kD and 90 -kD proteins are
the likely homologs of the budding yeast Prp4 and
Prp3 splicing factors, respectively. The 18-kD protein
is a novel cyclophilin that is similar but not identical
to cyclophilin A, and we have named it USA-CyP (U
snRNP-associated cyclophilin).
An alignment of Prp4 proteins from several
species showed the presence of seven WD40 repeats,
suggesting that hPrp4 and its homologs fold into a
sevenfold 13-propeller structure similar to those of the
13 subunits of G proteins. An alignment of Prp3 pro-
teins did not reveal unique motifs suggestive of spe-
cific mechanisms. The presence of a cyclophilin in
snRNP particles suggests possible roles for proline
isomerization and/or chaperonin functions in spliceo-
some assembly and/or snRNP biogenesis. In particu-
lar, previous work from the Kramer, Luhrmann, and
Kole labs showed that the disruption of splicing upon
heat shock is attributable to a defect in U4/U615
snRNP particle assembly; splicing could be restored
by adding a fraction containing tri-snRNP-particle-
associated polypeptides. The known link between
heat-shock chaperonins and cyclophilins suggests that
USA-CyP may be involved in the recovery of splicing
function after heat shock.
ROLE OF A TYPE 2C PROTEIN PHOSPHATASE
IN PRE-mRNA SPLICING
M. Murray used fractionation of He La nuclear extracts
and biochemical complementation to define an activi-
ty required for the first transesterification of splicing.
Purification of this activity to near homogeneity yield-
ed a 75 -kD polypeptide and several fragments thereof.
Microsequence analysis (in collaboration with R.
Kobayashi, CSHL), followed by cDNA sequencing
and sequence database comparisons, showed that this
protein is a type 2C serine/threonine protein phos-
phatase. The phosphatase activity due to this protein
precisely copurified with the splicing complementing
activity. We have obtained recombinant protein and
raised antibodies to it. Immunofluorescence analysis
showed that this phosphatase is nuclear. Immunopre-
cipitation experiments demonstrated its association
with spliceosomes. The recombinant protein is not
active in the complementation assay, perhaps because
the phosphatase is not sufficient for activity, and/or
because the recombinant form lacks modifications
necessary for splicing function. We are currently using
the antibodies for immunodepletion experiments.
Identification of specific targets for dephosphorylation
by this protein within the context of splicing should
yield new information on the role of phosphorylation
and dephosphorylation cycles in splicing.
THE AT-AC INTRON SPLICING PATHWAY
Q. Wu has been studying the biochemistry of splicing
of a small class of mammalian introns with unique 5'
FIGURE 1 Shuttling and nonshuttling SR proteins. (A) Diagram of interspecies heterokaryon assay of nucleocytoplasmic shut-
tling by transiently expressed SR proteins. The shaded nuclei indicate localization of the transiently expressed human SR pro-
tein. Cycloheximide (CHX) was added prior to fusion with polyethylene glycol (PEG) to prevent further protein synthesis from the
human mRNA in the heterokaryons. (8) Detection of the transiently expressed SR proteins in interspecies heterokaryons. He La
cells were transfected with expression plasmids encoding the indicated T7 epitope-tagged proteins, or hnRNP Al as a positive
control for shuttling. At 24 hr posttransfection, the cells were treated with CHX and then fused with mouse NIH-3T3 cells in the
presence of PEG to form heterokaryons. The cells were further incubated for 2 hr in the presence of CHX and fixed. The local-
ization of the transiently expressed proteins was determined by indirect immunofluorescence with anti-T7 tag monoclonal anti-
body and FITC-conjugated secondary antibody (left panels). The cells were simultaneously incubated with Hoechst 33258 dye
for differential staining of human and mouse nuclei within heterokaryons (middle panels). The arrows indicate the mouse nuclei
within human-mouse heterokaryons. Phase-contrast images of the same heterokaryons are shown (right panels). All of the pro-
teins, except SC35, were exported from the human nuclei and imported into the mouse nuclei. (C) Effect of Clk/Sty kinase
expression on SF2/ASF shuttling. He La cells were cotransfected with plasmids encoding either T7-tagged SF2/ASF (top panels)
or SC35 (bottom panels), together with a plasmid expressing a myc-tagged Clk/Sty kinase. The localization of the transiently
expressed SR proteins (left panels) was determined by indirect immunofluorescence as in panel 8, and that of Clk/Sty (right
panels) with rabbit anti-myc tag antibody and Texas-Red-conjugated secondary antibody. Kinase expression affects SF2/ASF
nuclear export and/or reimport, causing its accumulation in the cytoplasm (top left). The nonshuttling SR protein SC35 remains
nuclear (bottom left). This effect required a catalytically active form of the kinase.
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and 3' splice sites that do not conform to the consen-
sus sequences. Whereas most introns begin with GT
and end with AG, the noncanonical introns begin with
AT and end with AC, and are therefore known as AT-
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and intron 2 of the SCN4A voltage-gated skeletal
muscle sodium channel are AT-AC introns that we and
other workers have recently shown to be processed via
a unique splicing pathway involving several minor U
snRNAs. Interestingly, intron 21 of the same SCN4A
gene and the corresponding intron 25 of the SCN5A
cardiac muscle sodium channel gene also have 5 '-AT
and AC-3- boundaries, but they have divergent 5'
splice site and presumptive branch site sequences. We
demonstrated the accurate in vitro processing of these
two divergent AT-AC introns and showed that they
belong to a functionally distinct subclass of AT-AC
introns. Splicing of these introns does not require U12,
U4atac, and U6atac snRNAs, but instead requires the
major spliceosomal snRNAs Ul, U2, U4, U5, and U6.
Previous studies showed that G -eA mutation at the
first position and GC mutation at the last position of
a conventional yeast or mammalian GT-AG intron
suppress each other in vivo, suggesting that the first
and last bases participate in an essential non-Watson-
Crick interaction. Our results show that such introns,
termed AT-AC II introns, occur naturally and are
spliced by a mechanism distinct from that responsible
for processing of the apparently more common AT-AC
I introns. Therefore, commitment to the ATAC or
GTAG pathway is not specified by the boundary
nucleotides, but more likely by the rest of the 5' splice
site element.
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MOLECULAR MECHANISMS OF APOPTOSIS
Y. Lazebnik A. Doseff J. Rodriguez
L. Faleiro Y. Xu
H. Fearnhead
Apoptosis is a fundamental biological process critical
for the development of organisms and for maintaining
tissue homeostasis. Consequently, deregulation of
apoptosis contributes to diseases such as cancer and
neurodegenerative disorders. Our laboratory is investi-
gating whether the apoptotic machinery can be used to
kill cancer cells. Obviously, such a killing should be
selective for transformed cells, and we are trying to
understand how this selectivity can be achieved.
The emerging view of apoptosis is that diverse
regulatory pathways activate a conserved execution
machinery. An essential component of this machinery
is the caspases (formerly known as ICE-like proteas-
es), a family of cysteine proteases. Caspases are acti-
vated at the onset of apoptosis and once active, cleave
in a coordinated manner a number of proteins which
results in a precisely orchestrated cell death.
Preventing caspase activation prevents cell death.
Reciprocally, activation of caspases results in cell
death, even if this activation is achieved through
means unrelated to apoptotic signaling pathways. To
understand how a cancer cell can be killed, we study
which caspases are involved in apoptosis, how they
are activated, and how this activation leads to cell
death.
ONCOGENE-DEPENDENT APOPTOSIS IN EXTRACTS
FROM DRUG-RESISTANT CELLS
The failure to effectively and selectively eliminate
cancer cells is a major problem of cancer therapy.
Nonetheless, most mammalian cells, including those
that give rise to cancer, have an intrinsic machinery
whose function is to carry out cell suicide. Activation
of this execution machinery results in apoptosis, a
comprehensive process that can quickly eliminate
large numbers of cells without triggering adverse
responses such as inflammation. The efficiency of
such killing prompts the examination of the apoptotic
execution machinery as a potential tool for killing can-
cer cells.
Indeed, many anti-cancer drugs kill cells by acti-
vating the apoptotic machinery. However, this killing
is inefficient as activation is indirect. The direct effect
of these drugs is cell damage, such as DNA breaks or
cell cycle aberrations, which then triggers signaling
pathways that activate the execution machinery and
eventually leads to cell death. However, a cancer cell
may fail to die not because the drug does not induce
cell damage but because the information about this
damage fails to reach the execution machinery of
apoptosis. In principle, agents that directly activate the
execution machinery should bypass alterations which
prevent apoptosis and kill cells that are otherwise
resistant to cancer therapy. However, how to activate
the apoptotic machinery in cancer cells directly and,
most importantly, selectively is not clear.
During the previous year, we found that extracts
from transformed but not normal cells can sponta-
neously activate caspases and induce apoptosis in a
cell-free system. Importantly, this effect was observed
even when transformed cells were highly resistant to
apoptosis. We hypothesized that caspase activation is
caused by an endogenous oncogene-generated activity
(OGA) that is present in cells transformed with certain
oncogenes. These oncogenes, which include E1A,
myc, and E7, are known to induce apoptosis or sensi-
tize cells to apoptosis-inducing factors. However,
transformed cells may survive and give rise to cancer
when oncogene-induced apoptosis is suppressed by
overexpression of proteins with anti-apoptotic activity,
such as bcl -2. Whether the pro-apoptotic activity of
oncogenes is abolished when apoptosis is suppressed
or whether it becomes latent was not clear.
Our hypothesis implied that this activity is latent.
Using extracts from cells transformed with the aden-
ovirus E1A oncogene, we demonstrated that our
hypothesis is correct. We provided preliminary charac-
terization of this OGA and found that it activates cas-
pases in an ATP-dependent manner. We also found that
partially purified OGA can induce caspase activation
when added to extracts from untransformed cells.
During the last year, we purified OGA and identi-
fied it as APAF-1, a recently described human
homolog of CED-4, a protein that is required for apo-
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ptosis in Caenorhabditis elegans. Purified APAF-1
could induce ATP-dependent caspase activation when
added to extracts from untransformed cells, which was
consistent with our preliminary characterization of
OGA. These results, obtained in a cell-free system,
suggest that oncogene-induced apoptosis is mediated
through APAF-1, although how this is achieved is not
clear. The level of APAF-1 expression appears to be
unchanged during transformation, suggesting that
other factors or a modification of APAF-1 is involved.
We are investigating these possibilities.
As mentioned earlier, the key question for us is
whether the apoptotic machinery can be induced in
cancer cells selectively. Our results suggest that a
basis for selective activation of caspases in cancer
cells may lie in the mechanisms intrinsic to carcino-
genesis. Our results argue that OGA is present in trans-
formed cells, although in a latent form, even if these
cells become drug resistant. We suggest that agents
that link OGA to caspases in cells would kill tumor
cells otherwise resistant to conventional cancer thera-
py. As this killing relies on an activity generated by an
oncogene, the effect of these agents should be selec-
tive for transformed cells. Our progress in identifying
the molecular basis for OGA should hopefully make
the testing of our model possible.
DELINEATION OF CASPASE CASCADE
Caspases are thought to be activated in a cascade.
Studies in a cell-free system suggest that APAF-1 ini-
tiates caspase activation by activating caspase-9,
which then cleaves other caspases. We investigated
the order in which these caspases are cleaved. To do
this, we generated cell extracts that are immunode-
pleted of one or several caspases, a technique that was
called in the laboratory "the biochemical knockout."
This approach allows us to determine whether a cas-
pase is processed by another caspase or is activated
autocatalytically, to identify caspases whose process-
ing depends on the activity of the depleted caspases,
and also to find the function of the depleted caspases
in carrying out nuclear chances of apoptosis. Indeed,
we delineated the sequence in which caspases are acti-
vated and determined the effect of caspase depletion
on nuclear morphology. In a collaboration with Dr.
Scott Lowe (CSHL), we found that the effects of
depletion of caspase-3 in a cell-free system and in
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cells depleted from caspase-3 by genetic methods are
similar.
LOCALIZATION OF CASPASES INVOLVED
IN APOPTOSIS
Where the components of the apoptotic machinery are
in a cell is one of the many mysteries of apoptosis. It
is difficult without knowing where these components
are to devise a viable model of cell death. Indeed, a
significant part of our knowledge, as well as many
assumptions, about the mechanisms of apoptosis
comes from studies on cell-free systems, which are
made of a homogeneous cell extract and isolated
nuclei. Therefore, during the last year, we started to
analyze systematically the intracellular localization of
caspases.
We began with caspase-3 (cpp32) because we pre-
viously found it to be the most abundant caspase.
Using a set of monoclonal antibodies that we devel-
oped, we found that caspase-3 is localized in particles.
These particles, depending on cell type, are either dis-
tributed throughout the cell or are limited to the cyto-
plasm or the nucleus. This finding raised several ques-
tions. First, the current model of apoptosis suggests
that some caspases are activated by binding to an acti-
vator complex, such as a receptor. These activated
caspases then cleave the effector caspases, caspase-3
being one of them, which are assumed to be freely
available for this cleavage. If caspase-3 is compart-
mentalized, the question is, how are the two caspases
brought to the same location? The second question
that we are investigating is the composition of the cas-
pase-containing particles. One possibility is that these
particles contain other known components of the
apoptotic machinery.
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REGULATION OF APOPTOSIS AND SENESCENCE
S.W. Lowe A. Lin A.V. Samuelson
M.E. McCurrach M.S. Soengas
J. Polyakova R. Wallace-Brodeur
Our research is based on the premise that apoptosis, a
genetically controlled form of cell death, provides a
natural defense against tumor development and under-
lies the cytotoxicity of most current anticancer drugs.
Consequently, mutations that disrupt apoptotic pro-
grams can cause tumor progression and resistance to
cancer therapy. Earlier studies identified the p53
tumor suppressor as an important regulator of apopto-
sis and demonstrated that p53 mutations could pro-
mote oncogenic transformation, tumor progression,
and resistance to cytotoxic agents by reducing a cell's
apoptotic potential. Our current research is aimed at
elucidating how p53 promotes apoptosis and we are
characterizing p53-independent apoptotic pathways
that might function in tumor cells. We are also devel-
oping in vivo models to study apoptosis chemosensi-
tivity in spontaneous tumors. With Y. Lazebnik here at
CSHL, we are investigating how p53 and other regu-
lators of apoptosis affect activation of the apoptotic
"machinery." Finally, in a separate direction, we are
investigating how cells respond to ras oncogenes and
the consequences of this response for multistep car-
cinogenesis.
Modulation of Chemosensitivity
A. Samuelson, M. McCurrach, S. Lowe [in collaboration
with H. Fearnhead and Y. Lazebnik, Cold Spring Harbor
Laboratory; M. Mayo and A. Baldwin, University of
North Carolina, Chapel Hill]
Since most anticancer agents currently in use were
identified by empirical screens, the molecular mecha-
nisms underlying drug sensitivity and resistance
remain poorly understood. Work from our laboratory
and elsewhere demonstrates that many anticancer
agents induce apoptosis, implying that tumor cell
chemosensitivity is influenced by the efficiency with
which anticancer agents activate apoptotic programs.
Although the precise contribution of apoptosis to
tumor responsiveness remains unresolved, the fact that
apoptosis is controlled by genes raises the exciting
prospect that the problem of drug sensitivity and resis-
tance will be amenable to the approaches of modem
molecular biology. In principle, strategies that
enhance apoptosis specifically in tumor cells would
have widespread therapeutic potential.
Cells expressing the adenovirus early region 1A
(KM) oncogene provide a simple model for studying
cellular processes that modulate chemosensitivity.
With Y. Lazebnik, we have shown that E1A promotes
apoptosis in primary cells, in part, by producing or
modifying a cellular factor that enables efficient acti-
vation of the apoptotic machinery (Fearnhead et al.
1997). As a consequence, E1A-expressing cells
become extremely sensitive to toxic agents, including
radiation and most chemotherapeutic drugs. E1A
mutations that disrupt apoptosis and chemosensitivity
separate into two complementation groups, which cor-
relate precisely with the ability of E1A to associate
with either the p300/CBP or RB-related proteins
(Samuelson and Lowe 1997). Furthermore, E1A
mutants incapable of binding RB, p107, and p130 con-
fer chemosensitivity to fibroblasts derived from RB-
deficient mice, but not fibroblasts from mice lacking
p107 or p130. Hence, inactivation of RB, but not p107
or p130, is required for chemosensitivity induced by
E1A.
The results described above demonstrate that E1A
mutants unable to bind the RB protein family selec-
tively promote chemosensitivity in RB-deficient cells.
Since the RB gene is inactivated in familial retinoblas-
toma and a variety of sporadic tumors (and the RB
pathway is disrupted in the vast majority of cancer
cells), our results identify a strategy to selectively
make tumor cells more sensitive to anticancer drugs.
Specifically, certain E1A mutants-or small mole-
cules that mimic their action-should synergize with
standard anticancer agents to enhance the killing of
RB-defective cells. Since normal cells retain RB func-
tion, these agents are predicted to have minimal toxic-
ity to nonmalignant cells. We are currently defining
the E1A function(s) sufficient to promote chemosensi-
tivity in RB-deficient cells and conducting "proof-of-
concept" experiments to determine whether our strate-
gy would be effective in treating human tumors.
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In certain settings, oncogenic ras can modulate
apoptosis. We participated in a study with A. Baldwin
and colleagues at the University of North Carolina
showing that inactivation of NF-KB function can dra-
matically enhance apoptosis in ras-expressing cells
(Mayo et al. 1997). The effect appears to be indepen-
dent of the p53 tumor suppressor and hence suggests
an alternative strategy to manipulate apoptosis to
improve cancer therapy.
p53-dependent and -independent
Apoptotic Pathways
M. McCurrach, A. Samuelson, J. Polyakova,
M. Soengas, S. Lowe
We continue to explore the mechanisms whereby p53
promotes apoptosis. Recently, we demonstrated that
Bax (a cell death agonist that has homology with the
anti-apoptotic Bcl -2 protein) can function as an effec-
tor of p.53 in chemotherapy-induced apoptosis and
contributes to a p.53 pathway to suppress oncogenic
transformation (McCurrach et al. 1997). In a separate
direction, we have previously shown that E 1 A alters
p53 function from promoting growth arrest to apopto-
sis, which is associated with the ability of E 1 A to
increase the stability of p53 protein. Now we have
shown that the ElA regions required for p53 induction
and apoptosis correlate precisely with those required
for E 1 A's oncogenic potential and that inactivation of
the RB is strictly required for these effects (Samuelson
et al. 1997). This argues that p53 accumulation and
enhanced apoptosis is a cellular response to oncogenic
"stress" rather than a direct effect of ElA on p53.
Using our simple system of fibroblasts transformed
by El A and ras, we have identified agents that induce
apoptosis independently of p53. For example, adri-
amycin-induced apoptosis is p53-dependent, whereas
tumor necrosis factor-a (TNF-a)-induced apoptosis is
p53-independent (Lanni et al. 1997). Bax, which func-
tions downstream from p53 in adriamycin-induced
apoptosis, is dispensable for TNF-induced apoptosis.
Furthermore, adriamycin synergizes with TNF-a to
induce apoptosis in the absence of p53. Using MEFs
deficient for specific genes and various cell death
inhibitors, we are genetically characterizing these dis-
tinct pathways. We envision that this system will pro-
vide a simple model for understanding "cross-talk"
between apoptotic pathways.
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Caspase Function
M. Soengas, J. Polyakova, M. McCurrach [in collaboration
with J. Rodriguez and Y. Lazebnik, Cold Spring Harbor
Laboratory; M. Woo, R. Hakem, and T. Mak, University of
Toronto Cancer Center and Amgen Institute]
Proteases related to interleukin-113-converting
enzyme, called caspases, are thought to be essential
components of the apoptotic "machinery" (i.e., the
molecules directly responsible for apoptotic cell
death). The importance of apoptosis in cancer argues
that components of this machinery may be tumor
suppressors and/or drug sensitivity genes. Since prote-
olytic cleavage is essentially irreversible, caspase acti-
vation may represent the last regulated step in apopto-
sis. In this view, the endpoint of most, if not all, cyto-
toxic anticancer drugs is caspase activation.
Consequently, most mutations that limit drug cytotox-
icity act upstream of these proteases. If true, the cas-
pases represent attractive drug targets.
A major goal of our laboratory is to understand how
cell death regulators like p53 affect caspase activation.
First, with Y. Lazebnik, we continue to identify the
caspases activated during p53-dependent and -inde-
pendent apoptosis in the well-defined MEF system
described above. To this end, we are generating mon-
oclonal antibodies against all known murine caspases.
Second, using viral caspase inhibitors or cells defi-
cient for specific caspases, we study the contribution
of specific caspases to various apoptotic pathways.
In collaboration with T. Mak, we took a compre-
hensive approach to examine the role of caspase-3
(CPP32) in apoptosis using mice, embryonic stem
(ES) cells, and mouse embryonic fibroblasts deficient
for caspase-3 (Woo et al. 1997). CASP3 mice have
reduced viability and, consistent with an earlier report,
display defective neuronal apoptosis and neurological
defects. Inactivation of caspase-3 dramatically reduces
apoptosis in diverse settings, including activation-
induced cell death of peripheral T cells, as well as
chemotherapy-induced apoptosis of oncogenically
transformed CASP3 -'- MEFs. As well, the requirement
for caspase-3 can be remarkably stimulus-dependent:
in ES cells, caspase-3 is necessary for efficient apo-
ptosis following UV- but not y-irradiation. Conversely,
the same stimulus can show a tissue-specific depen-
dence on caspase-3: Hence, TNF-a treatment induces
normal levels of apoptosis in CASP3-i-thymocytes, but
defective apoptosis in oncogenically transformed
MEFs. Finally, in some settings, caspase-3 is required
for certain apoptotic events but not others:
Transformed CASP3 -' -MEFs undergoing cell death are
incapable of chromatin condensation and DNA degra-
dation but display other hallmarks of apoptosis.
Together, these results indicate that caspase-3 is an
essential component in apoptotic events that is
remarkably system- and stimulus-dependent. Conse-
quently, drugs that inhibit caspase-3 may preferential-
ly disrupt specific forms of cell death.
In Vivo Models of Drug
Sensitivity and Resistance
R. Wallace-Brodeur, M. McCurrach
Cancer is a complex phenotype that occurs only in
whole animals. For this reason, we always attempt to
extend observations from tissue culture studies to real
tumors. To develop in vivo models for studying apo-
ptosis and chemosensitivity, we are studying the ther-
apeutic response of spontaneous lymphomas occur-
ring in the Ep-myc transgenic mouse. These animals
constitutively express c-myc in the B-cell lineage and
typically succumb to B-cell lymphoma within 4-6
months of age. We hypothesized that these mice would
provide a useful model for studying apoptosis and can-
cer therapy since (1) tumor burden can be monitored
externally by lymph node palpation; (2) lymphomas
are detectable long before the animal dies, so animals
can be treated while still healthy, (3) large numbers of
tumor cells can be isolated from mice undergoing ther-
apy, (4) tumor cells readily adapt to culture, and (5)
suppression of apoptosis has been shown to accelerate
lymphogenesis, suggesting that regulation of apopto-
sis is important in these tumors.
During the past year, we examined the response of
Eye -myc lymphomas to adriamycin therapy, a drug
used to treat human lymphomas. As is observed in
human patients with lymphoma, the vast majority
(-90%) of Ep-myc transgenic mice respond to therapy.
Isolated tumor cells display features of apoptosis with-
in 8 hours of therapy, including chromatin condensa-
tion, caspase activation, and PARP cleavage. In virtu-
ally every animal, however, tumors eventually return,
and, moreover, treatment of animals with relapsed
tumors is much less effective than in mice with prima-
ry tumors (less than 50% of the animals respond).
Furthermore, in those animals that survive repeated
therapy, the recurrent tumors eventually become resis-
tant. Consequently, we feel that this model will be
excellent for studying the role of apoptosis in cancer
therapy, as well as the genetics of drug sensitivity and
resistance.
Multistep Carcinogenesis
A. Lin, M. McCurrach, S. Lowe [in collaboration
with M. Serrano and D. Beach, Cold Spring
Harbor Laboratory]
Cancer is a multistep process involving a series of
genetic changes that individually enhance the growth
or survival of developing tumor cells. Considerable
progress has been made in identifying tumor-specific
mutations and how they alter normal gene function,
but less is known about how these mutations interact
to produce the malignant phenotype. Perhaps the sim-
plest model of multistep carcinogenesis involves
oncogenic transformation of primary cells by ras
oncogenes. Oncogenic ras can transform most immor-
tal rodent cells to a tumorigenic state. However, trans-
formation of primary cells by ras requires either a
cooperating oncogene (e.g., E1A) or the inactivation
of tumor suppressors such as p53 or p16. Although
this paradigm has been studied since the early 1980s,
the biological basis for oncogene cooperation was
poorly understood.
We recently showed that expression of oncogenic
ras in primary human or rodent cells results in a per-
manent G1 arrest (Serrano et al. 1997). The arrest
induced by ras is accompanied by accumulation of
p53 and p16 and is phenotypically indistinguishable
from cellular senescence. Inactivation of either p53 or
p16 prevents ras-induced arrest in rodent cells, and
E1A achieves a similar effect in human cells.
Recently, we have shown that ras-induced cell cycle
arrest in primary cells proceeds through the same
effector pathways responsible for ras-induced mitoge-
nesis and transformation in immortal cells. Hence,
these data suggest that activation of premature senes-
cence is a cellular response to an aberrant mitogenic
stimulus, rather than some novel ras-mediated
antiproliferative pathway. Together, these observa-
tions suggest that the onset of cellular senescence does
not simply reflect the accumulation of cell divisions
but can be prematurely activated in response to an
oncogenic stimulus. Negation of ras-induced senes-
cence appears to account for the phenomenon of onco-
gene cooperation and may be important during multi-
step tumorigenesis.
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CELL SIGNALING IN HIV PATHOGENESIS
J. Skowronski S. Bronson A. lafrate
Y.-N. Chang M. Lock
D. Desrosiers N. Shohdy
M. Greenberg T. Swigut
Our main interest is in understanding the molecular
mechanisms underlying the pathogenesis of AIDS
and, in particular, understanding the functional conse-
quences of the interactions between viral proteins and
the cellular regulatory machinery. The focus of our
research is to understand the function of Nef, a regu-
latory protein of human and simian immunodeficien-
cy viruses (HIV and SIV). Evidence from HIV -1-
infected individuals and from the SIV-infected rhesus
monkey model of AIDS indicates that Nef is an
important determinant of viral pathogenicity. Viral
loads remain low and AIDS does not develop in rhe-
sus macaques experimentally infected with a nef-
deleted SIV variant. Moreover, a lack of disease pro-
gression in a subset of HIV-1-infected persons is asso-
ciated with deletions in nef. This evidence suggests
that disruption of Nef function will attenuate the
development of AIDS, and therefore Nef is an attrac-
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Live potential target for the development of new drugs
for AIDS treatment. The functions of Nef critical for
the development of AIDS are not known; uncovering
these functions has been a major focus of studies in
our laboratory for the past several years.
Since Nef is not required for the viral life cycle
under laboratory conditions, its function(s) has been
difficult to study; however, Nef has been shown to
have three effects on the function of cultured cells.
One effect is modulating signal transduction. The
other effects are down-regulating the expression of
CD4 and MHC class I molecules on the cell surface.
Since (1) HIV replication is modulated by the signal
transduction machinery of the infected cell, (2) CD4 is
a component of the receptor for HIV and SIV as well
as a component of the T-cell antigen receptor, and (3)
down-regulation of MHC class I surface expression in
cells infected by HIV helps these cells to evade the
antiviral immune response of the host, each of these
effects is likely to be important for the development of
AIDS. During the last year, our effort was directed
toward understanding the mechanisms mediating
down-regulation of CD4 surface expression by Nef.
We also initiated experiments to address the impor-
tance of the ability of Nef to down-regulate CD4
expression for the induction of AIDS by SIV in exper-
imentally infected rhesus monkeys (in collaboration
with Frank Kirchhoff, University of Erlangen,
Germany). Our experiments identified putative mole-
cular interactions of Nef with the cellular protein-sort-
ing machinery involved in the down-regulation of sur-
face CD4 expression and indicated that these interac-
tions are important for immunodeficiency virus repli-
cation in the infected host. Finally, we continued our
search for cellular proteins that mediate functional
interactions between Nef and both the signaling and
protein-sorting machineries.
NEF COLOCALIZES WITH AP-2 ADAPTOR COMPLEXES
To correlate the function of Nef with its subcellular
localization, we fused Nef to the green fluorescent
protein (GFP) and studied the distribution of this
Nef.GFP chimera in the cell. Control experiments
demonstrated that the chimeric protein was capable of
down-regulating expression of CD4 on the cell sur-
face, and therefore retained all the interactions
required for this function. In transiently transfected T
cells and fibroblasts, the Nef.GFP fusion protein pro-
duced a well-defined discrete pattern at the periphery
of the cell and in the perinuclear region of the cell.
This pattern of Nef.GFP fluorescence was similar to
that observed previously for clathrin and AP-1/AP-2
adaptor protein complexes. AP-1/AP-2 adaptor pro-
tein complexes mediate the traffic of transmembrane
proteins in the Golgi and at the plasma membrane via
clathrin-coated membranes and vesicles. The recruit-
ment of transmembrane proteins to clathrin coats
involves recognition of sorting signals in the cytoplas-
mic domains of these proteins by the multisubunit
adaptor protein complexes that interact directly (or
indirectly) with clathrin and with cytoplasmic
domains of transmembrane receptors. The observed
concentration of Nef.GFP at the structures containing
clathrin and adaptor complexes places Nef in physical
proximity to adaptor-containing coats in the cell and
imply that Nef interacts, either directly or indirectly,
with a component of the coat, possibly the adaptor
complex itself.
CD4 COLOCALIZES WITH NEF.GFP AND AP-2
AT THE PLASMA MEMBRANE
To address the possibility that Nef interacts with CD4
at the plasma membrane, we asked whether the
NA7.GFP protein colocalizes with CD4 expressed at
the cell surface. To stabilize a possibly transient asso-
ciation between Nef and CD4, these experiments were
performed under conditions that block endocytosis.
We found that in CD4+ T cells expressing the Nef.GFP
chimera, CD4 was redistributed into a punctate pattern
at the cell margin. In contrast, in the absence of Nef,
CD4 was uniformly distributed at the cell margin. The
cell-surface expression of a mutant CD4 protein lack-
ing most of the cytoplasmic domain, and unresponsive
to Nef-induced down-regulation from the cell surface,
was not affected by the NA7.GFP protein. The colo-
calization of CD4 at the cell surface with NA7.GFP,
and of NA7.GFP with P-adaptin, together suggest that
Nef redistributes CD4 to AP-2-containing coats at the
plasma membrane. Together, this evidence supports a
model whereby Nef recruits CD4 to the endocytotic
machinery via AP-2 containing clathrin coats at the
plasma membrane.
SCREENS TO IDENTIFY CELLULAR PROTEINS
THAT MEDIATE NEF FUNCTIONS
We have initiated experiments to identify cellular pro-
teins that mediate Nef functions, using the yeast two-
hybrid system. In initial experiments, we isolated a
large set of cDNA clones that specify proteins capable
of binding HIV-1 Nef. Subsequently, we have been
testing this pool of clones against a panel of mutant
Nef proteins selectively deficient in individual func-
tions to identify putative functionally relevant interac-
tions. In the near future, these experiments will be fur-
ther extended to SIV Nef because evidence from our
previous experiments indicated that the HIV and SIV
Nef proteins, although somewhat dissimilar at the
amino acid level, perform the same functions, have a
similar functional organization, and therefore are like-
ly to interact with the same set of cellular proteins. We
anticipate that this dual approach will greatly facilitate
our search for host-cell proteins that mediate function-
al interactions of Nef with cell machineries.
SELECTIVE DISRUPTION OF SIVmac239
NEF FUNCTIONS
Our studies of SIVmac239 Nef indicate that it is func-
tionally similar to HIV -1 Nef: It interferes with signal
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transduction in T cells and down-regulates both CD4
and MHC class I molecules from the cell surface.
Since SIV infection of rhesus macaques is currently
the best animal model of human AIDS, the role of Nef
in human AIDS can be inferred by studying
SIVmac239 Nef in macaques. Our first goal is to iden-
tify mutant Nef proteins that are defective for only a
single function. We then engineer an SIV to contain
this mutant Nef and infect rhesus macaques with this
mutant virus. By following the progress of the disease,
and by analyzing the DNA sequence of viruses in
these animals, we can make conclusions about the
importance of individual Nef functions for AIDS. So
far, we have identified mutations in SIVmac239 Nef
that selectively disrupt CD4 down-regulation. These
mutations are located in two clusters, one spanning
residues 65 to 74 and the other at residues 204 and
205. We have yet to identify the residues that are crit-
ical for MHC class I down-regulation or for interfer-
ing with signal transduction.
SEPARATE FUNCTIONS OF NEF
AND AIDS PATHOGENESIS
We have initiated a series of experiments that study
mutant Nef proteins using SIV-infected rhesus
macaques in collaboration with Dr. Frank Kirchhoff
(University of Erlangen, Germany). Although experi-
ments are still in progress which examine the impor-
tance of several conserved blocks of amino acids in
Nef, we have completed two experiments. One study
examined the importance of a conserved PxxP motif at
positions 104-107 in SIV Nef. In HIV-1 Nef, such a
PxxP motif mediates the interaction with the SH3
domain of Src-family tyrosine kinases. However, for
SIV, it mediates the interaction with a p62 serine/thre-
onine kinase. In macaques, we observed no significant
reversion of mutations at this sequence prior to the
development of AIDS. Therefore, the interaction of
SIVmac239 Nef with the p62 serine/threonine kinase
is not of critical importance for AIDS pathogenesis.
ONCOGENE REGULATION
W.P. Tansey S.E. Salghetti
The maintenance of normal cellular growth and dif-
ferentiation ultimately depends on mechanisms that
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A second study examined the importance of
residues in the two clusters that we had previously
shown to be required for CD4 down-regulation. Three
macaques were infected with a mutant SIVmac239
containing Nef with amino acid substitutions in both
clusters, P73E, A74D, and D204R. Interestingly, we
observed that early in infection, the mutant SW repli-
cated poorly. Sequence analysis showed that reversion
of arginine at position 204 to the wild-type aspartic
acid was rapidly selected in all three animals. Changes
were also rapidly selected at position 73, although not
to the wild-type proline. These changes were shown to
restore the ability of Nef to down-regulate CD4
expression. These experiments indicate that these
mutations at positions 73,74, and 204 disrupted a crit-
ical function of Nef and suggest that CD4 down-regu-
lation itself may be an important function of Nef in
AIDS pathogenesis.
We are currently developing mutant Nef proteins
with deletions in these regions that selectively disrupt
only CD4 down-regulation. We hope that it will be
more difficult for such mutations to revert in vivo and
that this may allow us to more directly relate the loss
of a single function (i.e., CD4 down-regulation) with
lack of disease progression.
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regulate cell cycle progression. Two of the most
important of these regulatory mechanisms are tran-
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FIGURE 1 Myc is ubiquitylated in vivo. Human HeLa cells were transiently trans-
fected with expression constructs encoding either HA-epitope-tagged Jun (lanes
3,4, 9,10), HA-epitope-tagged Myc (lanes 5,6,11,12), or His-tagged ubiquitin (lanes
2, 4, 6, 8,10,12). Following transfection, 90% of the cells were lysed, and His-tagged
proteins were recovered by nickel-affinity chromatography. The nickel-bound pro-
teins (lanes 7-12) were resolved by SDS-polyacrylamide gel electrophoresis, along-
side total proteins (lanes 1-6) from the remaining 10% of cells. Exogenously
expressed Myc and Jun proteins were then detected by immunoblotting using an
antibody against the HA-epitope tag. The position of Ub-Myc conjugates is indicat-
ed by the bracket.
scriptional activation and proteolytic destruction,
which together control the appropriate and
disappearance of key cell cycle players. Work in our
laboratory explores the intersection between these two
processes to understand how oncogene transcription
factors are regulated at the level of their own destruc-
tion.
The transcription factors controlling cell prolifera-
tion are tightly regulated at many levels, including
synthesis, cellular localization, activation potential,
and destruction. Indeed, many of these transcription
factors, including Jun, p53, E2F, and Myc, are rapidly
destroyed following their synthesis, with in vivo half-
lives ranging from 20 minutes for Myc to 3 hours for
E2F. The rapid and controlled turnover of these fac-
tors keeps their intracellular levels rapidly responsive
to environmental factors, such as mitogenic signals
and UV-irradiation, and maintains tight control over
cellular proliferation, a role that is underscored by the
fact that some oncogenic transcription factors escape
this rapid degradation and are present in elevated lev-
els in cancer cells. With the exception of Myc-for
which little is known-these proteins are destroyed by
ubiquitin-mediated proteolysis, in which their cova-
lent attachment to the protein ubiquitin (Ub) signals
their destruction by the 26S proteasome.
Ub-mediated proteolysis participates in many crit-
ical events within the cell, including signaling, DNA
repair, and cell cycle progression. Protein ubiquityla-
tion is a highly specific mutlistep process, which
begins when an element within the target protein,
termed a degron, is recognized by the ubiquitylation
machinery. After the degron has been bound and rec-
ognized, Ub is then transferred to a lysine residue
within the target protein. Repeated rounds of ubiqui-
tylation result in a highly ubiquitylated target protein
which is rapidly subject to proteasomal destruction.
Because proteasomal destruction depends on prior
substrate ubiquitylation, selectivity in degron recogni-
tion by the ubiquitylation machinery is central to the
control of Ub-mediated proteolysis. Despite the
importance of this process, however, the poor charac-
terization of degrons and their mechanism of action
have hampered our understanding of how proteins-
like the oncogene transcription factors-are targeted
for destruction.
Work in our laboratory is focused on uncovering
the mechanism of Myc destruction. Myc is the focus
of our work because (1) Myc is a prominent human
oncoprotein that is aberrantly expressed in many lym-
phomas and lung cancers, (2) Myc activates cell cycle
progression (via transcriptional activation of the
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cdc25 phosphatases), and (3) the mechanism of Myc
destruction has not been characterized. Indeed,
although Myc has long served as a paradigm for a
rapidly degraded nuclear protein, surprisingly little is
known about how Myc is turned over in vivo.
We began our characterization of Myc destruction
by asking if Myc, like many of its oncogene tran-
scription factor counterparts, is destroyed by ubiqui-
tin-mediated proteolysis. We have obtained three sep-
arate lines of evidence to support a role for the Ub-
proteasome pathway in Myc turnover. First, we have
shown that when a mouse cell line with a temperature-
sensitive defect in an enzyme required for ubiquitin
conjugation (El) is placed at the restrictive tempera-
ture, steady-state Myc levels rise dramatically.
Second, we have shown that chemical inhibitors of the
proteasome also cause Myc levels to rise, both in pri-
mary human epithelial cells and in several trans-
formed human cell lines. Finally, we have directly
detected ubiquitylated forms of Myc in vivo. Figure 1
shows the results of a transient transfection experi-
ment comparing the ubiquitylation status of exoge-
nously expressed Myc with that of another oncopro-
tein transcription factor, Jun. In these experiments,
approximately 1-2% of the total Myc population is
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trapped in a ubiquitylated state (lane 12), composed of
mono-ubiquitylated Myc and a broad spectrum of
higher-order Myc-Ub conjugates. The level of multi-
ubiquitylation of Myc is comparable to that of Jun
(compare lanes 10 and 12).
Together, these three lines of evidence demon-
strate a prominent role for the Ub-proteasome path-
way in directing Myc turnover. Future experiments in
the laboratory will be geared toward understanding
the Ub-mediated destruction of Myc in greater detail,
focusing specifically on (1) identifying the Myc
degron, (2) characterizing the factors responsible for
targeting Myc for destruction, (3) identifying process-
es that regulate Myc destruction, and (4) determining
whether the Myc destruction process is subverted or
changed in cancer. Results of these studies should illu-
minate mechanisms governing an important part in the
life (and death) of an important human oncoprotein.
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MOLECULAR GENETICS
This section comprises labs that study a diverse set of cellular phenomena, including signal
transduction, cancer, morphogenesis, and differentiation using mainly genetic approaches in
model eukaryotic systems. Michael Wigler's group identifies and analyzes the genes and loci that
are mutated in human cancer and studies signal transduction in humans and yeasts, with particu-
lar emphasis on RAS, an oncogene conserved in evolution, and PTEN, a tumor suppressor that
encodes a protein tyrosine phosphatase. Michael Hengartner's laboratory explores the compo-
nents of the programmed cell death pathway in the nematode Caenorhabditis elegans and have
begun to use that model genetic organism to study memory, learning, and neural cell functioning.
David Beach's laboratory works on the regulation of the eukaryotic cell cycle and the abnormali-
ties of cell cycle control that accompany oncogenic transformation. Greg Hannon's laboratory
explores mechanisms of growth control in animal cells with a specific focus on the disruption of
growth controls in tumor cells. Bruce Futcher's lab studies the control of cell division, with special
emphasis on cyclin-dependent kinases and their substrates. The lab also works on telomeres and
their relationship to aging. Rob Martienssen's laboratory is pursuing a systematic analysis of the
Arabidopsis genome using gene trap and enhancer trap transposons. They are also continuing
their analysis of leaf and chloroplast development, including the discovery of a chloroplast mem-
brane protein in maize that defines a universal pathway for sec-independent protein translocation
in bacteria and chloroplasts. Erich Grotewold's lab has made significant progress in elucidating
the mechanisms by which Myb domain proteins control gene expression in plants. They have
also determined that maize has more than 100 proteins containing this conserved domain, and
tools to determine Myb function in plants have been developed. Hong Ma's lab identifies and
studies genes important for reproductive development in Arabidopsis, particularly those required
for normal floral organ development or controlling male meiosis and pollen development. Ueli
Grossniklaus' group studies the genetic and molecular basis of plant reproduction in Arabidopsis,
focusing on the development and function of the haploid female gametophyte and the maternal
control of seed formation. David Jackson's group studies the development of the shoot apical
meristem in maize and Arabidopsis, both model genetic organisms. They are characterizing a
plant homeodomain protein that is involved in cell-to-cell communication and has the ability to
traffic between plant cells.
MAMMALIAN CELL GENETICS
M. Wig ler C. Yen
M. Hamaguchi
M. Nakamura
R. Lucito
L. Serina
D. Esposito
E. Hatchwell
D. Dong
J. Stolarov
H. Tu
K. Chang
J. West
Y. Han
L. Rodgers
M. Riggs
J. Troge
B. O'Conner
V. Tu
A. Weiner
Our overall research objectives are to define the genet-
ic alterations that cause human disease, especially can-
cer, and to determine their biochemical consequences.
This effort is focused on three areas: signal transduc-
tion, in which we study the pathways of communica-
A. Solanki
A. Bug lino
M. Katari
D. Almanzar
J. Brodsky
J. Douglas
tion that become deranged in cancer cells; genomics,
in which we apply and develop tools for the genetic
analysis of human disease; and combinatorial chem-
istry, in which we are trying to develop a general
methodology that will enable us to manipulate the bio-
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chemical pathways involved in cancer. The ras path-
way has figured prominently over the years in our
studies of signal transduction, and RDA (representa-
tional difference analysis) has figured prominently in
our genomic studies. RDA is a tool for genomic dif-
ference analysis developed in previous years in collab-
oration with Nikolai Lisitsyn (Lisitsyn et al., Science
259: 946 [1993]).
this. The regulatory domain of shkl binds its catalytic
domain, and mutations in the regulatory region that
abolish its binding to the catalytic region "open" the
conformation of shkl and genetically "activate" the
kinase. Using the opening of the wild-type shkl as a
genetic screen, we have identified a novel open read-
ing frame that may encode an upstream activator of
this kinase.
Studies of MAP Kinase Cascades
H. Tu, D. Dong
The MAP protein kinase cascade is a conserved motif
in the signal transduction repertoire of probably all
eukaryotic organisms. Our first encounter with it was
in the ras-controlled sexual differentiation pathway in
the yeast Schizosaccharomyces pombe. In that organ-
ism, rasl acts directly on byr2, the kinase that acti-
vates byrl, itself a kinase that activates spk 1 , the
kinase that is the homolog of the mammalian
MAP/ERK family of kinases. In the control of this
cascade, rasl is joined by ste4, a leucine zipper protein
that we have studied in previous years (Barr et al.,
Mol. Cell. Biol. 16: 5597 [1996]). We have demon-
strated that rasl and ste4 act independently and joint-
ly upon the regulatory domain of byr2. We have now
demonstrated the direct involvement of yet a further
protein kinase, shkl, which appears to act by releasing
the catalytic domain of byr2 from inhibition by its reg-
ulatory domain, thereby "opening" its conformation
(Tu et al. 1997). We assess these changes in confor-
mation by the two-hybrid system of Fields and Song
(Nature 340: 245 [1989]). Our results suggest that rasl
exerts its influence upon byr2 through two routes: one
by directly acting upon byr2 (Van Aelst et al., Proc.
Natl. Acad. Sci. 90: 6213 [1993]), and another through
a pathway involving scdl , cdc42, and shkl (Chang et
al., Cell 79: 131 [1994]).
byr2 is a member of the MEKK family of protein
kinases, and shkl, which acts upon it, has a similar
structure and belongs to another family of protein
kinases, the PAK family of protein kinases. Like the
MEKK kinases, these kinases also have a carboxy-ter-
minal catalytic domain and an amino-terminal regula-
tory domain that contains the binding site for a mem-
ber of the ras family of GTPases. We have tested
whether the tools for analyzing the regulatory compo-
nents of byr2 could be used for the study of the PAK
family of kinases. Preliminary studies encourage us in
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PTEN, a Tumor Suppressor Encoding
a Phosphoprotein Phosphatase
J. Strolarov, K. Chang, C. Yen
The use of RDA led to the identification of a region on
chromosome 10 deleted in a variety of human cancers,
including breast, prostate, and brain cancers. We there-
fore suspected that this region harbored a tumor sup-
pressor gene. In a collaboration with Ramon Parsons
of Columbia University, a gene from this region,
PTEN, was identified and found to be mutated in
many cancers (Li et al. 1997). In collaboration with
Michael Myers and Nick Tonks at CSHL, PTEN was
shown to encode a protein tyrosine phosphatase with a
somewhat atypical substrate preference (Myers et al.
1997). In addition to its relation to phosphatases, the
PTEN protein contains motifs also found in cytoskele-
tal proteins. The discovery by Parsons and collabora-
tors that the PTEN gene is mutated in a hereditary dis-
ease predisposing the afflicted with neoplastic growths
completes the demonstration that PTEN is a tumor
suppressor gene (Liaw et al., Nat. Genet. 16: 64
[1997]; Marsh et al., Nat. Genet. 16: 333 [1997]).
Three lines of investigation into the biology of
PTEN are being pursued. First, we have expressed the
PTEN protein in cultured tumor cells that lack a func-
tional PTEN gene. As yet we have not observed a clear
phenotypic response in cell culture. Second, PTEN
has a homolog in the yeast Saccharomyces cerevisiae,
and experiments looking at the effects of deleting or
overexpressing the gene in such yeast have begun.
Again, as yet no phenotype is apparent. Third, we have
searched for binding partners of PTEN using the two-
hybrid system of Fields and Song and have found a
number of binding partners, including proteins con-
taining PDZ domains. Many PDZ domain proteins act
as scaffolding proteins for proteins involved in signal
transduction (Ponting et al., BioEssay 17: 5876
[1997]). We are attempting to explore the physiologi-
cal relevance of our findings.
In a collaboration with Richard McCombie's lab at
CSHL, we initiated the sequencing of the PTEN locus.
Nearly 180 kbp of genomic sequence have been com-
pleted by his group.
Loci Amplified in Breast Cancer
M. Nakamura, R. Lucito, C. Yen
From the analysis of breast cancer biopsies, we have
derived many probes derived from amplified loci.
These loci are suspected to contain oncogenes that
drive the growth and malignancy of breast cancers.
Along with loci that were known previously, such as
the ErbB2, c-myc, and cyclin D loci, several new loci
have been observed. We are in the midst of trying to
identify the genes encoded in these regions and have
been concentrating on a region that lies near to but is
distinct from the c-myc region.
As a first step in characterizing amplified loci, we
need to perform "epicenter" mapping, a process that
delineates the minimum region which is commonly
amplified. To achieve this, it is necessary to search
through large archives of stored breast cancer biop-
sies. For this purpose, we have developed a technique
for "immortalizing" and amplifying the DNA of
samples for present and future analyses (Lucito et al.
1998). The technique is based on a high-complexity
"representation" of tumor DNA, which entails its
cleavage, ligation to adaptors, and subsequent PCR
amplification. We have shown that such representa-
tions are useful for measuring gene copy number and,
in collaboration with Joe Grey's laboratory
(University of California, San Francisco), can be used
for comparative genomic hybridization, a technique
useful for the global assessment of genomic changes
(Kallioniemi et al., Genes, Chromosomes & Cancer
10: 231 [1994]). "Quantitative" PCR can also be used
to measure gene copy number in high-complexity rep-
resentations (Gibson et al., Genome Res. 6: 995
[1996]) .
Loci Deleted in Breast Cancer
C. Yen, M. Hamaguchi, R. Lucito, Y. Han,
D. Esposito, M. Nakamura
Several loci have now been identified by RDA that are
homozygously deleted in breast cancer. Among these
are the PTEN locus and the locus encoding p16, the
inhibitor of the cdc2 and cdc4 cyclin-dependent pro-
tein kinases. Ten loci remain in which we are search-
ing for genes. This process also entails epicenter map-
ping, which as described above, narrows the region in
which we need to search for genes. Unfortunately, the
regions of homozygous deletion are quite large, often
greater than a megabase upon initial characterization,
and hence the process of gene searching has become
the rate-limiting step in discovery. Several steps have
been taken to accelerate this phase of our work. The
first is the use of high-complexity representations,
which has already been described. The second is the
development of a solution hybridization technique,
called RICH, for the cloning of cDNAs that hybridize
to a given large-insert chromosomal vector such as a
BAC or YAC (Hamaguchi et al. 1998).
RICH (rapid isolation of cDNAs by hybridization)
is meant to complement the searching of genes by
exon trapping and sequence analysis. The ends of
fragments of restriction-endonuclease-cleaved cDNA
libraries are modified so that when they hybridize to
fragments from the insert of large cloning vectors,
they can be selected and amplified and cloned. The
application of this technique has been successfully
tried on the c-myc locus (an example of amplification)
and the PTEN locus. In a "mock" comparison with
exon trapping and sequence analysis, the method fares
well.
Rearrangements in Cancer and
Spontaneous Genetic Disease
L. Serina, E. Hatchwell, C. Yen
We are beginning to adapt RDA to detect rearrange-
ments in cancer. Several reasons for attempting this
are, first, the present use of RDA for the discovery of
tumor suppressors is biased to the discovery of large
regions of homozygous deletion, and these may be
"gene-poor" regions of the genome. Second, every
deletion will create a rearrangement, and small dele-
tions or large deletions do so equally. Small deletions
are more likely to involve directly the rearrangement
of a target gene, and hence the bridging region is more
likely to be directly linked to a target gene. Although
we have encountered rearranged regions with RDA as
we now practice it, the method was not optimized for
that task. We are now testing a variety of improved
methods for the "co-representation" of tumor and nor-
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mal DNAs that are designed to find differences in the
mobility of restriction endonuclease fragments in the
respective genomes. The same kinds of methods may
find application to the discovery of the spontaneous
genetic lesions that can occur in the germ line of a par-
ent and be transmitted as de novo disease to offspring.
Combinatorial Chemistry
D. Dong
In collaboration with Peter Nestler's lab at CSHL, we
have been investigating the binding capacity of a class
of branched peptides, or "forcep" molecules. These
have been generated as members of encoded combina-
torial libraries, a method developed in collaboration
with C. Still's lab at Columbia University (Ohlmeyer
et al., Proc. Natl. Acad. Sci. 90: 10922 [1993]). As tar-
gets, we have chosen the carboxyl end of H-ras,
because it is the substrate of farnesyl transferase, the
first step in the essential processing of ras proteins
(Gibbs, Cell 65: 1 [1991]) and because this end is pre-
dicted to be exposed as a peptide. Several members of
this forceps library have been shown to bind specifi-
cally to the carboxy-terminal sequences of H-ras and
to recognize these sequences when they are fused to
other proteins. A subset of these forceps also block the
farnesylation of H-ras. These results, although very
preliminary at the moment, suggest that branched pep-
tidic molecules will have the general capacity to rec-
ognize peptides and may indicate that this will be a
fruitful class of molecules that can modulate biologi-
cal systems.
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CAENORHABDITIS ELEGANS DEVELOPMENTAL GENETICS
M. Hengartner S. Desnoyers Q. Liu
A. Gartner S. Milstein
T. Gumienny G. Parvilus (URP)
D. Hoeppner M. Spector
J. Keller S. Tharin
Our laboratory uses the small nematode Caenorhab-
ditis elegans as a model organism for the study of
basic biological problems. Our two main areas of
interest are (1) programmed cell death (apoptosis) and
(2) nervous system development and function.
PROGRAMMED CELL DEATH
Programmed cell death (PCD, also known as apopto-
sis) is a mechanism used by multicellular organisms to
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eliminate cells that are not needed or are potentially
dangerous. PCD plays important roles in animal
development and homeostasis and occurs in a wide
variety of tissues in both vertebrates and invertebrates.
Proper control of PCD is crucial: Breakdown in the
regulation of this process contributes to the pathogen-
esis of a large number of diseases, including cancer,
autoimmunity, neurodegenerative diseases, ischemic
stroke, and myocardial heart infarct.
The nematode C. elegans provides an attractive
system for the study of PCD, as its development has
been extensively characterized and the animal is read-
ily amenable to genetic and molecular manipulations.
Hundreds of mutations that affect nematode cell death
have been isolated over the years; these mutations
identify more than 16 genes that function in the regu-
lation and execution of apoptosis. Three genes encode
key regulators of the apoptotic cell fate. Two of these
(CED-3 and CED-4) are required for cell death; the
third (CED-9) neutralizes CED-3 and CED-4 in cells
that should live, thereby protecting them from apopto-
sis. Homo logs of all three nematode genes have key
roles in the regulation of apoptosis in mammals. CED-
9 is a member of the Bc1-2 family, CED-4 is similar to
the recently identified proapoptotic factor Apaf-1, and
CED-3 is homologous to a family of more than ten
cysteime proteases, known as the caspases.
The Central Death
Machinery in C. elegans:
The Apoptosome
M. Spector, S. Desnoyers
How does CED-9 prevent PCD? In the past year, we
have reported that CED-9 interacts physically with
CED-4, both in the yeast two-hybrid system and in
vitro. Mutations that reduce or eliminate ced-9 activi-
ty also disrupt its ability to bind CED-4, suggesting
that this interaction is important for CED-9 function.
Thus, CED-9 might control C. elegans cell death by
binding to and regulating CED-4 activity. Interesting-
ly, other investigators have shown that activation of
CED-3 requires a physical interaction between
proCED-3 and CED-4; this interaction somehow pro-
motes autocatalytic processing of proCED-3. We sus-
pect that in cells that should survive, CED-9 holds
CED-4 in an inactive conformation, thereby prevent-
ing CED-4-mediated activation of proCED-3. The
ability of CED-9, CED-4, and CED-3 to exist in a
multiprotein complex has led to the "apoptosome"
model of cell death regulation (Fig. la). Because the
genetic pathway for PCD in conserved through evolu-
tion, it is tempting to speculate that a similar regulato-
ry mechanism might exist in mammals (Fig. lb).
We are now in the process of confirming the exis-
tence and subunit composition of the worm apopto-
some, as well as the subcellular localization of its
component proteins in living and apoptotic cells.
Genetic Analysis of Caspase
Function in C. elegans
A. Gartner, D. Hoeppner [in collaboration with
Yuri Lazebnik, Cold Spring Harbor Laboratory]
CED-3 is a homolog of a mammalian family of cys-
teine proteases known as the caspases. As is the case
for CED-3, many of the caspases have been implicat-
ed in apoptosis. The ability of several of the caspases
to activate other members of the family has led to the
"caspase cascade" model of apoptosis, in which
upstream "regulatory" caspases activate downstream
"execution" caspases. Because only one caspase
homolog has been described in C. elegans, it is not
clear whether such a cascade could also be acting in
the worm. We have recently identified two additional
caspase homologs in the C. elegans genome. We are
very interested in understanding the role that these
genes might have in PCD (or other processes). We are
using a reverse genetic approach to identify mutations
in these genes. In addition, we have set up a collabo-
ration with Yuri Lazebnik and his colleagues to study
the biochemical characteristics of these two proteins.
Programmed Cell Death in the
C. elegans Germ Line
S. Milstein, T. Gumienny, A. Gartner
How is the apoptosome regulated? The answer to this
question is likely to be complex, as even a single cell
might need to integrate multiple signals to determine
whether it should activate the death pathway or keep
on living. To address this question in C. elegans, we
have set out to determine how specific cell types
decide between life and death.
One of the cell types on which we chose to focus
is the germ cell. PCD has a major role. in the adult her-
maphrodite germ line. Our previous studies have
shown that most of the germ cells that differentiate
along the oogenic pathway undergo PCD. We suspect
that these deaths serve a homeostatic function and are
needed to regulate the number of cells that are allowed
to differentiate into oocytes.
Interestingly, we have found, in collaboration with
Eric Lambie (Dartmouth University), that activation
of the ras pathway is necessary for germ cells to
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Figure 1 The apoptosome: A model for the mechanism of action of the cell death machinery. (a) In C.
elegans, the cell death regulators CED-3, CED-4, and CED-9 are predicted to be stably associated in
a multiprotein complex localized to the outer surface of mitochondria. This complex is expected to be
present in all cells, but in an inactive state. In cells fated to die, a proapoptotic stimulus modifies the
complex, possibly resulting in the dissociation of CED-3/4 from CED-9. Once freed, CED-4 allowsthe
CED-3 proenzyme to autoactivate. The active protease then cleaves the relevant apoptotic substrates,
bringing on the death of the cell. (b) A similar complex might exist in mammals. This complex would
be expected to include a BcI-2 family member, such as Bcl -xL, an adapter molecule such as Apaf-1,
and a procaspase. For the Apaf-1/procaspase-9 complex, cytochrome c has been shown to act as
an essential cofactor. (Adapted from Hengartner 1997.)
undergo PCD. We suspect that activation of the ras
pathway might be required for germ cell death because
it promotes progression from an early, cell-death-
resistant stage to a later, cell-death-sensitive stage of
meiosis. Presumably, further differentiation restores
death resistance to the mature oocytes. Alternation
between death-resistant and death-sensitive stages
during differentiation has previously been observed,
notably during B- and T-cell development. In several
of these cases, a striking correlation has been observed
between the sensitivity to death and levels of one or
more members of the CED-9/Bc1-2 family. Whether
germ cell death is regulated at the level of CED-9 is
not yet clear.
To further decipher how germ cells make the deci-
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sion between life and death, we have screened for
mutations that specifically affect PCD in the germ
line. In the last year, we have isolated more than 20
mutations that result in excessive germ cell death. We
are now in the process of characterizing and classify-
ing these mutations.
Genes Involved in the
Engulfment of Dying Cells
Q. Liu, T. Gumienny
Once a cell activates the apoptotic machinery, a num-
ber of downstream "subprograms" are activated, with
the goal of rapidly breaking down the cell and remov-
ing it from the body. One important subprogram
results in the generation of signals that promotes
recognition and phagocytosis of the dying cell by
other cells.
Six genes have previously been shown to function
in this process in C. elegans. In the past year, we have
cloned one of these six genes, ced-6. We found that the
CED-6 protein contains a phosphotyrosine-binding
(PTB) domain and a number of potential SH3-binding
sites, suggesting that CED-6 might act in a signal
transduction cascade activated once a cell recognizes
that one of its neighbors is undergoing PCD.
Consistent with this hypothesis, mosaic analysis indi-
cates that CED-6 acts within the engulfing cells.
NERVOUS SYSTEM FUNCTION
AND DEVELOPMENT
A second area under investigation in the lab is the ner-
vous system in C. elegans. The small size and relative
simplicity of the nematode nervous system allows us
to readily address complex questions at the genetic
and molecular levels.
Development of a
Tetracycline-responsive
System in C. elegans
S. Tharin, G. Parvilus
A tetracycline-responsive system for conditional gene
expression has recently been developed for use in
mammalian cells in culture and in transgenic mice.
Because such a conditional expression/repression
system would be useful for our studies of the nervous
system, we have been working toward adapting this
system for C. elegans.
In preliminary experiments, we had attempted to
control gene expression in the six touch cell neurons
using both a tet-transactivator and a reverse transacti-
vator system. Unfortunately, our initial results were
disappointing (some background expression, and little
if any specific expression). During the last year, we
have continued to experiment with different coinjec-
tion markers and stronger promoters driving the tet-
transactivator in an effort to overcome these two prob-
lems.
Learning and Memory
S.Tharin [in collaboration with John Connolly, Tim Tully,
Cold Spring Harbor Laboratory, and Derek van der Kooy,
University of Toronto, Canada]
We are interested in analyzing the molecular basis of
associative learning and memory in C. elegans. We are
pursuing this project in collaboration with the Tully and
van der Kooy laboratories. During the last year, we
have continued to make progress toward the develop-
ment of a satisfactory conditioning paradigm, which
we will use to screen for mutants defective in acquisi-
tion, short-term memory, or long-term memory.
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EUKARYOTIC CELL CYCLE CONTROL
D. Beach S. Allan K. Dai M. Serrano
A. Carnero K. Galaktionov P. Sun
J. Chen R. Maestro J. Wang
D. Conklin S. Salghetti L. Xie
During the course of the year, Manuel Serrano accept-
ed a staff investigator position at the Universidad
Autonoma Cantoblanco in Spain, Konstantin Galak-
tionov became an assistant professor at Baylor
College of Medicine in Houston, and Kang Dai
became a scientist II at Chiron Corporation. Amancio
Carnero accepted a postdoctoral fellowship at the
Institute of Child Health in London; Roberta Maestro,
a visiting scientist, returned to her lab at the Centro di
Riferimento Oncologico Aviano in Italy; and Simone
Salghetti left to have a baby and returned to work with
Bill Tansey. We were joined by Pedro Otavio de Cam-
pos Lima, a postdoctoral fellow from the Karolinska
Institute.
Genetic Screens to Identify Genes
Involved in Cellular Immortalization
and Anchorage-independent Growth
in Human Cells
D. Conklin, D. Beach [in collaboration with Cathy
Reznikoff, University of Wisconsin-Madison]
Cells in higher organisms are subject to genetically
programmed internal constraints on proliferation. The
processes of programmed cellular senescence and
anchorage-dependence of growth place important
restrictions on the extent and locale of cell division.
What little is known of these processes is directly
related to G1 cell cycle control and tumor suppression.
In an effort to identify new gene products that are
involved in cellular senescence and anchorage depen-
dence, two functional cloning screens, whose design
presupposes as little about these processes as possible,
have been undertaken in nearly normal human cells.
Cellular senescence was first used by Hayflick and
co-workers to describe the decreased ability of human
fibroblasts to divide upon continual subculture in
vitro. This is now viewed as a universal property of
almost all cells in vitro and, although difficult to
prove, of most cells in vivo as well. Genes whose
overexpression immortalizes or significantly extends
the replicative life span of normal presenescent human
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uroepithelial cells (HUCs) are being isolated in func-
tional screens using replication-defective retrovirus
cDNA libraries. HUCs are isolated from resected
ureters, which are normally discarded during kidney
transplant surgeries. They are routinely cultured in
vitro and predictably undergo approximately 50 popu-
lation doublings before senescing. Introduction of
HPV E7 results in an extended life span of two addi-
tional passages and the potential for low-frequency
immortalization. Cytogenetic evidence indicates that a
limited number of gene amplifications cooperate with
the HPV E7 oncoproteins in the immortalization of
HUCs. Retroviral cDNA libraries have been con-
structed using the mRNA of post-crisis immortalized
HUC cells. These libraries have been introduced into
presenescent HUCs, and retroviruses have been
excised from immortal cell populations. At present, 42
candidate genes from approximately 15 immortal cell
populations have been isolated and are being retested
for authenticity.
The loss of anchorage dependence of growth is
thought to be important in tumor formation and is
indeed the best known cellular correlate to tumori-
genicity. Genes whose overexpression or underexpres-
sion permits cells to grow in soft agarose are being
isolated using retroviral sense and antisense cDNA
libraries. The host strain for this screen is the human
fibroblast line MSU1.1, which is immortal, yet not
transformed. Retroviral cDNA libraries were con-
structed using the mRNA of both transformed and
untransformed cells. At present, several candidate
genes have been isolated and are being retested.
MDM-2 Overcomes TGF -f3
Growth Arrest via a
p53-independent,
RB/E2F-dependent Mechanism
P. Sun, D. Beach
Transforming growth factor-13 (TGF-(3) is a multifunc-
tional cytokine that has important roles in suppressing
tumorigenicity. In some tumors, progressive loss of
TGF-P sensitivity is associated with their aggressive-
ness. To identify genes that overcome cell cycle arrest
by TGF-P, we performed a genetic screen in mink
lung epithelial (Mv1Lu) cells, using a retroviral
expression system recently developed in our lab.
A mixture of poly(A)* RNA from Swiss-3T3 and
BALB-3T3 cells was chosen as the source of our
cDNA library. The library was cloned into a retroviral
expression vector HygroMaRXII, packaged in an
ecotropic virus packaging cell line LinX E, and used
to infect Mv1Lu cells, which were pseudotyped with
ecotropic virus receptor. The infected cells were
selected with hygromycin and then with TGF-P.
Integrated provirus was then recovered from TGF-
resistant cells with Cre recombinase. Three genes,
MDM-2, c-Myc, and NFIX, were cloned from this
screen. Among them, c-Myc was previously demon-
strated to be able to overcome TGF-P arrest in mouse
keratinocytes in a transient assay.
Because previously the oncogenic activity of
MDM-2 was attributed to its ability to inactivate p53,
and p53 was also shown to be involved in the TGF-P
responses, we asked whether MDM-2 overcomes
TGF-P arrest by eliminating p53. The expression of
two dominant-negative alleles of p53, p53Va1135 and
p53175H, was unable to rescue TGF-I3 arrest,
although they greatly reduced the p53-dependent
reporter activity to almost background in a transfec-
tion assay using a p53-dependent luciferase reporter.
This suggested MDM-2 probably overcomes TGF-P
arrest through a p53-independent pathway in Mv1Lu
cells.
The fact that MDM-2 could also bind to RB and
E2F led us to investigate whether MDM-2 confers
TGF-I3 resistance through the RB/E2F pathway. The
following observations were made. (1) In wild-type
My cells, TGF-13 treatment led to dephosphoryla-
tion of RB. However, in MDM-2-expressing cells, as
well as in c-Myc- and NFIX-expressing cells, RB
remained hyperphosphorylated with TGF-13 treatment.
(2) The endogenous E2F activity in MVILu cells was
assessed by transient transfection of a luciferase
reporter gene containing three copies of E2F DNA-
binding sites into wild-type cells or cells expressing
MDM-2, c-Myc, or NFIX in the presence or absence
of TGF-P. TGF-P treatment reduced E2F activity by
twofold in wild-type cells, and expression of MDM-2,
c-Myc, or NFIX abolished this reduction. (3) TGF-P
treatment led to a gradual decrease in E2F-1 protein
level in Mv1Lu cells. However, there was only a slight
decrease in MDM-2-, c-Myc-, and NFIX-expressing
cells. (4) E2F-1-overexpressing cells became TGF-
resistant to a similar extent as MDM-2-expressing
cells.
Our study demonstrated that in addition to inacti-
vating p53, overexpression of MDM-2 in tumors ren-
ders cells insensitive to the tumor-suppressing func-
tion of TGF-I3 through a p53-independent mechanism.
It is achieved by preventing TGF-P from dephospho-
rylating RB and down-regulating E2F expression.
Since it was shown that IL-6 also leads to growth
arrest by dephosphorylating RB and reducing E2F
protein level, it is likely that MDM-2 also insensitizes
tumor cells to other negative growth regulators, by
contributing to the malignancy of tumors. This study
also reveals a biological function of the p53-indepen-
dent activity of MDM-2. In certain tumors, p53
inactivation and MDM-2 overexpression occur inde-
pendently, which suggests that MDM-2 has p53-inde-
pendent oncogenic functions. The observation that
MDM2 overcomes growth arrest by TGF-I3 and other
growth inhibitors through a p53-independent pathway
may provide a potential mechanism for such functions
of MDM-2.
Myc Activates Telomerase:
Extension of Cellular
Life Span
J. Wang, D. Beach
Telomere maintenance has been proposed as an essen-
tial prerequisite to human tumor development. The
telomerase enzyme is itself a specific marker for
tumor cells, but the genetic alterations that activate the
enzyme during neoplastic transformation have
remained a mystery. Amplification of the myc onco-
gene is prevalent in a broad spectrum of human
tumors. Here, we show that myc induces telomerase
both in normal human mammary epithelial cells
(HMEC) and in normal human diploid fibroblasts.
Myc increases expression of hEST2 (hTRT/TP2), the
catalytic subunit of telomerase. Since hEST2 limits
enzyme activity in normal cells, myc may control
telomerase solely by regulating hEST2 levels.
Activation of telomerase through hEST2 is sufficient
to increase average telomere length and extend life
span in normal human mammary epithelial cells.
Since myc can also extend the life span of these cells,
activation of telomerase may be one mechanism by
which myc contributes to tumor formation.
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GROWTH CONTROL IN ANIMAL CELLS
G. Hannon P. Dong
A hallmark of tumor cells is the ability to survive and
proliferate under circumstances that are incompatible
with the growth and survival of normal cells.
Transformation of a normal cell into a tumor cell
requires myriad genetic alterations that permit escape
from governance by normal growth regulatory pro-
grams and that promote unchecked proliferation.
Control over the growth of normal cells comes in
many forms. For example, the growth and survival of
normal cells require the presence of specific extracel-
lular factors while different factors act in a dominant
manner to prevent proliferation. In transformed cells,
the dependence on extracellular signals is often
reduced by activation of cellular oncogenes; however,
in a normal cell, oncogene activation frequently leads
to programmed cell death unless additional mutations
counter this response. Normal cells are also subject to
a preprogrammed limit on the number of divisions that
they can execute. After this limit is reached, cells enter
replicative senescence, a growth arrest that is thought
to be irreversible. During the past year, we have used
a genetic approach to investigate multiple levels of
growth control in mammalian cells. Our efforts have
focused on those controls that are altered as a normal
cell evolves into a tumor cell.
RESISTANCE TO GROWTH-INHIBITORY CYTOKINES:
TRANSFORMING GROWTH FACTOR-I3
TGF43 is a multifunctional cytokine that halts the pro-
liferation of many normal epithelial cells. However,
tumor cells often acquire resistance to the inhibitory
effects of TGF-I3. To investigate the mechanisms by
which cancer cells resist growth inhibitory cytokines,
we searched for genes that, when inappropriately
expressed, bypass TGF-I3-mediated growth arrest.
This work, done in collaboration with Peiqing Sun and
David Beach here at the Laboratory, led to the identi-
fication of three gene products: c-myc, NF-1X, and
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mdm-2. The c-myc oncogene had previously been
shown to nullify TGF-I3 sensitivity in murine ker-
atinocytes, so isolation of this gene in a genetic screen
for TGF-13 resistance validated our approach. Neither
NF-1X nor mdm-2 had previously been connected
with the TGF -I3 response.
The mdm-2 oncogene is a regulator of the p53
tumor suppressor. Increased expression of mdm-2
inhibits p53 function at multiple levels, including
antagonism of transcriptional activation and promo-
tion of p53 degradation. Our results therefore seemed
to implicate p53 in TGF-13-mediated cell cycle arrest.
To test this possibility, we used dominant-negative
mutants of p53 to interfere directly with p53 function
in our target cells. Surprisingly, we found that loss of
p53 function did not affect the ability of TGF-13 to
enforce growth arrest.
We were therefore left to search for a new mecha-
nism by which the mdm-2 oncogene might affect cell
proliferation. Our experiments and those of numerous
other labs have suggested that growth arrest following
treatment with TGF-13 can be eliminated by inactiva-
tion of the Rb pathway. Two previous reports had sug-
gested that mdm-2 protein could interact in vitro and in
vivo with the Rb protein itself and with a transcription
factor, E2F-1, that is regulated by Rb. However, the
biological consequences of these interactions were
unclear. Following TGF-0 treatment, the Rb protein
accumulates in the hypophosphorylated, growth-
inhibitory state. In addition, the abundance of E2F-1
protein is diminished, probably through posttransla-
tional mechanisms. We found that mdm-2 expression
prevented both of these alterations. However, the pos-
sibility remained that mdm-2 might accomplish this
indirectly by effects on TGF-13 signal transduction or
through regulation of other cell cycle pathways.
To address more directly the biological interaction
between the mdm-2 and the Rb pathway, we asked
whether mdm-2 expression could abrogate the growth
arrest that is enforced by expression of INK4-family
CDK inhibitors. INK4 proteins prevent Rb phospho-
rylation by inhibition of an essential Rb kinase. Rb is
therefore locked in a hypophosphylated, growth
inhibitory state. One member of the INK4 family, p15
INK4B, is a downstream target of the TGF-13 signal
transduction pathway and is a likely effector of TGF-
13- mediated growth arrest. Expression of mdm-2 sub-
stantially rescued the growth inhibition caused by
either p15 INK4B or p16 INK4A or, in fact, by
enforced expression of Rb itself.
Considered together, our results point to a direct
connection between the mdm-2 and the Rb pathway.
Thus, mdm-2 is a cellular oncogene that, like many
viral oncoproteins, can interfere with multiple tumor
suppression pathways: the p53 pathway and the
Rb/p16 pathway.
RESCUE FROM ONCOGENE-INDUCED APOPTOSIS
When exposed to oncogenic insults such as increased
expression of cellular oncogenes (e.g., myc) or intro-
duction of viral oncoproteins (e.g., El A), normal cells
will often execute an apoptotic program that may
serve to protect multicellular organisms from unwar-
ranted proliferation. In tumors, oncogene activation is
often accompanied by increased expression of anti-
apoptotic genes such tumor cells not
only survive oncogene activation but thrive because of
it. We have used a genetic approach to identify genes
that can protect cells from apoptosis provoked by a
cellular oncogene, c-myc, that is commonly activated
in human tumors.
Roberta Maestro, a visiting scientist from the
C.R.O. in Aviano, Italy, introduced cDNA expression
libraries into a rat fibroblast cell line that conditional-
ly expresses the myc oncogene. These cells normally
undergo apoptosis when myc is activated and growth
factors are withdrawn. We therefore exploited this
response to identify genes that would the prevent cell
death that occurred following myc induction. A num-
ber of different genes were isolated by this approach.
It was initially gratifying to find among protective
cDNAs the MCL-1 gene. MCL-1 is a member of the
bc12 family, a group of antiapoptotic proteins that have
been implicated in the development of a variety of
human tumors. Of the remaining genes, we chose to
focus our initial efforts on a transcription factor, twist.
The twist protein was originally isolated in
Drosophila as one of the zygotic genes required for
dorsoventral patterning during embryogenesis.
Targeted deletion of the twist protein in mice is lethal,
and twist-null embryos show massive apoptosis in the
developing somites. Therefore, isolation of twist as an
anti-apoptotic factor in a genetic screen fit well with
the phenotype of twist disruption in vivo.
Apoptosis in response to myc activation depends
in part on the integrity of the p53 protein. Enforced
twist expression relieved the growth arrest caused by
p53 activation in murine embyro fibroblasts, suggest-
ing that twist might protect from myc-induced apopto-
sis by interfering with p53. Consistent with this
notion, twist expression reduced the ability of p53 to
activate transcription from p53-responsive elements.
twist can interact in vitro and in vivo with a p53 coac-
tivator, p300. Preliminary data indicate that twist may
also affect p53 function through a direct interaction
with the p53 protein.
Since twist can interfere with the function of a cel-
lular tumor suppressor protein and can thus protect
against oncogene-induced apoptosis, twist itself may
contribute to tumor formation. Interestingly, patients
affected by the Saethre-Chotzen syndrome due to
mutations in the twist gene show not only develop-
mental abnormalities, but also a tendency to develop
tumors. Continuing efforts will be directed toward
understanding the mechanism by which twist interacts
genetically with cellular oncogenes and tumor sup-
pressors and toward investigating the involvement of
twist in tumor formation.
Myc ACTIVATES TELOMERASE: EXTENSION OF
CELLULAR LIFE SPAN
Stabilization of telomeric repeats has been proposed
as a prerequisite for tumorigenesis. Circumstantial
support for this notion comes from the observation
that telomerase is activated in a high percentage of
late-stage human tumors, whereas telomerase is large-
ly absent from somatic cells in vivo and from normal
human cells in culture. As normal cells proliferate,
telomeric repeats are progressively lost due to the
incomplete replication of chromosome ends during
each division cycle. Telomere shortening has been
proposed as the mitotic clock that marks the progress
of a cell toward the end of its replicative life span.
According to this model, erosion of chromosome ends
triggers cellular senescence. The possibility that
telomere maintenance might be an essential compo-
nent of the tumorigenic phenotype led us to survey
known oncogenes for the ability to activate the telom-
erase enzyme.
In collaboration with Jenny Wang and David
Beach, oncogenes were introduced into normal human
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mammary epithelial cells. Of those tested, only c-myc
showed a substantial effect on telomerase activity. In
fact, expression of myc increased telomerase to a level
similar to that seen in a number of breast carcinoma
cell lines. Myc could also induce telomerase activity
in normal human fibroblast cells, again to levels
approximating those seen in fibroblast-derived tumor
cell lines.
Recently, a number of subunits of the telomerase
enzyme have been cloned. The abundance of one of
these, hEST2 (the catalytic subunit), has been proposed
to limit telomerase activity. In fact, expression of
hEST2 alone was sufficient to activate the telomerase
enzyme in a variety of cell types. In mammary epithe-
lial cells, increased myc expression led to increased
abundance of hEST2, providing a possible mechanism
for regulation of telomerase activity by myc.
To probe the link between telomere length and
replicative life span, myc and hEST2 were introduced
into normal human mammary epithelial cells which
were then continuously cultured. After a defined num-
ber of cell divisions (about 22 passages or 50-60 pop-
ulation doublings), normal cells entered replicative
senescence. In contrast, cells expressing either myc or
hEST2 have continued to proliferate. Escape from
senescence was accompanied by either a stabilization
or an increase in mean telomere length (for myc and
hEST2, respectively). This suggests that the sole act of
manipulating telomere length can affect cellular life
span and establishes telomeres as one mechanism by
which cells measure their replicative age.
Promotion of cell proliferation and oncogenic
transformation by myc probably requires induction of
a number of different target genes. As telomere main-
tenance may contribute to the long-term proliferative
potential of tumor cells, telomerase activation may be
an essential component of the ability of myc to facili-
tate tumor formation.
SUMMARY
The last 2 years were largely invested in the develop-
ment of genetic approaches that can be applied to a
variety of biological problems in mammalian cells.
This year has seen a successful application of these
technologies to three aspects of the process by which
a normal cell is converted into a tumor cell. Through
the study of an extracellular growth inhibitory factor,
we have found that a known cellular oncogene, mdm-
2, can interfere not only with the p53 pathway (as was
previously established), but also with the Rb/p16
tumor suppressor pathway. Studies of oncogene-
induced apoptosis are aimed at identifying the signals
that instruct activation of the apoptotic machinery in
response to inappropriate proliferative stimuli. This
project has thus far yielded a connection between a
developmental transcription factor and a tumor sup-
pressor gene, p53. This link raises the possibility that
the mechanisms that control apoptosis during develop-
ment may overlap those that promote cell survival in
tumors. Finally, our investigation of telomerase regu-
lation has identified a connection between an onco-
gene that is commonly activated in human tumors and
maintenance of telomeres. Although the contribution
of myc to neoplastic transformation may require the
induction of a number of target genes, activation of
telomerase is likely to be a key component of the
oncogenic potential of myc.
CELL CYCLE CONTROL IN SACCHAROMYCES CEREVISIAE
B. Futcher J. Donovan
N. Edgington
F. Ferrezuelo
S. Honey
M. Lessard T. Volpe
B. Schneider H. Wijnen
G. Sherlock J. Zhou
Our main interest continues to be regulation of Start
and mitosis in Saccharomyces cerevisiae. We are most
interested in the tethering of division to cell growth
and in the generation of the basic cell cycle oscillation.
Many key cell cycle events are regulated by protein
kinase complexes formed between Cdc28 and one of
nine cyclins. These fall into two broad groups: the G,
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cyclins, which include Clnl, Cln2, and Cln3, that reg-
ulate Start; and the mitotic, B-type cyclins Clbl, C1b2,
C1b3, and C1b4. Two other cyclins, C1b5 and C1b6, are
very important for DNA replication but also have roles
at Start and perhaps also in early mitosis. A second
interest is yeast and human telomerase, and how
telomere length relates to cell senescence.
A Network for Exit from Mitosis
J. Donovan
High Cdc28 kinase activity is required for mitosis. At
the end of anaphase, when chromosomes have been
separated, this Cdc28 kinase must be inactivated to
allow the mitotic spindle to dissolve and to allow
cytokinesis. This inactivation can be thought of as
consisting of two steps: first, a signaling step, in which
the completion of anaphase triggers some unknown
signal, and second, an inactivation step, in which
Cdc28 kinase is inactivated in two and possibly three
ways. These are (1) destruction of cyclins via the APC;
(2) inhibition of the kinases via the CDK inhibitor
Sic 1 ; and possibly (3) inhibitory phosphorylation of
Cdc28 at Tyr-19. A network of genes is required for
this signaling and inactivation pathway. The genes
include CDC5, CDC14, CDC15, DBF2, TEM1,
SP012, and others. The typical loss-of-function phe-
notype is a large budded cell with divided nuclei and a
long mitotic spindle.
We have been trying to dissect this genetic net-
work by characterizing high-copy suppressors of the
key mitotic exit mutation dbf2-3. We have found two
such suppressors; one encodes the CDK inhibitor
SIC1 the other is a novel gene called SDB24 (for
Suppressor of dbf2).
SDB24 encodes a protein with no close homologs,
but it has six potential sites for phosphorylation by
Cdc28, and it has a clear coiled-coil domain, and as
such it is related to structural proteins such as
myosins, kinesins, and certain spindle pole body and
kinetochore proteins. The transcript is cell-cycle-regu-
lated, with a peak in S phase. The sdb24 null mutant is
viable but is synthetically lethal with dbf2 and with
cdc23. The synthetic lethality of dbf2 sdb24 can be
rescued by overexpression of the mitotic exit genes
CDC5,S1C1, and SP012, but not of CDC15 or TEM1.
GAL-CLB2 and GAL-CLB5 are lethal in an sdb24
background. Most recently, we have found a two-
hybrid interaction with a protein thought to function at
the spindle pole body.
All of these results are consistent with the general
idea that SDB24 is somehow important for reducing
Cdc28 activity at the end of mitosis. However, sdb24
mutants have no obvious direct defect in cyclin prote-
olysis in G1 phase, nor does Sdb24 protein seem to be
a CDK inhibitor itself. Therefore, we believe that
SDB24, and also the other mitotic exit genes, probably
act to detect the end of anaphase and pass a signal to
the Cdc28 inactivation machinery. This signaling
machinery may reside in part at the spindle pole body;
Cdc15 is at the spindle pole body, and SDB24 may be
as well. In short, these genes comprise a checkpoint
allowing Cdc28 inactivation and exit from mitosis.
Instability of G1 Cyclins
in G, Phase
B. Schneider [in collaboration with E. Patton,
S. Lanker, M. Mendenhall, C. Wittenberg, M. Tyers]
There are two models explaining how the levels of G1
cyclins rise in G1 phase. In the first, G1 cyclins are
unstable throughout G1, but rise in abundance because
of increased CLN synthesis as cells approach Start.
After Start, transcription is repressed and Cln synthe-
sis drops. In the second model, G1 cyclins are stable in
G1, accumulate partly for that reason, and then are
reset to a low level after Start when Cln degradation is
triggered. It has recently been suggested that the
mitotic cyclins Clbl , 2, 3, and 4, which are expressed
after Start, instigate turnover of G1 cyclins. We have
examined this issue in detail. We looked at G1 cyclin
half-life in G1 phase cells obtained by elutriation and
found that this half-life was 5-10 minutes, the same as
the half-life seen in asynchronous cells. Furthermore,
the presence or absence of the CLB1, 2, 3, and 4 genes
had no influence on G1 cyclin half-life. Therefore, we
believe that G1 cyclins are constitutively unstable.
Substrates of Cdc28, and Gene
Arrays for Analysis of Cell Cycle
Gene Expression
G. Sherlock
We have done a computer screen of the S. cerevisiae
genome to find proteins with multiple clustered con-
sensus sites for Cdc28 phosphorylation. Many of the
proteins found in this screen are known to have a role
in the cell cycle; in particular, many of the proteins are
involved in DNA replication. We are mutating the sites
in some of these proteins to see if there is a phenotype.
We have knocked out all or nearly all the potential
sites in Orc2, Orc6, Cdc6, Mcm3, and Cdc54. So far,
all of these mutant genes are still functional if the
strain is otherwise wild type. However, some of these
mutant genes cause a high rate of plasmid loss (indica-
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tive of inefficient initiation of replication), and when
some combinations of mutants are made, severe phe-
notypes up to and including is lethality are seen. We
are now gathering further evidence that the pheno-
types are due to a lack of phosphorylation, as opposed
to the change in primary amino acid sequence.
The cdc6 site mutant, which we call cdc6*, has been
particularly interesting. We have found that overex-
pressed wild-type CDC6 can suppress cdc14 and part-
ly suppress dbf2. These latter two genes are involved
in exit from mitosis and somehow serve to decrease
levels of mitotic Cdc28 kinase after M phase. Thus,
CDC6 can be helpful in this process. However, cdc6*
is not capable of suppressing cdc14 or dbf2.
Furthermore, cdc6. is synthetically lethal with sic/,
which is known to be an inhibitor of Cdc28 kinase
important for mitotic exit. One possible interpretation
of these results is that CDC6, in addition to its role as
an initiator of DNA replication, also has a role as an
inhibitor of Cdc28 at the end of mitosis.
Finally, we are collaborating with the laboratories
of David Botstein and Pat Brown in analysis of cell-
cycle-regulated genes. These labs have arrayed all S.
cerevisiae genes on glass slides and have done quanti-
tative analysis of the expression of all S. cerevisiae
genes by hybridizing cDNAs to these slides. We have
done experiments using such gene arrays to find all the
genes induced or repressed by the G, cyclin CLN3 and
the mitotic cyclin CLB2. Hundreds of such genes have
been found and sorted into functional categories.
Promoter analysis is under way. We are in the midst of
analysis of changes in gene expression through the
whole cycle.
Analysis of WHI3, a New
Size Control Gene
T Volpe
The whi3 mutation was isolated some years ago by
Rob Nash, and we are continuing its characterization.
It contains an RNA-binding motif, but otherwise has
little similarity to other proteins. Like other whi
mutants, it gives a small cell phenotype. This seems to
be because whi3 mutants overexpress CLN1 and
CLN2 G1 cyclin. Overexpression of WHI3 turns off
CLN1 and CLN2 and is lethal. Presumably, then, the
normal role of WHI3 is to somehow repress CLN1, 2
expression.
The level at which WHI3 interferes with CLN
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expression has been unclear, however. WHI3 does not
interfere with CLN1 or CLN2 expression from a GAL
promoter, so WHI3 probably does not act directly on
the CLN1, 2 mRNAs. Because CLN1 and CLN2 tran-
scription is activated by CLN3, we asked whether
WHI3 might inhibit CLN3 posttranscriptionally.
Recently, CLN3-galactosidase translational fusions
were used to test this idea. We found that the P-galac-
tosidase fusion was expressed at about twofold higher
levels in the whi3 mutant than in wild type. This
strongly supports the idea that WHI3 inhibits transla-
tion of CLN3, and this accounts for the effects on
CLN1 and CLN2 transcription. Furthermore, we found
that in a cln3 deletion background, a whi3 deletion has
no effect (i.e., cln3 is epistatic to whi3). This also sug-
gests that WHI3 works on CLN3.
Recent work from other labs suggests that CLN3 is
likely to be the target of translational controls. WHI3
may be important for these controls. Furthermore,
there are a large number of WHI3 -like genes in yeast
and human cells; our results suggest that these too may
be translational regulators of specific mRNAs.
Mechanisms of Transcriptional
Activation by Cyclin-Cdc28
Complexes
H. Wijnen
One effect of the Cln3-Cdc28 complex-perhaps the
only effect-is to induce transcription of a large fami-
ly of genes involved in the G1 /S transition. These
include CLN1, CLN2, CLB5, CLB6, RNRI , and many
genes involved in DNA synthesis and cell wall syn-
thesis. We are trying to discover the mechanism of
induction. The promoters of the CLN3-inducible genes
all include binding sites for the Swi4 transcription fac-
tor or for its close relative Mbpl. The Swi4 and Mbpl
DNA-binding proteins each form a complex with
another protein called Swi6; these two complexes are
called the SBF or MBF transcription factors, respec-
tively. We have found that swi6 mutants are complete-
ly defective for CLN3-induced transcription, and this
argues that Swi6 is the direct or indirect target for
Cln3.
We have constructed a Ga14 (DB)-Swi6 fusion that
can bind DNA via the Ga14 DNA-binding domain.
This fusion places Swi6 on the DNA even when Swi4
is absent. We have found that even in the absence of
Swi4, this fusion can activate transcription of a het-
erologous gene in a CLN3-dependent manner. This
solidifies the evidence that CLN3 works through Swi6.
However, we still do not know the mechanism of
activation. The Cdc28 phosphorylation consensus
sites on Swi6 are not required. We are not able to con-
sistently detect significant amounts of Swi6 in Cln3
immunoprecipitates, so there is no evidence for a
direct interaction.
Telomerase
E Ferrezuelo, M. Lessard, J. Zhou
In the last year, other labs have identified a catalytic
component of ciliate, yeast, and human telomerases. It
is a reverse transcriptase called Est2. We are epitope-
tagging yeast and human Est2. This will allow us to
evaluate possible components of human telomerase
we identified in a three-hybrid screen and will also
PLANT GENETICS
R. Martienssen D. Bush (University of Illinois
E. Grotewold
allow direct biochemical tests of the composition of
telomerase complexes. So far, we have been able to
reconstitute human telomerase activity in vitro using
the Est2 protein and the human telomerase RNA; we
will soon see whether suspected accessory proteins
affect this activity. In addition, we are continuing with
the characterization of new yeast est mutants.
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Hcf106 Encodes an Ancient
Conserved Membrane Protein
Required for Sec-independent
Protein Trans location
A M. Settles, D. Bush, R. Martienssen [in
collaboration with K. Cline, University of Florida]
The hcf106 mutation of maize disrupts biogenesis of
the innermost (thylakoid) membrane of the chloroplast
(Martienssen et al., EMBO J. 8(6): 1633 [1989]) and
was previously shown to affect thylakoid protein
uptake (Voelker and Barkan, EMBO J. 14(16): 3905
[1995]). This process is analogous to plasma mem-
brane targeting in bacteria as chloroplasts are likely
derived from primitive prokaryotic organelles. We
have shown that the defect resides in mutant chloro-
plast membranes, and molecular cloning has revealed
that homologs of the HCF106 membrane protein are
R. Shen
J. Simorowski
P. Springer
C. Yordan
encoded by a hypothetical bacterial gene family that
includes the Escherichia coli gene YigT (Settles et al.
1997).
Several secreted proteins in E. coli do not depend
on the protein translocation machinery encoded by the
sec and ffh genes and may be substrates of Hcf106. A
good candidate is the small subunit of hydrogenase
(hyaA) which has a signal sequence motif found in
substrates for the Hcf106 pathway in chloroplasts. In
the course of generating transposon insertions in the
yigT operon in E. coli, we have generated insertions in
the conserved downstream ORF, yigU. Preliminary
activity assays indicate that hydrogenase-1 is not
active in the yigU insertion strain, consistent with a
defect in hyaA membrane targeting. A second E. coli
homolog of HCF106 is encoded by ybeC. Both yigT
and ybeC are relatively small (300 bp) so we have cho-
sen to knock out each ORF by gene replacement rather
than transposon insertion. We will use tagged potential
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substrates to monitor secretory defects in single and
double knockouts. By expression of maize HCF106 in
bacteria, we will determine if it directly interacts with
plastid and bacterial precursor proteins. We are also
using mutants in maize to investigate overlap and
redundancy between sec-dependent and sec-indepen-
dent translocation pathways.
The existence of a third universal pathway for pro-
tein translocation in organisms as diverse as plants and
bacteria confirms the prokaryotic nature of chloro-
plasts and the highly conserved nature of the protein
translocation process throughout evolution. Con-
versely, the absence of an Hcf106 or a SecA homolog
from yeast suggests that mitochondrial translocation
may have a different origin.
The iojap Gene in Maize
M. Byrne, R. Martienssen
The iojap mutation in maize affects chloroplast devel-
opment, resulting in green and white striped homozy-
gous mutant plants. Green sectors have normal chloro-
plasts while white sectors have defective plastids that
fail to elaborate chloroplast membrane structures and
also appear to lack ribosomes (Walbot and Coe, Proc.
Natl. Acad. Sci. 76: 2760 [1979]). In many genetic
backgrounds, heteroplastidic cells are pale green and
have both classes of plastids. The plastid defect is
transmitted epigenetically in that, after passage
through the egg, defective plastids fail to develop into
chloroplasts in the presence of the wild-type Ij allele
(Rhoades, Cold Spring Harbor Symp. Quant. Biol. 11:
202 [1946]). Furthermore, reversion of the mutant
allele to wild type appears to have little effect on
homoplastidic white leaf tissue (unpublished results).
The lojap gene has been cloned by transposon tag-
ging (Han et al., EMBO J. 11(11): 4037 [1992]).
Biochemical evidence suggests that the Ij protein
interacts with the chloroplast 50S ribosomal subunit.
A homolog has been identified in Arabidopsis and
maps to the top arm of chromosome 3. Homologs have
also been identified in a number of bacterial genomes
including that of E. coli, where the ij homolog is found
in an operon encoding cell division genes. We are fur-
ther defining the role of Ij in E. coli via targetted muta-
genesis. We have obtained soluble recombinant maize
and Arabidopsis Ij protein. We are using these
reagents to investigate interactions with ribosomal
components.
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Molecular Genetics of asymmetric
leaf 1 in Arabidopsis
M. Curtis, R. Martienssen
In plants, the genetic basis of initiation, determination,
and patterning of lateral appendages such as leaves is
almost entirely unknown. Leaves are initiated by the
recruitment of founder cells on the flanks of the vege-
tative meristem. This partitioning of the meristem is
reflected by the expression pattern of KNOTTED
(KNI) and related homeobox genes that are down-reg-
ulated in leaf primordia. Analysis of loss-of-function
mutations that affect leaf development provides useful
tools to help elucidate the genetic basis of their devel-
opment. One such mutant, asymmetric rosette leaves
(asl), leads to variably lobed leaves with growth pat-
tern changes in early leaf development characteristic
of a morphological change in the proximodistal axis of
the leaf. as] was first described by Redei and Hirono
in 1965 (Genetics 51: 519) and is allelic to magnifica
(Reinholz 1947 [Fiat Rep.]).
We are using our gene trap (GT) and enhancer trap
(ET) system to study this mutant phenotype. We are
currently examining the interaction of as1 with sever-
al GT and ET lines that show patterns of reporter gene
expression specific to the shoot apical meristem and
the leaf primordia and have identified several genes
whose expression pattern is altered in as1 mutants. We
are also using GT lines and ET lines with expression
patterns in hydathodes, trichomes, stomata, stipules,
veins, and the margins of the leaf, as both physical and
molecular markers, to help determine the alteration of
patterning in the mutant leaf. These mutant leaves
have altered spacing of these structures relative to the
leaf margin that is characteristic of a drastic change in
the proximodistal axis.
We are attempting to positionally clone as1 and have
mapped the mutant allele to an interval approximately
0.3 cM north of det2 on Arabidopsis chromosome 2.
This map position corresponds to a contig of overlap-
ping cosmid clones. Attempts to complement the as1
mutation with these candidate clones are in progress.
Dorsoventral Axis Specification
in Lateral Organs of Arabidopsis
C. Kidner, R. Martienssen
Most leaves develop as flattened blades with distinct
dorsal (adaxial) and ventral (abaxial) sides. These
dorsoventral characters are thought to be specified dur-
ing or soon after leaf initiation, and to involve signals
from the meristem that orient the primordium relative
to the main axis (I. Sussex, Nature 167: 651 [1951]).
We have identified a number of enhancer trap and gene
trap lines that have reporter gene expression confined
to the abaxial side (7 lines) or adaxial side (1 line) of
the immature leaf, as well as a number of lines that
mark the dorsal and/or ventral boundary of the pri-
mordium. A spontaneous mutant, unrelated to transpo-
son insertion, arose serendipitously in the Cold Spring
Harbor gene trap collection. The leaves of this mutant
are short and rod-like, and there is no apparent differ-
ence between the upper and lower sides. The inflores-
cence meristem produces short yellowish rods of tissue
instead of flowers, and no lateral branches are formed.
Lateral branches may also be dorsal characters as they
are clonally related to the adaxial side of the leaf.
A similar mutant, dandelion, has been described
previously (Bhatt et al., Plant J. 9(6): 935 [1996]). We
have performed complementation tests indicating that
these two mutants are allelic. However, the trans-het-
erozygotes produce flowers, and these flowers have
the correct arrangement of severely reduced, unifacial
organs. For example, they have unfused twin pistils. In
wild type, the carpels fuse along the dorsoventral
boundary, which is lacking in the mutant.
Characterization of these two alleles of dandelion is
proceeding by histological study and by genetic analy-
sis. Additional mutants have been described elsewhere
recently, some of which have been cloned molecular-
ly. We are investigating whether these are related. We
are considering renaming this locus deilen ddrean
(Welsh for "prickle leaf").
FRUITFULL Encodes a MADS-box Gene
Required for Cellular Differentiation
during Fruit and Leaf Development
Q. Gu, R. Martienssen [in collaboration with C. Ferrandiz
and M. Yanofsky, University of California, San Diego]
We have identified a mutation in Arabidopsis called
fruitfull (ful-1), which abolishes elongation of the
silique after fertilization. It arose during enhancer and
gene trap mutagenesis as an F, plant with reduced
silique (seed pod) length. The stunted silique has
crowded seeds (a "full fruit"), a failure of dehiscence,
and frequently ruptures prematurely. Wild-type seed
pods comprise two valves joined by the replum, a strip
of weakened cells that rupture to release mature seeds.
ful-1 valve cells remain small and unelongated after
fertilization. Stomata, which are frequent in wild-type
valves, are absent from mutant valves. ful-I also alters
leaf shape. Wild-type cauline (stem) leaves are small,
lanceolate, and lack a petiole. ful-1 cauline leaves are
broader, have an altered vascular pattern, and have a
reduced number of internal cell layers.
The ful-1 mutation is caused by the insertion of a
DsE transposable enhancer trap element into the 5'-
untranslated leader of the MADS-box gene AGA-
MOUS-LIKE 8 (AGL8). GUS reporter gene expression
in the enhancer trap line is observed in valve tissue,
but not in the replum, the septum, or the seeds, and
faithfully mimics RNA in situ hybridization data
reported previously (Mandel and Yanofsky, Plant Cell
7: 1763 [1995]). FRUITFULL is also transcribed in
the inflorescence meristem and in vegetative tissue
such as rosette leaves. However, these tissues appear
to be unaffected in the mutant. In collaboration with
M. Yanofsky, a series of double mutants were made
with other MADS-box genes to determine whether a
redundant role might be uncovered in leaves and
meristems. In most cases, no such role was discov-
ered. However, a triple mutant combination with the
closely related meristem identity genes APETALAI
(apl) and CAULIFLOWER (cal) has revealed a redun-
dant role for FRUITFULL in meristem identity (C.
Ferrandiz, Q. Gu, R. Martienssen, and M. Yanofsky,
unpubl.). apl and cal are thought to be responsible for
cauliflower and broccoli variants within Brassica
oleraceae (cabbages). It will be interesting to deter-
mine whether FRUITFULL is responsible for varia-
tions in inflorescence architecture and fruit size with-
in the Brassicaceae and beyond.
Functional Genomics: Systematic
Gene Trap and Enhancer Trap
Mutagenesis in Arabidopsis
C. Yordan, J. Simorowski, R. Benton (URP program),
R. Shen, P. Springer, R. Martienssen [in collaboration with
W. Richard McCombie, and with J. Healy, G. Latter, and A.
Reiner, Cold Spring Harbor Laboratory]
The Arabidopsis genome will be completely
sequenced by the end of the year 2000. This remark-
able acheivement opens up a new challenge for plant
biology, i.e., to determine systematically the function
of each of the 20,000 Arabidopsis genes, singly and in
combination. We are contributing toward this goal by
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systematic gene disruption using gene trap and
enhancer trap transposons. As each new insertion is
generated, DNA is prepared from individual plants,
and sequences flanking the insertion are amplified and
sequenced using TAIL PCR (Liu et al., Plant J. 8: 457
[1995]; Tsukegi et al., Plant J. 10: 479 [1996]). These
sequences are then compared with genomic DNA
sequence databases to map the insertion precisely
within the genome. Now that the complete sequence is
being determined, genome annotation can be used to
identify disrupted genes, without the need for RNA-
based methods, such as RACE PCR (Annual Report,
1995). Of the first few hundred lines, 17% match
genomic sequence, a further 17% match an EST, and
an additional 10% have some homology with an anno-
tated gene in Arabidopsis. Given that 15% of the
genome has been sequenced, that the gene density is
55%, and that a third of these genes are represented by
ESTs, these numbers are close to those predicted for
random insertion. A sophisticated relational database
linking sequence to expression pattern, pedigree, and
phenotype is under construction.
We are screening each transposant for lethal inser-
tions in essential genes. Such mutations result in
aborted embryos and semisterile siliques in heterozy-
gous transposants, which are conveniently screened as
they are generated (Springer et al., Science 268: 877
[1995]). A catalog of essential genes, comparable to
those in yeast and Drosophila, will thus be assembled.
Only a very small proportion of these genes are
expected to control patterning during early develop-
ment, and many of these will be required during veg-
etative and floral phases as well because of the reiter-
ative nature of plant development. Reporter gene
expression patterns and mosaic analysis will allow us
to uncover some of these functions.
We are taking advantage of the propensity of Ds
transposons to transpose to closely linked sites in
order to saturate the region around the prolifera locus
on chromosome 4. This is the region being sequenced
by the Cold Spring Harbor/WashU/ABI Arabidopsis
sequencing consortium. By selecting insertions from
two-dimensional pools of mutagenized plants, we
hope to recover insertions in most of the genes in this
region.
Myb Domain Proteinsin Maize
P.D. Rabinowicz, K. Tworkowski, E. Grotewold
The regulation of gene expression is a fundamental
process in all living organisms. Transcription factors
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are classified in structural families according to the
presence of specific DNA-recognition motifs. One
such family is constituted by proteins containing the
Myb homologous DNA-binding domain (Myb
domain), originally identified in the v-myb oncogene
found in the virus of the avian myeloblastosis.
Proteins containing the Myb DNA-binding domain
have since been found in all eukaryotes in which they
have been sought. Myb domains are usually formed by
two or three imperfect 51- or 52-residue repeats (R1,
R2, and R3). Each repeat encodes three a-helices with
the second and third helices forming a helix-turn-helix
structure (HTH) when bound to DNA, similar to
motifs found in the X repressor and homeodomain pro-
teins. R2 and R3 are usually sufficient for sequence-
specific DNA binding.
According to these criteria, three Myb domain pro-
teins have been identified to date in vertebrates, c-
Myb, A-Myb, and B-Myb. c-Myb has an essential role
in controlling the proliferation and differentiation of
hematopoietic cells. The cellular functions of A-Myb
and B-Myb are less well understood. A single c-Myb-
like gene has been reported so far in Drosophila, and
analysis of the Saccharomyces cerevisiae genome
indicates that yeast contains less than ten Myb-like
sequences. In sharp contrast, plants express a large
number of Myb homologous proteins.
Plant and animal Myb domain proteins differ in
several aspects. Plant Myb domains have usually two,
instead of three, Myb repeats. These are most similar
to the R2 and R3 repeats of their animal homologs.
Plant Myb domains contain an extra residue inserted
between the second and third helices of the R2 repeat,
and the DNA recognition helices of plant and animal
Myb domains have differences that are important for
their DNA-binding activities (Williams and
Grotewold 1997). Little is known about the evolution
of Myb domain proteins or how the Myb gene family
has expanded in plants compared to animals. It is not
known either whether the dramatic expansion of this
family has occurred prior to or after the divergence of
mono- and dicotyledons.
To answer these questions, we investigated the
number and sequences of Myb domain proteins
expressed in maize. We carried out RACE PCR of
mRNA obtained from different parts and developmen-
tal stages of the maize plant, including young
seedlings, roots, immature ears (18 days after pollina-
tion), silks, and immature tassels, using degenerate
primers that recognize the conserved DNA-recogni-
tion helices of R2 and R3. This region encodes 41-43
residues, and we termed it MybBIH (for Myb between
DNA-interaction helices). So far, we have sequenced
300 PCR fragments which correspond to 70 different
Myb domains. Our data suggest that we are only at
about 60% saturation of this screening, indicating that
maize may express more than 130 different Myb
genes. The sequences of these 70 novel Myb domains
suggest that plant Myb domains are much more vari-
able in the region between the two DNA recognition
helices than previously expected, in terms of number
of residues as well as amino acid composition. Our
data strongly indicate that Myb'H provides a finger-
print of Myb identity, convenient to carry out studies
on how this family of proteins has evolved during
plant evolution.
Identification of Transposable
Element Insertions in
Maize Genes Encoding Myb
Domain Proteins with Novel
Cellular Functions
P. D. Rabinowicz, E. Grotewold
The dramatic expansion of the Myb family of regula-
tory proteins in plants and their cellular roles has led
to the suggestion that plant Myb domain proteins are
primarily involved in controlling plant-specific
processes. The enlargement of the plant Myb gene
family may have occurred in conjunction with the
development of new cellular functions. An example of
how Myb domain proteins are utilized to promote
diversity in plant metabolic pathways is given by the
independent regulation of branched flavonoid biosyn-
thetic pathways by two related maize Myb domain
proteins, P and C 1 . Whereas the C 1 -regulated antho-
cyanins are almost universally found in the plant king-
dom, the P-regulated pathway is restricted to only
some grasses. This suggests that the appearance of P is
fairly recent, probably to supply a cellular function
solely needed in some grasses. Consistent with this is
the finding that P-controlled compounds accumulate
in maize silks protecting com from specific pathogens
(Grotewold et al. 1998). The functions of only a few
other plant Myb domain proteins are known, and these
include controlling epidermal cell shape and cell fate;
mediating the response to viral infection, hormones,
and drought; and regulating the accumulation of
phenylpropanoids.
Last year we reported the method that we devel-
oped to identify insertions of Mutator in gene families
encoding proteins with limited sequence similarity.
This method, termed SIMF (for systematic insertional
mutagenesis of protein families), was used to identify
insertions in genes encoding Myb domain proteins.
Oligonucleotides from Mutator ends and from con-
served regions in Myb domains are used to amplify by
PCR pools of genomic DNA made from from maize
seedlings containing active Mutator elements.
Currently, we use 12 macro DNA pools (6 derived
from rows and 6 derived from columns) each corre-
sponding to 10 pools, representing a population of
3600 plants grown in a 60 columns by 60 rows grid
array. From a large number of possible PCR products
of possible Mutator insertions in Myb genes, four
have been confirmed to correspond to insertions in
novel Myb genes. In three cases, the Mutator element
is inserted in a conserved intron in the region encod-
ing the Myb domain, whereas in the fourth case the
intron is absent and the insertion is in the coding
sequence, right between the two Myb repeats. The cor-
responding genes have been mapped (in collaboration
with Dr. Mike McMullen, University of Missouri),
and we are currently carrying out segregation analysis
to determine the possible effects caused by these inser-
tions. In addition, genomic clones for these insertions
are being sequenced to determine the properties of the
entire proteins.
Developing the Tools to
Dissect the Myb-associated
Complexes Involved in
the Control of Flavonoid
Biosynthesis
F Gao [in collaboration with Arthur Kroon, Ronald Koes,
and Jos Mol of the Free University, Amsterdam],
M. Tanurdzic (URP Program), E. Grotewold
Anthocyanin accumulation is controlled in maize and
other plants by two classes of regulatory proteins: a
Myb domain-containing class (C 1/P1 in maize; Ant in
Petunia) and a basic helix-loop-helix (bHLH) domain-
containing class (R/B in maize; Anl/Jaf13 in Petunia).
Anthocyanin production requires the interaction of a
member of the Myb domain family and a member of
the bHLH domain family. Previous studies have
shown that whether or not this interaction is absolute-
ly necessary, it is not sufficient to promote transcrip-
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tion of the flavonoid biosynthetic genes, suggesting
that other factors are required.
To investigate the possible nature of these other
factors, biochemical and genetic approaches are being
undertaken. For the biochemical strategies, monoclon-
al antibodies were developed against the maize C1
protein. A large number of monoclonal antibodies
were obtained, which recognize the Escherichia coli-
expressed Cl proteins with high affinity. In addition, a
handful of these antibodies also recognize the maize P1
and Petunia An2 orthologous proteins. So far, howev-
er, we have not been able to detect with any of these
antibodies the corresponding proteins in crude plant
cellular extracts. Monoclonal antibodies against the
R/B proteins are currently being generated against
strategically designed peptides.
The genetic strategy consists in utilizing the yeast
two-hybrid approach to identify possible partners for
the known regulators. For that purpose, cDNA
libraries were made from mRNA obtained from maize
and Petunia tissues where the R/B and Cl/P1 factors
are fully functional. The cDNA libraries are currently
being tested for interacting proteins with different
parts of the cloned factors from maize and Petunia.
In addition, we started investigating the ability of
the R, Ant, and Jaf13 bHLH factors to interact.
Surprisingly, the bHLH motif is not able to mediate
either homo- or heterodimer formation, but the region
carboxy-terminal to the bHLH motif is.
Using Reverse Genetics to
IdentifyMutator Insertions in
Genes Required for Flavonoid
Accumulation
Pablo Rabinowicz, M. Pizzirusso (Partner for the Future),
E. Grotewold
Flavonoids are a very large class of small phenolic
molecules found in all plants. Flavonoids have a num-
ber of important biological functions, including plant
and flower pigmentation, sexual reproduction, protec-
tion against UV radiation, defense against attack by
phytopathogens, in symbiotic interactions between
plants and microbes, and in the regulation of plant hor-
mone transport. Whereas most structural genes in the
maize flavonoid biosynthetic pathway have been char-
acterized, mutants in the genes encoding chalcone fla-
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vanone isomerase (chi) and flavonone 3 '-hydroxylase
(fah) have never been described.
We used a Mutator-based reverse genetic approach
to identify insertions in these two flavonoid biosyn-
thetic genes. We screened 3600 plants for Mutator
insertions and identified two transposon insertions in
the 3' regions of the chil gene, and one putative inser-
tion in the fah gene. Current studies are under way to
confirm these insertions, as well as to determine the
phenotypic effects of mutations in these two genes for
flavonoid accumulation.
Last year, we reported on the cloning of an Anll
homolog from maize (currently called MP1). In
Petunia, Anl 1 encodes a protein containing WD40
repeats, and it is required for normal accumulation of
anthocyanins in corollas. Using our Mutator stocks,
we identified one insertion of Mutator in the MP1
gene, which should allow us to determine whether
MP1 encodes the maize ortholog of An1 1 .
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ARABIDOPSIS FLOWER AND POLLEN DEVELOPMENT
H. Ma J. Busch
J. Cruz
S. Dhavia
A. Debrowski
J. Ellstein
H. Fan D. Liu K. Siddiqui
Y. Hu C. Machare J. Sylvan
H. Huang S. Moran S. Virani
E. Katz P. Rubinelli M. Yang
B. Laulicht L. Shao
We are interested in understanding the genetic control
of plant reproductive development, using Arabidopsis
thaliana. The research topics range from the control of
floral meristem identity during early flower develop-
ment to the regulation of meiosis and pollen develop-
ment. Much of our recent effort has been devoted to
the functional analysis of the floral homeotic genes
AGAMOUS (AG), which regulate early flower devel-
opment. AG is a member of the MADS-box gene fam-
ily, which is present in all major eukaryotic kingdoms.
Many other plant MADS-box genes were isolated
molecularly and designated as AGL for AG-Like.
Furthermore, we have used an enhancer trap/gene
trap transposon mutagenesis method to identify new
genes required for flower and pollen development.
One way to isolate new genes that function during late
floral organ development is to identify genes specifi-
cally expressed in floral organs. These genes are like-
ly to be involved in cell differentiation during late
flower development, and they provide molecular
markers for specific cells or tissues of the reproductive
organs. Another method is to screen for mutants with
abnormal development; we have isolated a large num-
ber of putative mutants and have begun to characterize
these mutants.
In 1997, our postdoctoral fellow Hai Huang took a
position as full professor at the Shanghai Center for
Life Science and the Institute for Plant Physiology of
the Chinese Academy of Science. In addition, another
postdoc, Hua-Ying Fan, moved back to New York
City. Shao Li, a first-year student in the MCB program
at SUNY Stony Brook, conducted rotation research in
our lab this summer. Joshua Busch, an URP from
Emory University, worked on immunodetection of the
AGAMOUS protein. Several other undergraduate stu-
dents, Julissa Cruz, Sumit Dhavia, and Cindy Machare
from SUNY Stony Brook and Jason Sylvan from
Brandeis University, participated in our projects.
Kashif Siddiqui, a visiting graduate student from
Ade 1phi University, has been working with Dehua Liu,
a postdoc, to characterize new floral mutants. Sophia
Virani completed her Partner for the Future program
and started college at Harvard University. In the fall,
Elisa Katz, our new Partner, started her project with
Ming Yang, a postdoc in the lab. Furthermore, high
school students Brian Laulicht, Sienna Moran, Amy
Debrowski, and Joshua Ellstein joined our gene trap
effort. As always, we appreciate greatly the assistance
of the Uplands Farm manager Tim Mulligan and his
assistant Stan Schwarz.
Characterization of
Organ-specific cDNAs
P. Rubinelli, Y. Hu, S. Virani, C. Machare, H. Ma
As described in previous annual reports, we have been
characterizing several cDNAs that are expressed
specifically or predominantly in the anther or the
pollen. A number of constructs have been made to test
their functions in vivo using antisense transgenic
plants. We have generated a large number of transfor-
mants carrying various constructs. Among these
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plants, we have focused our effort on plants carrying
constructs of ATA21 and ATA27. ATA21 is expressed
specifically in the pollen grain. A fusion was generat-
ed between the pollen-specific LAT52 promoter and
the ATA21 cDNA in the antisense orientation; nearly
100 T1 transformants with this construct were gener-
ated. Three of the Ti transformants showed a distort-
ed transmission of the kanamycin resistance marker.
One of these three T1 transformants showed a pollen
developmental defect in about 30% of the pollen
grains. These pollen grains had a collapsed appear-
ance, failed to stain with the nonspecific cytosolic
stain toluidine blue and the RNA-specific stain Azure
B, and appeared translucent, indicating a lack of cyto-
plasm. However, these transformants with transmis-
sion distortion or pollen phenotype had apparently
normal expression of the ATA21 gene as tested by
Northern blot. Furthermore, one control line, a
LAT52-GUS fusion, also showed the collapsed pollen
phenotype, suggesting a possible promoter-associated
effect on pollen development. The analysis of these
transgenic lines is still in progress.
The ATA27 gene was found to be specifically
expressed in the tapetum layer of the anther. To reduce
its expression, a fusion of the tapetum-specific TA29
promoter and the ATA27 cDNA in the antisense orien-
tation was constructed and introduced into
Arabidopsis by transformation. Thirty-three transfor-
mants were generated. Among 14 transformants
grown to maturity, one was sterile, and its pollen
development was abnormal. This transformant had an
approximately 90% reduction in ATA27 expression as
tested by Northern blot. However, transmission of the
transgene to the next generation was severely reduced,
suggesting that both male and female fertility is affect-
ed. In addition, about 30% of the flowers of this line
show ectopic stigma on both anthers and the carpal
wall, accompanied by fusion of stamens to the pistil.
Three out of four progeny studied so far from this
transgenic line are sterile and the fourth is only par-
tially fertile, suggesting that the phenotype is domi-
nant with some incomplete penetrance. This segrega-
tion pattern is consistent with an antisense RNA effect.
It is also possible that this phenotype may be due to a
defect in an endogenous gene due to the T-DNA inser-
tion. More study is needed to confirm that the sterility
is due to the ATA27 antisense RNA.
We have also generated transformants carrying
antisense constructs for ATA7, ATA18, ATA20, and
ATA26 cDNAs. We are in the process of analyzing
these and other transgenic plants.
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Generation of New Enhancer
and Gene Trap Transposants
M. Yang, A. Debrowski, J. Ellstein,
Y. Hu, S. Dhavia, J. Cruz, H. Ma
To identify new genes regulating Arabidopsis flower
development, we have continued to generate enhancer
trap/gene trap transposon insertional lines. We have
performed new crosses between Ac and Ds plants; the
total number of F, seeds now is more than 60,000. We
continue to plant the F, seeds and harvest the F, fami-
lies. About 11,000 F2 families have been screened for
independent new Ds insertional lines (transposants),
and we have now generated about 2700 transposants.
About two thirds of these lines have been screened for
floral expression patterns and for visible phenotypes
in the flower or in pollen development.
Characterization of a Mutant
Defective in Male Meiosis
M. Yang, E. Katz, J. Sylvan, H. Ma
We have searched for male-sterile or low-fertility
mutants among the enhancer/gene trap transposants.
One of these mutants, from transposant ET5223,
exhibits a severe defect in male meiosis. Light
microscopy revealed that the mutant produced abnor-
mal microspores with variable sizes. Examination of
earlier development indicates that the mutant tetrads
contain a variable number of microspores from 2 to 7
spores per tetrad. Further analysis of DNA contents
using DAPI staining suggests that the amount of DNA
in the abnormal spores is proportional to the size of the
spores. These results suggest that the mutant is defec-
tive in male meiosis. DAPI staining of microspore
mother cells undergoing meiosis uncovered an abnor-
mal pattern of staining that strongly suggests a severe
defect in separation of homologous chromosomes dur-
ing meiosis I. Meiosis I differs from meiosis II or
mitosis in that the homologous chromosomes pair and
then separate. Normal separation of homologs is criti-
cal for proper meiosis. The mutant phenotype, there-
fore, suggests that it could be a useful tool to study this
important process.
We have determined that mutant plants carry a co-
segregating Ds insertion. In addition, we have recov-
ered revertant sectors from mutant plants carrying an
Ac element, and the revertant alleles have lost the Ds
element. We have isolated genomic sequence adjacent
to the Ds, and several revertant alleles showed the
restoration of wild-type sequence, indicating that they
resulted from precise excisions of the Ds element. We
are in the process of further characterizing this gene.
Identification and Characterization
of Transposants with Floral
Expression and Phenotypes
D. Liu, Y. Hu, H.-Y. Fan, B. Laulicht,
K. Siddiqui, H. Ma
To identify floral genes, we have continued our analy-
sis of the GUS reporter gene expression in transposant
lines. We have analyzed about 1000 new lines for flo-
ral expressions. We found that the overall results were
similar to results we had obtained previously, although
specific new patterns have been recovered.
We have also performed a large-scale screening
for visible developmental phenotypes in the flower.
We found several mutants similar to known mutants;
these presumably are alleles of known genes. We also
found mutants that have novel floral phenotypes. For
example, a number of mutants have abnormal floral
organ sizes and/or shapes. In particular, several
mutants have short filaments; some of these produce a
large number of functional pollen grains, but have
reduced fertility because the pollen grains are not effi-
ciently delivered to the stigma.
We also found several new male-sterile mutants,
including a mutant from transposant ET2292 with a
defect in male meiosis. This mutant produced tetrads
with four to six spores; therefore, the mutant pheno-
type is different from that of the meiotic mutant from
ET5223. Pollination using normal pollen indicates that
the ET2292 mutant is female-fertile. In addition, the
male-sterile defect is due to a nuclear recessive muta-
tion. We have also found several revertant sectors
among mutant plants carrying an Ac element.
Preliminary analysis indicates that the ET2292 mutant
carries a single Ds insertion and the revertant alleles
have lost this Ds element. These results strongly sup-
port the hypothesis that the mutation was caused by a
Ds insertion. GUT staining experiments have not
revealed any clear expression pattern, suggesting
either that the gene is expressed at an extremely low
level or that the GUS reporter is not expressed, possi-
bly due to the Ds insertion being in the wrong orienta-
tion. We are currently analyzing the mutant pheno-
types and the corresponding gene.
A Male-sterile Mutant Defective
in Microsporogenesis
P. Rubinelli, L. Shao, H. Ma
The anther of flowering plants carries out three dis-
tinct developmental programs: cellular differentiation,
microsporogenesis, and cell degeneration associated
with dehiscence. Our lab has screened among
Arabidopsis the transposant lines for male-sterile
mutants. One such line, designated GT5302, segregat-
ed in its progeny male-sterile plants in a 3:1 ratio of
phenotypically normal to mutant, suggesting that the
phenotype is due to a single-gene nuclear recessive
mutation. Genomic Southern blot hybridization of
four male-sterile progeny of the GT5302 line with a
fragment from the 5' end of DsG indicated that all four
plants contain a single, identical Ds element insertion
in the genome. Light microscopy of sections through
the mutant inflorescence revealed the following
defects: incomplete dissociation of microspore tetrads,
abnormal pollen wall deposition, complete degenera-
tion of all microspores prior to pollen mitosis I, and
failure of the mature anther to undergo dehiscence. In
wild-type Arabidopsis, the stomium cell layer degen-
erates to allow a break in the anther wall, initiating
dehiscence. Ongoing experiments will clarify if the
stomium fails to degenerate in this mutant and if the
mutation is transposon-tagged.
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DEVELOPMENTAL GENETICS OF PLANT REPRODUCTION
U. Grossniklaus R. Baskar A. Coluccio J. Moore
R. Bicknell M. Hoeppner Y. Red ler
N. Castiaux C. Miller J.-P. Vielle-Calzada
Research in our laboratory focuses on plant reproduc-
tive biology. We are using genetic and molecular
approaches to characterize the developmental control
of plant reproduction, in particular the formation of the
female gametes. Unlike in animals, where the meiotic
products differentiate directly into gametes, the spores
of plants give rise to multicellular haploid organisms
that produce the gametes later in their development.
Thus, the plant life cycle alternates between a diploid
and a haploid phase, the sporophyte and the gameto-
phyte. The gametophytes of flowering plants (micro-
and megagametophytes) consist of a small number of
cells and develop within the reproductive organs of the
flower. The key events in female gametogenesis
(megasporogenesis, megagametogenesis, and double
fertilization) occur in ovules, which are specialized
reproductive structures of sporophytic origin. The
molecular and genetic bases controlling ovule devel-
opment and female gametogenesis are largely
unknown. The highly polar nature of the developmen-
tal events and the simple organization of ovule and
megagametophyte make it an ideal system to study
fundamental aspects of plant development. The goal of
our research is to investigate the role of positional
information, cell lineage, and cell-cell communication
in plant morphogenesis and cellular differentiation.
A better understanding of the molecular mecha-
nisms controlling megasporogenesis and megagame-
togenesis will not only yield important insights into
fundamental concepts in plant development, but also
provide tools for the manipulation of the reproductive
system. In particular, we are interested in engineering
components of apomixis, an asexual form of repro-
duction through seeds. In addition to using the tools
we generate in our basic research for a biotechnologi-
cal manipulation of plant reproduction, we are also
using genetic strategies to isolate mutants displaying
apomictic traits in maize and, in a collaborative effort
with Bob Pruitt (Harvard University), in Arabidopsis.
The introduction of apomixis into sexual crops would
have revolutionary implications for plant breeding and
agriculture, allowing for the immediate fixation of any
desired genotype and its indefinite clonal propagation.
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We would like to acknowledge the efforts of a
number of high school and undergraduate students
who assisted in our research. Nikhil Laud and Sean
Kass, both from Roslyn High School, helped with the
characterization of mutants disrupting megagametoge-
nesis. Bill Wagner, Duke University, spent his fourth
summer in our lab and helped with pollinations in the
field and with molecular and cytogenetic analyses.
We were sad to see Marilu Hoeppner and Nathalie
Castiaux leave; both gave birth to healthy boys and
moved on to new challenges. But we could welcome
new members in the lab: Alison Coluccio and Yvette
Redler took over the responsibilities of Marilu and
Nathalie, and Ross Bicknell (Crop and Food Research,
New Zealand) spent a 6-month sabbatical in our
group.
Dissection of Plant
Reproduction by
Enhancer Detection
U. Grossniklaus, J. Moore, J.-P. Vielle-Calzada, R. Baskar,
M. Hoeppner, N. Castiaux, A. Coluccio, Y. Redler
To dissect female gametogenesis in plants, we are per-
forming a large-scale enhancer detection/gene trap
screen in Arabidopsis thaliana, a small crucifer that
has been widely adopted as a model system for plant
developmental biology and genetics. Enhancer detec-
tion allows the identification of genes on the basis of
their pattern of expression. We are using an
enhancer/gene trap system based on the Ac /Ds trans-
poson of maize that was developed here at the labora-
tory by R. Martienssen, V. Sundaresan, and co-workers
(Sundaresan et al., Genes Dev. 9: 1810 [1995]). The
presence of a transposon at a locus of interest greatly
facilitates its subsequent molecular and genetic char-
acterization. The transposon provides a molecular tag
for the cloning of the locus and additional al-leles can
be isolated by excision and local transposition. During
the last few years, we generated close to 4500 lines
carrying single randomly distributed enhancer detec-
tor/gene trap transposons (transposants). We subject
these lines to four independent screens: (1) To identify
genes involved in early events during ovule develop-
ment (axis specification and pattern formation) and
megasporogenesis, young ovule primordia are charac-
terized for expression of the GUS reporter gene present
on the enhancer detector element. (2) Later stages of
development are analyzed for GUS expression to iso-
late genes acting specifically in the megagametophyte
and its constituent cell types. (3) Transposants are
screened for reduced seed set and segregation ratio dis-
tortion to identify potential gametophytic mutations.
(4) Screening is carried out for sporophytically
required mutations that disrupt ovule morphogenesis
and megasporogenesis. Using TAIL- PCR (Liu et al.,
Plant J. 8: 457 [1995]), we have isolated and
sequenced flanking genomic regions of about 130
transposants of interest. On the basis of sequence
homology, several genes that are likely to have impor-
tant regulatory roles in female gametogenesis have
been identified. The characterization of transposants at
various stages of reproductive development is an
ongoing long-term project in our laboratory.
Alterations of Megasporogenesis
and Induction of Apomixis
in Arabidopsis
J.-P. Vielle-Calzada, C. Miller (URP Program),
U. Grossniklaus
A single cell within the ovule primordium of
Arabidopsis differentiates into a megaspore mother
cell (MMC) and undergoes meiosis to generate four
haploid megaspores. Cytokinesis occurs only after the
completion of meiosis II. A single megaspore gives
rise to the female gametophyte, as the other three
degenerate. The initiation of apomixis, or asexual
reproduction through seeds, invariably takes place
during megasporogenesis. Differences between sexual
and apomictic reproduction may be determined by
regulatory genes that act during megasporogenesis
and that control events leading to the formation of
unreduced female gametophytes.
During the last year, we have made significant
progress in our genetic analysis of megasporogenesis.
To date, we have analyzed GUS expression patterns in
more than 1000 enhancer/gene trap lines in subse-
quent developmental stages, from the time when the
ovule primordium forms (before MMC differentia-
tion) to stages where the viable megaspore is differen-
tiated. We identified 25 lines that show expression in
specific regions of the developing ovule. For most of
these lines (18/25) the initiation of reporter gene
expression can be traced back to ovules at the onset of
megasporogenesis, either before or during MMC dif-
ferentiation. Specific lines show GUS expression
restricted to either the proximal, central, or distal por-
tion of the ovule primordium. We obtained genomic
sequences for 11 lines. Several show similarity to
genes that have important roles in plant and animal
development. These include cell cycle regulators,
leucine-rich repeat protein kinase receptors, and genes
encoding proteins involved in organelle differentia-
tion. Several others have homology with Arabidopsis
ESTs of unknown function. One line shows GUS
expression in a small cluster of distal cells of the
young nucellus before meiosis. This region is believed
to be of importance in the regulation of MMC specifi-
cation. A second line showed complex GUS expres-
sion throughout ovule development in proximal
regions, including the cells surrounding the surviving
megaspore. It was found to be inserted in the P-glu-
canase gene cluster. 13-glucanase degrades callose,
which has been proposed to have an important role in
megaspore selection. The absence of callose deposi-
tion around a megaspore or apomictic initial is highly
correlated with this cell initiating megagametogenesis,
in both sexual and apomictic species.
Using lines displaying significant GUS expression
patterns, we plan to investigate the effects of specific
alterations to megasporogenesis by misexpressing reg-
ulatory genes that could lead to the formation of unre-
duced megaspores, the first step in apomictic repro-
duction. Regulatory sequences controlling nucellar
and MMC-specific expression will provide important
tools to determine cellular interactions during mega-
sporogenesis and manipulate the reproductive poten-
tial of sexual plants.
Isolation of Mutants Disrupting
Megasporogenesis and Ovule
Morphogenesis
J.-P. Vielle-Calzada, J. Moore, A. Coluccio,
Y. Red ler, U. Grossniklaus
We are conducting a genetic screen to identify trans-
posants defective in megasporogenesis and ovule mor-
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phogenesis. Transposants were screened for families
that segregate sterile plants. To date, we have screened
about 3193 transposants and identified 40 lines that
produced sterile homozygotes; 31 candidates were
analyzed in reciprocal crosses to determine whether
they affect male or female reproductive development.
Six were found to be exclusively female sterile.
Among these, three show defects in ovule morpho-
genesis that are associated with a corresponding pat-
tern of GUS expression, suggesting that the gene
responsible for the mutation has been tagged. We iden-
tified four lines that are defective in both the male and
female gametogenesis and might be associated with
mutations affecting meiosis. One of the female-specif-
ic mutants forms morphologically normal ovules.
Preliminary cytological analysis suggests that mega-
sporogenesis is arrested at the onset of the haploid
phase, prior to the initiation of female gametophyte
formation. Most ovules contain a tetrad of meiotically
derived cells, but the viable megaspore is arrested
before the first mitotic division. The sequence of a
TAIL-PCR fragment flanking the insertion shows
homology with an Arabidopsis RNA helicase impli-
cated in the regulation of the cell cycle, and with sev-
eral hypothetical proteins of unknown function. The
characterization of such mutants will improve our
basic understanding of reproductive development in
plants and will set the basis for a sustained effort in
plant germ line biotechnology necessary for the trans-
fer of apomixis into sexual crops.
Charaterization of Mutants Disrupting
Female Gametogenesis
J. Moore. J.-P. Vielle Calzada, W. Gagliano, U. Grossniklaus
During megagametogenesis, the surviving megaspore
divides through three consecutive mitoses to form the
mature embryo sac consisting of seven cells: the egg
cell, two synergids, three antipodals, and a binucleate
central cell. After double fertilization of both the egg
and the central cell, the ovule develops into a seed.
Very few mutants affecting the gametophytic phase of
the plant life cycle have been described in the litera-
ture. The isolation and characterization of novel game-
tophytic mutants will provide new insights into the
genetic regulation of megagametophyte development
and function. In a screen involving about 5000 trans-
posants, we identifed 59 mutants that showed both
reduced fertility and a distorted segregation ratio of
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the kanamycin resistance marker present on the Ds
element, a characteristic typical of gametophytic
mutants. We have further characterized 14 Ds inser-
tion mutants that are semisterile, carry a single Ds ele-
ment, and show a reproducibly distorted segregation
pattern. By performing reciprocal crosses to wild type,
we determined the efficiency of transmission through
both gametophytes. Two mutants are specific to the
female and ten were found to affect both sexes to vary-
ing degrees. Interestingly, two were found to specifi-
cally affect the male, indicating that the mutation dis-
rupts a process occurring late during fertilization. It is
likely that the mutations are caused by gene disruption
as a consequence of the Ds insertion. Indeed, sequence
from the genomic region flanking the element has
shown that in 8 of these 14 lines, the insertion was
within a sequence that has homology with genes and
ESTs present in the databases. To determine unam-
biguously whether these mutants are molecularly
tagged, we are currently attempting to isolate rever-
tants by reintroducing Ac transposase.
To determine the morphological defects in these
lines, we characterized the development of the female
gametophyte in fixed and cleared ovules by light
microscopy. For each mutant, developmentally staged
ovules were compared to the equivalent stage in wild
type. The mutants could be grouped into five pheno-
typic classes affecting all stages of megagametophyte
development: (I) megagametophyte arrests before
mitosis, (II) megagametophyte arrests at various
points in the mitotic phase, (III) nuclei fail to migrate
properly and/or cellularization is abnormal, (IV) polar
nuclei fail to fuse, and (V) megagametophyte develops
to maturity but the fertilization process fails. Mutants
of class V can be female- or male-specific. For
instance, semisterility would result if the pollen tube
entered the ovule and discharged the sperm cells but
fertilization was not effected. In some of the class II
mutants, coordination of the mitotic cycles is lost and
asynchronous divisions give rise to variable numbers
of nuclei and aberrant nuclear positioning. For hadad
(hdd), one of the class II mutants, we performed a
detailed comparison to wild type throughout megaga-
metophyte development that gave us insight into tem-
poral aspects of the mutant phenotype. Mutant hdd
embryo sacs predominantly arrest after one or some-
times two mitotic cycles, but some may progress slow-
ly through all three mitotic divisions. Although
delayed, a small fraction (less than 2%) reaches matu-
rity and can get fertilized to form seeds. We are per-
forming similar phenotypic analyses for the other
mutants that we have isolated.
Cell Specification in the
Female Gametophyte
R. Baskar, J. Moore, J.-P. Vielle-Calzada, U. Grossniklaus
Although the seven cells of the megagametophyte are
of clonal origin, they develop along four alternative
developmental pathways. The small number of cell
types in the female gametophyte makes it an ideal sys-
tem to study cell specification processes in plants. We
have screened more than 2000 transposants for
reporter gene expression in mature ovules. Among the
enhancer detector transposants, about 5% show
expression in the female gametophyte. Whereas some
of these show expression in all cells of the megaga-
metophyte, others are specific to a subset of cells or to
individual cell types such as the egg cell, synergids,
and antipodals, suggesting that they may be involved
in cell specification processes. We are particularly
interested in the specification and function of the egg
cell. To date, we have identified two transposants with
expression in the egg, neither of which displays an
obvious mutant phenotype. To confirm that the Ds ele-
ments were within a transcription unit expressed in the
egg cell, we performed in situ hybridization with ribo-
probes derived from sequences flanking the insertion
site. Preliminary experiments suggest that the
enhancer detector expression pattern indeed reflects
the expression of a gene in the immediate neighbor-
hood of the insertion. We have isolated regions flank-
ing the two Ds elements from a genomic library and
are currently characterizing the promoter regions of
these genes. Once identified, egg cell-specific pro-
moters will be used for genetic cell ablation and mis-
expression of regulatory genes. Such experiments will
allow us to investigate cellular interactions between
the cells of the megagametophyte and to probe the
potential of the egg cell for autonomous activation, an
important component of apomictic reproduction.
MEDEA Encodes a Protein
of the Polycomb-Group
M. Hoeppner, J. -R. Vielle Calzada, U. Grossniklaus
During the past year, we concentrated on the molecu-
lar characterization of medea (mea), a gametophyti-
cally controlled embryo lethal mutant. MEA regulates
cell proliferation during seed development. Embryos
derived from mutant eggs grow to a giant size and
eventually die. The gametophytic maternal control of
this growth defect is consistent with the parental con-
flict theory of Haig and Westoby (Am. Nat. 134: 147
[1989]) which explains parent-of-origin-dependent
control of embryo size as the outcome of a conflict
between parental genomes. We had previously shown
that mea-1 is molecularly tagged by cosegregation and
reversion analyses. We used genomic fragments flank-
ing the Ds element to screen a floral cDNA library and
identified a single clone among 800,000 phages
screened. Since the cDNA was not full length, the 5'
end was isolated by RACE PCR. Sequence analysis
showed that MEA is similar to Enhancer of zeste
[E(z)], a Drosophila protein best known for its
involvement in the regulation of homeotic genes (Fig.
1A). The highest similarity between the two proteins
(55% identity) is found at the carboxyl terminus, in the
SET domain, which was named after the three found-
ing members of the family in Drosophila, Suppressor
of variegation 3-9 [Su(var)3-9], E(z), and trithorax
(trx) (Fig. 1B). Although the function of the SET
domain is unknown, the members of this family have
been implicated in the regulation of chromatin struc-
ture, and several have been shown to associate with
chromatin. E(z) shows characteristics of both the
trithorax-group (trx-G) and Polycomb-group (Pc-G)
in Drosophila. Pc-G and trx-G proteins play an impor-
tant role in the long-term activation and repression of
homeotic genes in Drosophila, mice, and plants.
Recently, the first Arabidopsis member of the SET
domain family, CURLY LEAF (CLF) (Fig. 1B) was
shown to have a similar function in the control of flo-
ral homeotic genes (Goodrich et al., Nature 386: 44
[1997]).
Many of the animal members of this protein fami-
ly show parent-of-origin-specific effects and are
involved in the regulation of cell proliferation. For
instance, the human homologs of trx (All-11Hrx) and
E(z) (Enx-1) control lymphocyte proliferation and
have been implicated in leukemias and lymphomas.
Thus, both aspects of SET domain protein function,
the control of homeotic gene expression (CLF) and the
regulation of cell proliferation (MEA), appear to be
conserved across kingdoms. MEA shares 43% identity
with E(z) in the CXC domain, a cysteine-rich region
amino-terminal to the SET domain (Fig. 1A). The
CXC domain and five additional highly conserved
cysteine residues are unique to E(z) and its vertebrate
and plant homologs. Although the function of these
cysteine-rich regions is unknown, they have been
shown to be required for E(z) function. Since MEA
encodes a SET domain protein, it is likely that MEA
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FIGURE 1 MEDEA ecodes a protein of the Polycomb-group. (A) Schematic align-
ment of MEA and E(z) showing the relative position and amino acid identity of the
SET and CXC domains, the putative nuclear localization signals (N), the five con-
served cysteines (C5) characteristic of E(z), and its plant and vertebrate
homologs, and a highly acidic domain (A) also found in trx. (B) Alignment of the
SET domain of plant (CLF), Drosophila [E(z)] and human (Enx-1) E(z) homologs
and the other founding members of the SET domain family, Su(var)3-9 and Trx.
Identities are indicated by a dot, and gaps by a dash. The Ds insertion site is indi-
cated. The MEA SET domain shows a higher degree of similarity to the plant E(z)
homolog CLF (60%) than to E(z) and Enx-1 (55% and 57%, respectively).
controls gene expression during embryogenesis
through the regulation of higher-order chromatin
structure. Our findings suggest that similar molecular
mechanisms operate in animals and plants to control
cell proliferation and to mediate parent-of-origin-spe-
cific effects.
Isolation of Molecular Markers
Associated with Apomixis in Hieracium
R. Bicknell, U. Grossniklaus
During the last several years, Ross Bicknell has devel-
oped Hieracium, a naturally occurring apomictic
species, into a powerful model system to study
apomixis. The purpose of Ross' sabbatical visit here at
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the laboratory was twofold: (1) The establishment of a
long-term collaboration to analyze the expression of
genes we identify in Arabidopsis in sexual and
apomictic accessions of Hieracium, which will allow
a direct comparison of gene expression during sexual
and apomictic reproduction, and (2) the isolation of
molecular markers associated with the locus control-
ling apomixis in Hieracium. From previous work, it
appeared that apomixis was inherited as a dominant
Mendelian trait. The molecular basis of the trait, how-
ever, is unknown. To develop RFLP probes linked to
the principal locus, we decided to use representational
difference analysis (RDA), a powerful technique
developed here at the laboratory (Lisitsyn et al.,
Science 259: 946 [1993]), which allows the direct iso-
lation of molecular differences between genomes.
Pooled segregant genomic DNA from sexual and
apomictic hybrid plants would be used for RDA. In
these pools, we expect all polymorphisms except for
those tightly linked to apomixis to be randomized.
We did not start out very well. The first shipment of
plant material was frozen in transit and the second was
held up at the border. Both arrived at Cold Spring
Harbor in the form of a green, smelly soup garnished
with rafts of small floating labels. After several weeks
of desperate nursing by Tim Mulligan and others, two
segregant populations were recovered from this puree,
one composed of sexual individuals and one of
apomicts. Three restriction enzymes were used to
fragment the genomic DNA of 11 and 15 sexual and
apomictic siblings, respectively. RDA was advanced
over three cycles of subtraction/amplification.
Twenty- four persisting fragments were cloned that
appeared to have different levels of abundance
between the DNA derived from the pool of sexual
plants and the DNA derived from the pool of the
apomictics. These were each tested individually by
Southern blotting and six were found to display repro-
ducible differences between the pools. One of these
six appears to be very promising since it has only been
detected in apomictic individuals. Other tests, howev-
er, need to be conducted to confirm this preliminary
result. Sadly, the 6-month period of leave ran out at
this point. All the experimental material, however, is
duplicated at Lincoln, New Zealand, where the work
will continue.
PLANT GENETICS
D. Jackson Z. Yuan
Research in our laboratory is aimed at understanding
the control of morphogenesis in plants, using maize
and Arabidopsis as model genetic systems. We are
currently focusing on two areas: (1) intercellular traf-
ficking of plant regulatory proteins and (2) genetic
analysis of shoot meristem function. As well as adding
to our basic understanding of the developmental
strategies of plants, the results from these studies will
aid in our understanding of cellular processes
involved in the regulation of plant growth and the
spread of plant pathogens.
Leaves and floral organs are initiated from shoot
meristems, groups of stem cells that are responsible
for the indeterminate growth characteristics of plants.
PUBLICATIONS
Hawkins, N.C., C. Van Buskirk, U. Grossniklaus, and T.
Schupbach. 1997. Post-transcriptional regulation of
gurken by encore is required for axis determination in
Drosophila. Development 124: 4801-4810.
Moore, J.M., J.-P. Vielle Calzada, W. Gagliano, and U.
Grossniklaus. 1997. Genetic characterization of hadad, a
mutant disrupting female gametogenesis in Arabidopsis
thaliana. Cold Spring Harbor Symp. Quant. Biol. 62:
35-47.
In Press
Grossniklaus, U. and K. Schneitz. 1998. The genetic and
molecular basis of ovule and megagametophyte devel-
opment and megagametogenesis. Seminars Cell Dev.
Biol. (in press).
Grossniklaus, U., J.M. Moore, and W. Gagliano. 1998.
Molecular and genetic approaches to understanding
and engineering apomixis: Arabidopsis as a powerful
tool. In Hybrid rice (ed. B. Hardy). International Rice
Research Institute, Manila, Philippines. (In press.)
Grossniklaus, U., J.-P. Vielle Calzada, M. Hoeppner, and W.
Gagliano. 1998. Maternal control of embryogenesis by
MEDEA, a Polycomb-group gene in Arabidopsis.
Science (in press).
Howden, R., S. Park, J.M. Moore, J. Orme, U. Grossniklaus,
and D. Twell. 1998. Selection of T-DNA-tagged male and
female gametophytic mutants by segregation distortion
in Arabidopsis. Genetics (in press).
Messing, J. and U. Grossniklaus. 1998. Genomic imprinting
in plants. In Results and problems in cell differentiation:
Genomic imprinting (ed. R,. Ohlsson). Springer Verlag,
Heidelberg, Germany. (In press.)
Genes that define the shoot apical meristem by their
expression patterns and functions have recently been
identified. The maize knotted] (knl) gene and mem-
bers of the knl gene family from diverse species are
expressed in shoot apical meristems but not in leaves;
in fact, down-regulation of KN1 protein and mRNA
precedes the outgrowth of a leaf primordium. knl con-
tains a homeodomain, a DNA-binding domain
involved in the control of cell fate during the develop-
ment of many organisms through transcriptional regu-
lation of specific target genes.
We are studying aspects of knl regulation and
characterizing other mutations that affect shoot meris-
tern function.
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INTERCELLULAR TRAFFICKING OF KNOTTEDI
GENE PRODUCTS
Intercellular communication is fundamental to the
development of multicellular organisms. This is espe-
cially evident in plants, where cell fate is determined
largely by positional rather than lineage cues.
Evidence for the importance of cell-to-cell communi-
cation throughout plant development has come from
mosaic analysis, which shows that many regulatory
genes in plants act non-cell-autonomously. In other
words, cells that carry a mutation in a particular devel-
opmental gene can be phenotypically complemented
in mosaics because they receive appropriate signal(s)
from adjacent wild-type cells. The nature of these sig-
nals was previously not known, although our recent
data together with data from other labs suggest that the
cell-to-cell trafficking of regulatory proteins through
plasmodesmata may define a novel intercellular sig-
naling pathway.
Mosaic analysis showed that expression of knl in
inner cell layers of the leaf induces a signal that
spreads to surrounding cells and alters their fate. To
our surprise, we were able to detect the presence of
KN1 protein outside of the domain of KN1 mRNA
localization, suggesting that the KN1 protein itself
may be the signal. We then demonstrated directly,
using microinjection assays, that KN1 protein can traf-
fic between plant cells through plasmodesmata, mem-
brane-lined cytoplasmic channels that traverse the
extracellular matrix to allow symplastic communica-
tion between cells. Functionally, plasmodesmata
resemble animal gap junctions in allowing the passage
of small molecules such as metabolites and small
growth regulators, with an upper size limit of 1 to a
few kilodaltons. Plasmodesmata were previously
known to also allow the passage of macromolecules,
because many viruses move through them to spread
infection to adjacent cells. The virus encodes a move-
ment protein that binds the viral genome and traffics it
through the plasmodesmata. The identification of KN1
as a specific plant gene product that traffics through
plasmodesmata provides an opportunity to dissect the
mechanism of this novel intercellular communication
pathway.
Our current research efforts are addressing the fol-
lowing questions: (1) What is the role of cell-to-cell
trafficking of KN1 in normal development? (2) Does
trafficking of KN1 protein occur in the shoot meri-
stem, where knl exerts its normal function? We are
combining the use of green fluorescent protein fusions
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FIGURE 1 Alteration of phyllotaxy in abphl seedlings.
Normal maize seedlings initiate leaves singly and opposite
from the previous leaf (A). In seedlings carrying the recessive
abphl mutation, leaves are initiated in opposite pairs (8).
This change in phyllotaxy is reflected in changes in the
expression of the knl homeobox gene in the shoot apical
meristem (C, D).
and high-resolution localization experiments with
genetic analysis to elucidate the pathway of intercellu-
lar trafficking of plant proteins.
GENETIC ANALYSIS OF MERISTEM FUNCTION
IN MAIZE
Organogenesis in plants occurs at the shoot apical
meristem, a group of indeterminate stem cells that are
formed during embryogenesis. Regular patterns of ini-
tiation of leaves or flowers from the meristem give rise
to the familiar geometric patterns observed throughout
the plant kingdom. The mechanism by which these
patterns, termed phyllotaxies, are generated, remains
unclear. Members of the grass family, including
maize, initiate leaves singly, alternating from one side
to the other in a regular pattern. We are characterizing
a new recessive maize mutant, abphyll , that initiates
leaves in opposite pairs rather than singly. Expression
of knl in the shoot apical meristem is altered in abphl;
specifically, the prepattern of knl down-regulation
predicts the different patterns of leaf initiation. The
abphl mutant phenotype is first manifest in the
embryo by a larger shoot apical meristem and a larger
domain of expression of knl. Therefore, the abphl
gene regulates pattern formation at an early step in
maize embryogenesis, prior to visible signs of true leaf
initiation. We are currently attempting to isolate the
abphl gene using transposon tagging.
Another class of meristem mutants are those in
which the balance between stem cell proliferation and
primordium initiation is disturbed. Normally, the pro-
liferation of stem cells is finely balanced with the
recruitment of cells into primordia, and the meristem
is maintained as an organized unit of fixed size. We are
isolating and characterizing mutations that cause over-
proliferation and enlargement of the meristem, also
known as fasciation. The normal role of these genes
may be in the control of cell proliferation in the meri-
stem, or in the control of organ initiation. We have
isolated several mutations with fasciated phenotypes,
one of which is from a Mutator transposon line. We
have identified a transposon that cosegregates with
the fasciated mutation and we are isolating flanking
maize genomic sequences to test whether the gene is
tagged and to isolate the fasciated gene. Isolation and
molecular characterization of fasciated genes should
enhance our understanding of cell proliferation in
plants, and it will be interesting to determine whether
the mechanisms are similar to those regulating cell
proliferation in animals.
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CELL BIOLOGY
This section comprises laboratories studying a diverse set of interests including signal trans-
duction events that regulate gene expression and ultimately growth in normal and cancer cells.
Carol Greider's laboratory continued their studies of telomerase and, together with
Ron DePinho, generated knockout mice that lacked telomerase activity. In these mice,
telomere function was lost after five or six generations, resulting in increased genomic
instability and a progressive decline both in fertility and in viability of highly prolifera-
tive tissues. Their data suggest that although telomerase is not essential for tumor for-
mation, its activity may contribute to tumor growth.
David Helfman's laboratory found that activation of cellular contractility is an indis-
pensable step in adhesion-dependent cellular signaling. Their observations suggest a
mechanism whereby the changes observed in actin filaments in transformed cells
could lead to aberrant cell growth by interfering with normal signaling functions.
Nouria Hernandez and colleagues continued their studies of transcription from the
human snRNA promoters and from the HIV-1 promoter. In characterizing the snRNA
activating protein complex (SNAPc), they have completed isolation of cDNA clones for
SNAPc subunits and reconstituted the complex from recombinant proteins. They have
also been studying the ability of the HIV-1 promoter to generate short, prematurely ter-
minated transcripts, which is dependent on a DNA element termed inducer of short
transcripts (1ST). A specific 1ST-binding factor has been purified and cloned, and its
role in short transcript formation is being characterized.
Tatsuya Hirano's laboratory uses a cell-free extract derived from Xenopus eggs to
study the molecular mechanisms underlying mitotic chromosome condensation and
segregation, with a particular emphasis on the role in these processes of two chromo-
somal ATPases, which are members of the SMC (Structural Maintenance of
Chromosome) family.
David Spector's group focuses on structural and functional organization of the mam-
malian cell nucleus. They have observed the dynamic movements of pre-mRNA splic-
ing factors in the nuclei of living cells and have shown that these movements are
dependent on ongoing RNA polymerase transcription. In addition, they have visual-
ized directly the recruitment of splicing factors to a specific active gene in living cells
using an inducible promoter system.
Nick Tonks' laboratory continues to take a variety of approaches to study the physio-
logical function of protein tyrosine phosphatases (PTPs), an important family of signal
transducing enzymes. They have developed "substrate-trapping" mutant forms of
these enzymes which form stable complexes with target substrates in a cellular con-
text. These complexes can be isolated and the substrates identified. This approach
has revealed that, contrary to popular belief, the PTPs display exquisite substrate
selectivity in a cellular context and thus may be specific regulators of cellular signal-
ing events.
Linda Van Aelst and her colleagues focus on defining the role of the small GTPases
Ras and Rac in signaling pathways that regulate cell growth. Recently, they have
shown that an activated form of Rac promotes integrin-mediated T-Iymphocyte adhe-
sion. In addition, they have shown that the Rac-binding protein POR1 may be an
important regulatory element in establishing specific patterns of cytoskeletal
rearrangements at the plasma membrane and may play a role in peripheral mem-
brane trafficking.
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SIGNAL TRANSDUCTION
L. Van Aelst B. Boettner M. McDonough
M. Marin R. Packer
Research in our lab is focused on the study of signal
transduction pathways implicated in cell growth con-
trol. In particular, one major interest of our lab is to
investigate the role of Ras and Rac genes in signal
transduction. The Ras and Rac genes encode low-mol-
ecular-weight guanine-nucleotide-binding proteins
that function as binary molecular switches by cycling
between the active GTP-bound state and the inactive
GDP-bound state. These proteins have been demon-
strated to have a central role in the signal transduction
pathways that mediate such diverse biological phe-
nomena as transformation, mitogenesis, metastasis
transcriptional activation, and cytoskeletal organiza-
tion. Our major objective is to uncover the effector
pathways mediating the effects of Ras and Rac pro-
teins. Another subject of our ongoing research is the
functional characterization of p62d°k, a Ras-GAP-
associated protein that is constitutively tyrosine-phos-
phorylated in chronic myelogenous leukemia (CML)
progenitor cells.
Ras and Rac Signaling Pathways
B. Boettner, M. McDonough, R. Packer, L. Van Aelst
Functional Characterization of a Novel RAS-bind-
ing Protein, AF-6. There is abundant evidence impli-
cating the dysregulation of the Ras proteins in the eti-
ology of human cancers. Most importantly, cellular
Ras genes have been found to be frequently activated
by mutation in a wide variety of human cancers. These
cancer cells exhibit morphological changes and alter-
ations of cell adhesion. We previously identified the
serine/threonine Raf kinase as a critical downstream
target of Ras, required for Ras-mediated transforma-
tion in mammalian cells. However, evidence for the
involvement of additional effector pathways con-
tributing to cell transformation has been obtained.
More recently, we have isolated the protein AF-6 as a
novel putative Ras target. AF-6 was previously identi-
fied as an in-frame fusion partner for ALL-1 in acute
lymphoblastic leukemias caused by translocation
events of the t(6;11) type (AF-6 hereafter stands for
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A11-1 fused gene on chromosome 6). ALL-1 in turn is
a homolog of Drosophila trithorax and, in a variety of
leukemias, due to chromosomal translocation, is
linked to coding regions on chromosomes 4, 6, 9, or
19. However, the putative malignant function of the
ALL-1/AF-6 fusion protein, as surmised for those
fusions of A11-1 to other loci, in lymphoblastic cells is
unclear. Presently, little is known about the biochemi-
cal function of AF-6. We determined that its interac-
tion with Ras is GTP-dependent and that the first 160
amino acids of AF-6 are sufficient for Ras binding. In
addition to the amino-terminal Ras-binding domain,
AF-6 contains an unc-104-like kinesin, a class V
myosin homolog, a PDZ, and a proline-rich carboxy-
terminal domain. A Drosophila homolog of AF-6, des-
ignated canoe, has been isolated, which shares a com-
mon domain organization. Canoe has been described
as a downstream component in Drosophila Notch sig-
naling involved in eye, bristle, and wing development
and has been shown to interact genetically with the
armadillo (b-catenin) gene. The products of the Notch
and armadillo genes are involved in adhesive cell-to-
cell communications. Furthermore, canoe is implicat-
ed in the formation of cone cells in the developing
compound eye in Drosophila. Interestingly, the phe-
notypic effects of canoe mutations on the cone cells
are dependent on the state of Ras. More recently, evi-
dence has been obtained that AF-6 is concentrated at
cell-cell contact sites of epithelial cells. One of our
major aims is to assess a role for AF-6 in Ras-mediat-
ed activities, in particular, whether AF-6 may account
for the functions of Ras in the regulation of cell-cell
contacts. Toward this end, we are currently determin-
ing the distribution and localization of AF-6 in epithe-
lial and endothelial cells expressing an activated
mutant form of Ras, and we are assessing the effects
of AF-6 WT and truncation mutants on cell-cell adhe-
sion. In addition, we recently succeeded in isolating
AF-6 interacting proteins and are in the process of fur-
ther characterizing them.
Effectors of RAC1 Function. One of the first func-
tions attributed to Rac was its involvement in the reor-
ganization of the actin cytoskeleton induced by
growth factors and constitutively active Ras
(RasV12). Later, Rac was shown to activate the tran-
scription factors c-Jun (mediated by the c-Jun amino-
terminal kinase, JNK), SRF, and the nuclear transcrip-
tion factor NF-1(13. More recently, Rac has been impli-
cated in multiple aspects of cell growth control. It is
well established that the GTPase Rac is an essential
component of Ras-induced malignant transformation.
Furthermore, evidence has been obtained that Rac has
a role in cell-cell/cell-ECM adhesion (see below),
invasion, and apoptosis. However, it remains a major
challenge to unravel the underlying molecular mecha-
nisms by which Rac mediates these various activities.
Toward this end, we have set out to identify Rac-inter-
acting proteins and devised a system to dissect genet-
ically the different functions of Rac.
With regard to the identification of Rac-interacting
proteins, we previously described the isolation of two
Rae-interacting proteins, PORI and POR2, and pro-
vided evidence for a role of PORI in Rac-induced
cytoskeletal rearrangements. We continued to further
characterize the function of PORI. Localization stud-
ies showed that POR1, similar to Rac 1 , can be found
both in the cytoplasm and along the surface of the
plasma membrane. Our preliminary studies revealed a
redistribution of PORI from the cytoplasm to the
we found more recently that PORI interacts with the
GTPase, ARF6. This study was performed in collabo-
ration with Crislyn D'Souza-Schorey (Washington
University School of Medicine, St. Louis). ARF6 is
the least conserved member of the ARF family of
GTPases. In addition to its role in regulating peripher-
al membrane trafficking, we showed that ARF6 and its
activated mutant, ARF6(Q67L), elicit cytoskeletal
rearrangements at the cell surface. Cytoskeletal
rearrangements induced by ARF6(Q67L) could be
inhibited by coexpression deletion mutants of PORT,
but not with the dominant negative mutant of Rac,
Rac(S17N). These findings indicate that ARF6 and
Rac function on distinct signaling pathways to medi-
ate cytoskeletal reorganization and suggest a role for
PORI as an important regulatory element in orches-
trating cytoskeletal rearrangements at the cell periph-
ery induced by ARF6 and Rac. It is possible that,
depending on the nature of the extracellular stimuli,
PORI could interact with either ARF6 or Rac or both
to establish highly specified patterns of cytoskeletal
rearrangements at the plasma membrane. More
recently, several reports suggest the possible interde-
pendence or cross-talk between signaling pathways
that regulate cytoskeletal architecture and membrane
trafficking. We are assessing a role for PORI in
peripheral membrane trafficking. We are also investi-
gating a role for PORI in the other Rac-mediated
activities.
To gain insight into the signaling pathways medi-
ating Rac-induced biological events, we screened for
Rac effector loop mutants that separate the ability of
Rac to interact with different downstream effectors. In
addition to the abovementioned POR proteins, a fam-
ily of serine/threonine kinases known as PAKs,
IQGAP, and pp70 S6 kinase were isolated as potential
Rac targets. The use of Rac effector domain mutants
allowed us to demonstrate that the ability of Rac to
mediate transformation is not dependent on its ability
to activate JNK. We expanded these studies, and in
collaboration with Channing Der were able to show
that SRF activation and the short-term cytoskeletal
rearrangements triggered by Rac are not required for
the transforming ability of Rac. Presently, the path-
way(s) mediating Rac's effect on cell proliferation
remains to be defined.
Several observations suggest a contribution of
short-term cytoskeletal rearrangements to invasive-
ness and metastasis. As mentioned above, a role for
Rac in invasion has been demonstrated. Adhesion,
motility are involved at various stages
during invasion and metastasis and are both dependent
on a functional actin cytoskeleton. We recently
observed that expression of an activated mutant form
of Rac, RacV12, induces increased adhesion of T cells
onto fibronectin in an integrin-dependent manner and
that adhesion is associated with dramatic cell spread-
ing and integrin clustering. Cell spreading is accom-
panied by cytoskeletal rearrangements and requires
actin polymerization. This effect was not mimicked by
expression of activated mutant forms of Rho, Cdc42,
Hras, or ARF6, indicating the unique role of Rac in
this event. Expression of Rac did not alter the expres-
sion levels or affinity state of the integrin receptors.
Moreover, our results show that the contribution of
Rac to T-cell adhesion involves events following
receptor occupancy, such as cell spreading and possi-
bly integrin clustering, rather than alterations of inte-
grin affinity or cell-surface expression. Cell spread-
ing, which imposes a more streamlined shape to the T
cells, aids in their resistance to the shear forces they
are exposed to during the vascular flow in the venules.
We also obtained evidence that the Rac-mediated sig-
naling pathway leading to T-cell spreading is not due
to activation of PAK, JNK, or S6 kinase. Interestingly,
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the drugs wortmannin and LY294002 at concentra-
tions of 50 ores and 100 pm, respectively, were able to
inhibit the RacV12-induced cell spreading, suggesting
a role of a lipid kinase in mediating Rac's effect on T-
cell spreading. Since the phenotypic alterations
induced by RacV12 are so distinctive, one of our long-
term goals is to screen a mammalian cDNA library
identifying clones that exhibit a spreading phenotype.
Functional Characterization
of p62d"
M. Marin, L. Van Aelst [in collaboration with R. Kobayashi,
Cold Spring Harbor Laboratory, and B. Clarkson,
P. Pandolfi, MSKI, New York]
The other research topic under investigation in the lab
is the functional characterization of a constitutively
tyrosine-phosphorylated, rasGAP-associated 62 -kD
protein (p62), which was detected within chronic
myelogenous leukemia (CML) progenitor cells. To
gain some understanding of the molecular mechanism
underlying human CML, Clarkson and co-workers ini-
tiated a series of biochemical studies utilizing primary
lin- Ph' chronic-phase CML blasts. CML is character-
ized by the presence of the fusion protein p210b"-abi,
which has an elevated tyrosine kinase activity relative
to normal c-Abl. Their aim was to identify possible
differences in the state of tyrosine phosphorylation
among proteins in whole-cell lysates of primary early
progenitors derived from normal or Ph' chronic-phase
CML marrows. They observed several proteins consti-
tutively phosphorylated on tyrosine residues in chron-
ic-phase blasts, whereas the similar set of phosphoty-
rosyl-containing proteins was undetectable in normal
blasts. Among them was a 62-kD phosphoprotein
which they thereafter demonstrated to form an in vivo
complex with p120 rasGAP. Using a human
megakaryoblastic cell line expressing p210b"-"'
(M07/p210), N. Carpino et al. (CSHL) purified and
cloned the cDNA of p62, which they designated
p62"k. p62 encodes a novel protein that displays some
interesting features: (1) A putative pleckstrin homolo-
gy (PH) domain at the extreme amino terminus; (2) 15
tyrosines, of which 10 are located within a carboxy-
terminal stretch spanning one-third the length of the
molecule; and (3) ten PXXP motifs, the core-con-
served sequence of proline-rich regions that are recog-
nized by SH3 domains.
A RasGAP-associated 62 -kD protein was also pre-
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viously observed as a common target of protein-tyro-
sine kinases such as v-Abl, v-Src, v-Fps, v-Fms, and
activated EGF receptor, and tyrosine phosphorylation
of p62 appears to correlate with the transforming
activity of the viral oncogenes.
Using antibodies raised against human p62d", we
confirmed that the tyrosine-phosphorylated 62-1(D
protein observed in src, v-abl, and p210b°' -abl trans-
formed cells is indeed p62"k. We also confirmed that
p62dak is rapidly tyrosine-phosphorylated after stimu-
lation of Mo7 cells with the c-kit ligand. In addition,
in fibroblasts, we observed that p625°1' is rapidly tyro-
sine-phosphorylated following PDGF, insulin, and
IGF-1 stimulation. With regard to p210b"-ab', we
recently obtained evidence indicating that p62dak is a
direct substrate of p210b"-abi.
In CML, evidence for constitutive Ras activation
and reduced Ras-GAP activity has been found. In
addition, evidence has been provided that CML pro-
genitor cells show an altered adhesion behavior
toward marrow stromal cells and some extracellular
matrix proteins, in particular fibronectin, and it has
been suggested that this altered adhesion may con-
tribute to the abnormal proliferation observed in CML.
In addition, c-kit ligand has been shown to increase
the adhesion properties of hematopoietic progenitor
cells to fibronectin. To further elucidate the function of
p62a ", we are currently measuring the catalytic activ-
ity of GAP toward ras and the GTP/GDP ratio of ras in
the presence of unphosphorylated and tyrosine-phos-
phorylated p62 and in cells lacking p62d". These cells
are provided by Dr. P. Pandolfi (Memorial Sloan-
Kettering). We set out to identify and characterize
p62"" interacting proteins. Furthermore, we started to
determine the structural features underlying the inter-
action of p62d" with GAP and other recently identified
p62dak interacting proteins. The information gained
from these studies will provide useful tools to address
the functional role of p62da in the cell, in particular
with an eye on its potential role in signal transduction
pathways implicated in adhesion and proliferation.
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PROTEIN TYROSINE PHOSPHATASES AND THE CONTROL OF
CELLULAR SIGNALING RESPONSES
N.K. Tonks A.M. Bennett
M.A. Daddario
R.L. Del Vecchio
A.J. Garton
M.J. Gutch
K. A. Ivarson
K.R. LaMontagne
M.P. Myers
The phosphorylation of tyrosyl residues in proteins is
a key component of the regulation of signaling path-
ways that control many fundamental physiological
processes including cell proliferation or differentia-
tion. Protein phosphorylation is a reversible, dynamic
process in which the net level of phosphate observed
in a target substrate reflects not only the activity of the
kinases that phosphorylate it, but also the competing
action of protein phosphatases that catalyze the
dephosphorylation reaction. We study the expanding
family of protein tyrosine phosphatases (PTPs) which,
like the kinases, comprise both transmembrane, recep-
tor-linked forms and nontransmembrane, cytosolic
species and represent a major family of signaling
enzymes. The structures of the PTPs indicate impor-
tant roles in the control of key cellular functions. We
are utilizing a variety of strategies to characterize the
normal physiological function of several members of
the PTP family. Disruption of normal patterns of tyro-
sine phosphorylation has been implicated as a contrib-
utor to several human diseases. Therefore, insights
into the mechanisms involved in modulating PTP
function may ultimately yield important information
to help counter such diseases.
During the last year, Tony Tiganis and Salim
Mamajiwalla completed their postdoctoral studies.
Tony has returned to Australia to take a position at St.
Vincent's Institute of Medical Research in Fitzroy,
Victoria, and Salim has joined the Intellectual
Property Group of the law firm of Blake, Cassels, and
Graydon in Toronto as a Technical Advisor in Life
S.N. Mamajiwalla
A.A. Samatar
T. Tiganis
S.H. Zhang
Sciences. Martha Daddario moved to the James Lab
as Building Manager, and her position in the lab as
technician has been taken by Kim Ivarson.
Identification of PTP
Substrates
A.J. Garton, K.R. LaMontagne, T. Tiganis
The identification of substrates of PTPs is an essential
step toward a complete understanding of the physio-
logical function of members of this enzyme family. In
1995, in collaboration with David Barford (Oxford
University), we determined the crystal structure of
PTP in a complex with a phosphotyrosyl peptide
substrate. From this structure, we defined several
residues in the enzyme that were important for sub-
strate recognition and catalysis. We have character-
ized the function of these residues further by site-
directed mutagenesis and have generated a form of
PTP that maintains a high affinity for substrate but
does not catalyze dephosphorylation effectively; i.e.,
we have converted an extremely active enzyme into a
"substrate trap." Furthermore, the residue that is
mutated to generate the substrate-trapping mutant is
the invariant catalytic acid (Asp-181 in PTP1B) that is
conserved in all members of the PTP family.
Therefore, this has afforded us a unique approach to
identification of physiological substrates of PTPs in
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general. Following expression, the mutant PTP binds
to its physiological substrates in the cell but, because
it is unable to dephosphorylate the target efficiently,
the mutant and substrate become locked in a stable,
"dead-end" complex. Potential substrates can be iden-
tified by immunoblotting lysates of cells expressing
the mutant PTP with antibodies to pTyr to reveal pro-
teins whose phosphorylation state is altered as a con-
sequence of expression of the mutant. In addition, the
complex between the mutant PTP and the pTyr sub-
strate can be isolated by immunoprecipitation, and
associated proteins can be identified by immunoblot-
ting or, on a larger scale, by primary sequence deter-
mination. We have now initiated such an approach to
substrate identification with intriguing results. The
major take-home message from this work is that mem-
bers of the PTP family display exquisite substrate
specificity in a cellular context.
TCPTP
TCPTP exists in two forms generated by alternative
splicing: a 48-kD endoplasmic reticulum (ER)-associ-
ated form (TC48) and a 45-kD nuclear form (TC45).
To identify TCPTP substrates, we generated substrate-
trapping mutants, in which the invariant catalytic acid
(D182 of TCPTP) is mutated to alanine. The TCPTP
D182A substrate-trapping mutants were transiently
overexpressed in COS cells, and their ability to form
complexes with tyrosine-phosphorylated proteins was
assessed (Fig. 1). No pTyr proteins formed complexes
with wild-type TCPTP. In contrast, TC48-D182A
formed a complex in the ER with pTyr-epidermal
growth factor receptor (EGFR), suggesting that TC48
may regulate the state of phosphorylation of nascent
EGFR that is in transit through the ER on the way to
the plasma membrane. In response to EGF, TC45-
D182A exited the nucleus and accumulated in the
cytoplasm where it bound tyrosine-phosphorylated
proteins of 50, 57, 64, and 180 kD. The 57-kD and
180-kD proteins were identified as p52sk and EGFR,
respectively. TC45 did not modulate EGF-induced
activation of p42Erk2 but did inhibit the EGF-induced
association of p52shc with Grb2, which was attributed
to the ability of the PTP to recognize specifically
p5,,L Shc phosphorylated on Y239. These results indicate
that TC45 not only recognizes selected substrates in a
cellular context, but also displays preference for par-
ticular sites within substrates and thus may regulate
discrete signaling events in vivo.
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PTP-PEST
Previously, we had demonstrated that PTP-PEST, a
ubiquitously expressed cytosolic PTP, manifested
selectivity for p130cas, a docking protein that has been
implicated in assembly of multiprotein signaling com-
plexes. We identified a high-affinity interaction
between the SH3 domain of p130cas and a proline-rich
sequence (P335PPKPPR) within the carboxy-terminal
segment of PTP-PEST. Mutation of Pro-337 to ala-
nine significantly impairs the ability of PTP-PEST to
recognize tyrosine-phosphorylated p130cas as a sub-
strate, without qualitatively affecting the selectivity of
the interaction. Thus, the highly specific nature of the
interaction between PTP-PEST and p130cas appears to
result from a combination of two distinct substrate
recognition mechanisms; the catalytic domain of PTP-
PEST contributes specificity to the interaction with
p130cas, whereas the SH3 domain-mediated associa-
tion of p130cas and PTP-PEST dramatically increases
the efficiency of the interaction. This represents a
novel example of an emerging paradigm in tyrosine-
phosphorylation-dependent signaling processes, in
that substrate specificity of both protein tyrosine
kinases and phosphatases is frequently influenced by
the noncatalytic segments of these enzymes. This
offers a versatile mechanism for restricting each
enzyme to specific roles in tyrosine-phosphorylation-
dependent signaling pathways.
PTP1 B
The p210 bcr-abl PTK appears to be directly respon-
sible for the initial manifestations of chronic myel-
ogenous leukemia (CML). In contrast to the extensive
characterization of this PTK and its effects on cell
function, relatively little is known about the nature of
the PTPs that may modulate p210 bcr-abl-induced sig-
naling. We have demonstrated that expression of
PTP1B is enhanced specifically in various cells
expressing p210 bcr-abl, including a cell line derived
from a patient with CML. This effect on expression of
PTP1B required the kinase activity of p210 bcr-abl
and occurred rapidly, concomitant with maximal acti-
vation of a temperature-sensitive mutant of the PTK.
The effect is apparently specific for PTP1B because
we tested several other PTPs and detected no change
in their expression levels, including TCPTP, the clos-
est relative of PTP1B. We have observed association
between a substrate-trapping mutant of PTP1B
(PTP1B-D181A) and p210 bcr-abl, but not v-Abl, in a
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FIGURE 1 Precipitation of TCPTP and PTP1B substrates using the Asp -sAla trapping
mutants. These data illustrate that PTP1B and TCPTP display substrate specificity in a cellu-
lar context, recognizing only selected pTyr proteins from the plethora of proteins phosphory-
lated on Tyr in response to EGF. Selectivity for substrates arises as a result of both intrinsic
differences in specificity (compare the ER-localized enzymes PTP1B and TC48) and differ-
ences in localization (compare TC48 and TC45). (A) COS1 cells were serum-starved and
stimulated with 100 ng/ml EGF for 15 min at 379C. Cells were lysed in 3x Laemmli sample
buffer and proteins were resolved by SDS-PAGE (10%) and immunoblotted using the anti-
pTyr-specific antibody G98. Molecular size markers (prestained from Sigma) are indicated on
the left. (B) COS1 cells transiently transfected with either wild-type TC48 or TC45 or D182A
mutants (TC48D, TC45D) or the PTP1B wild-type (1B) or D181A mutant (1BD) were serum-
starved and stimulated with EGF (100 ng/ml) for 15 min at 375C. Cells were then lysed and
TCPTP or PTP1B immunoprecipitates resolved by SDS-PAGE (10%) and immunoblotted with
the anti-pTyr antibody G98 (upper panel) or with TCPTP (CF4)- or PTP1B (FG6)-specific anti-
bodies (lower panel). The major pTyr-containing proteins coprecipitating with TC48D (p180),
TC45D (p180, p64, p57, p50), or 1BD (p180, p60) are indicated by arrows on the right and
molecular size standards are on the left. (Reproduced from Tiganis et al., Mol. Cell. Biol. 18:
1622 119981.)
cellular context. Consistent with the trapping data, we
observed dephosphorylation of p210 bcr-abl, but not
v-Abl, by PTP1B in a cellular context and demon-
strated that PTP1B inhibited binding of the adaptor
protein Grb2 to p210 bcr-abl and suppressed p210 bcr-
abl-induced transcriptional activation. We have now
developed these studies further and demonstrated that
expression of PTP1B, but not TCPTP, in p210 bcr-abl-
transformed Rat 1 fibroblasts inhibited the ability of
these cells to grow in reduced serum, form colonies in
soft agar, and form tumors in nude mice. Furthermore,
we have examined the effects of PTP1B on p210 bcr-
abl function in K562 cells, a Ph* CML cell line
derived from a patient in blast crisis. We observed that
CGP57148, a small molecule inhibitor of p210 bcr-abl
(Druker et al., Nat. Med. 2: 561 [1996]) induced K562
cells to differentiate along the erythroid lineage.
Similarly, expression of PTP1B induced erythroid dif-
ferentiation of K562 cells, as measured by expression
of a-globin, coincident with a decrease in the extent
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of phosphorylation of tyrosyl residues in cellular pro-
teins, including p210 bcr-abl. In contrast, expression
of TCPTP did not exert a pronounced effect on the
phosphorylation status of p210 bcr-abl and did not
induce expression of ot-globin. These results illustrate
selectivity in the effects of PTP1B in a cellular context
and suggest that it may function as a specific, negative
regulator of p210 bcr-abl signaling in vivo.
Characterization of Mechanisms
for Regulation of PTP Activity
R.L. Del Vecchio, S.N. Mamajiwalla, A.A. Samatar,
T. Tiganis, S.H. Zhang
In general, the structure of PTPs can be described in
terms of a conserved catalytic domain to which is
fused on either the amino- or carboxy-terminal side a
noncatalytic segment that serves a regulatory function
and can be used to distinguish individual PTPs. It is
now apparent that PTPs are regulated at multiple lev-
els. We have been characterizing a number of protein-
protein interactions involving members of the PTP
family that may be important in regulating activity
either directly or indirectly, through control of subcel-
lular distribution.
TCPTP
We have examined the role of the noncatalytic, car-
boxy-terminal segment of TCPTP in regulating activi-
ty. Limited tryptic proteolysis of TC45 releases first a
45-kD fragment, then a 33-kD catalytic domain that
displays 20-100-fold more activity toward RCML
(reduced, carboxamidomethylated and maleylated
lysozyme) than the full-length enzyme. Proteolytic
activation occurred following cleavage of a protease-
sensitive region (residues 353-387) located at the car-
boxyl terminus of TC45. The 33-kD catalytic domain,
but not the full-length enzyme, was inhibited in a con-
centration-dependent manner by addition of the non-
catalytic carboxy-terminal segment of TC45. A mono-
clonal antibody to TCPTP, CF4, which recognizes an
epitope located between residues 350 and 363, was
capable of fully activating TC45. These data indicate
that the noncatalytic segment of TC45 contains an
autoregulatory site that modulates activity via a
reversible intramolecular interaction with the catalytic
domain. Therefore, the carboxy-terminal noncatalytic
segment of TCPTP may not only control subcellular
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location, but also modulate activity in response to the
binding of regulatory proteins and/or posttranslational
modification.
PTPH1
We pursued further our observation that the band -4.1-
related PTP, PTPH1, interacts with 14-3-3p. The asso-
ciation is phosphorylation-dependent. Two novel
motifs, RSLS359VE and RVDS853P, in PTPH1 were
identified as major 14-3-3P-binding sites, both of
which are distinct from the consensus binding motif
RSxSxP recently found in Raf-1. Mutation of Ser-359
and Ser-853 to alanine significantly reduced the asso-
ciation between 14-3-3P and PTPH1. Association of
PTPH1 and 14-3-3P was detected in several cell lines
and was regulated in response to extracellular signals.
These results raise the possibility that 14-3-3 may
function as an adaptor molecule in the regulation of
PTPH1 and may provide a link between serine/threo-
nine and tyrosine-phosphorylation-dependent signal-
ing pathways.
PTPII
This year, we completed work on a paper to answer
the claim made by Zondag et al. (J. Cell Biol. 134:
1513 [19961) that the association we observe between
PTPI.t and members of the cadherin family of cell
adhesion molecules results from nonspecific cross-
reactivity between our anti-PTPla antibody BK2 and
cadherins. We have now characterized the association
further in a number of systems and demonstrated the
interaction between PTPI.t. and cadherins by coim-
munoprecipitation using three antibodies that recog-
nize distinct epitopes in PTPµ as well as antibodies to
cadherin. In addition, we have demonstrated directly
that the anti-PTIli antibody BK2 that we used initial-
ly did not cross-react with cadherin. Our data reinforce
the observation of an interaction between PTPIA, and E-
cadherin in vitro and in vivo, further emphasizing the
potential importance of reversible tyrosine phosphory-
lation in regulating cadherin function. Our primary
goal now is to examine the physiological function of
PT141, concentrating on endothelial cells (ECs) as a
model system.
CRYSTALLOGRAPHIC ANALYSES OF PTP
STRUCTURE AND REGULATION
All of our work on crystallographic analyses of mem-
bers of the PTP family is part of a long-standing col-
laboration with David Barford, formerly a Cold Spring
Harbor Fellow and now a member of the faculty of the
Laboratory of Molecular Biophysics, Oxford Univer-
sity. Recently, the crystal structure of a dimer of the
membrane proximal domain of RPTPa (RPTPa D1)
was described (Bilwes et al., Nature 383: 555 [1996]).
Within this structure, the catalytic site of each subunit
of the dimer is sterically blocked by the insertion of
the amino-terminal helix-turn-helix segment of the
dyad-related monomer. It was proposed that dimeriza-
tion would lead to inhibition of catalytic activity and
may provide a paradigm for the regulation of the
RPTP family. We have determined the crystal struc-
ture, to 2.3 A resolution, of RPTPR D1 which shares
46% sequence identity with that of RPTPa D1 .
Although the tertiary structures of RPTPa D1 and
RPTPli. D1 are very similar, with an r.m.s.d. between
equivalent Ca-atoms of 1.1 A, the quaternary struc-
tures of these two proteins are different. Neither the
catalytic site nor the amino-terminal helix-turn-helix
segment of RPTPII D1 participates in protein-protein
interactions. The catalytic site of RPT141, D1 is unhin-
dered and adopts an open conformation similar to that
of the cytosolic PTP, PTP1B. This suggests that dimer-
ization-induced modulation of RPTP activity may not
be a general feature of this family of enzymes.
Mechanisms by which the activity of PTPii, may be
regulated, including via association with the cad-
herin/catenin complex, are currently being investigat-
ed.
PTPs catalyze the dephosphorylation of phospho-
tyrosine residues via the formation of a transient cys-
teinyl-phosphate intermediate. We have examined the
mechanism of hydrolysis of this intermediate by gen-
erating a Gln-262 to alanine mutant of PTP that
allows the accumulation and trapping of the interme-
diate within a PTP1B crystal. The structure of the
intermediate at 2.5 A resolution reveals that a confor-
mationally flexible loop (the WPD loop) is closed over
the entrance to the catalytic site, sequestering the
phosphocysteine intermediate and catalytic site water
molecules and preventing nonspecific phosphoryl-
transfer reactions to extraneous phosphoryl-acceptors.
One of the catalytic site water molecules, the likely
nucleophile, forms a hydrogen bond to the putative
catalytic base, Asp-181. In the wild-type enzyme, the
nucleophilic water molecule would be coordinated by
the side chain of Gln-262. As a result of this analysis,
in combination with our previous structural data, we
can now visualize each of the reaction steps of the PTP
catalytic pathway.
A Genetic Analysis of
PTP Function
M. Gutch
We are using the nematode Caenorhabditis elegans as
a model system for a genetic analysis of PTP function.
The experiments are being performed in collaboration
with Michael Hengartner's group here at Cold Spring
Harbor. An attractive feature of C. elegans is that
many of the properties of its signaling pathways are
conserved with those found in mammals. Thus, the
lessons learned in C. elegans should be applicable to
humans.
We have generated C. elegans strains in which two
PTP genes, ptpl and ptp2, have been disrupted, pro-
ducing loss-of-function mutants. PTP-1 is a receptor
PTP containing three FN-III motifs in its extracellular
segment and two PTP domains in the intracellular por-
tion. We generated stable ptp-l-GFP transgenic
worms in which green fluorescent protein (GFP) is
expressed from the transcriptional regulatory
sequences of ptp -1. GFP was expressed early in devel-
opment (-100 cell stage) in a limited number of cells
and was restricted to the nervous system in larval and
adult hermaphrodites. We generated a Tc 1 transposon
insertion allele, op147::Tcl, in which Tc 1 was insert-
ed into the coding sequence for the membrane proxi-
mal PTP domain. This allele should generate a
catalytically inactive PTP. Homozygous op147::Tcl
hermaphrodites exhibit two incompletely penetrant
phenotypes. Approximately 5% of op147::Tcl
homozygotes are embryonic lethal and about 12.5%
are morphologically abnormal. The remainder are
phenotypically wild type. These incompletely pene-
trant phenotypes are reminiscent of a class of mutants
known as vab (variable abnormal). Recently, vab-1
was cloned and found to encode a receptor PTK with
similarity to the EPH family. We have generated a
double mutant with a weak vab-1 allele (e118), which
exhibits approximately 10% embryonic lethality.
Surprisingly, vab-1(e118) ptp-1(op147::Tc1) double
mutants show greater than 90% embryonic lethality,
with the remaining 10% arresting at variable stages of
development prior to the generation of viable self-
progeny. This enhancement of embryonic lethality
appears specific to vab-1, since double mutants
between ptp-1(op147::Tc1) and genes known to par-
ticipate in embryonic and/or neuronal development
(vab-2, mig-2, unc-4, unc-73) did not exhibit this
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effect. We will continue to characterize the expression
patterns of PTP-1, particularly from the perspective of
its genetic interaction with the VAB-1 PTK.
The ptp-2 gene encodes an SH2 domain-contain-
ing PTP. Using a Tcl transposon targeting strategy, we
isolated a recessive ptp-2 loss-of-function allele,
op194, which lacks the PTP domain. Homozygous
ptp-2(op194) hermaphrodites exhibit a completely
penetrant zygotic semisterile/maternal-effect lethal
phenotype, characterized by the presence of abnor-
mally large oocytes in the zygotic semisterile animals.
These phenotypes indicate that PTP-2 activity is
essential for proper oogenesis. Gain-of-function let-60
ras alleles rescued the defects associated with ptp-
2(op194), suggesting that LET-60 acts downstream of,
or in parallel to, PTP-2 during oogenesis. Although
ptp-2 function is not required for normal vulval devel-
opment, ptp-2(op194) altered significantly the vulval
phenotypes caused by mutations in several genes of
the inductive signaling pathway. The penetrance of the
multivulva phenotype caused by loss-of-function
mutations in lin-15, and gain-of-function mutations in
let-23 or let-60 ras, was reduced by ptp-2(op194).
Moreover, ptp-2(op194) increased the penetrance of
the vulvaless phenotype conferred by a weak loss-of-
function sem-5 allele. These data position PTP-2
downstream of LET-23 in the vulval induction sig-
naling pathway. Although PTP-2 functions to transmit
a requisite signal during oogenesis, PTP-2 function
during C. elegans vulval cell differentiation appears to
be directed at regulating the overall strength of the
inductive signal. Ultimately, we plan to initiate genet-
ic screens to identify components of the signaling
pathways regulated by these phosphatases.
Dual Specificity Phosphatases
and Growth Control
M.P. Myers, A. Bennett
This year, a new project was initiated in the lab. In
collaboration with the groups of Mike Wigler, here at
Cold Spring Harbor, and Ramon Parsons, at
Columbia, we have begun to characterize PTEN
(phosphatase and tensin homolog deleted from chro-
mosome 10), also known as MMAC1 (mutated in
multiple advanced cancers). PTEN is the product of a
candidate tumor suppressor gene from human chro-
mosome 10q23. Mutations have been observed in a
variety of tumor samples including glioblastoma,
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advanced prostate cancer, and endometrial cancer. In
addition, germ line mutations in PTEN have been
identified in three related, inheritable neoplastic disor-
ders, Cowden disease, Bannayan-Zonana syndrome,
and Lhermitte-Duclos disease, which give rise to mul-
tiple benign tumors and an increased incidence of
malignant cancers. When PTEN was first isolated by
the Wigler and Parson labs, they noted the homology
with tensin and the presence of the signature sequence
motif that characterizes the PTP family. This was an
exciting result because it suggested PTEN may have a
defined enzymatic function-protein dephosphoryla-
tion. Furthermore, in light of the critical role that tyro-
sine phosphorylation is known to have in oncogenesis,
it has long been suggested that PTPs would act as
tumor suppressors. Nevertheless, PTEN is the first
member of the PTP family to be implicated as a bona
fide tumor suppressor. Obviously, characterization of
the physiological function of PTEN will provide crit-
ical insights into how normal cellular signaling events
are subverted in cancer. We have now shown that
PTEN does possess intrinsic phosphatase activity and
that it is a member of the dual specificity family of
PTPs. Many point mutations in PTEN have been
detected that are associated with neoplastic disease.
We have demonstrated several examples in which
these are detrimental to phosphatase activity, again
highlighting the importance of the enzymatic function
of PTEN for its ability to serve as a tumor suppressor.
PTEN displays a marked preference for highly acidic
substrates in vitro, suggesting that its physiological
substrates also will be acidic. The search for such
physiological substrates is currently a major focus of
effort.
We are continuing our work on MKP-1, a highly
selective phosphatase that dephosphorylates and inac-
tivates members of the MAP kinase family of
enzymes in vivo. The MAP kinases have been impli-
cated as common and essential components of signal-
ing pathways induced by diverse stimuli, suggesting
that MKP-1 will be a crucial, central player in the con-
trol of cell function. We have been using MKP-1 as a
molecular probe with which to examine physiological
functions of the MAP kinases, particularly in the con-
text of skeletal muscle differentiation. The myoblast
cell line, C2C12, proliferates in high serum but differ-
entiates into multinucleated myotubes upon mitogen
deprivation. We have shown that ectopic expression of
MKP-1, from a tetracycline-regulated promoter, in the
presence of high serum leads to up-regulation of
expression of muscle-specific genes (MyoD, myo-
genin, myosin heavy chain). Thus, expression of mus-
cle-specific genes could be induced in vivo by inhibi-
tion of MAPK. However, myotube formation was not
observed. This indicates that muscle-specific gene
expression is necessary but not sufficient to commit
differentiated myocytes to form myotubes and sug-
gests a previously unexpected role for a member of
the MAPK family in the late stages of skeletal muscle
differentiation.
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THE CYTOSKELETON IN NORMAL AND TRANSFORMED CELLS
D.M. Helfman C. Berthier
C. Chen
J. Grossman
A.J. Rai
M. Selvakumar
A. Vaahtokari
Y.-C. Wang
Our laboratory studies the expression, structure, and
function of cytoskeletal components in normal and
transformed cells. We are interested in how specific
actin assemblies are organized and regulated and how
alterations in actin filament assembly contribute to
aberrant cell growth. Actin filaments have an impor-
tant role in cell movements, muscle contraction, cell
division, intracellular transport, and regulation of cell
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shape and adhesion. In addition, mounting evidence
suggests that cellular contractility is involved in adhe-
sion-mediated signaling. Eukaryotic cells contain
three major filamentous systems involved in
cytoskeletal structure: actin filaments, intermediate
filaments, and microtubules. Each of these filamen-
tous systems contains a number of different protein
components, although different cell types and tissues
express specific protein isoforms that comprise these
structures. We are investigating the regulation and
function of the cytoskeletal isoform diversity generat-
ed by alternative splicing. We are studying dynamic
and stable macromolecular assemblies of distinct actin
structures that are characteristic of specific cell types,
for example, stress fibers, lamellipodia, filopodia, and
contractile ring in fibroblasts or sarcomeres in skeletal
muscle, to determine if specific isoforms are required
for the assembly and regulation of specific structures.
These distinct actin assemblies form by the combina-
tion of different structural components and regulatory
factors. We are also interested in how the assembly of
different cytoskeletal structures is regulated by extra-
cellular signals, and how cellular contractility con-
tributes to signaling cascades that lead to focal adhe-
sion formation and regulation of adhesion-dependent
signal transduction. Below is a description of our stud-
ies during the past year.
Regulation and Role of Cell
Contractility in
Adhesion-dependent Signaling
D. Helfman, C. Berthier [in collaboration with A. Bershadsky,
Weizmann Institute of Science, Rehoyot, Israel]
Adhesion of cells to the extracellular matrix (ECM)
and neighboring cells has a critical role in various cel-
lular processes linked to transformation, including dif-
ferentiation, growth, motility, and survival. Adhesion
of cells to the ECM via transmembrane receptors of
the integrin family induces a rapid sequence of cyto-
plasmic protein events, including assembly and post-
translational modifications, e.g., formation of micro-
filament bundles and phosphorylation of junctional
plaque proteins. The molecular components for these
signaling events include cell adhesion receptors, their
interaction with the cytoskeleton via specific junction-
al plaque proteins, and the recruitment to these sites of
a number of regulatory molecules including kinases
and phosphatases. Recent studies demonstrate an inti-
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mate association between the organization and expres-
sion of cytoskeletal proteins and their function in sig-
naling in conjunction with the adhesion molecules and
soluble growth factors. The loss of adhesion-depen-
dent cell regulation is a characteristic property of
transformed cells and may be attributed in part to
alterations in the integrity of the cytoskeleton. These
events are responsible for adhesion-induced structural
alterations (formation of focal contacts and the associ-
ated actin microfilament bundles) and also affect
major cellular processes including proliferation, dif-
ferentiation, and cell survival. Although certain steps
in this signaling cascade are well characterized, for
example, tyrosine phosphorylation of focal adhesion
kinase (FAK), paxillin, and p130'', the complete
mechanism of adhesion-dependent signaling is not
well understood. In addition to attachment to the
appropriate ECM, the activation of adhesion-depen-
dent signaling requires, as a rule, costimulation by sol-
uble ligands (serum factors), whose effect is mediated
by the activation of the small GTP-binding protein
Rho. Rho activates cellular contractility through acti-
vation of Rho-associated kinase (Rho-kinase) that
phosphorylates, and thereby activates, the regulatory
light chain of myosin II (MLC) and inactivates MLC
phosphatase.
To investigate the role of cell contractility in adhe-
sion-dependent signaling, we have studied the effects
of forced expression of caldesmon on the adhesion-
dependent formation and tyrosine phosphorylation of
focal adhesions. Caldesmon is an actin-, myosin-,
tropomyosin-, and Ca"-calmodulin-binding protein
known to inhibit the actin-activated ATPase activity
by phosphorylated myosin H and can block myosin-II-
driven motility of actin filaments in vitro. Caldesmon-
mediated inhibition of the actin-dependent myosin II
ATPase can be released by Ca"-calmodulin and pos-
sibly by some other high-affinity Ca"-binding pro-
teins. Thus, caldesmon is a potential tool for the regu-
lation of myosin-II-driven contractility, independent
of MLC phosphorylation.
We found that overexpression of nonmuscle
caldesmon in cultured human fibroblasts blocks cell
contractility in a Ca"-sensitive manner and efficiently
prevents the assembly of focal adhesions and stress
fibers induced either by microtubule disruption or by
expression of activated Rho. These results demon-
strate that an increase in contractility is an indispens-
able step in these adhesion-dependent signaling
processes.
Our results also suggest a physiological role for
caldesmon in the regulation of cell contractility and
adhesion-dependent signaling. It has been shown in
some cases that changes in fibroblast contractility may
proceed without concomitant changes in the level of
myosin light chain phosphorylation, implying down-
stream regulation. Caldesmon would appear to be a
good candidate for such regulation. It is known that
caldesmon can be phosphorylated by different ser-
ine/threonine kinases, including MAP kinase and
p34"c2, and can be phosphorylated on tyrosine
residues in vivo. This phosphorylation may act to inte-
grate a variety of signaling pathways in their effect on
cell contractility, which in turn can affect adhesion-
dependent signaling as shown in our study.
Tropomyosin is a natural partner of caldesmon in
its regulation of actomyosin-based contractility. In
nonmuscle cells, the diversity of tropomyosins is very
large and caldesmon specifically interacts with certain
isoforms, the biological significance of which remains
unclear. The spectrum of tropomyosin expression
t=23
FIGURE 1 Dynamic localization of TM-5 during cell division. The localization of GFP-
TM5 (NM1) was followed during cytokinesis by time-lapse video microscopy. NIH-
3T3 fibroblasts stably expressing GFP-TM5 (NM1). The data show that GFP-
TM5(NM1) is diffusely distributed into the cytoplasm of dividing cells before cytoki-
nesis. During cytokinesis, GFP-TM5(NM1) progressively incorporates into the region
of the contractile ring.
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undergoes significant changes upon neoplastic trans-
formation. Moreover, we and others have shown that
transformation can be reversed in some cases by
forced expression of particular tropomyosin isoforms.
Disruption of adhesion-dependent signaling is a very
characteristic feature of neoplastic transformation;
such cells often display anchorage independence,
growing and dividing in suspension without ECM
contact. Based on our results demonstrating an ability
of caldesmon to regulate adhesion-dependent signal-
ing, we suggest that its interaction with specific
tropomyosins could be important in maintaining the
normal signaling function in the cell. Studies are in
progress to determine how contractility leads to
enhanced focal adhesion formation and what role
tropomyosin and caldesmon has in the signaling cas-
cades associated with adhesion-mediated signal trans-
duction events.
Distribution of Tropomyosin
Isoforms in Distinct and
Dynamic Actin-containing
Cytoskeletal Structures
C. Berthier
In nonmuscle cells, formation of actin filaments and
their assembly into a variety of structures are regulat-
ed and dynamic processes that involve severing, poly-
merization/depolymerization cycles, and stabilization
by actin-binding proteins. Several lines of biochemical
evidence have suggested that nonmuscle tropo-
myosins (TMs) could be involved in the stabilization
of actin filaments. The multiplicity of TM isoforms in
one single cell (e.g., seven isoforms per fibroblast)
raises the possibility that specific associations of given
isoforms are required for the formation, stabilization,
or regulation of specific actin-based structures in non-
muscle cells. This project was designed with regard to
the following questions: (1) Do different TM isoforms
achieve their function by binding to spatially distinct
subsets of actin filaments, (2) how is the localization
of the TMs restructured during dynamic cellular
events, and (3) is the incorporation of TMs into actin
filaments in vivo regulated by cooperative interactions
between isoforms and is it subject to direct or indirect
regulation by signaling molecules?
We have established stable cell lines of NIH-3T3
fibroblasts expressing fusion proteins of TM isoforms
and green fluorescent protein (GFP). The subcellular
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distribution and the dynamic behavior of the GFP-
tagged TMs have been investigated on living cells
using fluorescence CCD-camera microscopy and
time-lapse recording. Our experiments demonstrate
that some differences exist between the localization of
different GFP-TM fusions: TM-1, -2, and -5 appear to
better incorporate into actin stress fibers than the low-
molecular-weight TM-4, which is present in filopodia.
Moreover, recording of cells undergoing mitosis
showed an accumulation of low-molecular-weight
isoforms at the contractile ring (Fig. 1). These results
suggest that specific TM isoforms are involved in a
different subset of actin filaments, and experiments
are in progress to further characterize the dynamic
localization of the different TM isoforms in various
aspects of cellular motility.
Using cotransfection of tagged proteins followed
by immunofluorescence, we are also currently inves-
tigating the cooperative interactions between TM iso-
forms and the role of caldesmon and the small
GTPases in normal and transformed cells. Results
strongly suggest that caldesmon, which has been
shown to inhibit cellular contractility, helps the bind-
ing of TMs to actin filament bundles. We are in the
process of determining if caldesmon can have a role in
promoting the binding of specific isoforms to actin fil-
aments as in vitro results suggested and if specific TM
isoforms are able to regulate caldesmon function.
Moreover, the role of the small GTPases in the incor-
poration of TM isoforms into filopodia, lamellipodia,
and stress fibers is also under study. Several reports
have shown that expression of TMs is altered in trans-
formed cell lines, and we anticipate that our study will
give new insights into the role of TMs in the actin
cytoskeleton of cancerous cells.
Identification and Characterization
of a Novel Tropomyosin-binding
Protein from Nonmuscle Cells
A.J. Rai
Tropomyosin (TM) was first identified in 1948 by
Bailey as a component of the actin-rich thin filament
of muscle cells. Since its discovery 50 years ago,
much work has been done in elucidating its function
in muscle cells, which is in conjunction with the tro-
ponin complex, to serve as a calcium-sensitive regula-
tor of actin-myosin-based contraction. However, it
was not until almost three decades later that investiga-
tors realized TM is found in virtually all eukaryotic
cells and that nonmuscle cells express a multiplicity of
different yet related TM isoforms. It is the functional
significance of this isoform diversity that is poorly
understood and still remains enigmatic.
To address this question, we have sought to iden-
tify novel TM-binding proteins from nonmuscle cells.
We have conducted a two-hybrid screen with a He La
cell library and have identified several interacting
clones. One of these clones is particularly interesting
in that it exhibits isoform-specific binding. The cDNA
encodes a small protein of approximately 150 amino
acids. We have constructed the GST fusion of this pro-
tein and have been able to demonstrate in vitro bind-
ing using Far Western blotting. Furthermore, we have
been able to epitope tag this cDNA and transfect it
into human fibroblasts. Antibodies to the epitope tag
reveal a punctate and filamentous staining pattern.
BLAST searches using the encoded protein sequence
identify an EST from Drosophila which is 33% iden-
tical at the amino acid level. We are in the process of
raising antibodies to bacterially produced recombi-
nant protein. Isolation of these reagents will prove to
be particularly useful in the further characterization
and elucidation of function of this novel protein.
Regulation of Alternative
Splicing of Tropomyosin RNA
in Epithelial-Mesenchymal
Transition
A. Vaahtokari
Several different protein products can be produced
from a single gene by alternative RNA splicing. The
regulation of this cellular process is poorly under-
stood, despite its importance in the control of gene
expression. TMs are a family of actin-binding proteins
known to be involved in the regulation of contractili-
ty in muscle and nonmuscle cells. Because epithelial
and mesenchymal cells express different splicing
forms of TMs, we have begun to study the regulation
of alternative splice site selection of TMs during
epithelial-mesenchymal (E-M) transition. E-M transi-
tion is a crucial process in both cancer metastasis and
embryonic development, e.g., during mesoderm for-
mation and organogenesis. Recently, there has been
considerable progress in discovering growth factors
and other signaling molecules that regulate transition
of epithelial cells into mesenchymal cells. Studies of
TM isoform switching provide a model system for
identifying factors that regulate E-M transition.
Human IMR-90 fibroblasts and U-2 OS
osteogenic sarcoma cells transfected with the retro-
virus that contains the adenovirus early region lA
(E1A) 12S oncogene are used as model systems, as it
is known that E1A induces epithelialization of these
cells in vitro. In addition, cells transfected with mutant
forms of E1A 12S are used; one of the mutants is
unable to bind retinoblastoma (Rb) protein, and one is
defective in binding p300, which is a nuclear phos-
phoprotein homologous to CBP. The transfected cells
are from Andrew Samuelson (Scott Lowe's laborato-
ry, CSHL). Expression patterns of high-molecular-
weight TMs were studied by Western blot analysis
using whole-cell extracts from nontransfected IMR-
90 cells and IMR-90 cells transfected with either an
empty vector, 12S, or 12S mutants. In 12S-transfected
cells, the expression of TM-2 and TM-4 splicing iso-
forms was down-regulated. The same result was
observed in cells transfected with the 12S mutant that
cannot bind Rb, whereas the cells transfected with the
mutant form of 12S that is unable to bind p300 had the
same pattern of TM expression as the nontransfected
cells. Thus, p300 may be involved in the control of
alternative splice site selection of TMs.
The possible role of p300 in the regulation of
alternative splicing of TMs will be further studied by
using p300 constructs that do not bind E1A 12S pro-
tein, and by overexpressing p300. In addition, specif-
ic inhibitors will be used to block signaling pathways
(transforming growth factor-(3, epidermal growth fac-
tor, hepatocyte growth factor, Wnt, E-cadherin) that
are known to be involved in E-M transition, and their
effects on alternative RNA splicing of TMs will be
analyzed. These studies will hopefully increase our
understanding of the extracellular signaling molecules
and intracellular signaling pathways that are involved
in the regulation of alternative splice site selection.
The Mechanism of Blocking
the Use of a Skeletal Muscle
Exon in Nonmuscle Cells
C. Chen
We have been using rat 0-tropomyosin as a model sys-
tem to study the mechanism of alternative splicing.
The rat 13-tropomyosin gene consists of 11 exons; two
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exon pairs are alternatively spliced. Fibroblast and
smooth muscle TM-1 uses exon 6 and exon 11, and
skeletal muscle I3-TM uses exon 7 and exon 10. We
are interested in the alternative splicing of the internal
exon pair, exon 6 and exon 7, which is mutually and
exclusively spliced. Our previous data demonstrated
that the splicing of a minigene containing exons 5-9
reflected that of the endogenous gene in He La cells, in
which exon 6 was exclusively spliced to the common
exons 5 and 8, and exon 7 was excluded. Using this
substrate, we also demonstrated that at least two cis-
acting elements were involved in the down-regulation
of exon 7 splicing in nonmuscle cells. One element,
which was designated as intron-regulatory element
(IRE), is located in intron 6. Another element is locat-
ed in the upstream region of exon 7. The ex-1 muta-
tion, in which the element in the exon sequence is
mutated, completely switches exon usage, in which
the skeletal muscle exon 7 was used and the nonmus-
cle 6 excluded in nonmuscle cells in vivo.
We have further analyzed how and why the ex-1
mutation results in the use of muscle-specific exon in
a nonmuscle environment. By using a pair of simple
substrates that reflect the behavior of the ex-1 muta-
tion, we have ruled out the possibilities that the effect
of the ex-1 mutation is due to the creation of an
enhancer element or that a secondary structure is
involved. By using the UV-cross-linking assay, we
found that the ex-1 mutation disrupted the binding of
a putative suppressor, which we have identified as
hnRNP H. The binding of hnRNP H to RNAs is spe-
cific because it can be competed out by the wild-type
RNA, but not by the mutant RNAs. Work is in
progress to further characterize the involvement of
hnRNP H in the regulation of the rat I3-tropomyosin
gene alternative splicing.
Characterization of an Activity in
Myogenic Cells That Stimulates
Splicing of ii-TM Exon 7
Y.-C. Wang
Exons 6 and 7 of the 13-TM gene are mutually exclu-
sive. During the processing of I3-TM pre-mRNA, exon
7 is included in the splice product in skeletal muscle
cells, whereas exon 6 is used in nonmuscle and
smooth muscle cells. Previous studies suggest that
muscle-specific splicing of exons 5-7 is suppressed in
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He La cells by a negative factor. To understand how
skeletal muscle cells regulate exon 7 splicing, we have
used mouse myogenic cells to study the cis-acting ele-
ments and the trans-acting factors involved in regula-
tion.
Using an in vitro splicing assay comprising the
293 cell (nonmuscle) nuclear extract complemented
by the mouse BC3H1 cell (muscle) nuclear extract, we
have observed an activity that stimulates exon 5-7
splicing in the BC3H1 nuclear extract. This splicing
activity was detected in a fraction of 25-50% ammo-
nium sulfate precipitate followed by precipitation in
20 mm MgC12. Therefore, although we previously
showed that purified He La SR proteins facilitated
exon 5-7 splicing in BC3H1 nuclear extracts, SR pro-
teins might not be the only factors involved in the
splicing because they were in the 60-90% ammonium
sulfate precipitate. To further characterize this activity,
we fractionated BC3H1 nuclear extract over a CsC1
density gradient and tested the fractions for the exon
5-7 splicing activity in the complementation assay
with the 293 nuclear extract. An activity peak was
detected coinciding with the peak of SR proteins but
not U2AF, another general splicing factor essential for
3' splice site recognition. When He La SR proteins
were added to all fractions to relieve the limit of SR
proteins, so that we could detect the presence of the
other essential factor(s), the activity peak was extend-
ed three fractions toward the top of the gradient.
To identify cis-actin elements required for splice
site selection, we have transfected the mouse BC3H1
myogenic cells and several nonmuscle cell lines,
including He La, 293, and NIH-3T3 cells, with a
chimeric minigene that contains I3-TM exon 7 and por-
tions of its flanking introns inserted between two ade-
noviral exons of the major late transcription unit.
Although exon 7 was excluded in the splice product of
this minigene in all the nonmuscle cells tested, BC3H1
cells showed detectable levels of exon 7 inclusion
product. These data suggest that exon 7 and its flank-
ing intron sequences contain the cis-acting elements
that are, at least in part, responsible for the muscle-
specific regulation of exon 7. We thus used an RNA
probe containing these sequences in a UV-cross-link-
ing assay to detect protein factors that are bound to the
probe in the BC3H1 nuclear extract or its active frac-
tions. Among the proteins detected, at least one of 70
kD showed specific cross-linking in the active fraction
as well as in the whole BC3H1 nuclear extract, but not
in the 293 nuclear extract. Work is in progress to fur-
ther characterize these proteins and their exact roles in
the regulation of exon 7 splicing in myogenic cells.
Exon Sequences and
Commitment to Splicing
M. Selvakumar
Previous studies showed that the 3' splice site of exon
6 (nonmuscle/smooth muscle exon) in 3 -TM pre-
mRNA can be utilized only if a previous splicing
event joins exons 6 and 8 together. Thus, we showed
that exon sequences can contribute to splice site selec-
tion. Studies in other systems such as immunoglobu-
lin and troponinT pre-mRNAs have identified purine-
rich motifs as an important subset of exonic splicing
enhancers (ESE). These ESEs are believed to act as
binding sites for splicing factors such as SR proteins.
Examination of sequences within exons 6 and 8
revealed the presence of two purine-rich motifs in
exon 6 (6-1, 6-2) and three purine-rich motifs in exon
8 (8-1, 8-2, and 8-3) of the general consensus GAR-
GARGAR. Substitution mutagenesis of these motifs
to TARGCRTAR have shown that they are required
for the 3' splice site usage of exon 6. We see that indi-
vidual motifs have different effects, with 6-1, 6-2, and
8-2 being the most robust elements. Wild-type exon
sequences, but not mutant exon sequences (mutated at
6-1, 6-2, and 8-2), can also specifically compete splic-
ing of the wild-type pre-mRNA substrate. We used
wild-type and mutant exon sequences as probes for
UV-cross-linking in an effort to look for RNA:protein
interactions. Our results have shown that SF2/ASF, a
CELL BIOLOGY OF THE NUCLEUS
D.L. Spector S. Huang A. Miner
P. Lorenz T. Howard
T. Misteli J. McCann
P. Mintz
Studies in our laboratory are focused on the structur-
al-functional organization of the mammalian cell
nucleus. Our research program evolves around under-
standing the nuclear organization of factors associat-
ed with pre-mRNA splicing and the RNA substrates
with which these factors interact. The microscopy
core facility has been used extensively during the past
year and numerous collaborations are under way with
the excellent technical expertise of Tamara Howard.
member of the SR protein family, shows much higher
affinity to the wild-type exon sequences. Moreover,
SF2/ASF can rescue the splicing of wild-type pre-
mRNA in a competition assay. Using spliceosome
assembly assays, we observed that the mutant pre-
mRNA substrates are blocked at the E complex, one of
the earliest steps in splicing that determine if a pre-
mRNA can be committed to splicing. Thus, we have
shown that there are several ESEs in exons 6 and 8
that act by binding to an SR protein, specifically SF2,
thereby committing the exon to splicing. We also see
that these ESEs promote not only 3' splice site usage
of exon 6, but also 5' splice site usage (that is, in join-
ing exons 6 and 8 together), both in vitro and in vivo.
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The Cellular Organization
of Pre-mRNA Splicing
T. Misteli, D.L. Spector
Actively transcribed genes are found throughout the
nucleoplasm in mammalian cells. In contrast, essential
factors required for one of the first RNA processing
steps, pre-mRNA splicing, are concentrated in 20-40
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distinct nuclear domains, termed speckles. The func-
tion of nuclear speckles is unknown. To investigate the
behavior of nuclear speckles in vivo, we have visual-
ized pre-mRNA splicing factors in the nuclei of living
cells by fusing the autofluorescent green fluorescent
protein (GFP) to pre-mRNA splicing factors. The
fusion proteins are fully functional in vivo and can be
detected by fluorescence microscopy in living cells.
Using time-lapse fluorescence microscopy, we have
demonstrated that pre-mRNA splicing factors specifi-
cally responded to transcriptional activation of single
genes, by recruitment from speckles and accumulation
at sites of active transcription. These observations
demonstrate that transcription and pre-mRNA splicing
are spatially tightly coordinated in vivo by a recruit-
ment mechanism and suggest that the splicing factor
domains are storage sites for pre-mRNA splicing fac-
tors. Other events such as preassembly of spliceoso-
mal complexes or assembly of transcription/RNA pro-
cessing complexes might also occur in these nuclear
compartments.
We have investigated the molecular mechanism
for this recruitment process using mutational analysis
of several pre-mRNA splicing factors of the SR fami-
ly of proteins. A recruitment assay was developed in
which the ability of splicing factor mutants to be
recruited to the stably expressed and inducible PEM
gene can be monitored. We find that recruitment of
splicing factors from nuclear storage/reassembly sites
is likely a multistep process involving multiple protein
domains. Using deletion mutants of SR proteins
SF2/ASF, SRp40, SC35, and SRp20, we find that dis-
sociation of splicing factors from nuclear speckles is
mediated by the RS domain, whereas association of
the protein with the target RNA involves the RNA-
binding domains. Specifically, phosphorylation of the
characteristic RS domain of SR proteins is required for
efficient recruitment of splicing factors to transcrip-
tion sites, and we suggest that phosphorylation of ser-
ine residues in the RS domain acts as a switch for the
release of SR proteins from speckles. These findings
indicate that protein phosphorylation coordinates tran-
scription and pre-mRNA splicing in vivo. The data are
consistent with the recent identification of kinases that
specifically phosphorylate the RS domain of SR pro-
teins and, by doing so, cause the release of splicing
factors from splicing factor compartments (for a
review, see Misteli and Spector 1997). Furthermore,
we have previously demonstrated that a serine/threo-
nine phosphatase I activity has the opposite effect,
namely, the accumulation of splicing factors in nuclear
domains. These findings allow the formulation of a
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working model in which the cyclic phosphorylation
and dephosphorylation of SR protein splicing factors
determine their nuclear localization and thus, the
availability of splicing factors at sites of transcription.
We are currently further investigating the molecular
mechanisms of how the distribution of splicing factors
is controlled in the mammalian cell nucleus by use of
microscopy and molecular techniques.
Biochemical Characterization of
Nuclear Splicing Factor Pools
A. Miner (Undergraduate Research Program),
T. Misteli, D.L. Spector
Fluorescence and electron microscopy studies from
our lab and others have firmly established that splicing
factors are distributed in at least two morphologically
distinct pools in the cell nucleus: One fraction of splic-
ing factors is in nuclear speckles and a second fraction
appears diffusely distributed throughout the nucleo-
plasmic space. We have set out to determine the bio-
chemical properties of these two pools and to possibly
distinguish additional biochemical pools. To this end,
we have developed a standardized growth and extrac-
tion procedure for cultured human fibroblasts. He La
cells are grown in suspension and extracted with deter-
gent and increasing concentrations of NaC1, the solu-
ble and particulate fractions for each sample are recov-
ered, the proteins are separated by electrophoresis, and
the distribution of particular splicing factors is deter-
mined qualitatively and quantitatively by Western
blotting using specific antibodies. We established that
SR proteins, small nuclear ribonucleoproteins
(snRNPs), and heterogeneous nuclear RNPs (hnRNPs)
have distinct salt-extraction profiles, and we con-
firmed the presence of at least two nuclear fractions of
SR proteins and snRNPs, in vivo. One fraction is sol-
uble and most likely corresponds to the diffusely
localized pool, and the second fraction is salt-resistant,
representing the pool associated with nuclear speckles.
In cells where transcription was inhibited by a-aman-
itin, a specific inhibitor of RNA polymerase II, all
classes of splicing factors appeared to be more solu-
ble, most likely due to the dissociation of splicing fac-
tors from nascent transcripts. From the observed shift,
we estimated that at any given time, between 10% and
30% of total pre-mRNA splicing factors are associat-
ed with nascent transcripts. A similar increase in solu-
bility was observed for SR protein SF2/ASF upon
treatment of cells with inhibitors of protein phos-
phatases. This is consistent with the observation that
SF2/ASF is heavily phosphorylated in vivo and that
phosphorylation promotes its dissociation from splic-
ing factor domains. In contrast, two less phosphorylat-
ed splicing factors, hnRNP Al and U2-B", were not
affected by the phosphatase treatment. These observa-
tions demonstrate that splicing factors exist in multi-
ple, morphologically and biochemical distinct pools in
the cell nucleus and that distinct classes of splicing
factors have distinct biochemical properties. The
developed approach will be valuable for further bio-
chemical characterization of splicing factors in vivo.
Purification and Characterization of
Interchromatin Granule Clusters
P. Mintz, D.L. Spector
Immunofluorescence studies using antibodies directed
against pre-mRNA splicing factors have revealed a
speckled pattern and diffuse nucleoplasmic labeling in
the nucleus. It has been shown by electron microscopy
that the speckled regions are composed of two struc-
tures: interchromatin granule clusters (IGCs) and
perichromatin fibrils (PFs). The biochemical composi-
tion of these nuclear structures is not known. Immu-
nocytochemical studies have shown that the IGCs are
enriched with pre-mRNA splicing factors.
Biochemical studies have shown that the IGCs are
resistant to nuclease digestion, high salt, and detergent
extractions. Although the IGCs have been shown to
provide pre-mRNA splicing factors to sites of active
transcription, it is unclear what other roles they may
have in RNA metabolism. In addition, the architectur-
al framework of the IGCs is not known. Therefore, it
has become extremely important to isolate and bio-
chemically characterize the IGCs in order to better
understand their involvement in RNA metabolism.
We have developed a protocol to isolate the IGCs
from mouse liver. Mice are treated with a-amanitin
which inhibits transcription by specifically binding to
the large subunit of RNA polymerase II. This drug was
used in order to enrich for IGCs. Previous studies have
shown that the IGCs conglomerate into a few large
clusters when cultured cells or animals are treated with
a-amanitin. Mouse liver nuclei were isolated using a
sucrose gradient to separate the different organelles
based on their density. The isolated nuclei were first
treated with detergent to remove the inner and outer
nuclear membrane. Next, the chromatin was digested
with DNase I and extracted with high salt. After the
DNase I and salt treatment, the residual nuclei con-
tained the nuclear lamins and a few large clusters of
IGCs as well as internal nuclear matrix elements. The
IGCs were released from the residual nuclei by shear-
ing through a needle. The homogenate was fractionat-
ed using a Cs2SO4 gradient. Samples were taken from
all the stages in the protocol and examined by electron
microscopy for purity and morphological characteri-
zation. The Cs2SO4 pellet contained mostly nuclear
lamins and nuclear matrix elements, whereas the
Cs2SO4 supernatant contained the IGCs. The purified
interchromatin granules measured between 20 and 26-
nm in diameter. Immunogold labeling was performed,
with a monoclonal antibody that recognizes a family
of SR proteins, on the final fraction (IGC fraction) to
verify that it contained splicing factors. The immuno-
gold-conjugated antibodies labeled the purified IGCs.
We are currently performing biochemical analyses to
identify known marker proteins in all of the fractions
and to identify novel IGC-associated proteins.
Involvement of the Perinucleolar
Compartment in Transcription
S. Huang, D.L. Spector [in collaboration with T.J. Deerinck
and M.N. Ellisman, UCSD Microscopy and Imaging
Resource]
The perinucleolar compartment (PNC) is a unique
nuclear structure localized at the periphery of the
nucleolus and is predominantly present in transformed
cells. Several small RNAs transcribed by RNA poly-
merase III and two hnRNP proteins have been local-
ized in the PNC (Getti et al., Nucleic Acids Res. 20:
3671 [1992]; Matera et al., J. Cell Biol. 121:
1181[1995]; Timchenko et al., Nucleic Acids Res. 24:
4407 [1996]). The PNC is a dynamic structure that
dissociates at the beginning of mitosis and reforms
early in G1.
To resolve the three-dimensional organization of
the PNC at high resolution, we examined PNCs in ser-
ial thin sections of optimally fixed He La cell nuclei by
electron microscopy. The sections were not post-
stained and the PNC was readily distinguishable from
the nucleolus. Images acquired from the same nucleus
were aligned and a three-dimensional model was
reconstructed by using the programs SYNU and
SynuRender (Fig. 1). The model reveals a reticulated
mesh associated with a portion of the nucleolar sur-
face. Variability in the shape, size, and association of
the PNC with the nucleolus was observed. In some
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cases, the PNC was predominantly positioned on the
surface of the nucleolus (Fig. 1, top row), whereas in
other cases, the PNC appeared to extend into the
nucleolus like a plug (Fig. 1, middle row). Occasion-
ally, the nucleolus itself extended into the PNC (Fig. 1,
bottom row). The variability in the association
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between the PNC and the nucleolus may represent dif-
ferent conformations of a dynamic nuclear structure.
On the basis of the abundance of RNAs and RNA-
binding proteins in the PNC, we were interested in
examining whether the PNC is involved in transcrip-
tion. In situ Br-UTP incorporation experiments were
FIGURE 1 Stereopairs of three-dimensional models showing the association between the nucle-
olus (larger structure) and the perinucleolar compartment (smaller structure). Stereoglasses
can be used to observe the three-dimensional organization of these structures.
performed to evaluate the transcriptional activity of
the PNC. Simultaneous detection of transcription
sites and the PNC demonstrated that the PNC coin-
cides with sites of transcription. In fact, the Br-UTP
incorporation was more prominent in the PNC than in
the majority of the nucleoplasmic volume. The incor-
poration of Br-UTP is reduced when RNA poly-
merase II and/or III activity is inhibited, but it is not
significantly affected when RNA polymerase I activ-
ity is inhibited. The structure of the PNC is altered
upon the inhibition of RNA synthesis for 2-5 hours in
cultured cells, suggesting that the integrity of the
PNC is dependent on ongoing transcriptional activity.
In addition, RNA polymerase II and pre-mRNA pro-
cessing factors including splicing factors (snRNPs
and SC35) and 3'-end processing factors (poly[A]-
binding protein II), as well as poly(A)* RNA are
detected in the PNC. Together, these findings support
the idea that the PNC is involved in active transcrip-
tion. Studies are currently under way to identify the
RNAs synthesized in the PNC and the function of this
nuclear compartment.
Nucleocytoplasmic Transport of
Antisense Oligonucleotides
P. Lorenz, D.L. Spector [in collaboration with B.F. Baker
and C.F. Bennett, ISIS Pharmaceuticals]
Antisense phosphorothioate oligonucleotides (PS-
ONs) designed to specifically inhibit the expression
of their target genes have recently entered clinical tri-
als. However, it is still a matter of debate as to where
within a cell the antisense activity is exerted. In an
attempt to better define the cell biology of these com-
pounds, we observed that the majority of PS -ONs
localize to the cell nucleus under conditions of spe-
cific antisense activity. Their nuclear distribution con-
sists of simple nuclear bodies set against a diffuse
nucleoplasmic background (Lorenz et al., Mol. Biol.
Cell [in press]). Although their steady-state distribu-
tion is in the nucleus, PS-ONs are not restricted to this
compartment: We observed that these molecules
underwent active nucleocytoplasmic transport, mov-
ing out of and into the nucleus. Thus, PS-ONs shuttle
similar to such nuclear proteins as the ImRNP-A 1
protein. The shuttling of PS-ONs was temperature-
sensitive and energy-dependent and was abolished by
addition of wheat germ agglutinin, an inhibitor of
nuclear pore complex-mediated transport processes.
As a test system, we used naturally occurring binu-
cleate cells or heterokaryon fusions which were
microinjected with fluorochrome-tagged PS-ONs. We
were able to abolish the inhibitory effect of wheat
germ agglutinin by coinjection of an excess of unla-
beled PS -ONs, suggesting that we competitively
inhibited the nuclear-pore-mediated active PS-ON
transport. This provided evidence for a saturable, car-
rier-mediated transport process. An RCC1-negative
mutant cell line did not export poly(A)* RNA but
failed to show any influence on PS-ON shuttling.
Inhibition of RNA polymerase II transcription also
had no effect on shuttling. Therefore, it is not likely
that mRNA export and PS-ON export are coupled.
Export of a GFP-NES reporter protein was not inhib-
ited by an excess of PS-ONs. On the other hand, a
dominant-negative mutant form of the Ran protein
involved in nucleocytoplasmic export, RanT24N, not
only inhibited the export of GFP-NES, but also strong-
ly decreased the nuclear export of PS -ONs. The kinet-
ics of nucleocytoplasmic shuttling of PS -ONs were
rather slow: Maximal accumulation of the oligonu-
cleotides in the second nucleus in a binucleate cell was
seen 2 hours after injection. Therefore, our observa-
tions suggest an indirect effect of the RanT24N mutant
on PS-ON shuttling rather than a direct link to the Ran
export pathways.
When an antisense PS-ON was injected into one
nucleus of binucleate cells and a plasmid encoding the
target gene into the other nucleus 2 hours later, the tar-
get gene expression was significantly reduced. This
indicated that a shuttling PS-ON still had antisense
activity. Taken together, our studies revealed the
dynamic behavior of PS-ONs which must be taken
into account when considering the sites of action of
antisense oligonucleotides of this chemistry within the
cell.
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INITIATION AND TERMINATION OF TRANSCRIPTION IN HUMAN
snRNA GENES AND HIV-1
N. Hernandez T.L. Kuhlman V. Mittal S. Sepehri
E. Ford D. J. Morrison Y. Sun
R.W. Henry P.S. Pendergrast M.-W. Wong
B. Ma L. M. Schramm
We are interested in basal mechanisms of transcription
by RNA polymerases II and HI, and we currently use
two model systems: the human RNA polymerase II
and III small nuclear RNA (snRNA) genes and the
human immunodeficiency virus type 1 (HIV-1) pro-
moter. Transcription from the human snRNA genes is
unusual in several respects; in particular, the RNA
polymerase II and III snRNA promoters are very sim-
ilar to each other even though they are recognized by
different RNA polymerases, and they are very differ-
ent from the RNA polymerase II promoters of mRNA-
encoding genes or the typical 5S or tRNA-type RNA
polymerase III promoters.
To understand how RNA polymerase specificity is
determined at snRNA promoters, we are identifying
and characterizing the various factors that constitute
the RNA polymerase II and HI snRNA initiation com-
plexes. The RNA polymerase II and III snRNA pro-
moters both contain an enhancer with an octamer
sequence and a proximal sequence element known as
the PSE. The enhancers and PSEs can be exchanged
without loss of RNA polymerase specificity. The RNA
polymerase III snRNA promoters contain in addition a
TATA box located around position -25, between the
PSE and the transcription start site. The octamer with-
in the enhancer recruits the broadly expressed tran-
scription factor Oct-1, the TATA box recruits TBP, and
the PSE recruits a multisubunit complex we call
SNAP,.
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In the last year, we have obtained cDNAs for the
last two subunits of SNAP,, and we have been able to
generate functional SNAP, from recombinant sub-
units. We are now pursuing two general lines of
research: On the one hand, we are characterizing pro-
tein-protein and protein-DNA interactions within the
RNA polymerase II and III snRNA initiation com-
plexes. Our results so far reveal stabilizing protein-
protein interactions between Oct-1 and SNAP, and, in
an RNA polymerase III snRNA promoter, between
SNAP, and TBP. Thus, each DNA-binding member of
the RNA polymerase II and III snRNA initiation com-
plexes stabilizes each other on the DNA. On the other
hand, we want to identify the other players involved in
RNA polymerase II and III snRNA gene transcription.
To this end, we have pursued a collaboration with D.
Reinberg and colleagues to test the role of the RNA
polymerase II general transcription factors in snRNA
gene transcription. We are also fractionating an in
vitro transcription system to identify additional fac-
tors involved in RNA polymerase III snRNA gene
transcription. These studies should help define the key
protein-protein interactions that result in initiation
complexes capable of recruiting specifically RNA
polymerase II or RNA polymerase III.
Our interest in the HIV-1 model system is very
focused and concerns the ability of the HIV-1 promot-
er to synthesize short, prematurely terminated, tran-
scripts. The formation of these short transcripts is
dependent on a DNA element called the inducer of
short transcripts or IST, which is located in large part
downstream from the transcription start site. We do
not know how the IST functions, but we imagine that
it helps recruit an RNA polymerase II transcription
complex that is incapable of efficient elongation,
either because it is associated with a termination fac-
tor or because it lacks an elongation factor. To under-
stand how the IST functions, we have identified, puri-
fied, and cloned a factor that binds specifically to the
element. The next step is to try to demonstrate direct-
ly a role for this protein in the formation of short tran-
scripts and to decipher its biochemical function.
Characterization of the SNAP190
Subunit of SNAP,
M.-W. Wong, R.W. Henry, B. Ma, R. Kobayashi,
N. Hernandez
Isolating a full-length cDNA clone encoding the
largest subunit of SNAP,, SNAP190, was the result of
a collaboration with P. Matthias, from the Friedrich
Miescher Institute in Basel, and N. Klages and M.
Strubin, from the University of Geneva. We biochem-
ically purified SNAP190
sequences. From such sequence, we designed degen-
erate oligonucleotides, performed polymerase chain
reactions (PCRs), and obtained a partial cDNA clone
corresponding to a portion of the amino-terminal half
of the protein. Because SNAP, binds cooperatively
with Oct-1 to the DNA, we also checked whether any
of the cDNAs obtained in a one-hybrid screen per-
formed in yeast to isolate proteins interacting with
octamer-bound Oct-1 might correspond to SNAP190.
Indeed, two such cDNAs encoded several of the pep-
tide sequences we had obtained from the purified pro-
tein. These cDNAs encoded the entire carboxy-termi-
nal half of the protein. We then cloned the missing
segments by a combination of PCR and library
screening methods.
SNAP190 contains an unusual Myb DNA-binding
domain consisting of four and a half, rather than the
usual two or three, Myb repeats. The last two
SNAP190 Myb repeats, Rc and Rd, bind specifically
to the PSE, strongly suggesting that SNAP190 con-
tacts the DNA within the SNAP complex. Depletion
of transcription extracts with anti-SNAP190 antibod-
ies inhibits both RNA polymerase II and III transcrip-
tion of snRNA genes, and transcription can be recon-
stituted by the addition of purified SNAP complex.
Together with previous results showing that the same
is true for SNAP43, SNAP45, and SNAP50, these
results suggest that the SNAP complex involved in
RNA polymerase II and BI transcription contains at
least four common subunits.
SNAP190 could be coimmunoprecipitated with
SNAP45, but not with SNAP43 or SNAP50. We had
previously shown that SNAP43 and SNAP50 could be
coimmunoprecipitated. Thus, at this point we were
able to show interactions between SNAP43 and
SNAP50, and between SNAP190 and SNAP45, but
we could not assemble the two pairs of proteins into a
complex. As described below, the mystery was solved
with the cloning of yet another subunit of SNAP,,
SNAP19. SNAP190 could also interact with Oct-1 in
a band shift assay, as expected from the results
obtained in yeast. Thus, SNAP190 constitutes a key
subunit of SNAP,, that probably contacts the DNA and
mediates direct protein-protein interactions with the
transcriptional activator Oct-1.
Identification of the SNAP19
Subunit of SNAP,
R.W. Henry, V. Mittal, B. Ma, R. Kobayashi, N. Hernandez
The observation that a complex containing SNAP43,
SNAP45, SNAP50, and SNAP190 could not be
assembled suggested that we might be missing an
essential subunit. We have recently obtained a cDNA
clone encoding SNAP19, the fifth subunit of SNAP,.
When all five SNAP, subunits are cotranslated, they
can be coimmunoprecipitated as a complex. Indeed, a
functional SNAP, can be assembled from recombinant
subunits overexpressed in insect cells.
SNAP190 Domains Involved
in Protein-Protein Interaction
with Other Members of the SNAP
Complex
B. Ma, N. Hernandez
To understand the architecture of the SNAP complex,
we are defining which parts of SNAP190 interact with
other members of the SNAP complex as determined
by coimmunoprecipitation of in-vitro-translated pro-
teins.
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Cooperative Binding of TBP
and SNAPS to the Human
Basal U6 Promoter
V. Mittel, N. Hernandez
The basal U6 promoter consists of a PSE, which
recruits SNAP, and a TATA box located at a fixed dis-
tance downstream from the PSE, which recruits TBP.
TBP consists of two domains: A conserved carboxy-
terminal domain, which performs all the functions of
full-length TBP including binding to the TATA box,
interacting with other basal transcription factors and
activators, and directing basal RNA polymerase II
transcription in vitro, and a nonconserved amino-ter-
minal domain. The amino-terminal region contains a
long run of glutamine residues and can thus be arbi-
trarily divided into three segments, I, II, and III, cor-
responding to the sequences preceding, corresponding
to, and following the run of glutamine residues,
respectively.
We found that SNAP and TBP bind cooperative-
ly to their respective sites in the U6 promoter. Thus,
TBP is able to recruit SNAP to a low-affinity PSE.
Strikingly, this effect depends on the amino-terminal
region of TBP, more precisely on segments I and II. In
addition to its function in recruiting SNAP to the
PSE, the nonconserved amino-terminal domain of
TBP performs another function: It down-regulates
binding of TBP to the TATA box. Thus, full-length
TBP binds poorly to the U6 TATA box, whereas the
truncated protein missing the amino-terminal domain
binds efficiently. This effect is dependent on segment
I, and it is not limited to the U6 TATA box: It is also
observed with the TATA box of the adenovirus 2
major late promoter, a typical RNA polymerase II pro-
moter. This suggests that the amino-terminal domain
of TBP negatively autoregulates the binding of TBP to
DNA, perhaps to avoid binding of TBP to nonfunc-
tional TATA boxes located outside of promoter
regions.
Characterization of the
Cooperative Binding of Oct-1
and SNAP to the DNA
E. Ford, N. Hernandez
The POU domain of the transcription factor Oct-1, but
not the transcription factor Pit-1, can recruit SNAPS to
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the PSE and activate snRNA gene transcription in
vitro. We are interested in determining which subunit
of SNAP is contacted by Oct-1 POU. Our previous
efforts to demonstrate protein-protein interactions
between Oct-1 and SNAP43, SNAP45, and SNAP50
were unsuccessful. The identification of SNAP190 as
an Oct-1 interacting protein in the yeast one-hybrid
screen opened the door for the detailed analysis of the
region of interaction. We are mapping and character-
izing this region using a band-shift assay and, in col-
laboration with M. Strubin, the yeast one-hybrid
assay. We expect that these studies will provide us
with one of the best-characterized protein-protein
interactions between an activator and the basal tran-
scription machinery.
Characterization of Human
RNA Polymerase III
S. Sepehri, N. Hernandez
We are interested in identifying additional factors
required for RNA polymerase HI transcription of
snRNA genes, and one of the approaches we are pur-
suing is fractionation of transcription extracts. A prob-
lem we encountered is the lack of antibodies directed
against human RNA polymerase III. To obtain such
antibodies, and to characterize the human enzyme, we
isolated cDNA clones encoding the largest subunit of
human RNA polymerase III. The sequence revealed a
polypeptide with 50% and 40% identity to the yeast
and T. brucei homologs, respectively. The polypeptide
is also 29-34% and 22-27% identical to the largest
subunit of RNA polymerase II and RNA polymerase I,
respectively, from various species. The availability of
the cDNA allowed us to raise anti-RNA polymerase
III antibodies, which we are now using to follow the
enzyme during fractionation and to identify RNA
polymerase-III-associated polypeptides.
Factors Required for snRNA
Transcription by RNA
Polymerase II
T.L. Kuhlman, N. Hernandez
The RNA polymerase H snRNA promoters require the
SNAP complex for transcription, but little is known
about which other factors are required. We are contin-
uing our collaboration with Dr. D. Reinberg and col-
leagues, who have purified all, and cloned most, of the
factors required for basal transcription from the aden-
ovirus 2 major late promoter, a typical RNA poly-
merase II mRNA promoter, to determine which of the
general transcription factors are required for transcrip-
tion from RNA polymerase II snRNA promoters.
Isolation of cDNAs
Corresponding to FBI-1
D.J. Morrison, P.S. Pendergrast, R. Kobayashi,
N. Hernandez
We have previously identified and purified a cellular
factor whose binding to wild-type and mutant versions
of the HIV-1 IST correlates with the ability of these
various ISTs to direct the formation of short tran-
scripts in vivo. We have obtained cDNAs encoding
this factor, which we refer to as FBI-1, as well as anti-
FBI-1 antibodies, and are characterizing its properties.
Function of FBI-1
P.S. Pendergrast, N. Hernandez
As a first step toward understanding the biochemical
function of FBI-1, we are testing the effects of over-
expressing the protein in transfected cells. We are also
pursuing localization studies and identifying factors
that interact with FBI-1.
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TELOMERASE BIOCHEMISTRY AND REGULATION
C.W. Greider C. Autexier J. Hemish
S. Buck A. Kass-Eisler
M. A. Blasco S. Le
K. Buchkovich D. Mason
B.-K. Oh
M. Rudd
S.K. Smith
H. Yang
Telomerase is a specialized reverse transcriptase that
synthesizes telomere repeats onto chromosome ends.
The enzyme contains an essential RNA component
that provides the template for the simple telomere
repeats that are synthesized. In humans, telomerase is
activated in a large number of cancers, and evidence
from tissue culture suggests that telomerase activation
may be required for the growth of cancer cells. In the
past year, we have continued the biochemical charac-
terization of the Tetrahymena telomerase which we
began more than 10 years ago. We characterized a
large number of mutations in the RNA component and
defined regions of the RNA that are essential for
telomerase activity.
In addition, we have continued our analysis of a
knockout mouse that lacks telomerase activity and
shows telomere shortening. Finally, we have begun to
explore the recombinational pathways that can con-
tribute to telomere elongation when telomerase is
absent.
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11111 11111 111 1111 1111 U FIGURE 1 Functional dissection of the telomerase RNA.
CGCCC TJVCUG VAG GVAA CIJAUT, A
"°
.0 - Diagram of the secondary structure of the Tetrahymena
101.t A 13. telomerase RNA (Romero and Blackburn, Cell 67: 343
cu 'E. .59 [1991]). The telomerase RNA sequence is shown with func-
tional domains, including the template and alignment regions
5'- CAACCCCAA -3' (residues 43-51; open box) and the
upstream conserved region 5--(CU)GUCA-3' (residues
35-40; shaded box), which regulates the 5' boundary of the
template.
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TABLE 1 Mutational Analysis of Tetrahymena Telomerase RNA
Mutant RNAsa
Structure or sequence
targeted by mutation
Specific
nucleotide
changes
% Telomerase
activityb
Wild-type none none 100
sub4-8 stem I CCCGC to AAACA 36 ± 18
05'8 (Astern I) stem I none <10a
A5'11 stem I none 19 ± 5
A5'15 stem I none 0
sub15-16 nucleotides 15-16 CA to GU 38 ± 8
A5'19 stem I none 0
020-36 (Astern II) stem II none 25 ± 23
05'25 stem I-II none 0
sub26-29 stem II GUAA to CAUU 141 ± 53
A5'36 stem I-II none 0
437-40 conserved region (stem II) none 13 ± 12
sub69-72 (subw) pseudoknot (w) AACC to UUGG 53 ± 27
±t75 (Astern III-IV) stem III-IV none <10
476-99 (Astern III) stem III none 64 ± 42
sub84-87 (subw) pseudoknot (w) GGUU to CCAA 124 ± 48
sub89-90 stem III loop AA to UU 115 ± 47
4103-107 (Astern I) stem I none 34 ± 8
At111 (Astern IV) stem IV none <10
sub121-122 stem IV (GA bulge) GA to CU 93 ± 36
sub133-136 stem IV loop ACUA to UGAU 14 ± 11
t138 stem IV none <10
t146 stem IV none <10
8 Nomenclature given to the mutant Tetrahymena telomerase RNAs: For example, 45'8 is a deletion of residues
1-8 from the 5' end of the RNA. sub = substitution, t=truncation.
Telomerase activity of Tetrahymena telomerase reconstituted with the mutant RNAs, relative to reconstitution with
wild-type RNA, indicated as a percentage with standard deviation and the number of times assayed and quanti-
tated in parentheses.
For some mutants with weak activity, signal intensities are low. After substraction of background, values were
often zero. However, because these mutants generated telomerase repeats, so activity was scored less than 10%.
Functional Components of the
Tetrahymena Telomerase RNA
C. Autexier
The strong conservation of telomerase RNA sec-
ondary structure from a diverse group of ciliates sug-
gests that the RNA secondary and tertiary structure is
important for enzyme function (Fig. 1). To test what
regions, besides the template, are required for in vitro
telomere repeat synthesis, we made mutations in each
of the four stem loop structures and a number of the
other structural features such as the pseudoknot in
stem III. We also tested the sequence requirements in
regions of the RNA that had been predicted to bind
protein based on chemical mutagenesis (Table 1).
Deletion of more than 13 residues from the 5' end of
the RNA abolished telomerase activity, suggesting
that this region upstream of the template has an essen-
tial function in the elongation reaction. Surprisingly,
deletion of individual stems and alteration in the
sequence of the loop regions did not abolish the activ-
ity of the reconstituted enzyme. All ciliate telomerase
RNAs have a predicted long-range-based pairing that
brings the 5' and 3' regions of the RNA together.
Deletion of these residue or sequence alterations on
both sides of the stem still allowed telomerase func-
tion. The pseudoknot formed with stem III is also a
conserved feature of all ciliate RNAs and has been
proposed to play a part in the translocation reaction
during elongation. We found that two different muta-
tions which abolished the base pairing required for
pseudoknot formation were as active or more active
than wild-type RNA in the in vitro reaction. The fact
that highly conserved features of telomerase RNA
appear to not be essential for the in vitro telomere syn-
thesis reaction suggests that these regions are impor-
tant for carrying out functions in vivo that are not
assayed in the in vitro reaction. For example, there is
evidence that the pseudoknot region may be involved
in RNP assembly in vivo. These findings are particu-
larly interesting in light of evidence from yeast and
humans indicating that some proteins associated with
telomerase activity are not essential for in vitro
enzyme activity.
Telomerase Protein Components
J. Hemish, C. Autexier, H. Yang, D. Mason,
M. Rudd, C. Greider
To study the telomerase enzyme in vitro, we are estab-
lishing a fully recombinant telomerase enzyme. In
past years, we described the isolation and characteri-
zation of two telomerase proteins components, p80
and p95. Because Tetrahymena has an unusual genet-
ic code, to express recombinant proteins in E. coli, we
needed to change the coding sequence to eliminate
internal stop codons. As an alternative to multiple
rounds of site-directed mutagenesis, and to ensure
high-level expression, we reconstructed the two genes
using synthetic DNA oligonucleotides and overlap
extension polymerase chain reaction (PCR). First, the
Tetrahymena p95 and p80 protein sequences were
reverse-translated using selected codons that would
allow high-level protein expression. Pairs of 100 -
nucleotide primers were designed to span the entire
sequence of both the p95 and p80 genes. Each pair of
primers overlapped by 20 bases and was used in recur-
sive overlap extension PCR to reconstruct the entire
gene. The resulting gene fragments were then
sequenced and assembled together, and each gene was
cloned into an expression vector for protein produc-
tion.
In addition to p80 and p95, recent experiments
from Euplotes and Saccharomyces cerevisiae indicat-
ed that telomerase contains a component that has
homology with reverse transcriptase domains
(Lingner et al., Science 276: 561 [1997]). Homo logs
to this protein, TERT, have been isolated from
humans, mice, and Schizosaccharomyces pombe, and
the high degree of sequence conservation suggested
that this protein is conserved in eukaryotes. Using
degenerate PCR, we have cloned a gene from
Tetrahymena that contains protein domains which
suggest that it is a TERT homolog. Expression of this
protein along with the p80 and p95 will allow us to
test the role of the various telomerase protein compo-
nents in a fully recombinant system.
Generation of a Telomerase
Null Mouse
M. Blasco [in collaboration with H.-W. Le and R.A. DePinho,
Albert Einstein college of Medicine, and M.P. Hande and
P. Lansdorp, University of British Columbia]
To examine the role of telomerase in normal and neo-
plastic growth, the telomerase RNA component
(mTR) was deleted from the mouse germ line. mTR-/-
mice lacked detectable telomerase activity, and telo-
meres shortened progressively with each mouse gen-
eration. The first generation of mouse that lacked
telomerase was designated mTR-/- G1; mating of two
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FIGURE 2 Progressive decrease in litter size with increased
generations in the absence of telomerase. The number of off-
spring generated from crosses of each generation of cells of
mTR--/- mice are shown. The generation of mice crossed is
shown on the x-axis. The p values for statistical significance
in the difference in litter size relative to wild-type mice are
shown below each bar.
mTR-/- G1 animals produced mTR-1- G2 and addition-
al generations were produced in a similar manner. We
initially analyzed mice from G1 through G6 for telo-
mere length and chromosomal abnormalities.
Quantitative fluorescence in situ hybridization (Q-
FISH) showed that telomeres shorten at a rate of 4.8 ±
2.4 kb per mouse generation. Metaphase analysis of
mTR-/- cells showed chromosomal abnormalities, and
aneuploidy was frequently found in later-generation
mice. In late-generation animals, chromosome ends
lacking detectable telomere repeats and frequent end-
to-end fusions indicated that telomere function was
lost. Thus, telomerase is essential for telomere length
maintenance in the mouse, and loss of telomere func-
tion leads to chromosome instability as was predicted
from the work of McClintock and Muller more than
50 years ago.
Telomerase Is Essential for
Long Cell Term Viability
M. Blasco [in collaboration with H.-W. Lee and
R. A. DePinho, Albert Einstein College of Medicine]
Early tumor formation assays using the mTR÷ cells
indicated that telomerase is not essential in mouse
cells for tumor formation. However, in vivo analysis
suggests that lack of telomerase does appear to limit
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the growth of cells after many generations, and thus
may reduce the probability of tumor formation when
telomeres are very short. Phenotypic analysis of
m'TR--/- mice indicates that highly proliferative organ
systems require telomerase. Although we were able to
generate six generations of mTR-/- mice, there was a
progressive decline in litter size with each generation
of mouse that lacked telomerase, and, to date, no sev-
enth generation of mouse has been produced (Fig. 2).
Histology of the testes in sixth-generation mTR-i-
mice showed a lack of germ cells, although the sup-
port tissue appeared to be normal. Strikingly, with
increased generation of mTR-/- mouse, there was an
increased number of cells in the testis that stained pos-
itive in a TUNEL assay, indicating that cells with
shortened telomere are induced to undergo apoptosis.
Increased apoptosis was also seen in lymphocytes.
T cells were stimulated to proliferate using a variety
of stimuli and the incorporation of [3H]thymidine was
assayed. mTR-/- G, and G6 mice showed a reduction in
[3H]thymidine incorporation, yet the cell cycle distri-
bution of these populations determined by FACS
analysis was similar to that of wild type. Staining with
propidium iodide and anexin revealed that after mito-
genic stimulation, cells underwent apoptosis. This
suggests that the shortened telomeres in late-genera-
tion mTR--/- animals may signal a DNA damage path-
way and induction of apoptosis. Finally, we also
looked at the growth potential of bone marrow stem
cells in mTR-i- G, and G6 mice and found that there
was a significant decrease in several different stem
cell types compared to wild type. This suggests that
the highly proliferative stem cells may be the first to
be effected due to telomere shortening.
The apoptosis associated with late-generation ani-
mals in several different tissues suggests that telom-
erase inhibition may cause cell death when telomeres
are very short. Since many human tumors have very
short telomeres, telomerase inhibition may be useful
in limiting the growth of tumor cells, as we proposed
7 years ago. However, the fact that cells from the
mTR-/- G6 mice can form some tumors suggests that in
cells where telomerase is inactivated, selection of
cells which have activated an alternative pathway for
telomere maintenance may occur. In yeast, recombi-
nation pathways can allow telomere elongation and
cell division in the absence of telomerase. Thus,
understanding the alternative pathways that might be
activated for in telomere maintenance in mice will be
important to determine whether telomerase inhibition
will be useful in cancer therapy.
Role of Recombination
in Telomere Maintenance
in Yeast
S. Le, C. Greider
To examine the detailed mechanism of how recombi-
nation might allow telomere maintenance, we have
initiated studies in both mice and yeast. In yeast, a
recombination-mediated bypass pathway has been
documented which can elongate telomeres in the
absence of telomerase (Lundblad and Blackburn, Cell
73: 347 [1993]). When the essential telomerase RNA
component, TLCI, is deleted in yeast, telomeres short-
en and most cells die. However, gene conversion
mediated by RAD52 allows telomere lengthening in
some cells and these cells survive. To investigate fur-
ther the role of recombination in telomere mainte-
nance, we assayed telomere length and the ability to
generate survivors in several DNA recombination
mutants, including rad50, rad51, rad52, rad54,
rad57, xrs2, and mrell. Mutations in three different
genes in the RAD52 epistasis group, rad50, xrs2, and
mrell, resulted in significant telomere shortening.
Strikingly, rad51, rad52, rad54, and rad57 mutations,
but not rad50, xrs2, mrell , increased the rate of cell
death in the absence of TLCI. However, only the
rad52 mutants completely blocked the generation of
t/c/ survivors. Our results suggest that DNA recombi-
nation may have a role in telomere maintenance both
in the presence and in the absence of telomerase in
yeast.
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HIGHER-ORDER CHROMOSOME DYNAMICS
T. Hirano 0. Bowes (Eton School)
M. Hirano
K. Kimura
A. Losada
Our laboratory is interested in understanding the mol-
ecular mechanisms that regulate higher-order chromo-
some dynamics. Our approach is a biochemical one.
We use a cell-free extract derived from Xenopus lae-
vis (African toad) eggs in which higher-order chromo-
some structures can be reconstituted in vitro in a
cell-cycle-dependent manner. Using this system, we
previously identified protein complexes (termed con-
densins) that have a central role in mitotic chromo-
some condensation in vitro. Xenopus egg extracts con-
tain two major forms of condensins with sedimenta-
tion coefficients of 8S and 13S. The two forms share
two common subunits, XCAP-C and XCAP-E, that
belong to an expanding family of chromosomal
ATPases, the structural maintenance of chromosome
(SMC) family. Recent data from other laboratories
suggest that SMC proteins are involved in a wide vari-
ety of chromosome dynamics including dosage com-
pensation and recombinational DNA repair. Very little
is known, however, about the molecular mechanisms
of action of this new class of proteins. During the past
year, we have purified 13S condensin from Xenopus
egg extracts and identified a novel ATP-dependent
activity that induces structural changes of DNA. We
have also identified a second class of SMC protein
complexes (termed cohesins) in Xenopus egg extracts
that appear to be involved in sister chromatid cohe-
sion. Finally, we have begun biochemical characteri-
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FIGURE 1 SMC protein complexes from Xenopus laevis and
Bacillus subtilis. (Left) 13S condensin has a central role in
mitotic chromosome condensation and consists of two SMC
core subunits (XCAP-C and -E) and three non-SMC regula-
tory subunits (XCAP-D2, -G, and -H). (Center) 14S cohesin
appears to be required for sister chromatid cohesion and
contains two SMC subunits distinct from XCAP-C or XCAP-E.
(Right) An SMC from the gram-positive bacterium B. subtilis
forms a homodimer whose cellular function is currently
unknown.
zation of a bacterial SMC protein in order to under=
stand the "basics" of this remarkable class of pro-
teins.
Biochemistry of Condensins
K. Kimura, T. Hirano
13S condensin is a 5-subunit protein complex consist-
ing of two SMC (XCAP-C and -E) and three non-
SMC (XCAP-D2, -G, and -H) subunits (Fig. 1). Since
all SMC proteins share a nucleotide-binding motif in
their amino-terminal domains, we hypothesized previ-
ously that 13S condensin displays an ATP-dependent
activity that modulates higher-order chromatin struc-
ture. During the past year, we have purified 13S con-
densin from Xenopus egg mitotic extracts by
immunoaffinity column chromatography and demon-
strated that 13S condensin has a DNA-stimulated
ATPase activity. More strikingly, 13S condensin is
able to introduce positive supercoils into a closed cir-
cular DNA in the presence of topoisomerase I. The
supercoiling reaction is ATP-dependent and requires
ATP hydrolysis. It should be emphasized that this is a
novel activity that has never been reported in the liter-
ature. We speculate that 13S condensin wraps DNA in
a right-handed direction or overwinds the DNA helix
by utilizing the energy of ATP hydrolysis. The energy-
dependent introduction of superhelical tension of
DNA might represent a key mechanism underlying the
compaction of chromatin fibers during mitosis.
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Cell Cycle Regulation
of Condensins
K. Kimura, M. Hirano, T. Hirano [in collaboration with
R. Kobayashi, Cold Spring Harbor Laboratory]
How is the function of 13S condensin regulated dur-
ing the cell cycle? In the cell-free extracts, chromoso-
mal targeting of 13S condensin is mitosis-specific and
correlates with mitosis-specific hyperphosphorylation
of the non-SMC "regulatory" subunits. We have found
that the supercoiling activity of purified 13S con-
densin is mitosis-specific and phosphorylation-depen-
dent. Unlike 13S condensin purified from mitotic
extracts, the interphase form of 13S condensin
exhibits little supercoiling activity. Treatment of the
mitotic form with 2k, phosphatase abolishes its activity.
Conversely, purified cdc2/cyclin B is able to phos-
phorylate two of the regulatory subunits of 13S con-
densin, XCAP-D2 and XCAP-H, and to convert the
interphase inactive complex into an active one.
XCAP-D2 is a frontier protein highly conserved from
yeast to humans and contains a cluster of cdc2 phos-
phorylation sites in its carboxy-terminal domain. We
are attempting to show that these sites are indeed
phosphorylated by cdc2. If it turns out to be the case,
our results will provide the first direct link between
the major mitotic kinase and the key machinery of
mitotic chromosome condensation.
Cohesins: The Second Class
of SMC Protein Complexes
A. Losada, M. Hirano, T. Hirano
Eukaryotic SMC proteins can be classified into four
subfamilies (SMC1 to SM4 types). XCAP-C and
XCAP-E, the two core subunits of 13S condensin,
correspond to the SMC4 and SMC2 types, respective-
ly. Then what is the role of the SMC1 and SMC3
types? To address this question, we cloned cDNAs
encoding the Xenopus SMC1- and SMC3-type pro-
teins (termed XSMC1 and XSMC3, respectively) and
prepared specific antibodies against them. During the
past year, we have found that XSMC1 and XSMC3
associate with each other, forming large protein com-
plexes with sedimentation coefficients of 9S and 14S. '
The 9S form is likely to be a heterodimer of XSMC1
and XSMC3, whereas the 14S form contains three
additional subunits. In the cell-free extracts, the 14S
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FIGURE 2 Roles of eukaryotic SMC protein complexes in higher-order chromosome dynamics.
Cohesins (shown by the rectangles) mediate sister chromatid cohesion after DNA replication. At the
onset of mitosis, the majority of cohesin dissociates from chromatin, leading to reorganization of
cohesion. Condensins (shown by the circles) bind to chromatin and drive its condensation by chang-
ing the topological states of chromatin fibers. At the metaphase-anaphase transition, the linkage of
sister chromatids is dissolved and they start to segregate. It remains to be determined how cohesins
behave during this stage of the cell cycle.
form associates with interphase chromatin and disso-
ciates from it at the onset of mitosis. Immunodeple-
tion of the complexes from extracts produces a defect
in sister chromatid cohesion, but not in chromosome
condensation. Consistently, recent genetic studies in
yeast from other laboratories have shown that Smc 1p
and Smc3p might be directly involved in sister chro-
matid cohesion. We therefore propose to refer to these
complexes as cohesins (9S cohesin and 14S cohesin).
Despite their striking similarities in structural organi-
zation, condensins and cohesins share no common
subunits and have no overlapping functions. Thus, our
results provide a simple biochemical picture in which
the two distinct classes of SMC protein complexes,
cohesins and condensins, regulate sister chromatid
cohesion and chromosome condensation, respectively,
thereby contributing to faithful segregation of chro-
mosomes in eukaryotic cells (Fig. 2).
Biochemistry of a
Bacterial SMC Protein
M. Hirano, T. Hirano
Recent progress in the genome sequencing projects
has revealed that SMC proteins are highly conserved
in the three branches of life, Bacteria, Archaea, and
Eukarya. Virtually nothing is known, however, about
the cellular and biochemical functions of noneukary-
otic SMC proteins. Since the bacterial and archaeal
genomes fully sequenced so far each contains a single
SMC gene, noneukaryotic SMC proteins are likely to
form homodimers. During the past year, we have
cloned an SMC gene from the gram-positive bacteri-
um Bacillus subtilis and expressed it in Escherichia
coli. The recombinant SMC protein exhibits biochem-
ical properties consistent with the homodimer model.
The native SMC protein purified from B. subtilis is
also found to be a simple homodimer containing no
other subunits. We are now characterizing the bio-
chemical activities of this "primitive" SMC and hop-
ing to uncover the basic mechanism of action of this
novel class of proteins. The recombinant SMC protein
will be useful for detailed mutational analyses as well
as protein crystallization. We also anticipate that this
approach should provide us with fundamental insights
into the evolutionary aspects of chromosome architec-
ture and dynamics.
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STRUCTURE AND GENOMICS
Scientists in this section address a range of biological questions with a common thread of deter-
mining the correlation between structure and function in individual biomolecules and in their inter-
actions with one another. Many of the scientists in this group work on several of the classical
research areas: cancer biology, plant biology, and neurobiology. Xu Cheng (who left the Lab in
the past year), Leemor-Joshua Tor, and Rui-Ming Xu use X-ray crystallography and related tech-
niques to understand protein structure and protein-nucleic acid interactions during transcription
and DNA replication. Rujyi Kobayashi and Peter Nest ler use protein chemistry techniques and
combinatorial chemistry, respectively, to study protein structure and protein-protein interactions.
Andy Neuwald (who joined the Lab in 1997) uses computational methods to study the relation-
ship between protein structure and function. Michael Zhang, who has been using statistical
analysis of DNA sequence to develop methods to predict coding regions in genomic sequence,
has expanded his efforts in order to predict regulatory signals as well. Dick McCombie's studies
include determining the structure of large genomic regions using computational tools to analyze
the biological function of these regions.
Two of the more experienced scientists in this group have left in the past year, Tom Marr and
Xu Cheng. Despite this loss, the addition of several computational biologists in the past year and
the infusion of new ideas and new technology have expanded the role this group plays in the
intellectual life of the Lab, as witnessed by their many productive collaborations with other groups
here at Cold Spring Harbor Laboratory.
SEQUENCE-BASED ANALYSIS OF COMPLEX GENOMES
W.R. McCombie N. Dedhia
L. Parnell
L. Gnoj
M. de la Bastide
K. Schutz
E. Huang
K. Habermann
T. Gottesman
The goal of genomics research is to use the latest auto-
mated techniques to determine initially the structure,
but ultimately the function of complex eukaryotic
genomes. We have made major advances in our abili-
ty to do this in the past year. During this time period,
we have significantly enhanced our sequencing capa-
bility. This has resulted from an increase in size, from
the development of new software for sample tracking
and project management, and from increasing the effi-
ciency of our laboratory operations. This increase in
sequencing has been dramatic. In the years between
1992 and 1996, we placed slightly less than 200 kb of
finished sequence in Gen Bank. From 1997 to early
1998, we completed and submitted to Gen Bank more
than 1,000,000 bases. This increase in our capabilities
has opened new possibilities for our work.
We have used this capability to advance several
major projects in the past year: (1) genome sequenc-
A. Hameed
K. Jensen
N. Kaplan
M. Lodhi
N. Shohdy
A.F. Johnson
A. Hasegawa
S. Grant
ing of Arabidopsis thaliana in collaboration with Rob
Martienssen here at the Laboratory and groups at the
Washington University Genome Sequencing Center
and Applied Biosystems; (2) cancer genetics, in which
we sequenced regions of the human genome found to
be deleted in human cancer (in collaboration with
Mike Wigler); (3) sequencing sites of AcDs transposon
insertions in the Arabidopsis genome in collaboration
with Rob Martienssen; and (4) sequencing maize
expressed sequence tags and probes used for maize
mapping in collaboration with Rob Martienssen. All of
these projects are linked by a common intellectual
focus which is to understand the structure and/or func-
tion of large genetic regions or whole genomes.
Because of the limitations of space, this report focus-
es only on three aspects of our lab's work in the past
year: the development of new software tools to moni-
tor and control these efforts, Arabidopsis genome
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sequencing, and cancer genetics. The Arabidopsis
transposon project is described in Rob Martienssen's
section of this Annual Report.
ARABIDOPSIS GENOME SEQUENCING
The overall goal of this project, done as a consortium
with groups led by Rick Wilson and Bob Waterston
and Washington University (WUGSC) and Ellson
Chen at Applied Biosystems (ABI), is to map and
sequence 6.5-7 Mb of Arabidopsis chromosomes IV
and V. Arabidopsis is the most important plant model
organism and is extensively studied around the world.
Our group's efforts are part of a larger international
project to sequence the entire 100-Mb genome of this
organism by the early part of the next century. The
project started in October of 1996. Our plan called for
sequencing and mapping to begin immediately and for
sequencing to accelerate as more mapped clones
became available.
MAPPING [in collaboration with R. Martienssen,
M. Marra, J. McPherson, Washington University]
In the initial phase of the project, we needed to build
sequence-ready bacterial artifitial chromosome (BAC)
contigs in three regions of the genome: (1) the top arm
of chromosome IV (YAC contig I), (2) a region from
the bottom arm of chromosome IV (YAC contig II),
and (3) a region from the top arm of chromosome V
(YAC contig VII).
It became clear to us very early in the project that
our initial mapping strategy, based on that of the
European Arabidopsis sequencing group, was both
technically very challenging and prone to error and
that it had been superseded by far superior technology
developed by our collaborators at the WUGSC. This
latter technology enables an entire genome-wide map
to be made, rather than focusing on a few areas. As a
result, it was decided to use this new technology, and
we have made considerable progress in mapping these
areas by taking advantage of the BAC fingerprints
generated by Marco Marra at Washington University.
For details and data, see
http: / /genome. wustl .edu /gsc /arab /arabidopsis.html
These contigs have been mapped to our target
sequencing regions by anchoring individual BACs
with hybridization to mapped probes (cDNA, phage,
SSLP, and YACs have all been used). This work was
done in our lab at CSHL and at the WUGSC. These
contigs have been built up to cover almost all of the
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regions to which we have been assigned. We have
made our fingerprint data accessible in a searchable
form, allowing many users to build BAC contigs
using these data. The combination of fingerprinting
and BAC end sequencing has proven to be enormous-
ly powerful for the community as a whole as well as
for our project and should serve as an example for
future large-scale genome sequencing projects.
As a result, we now have a single BAC contig
from the nucleolar organizer (rDNA array) at the
telomere of chromosome IV to the end of YAC
CIC8B1. It spans about 20 cM, and about 2.5 Mb.
This contig has been confirmed by hybridization to
eight different YACs and six different genes or cDNA
clones that had previously been placed on the genetic
map. All 25 BACs in the minimal tiling path are cur-
rently either completed or being processed for
sequencing. In addition, a 180-kb contig from the
YAC CIC5B11 has been completed by Ellson Chen
and colleagues at ABI. This contig spans the junction
between the chromosome arm and the rDNA repeats
at the telomeric end of our assigned region. It is cur-
rently being annotated by our group at CSHL and will
provide the first view of such a junction from a plant
genome. We have additional contigs that cover our
target sequencing area. These include a contig that
extends from the centromeric repeats on the long arm
of chromosome IV to the region being sequenced by
our European collegues.
SEQUENCING [in collaboration with R. Martienssen,
R.K. Wilson, E.Y. Chen, R. Waterson]
Since our last annual report, our lab has sequenced
and submitted to Gen Bank 731,570 base pairs of the
Arabidopsis genome. This was composed of a total of
7 BAC clones. Our web page shows our current status
at any given time and can be accessed at
www.cshl.org/arabweb /detailedsummary.htm
Our consortium has sequenced 2.03 Mb during this
same time.
We are currently approaching the heterochromatic
structures near the centromere. Some of our clones
may be in the centromere or at least in the area of peri-
centromeric repeats. These have been difficult to fin-
ish due to their highly repetitive structure. We are pro-
viding help to the members of the community who
study centromeres, and they are reciprocating by pro-
viding us data and valuable insights on the cen-
tromere's structure and position.
Perhaps most exciting, we have one of the first
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FIGURE 1 Shown is a schematic of the genomic region surrounding the PTEN gene. The region depicted here covers over
150 kbp. The PTEN gene is composed of nine exons that span over 100 kbp. Each exon is depicted by a tall dark box
and identified by its corresponding number. Within this region were found four other ESTs that could potentially be incor-
porated into an alternately spliced version of the PTEN mRNA. Of particular note is the EST 5' to exon 1 as this EST may
represent the 5' region of PTEN. A/u, LINE, LTR, and other genomic repeat elements are noted by small shaded regions
beneath. The region near the cofilin-like gene has not yet been analyzed for repetitive elements.
sequence-ready contigs from a plant chromosome Mutator) that has proved to be so useful in maize.
arm, from telomere to centromere. The functional cen- These genes are listed at
tromere region is being defined by other investigators
using complementary approaches. This will be a par- http://www.cshl.org/arabweb/GenesTransposons-
ticularly important region to sequence. We have table-980106.html
already sequenced the junction between the rDNA and
the euchromatin, which may contain a region that con-
trols nucleolar dominance. Several interesting cytoge- CANCER GENETICS SEQUENCING [in collaboration
with M. Wigler, R. Lucito, M. Hamaguchi, R. Parsons,
netic features, including recombination hot and cold Columbia University]
spots, chromomeres, and so on, are found in this
region. The sequence data will provide a wealth of Our efforts in this area have been focused on two tar-
information on the organization, function, and struc- gets. One is from chromosome 10. This region was
ture of plant chromosomes. All of the clones from this found to contain a gene designated as PTEN (Fig. 1)
area are now either sequenced or in the production that contains a tumor suppressor. We have been
queue. sequencing two BACs from this region. These clones
In addition to sequencing this area, we have had a covered the minimal deletion identified by the Wigler
major effort in annotating this sequence. The WUGSC lab from this region. The sequencing of this region is
group carried out some automatic annotation on complete. The sequence is composed of about 200 kb,
regions they sequence. Our group at CSHL carries out which include about 108,000 bases encoding the
annotation on all of the sequences produced at ABI PTEN gene and about 92,000 bases of flanking
and CSHL, as well as adds additional annotation to sequence. Sequence analysis indicates the possibility
the sequence from the WUGSC. The development of of other genes, in addition to PTEN, being encoded in
these Web sites is described in more detail below, in this region. It is possible that these genes have a role
the software development section. in the properties of tumor cells deleted in this area.
Even in the early phases of this project, several We have also sequenced two other regions identi-
interesting observations have been made and a sum- fied as being deleted in tumor cells by Rob Lucito of
mary of some of them would be useful. In addition to the Wigler lab. One of the sequences, which is corn-
structural information, of course, we have discovered pleted, contains about 25,663 bases. No genes identi-
more than 250 genes. They include only three genes of fled by computational analysis of the sequencing can
previously assigned genetic function (PROLIFERA, be readily correlated with the malignant phenotype. In
LUMINIDEPENDENS, and GAI). Homologs of many the second area, we have completed the sequence of a
important genes have been identified, though, includ- 140,000-bp region of the deletion area. The remainder
ing numerous receptor kinases, a cluster of disease of the deletion is composed of a clone of about 40,000
resistance genes, and many transcription factors and bases that is in the finishing stage of sequencing and
signaling components. Very interestingly, several new is currently in four contigs. The sequences are being
families of transposons have been discovered, includ- analyzed for gene content. Interestingly, the larger,
ing the MuDR autonomous transposon (Robertson's 108,932-base clone contains several highly repetitive
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regions. These tandem repeats are different from each
other and are coinposed of between 16 and 70 by and
exist in 4 to 73 copies. The sequences of the unit
repeats vary from each other by only a few bases.
None of these repeat units are found elsewhere in the
sequenced regions of the human gene.
SOFTWARE AND ANNOTATION
To make the Arabidopsis data available in a user-
accessible form, there are two primary modes of mov-
ing through our web pages. These lead to the same
information, but correspond to the two intellectual
points of view from which we envision prospective
users approach our data. The first approach is
mapped-based and allows users to obtain information
about the genes and other features found in a region of
interest in the genome. The second approach provides
information about genes and other elements in the
sequence based on the nature of the feature itself, for
instance, all kinases. In either case, the Cold Spring
Harbor Laboratory Web pages now contain an
extremely detailed description of what can be deter-
mined about the genes and transposons found in the
BACs sequenced here at the Laboratory.
We have tried to make our annotation more close-
ly linked to other Arabidopsis information, in particu-
lar, the existing genetic map. This serves two impor-
tant purposes. It allows members of the community to
see where their regions of interest are located relative
to our sequence queue. This provides the information
they need to determine whether to wait for our
sequencing efforts to reach an area. These efforts
should greatly facilitate positional cloning efforts
being undertaken in the areas we are sequencing.
To facilitate the more global approach, we have
begun an integrative function for our annotation that is
also presented on our Web pages. We have assembled
putatively identified genes into groups and have
begun a "Master List" of all genes in our sequences.
PROTEIN CHEMISTRY
R. Kobayashi N. Carpino G. Binns
N. Kashige N. Poppito
P. Kearney K. Wanat
Research in our laboratory focused on two areas: (1)
method development for protein structure analysis
and (2) study of chronic myelogenous leukemia. This
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This will allow researchers to identify all members of
a gene family of interest in a very rapid fashion. This
list has hypertext links back to the initial, feature-rich
annotation.
In other areas of informatics, we have completed
the first complete version of our Web-based sample
tracking system. This allows us to monitor individual
projects as well as the quality of production sequenc-
ing. This system, called Kaleidaseq, tracks the flow of
sequencing samples through the steps of preparing
library plates, plaque-picking, preparing templates,
conducting sequencing reactions, loading samples on
gels, base-calling the traces, transferring the files to
project directories, assembling the sequences, and
conducting finishing reactions. The throughput rate at
each step and the holdup at each step can be instantly
viewed through the Web. The success rate of the
sequenced samples can be tracked on a daily basis; the
status of each project can also be tracked. Common
daily operations such as base-calling of traces using
base-calling engines developed by other groups and
transfer to directories have been given a simple Web
interface. Sample sheets for daily runs are generated
through a Web interface and transferred transparently
to the sequencing machine computers. A demonstra-
tion of this software can be found at
www.cshl.org/kaleidaseq
The design of the system will be described in a
paper that will be in the March 1998 issue of Genome
Research (Dedhia and McCombie 1998).
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year, Nick Carpino, Paul Kearney, and Georgia Binns
left our group and Nobuhiro Kashige joined us from
Japan.
FIGURE 1 HPLC profile of Achromobacter protease I digest
of p62.k.
Protein Chemistry Core Facility
N. Poppito, K. Wanat, G. Binns
Our collaboration with other scientists at Cold Spring
Harbor Laboratory has continued to be the major
activity in our laboratory. A new instrument, a matrix-
14....,0.....7....20m
1111 FIG 1 .VOUGUIVATAVIVUJINSMCOMAIS COMM. 01t1/77 1137 PM Urnple
6,0.0.03
0Q0tEDVIRADAIBOBVABOK (M.2161241
HP0.1.60
1.1e1.1f1,1,1
Mob. Undo/ ""' 20606 X Scam A.,. 16Cida Volhp: Ol.000%
wv Vak.p.0
13, ICO
Minor RM. 1.087
PSD Mr,v NI.
TImod an Salaee:1216.2OFF
Hawn. Wm: OFF
CM12.1 Cerc,,11,222970:23ro
ATAVITLL.M.5.10011.115 2/22.410.20 S:12
}:anvint
Matrst 1.11.1111
14:416: A116lor
Accol*,111 MO5
Gad
OabFYile Val.:0.10016
Ofty: 160 ON
wer:mooSentAverg..
Ponral 3.01441law lame. 400
Suer Rea IMP
Milneor
Itrad Ion Wed= .6 OFF
16.11. Fes OFF
FIGURE 2 (A) Mass spectrometry of p62d°k peptide K11 in
linear mode. (B) Mass spectrometry of p62d°k peptide K11 in
reflector mode.
assisted laser desorption ionization time-of-flight
mass spectrometer (MALDI-TOF-MS), showed its
power in analyzing posttranslational modification of
protein. With this instrument, we have been able to
identify in vivo phosphorylation sites by analyzing
peptide fragments separated by HPLC after protease
digestion of purified protein. For example, Figure 1
shows a peptide map of p62'Qk purified from a
hematopoietic cell line expressing p210bcr-', and one
of the peaks, indicated as K11, was analyzed by
MALDI-TOF mass spectrometry (Fig. 2A,B). In lin-
ear mode (Fig. 2A), an intact mass was observed that
is 80 mass units added to the calculated molecular
weight of the peptide fragment. On the other hand, in
reflector mode (Fig. 2B), fragment ions are observed
such as the dephosphorylated form in addition to the
phosphorylated form of the peptide. This state-of-the-
art instrument added to our laboratory a significant
capability for structural analysis of protein to study the
relationship between structure and function.
GAP-associated p62 in Chronic
Myelogenous Leukemia
N. Carpino, N. Kashige
We continued to study p62d°' phosphorylated in chron-
ic myelogenous leukemia (CML) in the presence of
the chimeric p210b"-66' protein tyrosine kinase.
Hematopoietic progenitors isolated from CML
patients in the chronic phase contain a constitutively
tyrosine-phosphorylated protein that migrates at 62
kD by SDS-PAGE and associates with the p120.s
GTPase-activating protein (GAP). We are in the
process of determining the phosphorylation sites of
p62d°' to understand its role in CML.
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MACROMOLECULAR CRYSTALLOGRAPHY
X. Cheng A. Dong T. Malone
W. Gong M. O'Gara
J.R. Horton X. Zhang
Y. Liu
After almost 7 years at Cold Spring Harbor Labor-
atory, I moved south and took a professorship in
Emory University School of Medicine and a position
as a Georgia Research Alliance eminent scholar. My
sense of excitement and anticipation somewhat
dimmed as I looked back over the long island which
had become my second home for the last 12 1/2 years.
With the closure of my laboratory in the spring, this
was a short year at CSHL for most of us. Tom Malone
stayed on with Ruiming Xu, my former postdoctoral
fellow and currently an assistant investigator at
CSHL, and John Horton moved with me to Atlanta as
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a research assistant professor, along with Aiping Dong
and Weimin Gong. Margaret O'Gara accepted a sci-
entist position in Pfizer Central Research and migrat-
ed across the Atlantic to the United Kingdom, and
Xujia Zhang accepted a position in the Institute of
Biophysics in Beijing, China.
The research in my laboratory explores several
different systems involved in DNA methylation and
protein phosphorylation, and in eukaryotic multipro-
tein transcription factors. The following paragraphs
summarize our current understanding on the mecha-
nism of DNA base flipping.
MECHANISTIC LINK BETWEEN DNA
METHYLTRANSFERASES AND DNA
REPAIR ENZYMES BY BASE FLIPPING
Rotation of a DNA nucleotide out of the double helix
and into a protein binding pocket (base flipping) was
first observed in the structure of the Hhai DNA
methyltransferase (Klimasauskas et al., Cell 76: 357
[1994]). There is now evidence that a variety of pro-
teins, particularly DNA repair enzymes, use base flip-
ping in their interactions with DNA.
Base flipping is a process by which a protein (usu-
ally an enzyme) can rotate a DNA nucleotide out of
the double helix, breaking only the base-pairing
hydrogen bonds, and trapping it in a protein-binding
pocket. In the DNA-(cytosine C5) methyltransferase
(5mC Mtase), M.HhaI, the catalytic side chains are
situated on a typical concave surface; the target cyto-
sine has rotated on its sugar-phosphate bonds such
that it projects out of the DNA and fits nicely into the
catalytic pocket of the Mtase. DNA distortion is con-
fined essentially to this "flipped" nucleotide and its
nearest neighbors on the same strand. We have sug-
gested that flipping a base out of the DNA helix may
be a widespread mechanism employed by many other
proteins (Klimasauskas et al., Cell 76: 357 [1994];
Roberts, Cell 82: 9 [1995]; Cheng and Blumenthal,
Structure 4: 639 [1996]).
Just within the last 3-4 years, base flipping has
been discovered to be a common mechanism among
DNA repair enzymes that function through either the
base excision repair pathway (BER) or a direct rever-
sal mechanism. The enzymes in the BER pathway
that are predicted to use base flipping encompass
DNA glycosylases, DNA glycosylase/abasic (AP)
lyases, and possibly AP endonucleases and DNA lig-
ase.
Overall, it appears that these enzymes utilize bind-
ing pockets for a variety of purposes that are ultimate-
ly related to recognition and/or catalysis. The concave
catalytic pockets in DNA Mtases can accommodate
many flipped bases, but only the target base can be
methylated. Some repair enzymes have highly specif-
ic binding pockets that restrict access of nontarget
bases to the binding pocket by steric interference
(uracil DNA glycosylase or photolyase), whereas oth-
ers achieve broad specificity by recognizing common
features of the damaged bases, such as a general elec-
tron deficiency of the base to be removed (3-methyl-
adenine DNA glycosylase II), whereas yet other
enzymes simply need to get a base out of the way to
achieve a catalytically competent complex (endonu-
clease V) (for review, see Lloyd and Cheng 1997).
Although there were subtle biochemical observa-
tions which suggested that altered base recognition
was not as simple as the recognition of the damaged
or mismatched bases within fully duplex DNA, no one
predicted that this entire class of repair enzymes
would, in some fashion, use extrahelical bases in
recognition and catalysis. Clearly, the credit for this
discovery rests with the cocrystal structures for DNA
Mtases, M.HhaI (Klimasauskas et al., Cell 76: 357
[1994]) and M.HaeIII (Reinisch et al., Cell 82: 143
[1995]), and for catalytically compromised forms of
T4 endonuclease V (Vassylyev et al., Cell 83: 773
[1995]) and uracil DNA glycosylase (Slupphaug et al.,
Nature 384: 87 [1996]), in which nucleotide flipping
has been directly observed.
The apparent universality of this mechanism has
been inferred from the crystal structures of two other
DNA Mtases, M. TaqI (Labahn et al., Proc. Natl. Acad.
Sci. 91: 10957 [1994]) and M.PvuH (Gong et al. 1997)
and several other DNA glycosylases and glycosy-
lase/AP lyases: E. coli endonuclease III, 3-methylade-
nine DNA glycosylase II or AlkA , the E. coli cyclobu-
tane dimer photoreversal enzyme, photolyase and the
E. coli hydrolytic abasic endonuclease, exonuclease
III (for reviews, see Lloyd and Cheng 1997; Roberts
and Cheng 1998). Although for those enzymes listed
above definitive proof of the general nature of this
mechanism awaits successful cocrystallization stud-
ies, the biochemical determination of active-site
residues and their relative positioning within deep
clefts in these enzymes strongly suggests that the
DNA must conform to the structure of the protein,
rather than the enzyme undergoing significant refold-
ing.
Base flipping may be fundamental to the function-
ing of many DNA-binding proteins. The DNA Mtases
combine base flipping with specific sequence recogni-
tion. The recognition of mismatched DNA structures
by M.HhaI and other prokaryotic Mtases and the
human DNA Mtase suggests that the evolution of
these enzymes and perhaps the evolution of DNA
methylation itself may have been driven by the for-
mation of mismatches in DNA. Concerning DNA
repair enzymes in the BER pathways, the use of base
flipping appears to be a common component in dam-
age recognition and catalysis. Throughout this path-
way, however, the specificity of the binding pockets
and purpose for which they are used varies greatly. In
summary, the phenomenon of base flipping is appear-
ing in a number of systems following its initial dis-
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covery in the DNA Mtases, and many additional
enzyme systems must be considered candidates to use
this novel mechanism. Unfortunately, detailed mecha-
nistic information is lacking, and it remains to be
proven whether base flipping is an active process in
which the protein pushes the base out of the helix, or
a passive one in which the protein binds to a tran-
siently flipped base. Further work is needed to settle
the issue. Particularly intriguing is the recent finding
that when M.Hhal binds to an abasic site, it flips the
deoxyribose ring and its flanking phosphates into the
same conformation as is adopted during base flipping
on its normal substrate (see below). Thus, if the
process is an active one, one might expect that the
push will take place not on the base, but rather on the
sugar-phosphate backbone.
MISMATCHED BASES (G:A, G:U, AND G:AP)
Following the discovery of base flipping by M.HhaI,
the effects of replacing the target cytosine by mis-
matched bases, including adenine, guanine, thymine,
and uracil, were investigated (Klimasauskas and
Roberts, Nucleic Acids Res. 23: 293 [1995]; Yang et
al., Nucleic Acids Res. 23: 1380 [1995]). By elec-
trophoretic mobility shift analysis, M.HhaI and
M.HpaII were found to bind even more tightly to such
mismatched substrates; the highest affinity was for a
gap formed by removal of the target nucleotide and
both phosphodiester linkages. Furthermore, the uracil
can be enzymatically methylated and converted to
thymine at low efficiencies; the binding of these
Mtases at the G:U mismatch prevented its repair by
uracil DNA glycosylase in vitro.
So far, three well-refined ternary structures of
M.HhaI complexed with AdoHcy and a nonpalin-
dromic oligonucleotide containing a G:A, G:U, or
G:AP mismatch at the target base pair, respectively,
have been determined (M. O'Gara, J.R. Horton, and
X. Cheng, in collaboration with R.J. Roberts). The
mismatched adenine, uracil, and abasic site are flipped
out and located in the enzyme's active site, respec-
tively. It seems likely that this pocket is nonspecific
for the binding, but specific for methylation. In the
light of the nonspecific binding pocket, the DNA
Mtase may be more related to the repair enzymes such
as 3-methyl-adenine DNA glycosylase II and endonu-
clease III, which have broad substrate specificity. On
the other hand, the methylation reaction is specific in
that catalysis occurs only when the flipped base is
cytosine or uracil (at low efficiency), more closely
resembling uracil DNA glycosylase.
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4--TH10-2 "-DEOXYCYTIDINE AND
DIHYDRO-5-AZA-CYTIDINE
The fact that M.HhaI does not show much binding
specificity for the flippable base may reflect a need to
leave that base unencumbered by recognition con-
tacts. This provides an opportunity to probe the struc-
tural and chemical interactions involved in sequence-
specific recognition and catalysis using nucleotide
analogs incorporated into synthetic oligonucleotides
in the position of the target nucleotide of M.HhaI. So
far, two nucleotide analogs, a 4"-thionucleoside and
5,6-dihydro-5-azacytosine, have been used in our
studies.
When 4'-thio-2'-deoxycytidine is incorporated as
the target cytosine in the recognition sequence for
M.HhaI, binding to the 4"-thio-modified DNA is
almost identical to that of the unmodified DNA under
equilibrium conditions (Kumar et al. 1997). In con-
trast, the methyl transfer was strongly inhibited in
solution. Surprisingly, the flipped 4'-thio-2'-deoxycy-
tidine in the crystal structure was partially methylated
(Kumar et al. 1997). These results show that 4'-thio-
2'-deoxycytidine does not disrupt DNA recognition,
binding, or base flipping by M.HhaI, but they suggest
instead that it interferes with a step in the methylation
reaction after flipping, but prior to methyl transfer.
5,6-Dihydro-5-azacytosine (DHAC) riboside was
originally synthesized to obtain a hydrolytically stable
replacement for the anti-leukemic drug, 5-azacytosine
riboside. DHAC contains a cytosine-like ring lacking
aromatic character with an sp3-hybridized carbon
(CH2 group) at position 6 and an NH group at position
5, resembling the transition state of a dihydrocytosine
intermediate in the reaction of 5mC Mtases. The struc-
ture, containing DHAC as the target, showed that
DHAC is also flipped out of the DNA helix similarly
to cytosine, but with no covalent bond formed
between the sulfur atom of nucleophile Cys-81 and
the pyrimidine C6 carbon (M. O'Gara and X. Cheng,
in collaboration with J.K. Christman). This result indi-
cates that the DHAC-containing DNA is sufficient to
produce strong inhibition of the DNA Mtase and that
the DHAC moiety occupies the active site of M.HhaI
as a transition-state mimic.
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STRUCTURAL BIOLOGY
L. Joshua-Tor T. Messick D. van Aalten
P. O'Farrell D. Vaughn
J. Rosenbaum
We study the molecular basis of cell regulatory
processes in terms of molecular recognition. We are
using tools of structural biology and biochemistry in a
combined approach to look at proteins and protein
complexes associated with these processes. X-ray
crystallography, our primary technique, enables us to
obtain an accurate three-dimensional structure of indi-
vidual proteins and the interactions in which they are
involved. We use biochemistry to study properties pre-
dicted by the structure and to direct our structural stud-
ies in an iterative manner. We are also combining
information from molecular biology and genetics in
collaborative efforts to study their functions. Our cur-
rent efforts center around two distinct themes. The
first is the study of an evolutionarily conserved fami-
ly of oligomeric self-compartmentalizing intracellular
proteases, the bleomycin hydrolases. The second
theme in the lab involves structural studies of tran-
scription factor complexes. We are also looking at the
effect of molecular motions on various biological
processes.
During the past year, Paul O'Farrell and Daan van
Aalten joined the group as postdoctoral fellows. Later
in the year, Dan Vaughn arrived as a joint postdoctor-
al fellow between Tim Tully's group and ours to work
hnRNP Al that contains two RNA-recognition motifs.
Structure 5: 559-570.
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and X. Cheng. 1997. Crystal structure of the DNA-bind-
ing domain of Mbpl, a transcription factor important in
cell-cycle control of DNA synthesis. Structure 5:
349-358.
In Press
Roberts, R.J. and X. Cheng. 1998. Base flipping. Annu. Rev.
Biochem. (in press).
Horton, J.R., J. Bonventre, and X. Cheng. 1998. How is mod-
ification of the DNA substrate recognized by the Pvull
restriction endonuclease? Biol. Chem. (in press).
on a collaborative effort which also includes Jerry Yin.
Tom Malone has been promoted to the new position of
crystallographic systems manager. Tom, who was pre-
viously a technician at the lab with Jim Pflugrath and
Xiaodong Cheng, now runs the X-ray and computer
facilities for the structural biology center.
Two important developments have greatly
enhanced our technical capabilities. We acquired a
new rotating anode X-ray generator for the Keck
Structural Biology Center. This generator has been
purchased with funds from the National Science
Foundation as well as laboratory funds. Most excit-
ingly, we have begun collecting X-ray data on our
beamline X26C at the National Synchrotron Light
Source (NSLS) at Brookhaven National Laboratory
(BNL). This is a joint venture with SUNY Stony
Brook and Brookhaven Biology and will be described
in more detail by Rui-Ming Xu in this Section
(Structure and Genomics).
Bleomycin Hydro lases
Resistance to antineoplastic drugs, whether intrinsic or
acquired, is a central problem in treatment of human
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cancers. Bleomycin hydrolase is a cysteine protease
discovered because of its ability to hydrolyze the anti-
cancer drug bleomycin and thus to limit its use in can-
cer therapy. The recent discovery of homologs of this
hexameric 300 -kD protein in yeast and bacteria
implies a conserved cellular function for this protein.
In humans, this protease is expressed in all tissues test-
ed and at elevated levels in several tumors. In mice,
expression is highest for newborn mice and decreases
with age. These proteases belong to the group of self-
compartmentalizing, or "sequestered" intracellular
proteases which include the proteasome as has been
realized from the crystal structure of the yeast
bleomycin hydrolase, GaI6, which we have deter-
mined previously. Characteristic of these proteases, it
has a ring structure with a central channel where the
active sites, six in this case, can be accessed only from
within the channel. Several other unique features have
been revealed from this structure, including a nucleic-
acid-binding activity and an unusual positioning of the
completely conserved carboxyl terminus of the protein
in its own active-site cleft. The yeast protein binds
preferentially to single-stranded DNA or RNA, with a
Kd of approximately 10 nat and to nicks in double-
stranded DNA. Moreover, its expression is regulated
by galactose and the Gal4 protein, and Ga16 itself acts
as a repressor of galactose-regulated genes. Clearly,
bleomycin hydrolase has complex cellular functions,
consistent with the increasing recognition of the
important role in general of intracellular proteases.
Human Bleomycin Hydro lase
P. O'Farrell, L. Joshua-Tor [in collaboration with
W. Zheng, H. Whelan, and S. A. Johnston,
Southwestern Medical Center]
In an effort to understand the mechanism of action of
the enzyme, and with the long-term goal of designing
an effective inhibitor and a cleavage-resistant
bleomycin, we have determined the crystal structure
of wild-type human bleomycin hydrolase (hBH) and
of an active-site mutant, C73S. X-ray data were col-
lected for the wild-type crystals at our beamline
(X26C) at NSLS and mutant crystals were collected
on beamline X25. Both crystallize in space group
C222,. Data were also collected for an additional crys-
tal form for the mutant, R32, which diffract much bet-
ter. Both structures were solved by molecular replace-
ment using the yeast Ga16 structure as a starting
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model, and are currently being refined to 2.6 A reso-
lution for the wild type and 1.85 A for the mutant.
With these structures near completion, we have begun
analysis of the structures and comparison with the
yeast homolog.
The Carboxyl Terminus of GaI6, the
Yeast Bleomycin Hydro lase, Dictates
Carboxypeptidase, Aminopeptidase,
and Peptide Ligase Activities
L. Joshua-Tor [in collaboration with W. Zheng and
S.A. Johnston, Southwestern Medical Center]
As in other self-compartmentalizing proteases, the
active sites of Ga16 are embedded in the channel,
sequestered from the outside. A unique feature of this
particular family of enzymes is that the carboxyl ter-
minus of the protein lies in the active-site cleft, block-
ing the access from the exterior of the protein, as well
as part of what would be the substrate-binding site. We
have investigated this unusual configuration of the
active site using mutational, structural, and biochemi-
cal methods. We find that Ga16 acts as a carboxypep-
tidase to create its active site, converting itself to an
aminopeptidase. The carboxyl terminus itself is the
major determinant of substrate specificity, conferring
"positional" rather than sequence specificity by acting
as an anchor and "molecular ruler" to position the sub-
strate (see Fig. 1). As a consequence, deletions of the
carboxyl terminus convert the protein to an endopep-
tidase. Interestingly, both the wild-type and the variant
forms of the protein have a peptide ligase activity. Our
model not only explains these diverse activities of the
enzyme, but also explains its unique ability to inacti-
vate the anticancer drug, bleomycin.
FIGURE 1 Cartoon illustration of the active site of Ga16. The
carboxyl terminus of the enzyme anchors the amino terminus
of a substrate and positions it for cleavage. The scissors rep-
resents the active site cysteine and histidine at the cleavage
site.
Transcription Complexes
Protein-Protein Complexes
Involved in Transcriptional
Activation
T. Messick, L. Joshua-Tor [in collaboration with
S.A. Johnston, Southwestern Medical Center]
The interplay between various protein components in
transcriptional regulatory systems and their response
to induction from exterior signals is central to under-
standing the mechanism of transcriptional activation.
We are currently screening crystallization conditions
for such complexes. Initial trials have already yielded
crystals of one such protein-protein complex, which
are currently being refined.
Structure and Dynamics of
the Myb DNA-binding Domain
D. van Aalten, L. Joshua-Tor [in collaboration with
E. Grotewold, Cold Spring Harbor Laboratory]
The Myb domain protein P is a transcriptional activa-
tor that regulates al, a flavonoid biosynthetic gene in
maize. The DNA sequences preferentially bound by P
are different from the sequences bound by animal Myb
proteins, and using a nuclear magnetic resonance
(NMR) structure of an animal Myb domain for mod-
eling P-Myb does not explain the binding characteris-
tics of DNA-binding mutants of P. To understand Myb
function and DNA binding at the atomic level, we are
performing X-ray crystallographic and computer sim-
ulation studies of the DNA-binding domain of P from
maize.
Initial purification of the Myb domain yielded
insoluble protein. Various constructs were used with
small amino-terminal and/or carboxy-terminal dele-
tions to screen for optimal solubility. A suitable con-
struct was found, giving a monodispersed protein
solution, as shown by dynamic light scattering. The
protein binds several oligonucleotides that contain the
P-binding element. Crystallization experiments with
one of these oligonucleotides yield small needlelike
crystals, and optimization of these conditions is under
way.
The NMR structure that is available for the Myb
domain of mouse c-Myb was used to study the dynam-
ic fluctuations that may be important for DNA binding.
The NMR structure consists of the second and third
Myb repeats (both are separate helix-turn-helix
motifs), connected by a linker. In computer simula-
tions the repeats were moved as rigid bodies, opening
and closing the DNA-binding site. These motions
pointed to a conserved proline in the middle of the
linker sequence as important for controlling the ampli-
tude of this fluctuation. A simulation of the proline-to-
alanine mutant was performed, and the amplitude of
the hinge-bending motions was found to be increased.
Molecular Motions Important in Binding
and Signal Transduction
Structure of a Cross-linked
DNA Decamer with Increased
Affinity to DNA-Methylases
D. van Aalten, L. Joshua-Tor [in collaboration with
G. Verdine, Harvard University]
DNA methylases are thought to act by binding to DNA
and flipping out a base, followed by the enzymatic
reaction. This base-flipping has been seen in the two
methylase-DNA cocrystal structures that were solved
in the laboratories of Xiaodong Cheng and Richard
Roberts here at Cold Spring Harbor Laboratory and in
the laboratories of William Lipscomb and Gregory
Verdine at Harvard University. Since it is necessary for
the enzyme to flip out a base, binding should be
improved when it is offered a DNA duplex with the
appropriate base already flipped out. In the lab of G.
Verdine, a palindromic decamer was designed, with a
linker and a disulfide cross-link between a central gua-
nine nucleotide of one strand to the same position on
the other strand. The modified DNA duplex was found
to bind significantly better to DNA methylase than the
unmodified form. Crystals of the cross-linked DNA
were grown in order to examine the structural basis for
this tighter binding. The crystals diffract to 1.75 A on
the in-house RAXIS generator and to 1.65 A on beam-
line X26C at NSLS. The structure was solved by mol-
ecular replacement and is currently being refined.
There are two structurally very different duplexes in
the asymmetric unit. One has a large bend in the mid-
dle of the helix and has the cytosine at position 6 on
one strand partially flipped out; the other is straight but
is stabilized by a calcium ion.
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Structure and Dynamics of a
Conformational ly Restricting
Glycine Mutant in the Human Muscle
Fatty-acid-binding Protein
D. van Aalten, L. Joshua-Tor [in collaboration with
J. Veerkamp, University of Nijmegen, The Netherlands]
The muscle fatty-acid-binding protein (FABP) is a
member of a large family of small hydrophobic mole-
cule transporters. It binds fatty acids presented to it via
a membrane transport system and delivers them to
intracellular locations. Ligand-protein complexes of
FABPs show the ligand bound deep inside the protein,
with no obvious entry/exit route. Computer simulation
of a FABP-ligand complex suggests large hinge-bend-
ing motions in the protein, transiently opening a tun-
nel through which the ligand could enter or exit. A key
residue appeared to be an evolutionarily conserved
glycine, which lies in the center of the hinge region
and might thus control the dynamics of this tunnel
opening. The Veerkamp lab has provided us with an
FABP mutant in which this glycine is replaced by a
conformationally more restricted serine. Two crystal
forms were observed, both in space group P212121.
One crystal form diffracts to 2.1 A on the in-house
RAXIS and has been refined to R = 20% and Rrree =
22%. The second form diffracts to 1.19 A on beamline
X26C at Brookhaven, and has been refined to an R =
18%, RfrGe = 19%. While the Veerkamp lab is perform-
ing kinetic measurements on the mutant, we will per-
form simulations to compare the hinge-bending
motions to those of the wild type.
Investigation of the Photocycle of the
Photoactive Yellow Protein by X-ray Cry-
stallography and Computer Simulation
D. van Aalten, L. Joshua-Tor [in collaboration with
K. Hellingwerf and W. Crielaard, University of Amsterdam,
The Netherlands]
The photoactive yellow protein is found in bacteria
isolated from hypersaline, sun-bathed lakes. This pho-
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toreceptor was found to be part of a signal-transduc-
tion pathway that is responsible for the negative pho-
totactic response of the bacterium to intense blue light.
Like bacteriorhodopsin, it has a multistate photocycle
in which a ligand is isomerized, followed by a con-
formational change in the protein, which is the first
step in signal transduction. Unlike bacteriorhodopsin,
which is a membrane protein, this protein is water-sol-
uble, making it an excellent candidate to study the
details of the photocycle at the atomic level. We are
currently studying the structure and dynamics of three
serine mutants of evolutionarily conserved glycines,
which have been implicated to act as hinge-bending
points in conformational changes during the photocy-
cle.
In the Hellingwerf lab, the mutants were shown to
have a slower photocycle. We have crystallized and
solved the structures of the mutants. All crystallize in
spacegroup P65 with approximately the same cell
dimensions and diffracted on the in-house generator to
2.0 A and on beamline X26C at Brookhaven to 1.75 A.
Refinement of two of the mutants is currently to 1.85
A with R = 16%, Rfree = 19% for one and R = 20% and
Rfree = 24% for the other. The photocycle occurs nor-
mally in crystals. We will perform computer simula-
tions of the mutants, restricted by the X-ray data, to
examine which areas of the protein are conformation-
ally restricted. This might have implications for the
photocycle and subsequent steps in the signal trans-
duction pathway.
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COMBINATORIAL LIBRARIES
H.P. Nest ler R. Liu
N. Batada (URP)
R. Sherlock
A. Anand (PFF)
Combinatorial "One bead-One structure" libraries
have opened a new dimension for the study of inter-
actions of small molecules with chemical and biolog-
ical ligands. We are employing such encoded combi-
natorial libraries to identify molecules that specifical-
ly interfere with the biological function of proteins of
physiological importance at specific functional sites.
Hereby, we pursue an approach that outlines a new
paradigm for molecular biology, as we will attempt to
prevent a biological process not by inhibiting the
enzyme connected with this process, but by masking
the substrate with a synthetic molecule. The second
aspect of our research is the identification of sub-
strates and subsequently of inhibitors of enzymes,
especially proteases. Although the identification of
peptidic substrates for proteolytic enzymes can be
done rather efficiently using combinatorial libraries,
there is still a need for methods to efficiently identify
protease substrates from protein mixtures. Finding
new substrates for enzymes not only will open ways to
design compounds inhibiting these enzymes, but will
also help to elucidate the pathways these enzymes are
involved in.
Molecular Forceps from
Combinatorial Libraries
That Bind RAS Proteins
R. Liu, R. Sherlock [in collaboration with D.L. Dong and
M.H. Wigler, Cold Spring Harbor Laboratory]
Our initial studies have shown that simple molecules
displaying two or more short peptide or peptide-like
chains (which we termed "molecular forceps") can
provide reasonable affinities and selectivities toward
peptide substrates. We are using libraries of molecular
forceps to identify molecules that are able to bind to
the carboxyl terminus of RAS proteins (also termed
"CaaX-box") and prevent its famesylation. The fame-
sylation of RAS has been shown as a crucial step in
the activation of RAS as a signal tranduction protein,
and pharmaceutical trials showed that molecules that
inhibit the famesyl transferase, the famesylating
enzyme, are able to stop tumor growth. The approach
we follow outlines a new paradigm for molecular biol-
ogy, as we attempt to prevent a biological process not
by inhibiting the enzyme connected with this process,
but by masking the substrate with a synthetic mole-
cule. To efficiently target our molecular forceps
toward the carboxyl terminus of RAS, we use the iso-
lated peptide sequence instead of the whole protein as
substrate for the screening of our libraries. The mole-
cules selected against the peptide epitope should bind
RAS site-specifically at the CaaX-box. Although there
is precedence that antibodies can be raised against
peptide epitopes in this fashion, it is unclear whether
this approach is suitable for the selection of synthetic
molecules. The carboxyl terminus of RAS is a suitable
test case for this novel approach, because it is confor-
mationally not restricted and should therefore be read-
ily accessible for the molecular forceps we intend to
generate.
In our assays of a library that contained two-armed
and four-armed molecular forceps with the octapep-
tide derived from the CaaX-box of RAS and the whole
RAS protein, we observed that the molecular forceps
with four peptide arms predominated as interacting
molecules. In a nonexhaustive screening of this
library, we identified 15 molecules binding to the
above mentioned CaaX-box octapeptide and 35 mole-
cules binding to the RAS protein. Subsequently, we
resynthesized 3 molecules that bound to the peptide,
three forceps that bound to the protein, and three that
did not show interaction in the screening. Each of the
resynthesized molecules that had been selected against
the peptide binds with micromolar affinities selective-
ly to the H-RAS protein with some specificity over
other proteins such as ovalbumin or BSA, supporting
our assumption that we can screen libraries with iso-
lated peptide epitopes to identify forceps binding to
the full-length protein.
Furthermore, two of the peptide binders not only
bind to the RAS protein, but also slow down the far-
nesylation of H-RAS with IC50 values of 100 pm and
400 pm. None of the protein binders or nonbinding
forceps prevents the famesylation in the micromolar
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range. These findings suggest that some molecular
forceps (although not all of them) that were selected
for binding to peptide epitopes recognize this epitope
on the full-length protein, whereas forceps selected
against the protein bind at other locations of the pro-
tein surface.
Beyond that, the retardation of famesylation by
the stronger acting forceps is sensitive to the peptide
used as substrate for the famesyl transferase: Whereas
the famesylation of a peptide derived from the CaaX-
box of RAS is inhibited with an IC50 of 100 lum, the
famesylation of a peptide derived from K-RAS B is
inhibited with an IC50> 1 mM (75% famesylation effi-
ciency at a concentration of 1 mM) and the famesyla-
tion of a hybrid peptide with an IC50 of about 500 pm.
The famesylation of a peptide derived from the car-
boxyl terminus of lamin B is not affected at concen-
trations up to 1 mM. We are currently establishing that
this retardation is caused by binding of the forceps to
the CaaX-box of RAS and not by coincidental inhibi-
tion of the famesyl transferase.
Detection of Hiss- tagged Peptides
and Proteins on Beads
H. Liu, R. Sherlock, H.P. Nest ler
Although antibodies have been employed very suc-
cessfully with combinatorial libraries as screening tar-
gets or to detect tightly bound proteins, there are
drawbacks to using antibodies coupled to alkaline
phosphatase for detection of beads that bind proteins
with low affinity. First, the extensive washing proce-
dures required for the staining tend to elute the pro-
teins from their ligands; second, some libraries we
have tested bind to the antibody or its conjugate; and
third, antibodies against certain proteins may not be
readily available.
The attachment of a hexa-histidine moiety ("His-
tag") to proteins that are engineered for overexpres-
sion into bacteria is now a standard means to purify
these proteins by affinity chromatography over a nick-
el column, making use of the strong affinity of the
His-tag to the nickel on the column. Beyond its abili-
ty to complex nickel ions, the His-tag also interacts
with other ions of transition metals, such as copper.
We could detect the interaction of copper(II) ions with
a hexa-histidine sequence covalently attached to resin
beads by a blue staining of these beads. However, the
colorization resulting from copper(II) ions interacting
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with His-tagged ligands that were not covalently
bound to beads was too faint to allow the unambigu-
ous identification of beads binding these ligands.
We have developed a way to detect noncovalently
bound His-tagged ligands on beads by catalytically
enhancing the signal: Copper(ll) ions are essential to
catalyze the Benzidine Blue reaction, where the color-
less substrate benzidine (biphenyl-diamine) is oxi-
dized by hydrogen peroxide to yield a dark blue
charge-transfer complex. If we perform the Benzidine
Blue reaction on beads, the precipitation of the blue
complex leads to a brown or violet staining of the
beads. Our experiments show that the developed
method is applicable to the screening of His-tagged
proteins as well as peptides.
A Two-dimensional, Diagonal
SDS-PAGE Technique to
Screen for Protease Substrates
in Protein Mixtures
H.P. Nestler, N. Batada [in collaboration with A. Doseff
and Y. Lazebnik, Cold Spring Harbor Laboratory]
Proteases have emerged during the past few years as
key players in the control of cell fate. Many have been
identified and cloned, but to understand their function
and to elucidate the pathways in which they are
involved, the intracellular substrates processed by
each protease must be identified. Even the intensive
efforts in genome sequencing and cloning that yield
new protein sequences every day do not provide a
complete solution: The occurrence of a cleavage motif
in a protein sequence is not sufficient for proteolytic
susceptibility, since folding may prevent access of the
protease to the substrate site. Indeed, many proteins in
their native conformation are resistant to proteolytic
digestion.
Electrophoresis of proteins in polyacrylamide gels
is a standard tool for separating proteins for analytical
and preparative purposes, and two-dimensional elec-
trophoresis is widely used for the high-resolution
mapping of proteins. However, two-dimensional elec-
trophoresis has seldom been used to monitor the trans-
formation of proteins, and in most instances isoelec-
tric focusing is used in the first dimension and SDS-
PAGE in the second dimension. We have developed a
technique for identifying protease substrates in protein
mixtures using two-dimensional gel electrophoresis
combined with in-gel proteolysis.
A mixture of proteins, i.e., a cellular extract, is
separated in a nonreducing SDS-slab gel. The proteins
are renatured in the gel by eluting the SDS from the
gel with a buffer appropriate for the proteolytic diges-
tion. The equilibrated gel is then incubated with the
protease of interest, and the digested proteins are sep-
arated by nondenaturing SDS-PAGE in a second
dimension orthogonal to the first. Since electrophoret-
ic development in each dimension occurs under the
same conditions, undigested proteins appear in a diag-
onal line through the gel with the products of the pro-
teolytic cleavage below this line. Initial attempts to
achieve separation under nondenaturing conditions
failed. The denaturation of the proteins with SDS dur-
ing the electrophoresis proved necessary to ensure
separation by molecular weight, which is crucial to
the diagonal alignment of uncleaved proteins in the
two-dimensional gel.
We show in our studies that we are able to suc-
cessfully renature proteins after the first electrophore-
sis dimension. Indeed, even with highly active pro-
teases that have a broad specificity, such as trypsin or
chymotrypsin, we are able to obtain specific fragmen-
tation patterns from the protein samples that are in
agreement with reported stabilities of the respective
proteins in their native state to proteolytic digestion.
Using CPP-32, a highly specific protease, we only
observed cleavage of Mch-2, a known substrate. The
other proteins in the used sample were unaffected
even over extended periods of proteolysis. Currently
we are employing this technique to identify substrates
of CPP-32 from cellular extracts.
PUBLICATIONS
Gennari, C., H.P. Nestler, U. Piarulli, and B. Salom. 1997.
Combinatorial libraries: Studies in molecular recognition
and the quest for new catalysts. Liebigs Ann./Recueil
637-647.
Nestler, H.P. and A. Doseff. 1997. A two-dimensional, diago-
nal sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis technique to screen for protease substrates
in protein mixtures. Anal. Biochem. 251: 122-125.
Quinkert, G., S. Scherer, D. Reichert, H.-P. Nestler, H.
Wennemers, A. Ebel, K. Urbahns, K. Wagner, K.-P.
Michaelis, G. Wiech, G. Prescher, B. Bronstert, B.-J.
Freitag, I. Wicke, D. Lisch, P. Belik, T. Crecelius, D.
Herstermann, G. Zimmermann, J.W. Bats, G. Durner,
and D. Rehm. 1997. Stereoselective ring opening of
electronically excited cyclohexa-2,4-dienones: Cause
and effect. Hely. Chim. Acta 80: 1683-1772.
In Press
Liu, R., R. Sherlock, and H.P. Nestler. 1998. Using the cop-
per-catalyzed benzidine blue reaction for the detection
of binding of hexahistidine-tagged proteins and pep-
tides to combinatorial library beads. In Innovation and
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SEQUENCE-BASED PREDICTION OF PROTEIN FUNCTION
A. Neuwald
Our work addresses a source of inefficiency in protein
research inasmuch as the information that researchers
seek through experimentation may already be avail-
able, hidden among the mass of data present in the lit-
erature and in the sequence and structural databases.
In particular, we aim to make protein functional infor-
mation implicit in multiple sequence data more acces-
sible to the research community. This is needed
because important relationships are now often over-
looked.
For example, some of this year's work (performed
prior to coming to CHSL) led to compelling predic-
tions concerning the structure, active-site residues,
and catalytic mechanism of a fruit fly membrane pro-
tein involved in germ cell migration. Yet experimen-
talists studying this protein overlooked the subtle
sequence relationships leading to these predictions.
Other recent work has revealed (similarly overlooked)
relationships relevant to our understanding of breast
cancer, cardiomyopathic disorders, and spinocerebral
ataxia. Thus, deciphering multiple sequence data can
help clarify the roles proteins play in disease mecha-
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nisms, leading to better diagnoses and treatments. To
further enhance our ability to predict protein function,
we are currently developing and improving methods
to gather, model, and interpret multiple sequence data.
A Comprehensive Set
of Protein Domains
A. Neuwald
To help develop advanced alignment models of pro-
tein domains, we are partitioning all available
sequences into protein families. This allows the inclu-
sion of as many proteins as possible in each set, which
helps align the sequences and construct an accurate
model of the protein family. These alignment models
can be used to search a database for distant relatives,
often leading to striking functional predictions.
By constructing a complete set of these align-
ments, we are obtaining an overview of the "protein
universe" so that the idiosyncrasies of the various
types of domains can be recognized, prioritized, and
studied. This, in turn, is helping us to develop more
highly refined alignment models. We will also use
these data for comprehensive statistical and compara-
tive analyses of protein domains. Moreover, a nearly
complete set of alignments helps detect and delineate
subtly conserved or interrupted domains in multiple
domain proteins by first delineating more easily
detected adjacent or inserted domains. Finally, by pre-
computing these alignments, many important relation-
ships are being detected that would have been missed
by thorough but more limited approaches.
For example, a protein that is mutated in a heredi-
tary cardiomyopathic disorder (Barth syndrome) was
found in one of the alignment sets. In this set, all of the
characterized proteins are acyltransferases involved in
phospholipid biosynthesis. This suggested a possible
disease mechanism where the abnormalities associat-
ed with this syndrome, which is characterized by
alterations in mitochondrial morphology and respira-
tory-chain dysfunction, may be due to alterations in
membrane phospholipids. This relationship was
missed during previous analyses starting with this dis-
ease-related protein because it lacks sufficient pair-
wise similarity to these acyltransferases. Nevertheless,
for these alignment models to achieve better sensitiv-
ity and selectivity, they need to more accurately repre-
sent family-specific features.
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Advanced Alignment
Models of Protein
Domains
A. Neuwald [in collaboration with J. Spouge and W.J.
Wilbur at the National Center for Biotechnology Information,
National Institutes of Health]
To tailor models to particular protein families, we are
pursuing a strategy of stepwise refinement. This
involves starting with the initial alignment models
constructed during partitioning of the sequence data-
base and then successively adding more details. First,
general features are being added to the models. These
include correcting for compositionally biased
sequences and adding empirically derived estimates of
the spacing between and gaps within conserved
regions. Second, more specific features are being
added, including structural constraints for families
with known structures and modeling of repetitive ele-
ments within domains. Finally, hierarchical alignment
models are being devised to represent commonly
occurring subdomains within domains. This will help
distinguish functional constraints shared by related
families from those specific to a particular family.
Regarding the first model refinement step, we
have recently developed statistical and algorithmic
procedures to model the spacing between conserved
regions in a multiple alignment. These procedures
were applied in an analysis of pleckstrin homology
(PH) domains, which occur in a wide range of proteins
involved in intracellular signaling or as constituents of
the cytoskeleton. This domain was selected for analy-
sis because it is weakly conserved and contains
numerous insertions and deletions. The modified mul-
tiple alignment model detects about 28% more PH
domains than an alignment model that ignores the
spacing between conserved regions and about seven
times as many domains as standard pairwise analysis
methods. Not surprisingly, this alignment also cap-
tures additional features of the PH domain (Fig. 1),
modeling it as five conserved regions versus three pre-
viously.
Regarding the second model refinement step, we
have been working recently on methods to incorporate
structural constraints into alignment models. Because
only structural features are conserved between the
most distant members of a protein family, this
approach should help maximize a model's informa-
tion about distant (unknown) family members. Recent
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FIGURE 1 Alignment of representative PH domains.
preliminary work confirms this notion.
Four sequences from among the top nonsignifi-
cant matches for a database search using a protein
kinase alignment model were threaded through a pro-
tein kinase structure. These sequences included two
non-protein kinases-an isomerase (E value = 6) and
a helicase (E value = 14)-and two known viral pro-
tein kinases distantly related to other protein kinas-
es-one from herpesvirus (E value = 3) and one from
cytomegalovirus (E value = 42). A protein kinase
structural core was defined using the ten conserved
regions of the alignment model. Similarly, sequence
threads through this core were defined by optimally
aligning each sequence to the alignment model.
Threading scores were based on three structural prop-
erties: solvent accessibility, secondary structure
propensity, and tertiary contact potentials. The signif-
icance of these threading scores was determined using
a Monte Carlo procedure for estimating small P val-
ues developed by Dr. Wilbur at the NCBI.
All of the threading score P values for these
sequences were relatively small. This is as expected
for nonsignificant but high-scoring sequences
retrieved in a large database search using a protein
kinase alignment model. However, P values for the
viral protein kinases were lower by a factor of three to
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five orders of magnitude relative to the nonprotein
kinases. Hence, these results indicate that, indeed,
there is additional information to be gained by incor-
porating structural features.
Regarding the last model refinement step, recent
preliminary work has examined the benefit of ignor-
ing a commonly occurring subdomain within an align-
ment model. This preliminary work, in a crude way,
mimics the effect of layering a subdomain beneath a
domain model-a more sophisticated approach that
we will implement in the near future. When applied to
NTP-binding motifs in a model of replication factor C
(RFC)-related proteins, this allowed better discrimina-
tion of this family. A database search using the RFC
family alignment model detected 265 protein
sequences. In contrast, a search that ignores the NTP-
binding subdomain detected 68 RFC-related proteins.
(Six conserved regions outside the NTP-binding
motifs characterize the RFC family.) Thus, this
method filters out 197 NTP-binding proteins other-
wise unrelated to RFC proteins. Moreover, during
construction of this alignment model, this approach
was able to detect and include distantly related,
unknown RFC family members that were not previ-
ously detected due to the abundance of NTP-binding
proteins.
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COMPUTATIONAL GENOMICS
M.Q. Zhang T. Chen (Part-time grad student) R. Klein (URP)
J. Feng (Part-time grad student) W. Orrick (Part-time grad student)
M. Huang (Visiting scientist) J. Tabaska
I. loshikhes
Our research interest is to identify and to characterize
genetic elements in nucleic acid sequences by compu-
tational means. As the Human Genome Project enters
its large-scale sequencing phase, developing efficient
computational methods for identification of genes and
their control/regulatory elements has become
extremely important. Knowing the organization of a
gene often becomes the prerequisite for further func-
tional studies. Our initial focus was to study statistical
characters of exons and introns in protein coding
regions and to develop coding-exon prediction pro-
grams by applying multivariate statistical pattern
recognition techniques. More recently, we began to
focus on promoters, translational start site, and
polyadenylation site regions to develop new computa-
tional methods for identification of the ends of genes.
T. Chen is now a postdoctoral fellow at Harvard.
W. Orrick went to Australia for a post-doc position. R.
Klein is back at Harvard as a senior. Tabaska joined
the lab in May as a post-doc from Stormo's lab at the
University of Colorado and Ioshikhes joined the lab in
July as a post-doc from Trifonov's lab at Weizmann
Institute. Huang came to visit the lab in July from
Otsuka America Pharmaceutical. Feng started in
December as a volunteer from Queens College.
POMBE: A Fission Yeast
Gene-finding Tool
T. Chen, M.Q. Zhang
Finding protein coding regions in a eukaryotic
genome is very difficult due to the presence of introns.
To improve our rule-based interactive computer pro-
gram (INTRON.PLOT) and to meet the needs of a
world-wide large-scale genomic sequencing project,
we analyzed 200 genes from an important model
organism-the fission yeast-and developed a new
fission yeast gene-finding and exon-intron organiza-
tion prediction system called POMBE. The sensitivi-
ty, the specificity, and the correlation coefficient were
98.5%, 99.9%, and 98.3%, respectively, at the
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nucleotide level. It is based on Linear Discriminant
Analysis and is now available at
ftp://cshl.org/pub/science/ POMBE/
and at
http://c.cshl.org/gene finder/
Identification of Protein-coding
Region in Human and
Mouse Genomes
M.Q. Zhang
Identification of exons in vertebrates is more chal-
lenging because an average vertebrate gene consists
of many short exons separated by introns that are ten
or a hundred times larger. As hinted by the exon-def-
inition model, the strategy for vertebrate gene-finding
should focus on exons. We carried out comprehensive
classification and statistical characterization of human
exons and their flanking regions. Further analyses
revealed novel correlation and constraints among dif-
ferent splicing features across an exon. On the basis of
our findings, we have developed a new powerful
exon-finding program called MZEF that uses the qua-
dratic discriminant function for multivariate statistical
pattern recognition. When compared with other lead-
ing gene-finders (such as HEXON or GRAIL2),
MZEF tends to have higher specificity (less false-pos-
itive) without sacrificing sensitivity (in a test of 43
human genes, the accuracy measured by the correla-
tion coefficient was 0.80 for GRAIL2, 0.83 for
HEXON and 0.90 for MZEF). MZEF has been ranked
top among all the human exon prediction programs in
a recent review. It is implemented for both human and
mouse gene-finding and is available at
ftp://cshl.org/pub/science/MZEF/
and at
http://www.cshl.org/gene finder/
Exploratory Study of
Kohonen Network
Classification of Promoters
W. Orrick, M.Q. Zhang
Classification of promoters of human genes is very
useful for understanding their relationship. There are
two methods: One is functional and the other is statis-
tical. Because of the lack of functional information,
we looked for a statistical technique for automated
sequence classification. The Kohonen self-organized
map (SOM) is a well-known unsupervised neural net-
work learning procedure that can automatically classi-
fy high dimensional samples (such as DNA
sequences) according to their degree of similarity. It
has been applied to both protein and nucleotide
sequence classification problems. We have imple-
mented SOM in JAVA language on our UNIX work-
station and started experimenting with human promot-
er sequences. Initial results showed that SOM was
able to partition promoter sequences into TATA and
TATA-less sectors; better visualization techniques are
needed for recognizing more subtle clusters in the
final Kohonen topology preserving map.
A Computational Description of the
Interaction between the Transcription
Factors E2F and Spl
R. Klein, M.O. Zhang
E2F is a eukaryotic transcription factor that has been
found to regulate many genes needed for DNA syn-
thesis. Several recent studies have indicated that E2F
and Spl work together to regulate expression of some
genes. By analyzing independent promoters contain-
ing both E2F and Sp 1 sites, we found most genes had
at least one E2F/Sp 1 pair with interdistance less than
50 by but larger than 10 bp. Using the weight matrices
constructed from aligned E2F and Sp 1 sites together
with the distance rule, we have searched the eukaryot-
ic promoter database (EPD). The scoring threshold
was established by searching a control set of random-
ly shuffled promoter sequences. Aside from many
homologs to the known genes, there are four likely
candidate genes for further experimental testing for
E2F/Spl regulation. Two are proto-oncogenes: mouse
c-myb and human c-abl. The third is chicken HMG-
17, which is a non-histone DNA-binding protein
found in chromosomes. Its human homolog has been
shown to have increased mRNA levels in S-phase.
Finally, htf9-a, which was identified in the original lit-
erature search as being regulated by both Spl and
E2F, but separated by a distance greater than 50 bp,
was shown to have a potential Sp 1 site closer to the
E2F site. However, homologs in the EPD for both c-
abl and HMG-17 did not have consensus E2F sites.
Another gene, transforming growth factor [3-1, which
was recently shown to be E2F regulated, also showed
up positive with appropriately spaced E2F and Sp 1
sites in its promoter. Whether each gene is actually
regulated by these two factors needs to be experimen-
tally determined.
Database Construction and Statistical
Analysis of Promoters That Contain
Specified Pairs of Transcription Factors
I. loshikhes, J. Feng, M. Q. Zhang
We have tried to make a functional classification of
promoters by requiring that each class must share
some common regulatory elements. We are extending
the analysis for the E2F/Spl pair to other transcription
factors, such as Sp 1/NF-Y or E2F/X, where X repre-
sents any other documented interacting factors.
Databases for specific families of promoters are being
built to facilitate further statistical analysis. Our goal
is to use significant spatial correlation of specific tran-
scription factor (TF) sites as a robust criterion for
identification of functional promoters and for screen-
ing new genes under similar regulatory pathways.
Another approach that explores the possible correla-
tion between certain TF sites and the "nucleosomal"
periodicity (Ioshikhes et a1.1996) is also being pur-
sued. Our preliminary result demonstrated some
prevalence of 10.3 ± 0.2 by periodicity in putative TF
site distribution within promoter regions, which may
indicate the important role of the chromatin structure
in gene expression.
Identification of Human
Core Promoter in Silico
M.Q. Zhang
A core-promoter, approximately from -60 to +40 by
relative to a transcriptional start site (TSS), consists of
a minimal DNA element that is necessary and suffi-
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cient for accurate transcription initiation in a reconsti-
tuted cell-free system. Due to the hierarchical and
modular nature of the promoter architecture, we pro-
posed a stepwise strategy: (1) given a large genomic
DNA sequence of 100 kb or larger, to localize a func-
tional promoter into a 1-2 kb region; (2) given such an
extended promoter region, to further localize a TSS
into a 50-100-bp (core promoter) region. Using posi-
tional dependent 5-tuple measures, a quadratic dis-
criminant analysis method has been implemented in a
new program, Core Promoter. Our experiments indi-
cate that when given a 1-2 kb extended promoter
sequence, Core Promoter will correctly localize the
TSS to a 100-bp interval approximately 60% of the
time. This may be compared with 37% when using a
similar promoter finder, TSSG (Solovyev and
Salamov 1997), which is based on a linear discrimi-
nant analysis. This program will soon become avail-
able on World Wide Web.
Computational Study of Upstream
Regulatory Elements in Yeast Genes
M. Huang, M.Q. Zhang
Although the complete yeast genome is available,
there are still no clues as to the function of 30% of the
genes. Since the expression pattern of a gene is close-
ly related to its function, one way to approach the
function of a novel gene is to determine which regula-
tory system controls its transcription. From the litera-
ture, we have classified some well-characterized yeast
genes into several functional groups. From published
upstream regulatory elements, we are in the process of
summarizing into specific rules and hope that the
function of many uncharacterized genes will be pre-
dicted by these rules. By grouping functionally related
genes and then aligning their 5' regulatory region, it is
also possible to detect new consensus sequences.
Some of them may represent weak regulatory ele-
ments that will give us some clues to those genes that
lack a strong promoter.
Computational Analysis of 5"- and 3"
untranslated Regions of mRNAs
J. Tabaska, M.Q. Zhang
The goal of this research is to find ways of recogniz-
ing the 5'- and 3--untranslated regions (UTRs), which
158
may then be used as markers to define the ends of
genes. Since no one secondary is structure-diagnostic
of all mRNAs, we need to look for general structure
properties within these molecules. To this end, we
have developed a structural potential score (SPS). The
SPS for a base in some sequence quantitates both the
number and stability of local base pairs in which the
base may engage, so that bases which are liable to con-
tribute to stable structures receive high SPSs. Analysis
of a large number of mRNAs has shown that bases in
the 5'- and 3'-UTRs have significantly higher SPS
scores than bases in the coding regions. This is thought
to reflect the fact that the coding bases are functional-
ly constrained relative to the UTR bases, so that if
there are any structures that are important for mRNA
processing or translational regulation, they are most
likely to occur in the UTRs. The utility of SPSs as a
component of a general gene-finding algorithm is
being evaluated.
mRNAs also contain signals involved in cotran-
scriptional and posttranscriptional processing and in
translational regulation. To help us identify possible
signals, we use a neural network which, when pre-
sented with a set of sequences believed to contain an
unknown signal, can "learn" to mimic a protein that
binds the signal (Heumann et al. 1994). We can then
query the model protein to characterize the signal we
were looking for. A variant of this neural network
approach can also be used to generate a model that
discriminates between true signals and pseudosignals.
Using this approach, we have developed recognition
models for the binding site of human cleavage stimu-
latory factor (CstF) and for some U-rich regulatory
elements, such as the mRNA destabilizer signal and
the cytoplasmic polyadenylation element (CPE).
Models have also been developed which suggest that
true AAUAAA polyadenylation signals tend to occur
downstream from AAUAAA-like sequences, whereas
AAUAAAs that do not direct polyadenylation appear
to be hidden by upstream pyrimidine-rich sequences.
Incorporation of these models into gene-finding pro-
grams is being studied, and the search for other sig-
nals by which mRNA UTRs may be recognized is
ongoing.
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STRUCTURAL BIOLOGY
R.-M. Xu J. Jiang K. Witkin (URP)
M. Hayashi Y. Zhang
We use X-ray crystallography as our principal method
to study protein-nucleic acid interaction in gene
expressions and molecular assembly in multiprotein
complexes. Our current studies focus on proteins
involved in pre-mRNA splicing and eukaryotic DNA
replication.
PROTEIN-RNA INTERACTIONS
IN PRE-MRNA SPLICING
hnRNP Al is one of the most abundant heterogeneous
nuclear ribonucleoproteins, which has been shown to
package nascent transcripts for processing, influence
alternative 5' splice site selection, catalyze the anneal-
ing of complementary RNA strands, and participate in
RNA transport. RNA-protein interaction plays an
essential part in these processes. We have undertaken
an initiative to understand the structural basis of pro-
tein-RNA interactions by hnRNP Al, in collaboration
with Adrian Krainer here at CSHL.
Last year, we determined the crystal structure of
human UP1, the domain of hnRNP Al that contains
two RNA recognition motifs (RRMs). From that
study, we learned that the two RRMs are antiparallel
and held together in a rigid structure, enabling the two
RRMs to function as a single entity in binding RNA.
We are continuing to analyze the structural basis of
RNA interaction by hnRNP Al. We have succeeded in
obtaining co-crystals of UP1 with two short RNA oli-
gos. Currently, we are optimizing crystallization and
data collection conditions for efficient structure deter-
mination.
Additionally, hnRNP A/B proteins have been
reported to bind to single-stranded d(TTAGGG)., the
human telomeric DNA repeat. The human telomeric
DNA repeat sequence shows striking similarity to the
high-affinity RNA sequence as determined by in vitro
Zhang, M.Q. 1998. A discrimination study of human core-pro-
moters. In Pacific Symposium on Biocomputing '98 (ed. R.
Altmann at al.), pp. 240-251. World Scientific, Singapore.
selection, which contains one or more copies of the
hexamer sequence r(UAGGGA/U). The similarity in
sequence requirements for deoxy- and ribonucleotides
in binding hnRNP Al implies that perhaps the under-
lying structural basis of sequence-specific interactions
with RNA and single-stranded DNA by hnRNP Al is
similar. We have crystallized and solved the structure
of UP1 with a 12-mer oligo d(TTAGGGTTAGGG).
The complex structure revealed an intriguing mode of
nucleic acid binding by hnRNP Al, where one single-
stranded telomeric DNA binds to the amino-terminal
RRM of one protein and the carboxy-terminal RRM
of another (Fig. 1). In the co-crystal structure, two
consecutive purines (adenine and guanine) base-stack
with two phenylalanines located in the conserved
RNP motifs. Arg-92, which is located in the linker
connecting the two RRMs, contacts three bases and
appears to play an important part in binding the telom-
eric DNA. The linker between the RRMs is highly
conserved both in length and in sequence among
hnRNP A/B proteins. Our finding suggests that this
high degree of conservation is perhaps evolutionarily
selected for the unique nucleic-acid-binding property
of hnRNP A/B proteins. It is worth noting that the two
protein molecules binding to the same strand of DNA
are related by crystallographic symmetry. This poses
the question of whether the observed binding mode
occurs in solution and whether it is sequence-depen-
dent. This question is being addressed biochemically
together with the Krainer laboratory.
Structural study of hnRNP Al is a part of our the-
matic investigation of the RRM cooperativity in pro-
teins that contain multiple copies of this RNA-binding
module. A significant number of the RRM-containing
proteins have multiple copies of RRMs; many of these
multi-RRM proteins require contiguous RRMs for
wild-type RNA-binding specificity. Cooperative inter-
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FIGURE 1 Crystal structure of UP1 in complex with human telomeric DNA repeats.
Two protein molecules are represented as ribbons, and the single-stranded DNA is
represented as ball and sticks.
actions between RRMs are believed to be a general
feature of proteins with multiple RRMs. We are inter-
ested in understanding how multiple RRMs are spa-
tially arranged and in what way this contributes to
cooperativity in RNA binding. We have chosen
U2AF65 (in collaboration with Adrian Krainer) and
polypyrimidine-binding protein (PTB, in collabora-
tion with David Helfman) for these studies. U2AF65
is the large subunit of the heterodimeric U2AF com-
plex, which is an essential splicing factor required for
U2 snRNP-branch point interaction and spliceosome
formation. U2AF65 contains three RRMs and binds
specifically to the polypyrimidine tract downstream
from the branch point. PTB contains four copies of
RRM, and it binds to the polypyrimidine tract within
the intron. PTB has been shown to be involved in tis-
sue-specific alternative splicing of tropomyosin pre-
mRNAs, and that of c-src and the GABAA receptor y2
subunit. It is believed that the binding of PTB to the
intronic sequence results in the repression of the splic-
ing of nearby exons, thus leading to the tissue-specif-
ic pattern of alternative splicing. We have made some
initial progress toward the structure determination of
these multi-RRM proteins, and we hope that the suc-
cessful determination of these structures will shed
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light on the common phenomenon of RRM synergy in
RNA binding.
STRUCTURE AND FUNCTION OF THE
SF2-ASSOCIATED PROTEIN P32
Human p32 protein, which co-purifies with splicing
factor SF2, is a ubiquitous eukaryotic protein. It has
been reported that p32 binds to the HIV-1 Tat and Rev
proteins, as well as EBNA-1 of Epstein-Barr virus,
and can potentiate trans-activation at the viral pro-
moter. In addition, p32 has been reported to bind to
the globular head domains of the complement compo-
nent Clq and inhibits the hemolytic activity of Clq.
However, the true physiological role of p32 remains
unknown. It has recently been shown that p32 is local-
ized in the mitochondrial matrix, and the disruption of
the gene homologous to the human p32 in budding
yeast causes growth retardation of yeast cells in glyc-
erol medium, but not in glucose medium. This obser-
vation points to the potential role of p32 in maintain-
ing mitochondrial oxidative phosphorylation.
We have undertaken the structural analysis of
human p32 (in collaboration with Adrian Krainer),
anticipating the structural information to aid in reveal-
ing the function of p32. p32 crystallizes with a P21
symmetry and cell dimensions of a = 58.63 A, b =
56.48 A, c = 93.83 A, and a = 96°. We have deter-
mined the crystal structure using the seleno-methionyl
multiple anomalous diffraction method, and the struc-
ture is currently being refined to 2.5 A resolution. The
crystal structure shows that p32 forms a trimeric ring.
Each p32 adopts an aa structure with seven antiparal-
lel (3- strands flanked by an amino-terminal and two
carboxy-terminal a-helices. The a-sheets from all
three monomers form the inner surface of the ring,
whereas the a-helices wrap around the ring and form
the outer surface. The structure of p32 will be ana-
lyzed in detail by comparing it with the existing pro-
tein structures in the database. In the end, we hope that
our structural analysis will lead to a better understand-
ing of the cellular function of p32.
MOLECULAR ASSEMBLY IN DNA REPLICATION
The ability to replicate the entire genome is essential
to all organisms. Recent progress in understanding the
initiation of DNA replication in eukaryotes has
demonstrated the importance of a six-subunit protein
complex, the origin recognition complex (ORC). ORC
is required for the recognition of the chromosomal ori-
gin of DNA replication and for the cell-cycle-depen-
dent assembly of prereplicative complexes. Sequence-
specific interaction with DNA requires ATP and
involves several subunits of the ORC complex. The
protein complex is quite ornate, having at least two
nucleotide-binding sites in different protein subunits,
and is regulated by specific DNA sequences.
Being structural biologists, we are fascinated by
how large protein complexes are assembled and how
individual subunits act together as a single functional
unit in some cases, whereas in other cases they exhib-
it their individualities. ORC provides us with the
opportunity to study these phenomena in the context
of eukaryotic DNA replication. In collaboration with
the Stillman laboratory, we have taken initial steps
toward the crystallization of ORC.
UNC69 AND AXONAL OUTGROWTH IN C. ELEGANS
In collaboration with the Hengartner laboratory, we
are carrying out the structure determination of UNC-
69 protein from Caenorhabditis elegans. Studies from
the Hengartner lab have shown that unc-69 causes
uncoordinated movement phenotype, and UNC-69 is
required for proper axonal fasciculation and out-
growth. A human homolog of UNC-69 has also been
identified. Interestingly, UNC-69 appears to interact
with itself and forms a multimeric complex in solu-
tion. We have crystallized UNC-69 fused with a hexa-
histidine tag at the amino terminus. We are currently
optimizing crystallization conditions to obtain bigger
crystals for X-ray diffraction experiments.
BEAMLINE DEVELOPMENT AT NATIONAL
SYNCHROTRON LIGHT SOURCE
We have made significant efforts in bringing the X26C
beamline into operation during the last year. The X-
ray crystallography operation at beamline X26C is
jointly run by Cold Spring Harbor Laboratory, SUNY
at Stony Brook, and the biology department at
Brookhaven National Laboratory. Thanks to the work
done by everyone from the CSHL X-ray crystallogra-
phy groups, Malcom Capel (BNL biology), and Grace
Shea (University of Chicago), X26C finally went into
operation during 1997. The beamline has been heavi-
ly used by the CSHL and Stony Brook groups. Further
development of the beamline will be necessary to
enable full-fledged macromolecular X-ray crystallog-
raphy operation. Nevertheless, the beamline has
already proven to be an important asset for a produc-
tive structural biology program at Cold Spring Harbor
Laboratory.
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NEUROSCIENCE
Molecular biological research during the last two decades has revealed a remarkable evolutionary conservation
of gene function across the animal kingdom. From cell proliferation and patterning of the embryo to the bio-
chemistry of cell signaling, genes of similar sequence have been found to have similar biological roles. This
new general law of biology holds as well for the neurosciences.
Continued neuroscience research at CSHL clearly has incorporated this new biological perspective. Single
genes are manipulated in almost every experiment, thereby revealing new roles or more intricate details during
neuronal development and function. These studies now often cross species boundaries. Enikolopov's group
studies nitric oxide (NO) function in human and rat cultured cells and in developing flies and frogs. Malinow's
group studies NMDA and AMPA receptor function in rat and mouse hippocampal slices and in the developing
frog visual system. Yin's group is studying CREB function in flies and mice. Zhong's group is studying NF1 func-
tion in flies and cultured mouse cells. Cline's group is investigating candidate plasticity genes in rats and frogs.
In each case, new insight is obtained from the different vantage points of each species' model system. Thus,
intellectual synergy emerges from a comparison of gene function among vertebrate and invertebrate species.
As units of biological function, gene products are minute and exert their effects primarily at the cellular level.
Hence, a mechanistic understanding of the roles of genes in more complex brain functions, such as neuronal
networks or behavior, requires visualization of molecules in cells. To this end, Dr. Karel Svoboda has joined the
neuroscience effort at CSHL. He brings with him an advanced, laser-based imaging system, which permits the
study of identified molecules in living brain tissue. With this new technology, Svoboda's group has begun to
visualize activity-dependent functional and structural changes in the synaptic connections among neurons-
with breathtaking resolution.
MOLECULAR NEUROBIOLOGY OF LEARNING AND
MEMORY IN DROSOPHILA
T. Tully C. Alexander S. Gossweiler M. Rahimzadeh
G. Bolwig M. Hannan M. Regulski
J. Christensen C. Jones M. Saitoe
J. Connolly R. Jones J. Salvatore
J. DeZazzo H. Li P. Smith
J. Dubnau J. Medal le B. Svedberg
T. Gill S. Pinto
Two major projects have been added to our efforts to
understand the biological bases of learning and mem-
ory in Drosophila. First, with support from the John
A. Hartford Foundation, we have begun a forward
genetic mutagenesis to identify new genes involved in
learning and memory. With perhaps 100 genes
involved in this form of learning and only 23 identi-
fied so far, our new mutagenesis promises to generate
the raw material that will fuel further insight to the
biological basis of learning and memory. Second, in
D. Vaughn
K. Velinzon
S. Xia
A. Chu (URP)
T. Bridges (Eton College)
R. Wlodarczyk (PFF)
collaboration with Helicon Therapeutics, Inc., we
have begun molecular screens for genes or their prod-
ucts that are differentially regulated during CREB-
dependent long-term memory formation. With access
to state-of-the-art DNA chip technology and pro-
teomics, this project will enhance greatly our molecu-
lar-genetic understanding of long-term memory for-
mation in fruit flies and will allow us to "leap-frog"
with such molecular information into the mammalian
genome.
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Molecular Search for
CREB-dependent
LTM Genes
T. Tully, J. Dubnau, J. Medal le, S. Gossweiler, J. Salvatore,
T. Gill [in collaboration with Helicon Therapeutics, Inc., and
J. Yin, Cold Spring Harbor Laboratory]
We have begun to search for genes downstream from
CREB that are transcriptionally regulated during LTM
formation. Parametric experiments have determined
that transcriptional changes of 150% can be detected
via five RNA extracts from adult heads. Both positive
and negative controls have been established with
extant genes known to be involved in cellular or
behavioral plasticity. Candidate genes X and Y have
been identified from a differential screen of a genom-
ic library with whole-head RNAs isolated immediate-
ly after spaced or massed training. Via our collabora-
tion with Helicon Therapeutics, we also have begun a
differential screen with two-dimensional protein gels.
To date, several candidate genes have been identified
from both nuclear and cytosolic fractions.
CREB Protein Structure
and Function
T Tully, D. Vaughn [in collaboration with L. Joshua-Tor
and J. Yin, Cold Spring Harbor Laboratory]
Ultimately, the modulation of long-term memory for-
mation will involve protein:: protein interactions at the
molecular level. Since the expression of different iso-
forms of dCREB2 is sufficient to modulate LTM for-
mation, these CREB isoforms and their binding part-
ners likely represent one set of interactions. Work on
vertebrate CREB has identified CBP as a partner nec-
essary for transcriptional regulation. Moreover, the
CREB-binding domain has been localized to an 80-
amino -acid region, and the structure of this domain-
with a 25-amino-acid CREB phosphopeptide-has
been solved by nuclear magnetic resonance (NMR).
Both the activator and repressor isoforms of CREB
contain this phosphopeptide sequence, suggesting that
presentation of this peptide within the overall struc-
tural framework of a CREB isoform is what deter-
mines whether CREB functions as a transcriptional
activator or blocker. To understand better this struc-
tural context, we have begun an X-ray crystal struc-
ture determination of Drosophila CREB.
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A significant amount of soluble CREB blocker has
been expressed as an amino-terminal HIS-tagged con-
struct in Escherichia coli. Several milligrams of solu-
ble blocker have been purified, and screening for crys-
tallization conditions has begun. CREB blocker with-
out a HIS-tag also has been purified. This will allow
expression, purification, and ultimately crystallization
trials with the native protein.
Identification of New Genes
Involved with Associative
Learning
T. Tully, C. Jones, S. Pinto, J. Christensen, G. Bolwig,
T. Bridges, J. DeZazzo, K. Velinzon, M. Rahimzadeh,
C. Alexander, M. Hannan, H. Li, M. Saitoe, P. Smith,
B. Svedberg [in collaboration with K. Broadie,
University of Utah]
We continue our molecular genetic characterizations
of latheo, linotte, nalyot, and golovan. We have iden-
tified DNA sequence lesions in independently isolated
mutant alleles of latheo, thereby confirming that we
have cloned the correct transcript. Experiments con-
tinue to search for proteins that interact with the novel
Lat protein. On the basis of fine-scale sequence analy-
sis, we putatively have identified the biochemical
nature of linotte. Combined with its preferential
expression in nerve terminals of the central brain, this
gene promises to open important new vistas in our
understanding of the biological basis of learning.
Behavioral "rescue" experiments have established
that the nalyot mutation resides in the Adf-1 gene,
which encodes a transcription factor. Chronic expres-
sion of hs-Adfl' in nalyot mutants yields normal
learning, whereas chronic expression of hs-Adfl' in
wild-type flies yields defective learning. Interestingly,
Adfl is expressed throughout the adult brain. These
and other data suggest that nalyot functions during
+1+ nal/nal
rY,
FIGURE 1 Adf1 expression in wild-type (+/+) and mutant
(nal/nal) adult brains. Note the lower levels in mutant brain.
development to produce normal learning. We now are
turning our attention to long-term memory formation
in nalyot mutants under conditions when learning is
normal. Initial results suggest an additional, function-
al role for Adfl when long-term memory is induced.
Similar experiments are under way with golovan.
Characterization of Extant
Mutants
T. Tully, C. Jones, M. Regulski, J. DeZazzo
[in collaboration with U. Heberlein, San Francisco
General Hospital]
U. Heberlein's group has shown that amnesiac
mutants are more sensitive to the anesthesia produced
by chronic exposure to alcohol. Induced expression of
our hs-amn+ transgenes rescues this alcohol sensitivi-
ty defect in amnesiac mutants, thereby indicating that
the neuropeptide encoded by amnesiac may be
involved in modulating drug sensitivities. Experiments
now are under way to determine whether the hs-amn+
transgene is able to rescue the memory defect of amne-
siac mutants.
To date, behavioral experiments have failed to
demonstrate the involvement of nitric oxide (NO) in
fruit fly behavioral plasticity. Wild-type flies fed
inhibitors of nitric oxide synthase (NOS) show no reli-
able defects in olfactory learning or early memory for-
mation thereafter. Possibly this lack of effect is due the
inability of flies to ingest enough of NOS inhibitor to
have effect. To address this issue genetically, we have
tried, to no avail, to generate mutations in the dNOS
gene. We also have generated various dNOS constructs
and are screening them in cell culture to identify dom-
inant-negative forms. Transgenic flies carrying such
dominant-negative NOS constructs then will be bred
ultimately for more behavioral experiments.
Functional Properties of Learning
and Memory in Normal and
Mutant Flies and in Worms
T. Tully, J. Connolly, R. Wlodarczyk, K. Velinzon,
S. Xia, M. Saitoe [in collaboration with M. Hengartner,
Cold Spring Harbor Laboratory]
In collaboration with Kendall Broadie at the
University of Utah, we have characterized synaptic
plasticity at the larval neuromuscular junction of lath-
eo mutants. In a manner analogous to dunce mutants,
latheo mutants show increased calcium cooperativity,
leading to an enhancement of evoked excitatory junc-
tion currents (ejcs); spontaneous mini-ejcs, in contrast,
are normal. This defect in basic synaptic transmission
yields aberrant synaptic plasticity (paired-pulse facili-
tation, short-term facilitation, augmentation, and post-
tetanic potentiation).
Unlike dunce, however, no structural defects are
observed at the neuromuscular junction. More gener-
ally, these data suggest that other learning and memo-
ry mutants will show defects in synaptic function. To
this end, we have begun to look at linotte and nalyot
neuromuscular junctions.
We also have begun to study plasticity in nema-
todes. Initial work from D. Van der Kooy's group at
the University of Toronto indicates that flatworms are
capable of Pavlovian learning using a task analogous
to that used with fruit fly larvae. We are trying to repli-
cate these results and then to initiate a study of mem-
ory formation thereafter, with particular emphasis on
the effects of spaced and massed training. If "homolo-
gy of function" exists, a mutagenesis in this species
will yield new L&M genes more efficiently.
New Genetic Tools
T. Tully, J. Dubnau, R. Jones
We are progressing in our efforts to develop the next
generation of genetic tools for Drosophila. We have
nearly completed building the DNA constructs with
which to generate transgenic flies carrying (1) an
inducible transgene also with limited spatial expres-
sion and (2) a "gene conversion" transgene to attempt
in vivo gene replacement. These constructs will be
injected into fly eggs presently. Finally, molecular
experiments designed to identify EMS-induced point
mutations have been less successful, necessitating
more extensive analysis.
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LONG-TERM MEMORY FORMATION IN DROSOPHILA
J. Yin M. Belvin E. Drier J. Nagel J. Waskewich
J. Bikoff (URP) J. Horiuchi M. Stebbins P. Wu
E. Cahill Z. Lin M. Tel lo H. Zhou
J. Daniell A. Morotti J. Wallach
Circadian Regulation of
CRE-responsive
Transcription
M. Belvin, H. Zhou, P. Wu, J. Daniell
In Drosophila, [CRE-TATA-luciferase] transgenic
flies exhibit circadian patterns in luciferase activity,
whether measured in tissue extracts or in behaving
flies (see Fig. 1). There are two peaks in luciferase
activity, one during the morning and the other shortly
after lights out. These rhythmic transcriptional pat-
terns are regulated through the circadian system. Flies
entrained on a 12-hour light:12-hour dark cycle main-
tain this pattern of transcription when switched to
constant darkness, and the periodicity of the pattern is
affected by mutations in the clock gene per, being
shortened in per', lenghthened in per', and destroyed in
per° mutants. High-level rhythmic transcription is
dependent on a consensus CRE site (TGACGTCA),
since single nucleotide changes in each of the half-
sites drastically reduce activity, although the remain-
ing low-level transcription may still show a hint of
rhythmicity. We are currently determining if proteins
from the dCREB2 gene regulate this pattern of tran-
scription, and if not, which Drosophila CRE-binding
proteins are responsible.
We are intrigued by the possibility that this pattern
of rhythmic transcription may be involved in the for-
mation of long-term memory (LTM). Since CRE-
responsive transcription, mediated by the dCREB2
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gene and its various protein isoforms, is critical for the
establishment of LTM in many organisms, including
flies, it is possible that the time of training (relative to
the circadian clock) is important for memory forma-
tion. In addition, there is a large amount of data in var-
ious systems, at the behavioral and cellular levels, that
implicate the involvement of parts of the sleep cycle
in memory consolidation. It is widely believed that the
physical basis for LTM is increased connectivity
between the neurons that subserve the particular
behavior. Since it is also likely that neuronal circuits
become weaker if they are not periodically used ("use
it or lose it"), systems-wide mechanisms must exist
for reuse and restrengthening of circuits during the
maintenance of LTM. We are trying to establish
whether circadian-controlled, CRE-responsive tran-
scription is the underlying molecular mechanism for
this important aspect of memory consolidation.
Subcellular Localization
M. Belvin, H. Zhou, J. Bikoff, M. Tel lo, P. Wu
When total proteins from flies are subjected to tradi-
tional nuclear:cytoplasmic fractionation, two of the
major isoforms from the dCREB2 gene appear to be
largely cytoplasmic. When certain protein isoforms
are overproduced in transgenic flies, they also show
preferential subcellular localization, some being pre-
dominantly cytoplasmic and others more nuclear.
MIN MIN A 7 A
FIGURE 1 Circadian cycling of CRE-luciferase reporter.
These biochemical data are supported by immunocy-
tochemistry, although there are clearly significant lev-
els of nuclear staining on tissue sections.
The dCREB2-b isoform, which we previously have
shown to block LTM formation completely and
specifically, fractionates largely into the cytoplasm,
whereas the dCREB2-a isoform is more nuclear. The
dCREB2-a isoform contains three alternatively
spliced exons (2, 4, and 6), which are spliced into the
dCREB2-b backbone. Exon 2, the most amino-termi-
nal of the alternatively spliced exons, was originally
identified using RT-PCR analysis of head RNA. All of
these protein isoforms contain extremely good match-
es to a consensus nuclear localization signal in their
bZIP domain, suggesting that the cytoplasmic local-
ization of some of the isoforms may reflect an active,
regulated process. Mutation of eight different possible
phosphorylation sites, which are conserved across
CREB molecules from many species, does not affect
the subcellular localization of the dCREB2-a isoform.
We are currently investigating the possible phospho-
rylation sites, signaling pathways, and combination of
exons that might control subcellular distribution of
these proteins. We are also testing the dCREB2-d iso-
form, which only contains two of the three alterna-
tively spliced exons, for transcriptional activity in
cells, subcellular localization, and its effect on LTM
formation. One of the two dominant endogenous
bands that our antibodies detect probably corresponds
to dCREB2-b, whereas the other band comigrates
with dCREB2-d.
The Role of Phosphorylation
in Regulating dCREB2
Activity
J. Horiuchi, M. Belvin, H. Zhou
Phosphorylation, notably on the well-conserved Ser-
133 residue, regulates the activity of the CREB fami-
ly of transcription factors. We are interested in the
possible roles of the other well-conserved residues on
dCREB2 transcriptional activity and LTM formation.
Alanine substitution mutations have been placed on
all of the known phosphorylation sites on the
dCREB2-a and dCREB2-b isoforms, and transgenic
flies have been made. In addition, we are analyzing
some of these mutations in transiently transfected F9
cells.
We previously reported that induced overexpres-
sion of the dCREB2-a isoform enhances LTM forma-
tion, accelerating its rate of formation. Subsequent
molecular analysis reveals that the transgene used in
these experiments contained a sequence rearrange-
ment generated sometime during its manipulation,
prior to making the flies. This rearrangement results in
premature termination of translation early in the
dCREB2-a open reading frame. However, in reticulo-
cytes, this rearranged DNA makes a truncated protein
when an internal, in-frame, translation initiation site is
used, making a protein of about 28 kD that contains all
of the phosphorylation sites and the bZIP domain.
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This 28-1(13 protein is also the protein that shows
PKA-responsive, CRE-binding transcriptional activi-
ty in transiently transfected F9 cells. When the
sequence rearrangement is repaired and expressed in
reticulocyte or flies, two proteins are made, one full
length (about 40 kD) and the other truncated. We are
currently assaying constructs that make the shorter
protein only, the longer protein only, or both, in tran-
siently transfected cells, transgenic reporter flies, and
transgenic flies for their effects on transcription and
LTM formation.
Tetracycline-inducible
Expression in Flies
and Mice
M. Stebbins, Z. Lin
We have continued to develop our (hopefully)
improved version of the tetracycline inducible sys-
tem. This system consists of two separate trans-
genes, one carrying the trans-activator gene, the
other the target gene of interest. We have made
transgenic flies and mice carrying various versions
of the trans-activator (forward or tet "on" in flies
and mice, reverse or tet "off' in flies). In flies, the
trans-activator is being driven ubiquitously by the
actin promoter, whereas in mice it is being driven by
the spatially restricted aCaM kinase II promoter,
which is forebrain-specific. Two different antibodies
detect a protein band of the proper size in total
extracts from transgenic flies, indicating that both
the forward and reverse trans-activators are made at
detectable levels. We have made transgenic animals
carrying target genes in both systems and will use
luciferase and lacZ targets to evaluate the inducibil-
ity of the system, the amount of leakiness in the
absence of the antibiotic (for the forward system),
the kinetics of induction, and the spatial regions
where inducible expression occurs. We have also
made a number of target transgenic animals that
carry genes of interest, hopefully to apply the sys-
tem to the study of memory formation in both flies
and mice.
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Searching for Neurons Where CREB Is
Activated during LTM Formation
J. Wallach, H. Zhou
We have used transgenic reporter flies and mice to try
to detect CREB activation in response to behavioral
training. In flies, we have used and analyzed "simple"
reporters (which contain 3-15 CRE sites in front of a
TATA box and lacZ), as well as complex reporters dri-
ven by native promoter fragments from genes that we
suspect to be "downstream" target genes of CREB
activation (e.g., fos, tyrosine hydroxylase, dCREB2).
These reporters are being analyzed for differences in
tissue staining from flies that receive spaced, massed,
or no training.
In mice, we have a transgenic line that carries a
7xCRE- TATA -lacZ reporter. This line shows fairly
high basal Xgal staining in the CA1 and CA3 fields of
the hippocampus and throughout the amygdala,
although the staining in the dentate gyms region of the
trisynaptic circuit of the hippocampus is very low.
Kainate injection dramatically induces staining in the
dentate region and increases the number and intensity
of cells that stain in CAl and CA3. We are using these
mice to look for new staining after behavioral training
in cued and contextual fear conditioning.
Mouse Behavior: The Development
of Behavior with a Spaced
Versus Massed Distinction
J. Wallach, J. Waskewich, J. Nagel [in collaboration with
Tim Tully, Cold Spring Harbor Laboratory]
We are investigating behavioral parameters that might
allow the identification of a mouse behavioral task
which yields a memory difference after spaced versus
massed training. Various parameters, such as strain
differences, stimulus intensity, duration, and frequen-
cy, and behavioral tasks are being investigated.
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NEURAL BASIS OF LEARNING AND MEMORY IN DROSOPHILA
Y. Zhong N. Wright Y. Wang L. Luo
F. Hannan Z. Xie J. Sheng
F. Guo J. An J. Tong
Our primary interest is focused on the neural basis of
learning and memory by studying Drosophila
mutants. A number of Drosophila mutants have been
isolated by their defects in learning, short-term mem-
ory, or long-term memory. These mutants provide a
unique opportunity to gain insights into neuronal or
neural network properties that are important for learn-
ing and memory. Currently, we have built our research
on two model systems.
First, the larval neuromuscular junction prepara-
tion has been used because of its accessibility to elec-
trophysiological analysis of identifiable synapses in
Drosophila. It allows us to examine how in general
synaptic transmission and neuromodulatory responses
are altered in the mutants and to identify new compo-
nents that act in concert or sequentially with the
mutant molecules and are potentially important for
learning and memory. This study has led us to pursue
the biochemical and behavioral significance of the
newly identified components. Second, we have devel-
oped methods of monitoring neuronal activities from
living fly brains, including intracellular recordings
and optic Ca-E÷ imaging, in response to odors. This
preparation allows us to investigate sensory informa-
tion processes and neural activities more directly
related to learning and memory.
K+ Channels Mediating
the PACAP Response
J. Sheng, Y. Zhong
Pituitary adenylyl cyclase-activating polypeptide
(PACAP) is a vertebrate neuropeptide that can induce
a 100-fold enhancement of K* currents in larval mus-
cle cells (Fig. 1). This response is abolished by rut and
NFl mutants, both affecting learning and short-term
memory. It has been indicated that this PACAP
response is mediated by coactivation of the adenylyl
cyclase/cAMP/PKA and Ras/Raf pathways. However,
K.' channel subunits mediating the PACAP response
remain to be determined. We investigated a number of
ICE channel mutants. The preliminary results indicate
that the PACAP response was normal in all single
mutants examined, including Sh, eag, Hk, and slo, and
diminished in Sh, slo double mutants, suggesting that
Sh-encoded voltage-activated K+ channels and slo-
encoded Ca++-activated channels may mediate the
response.
Biochemical Analysis of NF1-dependent
Activation of Rut-adenylyl Cyclase
J. Tong, F Hannan, L. Luo
NFl is a tumor suppressor gene that encodes a large
protein containing a fragment homologous to the cat-
alytic domain of ras-GAP. NFl causes skin tumors
and a variety of symptoms, including specific learning
deficits, in human beings, which has been thought
mainly to result from the defect of its GAP function.
However, previous electrophysiological experiments
have suggested that NFl mediates the cAMP pathway
in addition to inhibiting ras activity. Yet, whether and
how NFl affects cAMP synthesis remains elusive
because the electrophysiological data only provide
indirect evidence. Here, we analyzed how the mem-
brane fraction of adenylyl cyclase activity is affected
in NFl mutants, but the stimulated cAMP synthesis by
adding GTPrs was altered by the mutations (Fig. 2).
GTPrs induced a strong increase in adenylyl cyclase
activity in wild-type flies; the increase of activity was
much smaller in NFl null mutants. This suggests that
there are two components of stimulated adenylyl
cyclase activities: one NFl- independent and another
NFl- dependent. We are currently investigating how
PACAP38
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FIGURE 1 PACAP38-induced enhancement of K+ currents in
larval body-wall muscles. The arrow indicates focal applica-
tion of PACAP38 (5 j.t.m). Control current traces were record-
ed before application of PACAP38. The time in seconds after
pressure-ejection of PACAP38 is indicated above current
traces.
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FIGURE 2 GTPrs-stimulated adenylyl cyclase activity is
reduced in NF1 mutants. Adenylyl cyclase activity was
assayed on the membrane fraction extracted from homoge-
nized abdominal tissues.
mechanistically NF1 proteins affect activation of
adenylyl cyclase.
Two-hybrid Screening of NF1
Targets That Mediate
the NF1-dependent cAMP Pathway
F. Hannan
Because a yeast homolog of NFl, IRA, has been pro-
posed to bind to the yeast adenylyl cyclase and Ras to
mediate Ras-dependent cAMP synthesis, and because
of indications from electrophysiological data that NFl
may regulate activation of rut-encoded adenylyl
cyclase, we examined the possibility that the NFl pro-
tein binds to Rut-adenylyl cyclase by the yeast two-
hybrid analysis. Various combinations of fragments of
the coding region of the two genes were cloned into
vectors to test their interactions; none were found to
give a positive result. Thus, we turn to the second sce-
nario in which NFl may interact with adenylyl
cyclase via an intermediate. We are now setting up
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the yeast two-hybrid system for screening potential
targets of NFl from a fly cDNA library.
Molecular Basis of Learning
Defect in NF1 Mutants
F. Guo
The observations that NFl patients, as well as NFl
mouse knockouts, display a learning disability have
interested our group from beginning of this project.
The finding that NFl regulates activation of Rut-
adenylyl cyclase in Drosophila provides a plausible
explanation for the molecular basis of the observed
learning defects because diminished activity of Rut-
adenylyl cyclase in flies and mice disrupts learning
and memory. Our investigation of NFl behavior sup-
ports the hypothesis.
Greatly facilitated by the help from Tim Tully's
lab, we showed that associative learning is defective
(Fig. 3) in NF1 mutants, whereas the peripheral senso-
ry modalities related to the learning behavior are near
normal. This phenotype could be rescued by express-
ing the normal NFl protein. The double mutant
rut;NF1 did not make the learning score any worse
than that in NFl single mutants. Moreover, the NFl
learning defects can be rescued by expressing the
transgenic catalytic subunit of PKA. These results
strongly suggest that NFl is a component involved in
learning processes by regulating the cAMP pathway,
mainly on Rut-encoded adenylyl cyclase.
K33 NF1,2 fkF1l<4;
FIGURE 3 Learning defect in NF1 mutants is rescued by
expression of transgenic PKA subunit. The performance
index is in a scale where 1 indicates a perfect learning and
0 no learning. The learning score was obtained by using the
Tully-Quinn procedure.
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FIGURE 4 Changes in fluorescent intensity induced by odor
recorded from mushroom bodies of living flies. Each trace
indicates the time course of fluorescent change of different
regions in the mushroom body, but recorded simultaneously.
The arrows mark the period during which odor EA was
puffed.
NF1 Function in Vertebrates
Z. Xie, J. An, L. Luo [in collaboration with
A. Silver, Cold Spring Harbor Laboratory]
The data supporting the hypothesis that tumor sup-
pressor NF1 mediates the cAMP pathway are all
obtained from studies of Drosophila mutants.
Whether such a mechanism also operates in verte-
brates remains to be examined. Since the mouse NF1
knockouts are available and cultured NF1 mutant neu-
rons exhibit abnormal neurotrophin-independent sur-
vival, we used cultured mouse hippocampal neurons
to test this possibility. We found that puffs of neu-
rotrophin BDNF or NT3 stimulate new neurite out-
growth from the middle of axons or dendrites. The
newly formed neurites were oriented toward the gra-
dient of the puffed neurotrophin and were at the loca-
tion that was hit by the neurotrophin. This neu-
rotrophin-dependent new neurite formation may be an
important mechanism for neural plasticity. Similar
neurite outgrowth was also stimulated by forskolin, a
drug stimulating adenylyl cyclase activity. We are
now investigating whether this neurotrophin-depen-
dent process is altered in NF1 mutant neurons. We
will also investigate whether GTPrs-stimulated
adenylyl cyclase activity is affected in NF1 mouse
knockouts.
Ca" Imaging of
Neuronal Activity of
the Mushroom Body
N. Wright, Y. Wang
The mushroom body is a distinct CNS structure that is
crucial for olfactory-related associative learning in
insects, including flies. Since action potentials induce
influx of Ca ", which is required for transmitter
release, we used change of Ca" concentrations as an
indicator of neuronal activity in the brain. A piece of
cuticle above the mushroom body region was
removed for loading the Ca"--sensitive dye and for
recordings of optic imaging. When air-borne odor was
delivered to flies, changes of fluorescence intensity
were observed around the mushroom body region
(Fig. 4). Our current working hypothesis is that the
mushroom body encodes information regarding
whether a particular odor is attractive or repulsive. We
will investigate how this coding of information may
be modified by conditioning stimuli and how such
modification may be altered in learning and memory
mutants.
PUBLICATIONS
Guo, I. The, E Hannan, A. Bernards, and Y. Zhong.
1997. Requirement of Drosophila NF1 for activation of
adenylyl cyclase by PACAP38-like neuropeptides.
Science 276: 795-798.
The, I., G.E. Hannigan, S. Reginald, Y. Zhong, J.E. Gusella,
I.K. Hariharan, and A. Bernards. 1997. Rescue of a
Drosophila NF1 mutant phenotype by protein kinase A.
Science 276: 791-794.
In Press
Wright, N.J.D. and Y. Zhong. 1998. Serotonin-sensitive leak-
age channel in Drosophila central neurons, J. Neurobiol.
34: 83-95.
171
ACTIVITY-DEPENDENT NEURONAL DEVELOPMENT
H. Cline R. Bari J. Edwards I. Rajan
B. Burbach Z. Li G-Y. Wu
I. Cantallops I. Miloslayskaya D-J. Zou
A. Demetriades (URP) E. Nedivi
Our laboratory is working toward an understanding of
the cellular and molecular mechanisms that control
the development of structure and function in the CNS.
We perform our studies using the developing visual
system of the frog Xenopus. We use several approach-
es to this system which allow us to assess and manip-
ulate the coordinated development of neuronal mor-
phology and synaptic transmission in the CNS. One
approach is to use imaging of single retinal axons or
tectal neurons in the intact anesthetized animal to
observe their morphological development for up to 5
days in vivo with time-lapse confocal microscopy. A
second approach is to perform functional imaging,
using a calcium-sensitive fluorescent dye, to report
changes in intracellular calcium in response to visual
stimulus. A third approach is use a whole-brain prepa-
ration to take whole-cell patch-clamp recordings from
neurons at different stages in the process of matura-
tion. This is one of the only experimental systems that
permits direct recordings of synapse formation and
maturation in the intact CNS. To manipulate the
genetic and protein components of the neurons, we
use viral vectors to deliver genes of interest into frog
neurons. We are now using this range of techniques to
test the hypothesized roles of synaptic activity and
activity-regulated proteins in the coordinated develop-
ment of the structure and function of the CNS.
Stabilization of Dendritic
Structure In Vivo by CaMKII
G.-Y. Wu, K. Bronson, I. Miloslayskaya, B. Burbach,
R. Bari, H. Cline
Developing neurons must coordinate their morpho-
logical and functional development. We showed last
year that CaMKII promotes the maturation of retino-
tectal glutamatergic synapses in Xenopus. Whether
CaMKII activity also controls morphological matura-
tion of optic tectal neurons was tested using in vivo
time-lapse imaging of single neurons over periods of
up to 5 days. We divided morphological development
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of tectal cells into three stages: Stage-1 neurons are
newly differentiated. They undergo axonogenesis with
little elaboration of the dendritic arbor. Stage-2 neu-
rons are in a phase of rapid dendritic growth. After
several days, neurons enter stage 3, a period of slow-
er dendritic arbor growth. Short-interval observations
indicate that stage-2 neurons have twice the rates of
branch additions and retractions as more mature stage-
3 neurons.
To examine the role of CaMKII in tectal cell mor-
phological development, we used CaMKII antibodies
to study the time course and distribution of CaMKII
expression. CaMKII is expressed in a developmental
gradient such that more mature neurons express
intense CaMKII-immunoreactivity (CaMKII-IR),
whereas younger neurons in caudal tectum have no
detectable CaMKII-IR. Neurons first express
detectable CaMKII-IR in their somata when they have
a total dendritic branch length greater than 300 pm
and are more than 3 days old, according to BrdU birth-
dating. This series of observations indicates that
CaMKII expression in tectal neurons correlates with
the transition from rapidly growing stage-2 neurons to
more stable stage-3 neurons. Dendritic arbor elabora-
tion slows with maturation, in correlation with the
onset of CaMKII expression. Elevating CaMKII
activity in young neurons by viral expression of con-
stitutively active CaMKII slowed dendritic growth to
a rate comparable to that of mature neurons. CaMKII
overexpression stabilized dendritic structure in more
mature neurons, and pharmacological CaMKII inhibi-
tion increased their dendritic growth. Thus, endoge-
nous CaMKII activity limits dendritic growth and sta-
bilizes dendrites and may act as an activity-dependent
mediator of neuronal maturation.
These observations on neuronal morphology,
taken together with the electrophysiology data, in
which it appears that elevated CaMKII promotes the
maturation of synapses, suggest the following type of
coordinated regulation of neuronal structure and func-
tion: When NMDA receptors are active and there is
calcium influx, the resultant increase in CaMKII
activity has two distinct effects on the tectal cell. One
is to promote the maturation of the synaptic physiolo-
gy and the other is to deter additional growth of the
dendrite at the local site where CaMKII activity was
elevated. As a result of the decreased branch addition
and branch extension in the tectal neurons, the retinal
axons retract the newly added short branch tips that
have failed to establish synaptic contacts with target
neurons. In our experiments, we increase CaMKII
activity throughout the tectal cell, but in the normal
neuron, NMDA receptor activity, calcium influx, and
CaMKII activity would occur at discrete sites within
the arbor corresponding to sites of converging inputs.
This would result in highly localized control of
synapse maturation and neuronal growth.
The Role of Glutamate Receptor
Activity in the Development
of Tectal Cell Dendrites In Vivo
I. Rajan, R. Bari, K. Bronson, H. Cline
The model outlined above suggests that glutamate
receptor activity will also influence tectal cell devel-
opment. To test this hypothesis, I. Rajan took in vivo
time-lapse images of single DiI-labeled tectal neurons
from normal animals and from animals treated with
pharmacological blockers of the NMDA and AMPA
type glutamate receptors, as well as the sodium chan-
nel blocker tetrodotoxin. Exposure to APV (100 gm),
CNQX (201.(m), or TTX (1 gm) all blocked the normal
development of the tectal cell dendritic arbor. These
observations indicate that glutamatergic activity pro-
motes the initial development of the dendritic arbor.
Inhibition of Protein Kinase
Function In Vivo
D.-J. Zou, B. Burbach
During the last 2 years, we have generated recombi-
nant vaccinia viruses expressing stable forms of pep-
tide inhibitors specific for two of the major calcium-
regulated protein kinases in the brain, CaMKII and
PKC. We have determined the relative potency and
specificity of peptide inhibitors on the activity of
endogenous enzymes by doing kinase assays in tad-
pole brain homogenates. In the last year, D.-J. Zou has
found that inhibition of endogenous CaMKII in tectal
neurons increases the elaboration of the dendritic
arbor in more mature tectal neurons, without signifi-
cantly changing the growth rate of more simple neu-
rons. This is consistent with our observations that sim-
ple neurons have little CaMKII and are therefore not
susceptible to the effect of CaMKII inhibitor. Zou fur-
ther tested the effect of inhibiting CaMKII in the post-
synaptic tectal neurons on the elaboration of the
presynaptic retinal axon arbors. His previous work has
shown that increasing CaMKII activity in tectal neu-
rons decreased the elaboration of retinal axons, by sta-
bilizing their structure. In these complementary exper-
iments, he has found that inhibition of endogenous
tectal cell CaMKII causes an enhanced elaboration of
retinal axons.
Candidate Plasticity
Genes
E. Nedivi, I. Rajan, H. Cline, R. Ban, K. Bronson,
I. Miloslayskaya, G.-Y. Wu [in collaboration with
P. Worley, Johns Hopkins University]
The experiments summarized above have allowed us
to test the potential function of previously identified
and characterized proteins in the control of neuronal
development and circuit formation. In an effort to test
the function of novel genes and their protein products
in developmental plasticity, we have established col-
laborations with scientists who have isolated activity-
regulated genes through differential screening tech-
niques. These screens were performed by E. Nedivi
when she was in Y. Citri's lab at the Weismann
Institute and by P. Worley's group at Johns Hopkins
University. Activity-regulated genes may be induced
in retinal ganglion cells or tectal neurons in response
to visual activity and thereby promote the further
activity-dependent development of the visual system.
Experiments mentioned above by I. Rajan indicate
that blocking retinotectal synaptic transmission
impairs the development of tectal cell morphology.
This may occur due to failure to induce activity-regu-
lated genes. The candidate plasticity genes are regu-
lated by neuronal activity and during development.
Expression of four candidate plasticity genes in optic
tectal neurons in vivo using recombinant vaccinia
viral constructs results in four unique phenotypes with
respect to neuronal development. Results from one
such study are outlined below.
CPG15, a GPI-linked signaling molecule induced
by synaptic activity, promotes dendritic growth in
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FIGURE 1 Drawings of images collected at daily intervals
over 3 days of neurons from animals infected with a vaccinia
virus expressing the candidate plasticity gene, cpg15, com-
pared to control neurons. Neurons from cpg15-VV-infected
animals grow bigger faster than normal neurons. The first
image was collected about 24 hr after viral expression of
cpg15 had begun. Experiment performed by E. Nedivi and
G.Y. Wu.
vivo. Using time-lapse imaging and virally mediated
gene transfer, we demonstrate that CPG15 promotes
dendritic arbor growth in vivo. CPG15 accelerates the
growth of projection neurons, but has no effect on the
growth rate of interneurons. We further show that
CPG15, a GPI-linked protein, controls growth of
neighboring neurons through an intercellular signal-
ing mechanism. Thus, CPG15 is a signaling molecule
capable of translating neuronal activity into structural
changes. Our findings posit the existence of a new
class of activity-regulated growth factors, which by
virtue of being membrane bound, may permit exquis-
ite spatial and temporal control of neuronal growth
(see Fig. 1).
Calcium Imaging
in Retinal Arbors
J. Edwards, I. Miloslayskaya, R. Ban, H. Cline
We have used in vivo imaging of the calcium-sensi-
tive dye, calcium green dextran, to perform function-
al imaging of retinal ganglion cell axon activity in
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response to light stimulus to the retina. We have found
that light stimulus to the eye causes changes in calci-
um levels in the RGC axons within the optic tectum.
We tested whether the changes in calcium in the axon
terminals were due to stimulation of RGCs.
Intraocular application of the sodium channel blocker
tetrodotoxin (TTX [10 Ituvi]) blocked the stimulus-
induced increase in axonal fluorescence, whereas
lower concentrations (100 nM) had no effect. Similar
intraocular application of the selective L-type voltage-
sensitive calcium channel antagonist nifedipine (1 i.tm
and 10 Rm) blocked increases in fluorescence intensi-
ty in RGC axon arbors. A second series of pharmaco-
logical investigations were designed to determine the
mechanism of the calcium elevation in the axon ter-
minals within the optic tectum. Intraventricular injec-
tion of caffeine (10 mivt) causes a large increase in cal-
cium, indicating that intracellular stores contribute to
the calcium signal. Presynaptic nicotinic acetylcholine
receptors (nAChRs) may play a part in axon arbor
development and retinal topography. Injection of
nicotine (10 pm) significantly elevated RGC axonal
calcium levels, whereas application of the specific
nicotinic-cholinergic receptor blocker a-bungarotoxin
(100 titer) blocked the stimulus-evoked rise in axonal
calcium. These data suggest that light stimulus to the
retina increases calcium in the axon terminal arbors
through a mechanism that may include calcium-
induced calcium release and could be modulated by
nAChRs.
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THE BIOLOGY OF LEARNING AND MEMORY
A.J. Silva 0. Carvalho S. Kida E. Friedman
J. Coblentz P. Chen K.P. Giese
N.B. Fedorov Y. Elgersma J.H. Kogan
P.W. Frank land
Our laboratory is studying the molecular and cellular
processes that underlie learning and memory. Our
approach is to study the behavior and electrophysiol-
ogy of mice with specific genetic modifications.
Below, are summarized our research efforts of the last
year.
AUTOPHOSPHORYLATION AT T286
OF THE ocMKII IS REQUIRED FOR LTP
FOR PLACE CELL STABILITY AND FOR
PLACE LEARNING
Long-lasting changes in synaptic strength (such as
LTP) are thought to underlie learning and memory.
Previous studies in our laboratory showed that the
genetic deletion of the a calcium-calmodulin-kinase
II (aCaMKII) impairs both LTP and learning.
Autophos-phorylation at T286 allows aCaMKII to
switch from a CaM-dependent to a CaM-independent
state, and J. Lisman and colleagues at Brandeis have
proposed that the T286 autophosphorylated (constitu-
tively active) state of CaMKII is crucial for LTP and
learning. Consistent with the model, previous results
showed that both LTP induction and learning trigger a
long-lasting increase in the autophosphorylated form
of CaMKII. These studies, however, did not demon-
strate that the autophosphorylation of CaMKII is
required for either LTP or learning. To determine
whether the autophosphorylation of aCaMKII at
T286 is required for LTP and learning, we substituted
T286 for alanine (T286A) with a novel gene-targeting
procedure. The T286A mutation results in mutant
mice (aCaMKII T286A) with a kinase that is unable
to switch to its constitutively active state.
LTP was tested in the aCaMKIIT286A mutants
both with extracellular field recordings and with
whole-cell recordings (pairing protocol) in the CA1
region of hippocampal slices. This analysis revealed
that NMDAR-dependent LTP is especially impaired in
the mutants. In contrast, basal synaptic transmission,
NMDAR function, and several forms of short-term
plasticity are normal in these mutants. Our studies
with the water maze also showed that the autophos-
phorylation of aCaMKII is required for spatial learn-
ing, a hippocampus-dependent task. During training,
the mutants needed more time than wild-type mice to
locate the platform, and during a transfer test given at
the end of training, the wild-type mice searched selec-
tively for the platform, whereas the mutant mice did
not. In contrast, the mutants could learn a hippocam-
pus-independent task, the visible platform version of
the Morris water maze, indicating that they had the
vision, motivation, and motor coordination required
for learning in the water maze. Altogether, these
results show that the autophosphorylation of
aCaMKII at T286 is crucial for hippocampal LTP and
hippocampus-dependent learning.
In the hippocampus, spatial representations are
thought to be mediated by "place cells," neurons that
fire selectively when an animal is in a specific loca-
tion. LTP may underlie the fine-tuning and stability of
firing patterns in place cells. Y. Cho, a post-doe in the
laboratory, went to Howard Eichenbaum's laboratory,
and there she compared the properties of place cells in
two mutants with different severities of impairment in
LTP and place learning: the aCaMKIIT286A mice,
and mice deficient for the a6, isoform of the cAMP-
responsive element binding protein (CREB"A-). Place
cells from both mutants showed decreased selectivity
in spatial tuning, suggesting that the spatial maps of
these mutants were of "lower" resolution than in con-
trols. In addition, consistent with the idea that stable
long-lasting changes in synaptic strength underlie the
stability of place maps in the hippocampus, the
aCaMKIIT286A mutants with severely abnormal LTP
also showed profoundly unstable place fields, the
functional units that make up hippocampal place
maps. Consistent with these findings, the CREB`1°-
mutants, which have milder LTP deficits, also have
milder impairments in place field stability and in spa-
tial learning. Together, these results indicate that LTP
is important for the fine-tuning and stabilization of
place cells, and these properties are key to place learn-
ing.
175
THE HIPPOCAMPUS IS ESSENTIAL FOR CONTEXT
DISCRIMINATION, BUT NOT FOR CONTEXT
RECOGNITION
Mutations can cause very specific behavioral deficits.
This specificity is important because it can often sug-
gest which brain regions should be used to search for
the mechanism underlying the learning deficit of the
mutants. For example, many of the mutants we have
studied have been analyzed in contextual fear condi-
tioning, a form of associative learning in which ani-
mals learn to associate an aversive event with a spe-
cific context. Previously, it has been proposed that the
hippocampus is required for forming a polymodal rep-
resentation of context. However, recent studies have
shown apparently normal contextual fear conditioning
in hippocampus-lesioned animals. This uncertainty
complicates the interpretation of contextual condition-
ing studies of mutant mice, and therefore we decided
to address this problem. Our recent studies showed
how (1) the timing of hippocampal lesions and (2) the
behavioral/representational demands of the task affect
the requirement for the hippocampus in contextual
fear conditioning. Our results showed that whereas
lesions given after training abolished contextual fear
conditioning, lesions given before training did not.
Thus, animals lacking a functional hippocampus can
be trained to recognize an aversive context, whereas
lesioning the hippocampus of trained mice complete-
ly abolished their ability to recognize the aversive
context in which they were trained. First, these results
demonstrate that an animal's ability to recognize an
aversive context can be mediated by both hippocam-
pal and nonhippocampal neural systems; in contrast
with previous reports, a functional hippocampus does
not seem to be essential for contextual fear condition-
ing in mice. In the absence of the hippocampus, con-
ditioned responding may be mediated by hippocam-
pus-independent learning, such as cue/shock associa-
tions mediated by other brain regions (e.g., amygdala
and neocortex). Second, our results indicate that
strategies mediated by nonhippocampal systems, such
as cue/shock associations, are normally suppressed by
the hippocampus. If there were no suppression under
normal conditions, and memory of the aversive con-
text were processed in parallel by hippocampal and
nonhippocampal systems, then lesions given after
training would have the same effect as lesions given
before training. It is important to note that although
our studies showed that the hippocampus is not essen-
tial for contextual conditioning, they demonstrated
that normally this structure is involved in contextual
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fear conditioning (i.e., lesions given after training
abolish conditioned freezing responses).
In contrast with contextual conditioning, even hip-
pocampal lesions given prior to training disrupted
context discrimination, a novel procedure where mice
are trained to discriminate between two similar cham-
bers: one in which the animals receive a foot shock,
and another in which they do not. These data dissoci-
ate hippocampal and nonhippocampal contributions to
contextual fear conditioning, and they provide direct
evidence that the hippocampus has an essential role in
the processing of contextual stimuli. Although non-
hippocampal systems can support recognition of an
aversive context, they are inefficient at discriminating
between two similar contexts.
These results also offer an explanation for the
seemingly paradoxical results we obtained with the
NMDAR/Nf 1 compound heterozygous mice. These
mice have hippocampus-dependent spatial learning
deficits, but seemingly normal contextual condition-
ing. However, tests of contextual discrimination
revealed a pronounced deficit in these mutant mice.
The phenotype of these mutants parallels the results
obtained with hippocampal lesioned mice, suggesting
that the NMDAR/Nfl mutation blocked hippocampal
function. The resolution of this discrepancy demon-
strates the importance of neuroanatomical lesion stud-
ies for the interpretation of experiments with mutant
mice.
THE N-RAS HETEROZYGOUS MUTATION RESCUES
THE LEARNING DEFICITS CAUSED BY THE
NF1 HETEROZYGOUS MUTATION
Specific learning disabilities are the most common
neurological complication in children with neurofibro-
matosis type 1 (NF1), a neurological disorder that
affects 1/4000 people worldwide. The complexity of
these cognitive deficits, and the difficulty of pursuing
their study in patients, motivated us to study them in
mice mutant for the neurofibromin gene (Nfl+/-).
Additionally, uncovering the causes for the learning
deficits in Nf 1 mutant mice will reveal molecular, cel-
lular, and neuroanatomical substrates of learning and
memory. We have previously shown that the Nfl+/-
mice are a model for the learning disabilities caused
by the mutation of the NF1 gene in humans.
Neurofibromin, however, is a large protein that may
have multiple functions. Biochemical studies showed
that it is a Ras GTPase-activating protein. Addition-
ally, recent Drosophila genetic studies uncovered evi-
dence suggesting that neurofibromin regulates (direct-
ly or indirectly) the activity of adenylate cyclase. To
investigate whether the learning deficits of the Nfl
heterozygous mutants are caused by abnormally high
Ras activity, we tested whether a decrease in N-Ras
levels ameliorates/rescues the learning deficits of the
Nfl heterozygotes. Thus, we tested Nfl heterozy-
gotes, N-Ras heterozygotes, Nfl/N-Ras compound
heterozygotes, and their wild-type littermates in the
Morris water maze. Consistent with our previous
results, the Nfl mutants showed clear deficits in the
spatial version of the Morris water maze. In contrast,
the Nfl/N-Ras compound heterozygous mutants per-
formed normally throughout training and testing. Just
like wild-type controls, the Nfl/N-Ras mice learn the
task after only 5 days of training (6 trials per day): The
time required by the mice to reach the platform during
training and the specificity of their searches in probe
trials were indistinguishable from those of controls.
Additionally, our results showed that the N-Ras het-
erozygous mutation does not affect performance in the
Morris water maze. Similar results with other behav-
ioral tasks confirmed that the N-Ras heterozygous
mutation rescues the spatial learning impairments
caused by the Nfl mutation and suggest that the learn-
ing deficits observed in the Nfl heterozygotes are
caused by abnormally high Ras signaling. Current
studies are addressing the cellular implications of
these behavioral results.
DEVELOPING INDUCIBLE AND REGION-RESTRICTED
KO SYSTEMS: THE CRE/LBD-ESTROGEN
AND TET INDUCIBLE SYSTEMS
In the last year, we have tested the Cre/LBD-estrogen
inducible system in mice. Cell culture studies showed
that fusions of the LoxP/Cre site-specific recombinase
with the ligand binding domain (LBD) of a human
mutant estrogen receptor confer hormone-dependent
regulation to the activity of that recombinase. Our lab-
oratory derived 12 transgenic lines for a vector
designed to direct the expression of Cre-LBD (from
the estrogen receptor with the G525R mutation) to the
hippocampus using regulatory sequences of the
aCaMKII gene, a forebrain, postnatally expressed,
and neuron-specific promoter highly expressed in the
hippocampus. In addition, we derived mice that con-
tain a loxP- flanked (foxed) neo gene within the
crCaMKII gene. We have already tested 7 of the 12
lines generated, and so far we have not seen any dele-
tion of the floxed gene with a variety of induction pro-
tocols. To confirm that the foxed neo allele can be
deleted by Cre recombinase, we have deleted it in ES
cells transfected with Cre. Currently, we are selecting
for transgenic lines that express high levels of the
fusion protein.
In addition to the LBD-Cre system, we are also
testing tetracycline-regulated gene expression. This
system (tet system) has become an important tool for
the analysis of gene function in a variety of species.
This system normally consists of two components,
one encoding the trans-activator protein under control
of a promoter (in our case we used the aCaMKII pro-
moter), and the second component is the tet-operator
minimal promoter controlling the gene of interest (in
our case Cre recombinase). The tet-mice that we have
generated (5 lines) were crossed with mice with two
loxP sites flanking a neo gene in the crCaMKII locus.
We are currently using these transgenic mice to test
the efficiency of Cre-mediated deletion of the floxed
allele. Preliminary results suggested inducible Cre-
mediated deletion in one of the transgenic lines tested.
We are currently confirming and characterizing in
detail this observation.
Another system that we have tested involves trans-
genic mice (4 lines) that we have derived with Cre
recombinase under the regulation of the ocCaMKII
promoter. This simpler noninducible system allows
the deletion of genes only in regions of the brain that
express the aCaMKII gene (forebrain neurons of the
postnatal brain).
DERIVATION OF LOXP FLANKED ALLELES
FOR RAF-B AND KV6.2
The Cre-mediated gene deletion systems described
above work on genes/exons flanked by loxP sites. The
Cre recombinase recognizes these sites and deletes
DNA sequences between them. This past year we have
generated lines of embryonic stem cells with loxP-
flanked genes: Raf-B kinase and Kv6.2 potassium
channel. The Raf-B kinase is activated by Ras func-
tion and is highly expressed in the brain. The Kv6.2
potassium channel is in axons of CA3 and dentate
gyms neurons of the hippocampal formation, and it
changes the I/V kinetics of other channels.
DEVELOPMENT OF CREB-INDUCIBLE AND
CREB-REPORTER TRANSGENIC MICE
To test whether the LBD system could regulate the
expression of the cAMP responsive element binding
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protein (CREB), our laboratory has derived three
types of transgenic mice: CREB-mutant inducible
mice, ICER-inducible mice, and CRE-promoter
LacZ/GFP mice (CREB-function reporter mice). To
derive mice in which the function of a mutant CREB
is under inducible and tissue-restricted regulation, our
laboratory designed a construct in which a mutant ver-
sion of the CREB gene (at Ser-133) was fused to the
mutant LBD described above. Cell culture studies
done in M. Montminy's laboratory showed that
CREB's transcriptional function can be regulated
when fused with LBD-estrogen. In our laboratory, the
LBD/CREB fusion protein was placed under the reg-
ulation of the forebrain aCaMIGE promoter. We have
tested one of the four transgenic lines generated and
failed to see any evidence of CREB repression with
this transgene. Constitutive expression of this trans-
gene is known to repress CREB transcription in mice.
The other three lines are currently being tested. We
have also derived similar transgenic mice with ICER,
a CREB repressor (two lines; others under derivation).
These lines are currently being tested. To test CREB
function in the inducible transgenics described, we
have also created a transgenic mouse with a P-galac-
tosidase/green fluorescence protein fusion (LacZ/
GFP) under the control of a cAMP responsive element
(CRE) containing promoter. For better temporal re-
solution of the induction events, the LacZ/GFP gene
also included sequences that accelerate the degrada-
tion of its protein product.
MASSED VERSUS SPACED TRAINING EFFECTS ON
PROTEIN SYNTHESIS INDEPENDENT LTP
AND MEMORY
Studies from a number of laboratories, including our
own, demonstrated the advantages of spaced training
in the formation of long-term memory (protein-syn-
thesis-dependent). In the last year, we discovered that
memory that is not protein-synthesis-dependent is
also sensitive to the effects of massed versus spaced
training. Mice were trained on a contextual condition-
ing task with two trials separated by either 6 or 60 sec-
onds, and they were then tested 2 hours after training.
Our studies had shown that anisomycin, a protein syn-
thesis blocker, does not impair memory 2 hours after
training, but that it does block it 24 hours later.
Surprisingly, we found that the animals trained with a
60-second interval between trials performed better
than those trained with only a 6-second inter-trial
interval. These results show that spaced training
improves memory that is not protein-synthesis-depen-
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dent, demonstrating that spaced training can affect
mechanisms other than transcription (e.g., synaptic
mechanisms).
Previous findings from our laboratory revealed
that the CREB"°- mutation caused a profound loss in
long-term memory, even though short-term (30
minute) memory triggered with a single trial was
unaffected, a result that we have confirmed recently.
In the last year, we found that memory tested 2 hours
after training (middle-term memory; anisomycin
insensitive) is also affected by the CREB mutation.
Interestingly, recent results reported by Kandel and
colleagues suggested that besides its role as a tran-
scription factor, CREB may also have a cytoplasmic
role in protein-synthesis-independent memory forma-
tion as a modulator of cellular signaling. Thus, the
CREB mutants have deficient middle-term memory, a
result consistent with a cytoplasmic role for CREB in
memory formation.
Previous results from our laboratory found that the
long-term memory deficit of the CREW' mutants
could be rescued by lengthening the interval between
training trials. One-hour intervals triggered seemingly
normal memory, whereas 1-minute intervals failed to
trigger long-term memory in the mutants. These
results, together with similar results in other species,
indicated that CREB has a critical role in determining
training schedules required for long-term memory for-
mation. To determine whether CREB could also have
a role in determining training schedules required for
protein-synthesis-independent memory, we tested the
impact of massed and spaced training on 2-hour mem-
ory (middle-term memory) in the CREW"- mutants.
Interestingly, spaced training (1-hour inter-trial inter-
val) rescues the middle-term memory deficit of the
mutants just as it rescued their long-term memory
deficits. In contrast, massed training (1-minute inter-
trial interval) does not rescue the deficits in either of
these two memory phases. These data suggest that
CREB is a key factor in determining the training
schedules required for the formation of both middle
and long-term memory.
In striking parallel with the behavioral results
described above, we found that spaced tetani (10
minute) also rescue the LTP deficits measured both
minutes (protein-synthesis-independent) and 5 hours
(protein-synthesis-dependent) in the CREB" mutants.
Altogether, these findings involve CREB function in
two distinct memory phases, and they indicate that the
hippocampal LTP deficits of the mutants underlie their
hippocampus-dependent memory impairments.
THE CREM GENE IS INVOLVED IN SPATIAL LEARNING
AND MEMORY
Previous results from our laboratory involved the
CREB gene in learning and memory. CREB is known
to form functional heterodimers with the cAMP
response modulator (CREM), a closely related mem-
ber of the CREB family of transcription factors. Thus,
we suspected that CREM may also be involved in
learning and memory. Consistent with this hypothesis,
we found that the CREM null mutants have impaired
spatial learning in the Morris water maze.
In the last year, we have also found that the CREM
gene appears to rescue the spatial learning deficits of
the CREB".6- mutants. Analysis of memory formation
in the CREIr'a- mutants showed that not all of the
mutants are equally affected by the loss of the CREB
aA isoforms. Instead, we found that some of the
CREBa°- mutants had nearly normal memory.
Therefore, we examined whether up-regulation of the
CREM gene could be responsible for the partial res-
cue of memory in these CREB"°- mutants.
Immunocytochemical studies showed that all of the
CREWth- mutants showed increases in the levels of
CREM, but these increases were more pronounced in
the mutants with nearly normal memory. Analysis of
the dentate gyms and of CA1 /CA3 regions of the hip-
pocampus showed that the levels of CREM in these
regions were directly proportional to the performance
of the CREB"°- mutants in the spatial version of the
water maze, a hippocampal-dependent task. RT-PCR
analysis and RNase protection assays showed that
both activator and repressor products of the CREM
gene were up-regulated in the hippocampus of
CREB"°- mutants. Thus, the loss of CREM affects
spatial learning, and increases in the expression of this
gene appear to compensate for the loss of the CREB
aA isoforms. Altogether, these results indicate that
CREM is involved in learning and memory.
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TRANSMISSION AND PLASTICITY IN MAMMALIAN
CENTRAL SYNAPSES
R. Malinow N. Dawkins
J. Esteban
Y. Hayashi
A. Laskey
S. Shi
M. Maletic-Savatic
J.-C. Poncer
S. Zaman
Y. Aoki (visiting medical student)
We address issues directed toward an understanding
of learning and memory by studying the physiology of
synapses. We study synaptic transmission and plastic-
ity in rodent brain slices which are complex enough to
show glimpses of emergent properties, as well as sim-
ple enough to allow hard-nosed biophysical scrutiny.
To monitor and perturb the function of synapses, we
use a combination of electrophysiology, microscopic
imaging, and viral transfection techniques. This
allows us to examine the cell biological basis for
changes in electrophysiological function. It is our phi-
losophy that synapses have key properties whose
understanding will provide insight into phenomena at
higher levels of complexity.
Probing Mechanisms of
Plasticity with Use-dependent
Synaptic Blockers
Z. Mainen [in collaboration with John Roder,
University of Toronto)
The mechanisms responsible for enhanced transmis-
sion during long-term potentiation (LTP) at CAl
synapses remain elusive. Several popular models pro-
pose an increase in use of existing synaptic elements,
e.g., increased probability of transmitter release or
increased opening of postsynaptic receptors. To test
these models directly, we have employed a GluR2
knockout mouse in which AMPA-R transmission is
sensitive to use-dependent block by polyamine toxins.
We developed a method that can detect increased
release probability or AMPA receptor channel open-
ing, but find no such changes during LTP. Our results
suggest that previously documented enhancement of
quantal size is due to increased number or conduc-
tance of AMPA receptors and that enhanced quantal
content reflects activation of previously silent synaps-
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es. In general, these results argue against increased
use of previously functioning structures and indicate
recruitment of new functional synaptic elements dur-
ing LTP. The methods developed in this study will
provide tools by which to understand modulation of
transmission by activity-induced and pharmacologi-
cally induced plasticity.
Delivery of Glutamate
Receptors to Synapses
during LTP
Y. Hayashi
One possible mechanism by which LTP can be
expressed is the rapid delivery of receptors from
regions not accessible by transmitter (either intracel-
lular storage or extrasynaptic dendritic surfaces) to the
synaptic surface. One method of testing this possibili-
ty is to use tissue from mice in which GluR2 is genet-
ically deleted, and to acutely express G1uR2 with
Sindbis-GluR2. AMPA receptors lacking GluR2 have
a clear electrophysiological phenotype: Agonist-acti-
vated currents show rectification. In mice lacking
GluR2, synaptic responses show such a phenotype.
We can infect neurons in hippocampal slices from
GluR2-1- mice with a Sindbis virus that expresses
GluR2-EGFP. In infected cells, we see the appearance
of nonrectifying synaptic responses, indicating the
appearance of G1uR2-containing AMPA receptors to
synapses. The amount of G1uR2-containing AMPA
receptors at synapses increases over the several days
after infection, which provides information regarding
the time course of receptor turnover. To determine if
newly synthesized receptors are delivered to synapses
during LTP, we can test whether LTP increases the
amount of nonrectified synaptic current.
Is Phosphorylation of the GIuR1
Subunit of AMPA Receptors
Required to Generate LTP?
Y. Hayashi [in collaboration with Hannah Monyer and
Peter Seeburg, Heide !burg]
G1uR1 is a common subunit to most AMPA receptors
on pyramidal neurons in CA1 hippocampus. There are
several phosphorylation sites on GluRl. Ser-831 is
hypothesized to be phosphorylated by endogenous
CaMKII at synaptic sites. Such phosphorylation in
recombinant expression systems has been shown to
increase the function of AMPA receptors. We want to
test the possibility that phosphorylation at this site is
necessary to generate LTP. Toward this end, we have
designed several experiments, in collaboration with
H. Monyer and P. Seeburg. Seeburg and colleagues
have generated mice in which G1uR1 is deleted. We
have made constructs with point mutations (or no
mutations, as controls) in G1uR1. These have been
inserted by H. Monyer into the genome of the G1uR1
KO mice. We will test if such mice (expressing only
mutant G1uR1) lack LTP. We can also do such experi-
ments on acute slices by acute expression of G1uR1
(introduced by recombinant viruses) in slices from the
GluR1÷ mice.
Dendritic Trafficking, Clustering,
and Synaptic Delivery of
AMPA Receptors in
Hippocampal Neurons
S. Shi, J. Esteban, Y. Hayashi
Using GFP-tagged subunits of AMPA receptors, we
have examined the spatial, temporal, and activity-
dependent characteristics of recombinant AMPA
receptors expressed in hippocampal neurons. Using
HEK293 cells, we first established that G1uR1 with
enhanced GFP tagged on the amino terminus (the
expected extracellular domain) is electrophysiologi-
cally functional. Upon infection of dissociated cul-
tured hippocampal neurons with Sindbis virus
expressing G1uR1 -GFP, we see expression within 6
hours that increases over the next 48 hours. The dis-
tribution of receptor is initially diffuse and becomes
more clustered over time. Using immunohistochem-
istry, we can determine the amount of receptor that is
exposed to the surface (-50% at 24 hours) and the
amount of clustered receptor that appears at synapses
(colocalization with the synaptic marker, synapsin I;
-50% of clustered GluRl-GFP is within 1 gm of
synapsin I-positive regions). With immunohistochem-
istry directed against G1uR1, we can also determine
the level of overexpression of GluRl produced by the
virus. At the cell body, the value is 10- to 30-fold; this
falls monotonically to about 2-fold overexpression at
sites on dendrites 100 gm from the cell body. One
interesting observation is that despite the different lev-
els of overexpression, the amount of receptor exposed
at the surface is constant; indeed, it appears to be no
greater in infected cells than in uninfected cells. This
indicates that delivery to the surface is a saturable/reg-
ulated process that "keeps track" of how much recep-
tor is at the surface. We are conducting similar exper-
iments on organotypic hippocampal slices. We are
currently testing whether such surface delivery is con-
trolled by neuronal activity and/or protein kinase
activity.
Silent Synapses: Electron
Microscopic Analysis
J. Esteban [in collaboration with R. Wenthold
and R. Petralia, National Institutes of Health]
The synapses we study (which are similar to and serve
as a model for most excitatory synapses in the verte-
brate brain) use glutamate as the neurotransmitter and
have two types of postsynaptic glutamate-sensitive
receptors: AMPA-type and NMDA-type. Roughly
speaking, AMPA receptors transmit all presynaptic
release events, whereas NMDA receptors require
intense activity and trigger plasticity. We and other
investigators have provided electrophysiological evi-
dence that initially formed synapses contain only
NMDA receptors and, through plasticity, AMPA
receptors are added. There are other models, however,
to explain the physiological results. To shed light on
this issue, we have examined the distribution of
AMPA and NMDA receptors using immunogold elec-
tron microscopic analysis. We have examined tissue
from the hippocampus of rats at day 2, day 10, and
adult using five antibodies against AMPA receptors
and three antibodies against NMDA receptors. We
find that in general, AMPA receptors increase in num-
ber during development, whereas NMDA receptors
remain constant. Furthermore, the frequency of
synapses with no AMPA receptor immunoreactivity is
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83% at day 2, 71% at day 10, and 50% in adult. Since
immunogold techniques are low-detection methods,
we have used several computational methods to esti-
mate the fraction of synapses without AMPA recep-
tors. After compensating for low detection, the frac-
tion of synapses lacking AMPA receptors is 75% at
day 2, 51% at day 10, and 30% for adults.
Silent Synapses: Calcium
Imaging Analysis
Z. Mainen [in collaboration with Karel Svoboda,
Cold Spring Harbor Laboratory]
We and other investigators have observed electrophys-
iological responses mediated purely by action on
NMDA receptors. One interpretation is that there are
synapses that have only NMDA receptors (examined
above). Another interpretation is that sufficient trans-
mitter can leak out of synapses to activate only
NMDA receptors on nearby synapses. The higher
affinity of NMDA receptors for glutamate, compared
to that of AMPA receptors, makes this scenario plausi-
ble. To examine the biophysical basis for pure NMDA
responses, we are monitoring the stochastic responses
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of single synapses that are positioned next to each
other. If there is transmitter leakage, nearby synapses
should respond synchronously. If there is no leakage,
synapses should respond independently.
Interactions between Short-term
and Long-term Plasticity
J.-C. Poncer
If synapses are activated twice within approximately
100 msec, the second response is generally different in
amplitude from the first. At some synapses, the second
response is larger (paired-pulse facilitation), whereas
at other synapses, the second response is smaller
(paired-pulse depression). This short-term plasticity
has been studied extensively at a number of synapses
and likely reflects properties of the presynaptic trans-
mitter release and recycling machinery. There have
been reports that such short-term plasticity changes
during LTP. Does this indicate that LTP produces
changes in presynaptic function? We find that changes
in short-term plasticity during LTP can be explained
by recruitment of previously silent synapses. This
FIGURE 1 Dissociated cultured hippocampal neuron infected with GFP-Sindbis
virus imaged with epifluorescence and cooled CCD camera. Before (left) and 20
min after (right) transient rise in intracellular calcium produced by application of
calcium ionophore A23187. Note selective neuronal infection (underlying glia are
not infected) and growth of new processes with calcium stimulus.
recruitment may occur by addition of AMPA receptors
to synapses containing only NMDA receptors.
Rapid Structural Changes in
Hippocampal Neurons Induced
by High-Frequency
Synaptic Stimulation
M. Maletic-Savatic [in collaboration with
Karel Svoboda, Cold Spring Harbor Laboratory]
A central issue regarding activity-induced synaptic
plasticity is: Are there structural changes that accom-
pany or even underlie changes in synaptic efficacy?
To address this possibility, we have examined in liv-
ing hippocampal slices the structure of GFP-express-
ing neurons with two-photon laser scanning
microscopy before and after intense synaptic stimula-
tion. We have generated a Sindbis virus that expresses
enhanced GFP. When injected into hippocampal
slices, this virus selectively infects neurons (100:1
selectivity over glia) (Fig. 1). When examined 24
hours after infection, GFP appears to fill the entire cell
homogeneously, including dendrites, spines, filapo-
dia, and axonal processes. With two-photon imaging,
we place a stimulating electrode close to a GFP-
labeled dendritic process. After several baseline
images, a high-frequency stimulus (similar to one
used to induce LTP) is delivered, and several more
images are obtained. Our initial observations are that
there is a rapid growth of new structures, both spines
and filapodia. Such growth appears to be blocked by
the NMDA-receptor antagonist, DL-APV. These
observations raise many interesting questions: (1)
What is the relationship between the structural
changes and the electrophysiological changes? (2) Are
the new structures synapses? (3) Do the new struc-
tures contain NMDA receptors? AMPA receptors? On
the surface or intracellularly? (4) Does the new
growth require protein synthesis? New transcription?
(5) Are the new structures due to growth of existing
synapses contacting the dendrite, or completely new
synapses? (6) Is a rise in intracellular calcium at the
growing site necessary/sufficient to produce this
growth? (7) What signal transduction cascades are
necessary/sufficient? (8) Is dendritic exocytosis nec-
essary to produce growth?
Electrophysiology
of Transgenic Mice
Carrying Mutated
Presenilin 1
S. Zaman, A. Laskey [in collaboration with
Sangram Sisodia, Angele Parent, David Borchelt,
Johns Hopkins University]
A protein which when mutated is responsible for
approximately 50% of familial Alzheimer's disease,
presenilin-1 (PS1), was recently cloned. Little is
known regarding its cellular distribution and function.
We are now studying the electrophysiology of mice
expressing a mutant form of PS-1 that is known to
cause disease in humans. Preliminary studies indicate
that various properties of synaptic transmission and
plasticity in these mice show subtle abnormalities. We
are defining the stimulus protocols that best show
these abnormalities.
In conclusion, we are continuing to elucidate the
basic mechanisms involved in central synaptic trans-
mission. Such an understanding is necessary to derive
a mechanistic flowchart of plastic processes. We also
continue to probe the role of different molecules,
including CaMKII and PS-1, in activity-induced and
developmental synaptic plasticity.
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SIGNAL TRANSDUCTION AND DIFFERENTIATION
G. Enikolopov A. Hazan B. Kuzin J. Mignone N. Peunova
S. John C. Mannino N. Nakaya V. Scheinker
P. Krasnov T. Michurina M. Packer Y. Stasiv
Our main interest is in signals that link cell activity
with cell differentiation. In the past year, our research
mostly focused on the role of nitric oxide (NO) in
development. We are testing a hypothesis that NO acts
as an antiproliferative agent and, ultimately, controls
the shape and size of tissues and size of organs during
normal development. We started several projects with
different models of animal development, and our cur-
rent results support the notion of NO as a critical com-
ponent of the developmental program. We are now
focusing on genetic and biochemical interactions of
NO with systems that control cell division and cell
differentiation in the developing organism.
NO and Rb Pathways Interact to
Control Eye Development
in Drosophila
B. Kuzin, G. Enikolopov [in collaboration with
M. Regulski and T. Tully, Cold Spring Harbor Laboratory]
NO can reversibly suppress DNA synthesis and cell
division in most cell types; however, the mechanisms
of the antiproliferative action of NO in developing
organisms are not known. We used a genetic approach
to address this problem and tested the genetic interac-
tions of NOS with various components of the cell
cycle. We used transgenic flies that express the
Drosophila NOS gene (dNOS1) under the control of
the heat-shock promoter and flies that express proteins
involved in the cell cycle (RBF, dE2F, dDP, dacapo,
and p21) under the control of the eye-specific GMR
promoter (gifts from N. Dyson and I. Hariharan). We
have found that manipulations of NOS activity can
enhance or suppress the effect of the RBF and E2F
components. In particular, we found that (1) dNOS
interacts with dRBF to suppress cell proliferation in
the developing eye; (2) dNOS enhances the suppres-
sive action of dRBF; (3) inhibition of NOS rescues the
eye phenotype caused by ectopic expression of dRBF;
(4) dNOS rescues the eye phenotype caused by
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ectopic expression of dE2F and dDP; and (5) inhibi-
tion of NOS prevents dRBF from suppressing the phe-
notype of dE2F/dDP transgenic flies. Our results
argue that NO controls cell division in the developing
eye by controlling entry in the S phase of the cell
cycle. These experiments present the first example of
analyzing the genetic interactions of NOS. They
demonstrate that NOS cooperates with the Rb path-
way to control the number of cells in the ommatidia
during Drosophila eye development.
Molecular Mechanisms of
Nitric Oxide Synthesis during
Drosophila Development
Y. Stasis, A. Hazan [in collaboration with M. Regulski
and T. Tully, Cold Spring Harbor Laboratory]
We have recently shown that NO is involved in the
control of organ size during Drosophila development.
Now we are searching for the RNA species that might
be responsible for the action of NO in the developing
fly. Using RT-PCR and Drosophila cDNA libraries,
we found a family of five alternatively spliced tran-
scripts arising from the NOS locus. Two of them give
rise to unusual new proteins, dNOS3 and dNOS4,
which do not possess enzymatic activity; however,
dNOS3 can inhibit dNOS1 activity in cotransfection
assays. We have generated antibodies against the
dNOS3-specific peptide and demonstrated that it rec-
ognizes a protein differentially expressed at various
stages of Drosophila development. Our results argue
that dNOS3 may code for a natural negative regulator
of NOS activity during Drosophila development.
Furthermore, these results also suggest that dNOS3
can be used as a dominant-negative regulator of NOS
when introduced to the Drosophila germ line. We are
currently generating transgenic flies expressing
dNOS3 under heat-shock- and eye-specific promoters
to test this hypotheses.
Genes Activated by NO
in Neuronal Cells
N. Nakaya
Although the action of NO in cells was studied in
many details, very little is known about the transcrip-
tional targets of NO, and very few genes have been
identified whose activation is dependent on NOS
activity in the cell. In this project, we are searching for
genes whose expression in neuronal cells is affected
by NO. We expect to obtain reliable markers of NO
action in the cell and to identify NO-responsive pro-
moter elements. Using suppressive subtraction
hybridization, we cloned several genes that are
induced by NO in neuronal cells. We are currently
searching for their control elements and using them to
probe the action of NO as a transcellular messenger.
NO and Xenopus
Brain Development
N. Peunova, C. Mannino [in collaboration with
H. Cline, Cold Spring Harbor Laboratory]
To examine whether NO has an antiproliferative role
during vertebrate development, we used Xenopus lae-
vis as a model organism, focusing on the possible role
of NO in the development of the tadpole's brain.
Using cytochemical and immunochemical staining,
we found that NOS is accumulated in maturing neu-
rons, whereas the zones of active proliferation in the
germinal layer remained free of NOS. This suggests
that, similar to neuronal cells in culture and imaginal
discs of Drosophila, NOS may be involved in cessa-
tion of proliferation of neuronal precursors. To test
whether NOS is involved in growth arrest of precursor
cells in the developing Xenopus brain, we blocked NO
Production by introducing a slow-release polymer
implant impregnated with NOS inhibitors in the ven-
tricle of the tadpole brain. BrdU labeling of the brain
demonstrated a dramatic increase in the number of
cells in the S phase of the cell cycle in the brains treat-
ed with inhibitors, compared to the control brains.
Staining of cell nuclei with DAPI revealed a higher
number of cells in the brains of experimental animals,
indicating that excessive cells in the S phase success-
fully completed the cell cycle by mitosis. The overall
size of the brain was also increased after introduction
of the inhibitor. The most affected areas are the optic
tectum and the area immediately adjacent to the ven-
tricle where the impregnated matrix was implanted.
Using antibodies to specific neuronal markers, we
found that development of some types of neurons is
grossly perturbed by excessive proliferation of precur-
sors, whereas other types, produced at the early stages
of neurogenesis, are not affected. Our results strongly
argue that NOS activity is essential for the normal pat-
tern of cell proliferation in the developing Xenopus
brain.
Cloning of the Xenopus
NOS Gene
V. Scheinker, Y. S asiv
Using the information about the known NOS genes,
we cloned the NOS cDNA from Xenopus. Its primary
structure suggests that the cloned gene (XeNOS) is an
ortholog of the Ca "- dependent neuronal NOS isoform
of mammals. Analysis of the gene reveals a remark-
able degree of evolutionary conservation with long
stretches of amino acid sequences identical to those of
humans, mice, rats, and Drosophila. The cloned gene
produces enzymatically active protein when transfect-
ed in cultured cells. Using specific antibody and RT-
PCR analysis, we found that XeNOS is strongly ex-
pressed in tadpoles and in the frog brain.
Protein Targeting to
Neuronal Cell Terminals
P. Krasnov
We have recently identified the structural elements
that are necessary and sufficient for transporting the
synaptotagmin molecule to the terminals of neuronal
cells. Using alanine-scanning mutagenesis, we have
identified two amino acids that are absolutely critical
for accumulation of synaptotagmin at the terminal.
These amino acids are conserved among all known
synaptotagmin isoforms, suggesting that different
synaptotagmins may have similar or common mecha-
nisms of targeting. The information about the traffick-
ing signal allowed us to isolate proteins that bind the
signal. We used columns with immobilized synthetic
peptides that correspond to the wild-type and mutated
inactive versions of the signal to search for the inter-
acting proteins in the extracts of neuronal PC12 cells.
We found three proteins, two of which bind only the
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wild-type but not the mutated peptide. We have
obtained their partial sequence, and we are currently
trying to identify them and to test if they are indeed
responsible for the accumulation of the synaptotagmin
protein at the terminals.
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NEOCORTICAL CIRCUITRY AND ITS PLASTICITY
K. Svoboda B. Burbach Z. Mainen
C. Gray P. O'Brien
The neocortex is by far the largest brain structure in
mammals, and it is central to most cognitive func-
tions. Neocortical anatomy is highly conserved.
between species. As its name implies, the neocortex is
also the most recent arrival in evolutionary terms.
Neocortical circuitry is further distinguished by its
phenomenal complexity. One microliter of neocortical
tissue alone contains nearly one million neurons and
more than a billion synapses. A single neuron con-
nects to a thousand other neurons, near and far. This
awesome network underlies the dynamics of our
brains and our perception of the world. To unravel
neocortical function, we are studying how the basic
hardware of this network, namely, neurons and their
dendrites and synapses, functions within the intact
system. To observe neuronal function, we require
highly sensitive tools that can be applied to the diffi-
cult experimental situation in the intact brain. Two-
photon excitation laser-scanning microscopy
(TPLSM) allows us to image neuronal function and
structure at micrometer-level resolutions in highly
scattering tissue. Optical uncaging of neurotransmit-
ters allows us to excite subcellular structures with
great spatial and temporal control. Intracellular elec-
trical recordings using sharp and whole-cell electrodes
allow us to monitor the electrical membrane potential
and synaptic currents in the soma and dendrites. As
model systems, we use the rodent somatosensory cor-
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tex in vivo and in brain slices. For synaptic physiolo-
gy, we use slices derived from the hippocampus.
Morphogenesis Induced
by Synaptic Activity
K. Svoboda [in collaboration with M. Maletic-Savatic
and R. Malinow, Cold Spring Harbor Laboratory]
How is the cortical network established and main-
tained? And how does it change in response to experi-
ence? The formation of precise synaptic connections
between neurons during development and learning
and memory in the adult brain is no doubt critical to
the normal functioning of the brain. For the case of
development, it is likely that activity-dependent
mechanisms can induce structural reorganization, but
this has not been directly demonstrated. For the case
of learning and memory in the adult, it is unknown if
structural changes are necessary for synaptic plastici-
ty, despite decades of research. In previous studies,
neurons in brain slices were tetanized to produce long-
term potentiation (LTP) and subsequently analyzed
for morphological changes. These studies have pro-
duced mixed results, we believe for two principal rea-
sons. (1) The morphological analysis occurred in
fixed tissue that made a "before-and-after" compari-
son impossible; subtle and sparse changes in synaptic
structure would therefore have remained buried in the
large intrinsic variability in synaptic structure. (2)
Tetanically induced LTP would be expected to change
only a small subset of a pyramidal neuron's 10,000
synapses; these changes would be hard to find by ran-
dom sampling.
We have recently been able to circumvent these
problems by directly observing morphogenesis of
dendritic spines, the postsynaptic partners of synaps-
es. To stimulate a spatially restricted set of synapses,
we placed a glass electrode very close (<10 pm) to a
small dendritic branch. For TPLSM imaging, CA1
pyramidal cells in cultured hippocampal slices were
infected with a virus expressing green fluorescent pro-
tein (GFP), a bright fluorophore that allows excellent
imaging with low photodamage. We find that synaptic
activity produces rapid local sprouting of spines and
fillopodia in a small region of the dendrite. These
structures can be stable over hours. Synaptically
induced sprouting is blocked by antagonists of the
NMDA receptor. We are currently trying to determine
if our observations apply primarily to the activity-
dependent processes of development or if they are
applicable to the adult brain.
Optical Studies of Synaptic
Function at Individual
Synapses
Z. Mainen [in collaboration with R. Malinow, Cold Spring
Harbor Laboratory]
In contrast to the classical preparations for synaptic
physiology, such as the neuromuscular junction, CNS
synapses are difficult to study with electrophysiologi-
cal techniques alone. Important issues regarding sto-
chastic fluctuations and spatial specificity in synaptic
transmission require direct measurements of transmis-
sion at individual synapses. For this purpose, we have
begun to use high-resolution functional TPLSM imag-
ing. Individual pyramidal neurons in hippocampal
slices are filled with a calcium indicator through a
whole-cell patch clamp electrode. Synaptic transmis-
sion at glutamatergic synapses is associated with post-
synaptic calcium influx through NMDA receptors. We
therefore use these synaptically activated calcium
transients at individual dendritic spines as indicators
of synaptic function. We compare these signals with
measurements of synaptic currents recorded via the
whole-cell electrode. This powerful approach allows
us to address tenacious questions of synaptic physiol-
ogy: (1) Is synaptic transmission a point-to-point or
spatially distributed process? This question has pro-
found implications for the information storage capac-
ity of the brain. Although the canonical view is that
the release of an individual vesicle activates only one
dendritic spine, this view has recently come under
attack. Since the release of individual vesicles is sto-
chastic, temporal correlations in activity in close-by
spines would indicate spread of transmitter to neigh-
boring spines. We are currently looking for such cor-
relations. (2) What is the distribution of probability of
release? This question also has importance for infor-
mation coding in the brain. (3) Finally, do changes in
the probability of release underlie some forms of
synaptic plasticity? Activity-dependent modulation of
synaptic strength (such as LTP) is the most popular
model for long-term information storage in the CNS.
In the brain slice preparation, coincident pre- and
postsynaptic stimulation can produce LTP. Although
LTP has received a lot of experimental attention, the
cellular mechanisms underlying LTP are highly con-
troversial; modulation of release probability is one
such candidate mechanism.
Mechanisms of Current
Amplification in
Neocortical Dendrites
C. Gray, K. Svoboda
Some neocortical dendrites pose an interesting prob-
lem in "neuro-engineering." In particular, the den-
drites of layer 5 pyramidal cells are so long and thin
(length -1 mm; thickness -5 pm) that it is difficult to
fathom how the synapses on their distal dendrites
could have an influence on the electrical behavior of
the cell body and hence the cell's output. From a sys-
tems function perspective, this is an interesting prob-
lem, because feedback from higher cortical areas is
mediated mostly through the distal synapses of layer
1. It has long been hypothesized that these remarkable
dendrites must possess the ability to amplify synaptic
currents, and a variety of detailed models of this
amplification exist. Distinguishing between these
models will enhance our understanding of the role and
function of neocortical feedback projections and the
role of dendritic electrogenesis in general. The
detailed biophysical experiments required to discover
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the mechanisms of current amplification in long den-
drites are best performed in neocortical brain slices.
Direct postsynaptic stimulation using optical uncaging
of caged precursors of neurotransmitters is required
for these experiments. Simultaneous whole-cell mea-
surements of the resulting postsynaptic currents at the
soma probe the coupling between dendrites and soma.
To perturb current amplification, we manipulate spe-
cific dendritic voltage-sensitive conductances using
pharmacological tools. The dendrites and their voltage
sensitive conductances are analyzed using compart-
mental models constructed in NEURON.
Dendritic Excitation In Vivo
K. Svoboda
Recent experiments in brain slices have produced a
wealth of data suggesting that action potential propa-
gating from soma to dendrite is necessary for the
induction of synaptic plasticity. In particular, back-
propagating action potentials may be the feedback sig-
nals underlying Hebbian synaptic plasticity underly-
ing learning and memory. With the long-term goal to
bridge the gap between cellular physiology and brain
function and behavior, we have begun to directly
study dendritic excitation in the intact brain under sen-
sory stimulation. We find that somatically recorded
action potentials produce fast calcium transients,
where the calcium concentration codes for the recent
activity of the cell. Surprisingly, these transients are
restricted to the proximal apical dendrite, with no
influx into the tuft of layer 1. Using direct dendritic
membrane potential recordings, we found that this
inhomogeneous calcium accumulation is due to a fail-
ure of action potential back-propagation into these
dendrites. Interestingly, these stunted back-propagat-
ing action potentials can be enhanced by subcortical
modulatory systems, such as the ascending choliner-
gic pathway. This is important because these modula-
tory systems are particularly active during attention
and arousal and are intimately related to learning and
memory.
Cellular Basis of Neocortical
Plasticity
K. Svoboda, B. Burbach
The central nervous system is distinguished by its
ability to reorganize itself in response to changes in
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experience. These changes underlie learning and
memory as well as our ability to deal with damage to
our sensory periphery. Rodents are excellent model
systems for the study of plasticity in the neocortex.
Individual whiskers preferentially activate a small col-
umn of neurons in the primary somatosensory (barrel)
cortex. Plasticity can be induced by trimming one or
several whiskers with predictable effects on a cortical
column and its neighbors. After whisker-trimming, the
part of the cortex corresponding to the trimmed
whisker will begin to preferentially respond to
untrimmed whiskers. This is an example of experi-
ence-dependent receptive field plasticity and it is
related to procedural learning. What happens at the
level of neurons, dendrites, and synapses when the
neocortex reorganizes? As a first step in determining
the cellular mechanisms underlying neocortical plas-
ticity, we are using TPLSM to image neocortical neu-
rons over very long time scales (days) to assess their
normal morphological stability. We will then perturb
the sensory experience of the animal by trimming a
whisker and look for morphological correlates of the
resulting receptive field plasticity.
FIGURE 1 CPG15 induction in mouse barrel cortex 12 hr
after whisker-trimming. In situ hybridization to a tangential
section through layer 4 is shown. The barrel field appears as
an approximately 1 x 1 mm2 area of dark tiles (to the left of
the arrow) All whiskers but one (D1) were trimmed, which
leads to increased representation of this whisker in the bar-
rel cortex. The cortical column corresponding to the spared
whisker shows enhanced expression of CPG15 in layer 4
(light spot within the barrel field, arrow) and also in layers 2
and 3 (not shown).
Molecular Basis of Neocortical
Plasticity
B. Burbach, K. Svoboda [in collaboration with
E. Nedivi, Cold Spring Harbor Laboratory]
It has been known for a long time that long-term plas-
ticity requires gene expression. The vibrissa cortex
offers a good system to discover the genes that are
associated with experience-dependent neocortical
plasticity. Luckily, we have at our disposal several
candidate plasticity genes (CPGs) that were isolated
by E. Nedivi in a differential screen at the Weizmann
Institute. These genes are regulated during develop-
ment and by sensory activity. We are now in the
process of using in situ hybridization of CPGs to rat
brain sections to discover the subset of activity-depen-
dent genes that are regulated by experience-dependent
plasticity. We have already found that CPG-15 is up-
regulated during the early phase of receptive field
plasticity (Fig. 1). In the future, we plan to explore the
function of CPGs in the intact neocortical network by
combining virally mediated gene transfer with
TPLSM in vivo imaging of neuronal morphology and
synaptic function.
PUBLICATIONS
Svoboda, K., W. Denk, D. Kleinfeld, and D. Tank. 1997. In
vivo dendritic calcium dynamics in neocortical pyrami-
dal neurons. Nature 385:161-165.
Instrumentation
K. Svoboda, P. O'Brien
Much of the work we do depends on sensitive instru-
mentation to study neural function in intact tissue. For
example, TPLSM allows imaging of neural function
at submicron resolution in the intact brain, an envi-
ronment that is hostile to traditional microscopies. In
addition, living specimens are sensitive to photodam-
age. Photodamage can be minimized by maximizing
fluorescence detection efficiency. Finally, suitable
microscopes must be able to accommodate large spec-
imens such as rats and assorted micromanipulators for
intracellular membrane potential measurements. For
this reason, we typically build the microscopes our-
selves. The first microscope we have constructed is
for imaging and electrophysiology in acute brain
slices. We have recently completed a second micro-
scope, based on a completely novel geometry, that is
ideal for subcellular imaging in the intact neocortex.
These instruments are continually being modified
based on feedback gained from performing biology
experiments.
Denk, W. and K. Svoboda. 1997. Photon upmanship: Why
multiphoton imaging is more than a gimmick. Neuron 18:
351-357.
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The academic program at Cold Spring Harbor now takes place during a 9-month period extending from mid-
March through the first half of December. During that time, new ideas, discoveries, and technologies are com-
municated in a wide-ranging series of postgraduate laboratory and lecture courses, workshops, large meetings,
and a summer research program for undergraduates.
The courses emphasize teaching the latest in state-of-the-art methodologies set in the context of recent sci-
entific advances and are of relatively short duration so that senior scientists as well as junior faculty, postdoctor-
al fellows, and graduate students can attend. All of the courses are oversubscribed, which is a tribute to the
skills and talents of the instructors as well as the timeliness of the courses. The 1997 meetings also emphasized
communicating the latest results in a broad range of topics in molecular biology and neurobiology. This year,
more than 6000 scientists came to the laboratory to serve as instructors, lecturers, and students in the courses
as well as participants in the meetings.
This year, 25 courses were held at the laboratory, including 19 molecular genetics, genomics, structure, and
neurobiology laboratory courses. These were held in the DelbrUck Laboratory and the Howard Hughes Medical
Institute (HHMI) teaching laboratories in the Beckman Neuroscience Center. Five neurobiology lecture courses
were held at the Banbury Center. Course instructors, assistants, lecturers, and students are listed below. It is
certainly a pleasure to note here the contributions of the instructors who come from universities and research
institutes around the world to teach at Cold Spring Harbor. It is their creativity and skill that really make the
courses work so well.
A group of scientists who have taught in the courses for several years each are retiring after this year. We
are most grateful to them, even more so because we know that we can count on them to return to give advice
and lectures in future years. These include Steve Smale, an instructor in the Eukaryotic Gene Expression
course; Rob Last, who taught in the Arabidopsis Molecular Genetics course; Alison Adams, a Yeast Genetics
course instructor; Fabio Rupp, who taught the course on Molecular Cloning of Neural Genes; and Arthur
Konnerth, Fred Lanni, and Rafael Yuste, instructors for the course of Imaging Structure and Function in the
Nervous System. Two fall session instructors are also retiring with our thanks-Dennis Burton and Roger
Reeves
The courses are supported by, and would not be possible without, a series of grants from federal and pri-
vate sources. The summer molecular genetics courses have been supported for many years by grants from the
National Institutes of Health (NIH) and the National Science Foundation (NSF). A grant from the National Institute
of Mental Health supports several of the neurobiology courses. This year, a grant from the National Cancer
Institute that supports several of the molecular biology courses was renewed, as was an NSF grant that sup-
ports the Arabidopsis Molecular Genetics course. A large education grant from HHMI has provided stable sup-
port for the neurobiology program and has allowed the Laboratory to begin and to expand its series of spring
and fall courses. We are most pleased that an award from the Esther and Joseph A. Klingenstein Fund for the
support of neurobiology courses was renewed this year. As has been the case for several years, the Grass
Foundation provided funds for scholarships for students in neurobiology courses. A grant from the Department
of Energy has also helped in the funding of the course in Macromolecular Crystallography. In addition, the
Laboratory receives valuable support from many companies that donate supplies and lend equipment for the
courses.
Sixteen meetings were held at the Laboratory this year, but the Symposium remains, as always, central. This
year's Symposium on Pattern Formation during Development, discussed below by Bruce Stillman, brought
together a broad array of developmental biologists to discuss current research. Several new meetings were
held this year. These include the Biology of Proteolysis organized by Charles Craik, Susan Gottesman, Mark
Hochstrasser, and Yuri Lazebnik, and Microbial Pathogenesis and Host Response organized by P.T. Magee,
Stan Maloy, and Ron Taylor. A very interesting new meeting on Human Evolution was held in October, organized
by Luigi Cavalli-Sforza and Jim Watson. We expect these new meetings to be held again in 2 years' time. Other
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meetings, which are held in alternate years, covered topics ranging from Eukaryotic DNA Replication to
Tyrosine Phosphorylation and Signaling to Neurobiology of Drosophila. Several conferences of long standing
continue to be oversubscribed, such as the meetings on Retroviruses and Mechanisms of Eukaryotic
Transcription. This year, two biotechnology conferences on Vector Targeting Strategies for Gene Therapy and
The Arabidopsis Genome: From Sequence to Function were held outside of the regular meetings season. These
biotechnology conferences, now in their second successful year, are overseen by David Stewart and will contin-
ue in future years. All organizers and contributors to the meetings are listed below. The sources of support for
these meetings come from the Laboratory's Corporate Sponsor program, NIH, NSF, DOE, and various corpora-
tions and foundations. Grants helped scientists at all stages of their careers to attend the conferences.
While graduate students, postdoctoral fellows, and faculty participate in the courses and meetings, the
Undergraduate Research Program (URP) provides an opportunity for college undergraduates to spend 10
weeks at the Laboratory during the summer. The program, headed by Michael Hengartner, allows students to
do research in the laboratories of staff scientists.
The large numbers of courses and meetings proceed with skill and efficiency, thanks to the collaborative
efforts of a large number of people at the Laboratory. The staff of the Meetings and Courses Office, headed by
David Stewart, Director of Meetings and Courses, coordinates the arrangements for all of the visiting scientists.
This enormous job, which seems to grow every year, is carried out not only extremely efficiently, but with
patience and tact as well. The staff includes Micki McBride, the Course Registrar; Nancy Weeks, Head
Concierge; Jim Koziol, Diane Tighe, Marge Stellabotte, Andrea Stephenson, Drew Mendelson, Mary Smith, and
Michael Glaessgen, as well as Herb Parsons, Ed Campodonico, Bill Dickerson, and the part-time audiovisual
staff. Staff from several other departments are crucial to the success of the meetings and courses, including
Cliff Sutkevich and his staff who set up and maintain course equipment, and Edie Kappenberg, the course
coordinator. In particular, Wendy Crowley, taking over in Grants as Educational Grants Manager after Mary
Horton's departure, provides invaluable support in the preparation and management of grants in support of the
meetings and courses.
Terri Grodzicker
62nd Symposium: Picnic at Airs lie
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62nd COLD SPRING HARBOR SYMPOSIUM
ON QUANTITATIVE BIOLOGY
Pattern Formation during Development
May 28-June 2 391 participants
ARRANGED BY Bruce Stillman, Cold Spring Harbor Laboratory
One of the great scientific accomplishments in the past decade was the recognition that
the mechanisms used for patterning of tissues and organs during development are
remarkably similar among species. What works for flies and frogs also serves human
beings very well as embryos acquire their form and identity. To celebrate these mar-
velous discoveries, the 62nd Symposium focused on pattern formation during develop-
ment, with a particular emphasis on the evolutionarily conserved mechanisms and mole-
cules.
This outstanding series of meetings began in 1933, in the midst of economic depres-
sion. Each meeting lasted for 5 weeks while scientists were in residence at Cold Spring
Harbor, and there were no time limits on the length of presentations or discussion! This
"experiment in scientific procedure," reflecting the apparent tranquility of academic life
in those days, lasted for 8 years. The second Symposium, entitled Aspects of Growth,
included several papers dealing with differentiation and development.
For the 1941 Symposium, the new Director of the Laboratory, Milislav Demerec, con-
densed the program into 2 weeks, and his second Symposium focused on The Relation
of Hormones to Development, with 17 presentations. In 1948, Demerec changed the
meeting to 8 days, held in early June, and this has been the arrangement until this year.
Given the dramatic changes in the pace of scientific discovery in the biological sci-
ences, the modern methods for rapid dissemination of information, and the fact that in
many families, both spouses have demanding careers, the program has been shortened
to 5 days, still considered by some to be a long time for a meeting. But we must not for-
get the goals of this particular series, and indeed all of the meetings at Cold Spring
Harbor Laboratory. The idea is not to present a series of observations from a collection
of individuals, but to provide sufficient time for the experts in a field of biology to discuss
the issues of the day and to determine how progress might be accomplished.
During eight days in 1954, the Symposium focused on The Mammalian Fetus:
Physiological Aspects of Development. The science was descriptive, but some ideas
presented were the forerunners of the modern approaches to understanding develop-
ment. Salome Glueckshon-Waelsch discussed the T (Brachyury) locus and a genetic
approach to understanding development that foreshadowed the powerful approaches to
come. Then after a long hiatus between Symposia on this topic, Joe Sambrook orga-
nized in 1985 the 50th Symposium on the Molecular Biology of Development. The
Symposium celebrated the conversion of developmental biology from a descriptive,
anatomically based science to a mechanism-driven science of great interest.
In the dozen years hence, we have learned much about the exquisite mechanisms
that specify development, but most importantly, the evolutionary conservation of the
pathways that govern development has emerged. We are no longer bound by technolo-
gy, as in the early days of these Symposia, and modern technology has taken us to new
heights unimagined even 12 years ago.
The field of developmental biology is now very large, and coupled with the decision
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to shorten the program, difficult decisions about the selection of speakers and topics
had to be made. Brigid Hogan and Gerry Rubin gave much valuable advice and help
with the scope of the meeting and potential speakers. The formal scientific program
consisted of 64 oral presentations and a remarkable 233 poster presentations, and the
meeting attracted more than 390 participants. Introductory talks on the first evening
were given by Mario Capecci, Brigid Hogan, Roland Nusse, and Gail Martin, and the
Reginald G. Harris Lecture was presented by John Gurdon. Sean Caroll presented a
fascinating Dorcas Cummings Lecture on the formation and evolution of animal body
patterns to both the visiting scientists and the local community.
J. Watson, M. Scott R. Beddington, N. Rosenthal
B. Hogan, P. Beachy
G. Rubin, D. Melton, M. Levine I. Herskowitz, T. Grodzicker, R. Losick
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Essential funds to run this meeting were obtained from the National Institute of Child
Health & Human Development and the National Institute of Neurological Disorders &
Stroke, both branches of the National Institutes of Health. Contributions from the
Corporate Sponsors provide core support for the Cold Spring Harbor meetings program
and we are grateful for their continuing support: Amgen, Inc.; BASF Bioresearch
Corporation; Becton Dickinson and Company; Boehringer Mannheim Corporation;
Bristol-Myers Squibb Company; Chiron Corporation; Chugai Research Institute for
Molecular Medicine, Inc.; Diagnostic Products Corporation; The Du Pont Merck
Pharmaceutical Company; Forest Laboratories, Inc.; Genetech, Inc.; Glaxo Wellcome,
Inc.; Hoechst Marion Roussel; Hoffmann-La Roche, Inc.; Johnson & Johnson; Kyowa
Hakko Kogyo Co., Ltd.; Life Technologies, Inc.; Eli Lilly and Company; Merck Genome
Research Ilnstitute; Novartis Pharma Research; Oncogene Science, Inc.; Pall
Corporation; The Perkin-Elmer Corporation; Applied Biosystems Division; Pfizer Inc.;
Pharmacia & Upjohn, Inc.; Research Genetics, Inc.; Schering-Plough Corporation;
SmithKline Beecham Pharmaceuticals; Wyeth-Ayerst Research; and Zeneca Group plc.
We also thank our Plant Corporate Associates: American Cyanamid Company; Kirin
Brewery Co., Ltd.; Monsanto Company; Pioneer Hi-Bred International, Inc.; and
Westvaco Corporation.
PROGRAM
Welcoming Remarks: Bruce Stillman
Introduction
Chairperson: R. Lehmann, New York University Medical
Center, New York
Patterning and Transcription
Chairperson: M. Capecchi, University of Utah, Salt Lake City
Reginald G. Harris Lecture: "Long-range Signaling and a
Morphogen Gradient in Xenopus Development"
Speaker: J. Gurdon, University of Cambridge, United
Kingdom
Morphogens
Chairperson: B. Hogan, Howard Hughes Medical Institute,
Vanderbilt University Nashville, Tennessee
Signaling in Organogenesis
Chairperson: L. Zipursky, Howard Hughes Medical Institute,
University of California, Los Angeles
Inductive Mechanisms
Chairperson: E. Robertson, Harvard University Cambridge
Massachusetts
Tissue Specification
Chairperson: R. Beddington, National Institute for Medical
Research, London, United Kingdom
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Neural Induction and Pathfinding
Chairperson: D. Melton, Howard Hughes Medical Institute,
Harvard University Cambridge, Massachusetts
Asymmetric Divisions
Chairperson: G. Rubin, Howard Hughes Medical Institute,
University of California, Berkeley
Polarity and Position Specification
Chairperson: R. Losick, Harvard University Cambridge,
Massachusetts
Dorcas Cummings Lecture: "Embryos and Ancestors: The
Formation and Evolution of Animal Body Patterns"
Speaker: S. Carroll, University of Wisconsin, Madison
Patterning Pathways
Chairperson: J. Rossant, Samuel Lunenfeld Research
Institute, Toronto, Canada -
Axis Formation
Chairperson: M. Levine, University of California, Berkeley
Summary: M. Scott, Stanford University School of Medicine
MEETINGS
Vector Targeting Strategies for Therapeutic Gene Delivery
March 14-16 141 participants
ARRANGED BY David T. Curiel, M.D., University of Alabama
Wayne Marasco, M.D., Ph.D., Dana-Farber Cancer Institute
The basic premises of gene therapy are subservient to the pharmacologic goal of efficient and
specific delivery of therapeutic nucleic acids to relevant somatic cells. In this regard, current
generation gene transfer vectors have been suboptimal for this purpose. This is especially
apparent in the context of gene therapy strategies requiring direct, in vivo, gene transfer. The
basis of these shortcomings has been related to the very limited attempts to engineer vectors
specifically for their delivery purposes. The technology to do this, however, has recently been
developed. Specifically, methods to achieve cell-specific gene delivery via viral and nonviral vec-
tors have been described. A second issue, however, is the definition of appropriate surface
markers on target cells. In this context, the recent "high-thruput" target definition technologies
based on phage panning allow the ability to define cell-specific targeting moieties. On the basis
of this concept, Vector Targeting Strategies for Therapeutic Gene Delivery meeting was designed
to bring together basic vectorologists endeavoring targeted vector delivery, as well as scientists
working in the area of target definition. It is anticipated that the scientific linkages between these
groups within the Cold Spring Harbor meeting framework will allow more rational design of vec-
tors of utility for gene therapy purposes.
This meeting was funded in part by Canji, Inc.; the Cystic Fibrosis Foundation; Gene
Medicine, Inc.; Genzyme; Glaxo Wellcome, Inc.; Intraimmune Therapies, Inc.; Microbiological
Associates/MAGENTA; Prolinx, Inc.; Rhone Poulenc Rorer; Targeted Genetics Corporation;
Therexsys Limited; Transgene, S.A.; Virus Research Institute; and Wyeth-Ayerst Laboratories.
PROGRAM
Introductory Lectures: D.T. Curiel, University of Alabama,
Birmingham; W. Marasco, Dana-Farber Cancer Institute,
Boston, Massachusetts
Target Definition
Chairperson: H.R. Hoogenboom, University of Mastricht, The
Netherlands
Liposomes and Molecular Conjugates
Chairperson: E. Wagner, Vienna University Biocenter, Austria
Targeted Retroviruses
Chairperson: W. Marasco, Dana-Farber Cancer Institute,
Boston, Massachusetts
Targeted Adenoviruses
Chairperson: D.T. Curiel, University of Alabama, Birmingham
Emerging Technologies
Chairperson: J.C. Glorioso, University of Pittsburgh School of
Medicine, Pennsylvania
Keynote Speaker
Richard Vile, Imperial Cancer Research Fund, United Kingdom V. Krasnykh, I. Dmitriev, D. Curiel
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Cell and Molecular Biology of Aplysia and Related Invertebrates
April 16-20 77 participants
ARRANGED BY John H. Byrne, University of Texas-Houston Medical School
Reinhardt Jahn, Yale University School of Medicine
Leonard Kaczmarek, Yale University School of Medicine
Eric Kandel, Columbia University College of Physicians & Surgeons
This fifth international meeting continued the trend of including presentations on data gleaned
from work with identifiable neurons of Aplysia, squid, Lymnaea, as well as with some crustaceans
and annelids (preparations). For the neurobiologist, the major advantage to using these animals
(preparations) is the large size of their somata, which allows intracellular injection of enzymes
and other reagents to probe synaptic transmission and other aspects of neuronal plasticity. This
feature has allowed workers to gain numerous insights into the mechanisms of exocytosis of
synaptic vesicles and the modulation of membrane channels. In addition, the fact that the nerve
cells of these animals are readily identifiable from preparation to preparation allows them to be
used to determine the changes that occur in neuronal properties during learning and other pro-
longed changes in animal behavior.
This meeting was funded in part by the National Institute of Neurological Disorders and
Stroke, a division of the National Institutes of Health; and the National Science Foundation.
Contributions from the Corporate Sponsors and Plant Corporate Associates also provided core
support for this meeting.
PROGRAM
Plenary Lecture
I. Levitan, Brandeis University, Waltham, Massachusetts
Cellular and Molecular Biology of Ion Channels and Synaptic
Transmission I
Chairperson: R. Jahn, Yale University, New Haven,
Connecticut
Cellular and Molecular Biology of Ion Channels and Synaptic
Transmission II
Chairperson: L. Kaczmarek, Yale University New Haven,
Connecticut
Peptides and Small Molecule Transmitters
Chairperson: P. Lloyd, University of Chicago, Illinois
Neural Control of Behavior
Chairperson: J. Byrne, University of Texas Medical School,
Houston
Tanks and Home Tanks
Chairpersons: P. Walsh, University of Miami, Florida; D.
Gardner, Cornell University New York
Rhythms: Generation and Modulation
Chairperson: I. Kupfermann, Columbia University New York,
New York
Learning and Memory I
Chairperson: C. Sahley, Purdue University West Lafayette,
Indiana
Learning and Memory II
Chairperson: C. Rankin, University of British Columbia,
Vancouver, Canada
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J.H. Byrne, T. Carew
R. Jahn, B. Garetsky
Biology of Proteolysis
April 23-27 233 participants
ARRANGED BY Charles S. Craik, University of California, San Francisco
Susan Gottesman, National Cancer Institute
Mark Hockstrasser, University of Chicago
Yuri Lazebnik, Cold Spring Harbor Laboratory
Proteolytic processing has emerged as a key regulatory step in a wide range of biological
processes ranging from cell cycle and development to cell death. This created a need for a
forum that would fertilize crosstalk between experts on these processes and experts on the pro-
teases as enzymes. This new meeting, which will be held every other year, attracted more than
230 scientists that discussed the role of proteolysis in signal transduction, gene regulation, devel-
opment, cell cycle, control of protein expression, neoplasia and cell transformation, immune con-
trol, and cell death. The reported experimental systems ranged from prokaryotes to animals and
plants, whereas the interests of speakers varied from the dissection of protease structure to find-
ing out how plants know that they are eaten by caterpillars. Despite such a diversity, the partici-
pants commented that the meeting was focused, informative, and very exciting. The crosstalk
was made possible in large part by the chairpersons who presented extensive overviews at the
beginning of each session. In summary, this meeting promises to be a unifying forum that will
help us to understand how proteases control life and death. (For a detailed review of this meet-
ing, see Trends in Cell Biology 7: 333-335 [1997].)
Contributions from the Corporate Sponsors and Plant Corporate Associates provided core
support for this meeting.
PROGRAM
Signal Transduction
Chairperson: T. Maniatis, Harvard University Cambridge,
Massachusetts
Gene Regulation and DNA Replication
Chairperson: T.A. Baker, Howard Hughes Medical Institute,
Massachusetts Institute of Technology Cambridge
Development
Chairperson: K.V. Anderson, Memorial Sloan Kettering
Cancer Institute, New York, New York
Neoplasia and Cell Transformation
Chairperson: P.M. Howley, Harvard Medical School, Boston,
Massachusetts
Cell Cycle
Chairperson: J. Ruderman, Harvard Medical School,
Boston, Massachusetts
Quality Control
Chairperson: F.U. Hartl, Howard Hughes Medical Institute,
Memorial Sloan Kettering Cancer Center, New York, New
York
Host-Pathogen Interaction and Antigen Presentation
Chairperson: H. Ploegh, Massachusetts Institute of
Technology Cambridge
Cell Death
Chairperson: V.M. Dixit, University of Michigan, Ann Arbor
F. Goldberg, C. Craik
R. Deshaies, M. Hockstrasser
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Regulation of Liver Gene Expression in Health and Disease
April 30-May 4 252 participants
ARRANGED BY Gretchen Darlington, Baylor College of Medicine
Rebecca Taub, University of Pennsylvania School of Medicine
Ken Zaret, Brown University
This meeting featured eight sessions on topics that highlighted recent progress in the area of
liver biology. This year, each session featured speakers from fields other than liver function, in
order to broaden the perspective of the participants and to provide cross-fertilization of ideas
within different experimental systems.
The initial session addressed the Embryonic and Neonatal Development of the Liver and pre-
sentations in this session covered the similarity of developmental mechanisms for the major
organ systems in Drosophila and mouse. Exciting data were presented about the role of fibro-
blast growth factor in directing the development of the initial stages of liver organogenesis. The
second session, Transcriptional Control and Chromatin Structure, featured presentations on a
powerful in vitro system for examining transcription and chromatin structure. In addition, recent
findings were presented on the complexity of function of several transcription factor families that
have critical roles in governing gene expression in the liver. Differentiation of Other Tissues from
the Gut highlighted the similarities and differences in gene regulatory events that lead to differen-
tiation of adipose tissue, lung, pancreas, and intestine. New findings of significance to metabo-
lism were presented that showed how alterations in adipose tissue function lead to serious com-
plications in liver function, suggesting a new disease mechanism for fatty liver. The fifth session
focused on Hormonal and Nutritional Control of liver function. The interplay between certain fami-
lies of liver transcription factors, carbohydrate metabolism, and insulin regulation was presented,
giving insight into the molecular mechanisms that govern metabolic homeostasis. The Liver
Growth and Regeneration session contained several exciting papers that revealed new mecha-
K. Fournier, G Darlington R Hanson
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K. Zaret, J. Whitsett D. Robins, K. Tullis, S. Duncan
nisms of the regenerative response. The well-studied system of liver regeneration following par-
tial hepatectomy has only recently been dissected at the molecular level and the work presented
here by several investigators has formed the basis for a new paradigm for pathways of mitotic
response, showing that the control of hepatic proliferation has components that have not been
identified in the cultured fibroblast systems commonly studied thus far. The role of Cytokines in
Gene Expression featured talks on the signal transduction pathways for the acute phase
response in the liver including the Stat factors and the IL-6 receptor. The final topic dealt with
Liver Gene Therapy. This stimulating session revealed the recent advances in the use of the liver
as the organ of choice in gene therapy protocols. The benefits of each method were presented
leaving the audience with both insight and high expectations for future developments in this new
area of medicine.
The "Liver Meeting" at Cold Spring Harbor continues to attract a large number of partici-
pants and the level of audience participation is particularly strong. Prominent investigators
regard this meeting as the premier forum for presentation of their latest findings. This meeting
was funded in part by the National Institute of Child Health and Human Development, the
National Cancer Institute, and the National Institute of Diabetes and Digestive and Kidney
Diseases, divisions of the National Institutes of Health; the Council for Tobacco Research, USA,
Inc.; Dupont Merck Pharmaceutical Company; Genetic Therapy, Inc.; the March of Dimes; and
Pfizer, Inc.
Contributions from the Corporate Sponsors and Plant Corporate Associates also provided
core support for this meeting.
PROGRAM
Embryonic and Neonatal Development
Chairperson: K. Zaret, Brown University Providence, Rhode
Island
Transcriptional Control and Chromatin Structure
Chairperson: U. Schibler, University of Geneva, Switzerland
Differentiation of Other Tissues from the Gut
Chairperson: J. Whitsett, Children's Hospital Medical Center,
Cincinnati, Ohio
Hormonal and Nutritional Control
Chairperson: G. Darlington, Baylor College of Medicine,
Houston, Texas
Liver Growth and Regeneration
Chairperson: R. Taub, University of Pennsylvania School of
Medicine, Philadelphia
Hepatocellular Carcinoma, Cirrhosis, Viral Hepatitis
Chairperson: R. Jirtle, Duke University Medical Center,
Durham, North Carolina
Cytokines and Gene Expression in the Liver
Chairperson: G. Fey, University of Erlangen- Nurnburg,
Germany
Liver Detoxification and Gene Therapy
Chairperson: S. Woo, Mt. Sinai School of Medicine, New
York, New York
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Tyrosine Phosphorylation and Cell Signaling
May 7-11 300 participants
ARRANGED BY Ben Neel, Beth Israel Hospital, Harvard Medical School
Nick Tonks, Cold Spring Harbor Laboratory
This second meeting at Cold Spring Harbor marked the 20th anniversary of the discovery
of the vSrc protein tyrosine kinase. As such, it was particularly appropriate that the meeting
was opened with keynote addresses by Ray Erikson and Sara Courtneidge, providing an
overview of historical perspective, current progress, and future directions in the field. The
format of the meeting provided a combined emphasis on the physiological roles of protein
tyrosine kinases and phosphatases and how their actions are integrated to modulate sig-
naling events in vivo. The sessions were based around physiological processes and cellu-
lar functions rather than around particular categories of enzymes, so as to try to provide
biological context to the data. The program included scientists from the United States,
Europe, the Far East, and the South Pacific. There were 63 speakers selected to present
their data in sessions that dealt with Receptor Protein Tyrosine Kinase Signaling and
Growth Control, Neuronal Signaling, Cytoskeleton and Cell Adhesion, Tyrosine
Phosphorylation and the Immune System, Hematopoietic Cell Signaling Development, and
Human Disease. A variety of systems were described with great progress reported in
genetic and biochemical approaches to the characterization of physiological functions for
tyrosine phosphorylation. The meeting continues to be successful and now alternates with
a conference with the same format at The Salk Institute with the result that there is an annu-
al meeting on "Tyrosine Phosphorylation" that alternates in venue between Cold Spring
Harbor and The Salk.
The meeting was supported by grants from the National Institutes of Health, National
Science Foundation, and Upstate Biotechnology Inc. with contibutions from the Corporate
Sponsors and Plant Corporate Associates.
PROGRAM
Keynote Speakers: Ray Erikson, Harvard University; Sara
Courneidge, SUGEN, Inc.
Neuronal Signaling
Chairperson: K. Zinn, California Institute of Technology
Pasadena
Receptor Signaling and Growth Control I
Chairperson: T. Hunter, The Salk Institute, La Jolla, California
Cytoskeleton and Cell Adhesion
Chairperson: M. Streuli, Dana-Farber Cancer Institute,
Boston, Massachusetts
Tyrosine Phosphorylation in the Immune System
Chairperson: K. Siminovitch, Samuel Lunenfeld Research
Institute, University of Toronto, Canada
Hematopoietic Cellular Signaling
Chairperson: A.-M. Pendergast, Duke University Durham,
North Carolina
Development
Chairperson: P. Soriano, Fred Hutchinson Cancer Center,
Seattle, Washington
Human Disease
Chairperson: J. Brugge, Ariad Pharmaceuticals, Cambridge,
Massachusetts
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T. Hunter
Receptor Signaling and Growth Control II
Chairperson: M. Roussel, St. Jude's Children's
Research Hospital, Nashville, Tennessee
N. Tonks
Genome Mapping and Sequencing
May 14-18 461 participants
ARRANGED BY David Bentley, Sanger Centre
Eric Green, National Institutes of Health
Philip Hieter, Johns Hopkins University
This meeting marked the tenth annual gathering of genome scientists in this setting and, as such,
the meeting was a celebration of this important milestone. Just over 460 people from around the
world attended the meeting, with 238 abstracts presented describing a broad array of topics
relating to the analysis of genomes from a number of different organisms.
The session topics included areas such as biological insights from multi-organismal
genomics, mapping methods and technologies, DNA sequencing production and technology,
functional genomics, computational genomics, and gene discovery and transcript mapping. This
year's poster symposium featured progress on sequencing the human genome. Once again, pro-
jection-style, interactive computer demonstrations in Grace Auditorium effectively highlighted the
critical new bioinformatics tools being developed for storing, organizing, and analyzing genomic
maps and sequences. There was also a panel discussion on the genome ELSI (Ethical, Legal,
and Social Implications) program, which included a timely presentation on the ethical and scien-
tific issues relating to cloning.
The major themes of the meeting related to the exciting initiation of human genomic sequenc-
ing and the increasing number of approaches being developed for using sequence data to per-
E. Green, R. Myers, J. Witkowski, R. Gibbs D. Bent ly
M. Boguski, L. Goodman P. Hieter, D. Porteous
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form important biologic studies. Specific presentations reported major achievements in the
sequencing of microbial genomes, the development of new sequencing technologies, and the use
of microarrays for performing genome analysis. As a major pioneer of the Human Genome Project
and initiator of the annual Cold Spring Harbor meeting, it was only fitting that the keynote speaker at
the tenth annual meeting be Dr. James D. Watson. His talk was nothing short of spectacular, focus-
ing on the ethics of genome research and the history of eugenics. With the anticipated achieve-
ments in the next decade, future Genome Mapping and Sequencing meetings should continue to
serve as the premiere showcase for the Human Genome Project and genome research.
This meeting was funded in part by the National Human Genome Research Institute, a division
of the National Institutes of Health. Contributions from the Corporate Sponsors and Plant Corporate
Associates also provided core support for this meeting.
PROGRAM
Multi-Organismal Genomics: Biological Insights
Chairpersons: D. Porteous, MRC Human Genetics Unit,
Edinburgh, United Kingdom; R. Reeves, Johns Hopkins
University Baltimore, Maryland
Mapping Methods and Technologies
Chairpersons: C. Cantor, Boston University Massachusetts;
S. Foote, Walter and Eliza Hall Institute, Victoria, Australia
Computer Demonstrations I
Chairperson: M. Boguski, National Institutes of Health, Beth-
esda, Maryland
DNA Sequencing: Production and Technology
Chairpersons: E. Mardis, Washington University St. Louis,
Missouri; A. Rosenthal, institute of Molecular
Biotechnology Jena, Germany
Human Genome Sequencing Poster Symposium
Chairpersons: D. Bentley, Sanger Centre, Cambridge,
United Kingdom; E. Green, National Institutes of Health,
Bethesda, Maryland
Computer Demonstrations II
Chairperson: M.P. Reeve, Whitehead Institute/MIT Center for
Genomics: The Next Step
Genome Research, Cambridge, Massachusetts
ELSI Panel Discussion
Moderator: E. Meslin, National Institutes of Health, Beth-
esda, Maryland
Functional Genomics
Chairpersons: P. Brown, Stanford University California; P.
Hieter, Johns Hopkins University Baltimore, Maryland
Computational Genomics
Chairpersons: R. McCombie, Cold Spring Harbor Labora-
tory New York; R. Myers, Stanford University California
Computer Demonstrations III
Chairperson: T Matise, Rockefeller University New York,
New York
Keynote Speaker
James Watson, Cold Spring Harbor Laboratory
Gene Discovery and Transcript Mapping
Chairpersons: R. Roberts, New England Biolabs, Beverly
Massachusetts; R. Waterston, Washington University St.
Louis, Missouri
May 18-19 145 participants
ARRANGED BY Mary Ann Gray, Dillon, Read & Co. Inc.
David Stewart, Cold Spring Harbor Laboratory
This second annual Dillon Read genomics conference sponsored jointly by the Laboratory and the
New York investment bank Dillon, Read & Co. Inc. (now SBC Warburg Dillon Read) brought leaders in
the investment and financial communities to Cold Spring Harbor to learn from current leading practi-
tioners and companies about the present state of knowledge and technology in genomics research.
Participation in the meeting was by invitation only from both East and West coast financial communities
and also from abroad, and included senior executives of biotechnology, pharmaceutical, and venture
capital companies. The meeting was relatively informal in style, and all the participants, scientists as
well as executives, found the meeting to be both intellectually stimulating and very enjoyable. Eminent
keynote speakers including Jim Watson, Ham 0. Smith, Rich Roberts, and Jan Witkowski were able to
give a broad overall view of certain aspects of the field to a predominantly lay though informed audi-
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ence. The keynote talks set the scene for discussions of particular technologies given by senior
researchers from leading biotech companies (both established and start-up) who explained the sci-
ence underlying their technology platforms in the context of the commercial environment. Presentations
were made by 30 biotechnology companies including Acacia Biosciences, Algene Biotechnologies
Corporation, Alpha Gene, Inc., Ariad Pharmaceuticals, Aurora Biosciences Corporation, Cadus
Pharmaceutical Corporation, Darwin Molecular Corporation, deCODE Genetics, Digital Gene
Technologies, Inc., Exelixis Pharmaceuticals, Gene Logic, Inc, Gene/Networks, Genetics Institute,
Gene Trace Systems Inc., Genome Therapeutics Corporation, Genzyme Molecular Oncology, Human
Genome Sciences, Incyte Pharmaceuticals, Millenium Pharmaceuticals, MitoKor, Myriad Genetics, Inc.,
Nanogen Inc., Neurocrine Biosciences Inc., Novalon Pharmaceutical Corporation, Ontogeny Inc.,
Progenitor Inc., SEQ Ltd, Sequana Therapeutics, Variagenics Inc., and Visible Genetics Inc. A round-
table discussion on "Building a Business in Drug Discovery" (moderator Karen Bernstein) was of con-
siderable interest to the audience, and Kevin Kinsella's post-banquet multimedia presentation once
again provided an amusing personal and anecdotal history of the genome biotechnology industry.
This meeting was sponsored by Dillon, Read & Co. Inc., New York.
PROGRAM
Introduction to Genomics: J.
Witkowski, Cold Spring Harbor
Laboratory
Keynote Speaker: K.J. Kinsella,
Sequana Therapeutics
Welcome: J.D. Watson, Cold Spring
Harbor Laboratory
Keynote Speaker: H.O. Smith, Johns
Hopkins University School of
Medicine
Corporate Presentations I
Progenitor
Myriad Genetics
Sequana Therapeutics
Exelixis Pharmaceuticals
Roundtable: Building a Business in
Drug Discovery
Chairperson: K. Bernstein, BioCentury
Publications, Inc.
Corporate Presentations II
Genome Therapeutics
Incyte Pharmaceuticals
Mitokor
Ariad Pharmaceuticals
Keynote Speaker: R.J. Roberts, New
England Biologicals
Corporate Rapid Fire Session
Acacia
Alpha Gene
deCODE
Digital Gene
Gene Logic
GeneTrace Systems
Neurocrine Biosciences
Nova Ion
SEQ
Variagenics
Corporate Presentations III
Human Genome Sciences
Genzyme Molecular Oncology
Nanogen
Visible Genetics
Corporate Presentations IV
Millennium Pharmaceuticals
Genetics Institute
Darwin Molecular, Chiroscience Group
Aurora Biosciences
gene/Networks
Ontogeny
Algene Biotechnologies
Cadus Pharmaceutical
A. Walton, R. Whitsfield D. Stewart, R. Roberts
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Retroviruses
May 20-25 437 participants
ARRANGED BY Stephen H. Hughes, National Cancer Institute
John M. Coffin, Tufts University School of Medicine
Although there were exciting developments in a number of areas of retrovirus research, assem-
bly, reverse transcription, integration, expression, HIV accessory proteins, and fish retroviruses,
the greatest progress was made in understanding the envelope glycoproteins and their interac-
tions with host-cell receptors. We saw, for the first time, the structure of the critical elements of
an SU protein. The structure is both aesthetically pleasing and informative. The segments of SU
involved in receptor recognition are positioned on the surface of the protein, and a plausible
model of a trimeric SU was presented. We learned more about the HIV-1 coreceptors and the
role these proteins have in defining the tropism of particular strains of HIV-1. Despite the fact
that in nature the envelope glycoprotein is always on the virus and the receptor always on the
cell, there is nothing magical about this arrangement. If by experimental manipulation the
receptor is expressed on the virus and the envelope glycoprotein on the surface of the cell,
efficient infection can still occur. Happily, these experiments answer important questions and,
at the same time, provide us with new problems to solve. Contributions from the Corporate
Sponsors and Plant Corporate Associates provided core support for this meeting.
PROGRAM
Entry
Chairpersons: L. Albritton, University of Tennessee,
Memphis; M. Eiden, National Institutes of Health,
Bethesda, Maryland
Reverse Transcription
Chairpersons: R. Bambara, University of Rochester, New
York; W.-S. Hu, West Virginia University Morgantown
Integration
Chairperson: A. Engelman, Dana-Farber Cancer Institute,
Boston, Massachusetts
Assembly
Chairpersons: W. Sundquist, University of Utah, Salt Lake
City; H.-G. Krausslich, German Cancer Research Center,
Heidelberg
Vectors/Evoluton
Chairpersons: J.A. Anderson, West Virginia University
Morgantown; B. Preston, University of Utah, Salt Lake City
Accessory Proteins
Chairperson: J. Elder, Scripps Clinic and Research
Foundation, La Jolla, California
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J. Coffin, A.-M. Skalka, J. Lew
HIV Pathogenesis
Chairpersons: R. Swanstrom, University of North Carolina,
Chapel Hill; L. Ratner, Washington University St. Louis,
Missouri
Expression
Chairpersons: M.-L. Hammarskjold, University of Virginia,
Charlottesville; M. Malim, Howard Hughes Medical
Institute, University of Pennsylvania, Philadelphia
TAT I/II
Chairperson: A. Rabson, University of Medicine and
Dentistry of New Jersey Piscataway,
Non-HIV Pathogenesis I/II
Chairperson: D. Derse, National Cancer Institute, Bethesda,
Maryland
Special Topics
Chairpersons: H. Fan, University of California, Irvine; J.
Stoye, National Institute for Medical Research, London,
United Kingdom
P. Jolicocur, J. Wills
Yeast Cell Biology
AUGUST 12-17 472 participants
ARRANGED BY Trisha Davis, University of Washington
Mark Rose, Princeton University
Tom Stevens, University of Oregon
This conference was the sixth bi-annual international meeting devoted to major aspects of cell
biology in yeast. It is unique in that the study of all major areas of cell biology are integrated in a
single simple eukaryotic organism, Saccharomyces cerevisiae.
A common interest in one organism allowed for extensive cross-fertilization of ideas and
methodologies. Important insights were further gained by studies in the fission yeast
Schizosaccharomyces pombe as well as other yeasts. The completion of the sequencing of the
Saccharomyces genome had a profound impact on the meeting, greatly facilitating the identifica-
tion of genes identified by their effects on critical cellular processes. One major area of interest
included the functions of the actin cytoskeleton particularly with respect to cell polarity and
organelle movement. A second area that was extensively described concerned the roles of
microtubules and associated proteins and organizing structures in chromosome and nuclear
movement. Third was targeting and sorting of proteins in the secretory, endocytotic, and nuclear
localization pathways, and integration of these processes was discussed in various sessions
devoted to mating pathways, the cell cycle, and protein transport and degradation. Additional
sessions focused on organelle biogenesis and genome analysis, and signaling, ions, and cell
wall. It was a very exciting meeting with 368 abstracts, 114 talks, and 254 posters.
Contributions from the Corporate Sponsors and Plant Corporate Associates provided core
support for this meeting.
PROGRAM
Mating Pathways
Chairperson: K. Blumer, Washington University School of
Medicine, St. Louis, Missouri
Cell Cycle and Microtubule Organization
Chairperson: B. Andrews, University of Toronto, Canada
Secretion and Endocytosis
Chairperson: N. Segev, University of Chicago, Illinois
Microtubule Organization
Chairperson: D. Botstein, Stanford University School of
Medicine, California
Organelle Biogenesis and Genomic Analysis
Chairperson: A. Hopper, Hershey Medical Center,
Pennsylvania
Nuclear Transport, ER Protein Degradation, and Folding
Chairperson: J. Rine, University of California, Berkeley
Actin Cytoskeleton and Cell Polarity
Chairperson: J. Pringle, University of North Carolina, Chapel
Hill
Cell Polarity and Development
Chairperson: L. Pon, Columbia University New York, New
York
Signaling, Ions, and Cell Wall
Chairperson: J. Thorner, University of California, Berkeley
Golgi Function and Protein Sorting
Chairperson: S. Michaelis, Johns Hopkins School of
Medicine, Baltimore, Maryland
T. Davis
D. Botstein, T. Stevens, F. Sherman
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Eukaryotic mRNA Processing
August 20-24 272 participants
ARRANGED BY Adrian R. Krainer, Cold Spring Harbor Laboratory
James Manley, Columbia University
Timothy W. Nilsen, Case Western Reserve University
This first meeting focused on the mechanisms and regulation of pre-mRNA splicing and 3'-end
formation in yeast and multicellular eukaryotes. The format of this meeting was modeled after
the highly successful RNA processing conferences that were held annually or every other year
at Cold Spring Harbor from 1982 to 1995. The major difference is in size and scope, in that the
current meeting, which will be held every other year, deals exclusively with eukaryotes and with
the processing of messenger RNA.
A major area of discussion at this meeting was in the characterization of SR proteins, which
are involved in multiple aspects of constitutive and alternative splicing, as well as in the recog-
nition of splicing enhancer elements. Many presentations focused on other mammalian, inverte-
brate, or yeast splicing factors, including U2AF, SF1, Prp proteins, as well as several RNA heli-
case motif proteins, or on further characterization of hnRNP proteins and individual polypep-
tides from snRNP particles. RNA-RNA interactions among the spliceosomal snRNAs and critical
sites on pre-mRNA were described in increasing detail.
Related studies were presented in the context of trans-splicing in nematodes and try-
panosomes, as well as in the context of the recently identified ATAC cis-splicing pathway for a
minor class of introns present in several genes; this splicing reaction involves a distinct set of U
snRNAs. Recent progress in characterizing a novel mRNA splicing reaction involving the yeast
Heel transcription factor pre-mRNA was presented; this reaction does not involve the major or
minor spliceosomes but rather tRNA ligase. It now appears that kelp-a transmembrane
kinase involved in the unfolded protein response signaling pathway-also serves as the splicing
endonuclease to cleave the Hac-I unusual intron in Hact Interestingly, this peculiar splicing
pathway appears to be conserved in mammalian cells.
Other presentations at the meeting dealt with 3'-end processing mechanisms and regula-
tion, mRNA editing, mRNA turnover, cellular and viral RNA transport, and localization of mRNA
and RNA processing factors in yeast and metazoans. Genetic, biochemical, and cell biological
approaches were brought to bear on each of these problems. Finally, several presentations
dealt with the integration of mRNA processing reactions-including capping, splicing, 3'-end
formation, and mRNA turnover-with each other and with transcription, translation, and the cell
cycle.
1997 marked the 20th anniversary of the discovery of split genes in adenovirus. Reports of
this remarkable discovery were given at the 1977 XLII Cold Spring Harbor Annual Symposium
by teams from Cold Spring Harbor Laboratory and MIT. To commemorate this important occa-
sion, copies of the 1977 abstracts, Symposium articles, and papers, as well as pictures of
Symposium participants, were on exhibit after the Saturday afternoon session. Cold Spring
Harbor Laboratory President James Watson talked about the XLII and other annual symposia,
followed by remarks from two meeting participants and co-authors of one of the landmark 1977
papers: Nobel Laureate Philip Sharp from MIT and Susan Berget, now at the Baylor College of
Medicine. This was followed by a champagne toast.
This meeting was funded in part by the National Cancer Institute and the National Institute
of Child Health and Human Development divisions of the National Institutes of Health, by the
National Science Foundation, and by Promega Corporation. Contributions from the Corporate
Sponsors and Plant Corporate Associates also provided core support for this meeting.
The Laboratory would in addition like to thank the RNA Society for its support of this meeting.
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S. Berget, J. Alwine, J. Manley
PROGRAM
B. Blencowe, P. Sharp, A. Beyer
Splicing Regulation
Chairperson: T. Maniatis, Harvard University Cambridge,
Massachusetts
Mechanisms and Regulation of Polyadenylation
Chairperson: N. Proudfoot, Sir William Dunn School of
Pathology, Oxford, United Kingdom
Splicing Mechanisms
Chairpersons: M. Konarska, Rockefeller University New
York, New York; A. Newman, MRC Laboratory of Molecular
Biology Cambridge, United Kingdom
Localization and Transport
Chairperson: R. LCihrmann, Philipps-Universitat Marburg,
Germany
snRNPs and Splicing Factors
Chairperson: S. Berget, Baylor College of Medicine,
Houston, Texas
SR Proteins and Phosphorylation
Chairperson: P. Sharp, Massachusetts Institute of
Technology Cambridge
In Celebration of Twenty Years of Splicing
Remarks by James D. Watson, Cold Spring Harbor
Laboratory
mRNA: Beyond Splicing and 3' Ends
Chairpersons: L. Maquat, Roswell Park Cancer Institute,
Buffalo, New York; J. Richter, Worcester Foundation for
Experimental Biology Shrewsbury Massachusetts
Mechanisms of Eukaryotic Transcription
August 27-31 424 participants
ARRANGED BY Nouria Hernandez, Cold Spring Harbor Laboratory
Robert Kingston, Massachusetts General Hospital
Keith Yamamoto, University of California, San Francisco
This was the fifth biennial meeting devoted to mechanisms of transcriptional regulation in eukary-
otes. The conference focused on the structure and function of the basal transcription apparatus
involved in transcription initiation and elongation, on activation and repression mechanisms, on
mechanisms of chromatin remodeling, and on the role of chromatin and chromatin remodeling for
the regulation of transcription initiation and elongation. The conference was attended by scientists
from around the world who study transcription in systems as diverse as yeast, plants, and inverte-
brate and vertebrate animals. Important advances in our understanding of transcriptional regula-
tion were presented, including the characterization of protein-protein and protein-DNA interac-
tions in transcription initiation complexes, the identification of new factors involved in the regula-
tion of transcription elongation, and the characterization of the interplay between chromatin
remodeling factors and transcription regulation. The meeting was summarized by Arnold J. Berk.
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R. Kingston, R. Treisman A. Berk, G. Gill M. Carey R. Roeder, W. Slumph
This meeting was funded in part by the National Cancer Institute and National Institute of
Child Health and Human Development, both branches of the National Institutes of Health; the
National Science Foundation; Ariad Pharmaceuticals Inc.; and Tularik, Inc. Contributions from the
Corporate Sponsors and Plant Corporate Associates also provided core support for this meeting.
PROGRAM
Basal Machinery
Chairperson: W. Herr, Cold Spring Harbor Laboratory
Basal Machinery/Elongation
Chairperson: C. Prives, Columbia University New York
Activation Mechanisms
Chairperson: C. Abate-Shen, University of Medicine and
Dentistry of New Jersey-Robert Wood Johnson Medical
School, Piscataway
Activation Mechanisms/Chromatin Remodeling
Chairperson: D. Allis, University of Rochester, New York
Eukaryotic DNA Replication
Chromatin: Acetylation, Deacetylation, and Elongation
Chairperson: S.M. Gasser, ISREC, Epalinges, Switzerland
Modifying Activator Function
Chairperson: E.N. Olson, University of Texas Southwestern
Medical Center, Dallas
Repression and Activation
Chairperson: M. Carey, University of California, Los Angeles
Transcription Factor Function In Vivo
Chairperson: L. Guarente, Massachusetts Institute of
Technology Cambridge
September 3-7 395 participants
ARRANGED BY Thomas Kelly, Johns Hopkins University School of Medicine
Bruce Stillman, Cold Spring Harbor Laboratory
This was the sixth biannual meeting on eukaryotic DNA replication held at Cold Spring Harbor.
Studies of eukaryotic DNA replication are advancing rapidly and advancing on many fronts,
and this meeting is now established as the most important in the field. A record number of
investigators participated in the ten scientific sessions and there were nearly 300 platform and
poster presentations. Thus, interest in the mechanisms and regulation of DNA replication in
eukaryotic cells remains extremely high and the meeting is playing a key part in fostering the
exchange of new ideas and experimental approaches.
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T. Kelly
A major goal of work in the field is to define the mechanisms of initiation of eukaryotic DNA
replication at replication origins. Several laboratories reported important advances in identifying
the proteins that assemble at cellular origins of replication prior to initiation and in defining the
critical protein-protein and protein-DNA interactions required for assembly. The nature of the
replication switch that links initiation of DNA synthesis to the eukaryotic cell cycle was the sub-
ject of a number of genetic and biochemical studies. This work highlighted the central role of
cyclin-dependent kinases in triggering initiation and in preventing re-replication prior to mitosis.
The enzymology of the eukaryotic replication fork also remains a major focus of study for many
laboratories. Work presented at the meeting provided new perspectives on the mechanisms of
action of purified DNA polymerases and accessory proteins, as well as insight into the functional
interactions that contribute to the efficiency and fidelity of DNA chain elongation. Finally, several
groups reported exciting progress in defining and characterizing the protein components of
yeast and human telomerase, the enzyme responsible for maintaining the integrity of the ends of
chromosomes. The initial characterization of a strain of mice lacking telomerase activity was also
discussed.
Essential funding for the meeting was provided by in part by the National Cancer Institute, a
division of the National Institutes of Health, and the National Science Foundation. Contributions
from the Corporate Sponsors and Plant Corporate Associates also provided core support for this
meeting.
PROGRAM
Initiation of Replication
Chairperson: J. Diffley, Imperial Cancer Research Fund,
South Mimms, United Kingdom
Control of Initiation
Chairperson: E. Fanning, Vanderbilt University Nashville,
Tennessee
Chromosome Replication
Chairperson: K. Downey, University of Miami, Florida
DNA Unwinding?
Chairperson: B. Brewer, University of Washington, Seattle
Replication Fork Accessory Proteins
Chairperson: T. Wang, Stanford University School of
Medicine, California
Polymerases and Mitochondria
Chairperson: M. DePamphilis, NICHD, National Institutes of
Health, Bethesda, Maryland
Telomeres and Telomerase
Chairperson: P. Traktman, Cornell University Medical
College, New York, New York
Virus Chromosome Replication
Chairperson: A. Stenlund, Cold Spring Harbor Laboratory
B. Stillman, S. Bell, M. Botchan
L. Harrington, C. Greider
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Microbial Pathogenesis and Host Response
September 10-14 305 participants
ARRANGED BY P.T. Magee, University of Minnesota
Stanley Maloy, University of Illinois
Ronald Taylor, Dartmouth Medical School
Understanding microbial pathogenesis demands a detailed knowledge of the host response as
well as the pathogen itself, and requires an interdisciplinary approach, integrating the fields of
microbiology, eukaryotic cell biology, and immunology. This first Cold Spring Harbor meeting was
planned to facilitate such interactions, and the meeting attracted more than 300 international sci-
entists who approach the study of bacterial and fungal pathogens from a broad range of per-
spectives.
Each session focused on recent insights into a specific mechanism of pathogenesis. The first
session dealt with bacterial pathogens that produce toxins which cause the primary disease
symptoms. A major highlight of this session was a talk by John Mekalanos on how a bacterial
virus can convert nonvirulent strains of Vibrio cholerae into a highly virulent strain. Another ses-
sion dealt with Shigella, Listeria, and Legionella, three bacterial pathogens that evade the host
immune system by growing inside eukaryotic cells. A highlight of this session was a talk by
William Dietrich on the creative combination of classical mouse genetics and genomics to identify
genes involved in susceptibility to Legionella infections. A session dealt with the infamous bacter-
ial pathogens Salmonella and Yersinia, which invade a host and cause serious systemic disease,
whereas another session dealt with another growing threat, opportunistic gram-positive
pathogens such as Staphylococcus, Streptococcus, and Bacteriodes. These pathogens are often
resistant to multiple antibiotics and are a common cause of life-threatening, hospital-acquired
infections, and several talks highlighted new approaches for developing novel antibiotic targets
by identifying genes required for virulence in a eukaryotic host. Another session dealt with
Mycobacterium, the causative agent of tuberculosis. Two sessions focused on the fungal
pathogens Candida, an opportunistic yeast pathogen that causes serious illness in immunocom-
promised hosts, and Histoplasma and Coccidiodes, two fungal pathogens that
cause widespread diseases but are less well studied, and in which William
Goldman demonstrated how the clever development of new molecular genetic
tools can facilitate the dissection of the mechanism of pathogenesis in an organ-
ism that was previously intractable. One session dealt with how the recent devel-
opments in genomics have provided powerful new approaches to study micro-
bial pathogenesis, with highlights being talks by Christopher Gray, on how
genome sequences can be used to rapidly determine the structure and function
of proteins (proteomics), and Daniel Shoemaker, on the use of high-density
arrays (DNA chips) to rapidly identify genes that are turned on or off under spe-
cific conditions. Another session dealt with novel model systems for dissecting
host-pathogen interactions and examined the innovative uses of worms, gold-
fish, and plants to identify virulence genes that also play a role in human patho-
genesis. Finally, Abigail Salyers gave an introspective talk on future challenges
facing the field of microbial pathogenesis. Based upon the support and enthusi-
asm of the participants, the meeting was a resounding success. Thus, a second
Microbial Pathogenesis and Host Response meeting will be held in Fall of 1999.
This meeting was funded in part by the National Institute of Allergy and
Infectious Diseases, a division of the National Institutes of Health; and the United
States Department of the Army. Contributions from the Corporate Sponsors and
Plant Corporate Associates also provided core support for this meeting.
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S. Maloy
P. Sansonetti, H. Shuman
PROGRAM
J. Scott, J.-F. Tomb, P. Model
Toxigenic Pathogens: Vibrio Cholerae and Toxinogenic E.
coli
Chairperson: R. Taylor, Dartmouth Medical School, Hanover,
New Hampshire
Keynote Speaker: J. Mekalanos, Harvard Medical School,
Boston
Intracellular Pathogens: Shigella, Listeria, and Legionella
Chairperson: P. Sansonetti, Institut Pasteur, Paris,
France
Keynote Speaker: P. Cossart, lnstitut Pasteur, Paris,
France
Disseminating Pathogens: Salmonella and Yersinia
Chairpersons: V. Miller, Washington University School of
Medicine, St. Louis, Missouri; J. Slauch, University of
Illinois, Urbana
Keynote Speaker: R. lsberg, Tufts University School of
Medicine, Boston, Massachusetts
Opportunistic Gram-positive Pathogens: Staphylococcus
Chairperson: M. Schmid, Microcide Pharmaceutics, Inc.,
Mountain View, California
Keynote Speaker: A. Tomasz, Rockefeller University New
York, New York
Programmed Cell Death
Opportunistic Bacterial Pathogens II: Streptococcus and
Bacteriodes
Chairperson: S. Maloy, University of Illinois, Urbana
Chronic Bacterial Pathogens: Mycobacterium
Chairperson: I. Behlau, Tufts University School of Medicine,
Boston, Massachusetts
Keynote Speaker: W. Jacobs, Albert Einstein College of
Medicine, Bronx, New York
Genomics
Chairperson: J.-F. Tomb, The Institute for Genomic
Research, Rockville, Maryland
Opportunistic Yeast Pathogens: Candida
Chairperson: P.T. Magee, University of Minnesota, St. Paul
Keynote Speaker: G. Fink, Whitehead Institute/MIT,
Cambridge, Massachusetts
Other Fungal Pathogens: Histoplasma and Coccidiodes
Chairperson: B. Keath, St. Louis University Missouri
Keynote Speaker: W. Goldman, Washington University
School of Medicine, St. Louis, Missouri
Novel Model Systems for Dissecting Host-Pathogen
Interactions
Chairperson: S. Maloy, University of Illinois, Urbana
September 17-21
ARRANGED BY
450 participants
Stanley J. Korsmeyer, Washington University School of Medicine
Eileen White, Rutgers University
H. Robert Horvitz, Massachusetts Institute of Technology
The field of programmed cell death has greatly expanded since the first Cold Spring Harbor
meeting on the topic 2 years ago. With the auditorium filled to capacity, the meeting proceeded
with a consistent stream of new and engaging information on the mechanisms to regulate cell
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death, and components of the cell death machinery. The scope of the talks and posters spanned
yeast, nematodes, Drosophila, viruses, mice, and humans. The approaches were genetic, devel-
opmental, disease-related, and biochemical. Highlights of the meeting were numerous and
included identification of genes encoding Drosophila caspases and their requirement for devel-
opment, and the discovery of direct protein complex formation between Ced-3, Ced-4, and Ced-
9 gene products of C. elegans. Mammalian Bcl -xL and FLICE can replace Ced-9 and Ced-3,
respectively, in the Ced-4 protein complex, suggesting that control of caspase activation by
members of the BcI-2 family may be mediated by direct binding to Ced-4. Ion channel activity
associated with Bcl -2, Bax, and BcI-xL in artificial bilayers was reported, in support of the struc-
tural similarity of Bcl -xL with the pore-forming domain of diphtheria toxin. The role of mitochondria
in the cell death process and caspase activation was also reported. Bax localizes to mitochon-
dria, and in the presence of a death stimulus, cytochrome c is released causing Ced-4/Apaf-1-
dependent caspase activation. The protein kinase Akt, which is a component of survival factor
signal transduction pathways, was reported to phosphorylate Bad and thereby prevent inhibition
of Bcl -2 by Bad. Induction of apoptosis by deregulated c-Myc was found to be mediated by the
Fas pathway since blocking that pathway with dominant-negative FADD prevents apoptosis. The
specificity of caspase cleavage sites has been elucidated suggesting a hierarchy of activation
and a grouping of activities. Caspase cleavage of BcI-2 and BcI-xL was found to completely
reverse their function to that of pro-apoptotic proteins, suggesting the existence of an amplifica-
tion step in the apoptotic process. Signal transduction pathways from the Fas and TNF receptors
to induce cell death are now well understood. The identification of decoy receptors for Fas lig-
and-related molecules was reported as a novel mechanism to regulate cell death. The identifica-
tion of new p53 target genes and their role in cell cycle arrest and apoptosis was reported. The
induction of Fas ligand expression in melanoma and other tumors was established as a possible
mechanism for tumor cells to evade immune surveillance. Finally, viral and cellular proteins were
identified that encode direct antagonizers of the Fas and TNF pathways through interaction with
adaptor molecules and caspases. These and numerous other discoveries, with lively discussions
thereafter, produced a meeting of extraordinary intellectual interest which was well received in
this very fast-paced field.
This meeting was funded in part by the National Institute of Aging, and the National Institute
of Child Health and Human Development, both branches of the National Institutes of Health.
Contributions from the Corporate Sponsors and Plant Corporate Associates also provided core
support for this meeting. M. Roth
S. Nagata, P. Krammer
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M.-C. Hsu, E. White
PROGRAM
Opening Address
A. Wyllie, CRC Laboratories
Invertebrate Development
Chairpersons: M. Hengartner, Cold Spring Harbor
Laboratory K. White, Massachusetts General Hospital,
Charlestown
BCL-2 Family
Chairpersons: C. Thompson, University of Chicago, Illinois;
G. Nunez, University of Michigan Medical School, Ann
Arbor
Caspases
Chairpersons: N.A. Thornberry, Merck Research
Laboratories, Rahway New Jersey W.W. Wong, BASF
Bioresearch Corporation
Special Lecture
S. Nagata, Osaka University Medical School, Japan
Vertebrate Development
Chairpersons: J. Yuan, Massachusetts General Hospital,
Neurobiology of Drosophila
Boston; S. Cory, Walter and Eliza Hall Institute of Medical
Research, Parkville, Australia
Signal Transduction
Chairpersons: D. Goeddel, Tularik, Inc. V.M. Dixit, University
of Michigan, Ann Arbor
Oncogenesis
Chairpersons: M. Oren, Weizmann Institute of Science,
Rehovot, Israel; D. Hanahan, University of California, San
Francisco
Viral Control of Apoptosis
Chairpersons: L. Miller, University of Georgia, Athens; J.M.
Hardwick, Johns Hopkins School of Medicine, Baltimore,
Maryland
Immunology/Neurobiology
Chairpersons: P. Krammer, German Cancer Research
Center, Heidelberg; B.A. Barres, Stanford University
School of Medicine, California
September 24-28 314 participants
ARRANGED BY Chris Doe, University of Illinois
Linda Hall, State University of New York, Buffalo
The primary goal of this year's meeting on Drosophila neurobiology was to provide a forum for
exchange of ideas, techniques, and new discoveries within the field of Drosophila neurobiolo-
gy. The meeting consisted of platform and poster presentations by 314 junior and established
investigators. The platform sessions were arranged to reflect the exciting advances that have
been made in understanding the molecular mechanisms underlying neuronal-glial specifica-
tion, cell-cell signaling, axon guidance, synaptic cell biology, receptor and ion channel func-
tion, sensory systems, and complex behavior. The work presented included genetic, cell bio-
logical, molecular, neurophysiological, and behavioral approaches to address questions that
spanned from nervous system development to nervous system function. The highlights of the
meeting included presentations of exciting new developments in several areas, including neu-
ronal-glial determination, cell-cell signaling, axon guidance, sensory systems, biological
rhythms, learning and memory, plasticity, and synaptic cell biology. Also noteworthy were
reports of cloning and characterization of several novel genes encoding molecules of impor-
tance to nervous system development and function, new behavioral paradigms, and a new
way to visualize nervous system function in the living animal. The setting of the meeting pro-
vided for ample opportunities for informal discussions. The high quality of presentations and
the novel findings in many areas made it amply clear that this format, which is inclusive of all
aspects of neurobiology, is extremely useful to young and seasoned scientists because it pro-
vides an ideal opportunity to cover all the different aspects of Drosophila neuroscience.
This meeting was funded in part by the National Institute of Neurological Disorders and
Stroke, a branch of the National Institutes of Health, and the National Science Foundation.
Contributions from the Corporate Sponsors and Plant Corporate Associates also provided
core support for this meeting.
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P. Kolodzig, S. Kunes
PROGRAM
Neuronal-Glial Specification
Chairperson: S. Datta, Texas A&M University College
Station
Cell-Cell Signaling
Chairperson: S. Kunes, Harvard University Cambridge,
Massachusetts
Axon Guidance
Chairperson: H. Keshishian, Yale University New Haven,
Connecticut
Human Evolution
D. Ebert, L. Hall
Synapse Formation and Function
Chairperson: M. Bate, University of Cambridge, United
Kingdom
Neurotransmitters, Receptors, Ion Channels
Chairperson: L. Iverson, Beckman Research Institute of the
City of Hope, Duarte, California
Sensory Systems
Chairperson: J. Fischer, University of Texas, Austin
Behavior
Chairperson: R. Greenspan, New York University New York
October 4-8 199 participants
ARRANGED BY Luca Cayalli-Sforza, Genetics Department, Stanford University
James D. Watson, Cold Spring Harbor Laboratory
This meeting originated from a suggestion by Jim Watson and was organized in collaboration
with him. Approximately 200 participants, mostly molecular geneticists, physical anthropologists,
paleoanthropologists, primatologists, and linguists attended. The meeting was most successful,
judging from reactions of participants and reviews. The subject had been rarely touched upon in
previous symposia; there were previously three Cold Spring Harbor meetings on human genetics
or related subjects in which attention was also paid to human evolution, and they took place in
1957, 1964, and 1985. The meeting will most probably be repeated in 1999. The focus was
largely on molecular evolution at the DNA level, with much attention on the new techniques of
detection of single nucleotide polymorphisms, comparison of entire sequences, studies on mito-
chondria) DNA and Y chromosomes, their relative merits and differences, and applications to
human fossils, in particular the recent results on the original Neanderthal remains showing that it
is not on the direct evolutionary line to modern humans. A definite majority favored the recent
African origin of modern humans, but there were supporters of the multiregional hypothesis.
Members interested in the development of the Human Genome Diversity Project had three meet-
ings in which programs were discussed. At the time of the meeting, the report of the National
Research Council Workshop on the usefulness and feasibility of the study of Human Genome
Diversity was not yet published, but it appeared shortly thereafter, finally removing the major polit-
ical obstacles that had been generated largely by antiscience organizations.
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This meeting was largely supported by the Oliver Grace Professorship Fund with additional
funding provided by the John D. and Catherine T. MacArthur Foundation. Contributions from the
Corporate Sponsors and Plant Corporate Associates also provided core support for this meeting.
Participants watching a video poster
PROGRAM
Genetic Markers for Human Molecular Evolution
Chairperson: K.K. Kidd, Yale University School of Medicine,
New Haven, Connecticut
Molecular Genetics of Living Populations
Chairperson: K. Weiss, Pennsylvania State University
University Park
Genes and Language
Chairperson: L.L. Cavalli-Sforza, Stanford University
California
Ethics and the HGDP
Chairperson: L.L. Cavalli-Sforza, Stanford University
California
Special Lecture
S. Paabo, University of Munich
Paleoanthropology and Human Evolution
Chairperson: R. Klein, Stanford University California
Primate Behavior and the Reconstruction of Human Social
Evolution
Chairperson: F.B.M. de Waal, Emory University Atlanta,
Georgia
Mitochondrial DNA Studies
Chairperson: M.-C. King, University of Washington, Seattle
Y-chromosome Variation
Chairperson: S. Paabo, University of Munich, Germany
Methods for Microsatellite and Other Studies
Chairpersons: M. Feldman, Stanford University California; M.
Slatkin, University of California, Berkeley
Isolated Populations and Disease
Chairperson: N. Risch, Stanford University California
HLA and Population Genetics
Chairperson: W.F. Bodmer, Imperial Cancer Research Fund,
Oxford, United Kingdom
S. Paabo
R. Cooke, M.-C. King
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The Arabidopsis Genome: From Sequence to Function
December 11-14 133 participants
ARRANGED BY Rob Martienssen, Cold Spring Harbor Laboratory
Michael Bevan, John Innes Center, United Kingdom
The sequence of the Arabidopsis genome is likely to be completely, or nearly completely, deter-
mined by the year 2000. This meeting served as the first of a series of annual biotechnology sym-
posia aimed at bringing together those groups sequencing and interpreting the sequence and
those groups attempting to determine the biological function of genes and other chromosomal
sequences. Sessions on sequencing progress and annotation were followed by a session on
positional cloning of genes identifed by mutation. This session outlined progress in cloning a
number of genes using novel PCR-based markers, as well as progress in identifying centromeric
regions by recombinational analysis. Sessions devoted to insertional mutagenesis using transfer
DNA and transposons gave a comprehensive overview of insertion banks and their utility in gene
disruption. It was clear that sufficient material had already been generated in many laboratories
for site-selected mutagenesis by screening pools of plants via the PCR. Systematic characteriza-
tion of gene expression via EST sequencing, enhancer and gene trapping, and biochip technolo-
gy presented an impressive array of tools for analyzing gene expression at high resolution
throughout the genome. A final session on bioinformatics highlighted novel means to catalog,
assemble, interpret, and disseminate this vast flood of new data. The remarkable conservation of
genes and gene clusters emerging from comparative studies of plant genomes was an eye-
opener to many. The need to examine gene function and expression simultaneously in a system-
atic way was emphasized in a large number of the presentations. Perhaps an unexpected out-
come of the meeting was the surprising degree of duplication and redundancy and the relatively
low level of lethality associated with disrupted Arabidopsis genes, compared with animal and
fungal studies. It is clear that imaginative approaches are going to be required to take maximum
advantage of this exciting new era in plant biology.
This meeting was funded in part by DEKALB Genetics Corporation; Diatech, Ltd.; Keygene
(The Netherlands); and Monsanto Company. Contributions from the Corporate Sponsors and
Plant Corporate Associates also provided core support for this meeting.
J. Mundy, M. Bevan
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R. Flavell, D. Jackson. R. Martienssen
PROGRAM
Progress in Genome Sequencing
Chairperson: F. Ausubel, Massachusetts General Hospital,
Boston
Advances in Positional Cloning
Chairperson: J. Jones, Sainsbury Laboratory John Innes
Centre, Norwich, United Kingdom
Annotation Workshop
Moderator: S. Rounsley, The Institute for Genomic Research,
Rockville, Maryland
T-DNA Mutagenesis and Antisense Strategies
Chairperson: N. Fedoroff, Pennsylvania State University,
University Park
Transposon Mutagenesis
Chairperson: R. Martienssen, Cold Spring Harbor
Laboratory
Novel Approaches to Gene Expression
Chairperson: M. Bevan, John lnnes Centre, Norwich, United
Kingdom
Informatics and Databases
Chairperson: N. Federspiel, Stanford University DNA
Sequencing and Technology Center, Palo Alto, California
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POSTGRADUATE COURSES
The summer program of Postgraduate Courses at Cold Spring Harbor Laboratory is aimed at
meeting the special need for training in interdisciplinary subjects that are either so new or so
specialized that they are not adequately treated by universities. Our aim is to provide intensive
study in the most recent developments and techniques in these subjects and to prepare stu-
dents to enter directly into research in a particular area. To ensure up-to-date coverage of current
research work, we bring together a workshop staff from many laboratories around the world and
supplement this staff with a series of seminar speakers.
Advanced Genome Sequence Analysis
March 14-27
INSTRUCTORS
Chen, El !son, Ph.D., Applied Biosystems Division of Perkin Elmer Corporation
Gibbs, Richard, Ph.D., Baylor College of Medicine
McCombie, Richard W., Ph.D., Cold Spring Harbor Laboratory
Wilson, Richard, Ph.D., Washington University School of Medicine
CO-INSTRUCTORS
Mardis, Elaine, Washington University School of Medicine
Muzny, Donna, Baylor College of Medicine
Zuo, Lin, Sequana
ASSISTANTS
Anari, Ali, Baylor College of Medicine
Chen, Chun-Nan, Applied Biosystems Division of Perkin Elmer Corporation
De La Bastide, Melissa, Cold Spring Harbor Laboratory
Dedhia, Nei lay, Cold Spring Harbor Laboratory
Evans, Cheryl, Genetics Institute
Fitzgerald, Michael, Massachusetts General Hospital
Gnoj, Lidia, Cold Spring Harbor Laboratory
Greco, Trade, Washington University School of Medicine
Johnson, Doug, Washington University School of Medicine
Kaplan, Nancy, Cold Spring Harbor Laboratory
Nahn, Michael, Washington University School of Medicine
Parnell, Larry, Cold Spring Harbor Laboratory
Schutz, Kristin, Cold Spring Harbor Laboratory
Touchman, Jeffrey, National Institutes of Health, National Human Genome Research Institute
The purpose of the course was to teach students the range of techniques and project manage-
ment skill required to carry out a large-scale sequencing project. The course provided a 2-week,
extensive laboratory experience in which the students work as a team to carry out a large-scale
sequencing project.
Recent advances in the automation of DNA sequencing have opened new possibilities for the
analysis of complex genomes at the DNA sequence level. This 2-week course provided intensive
training in this rapidly evolving field. The course emphasized techniques and strategies for using
automated sequences to sequence large, contiguous genomic regions. Students carried out all
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of the steps in the sequencing process from preparing cosmid DNA to computer analysis of the fin-
ished sequence. Topics included subclone library generation, large-scale template purification,
sequencing reactions, gel analysis on automated sequencers, sequence assembly, gap filling, and
conflict resolution. Students worked in groups to sequence a large region of DNA. For instance, in
the 1997 course, a 143-kb human BAC clone containing two chemokine receptor genes was
sequenced. Through this process, they were trained in crucial project and data management tech-
niques. A series of lecturers discussed their applications of these techniques as well as alternate
strategies for high-speed automated DNA sequencing.
PARTICIPANTS
De Silva, U., B.S., National Institutes of Health, Bethesda,
Maryland
Diaz-Perez, S., B.S., Ph.D., University of California, Los
Angeles
Doggett, N., B.A., Ph.D., Los Alamos National Laboratory,
New Mexico
Dragan, Y., B.A., Ph.D., University of Wisconsin, Madison
Garcia, D., B.S., M.S., University of Texas Health Science
Center, San Antonio
Giacalone, J., B.A., Ph.D., New York University
Pae, A., B.S., Millennium Pharmaceutical, Inc.,
Massachusetts
Porcel, B.M., B.S., Ph.D., Uppsala University, Sweden
SEMINARS
Bevan, M., John Innes Centre, Norwich, United Kingdom.
The European Arabidopsis genome initiative.
Chee, M., Affymetrix. Santa Clara, California. New technolo-
gies for DNA sequencing.
Fraser, C., Institute for Genomic Research, Rockville,
Maryland. Microbial genome sequencing at TIGR.
Green, E., National Institutes of Health, Bethesda, Maryland.
Physical mapping of human chromosomes.
Mathies, R., University of California, Berkeley. New develop-
ments In fluorescent sequencing.
Powell, E., B.A., M.P.A., Ph.D., Tuskegee University,
Alabama
Sagripanti, J.-L., B.S., Ph.D., Food & Drug Administration,
Rockville, Maryland
See, L.H., B.S., M.S., Defence Medical Research Institute,
Singapore
Solinsky, K., B.S., Case Western Reserve University,
Cleveland, Ohio
Tang, M., B.S., Ph.D., University of California, Berkeley
Watanabe, M., B.S, Ph.D., Chiba University, Chiba, Japan
Yu, Y., B.S., M.S., Clemson University, South Carolina
Zhou, X., M.S., Millennium Pharmaceutical, Inc.,
Cambridge, Massachusetts
McPherson, J., Washington University School of Medicine,
St. Louis, Missouri. Developing sequence-ready maps of
the human genome.
Roe, B., University of Oklahoma, Norman. Experience from
sequencing more than 1 megabase of human genomic
DNA.
Schwartz, D., New York University Medical Center. Optical
mapping of large-molecular-weight DNA molecules.
Watson, J., Cold Spring Harbor Laboratory. History of the
human genome project.
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Early Development of Xenopus laevis
April 8-17
INSTRUCTORS
Krieg, Paul, Ph.D., University of Texas, Austin
Moody, Sally, Ph.D., George Washington University Medical Center
ASSISTANTS
Kenyon, Kristy, George Washington University Medical Center
Kroll, Kristin, Harvard Medical School
Zorn, Aaron, University of Cambridge/Wellcome CRC Institute
This course provided extensive laboratory exposure to the biology, manipulation, and use of
embryos from the frog, Xenopus laevis. The course was suited both for investigators who had no
experience with Xenopus and for those who had worked with Xenopus and wished to learn new
techniques. All students had current training in molecular biology and some knowledge of devel-
opmental biology. The course consisted of intensive laboratory sessions, supplemented by daily
lectures and demonstrations from experts in both experimental and molecular embryology. Areas
covered included (1) care of adults and embryo isolation; (2) stages of embryonic development
and anatomy; (3) whole-mount in situ hybridization and immunocytochemistry; (4) microinjection
of eggs and oocytes, including fluorescent lineage tracers, DNA constructs, mRNA, and anti-
sense oligonucleotides; (5) micromanipulation of embryos, including explant and transplantation
assays; and (6) use of cell cycle extracts, including preparation of transgenic embryos.
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PARTICIPANTS
Brittingham, J., B.S., Ph.D., University of Iowa, Iowa City
Coumailleau, P., B.S., Ph.D., Karolinska Institute, Stockholm,
Sweden
Furutani-Seiki, M., M.D., Ph.D., Max Planck Institute fur
Entwicklungsbiologie, Tubingen, Germany
Hoskins, S., B.S., Ph.D., City College of the City of New York
Lee, Y.J., B.S., Ph.D., Harvard University/Dana Farber
Cancer Institute, Boston
Liu, X B.S., Ph.D., Harvard Medical School/Center for
Blood Research, Boston
Lupo, G., B.S., University of Pisa, Chezzano, Italy
Matsuo-Takasaki, M., B.S., Ph.D., National Institutes of
Health, Bethesda, Maryland
SEMINARS
Cho, K., University of California, Irvine. Molecular mecha-
nisms of activin and BMP signaling during Xenopus
embryogenesis.
Christian, J., Oregon Health Sciences University, Portland.
Regulation of BMP signaling during vertebrate develop-
ment.
Grainger, R., University of Virginia, Charlottesville. Lens
induction, and genetics as a strategy.
Harland, R., University of California, Berkeley. Expression
cloning of developmental genes.
Heasman, J., University of Minnesota School of Medicine,
Minneapolis. Adhesion molecules and antisense oligo-
Nick, T., B.A., B.S., Ph.D., University of Colorado Health
Sciences Center, Denver
Pandur, P., B.S., University of Ulm, Germany
Peunova, N., M.S., Ph.D., Cold Spring Harbor Laboratory
Popsueva, A., M.S., Engelhardt Institute of Molecular
Biology RAS, Moscow, Russia
Rettig, J., B.S., Ph.D., Max Planck Institute for Biophysical
Chemistry, Goettingen, Germany
Sib le, J., B.S., Ph.D., University of Colorado School of
Medicine/HHMI, Denver
Sokac, A.M., B.S., University of Wisconsin, Madison
Samanas, S., B.S., University of Minnesota, Minneapolis
nucleotide inhibition of function.
Keller, R., University of Virginia, Charlottesville. Xenopus
gastrulation.
Kessler, D., University of Pennsylvania School of Medicine,
Philadelphia, Regulation of vertebrate cell fate by maternal
inducers.
Sive, H., Massachusetts Institute of Technology, Cambridge.
Early events in Xenopus anteroposterior patterning:
Approaches using subtractive cloning and inducible gene
expression.
Slack, J., University of Bath, United Kingdom. The role of
fibroblast growth factors in Xenopus development.
Cloning and Analysis of Large DNA Molecules
April 8-21
INSTRUCTORS
Abderrahim, Hadi, Ph.D., Stanford University
Riethman, Harold, Ph.D., The Wistar Institute
Wing, Rod, Ph.D., Clemson University
CO-INSTRUCTOR
Dewar, Ken, University of Pennsylvania
ASSISTANTS
Choi, Sangdun, Clemson University
Frisch, David, Clemson University
This course covered the theory and practice of manipulating, cloning, and mapping large segments
of DNA. The course focused on the hands-on construction of bacterial artificial chromosome (BAC)
clone libraries and the use of several types of large-insert clone libraries (YAC, BAC, PAC) and
genomic DNA for the analysis of large chromosome regions in the physical mapping and contig-
building phases of positional cloning projects. Lectures and laboratory work included BAC clone
library preparation, preparative and analytical pulsed-field gel electrophoresis (PFGE), techniques
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for the isolation and manipulation of high-molecular-weight DNA from a variety of sources
(including plants and animals), and an introduction to relevant bacterial and yeast genetics.
BAC- and YAC-based positional cloning methods included library screening, contig assembly,
long-range restriction and RecA-assisted restriction endonuclease (RARE) cleavage mapping,
and recovery/analysis of large-insert clone end-fragments. Lectures by outside speakers on
topics of current interest supplemented the laboratory work.
PARTICIPANTS
Basinski, M., M.S., Lilly Research Laboratories, Indianapolis,
Indiana
Berghmans, S., D.V.M., University of Liege, Belgium
Champagne, G., B.S., M.S., DNA Land Marks, Inc., Quebec,
Canada
Di Girolamo, M., B.S., Consorzio Mario Negri Sud, S. Maria
Imbaro, Italy
Ebeling, S., B.S., Ph.D., The Netherlands Red Cross,
Amsterdam
Goff, S., B.A., Ph.D., Novartis Corporation, Research
Triangle Park, North Carolina
Hornum, L., M.S., Ph.D., Hagedorn Research Institute,
Gentofte, Denmark
Jeon, J.-T, B.S., Ph.D., Swedish University of Agricultural
SEMINARS
Birren, B., Whitehead Institute, Cambridge, Massachusetts.
Large library screening physical mapping.
Cheung, V., University of Pennsylvania/Children's Hospital of
Philadelphia. Gene chip technology.
Doggett, N., Los Alamos National Laboratory, New Mexico.
Integrated maps of human chromosome 16.
Ganal, M., Institute for Plant Genetics and Crop Plant
Research, Gatersleben, Germany. Plant genome analysis.
Sciences, Uppsala, Sweden
Lidmer, A.-S., M.S., Astra Hassle AB, Molndal, Sweden
Lodhi, M., M.S., Ph.D., Cold Spring Harbor Laboratory
Morshed, S.A., M.D., Ph.D., Yale University, New Haven
Parkin, I., B.S., M.S., Ph.D., John Innes Center, Norwich,
United Kingdom
Podlutsky, A., B.S., Karolinska Institute, Huddinge, Sweden
Reddy, A., B.S., M.S., Ph.D., University of Michigan, Ann
Arbor
Rogel-Gaillard, C., B.S., Ph.D., Institut National de Is
Recherche Agronomique, Jouy en Josas, France
Zhang, Y.H., B.S., M.S., Ph.D., University of Massachusetts,
Boston
Gnirke, A., Mercator Genetics, Inc., Menlo Park, California.
RARE cleavage.
Larionov, V., National Institutes of Health, Research Triangle
Park, North Carolina. TAR cloning.
McCombie, W.R., Cold Spring Harbor Laboratory. Large-
scale sequencing.
Reeves, R., Johns Hopkins University School of Medicine,
Baltimore. Positional cloning strategies.
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Protein Purification and Characterization
April 8-21
INSTRUCTORS
Burgess, Richard, Ph.D., University of Wisconsin, Madison
Courey, Albert, Ph.D., University of California, Los Angeles
Lin, Sue-Hwa, Ph.D., University of Texas/MD Anderson Cancer Center
Mische, Sheenah, Ph.D, Rockefeller University
ASSISTANTS
Bai, Yijian, University of California, Los Angeles
Earley, Karen, University of Texas/MD Anderson Cancer Center
Gharandaghi, Farzin, Rockefeller University
Pietz, Brad, University of Wisconsin, Madison
Thompson, Nancy, University of Wisconsin, Madison
Valentine, Scott, University of California, Los Angeles
Weinberg, Catherine, Rockefeller University
This course was intended for scientists who were not familiar with techniques of protein isolation and
characterization. It was a rigorous program that included laboratory work all day and a lecture with
discussion session every evening. Each student became familiar with each of the major techniques
in protein purification by actually performing four separate isolations including (1) a regulatory pro-
tein from muscle tissue; (2) a sequence-specific, DNA-binding protein; (3) a recombinant protein
overexpressed in E. coli; and (4) a membrane-bound receptor. A variety of bulk fractionation, elec-
trophoretic, and chromatographic techniques were employed including precipitation by salts, pH,
and ionic polymers; ion-exchange, gel-filtration, hydrophobic interaction, and reverse-phase chro-
matography; lectin affinity, ligand affinity, oligonucleotide affinity, and immunoaffinity chromatogra-
phy; polyacrylamide gel electrophoresis and electroblotting; and high-performance liquid chro-
matography. Procedures were presented for solubilizing proteins from inclusion bodies and refolding
them into active monomeric forms. Methods of protein characterization were utilized including
immunological and biochemical assays, peptide mapping, amino acid analysis, protein sequencing,
and mass spectrometry. Emphasis was placed on strategies of protein purification and characteriza-
tion rather than on automated instrumental analysis. Guest lecturers discussed protein structure,
modification of proteins, methodologies for protein purification and characterization, and applica-
tions of protein biochemistry to cell and molecular biology.
PARTICIPANTS
Be lien, A., B.S., University of Zurich, Switzerland
Bertaux, F., B.S., M.S., Ph.D., Guy's Hospital, London,
United Kingdom
Bordo, D., B.S. Ph.D., Advanced Biotechnology Center,
Genoa, Italy
Chalfie, M., B.A., Ph.D., Columbia University, New York
Delgado, A., B.S., M.S., Ph.D., University of California, Los
Angeles
Drabkin, H., B.A., M.D., University of Colorado Health
Science Center, Denver
Dumont, E., B.A., M.A., Ph.D., Northeastern Ohio University,
Rootstown
Flower, A., B.S., Ph.D., University of North Dakota School of
Medicine, Grand Forks
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Gershenson, A., B.A., Ph.D., California Institute of
Technology, Pasadena
Gwynn, B., B.S., M.S., The Jackson Laboratory, Bar Harbor,
Maine
Ingham, C., B.S., Ph.D., Nottingham University, United
Kingdom
Koshland, D., B.A., Ph.D., Carnegie Institute of Washington,
Baltimore, Maryland
Li, D.W.-C., B.S., Ph.D., Columbia University, New York
Little, E., B.S., University of Arizona, Tucson
Roll, U., B.S., M.S., Ph.D., University of California, San
Francisco
Schuyler, S., B.A., Harvard Medical School/Dana Farber
Cancer Center, Boston
SEMINARS
Baker, T., Massachusetts Institute of Technology,
Cambridge. Assembly, organization, and remodeling of
the recombination machinery.
Courey, A., University of California, Los Angeles.
Transcriptional regulation of dorsal/ventral pattern forma-
tion in Drosophila.
Greenblatt, J., University of Toronto, Canada. Multiprotein
complexes involved in transcriptional initiation and elonga-
tion.
Greider, C., Cold Spring Harbor Laboratory. Telomerase:
Biology and biochemistry.
Guidotti, G., Harvard University, Cambridge. Are insulin
receptors dimers?
Developmental Neurobiology
Lin, S.-H., University of Texas/MD Anderson Cancer Center,
Houston. Role of cell adhesion molecule (C-CAM) in
prostate cancer.
Marshak, D., Osiris Therapeutics, Baltimore, Maryland.
Mesenchymal stem cells and associated glycoproteins.
Mische, S., Rockefeller University, New York. Microanalytical
protein preparation and characterization.
Raines, R., University of Wisconsin, Madison. Protein folding
and disulfide bond formation
Stillman, B., Cold Spring Harbor Laboratory. Biochemical
approach to understanding replication of the eukaryotic
cell genome.
June 4-17
INSTRUCTORS
Bargmann, Cornelia, Ph.D., University of San Francisco
Burden, Steven, Ph.D., New York University Medical Center
Cline, Holly, Ph.D., Cold Spring Harbor Laboratory
The aim of this lecture course was to discuss principles and recent advances in developmental
neurobiology. Major topics considered included determination, proliferation, and differentiation of
neural cells; trophic interactions in neural development; gradients and compartments; guidance
of axons to targets; and the formation of synapses. These topics were considered within the con-
text of the development of both invertebrate and vertebrate neural systems. Prospective students
had a background in neurobiology or molecular biology.
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PARTICIPANTS
Alcamo, E., B.S., Massachusetts Institute of Technology,
Cambridge
Bradke, F., B.S., European Molecular Biology Laboratory,
Heidelberg, Germany
Brosamle, C., M.A., University of Zurich, Switzerland
Durand, B., M.S., Ph.D., University College London, United
Kingdom
Gary, S., B.S., Ph.D., Yale University, New Haven
Hines, P., B.A., Ph.D., Science Magazine, Washington, D.C.
Hummel, T., B.S., Universitat Munster, Germany
Lothian, C., B.S., M.D., Karolinska Institute, Stockholm,
Sweden
Monaghan, A.-P., B.A., Ph.D., German Cancer Research
Center, Heidelberg, Germany
Moore, A., B.A., Medical Research Council, Edinburgh,
SEMINARS
Bargmann, C., University of California, San Francisco. The
cell biology of neuronal development/Mechanisms of con-
trolling axon guidance in C. elegans.
Barres, B., Stanford University School of Medicine,
California. Myelination in the central nervous system.
Bonhoeffer, T., Max Planck Institute, Munich, Germany. Role
of activity and neurotrophins in the development of the
visual cortex.
Hemmati Brivanlou, A., Rockefeller University, New York.
Control of ectoderm and mesoderm patterning during
Xenopus development.
Burden, S., New York University Medical Center, New York.
Neuromuscular synapse formation.
Cline, H., Cold Spring Harbor Laboratory. Regulation of
presynaptic differentiation.
Eisen, J., University of Oregon, Eugene. Motor neuron devel-
opment in Zebrafish.
Fox, K., University of Wales, Cardiff, United Kingdom.
Activity-dependent development in the barrel cortex.
Goodman, C., University of California, Berkeley. Pathfinding
in the central and peripheral nervous systems of
Drosophila.
Hatten, M.B., Rockefeller University, New York. Neuronal
migration during cortical development.
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United Kingdom
Murgia, M., B.S., Ph.D., University of Padova, Italy
Ren, P., B.S., Ph.D., University of Missouri, Columbia
Schaefer, A., B.S., Washington University School of
Medicine, St. Louis, Missouri
Shiraishi, Y., M.S., Tokyo University, Japan
Sigal, C., B.S., Ph.D., National Institutes of Health,
Bethesda, Maryland
Smithers, L., B.S., Imperial Cancer Research Fund, London,
United Kingdom
Solomin, L., M.D., Karolinska Institute, Stockholm, Sweden
Van der Sar, A., M.S., The Netherlands Institute for
Developmental Biology, Utrecht
Wang, S., B.S., M.D., Ph.D., Stanford University, Palo
AIto,California
Jan, Y.N., University of California, San Francisco. Control of
cell fate decisions during neural differentiation in
Drosophila.
Jessell, T. Columbia University College of Physicians &
Surgeons, New York. Patterning in the developing neural
tube.
Jin, Y., University of California, Santa Cruz. Control of neural
fate and differentiation in C. elegans.
Kinter, C., The Salk Institute, San Diego, California. Neural
induction and neurogenesis in Xenopus.
Lemke, G., The Salk Institute, San Diego, California.
Regulation of Schwann cell differentiation.
Lichtman, J., Washington University, St. Louis, Missouri.
Editing of synaptic connections.
O'Leary, D., The Salk Institute, San Diego, California.
Pathfinding in the developing visual system.
Raff, M., University College London, United Kingdom.
Control of cell number.
Reichardt, L., University of California, San Francisco.
Regulation of neural differentiation by adhesion molecules
and neurotrophins.
Zipursky, L., University of California, Los Angeles. Signaling
during development of the Drosophila eye.
Advanced Bacterial Genetics
June 6-26
INSTRUCTORS
Bass ler, Bonnie, Ph.D., Princeton University
Manoil, Colin, Ph.D., University of Washington
Slauch, James, Ph.D., University of Illinois
ASSISTANTS
Callahan, Jennifer, University of Washington
Freeman, Jeremy, Princeton University
Ho, Theresa, University of Illinois
The laboratory course presented logic and methods used in the genetic dissection of complex
biological processes in bacteria. The methods presented included mutagenesis using trans-
posons, mutator strains, and chemical and physical mutagens; mapping mutations using genetic
and physical techniques; generation and analysis of gene fusions; molecular cloning; poly-
merase chain reaction; Southern blot analysis; epitope insertion mutagenesis; and site-directed
mutagenesis. A key component of the course was the use of sophisticated genetic methods in
the analysis of pathogenic and "undomesticated" bacteria. Invited lecturers described the use of
genetic approaches to study biological processes in a variety of bacteria.
PARTICIPANTS
Blum, J., B.S., M.D., Ph.D., Harvard Medical School, Boston,
Massachusetts
De Wulf, P., M.S., Ph.D., Harvard Medical School, Boston,
Massachusetts
Durrant, L., M.S., Ph.D., Campinas, State University, Sao
Paulo, Brazil
Ershova, G., M.S., Ph.D., Institute of Molecular Genetics,
Moscow, Russia
Gizatullin, F., M.S., Ph.D., Massachusetts Institute of
Technology, Cambridge
Handfield, M., B.S., M.S., Laval University, Quebec, Canada
McKay, D., B.S., Ph.D., Stanford University, California
Morfeldt, E., B.S., Ph.D., Karolinska Institute, Stockholm,
Sweden
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Moxley, R., D.V.M., Ph.D., University of Nebraska, Lincoln
Pace, J., B.S., M.S., Ph.D., Antex Biologics, Inc.,
Gaithersburg, Maryland
Rech, S., B.S., M.A., Ph.D., University of California, Los
Angeles
Sanders, G., B.A., Ph.D., Massachusetts Institute of
SEMINARS
Gross, C., University of California, San Francisco. Sensing
stress in the periplasm.
Kleckner, N., Harvard University, Boston. Mechanisms and
regulation of Tn10 transposition.
Isberg, R., Tufts University, Boston. Intracellular trafficking in
L. pneumophila.
Mekalanos, J., Harvard University Medical School, Boston.
Molecular genetics analysis of V cholerae pathogenesis.
Ohman, D., University of Tennessee, Memphis. Genetic
Technology, Cambridge
Schauder, S., B.S., University of Bern, Switzerland
Schuler, D., B.S., Ph.D., Iowa State University, Ames
Sibley, M., B.A., Ph.D., New England Biolabs, Beverly,
Massachusetts
Wu, G., B.S., Ph.D., University of Sheffield, United Kingdom
analysis of protease processing and secretion in P aerugi-
nose.
Rudd, K., University of Miami, Florida. Whole genome
sequence: Ultimate bacterial genetics.
Silhavy, T., Princeton University, New Jersey. Parallel path-
ways perceive periplasmic problems.
Wright, A., Tufts University, Boston. Visualizing chromosome
behavior in E. coli.
Integrated Approaches to Ion Channel Biology
June 6-26
INSTRUCTORS
of Colorado
Levinson, Rock, Ph.D., University of Colorado
Maue, Robert, Ph.D., Dartmouth Medical School
ASSISTANTS
Koszowski, Adam, University of Colorado
Shah, Ruta, Dartmouth Medical School
Spooner, Edward, Dartmouth Medical School
This intensive laboratory/lecture course introduced students to the multidisciplinary use of molecular
biological, biochemical, immunological, and electrophysiological approaches to the study of ion
channels. The laboratory focused on the cellular regulation of channel expression and function.
Hands-on exercises included characterization of regulatory elements that control transcription of
channel genes, identification of ion channel isoform transcripts and proteins, visualization of channel
distributions, and the biophysical analysis of channel isoform function in excitable cells and tissues
and in exogenous expression systems. Specific techniques employed included PCR, Western blot,
transient transfection and expression, immunocytochemistry, and patch-clamp analysis of ionic cur-
rents. Lectures covered the techniques employed while providing broad exposure to current issues
surrounding ion channel mechanisms and cellular expression. This course was intended for
advanced students with specific plans to apply the techniques taught to a defined problem, and
students were encouraged to bring their preparation to the course for preliminary studies.
Lectures were given by Dave Dawson, Dan Goldman, Bill Green, Leslie Henderson, John Kusiak,
Gail Mandel, Hannah Monyer, Lorna Role, Peter Sargent, Terry Snutch, and Jim Trimmer.
232
PARTICIPANTS
Bertaso, F., B.S., Kings College School of Medicine, London,
United Kingdom
Charlier, C., D.V.M., University of Utah, Salt Lake City
Didier, M., B.S., Ph.D., Universite Laval, Quebec, Canada
Escayg, A., B.S., Ph.D., University of Michigan, Ann Arbor
Ferreira, G., M.S., M.D., Rush Presbyterian St. Luke's
Medical College, Chicago, Illinois
Groot Kormelink, P., B.S., University of Leuven, Belgium
MacDonell, K., B.S., M.S., Ph.D., University of Calgary,
SEMINARS
Bargmann, C., University of California, San Fancisco.
Genetic approaches to the study of ion channels and
behavior in C. elegans.
Barres, B., Stanford University, California. Induction of sodi-
um channel clustering by oligodendrocytes.
Caldwell, J., University of Colorado Health Sciences Center,
Denver. Sodium channel six: Developmental expression
and distribution in the nervous system.
Froehner, S., University of North Carolina, Chapel Hill.
Regulation of ion channel distribution.
Gardner, P., University of Texas Health Science Center, San
Antonio. Brawn and brain and nicotinic acetylcholine
receptor gene expression.
Henderson, L., Dartmouth Medical School, Hanover, New
Hampshire. Sex and GABAA receptors: The Ego and Id of
neurotransmission.
Levinson, R., University of Colorado Health Sciences Center,
Denver. Sodium channel expression and distribution in the
peripheral nervous system.
Malinow, R., Cold Spring Harbor Laboratory. Synaptic trans-
mission and plasticity in hippocampal slices.
Mandel, G., State University of New York, Stony Brook.
Alberta, Canada
O'Connell, D., B.S., Ph.D., University College Dublin, United
Kingdom
Sampo, B., B.S., M.S., INSERM U 464, Marseille, France
Santi, C., M.D., University of Mexico, Mexico DF, Mexico
Thompson, R., B.S., McMaster University, Ontario, Canada
Verbitsky, M., B.S., National Council of Science and
Technology Research, Buenos Aires, Argentina
Silencing the type II Na channel gene: A model for neuron-
specific gene regulation.
Maue, R., Dartmouth Medical School, Hanover, New
Hampshire. Structural and functional analysis of epitope-
tagged Na channel B1 subunits/Mechanisms underlying
Na channel induction by neurotrophic factors.
O'Dowd, D., University of California, Irvine. Development of
electrical excitability and synaptic connections in the
mammalian CNS.
Salkoff, L., Washington University, St. Louis, Missouri. The
impact of the C. elegans genome sequencing project on
potassium channel biology.
Sargent, P., University of California, San Francisco.
Structural and functional diversity of nicotinic receptor
families in the brain.
Snutch, T., University of British Columbia, Vancouver,
Canada. Modulation of calcium channel activity by protein
kinases and G-proteins.
Zweifach, A., University of Colorado Health Sciences Center,
Denver. Analysis of CRAC channel regulation in lympho-
cytes.
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Molecular Embryology of the Mouse
June 6-26
INSTRUCTORS
Koopman, Peter, Ph.D., University of Queensland, Australia
Magnuson, Terry, Ph.D., Case Western Reserve University
CO-INSTRUCTORS
Nagy, Andras, Ph.D., Samuel Lunenfeld Research Institute, Canada
Tam, Patrick, Ph.D., Children's Medical Research Institute, Australia
ASSISTANTS
Bowles, Jo, University of Queensland, Australia
Schumacher, Armin, Case Western Reserve University
This course was designed for biologists interested in applying their expertise to the study of mouse
embryonic development. Laboratory components provided an intensive introduction into the techni-
cal aspects of working with and analyzing mouse embryos, and lecture components provided the
conceptual basis for current research. Procedures described included isolation and culture of pre-
and postimplantation embryos; oviduct and uterine transfer; formation of aggregation chimeras; iso-
lation of germ layers in gastrulation-state embryos, establishment, culture and genetic manipulation
of embryonic stem cell lines; in situ hybridization to whole mounts of embryos; LacZ staining; skele-
tal preparation, electrofusion, microinjection of DNA into pronuclei; and microinjection of embryonic
stem cells into blastocysts.
Last year's speakers were: R. Behringer, A. Bradley, M. Bronner-Fraser, A. Efstratiadis, R. Ham-
mer, P. Koopman, T. Jessell, A. Joyner, R. Lovell-Badge, J. Mann, T. Magnuson, A. McMahon,
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A. Nagy, V. Papaioannou, L. Parada, E. Rinchik, E. Robertson, J. Rossant, D. Solter, P. Soriano, P. Tam, and D.
Wilkinson.
PARTICIPANTS
Aris De La Fuente, Maria Del Carmen, B.S., Centro de
Investigaciones Biologicas, Madrid, Spain
Blair, H., B.S., Medical Research Council, Oxon, United
Kingdom
Blank, V., B.S., Ph.D., Harvard Medical School, Boston
Brown, N., B.A., Ph.D., University of Michigan, Ann Arbor
Chang, A., B.S., Ph.D., Children's Medical Research
Institute, New South Wales, Australia
Holcik, M., B.S., Ph.D., University of Ottawa, Ontario,
Canada
Jensen, J., B.S., M.S., Hagedorn Research Institute,
SEMINARS
Behringer, R., University of Texas/MD Anderson Cancer
Center, Houston. Organization of pattern during mouse
embryogenesis/Transgenic animals in biomedical
research/Transgenic mouse video.
Bowles, J., University of Queensland, Brisbane, Australia.
Structural and regulatory analysis in Sry in mice.
Bradley, A., Baylor College of Medicine, Houston, Texas.
Introduction to ES cells/Screening the genome for tumor
suppressor genes.
Costantini, F, Columbia University College of Physicians &
Surgeons, New York. The role of the Fused gene in verte-
brate embryogenesis and signal transduction.
Efstratiadis, A., Columbia University, New York. Genetics of
growth: Developmental roles of insulin-like growth factors.
Hogan, B., Vanderbilt University Medical School, Nashville,
Tennessee. Functional analysis of forkhead/winged helix
genes in skeletal and brain development.
Jaenisch, R., Whitehead Institute/Massachusetts Institute of
Technology, Cambridge. Methylation, imprinting, and X
inactivation.
Jenkins, N., National Cancer Institute, Frederick, Maryland.
The role of unconventional myosins in development and
disease.
Joyner, A., New York University, New York. Genetic control of
mid/hindbrain and limb patterning.
Koopman, P., University of Queensland, Brisbane, Australia.
Strategies for molecular genetic analysis of mouse devel-
opment/Sry and Sox genes: Multiple roles in mammalian
development.
Krumlauf, R., Medical Research Council, United Kingdom.
Events patterning the hindbain and cranial neural crest.
Lovell-Badge, R., Medical Research Council, United
Kingdom. Sex determination and the role of Daxl/Sox
genes and neural fate.
Magnuson, T., Case Western Reserve University, Cleveland,
Ohio. The role of eed during mouse gastrulation.
Mann, J., Beckman Research Institute, Duarte, California.
Allele-specific expression of imprinted genes and its role
in development.
Martin, G., University of California, San Francisco. Limb bud
Gentofte, Denmark
Kettunen, P., D.D.S., University of Helsinki, Finland
Kielman, M., B.S., Ph.D., Leiden University, The Netherlands
Klarman, L., B.A., Ph.D., Harvard University, Boston
Schulz, H., B.S., Ph.D., San Raffaele Scientific Institute,
Milan, Italy
Stover, P., B.S., Ph.D., Cornell University, Ithaca, New York
Suh, H., B.S., M.S., Ph.D., Ajou University School of
Medicine, Kyeongi-do, South Korea
Wallis, J., B.A., Ph.D., University of Edinburgh, United
Kingdom
induction, outgrowth, and patterning/The use of DNA
recombinases to control gene expression in mice.
McLaren, A., Wellcome/CRC Institute, Cambridge,
Massachusetts. Origin and development of germ cells.
Nagy, A., Mount Sinai Hospital/Samuel Lunenfeld Research
Institute, Ontario, Canada. Applications of gene knockout
technology in mice.
Papaioannou, G., Columbia University College of Physicians
& Surgeons, New York. Chimeras in experimental embryol-
ogy/T-box genes and development.
Rinchik, G., Sarah Lawrence College, Bronxville, New York.
Recovery of radiation- and chemical-induced germline
mutations in the mouse.
Robertson, L., Harvard University, Cambridge. Roles of TGF-
p proteins in axis formation and organogenesis.
Rossant, J., Mount Sinai Hospital/Samuel Lunenfeld
Research Institute, Ontario, Canada, Preimplantation
development, implantation, and extraembryonic struc-
tures/Patterning the developing body axis.
Schumacher, A. Case Western Reserve University,
Cleveland, Ohio. Genetic control of axial patterning in the
mouse.
Skarnes, B., University of Edinburgh, United Kingdom. Gene
trapping and functional analysis of the mammalian
genome.
Solter, D., Max Planck Institute, Freiburg, Germany.
Imprinting and control of gene expression during preim-
plantation mouse development.
Soriano, P., Fred Hutchinson Cancer Research Center,
Seattle, Washington. Insertional mutagenesis screens and
tyrosine kinase signaling during mouse development.
Tam, P., Children's Medical Research Institute,
Wenworthville, Australia. Postimplantation
development/Analyzing X-chromosome activity with a tacZ
transgene.
Wilkinson, D., Medical Research Council, United Kingdom.
In situ hybridization: Methods and research
applications/Segmental restrictions in vertebrate develop-
ment.
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Structure, Function, and Development of the Visual System
June 19-July 1
INSTRUCTORS
Bonhoeffer, Tobias, Ph.D., Max Planck Institute
Fitzpatrick, David, Ph.D., Duke University
This lecture/discussion course explored the functional organization and development of the visual
system as revealed by the use of a variety of anatomical, physiological, and behavioral methods. It
was designed for graduate students and more advanced researchers who wished to gain a basic
understanding of the biological basis for vision and to share in the excitement of the latest develop-
ments in this field. Topics included phototransduction and neural processing in the retina; functional
architecture of striate cortex; cellular basis of cortical receptive field properties; the anatomy, physiol-
ogy, and perceptual significance of parallel pathways; functional parcellation of extrastriate cortex;
sensory-motor integration in the superior colliculus; human functional imaging; and role of patterned
neuronal activity in the development of central visual pathways. Past lecturers included B.
Chapman, D. Dacey, C. Gilbert, C. Gray, D. Hubei, L. Katz, K. Martin, J. Maunsell, T. Movshon, K.
Nakayama, C. Shatz, A. Thompson, D. Van Essen, and R. Wong.
PARTICIPANTS
Bar, M., B.S., M.S., University of Southern California, Los
Angeles
Crowley, J., B.A., Duke University, Durham, North Carolina
Dantzker, J., B.A., The Salk Institute, La Jolla, California
Demains, R., B.S., 0.D., M.S., McGill University, Montreal,
Canada
Gepshtein, S., M.S., University of Virginia, Charlottesville
Herzog, A., B.A., Ph.D., The Salk Institute, La Jolla,
California
Hooper, J., B.A., Ph.D., Eastman Kodak, New Haven,
Connecticut
Huang, J., B.S., M.S., Ph.D., Massachusetts Institute of
Technology, Cambridge
Huber, K., B.S., Ph.D., Brown University, Providence, Rhode
Island
Hung, C., B.S., Yale University, New Haven
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Mrsic-Flogel, T, B.A., Oxford University, United Kingdom
Nace, K., B.A., University of California, Davis
Nase, G., B.S., Max Planck Institute for Brain Surgery,
Frankfurt, Germany
Sharon, D., B.S., M.S., Weizmann Institute, Rehovot, Israel
Song, H., B.S., M.A., University of California, San Diego
Starsinic, S., B.S., University of California, Davis
Tavazoie, S., B.A., Harvard Medical School, Boston
Tong, P., B.S., M.D., Ph.D., Johns Hopkins University School
of Medicine, Baltimore, Maryland
Trachtenberg, J., B.A., Ph.D., University of California, San
Francisco
Wainwright, M., B.M., Harvard University, Cambridge
Wu, S.-M., B.S., Ph.D., Georgetown University Medical
Center, Washington, D.C.
SEMINARS
Bonhoeffer, T., Max Planck Institute, Munich, Germany.
Intrinsic circuits and functional architecture/Development
of central visual pathways.
Dacey, D., University of Washington, Seattle.
Phototransduction, retinal circuitry.
Ferster, D., Northwestern University, Evanston, Illinois.
Connectivity between retina, LGN, and striate cortex.
Fitzpatrick, D., Duke University, Durham, North Carolina.
Intrinsic circuits and functional architecture.
Hendry, S., Johns Hopkins University, Baltimore, Maryland.
Molecular aspects of visual system organization.
Hockfield, S., Yale University, New Haven. Molecular
aspects of visual system organization.
Hubei, D., Harvard Medical School, Boston. Fundamentals
of visual cortical processing.
Katz, L., Duke University Medical Center, Durham, North
Carolina. Development of central visual pathways.
Arabidopsis Molecular Genetics
Konig, P., The Neuroscience Institute, La Jolla, California.
Synchronization and oscillations.
Logothetis, N., Max Planck Institute, Germany. Studies of the
human visual system.
Kevan, M., University of Zurich, Switzerland. Connectivity
between retina, LGN, and striate cortex.
Maunsell, J., Baylor College of Medicine, Houston, Texas.
Higher cortical processing and parallel pathways.
Newsome, B., Stanford University School of Medicine,
California. Higher cortical processing and parallel path-
ways.
Reid, C., Harvard Medical School, Boston. Connectivity
between retina, LGN, and striate cortex.
Sereno, M., University of California, San Diego. Studies of
the human visual system.
Wong, R., Washington University School of Medicine, St.
Louis, Missouri. Development of central visual pathway.
June 30-July 20
INSTRUCTORS
Glazebrook, Jane, Ph.D., University of Maryland
Lam, Eric, Ph.D., Rutgers University/Ag Biotech Center
Last, Robert, Ph.D., Boyce Thompson Institute/Cornell University
ASSISTANTS
Jirage, Dayadevi, University of Maryland
Meisel, Lee, Rutgers University
Saracco, Scott, Boyce Thompson Institute/Cornell University
This course provided an intensive overview of topics in plant growth and development, focusing
on molecular genetic approaches to understanding plant biology. It emphasized recent results
from Arabidopsis thaliana and other model plants and provided an introduction to current meth-
ods used in Arabidopsis research. The course also demonstrated the use of microbial systems in
plant research, including Agrobacterium rhizobium, E. coli, and S. cerevisiae. It was designed for
scientists with experience in molecular techniques or in plant biology who wish to work with
Arabidopsis. The course consisted of a vigorous lecture series, a hands-on laboratory, and infor-
mal discussions. Speakers provided both an in-depth discussion of their own work and a review
of their specialty.
Discussions of important topics in plant research were presented by the instructors and by
invited speakers. These seminars reviewed plant anatomy; plant development (including devel-
opment of flowers, roots, meristems, embryos, and the epidermis); perception of light and photo-
morphogenesis; responses to pathogens and to other environmental stresses; synthesis and
function of secondary metabolites and hormones; nitrogen assimilation; unique aspects of plant
cell biology (including the plant cytoskeleton, cell wall, and chloroplasts); biotechnological
improvement of plants; the importance of transposons and Agrobacterium for manipulating plant
genomes and current approaches to genome analysis.
237
The laboratory sessions provided an introduction to important techniques currently used in
Arabidopsis research. These included studies of Arabidopsis development, mutant analysis, studies
of epidermal features, in situ detection of RNA, histochemical staining and immunolabeling of pro-
teins, transformation with Agrobacterium, transient gene expression in protoplasts, expression of
plant proteins in microorganisms, detection and analysis of plant pathogens, and techniques com-
monly used in genetic and physical mapping.
PARTICIPANTS
Adhami, F, B.S., Universitat fur Bodenkultur, Vienna, Austria
Azumi, Y., B.S., Ph.D., Kanagawa University, Hiratsuka,
Japan
Barker, B.M., B.A., University of Montana, Missoula
Bougourd, S., B.S., Ph.D., University of York, North
Yorkshire, United Kingdom
Bustos, M., B.S., Ph.D., University of Maryland, Baltimore
Kahn, K., B.S., Ph.D., University of Missouri, Kansas City
Kargul, J., B.S., M.S., University of Warwick, Coventry,
United Kingdom
Mande, K., B.S., National University of Singapore, Singapore
Mouradov, A., Ph.D., ForBio Research, Brisbane, Australia
SEMINARS
Arntzen, C., Boyce Thompson Institute/Cornell University,
Ithaca, New York. Genetic engineering in plants.
Banks, J., Purdue University, West Lafayette, Indiana. Ferns.
Briggs, W., Carnegie Institute of Washington, Stanford,
California. Light perception.
Chapple, C., Purdue University, West Lafayette, Indiana.
Secondary metabolism.
Cook, D., Texas A&M University, College Station. Rhizobium.
Curtis, M., Cold Spring Harbor Laboratory. Enhancer traps
in Arabidopsis.
Drews, G., University of Utah, Salt Lake City. Flower devel-
opment.
Panda, S., B.S., M.S., Scripps Research Institute, La Jolla,
California
Raman, R., B.S., M.S., Scripps Research Institute, La Jolla,
California
Ramsay, N., B.S., University of Warwick, Coventry, United
Kingdom
Sathyanarayanan, P, B.S., Washington State University,
Seattle
Stranger, B., B.A., University of Montana, Missoula
Sattler, S., B.S., University of Minnesota, St. Paul
Weaver, A., B.S., Purdue University, West Lafayette, Indiana
Glazebrook, J., University of Maryland, College Park. Plant
defense responses/Map-based cloning strategies.
Guerinot, M.L., Dartmouth College, Hanover, New
Hampshire. Ion channels and transport.
Hobbie, L., Ade 1phi University, Garden City, New York.
Hormones.
Irish, V., Yale University, New Haven. Plant anatomy, plant
development.
Katagiri, F., Massachusetts General Hospital, Boston. Plant
resistance genes.
Lam, E., Rutgers University/Ag Biotech Center, New
Brunswick, New Jersey. Programmed cell death.
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Larkin, J., Louisiana State University, Baton Rouge.
Trichomes.
Last, R., Boyce Thompson Institute/Cornell University,
Ithaca, New York. Amino acid biosynthesis/Plant stress
responses.
Lemieux, B., Stanford University, Palo Alto, California. The
Arabidopsis genome project.
Ma, H., Cold Spring Harbor Laboratory. Molecular analysis
of plant development.
McClung, R., Dartmouth College, Hanover, New Hampshire.
Circadian rhythms.
Preuss, D., University of Chicago, Illinois. Male and female
Molecular Cloning of Neural Genes
gametophytes and fertilization.
Reed, J., University of North Carolina, Chapel Hill.
Photomorphogenesis.
Richards, E., Washington University, St. Louis, Missouri.
Genome organization and epigenetics.
Rose, A., University of California, Davis. Cloning genes by
complementation in microbes.
Rounsley, S., The Institute for Genomic Research, Rockville,
Maryland. Arabidopsis resources AtDB.
Shirley, B., Virginia Tech, Blackburg. Protein-protein interac-
tions.
June 30-July 20
INSTRUCTORS
Darnell, Robert, Ph.D., Rockefeller University
Du lac, Catherine, Ph.D., Harvard University
Rupp, Fabio, Ph.D., Johns Hopkins University
Serafini, Tito, Ph.D., University of California, Berkeley
CO-INSTRUCTOR
Lai, Cary, Ph.D., Scripps Research Institute
ASSISTANTS
Herrada, Gilles, Harvard University
Jensen, Kirk, Rockefeller University
Lander, Cynthia, Yale University
Okano, James, Rockefeller University
Yang, Yolanda, Rockefeller University
This intensive laboratory and lecture course was intended to provide neuroscientists at all levels
with an introduction to modern molecular neurobiology. The course consisted of daily laboratory
exercises, detailed discussions on the practice of molecular biology and modern approaches to
cloning neural genes, and a series of evening research seminars by invited speakers. This lec-
ture series emphasized the ways in which molecular techniques studied in the laboratory have
been successfully applied to the study of neural genes.
The laboratory portion of the course included a module on basic gene cloning and a module
on more advanced methods in cloning and expression of neural genes. Gene cloning techniques
included isolation and characterization of poly(A)* RNA; synthesis of cDNA libraries; standard
screening and expression screening of cDNA libraries; analysis of cDNA clones, including
phagemid rescue, restriction analysis, Southern blotting, ligations, transformation, electropora-
tion, and subcloning; PCR analysis including oligonucleotide design, synthesis, and purification,
and an exploration of advanced cloning techniques including single-cell library synthesis and
PCR-based subtraction cloning. Gene expression studies included Northern blot analysis, RT-
PCR analysis, in vitro transcription, in situ hybridization, and mammalian cell transfection.
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PARTICIPANTS
Bi, G., B.S., Ph.D., University of California, San Diego
Bruses, J., M.D., Ph.D., Case Western Reserve University,
Cleveland
Cesare, P., B.S., M.S., King's College London, United
Kingdom
Degtiar, V., M.S., Ph.D., Stanford University, Stanford,
California
Haas, K., B.S., Ph.D., Albert Einstein College of Medicine,
Bronx, New York
Halfter, W., B.S., Ph.D., University of Pittsburgh,
Pennsylvania
Hoke, K., B.S., Stanford University, Stanford, California
Hong, W., B.S., George Washington University, Washington,
D.C.
SEMINARS
Darnell, R.B., Rockefeller University, New York. Using
autoimmune neurologic disease antisera to clone neuron-
specific genes.
Du lac, C., Harvard University, Boston. Molecular biology of
pheromone perception in mammals.
Edwards, R., University of California, San Francisco.
Neurotransmitter packaging and the synaptic vesicle
cycle: From bioenergetics to synaptic
transmission.
Friedman, J.M., Rockefeller University, New York. Thin mice
do it with leptin: Cloning hypothalamic hormones.
Hemmati-Brivanlou, A., Rockefeller University. New York. In
vivo systems for expression cloning in vertebrates.
Lavery, D., Glaxo Wellcome Research & Development,
Zurich, Switzerland. Isolation of novel circadian target
genes by a new subtractive cloning method.
Mombaerts, P., Rockefeller University, New York. Targeting
Kelic, S., B.S., Ph.D., Albert Einstein College of Medicine,
Bronx, New York
Nagan, N., M.S., Ph.D., Boston University School of
Medicine, Massachusetts
Schacher, S., B.S., Ph.D., Columbia University College of
Physicians & Surgeons, New York
Schmid, A., B.S., Ph.D., University of Illinois, Urbana
Schulz, D., B.S., M.S., University of Illinois, Urbana
Tole, S., B.S., Ph.D., University of Chicago, Illinois
Trainer, P., B.S., Ph.D., National Institute of Medical
Research, London, United Kingdom
Wizenmann, A., B.S., Ph.D., UMDS at Guy's & St. Thomas's
Hospital, London, United Kingdom
olfaction.
Orr, H.T., University of Minnesota, Minneapolis. So, you have
a neural gene now what? From gene to function.
Rupp, F, Johns Hopkins School of Medicine, Baltimore,
Maryland. Molecular analysis of motor neurons: It isn't how
big it is, it's how you screen it.
Reed, R., Johns Hopkins School of Medicine, Baltimore,
Maryland. Regulating gene expression in neurons. How
the nose knows and why the worm turns.
Serafini, T., University of California, Berkeley. In vitro analysis
of axon guidance and targeting.
Walsh, Israel Hospital/Harvard Medical School,
Boston. Genetic control of neuronal migration to the cere-
bral cortex.
Yancopoulos, G., Regeneron Pharmaceutical Inc.,
Tarrytown, New York. Expression cloning growth factors
and receptors in the nervous system.
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Neurobiology of Drosophila
June 30-July 20
INSTRUCTORS
Dickinson, Michael, Ph.D., University of California, Berkeley
Patel, Nipam, Ph.D., University of Chicago
Taylor, Barbara, Ph.D., Oregon State University, Corvallis
ASSISTANTS
Lear, Bridget, University of Chicago
Sane, Sanjay, University of California, Berkeley
This laboratory/lecture course was intended for researchers at all levels who wish to use
Drosophila as an experimental system for studying behavior, physiology, and development. Daily
seminars introduced students to a variety of research topics drawn from recent experimental
contributions in the field of Drosophila neurobiology. The lectures and laboratories focused on
both the development of the nervous system and its role in controlling larval and adult behaviors.
Guest lecturers brought original preparations for viewing and discussion and direct laboratory
exercises and demonstrations in their area of interest. The course provided students with hands-
on experience using a variety of experimental preparations that are used in the investigation of
current neurobiological questions, including embryo in situ hybridization, labeling of identified
neurons, electrophysiological recording from nerves and muscles, and the analysis of larval and
adult behavior. Collectively, the course provided a comprehensive and practical introduction to
modern experimental methods for studying the Drosophila nervous The specific topics
from this year's course included neurogenesis, axon pathfinding, synaptogenesis, membrane
excitability, learning and memory, courtship, walking, flight, and crawling behaviors.
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PARTICIPANTS
Afshar, K., B.S., Ph.D., University of Wisconsin, Madison
Barron, A., B.A., Cambridge University, United Kingdom
Bergmann, A., B.S., Ph.D., Massachusetts Institute of
Technology, Cambridge
De Sousa, D., B.S., McMaster University, Ontario, Canada
Koh, Y.H., B.S., M.S., University of Massachusetts, Amherst
Korey, C., B.S., Harvard University Medical School, Boston
McClung, C., B.S., University of Virginia, Charlottesville
SEMINARS
Atwood, H., University of Toronto, Canada. Larval neuromus-
cular physiology.
Bossing, T, Wellcome/CRC Institute, Cambridge, United
Kingdom. Neuroblast lineages and CNS midline formation.
Dickinson, M., University of California, Berkeley. Physiology
and mechanisms of flight.
Gaul, U., Rockefeller University, New York. Visual system
development.
Hall, J., Brandeis University, Waltham, Massachusetts.
Behavioral mutants and genetics: An overview.
Heberlein, U., University of California, San Francisco.
Genetics of alcohol and drug sensitivity.
Meinterzhagen, I. and Sun, X.J., Dalhousie University, Nova
Scotia, Canada. Synaptic plasticity and the adult visual
system.
Murphey, R., University of Massachusetts, Amherst. Sensory
systems and adult behaviors.
O'Dowd, D., University of California, Irvine. Ion channels and
neuronal diversity.
Brain Mapping
Prichard, M., B.A., University of Hawaii, Manoa, Honolulu
Prokopenko, S., B.S., Baylor College of Medicine, Houston,
Texas
Straube, A., B.S., Ph.D., University of Freiburg, Germany
Vijayraghavan, S., B.S., Tata Institute of Fundamental
Research, Bangalore, India
Zhu, J.-c., B.S., State University of New York, Stony Brook
Patel, N., University of Chicago, Illinois. Embryogenesis and
early pattern formation.
Restifo, L., University of Arizona, Tucson. Metamorphosis
and adult development.
Sink, H., University of California, Berkeley. Axonal pathfind-
ing.
Skeath, J., Washington University School of Medicine, St.
Louis, Missouri. Early neurogenesis.
Sokolowski, M., York University, Ontario, Canada. Larval
behaviors.
Strauss, R., Max Planck Institute fur Biologie Kybernetik,
TObingen, Germany. Central processing centers and walk-
ing behavior.
Taylor, B., Oregon State University, Corvallis. Genetics of
sex-specific behaviors.
Tully, T., Cold Spring Harbor Laboratory. Learning and mem-
ory.
Zhong, Y., Cold Spring Harbor Laboratory. Peptide neuro-
transmitters and plasticity.
July 8-14
INSTRUCTORS
Mazziotta, John, M.D., Ph.D., University of California, Los Angeles
Toga, Arthur, Ph.D., University of California, Los Angeles
The aim of this lecture and practical course was to describe the rapidly evolving developments in
brain mapping that have been applied to the problem of mapping the structure and function of the
brain. The goal of brain mapping is to understand cerebral anatomy and physiology in health and
disease and to evaluate neurological, neurosurgical, and psychiatric disease states. This course
described new methods as well as the application of traditional techniques to the study of brain
structure and function. Methodologies discussed included magnetic resonance imaging (including
functional, spectroscopic, and angiographic approaches), positron emission tomography, electro-
physiological techniques, optical intrinsic signal imaging, digital approaches to conventional post-
mortem neuroanatomical investigations, data analysis, statistical analysis, statistical approaches,
visualization, and stereotaxy. The course was not designed to simply describe methods, but rather
to discuss how brain mapping strategies can be employed in combination with biological models for
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understanding the structure and function of the brain. Findings relevant to the function of the
visual, motor, language, memory, and cognitive brain systems, as well as diseases that adversely
affect them, were discussed. Specific hypotheses and experimental designs were developed by
the students for remote execution, as an actual experiment. In addition, a field trip to a local
imaging laboratory was arranged. Invited speakers included world leaders in each of the respec-
tive brain mapping subspecialties.
PARTICIPANTS
Breen, E., B.A., M.A., Indiana University School of Medicine,
Indianapolis
Elizondo, I., B.A., National Institutes of Health, Bethesda,
Maryland
Goldbloom, L., B.S., Albert Einstein College of Medicine,
Bronx, New York
Hoffman, E., B.A., M.S., National Institutes of Health,
Bethesda, Maryland
Jiang, Y., B.S., Ph.D., National Institutes of Health,
Bethesda, Maryland
Kupers, R., B,S., Ph.D., Karolinska Institute, Huddinge,
SEMINARS
Belliveau, J., Massachusetts General Hospital, Charlestown.
Image integration: Visual system.
Cohen, M., University of California, Los Angeles. MRI.
Fletcher, P., Wellcome Institute of Neurology, London, United
Kingdom. Language and memory.
Goldman-Rakic, P., Yale University, New Haven. Cerebral
cortex: Cyto- and chemoarchitecture.
Haxby, J., National Institutes of Health, Bethesda, Maryland.
Object recognition: Visual system.
Mazziotta, J., University of California, Los Angeles.
PET/SPECT.
Pascual-Leone, A., Harvard University Medical School,
Boston. Transcranial magnetic stimulation (epilepsy and
Sweden
Lang, D., B.S., University of British Columbia, Vancouver,
Canada
Pankhaniya, R., B.S., M.D., University of California, San
Francisco
Rey-Hipolito, C., B.S., National Institute of Mental Health,
Bethesda, Maryland
Salat, D., B.A., Oregon Health Sciences University, Portland
Schmid, A.M., B.S., London University, United Kingdom
Tzelepi, A., B.S., State University of New York, Brooklyn
Vaina, L., M.S., Ph.D., Boston University, Massachusetts
motor system).
Petersen, S., Washington University, St. Louis, Missouri.
Experimental design.
Simpson, G., Albert Einstein College of Medicine, New York.
EEG/MEG/ERP (visual system).
Toga, A., University of California, Los Angeles. Optical, mor-
phological analyses.
Weinberger, D., National Institute of Mental Health,
Washington, D.C. Mental illness.
Woolsey, T., Washington University School of Medicine, St.
Louis, Missouri. Intravascular dyes.
Zeffero, T, Sensor Systems, Inc., Sterling, Virginia. Data
analysis.
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Biology of Memory: From Molecules to Behavior
July 18-31
INSTRUCTORS
Byrne, Jack, Ph.D., University of Texas, Houston Medical School
Eichenbaum, Howard, Ph.D., Boston University
Pearson, Keir, Ph.D., University of Alberta, Canada
Squire, Larry, Ph.D., University of California, San Diego
This lecture course provided an introduction to cell, molecular, and systems approaches to learning
and memory. It was suited for graduate students in molecular biology, neurobiology, and psychology
as well as research workers who are interested in an introduction to this field. The course covered
topics ranging from behavioral considerations of learning and memory to gene regulation in the ner-
vous system. The lectures provided an intensive coverage of six selected areas: (1) an introduction
to modern behavioral studies of learning and memory; (2) an overview of the cell biology of neuronal
plasticity and second messenger systems; (3) the regulation of gene expression; (4) cellular and
molecular mechanisms of simple forms of learning and memory in invertebrates and vertebrates; (5)
cellular and molecular mechanisms of long-term potentiation and depression in various regions of
the mammalian brain; and (6) systems approaches to learning in vertebrates and humans.
PARTICIPANTS
Ikema, M., B.S., M.S., Ph.D., Massachusetts Institute of
Technology, Cambridge
Barris-Roman, A., B.S., Oregon Health Sciences University,
Portland
Brodie, C., B.A., B.S., University of Minnesota, Minneapolis
Candy, S., B.S., Imperial College School of Medicine at St.
Mary's, United Kingdom
Celikel, T., B.S., Bogazici University, Istanbul, Turkey
Chan, K.-H., B.A., Purdue University, West Lafayette, Indiana
Jimenez de Asua, L., M.D., Ph.D., Fundacion Campomar,
Buenos Aires, Argentina
Joiner, M.-L., B.S., M.S., Brandeis University, Waltham,
Massachusetts
Kellendonk, C., B.S., German Cancer Research Center,
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Heidelberg, Germany
Kirchhoff, B., B.A., Boston University, Massachusetts
Korzus, E., B.S., M.S., Ph.D., University of California, San
Diego
Texas, Houston
Lipton, P., B.A., Boston University, Massachusetts
Olmstead, M., B.S., M.S., Ph.D., University of Cambridge,
United Kingdom
Panchal, P., B.S., M.S., Tata Institute, Maharashtra, India
Pike, F., B.A., University of Oxford, United Kingdom
Steele, P., B.S., University of Texas, Houston
Swensson, P., B.S., Lund University, Sweden
Teng, E., B.S., University of California, San Diego
SEMINARS
Ball, G., Johns Hopkins University, Baltimore, Maryland.
Ethological approaches to learning.
Byrne, J., University of Texas, Houston. Introduction to the
cellular study of learning/Overview of membranes and
synaptic transmission.
Eichenbaum, H., Boston University, Massachusetts. Role of
LTP and LTD in learning/Memory systems in rodents.
Greenough, W., University of Illinois, Urbana. Morphological
correlates of learning and experience.
Gilbert, C., Rockefeller University, New York. Dynamics of
adult visual cortex.
Holland, P., Duke University, Durham, North Carolina.
Introduction to learning theory I/Introduction to learning
theory II.
Kandel, E., Columbia University, New York. Nonassociative
learning in Aplysia I/Nonassociative learning in Ap/ysia/
Long-term potentiation II.
LeDoux, J., New York University, New York. Modulation of
memory.
Levitan, I., Brandies University, Waltham, Massachusetts.
Structure, function, and modulation of ion channels.
Lo, D., Duke University Medical Center, Durham, North
Carolina. Growth factors.
Eukaryotic Gene Expression
Malenka, R., University of California, San Francisco. Long-
term potentiation I/Long-term depression.
Pearson, K., University of Alberta, Edmonton, Canada.
Mechanisms of motor learning.
Pfaffinger, P., Baylor College of Medicine, Houston, Texas.
Cloning of genes important to learning.
Posner, M., University of Oregon, Eugene. Neuropsychology
of cognition.
Schulman, H., Stanford University School of Medicine,
California. Overview of second-messenger systems and
their role in learning and memory I/Overview of second-
messenger systems and their role in learning and memory
Silva, A., Cold Spring Harbor Laboratory. Gene-knockout
approaches to study learning.
Squire, L., University of California, San Diego. Memory sys-
tems in non-human primates/Human memory and disor-
ders of memory.
Steinmetz, J., Indiana University, Bloomington. Classical
conditioning of the nictitating membrane response.
Tully, T., Cold Spring Harbor Laboratory. Genetic approach-
es to study associative learning in Drosophila.
July 23-August 12
INSTRUCTORS
Carey, Michael, Ph.D., University of California, Los Angeles
Gill, Grace, Ph.D., Harvard Medical School
Gilmour, David, Ph.D., Pennsylvania State University
Smale, Stephen, Ph.D., University of California, Los Angeles
ASSISTANTS
Ellwood, Katherine, University of California, Los Angeles
Soccio, Ray, Harvard Medical School
Le, Trinh, University of California, Los Angeles
The rapid cloning of eukaryotic promoters and regulatory factors has led to a dramatic increase
in studies of gene regulation. This course was designed for students, postdocs, and professors
who have recently ventured into this dynamic area of contemporary biology. The course focused
on state-of-the-art strategies and techniques that are employed to study gene expression, with a
special emphasis on transcriptional regulation. Regulation of transcription by nuclear proteins
was examined by in vitro transcription in cell-free extracts and by transfection of mammalian tis-
sue culture cells. Analytical techniques for measuring gene expression included primer extension
ies of protein-DNA interactions. Transcription factors were expressed in a heterologous system
such as E. coli or baculovirus and purified by affinity chromatography. A detailed characteriza-
tion of the DNA-binding properties of the recombinant factors was carried out using mobility shift,
DNase I footprinting, and methylation interference assays. During the past few years, the gene
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regulation field has begun to emphasize the importance of in vivo approaches to studying protein-
DNA interactions. Students were therefore instructed in the most advanced in vivo footprinting and
UV cross-linking methodologies. Students also learned strategies and techniques for executing a
structure-function study of a regulatory factor, including an introduction to site-directed mutagenesis,
basic computer analyses, and the two-hybrid approach in S. cerevisiae for studying protein-protein
interactions. Experience with basic recombinant DNA techniques was a prerequisite for admission
to this course. Lectures by the instructors covered the current status of the gene expression field,
theoretical aspects of the methodology, and broader issues regarding strategies for investigating the
regulation of gene expression in eukaryotes. Guest lecturers discussed contemporary problems in
eukaryotic molecular biology and technical approaches to their solution.
PARTICIPANTS
Antonnsson, C., B.S., Karolinska Institute, Stockholm,
Sweden
De Luca, P., B.S., University "Federico II" of Naples, Italy
Englund, M., M.S., Sahlgrenska University Hospital,
Goteborg, Sweden
Ernst, J., B.S., Yale University, New Haven
Hastings, M., B.A., Marquette University, Milwaukee,
Wisconsin
Holmberg, C., M.S., Turku Center For Biotechnology, Turku,
Finland
Huh, S., B.A., Yale University, New Haven
Joutel, A., M.S., M.D., Ph.D., INSERM U 25, Paris, France
SEMINARS
Abate-Shen, C., UMDNJ/ Robert Wood Johnson Medical
School, Piscataway, New Jersey. Homeoprotein function in
development and oncogenesis.
Burley, S., Rockefeller University, New York. X-ray crystallo-
Kapatos, G., B.S., Ph.D., Wayne State University, Detroit,
Michigan
Martin, M., B.S., M.S., M.D., University of California, Los
Angeles
Minchin, S., B.S., Ph.D., University of Birmingham, U.K.
Morgan, K., B.S., Ph.D., Nottingham University, U.K.
Mourelatos, Z., M.D., University of Pennsylvania,
Philadelphia
Warnmark, A., M.S., Karolinska Institute, Huddinge, Sweden
Yoon, C., B.A., Harvard Medical School, Cambridge
Yu, C., B.A., Ph.D., University of California, Irvine
graphic studies of eukaryotic transcription factors.
Carey, M., University of California, Los Angeles. Biochemical
mechanism of gene activation.
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Fink, G., Whitehead Institute, Cambridge, Massachusetts.
The latest and greatest in yeast.
Gill, G., Harvard Medical School, Boston. A transcriptional
repressor that antagonizes E1A-mediated activation.
Gilmour, D., Pennsylvania State University, University Park.
In vivo and in vitro analysis of the hsp70 heat shock gene
promoter from Drosophila.
Goldstein, J., University of Texas, Dallas. The SREBP path-
way: Regulation of cholesterol metabolism by proteolysis
of a membrane-bound transcription factor.
Goodrich, J., University of Colorado, Boulder. RNA poly-
merase II transcriptional regulation.
Grosschedl, R., University of California, San Francisco. Role
of MARs in the regulation of gene expression and chro-
matin accessibility.
Jones, K., The Salk Institute, La Jolla, California. Regulation
of HIV-1 transcription: From chromatin to Tat.
Kingston, R., Massachusetts General Hospital, Boston.
Moving through chromatin.Lis, J., Cornell University,
Ithaca. Multiple mechanisms of eukaryotic transcription
regulation: Different schemes for different genes.
Maniatis, T., Harvard University, Boston. Mechanism of NF-
:KB activation.
Sen, R., Brandeis University, Waltham, Massachusetts.
Factors regulating Ig gene expression.
Smale, S., University of California, Los Angeles. Regulation
of IL-12 expression in antigen-presenting cells.
Orkin, S., Harvard Medical School, Boston. Transcriptional
control of blood cell development.
Pugh, F., Pennsylvania State University, University Park.
Kinetic steps in transcription complex assembly.
Roeder, R., Rockefeller University, New York.The role of gen-
eral and gene-specific cofactors in transcriptional regula-
tion.
Stillman, B., Cold Spring Harbor Laboratory. Cell cycle con-
trol of yeast chromosomal DNA replication.
Struhl, K., Harvard Medical School, Boston. Molecular
mechanisms of yeast transcriptional regulation.
Young, R., Massachusetts Institute of Technology,
Cambridge. New insights into eukaryotic gene regulation.
Zaret, K., Brown University, Providence, Rhode Island.
Specifying tissues and gene expression programs in
development.
Imaging Structure and Function in the Nervous System
July 23-August 12
INSTRUCTORS
Konnerth, Arthur,
Lanni, Fred, Ph.D., Carnegie-Mellon University
Yuste, Rafael, Ph.D., Columbia University
ASSISTANTS
Eilers, Jens, University of Saarland, Germany
Smetters, Diana, Columbia University
Tsiola, Areti, Columbia University
Vanni, Steve, Carnegie-Mellon University
Advances in light microscopy and digital image processing and the development of a variety of
powerful fluorescent probes present expanding opportunities for visualizing and measuring the
structure and function of neurons, synapses, and networks in the brain. This intensive laboratory
and lecture course provided participants with the theoretical and practical tools to utilize these
emerging technologies. The primary emphasis of the course was on light microscopy, including
fluorescence, differential interference and phase contrast, confocal scanning, and 2-photon
scanning, as well as the use of different types of electronic cameras and the application of digital
processing to enhance and analyze microscope images. Students learned the principles of light
microscopy, the use of calcium-sensitive probes (e.g., Fura-2), voltage-sensitive dyes, photo-acti-
vated ("caged") compounds, exocytosis tracers, whole-cell patch-clamp methods, single-cell
microinjection of fluorescent indicators, and other methods to explore neuronal function. They
used a variety of neural systems, including living animals, brain slices (e.g., hippocampus, cere-
bellum, and neocortex), and cultured cells. Applicants had a strong background in the neuro-
sciences or in cell biology.
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PARTICIPANTS
Batch ler, A., B.S., Ph.D., University College London, U.K.
Cambridge, S., B.S., Ph.D., Carnegie-Mellon University,
Pittsburgh, Pennsylvania
Castro-Alamancos., M., B.S. M.S., Ph.D., Brown University,
Providence, Rhode Island
Dill, T., B.A., M.S., Ph.D., College of Notre Dame of
Maryland, Baltimore
Episkopou, V., B.S., Ph.D., Medical Research Council,
London, United Kingdom
Esteban, J., B.S., Ph.D., Cold Spring Harbor Laboratory
SEMINARS
Augustine, G., Duke University, Durham, North Carolina.
Using calcium indicators.
Betz, B., University of Colorado, Denver. FM 1-43 imaging.
Chalfie, M., Columbia University, New York. GFP.
Christenson, M., Princeton Instruments, Princeton, New
Jersey. Cameras.
Cline, H., Cold Spring Harbor Laboratory. In vivo observa-
tions of neuronal form and function.
Cohen, L., Yale University, New Haven. Voltage-sensitive
dyes.
Denk, W., Lucent Technologies Bell Labs, Murray Hill, New
Jersey. Two-photon microscopy.
Helmchen, F, Max Planck Institute, Heidelberg, Germany.
Calcium dynamics-1.
Katz, L., Duke University Medical Center, Durham, North
Carolina. Photostimulation.
Kay, S., Scripps Research Foundation, La Jolla, California.
Bioluminescence.
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Goedecke, I., B.S., Ph.D., Max Planck Institute, Munich,
Germany
Myhr, K., B.S., Ph.D., Washington University School of
Medicine, St. Louis, Missouri
Naegerl, V, B.S., University of California, Los Angeles
Patzke, H., B.S., Max Planck Institute, Frankfurt, Germany
Takahashi, M., L.I.B., B.S., Ph.D., Duke University Medical
Center, Durham, North Carolina
Zhou, Q., B.S., M.S., State University of New York, Stony
Brook
Konnerth, A., University of Saaland, Sarr, Germany. Calcium
dynamics-2/Imaging calcium in Purkinje cells.
Lanni, F, Carnegie Mellon University, Pittsburgh,
Pennsylvania. Basic microscopy.
Lichtman, J., Washington University, St. Louis, Missouri.
Confocal microscopy.
O'Malley, D., State University of New York, Stony Brook.
Imaging zebrafish in vivo.
Svoboda, K., Cold Spring Harbor Laboratory. Imaging calci-
um in vivo.
Tsien, R., University of California, San Diego. Design of cal-
cium indicators/GFP and voltage-sensitive dyes.
Wong, R., Washington University School of Medicine, St.
Louis, Missouri. Imaging retinal waves.
Yuste, R., Columbia University, New York. Imaging calcium
in spines.
Zucker, B., University of California, Berkeley. Uncaging cal-
cium.
Yeast Genetics
July 23-August 12
INSTRUCTORS
Adams, Alison, Ph.D., University of Arizona
Gottschling, Daniel, Ph.D., Fred Hutchinson Cancer Research Center
Stearns, Tim, Ph.D., Stanford University
ASSISTANTS
Dubois, Michelle, Fred Hutchinson Cancer Research Center
Feierbach, Becket, Stanford University
Kandl, Kimberly, University of Arizona
The major laboratory techniques used in the genetic analysis of yeast were studied, including the
isolation and characterization of mutants, tetrad analysis, complementation, and mitotic recombi-
nation. Micromanipulations used in tetrad analysis were carried out by all students. Molecular
genetic techniques, including yeast transformation, gene replacement, analysis of gene fusions,
and generation of mutations by transposon mutagenesis, were studied. Indirect immunofluores-
cence experiments were performed to identify the nucleus, microtubules, and other cellularcom-
ponents. Lectures on fundamental aspects of yeast genetics were presented along with seminars
given by outside speakers on topics of current interest.
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PARTICIPANTS
Barros, M.H., B.S., M.S., University of Sao Paolo, Brazil
Bognar, A., B.D., Ph.D., University of Toronto, Ontario,
Canada
Brown, B.J., B.S., M.D., Ph.D., University of Michigan, Ann
Arbor
Greger, I., B.S., M.S., University of Oxford, United Kingdom
Hammer, M., M.S., Ph.D., Karolinska Institute, Stockholm,
Sweden
Janssen, M., M.S., Utrecht University, The Netherlands
Jin, Q.-W., B.S., M.S., University of Vienna, Austria
Kalaitzis, P., B.S., Ph.D., University of Maryland, College
Park
SEMINARS
Boeke, J., Johns Hopkins University, Baltimore, Maryland.
Transposition in yeast.
Dawson, D., Tufts University, Boston, Massachusetts.
Meiosis in yeast.
De Shaies, R., California Institute of Technology, Pasadena.
Role of proteolysis in triggering G1-S transition in yeast.
Elion, E., Harvard University, Boston. Signal transduction in
the yeast mating pathway.
Fink, G., Massachusetts Institute of Technology, Cambridge.
The latest and greatest in yeast.
Fox, T, Cornell University, Ithaca. Mitochondrial function in
yeast.
Kaiser, C., Massachusetts Institute of Technology,
Cambridge. The yeast secretory pathway.
Lindquist, S., University of Chicago, Illinois. Heat shock pro-
Kok, R., B.S., Ph.D., Gist-Brocades, Delft, The Netherlands
Lin, H., B.S., M.S., St. John's University, Jamaica, New
York
Mayer, A., B.S., Ph.D., Max Planck Institute, TObingen,
Germany
Nemoto, Y., M.D., Ph.D., Yale University, New Haven
Schmekel, K., B.S., M.D., Stockholm University, Sweden
Swire-Clark, G., B.S., Clemson University, South Carolina
Then, A.B.S., University of Heidelberg, Germany
Tsukiyama, T., B.S., M.S., D.V.M., Ph.D., National Institutes of
Health, Bethesda, Maryland
teins in yeast.
Michaelis, S., Johns Hopkins University, Baltimore,
Maryland. Mating factor synthesis in yeast.
Petes, T., University of North Carolina, Chapel Hill.
Recombination and repair.
Rose, M., Princeton University, New Jersey. Nuclear fusion.
Sanders, S., Massachusetts Institute of Technology,
Cambridge. Cell polarity in yeast.
Stillman, B., Cold Spring Harbor Laboratory. Cell cycle con-
trol of yeast chromosomal DNA replication.
Struhl, K., Harvard Medical School, Boston. Molecular
mechanisms of yeast transcriptional regulation.
Young, R., Whitehead Institute for Biomedical Resesarch,
Cambridge, Massachusetts. New insights into eukaryotic
gene regulation.
Neurobiology of Human Neurological
Neurodegeneration
Disease: Mechanisms of
August 4-10
INSTRUCTORS
Gandy, Sam, M.D., Ph.D., Cornell University
Sisodia, Sangram, Ph.D., Johns Hopkins University Medical School
How and why do neurons die in specific acute or chronic human neurological disorders? What are
the molecular and biochemical manifestations of specific genetic lesions in neurodegenerative dis-
orders? Do different pathological neuronal death phenotypes share common mechanisms? What
practical treatments can be contemplated? This lecture course explored possible answers to these
important questions. Recent advances in neurogenetics and in molecular and cell biology have
begun to shed light on the mechanisms that underlie nervous system injury in disease states such
as Alzheimer's disease, amyotrophic lateral sclerosis, prion diseases, Huntington's disease, epilep-
sy, and stroke. Taking advantage of small class size and extensive discussion, invited faculty lectur-
ers examined critical issues in their areas of expertise. Overview was provided and course partici-
pants did not need to be familiar with neurological diseases. The course focused principally on the
specific hypotheses and approaches driving current research. Emphasis was placed on the highly
dynamic interface between basic and clinical investigation, including the interdependence of clinical
research and disease model development, and the value of disease research in understanding the
function of the normal nervous system.
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PARTICIPANTS
Bertuzzi, S., B.S., Ph.D., The Salk Institute, La Jolla,
California
Coulliard-Despres, S., B.S., McGill University, Quebec,
Canada
Debburman, S., B.A., Ph.D., University of Chicago, Illinois
Gschwentner, C., B.S., M.S., University of Vienna, Austria
Heinonen, 0., M.S., Ph.D., National Public Health Institute,
Helsinki, Finland
Hofmann, S., B.A., M.D., Ph.D., University of Texas
Southwestern Medical Center, Dallas
Holder, J., B.A., University of Texas Southwestern Medical
Center, Dallas
Karpuj, M., B.S., M.S., Weizmann Institute of Science,
Rehovot, Israel
Lindblad, K., M.S., Karolinska Hospital, Stockholm, Sweden
Meyer, T., M.D., University of Ulm, Germany
Perez, M., B.S., University of Pennsylvania, Philadelphia
Perry, E., B.A., National Institutes of Health, Bethesda,
SEMINARS
Bredesen, D., La Jolla Cancer Research Foundation,
California. What is the relationship between developmental
and degenerative neural cell death?
Chao, M., Cornell University Medical College, New York.
Receptor signaling mechanisms for cell survival and
death.
Collinge, J., St. Mary's Hospital Medical School, London,
United Kingdom. Human and veterinary prion diseases.
Edwards, R., University of California, San Francisco. The
pathogenesis of Parkinson's disease.
Gandy, S., Cornell University Medical College, New York.
Vesicle biology of the Alzheimer amyloid precursor and the
presenilins.
Griffin, J., Johns Hopkins University Medical College,
Baltimore, Maryland. Molecular pathology of peripheral
neurological disorders.
Lipton, S., Harvard Medical School, Boston. Pathways to
neuronal injury in AIDS dementia and stroke: Apoptosis,
necrosis, excitotoxins, and free radicals/Potential treatment
of AIDS dementia and stroke: NMDA channel blockers and
NO-related species.
Maryland
Peters, M., B.S., Ph.D., University of North Carolina, Chapel
Hill
Pinter, J., B.A., M.D., University of California, San Francisco
Pong, K., B.S., Amgen, Inc., Thousand Oaks, California
Ray, J., B.S., M.S., Washington University Medical School,
St. Louis, Missouri
Sanicola, M., B.S., Ph.D., Biogen, Inc., Cambridge,
Massachusetts
Servadio, A., B.S., Ph.D., Telethon Institute of Genetics &
Medicine, Milan, Italy
Shamraj, 0., B.S., Neurogen Corporation, Branford,
Connecticut
Takahashi, R., M.D., Ph.D., The Burham Institute, La Jolla,
California
Tasaki, Y., B.S., Ph.D., Yamanouchi Pharmaceutical Co.,
Ibaraki, Japan
McNamara, J., Duke University Medical Center, Durham,
North Carolina. Epilepsies and neurodegeneration.
Mobley, B., University of California, San Francisco.
Neurotrophic factors and neurological disease.
Posner, J., Memorial Sloan-Kettering Cancer Center, New
York. Paraneoplastic syndromes.
Price, D., Johns Hopkins University School of Medicine,
Baltimore, Maryland. Motor neuron disease.
Relkin, N., Cornell University Medical College, New York.
Clinical case study of Alzheimer's disease.
Ross, C., Johns Hopkins University Medical College,
Baltimore, Maryland. Huntington's disease and other triplet
repeat disorders.
Rothstein, J., Johns Hopkins University School of Medicine,
Baltimore, Maryland. Excitotoxicity.
Sisodia, S., Johns Hopkins University School of Medicine,
Baltimore, Maryland. Molecular neuropathology of
Alzheimer's disease.
Young, A., Massachusetts General Hospital, Boston.
Huntington's disease and other triplet repeat disorders.
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Positional Cloning: Contig to Candidate Gene
October 14-27
INSTRUCTORS
Reeves, Roger, Ph.D., Johns Hopkins University School of Medicine
Silverman, Gary, Ph.D., Harvard Medical School
Spencer, Forest, Ph.D., Johns Hopkins University School of Medicine
CO-INSTRUCTORS
Church, Deanna, Ph.D., Mount Sinai Hospital/Samuel Lunenfeld Research Institute
Parimoo, Satish, Ph.D., Johnson & Johnson
ASSISTANTS
Bartuski, Alison, Harvard Medical School
Wiltshire, Tim, Johns Hopkins University School of Medicine
This lab-based course was aimed at investigators using genetic and physical mapping and func-
tional assays to isolate a gene of interest. It was designed to cover those procedures used from the
time a gene is localized genetically to the point where candidate genes are isolated and character-
ized for mutations in a positional cloning project. Methods for physical mapping included contig
construction using YACs and BACs/PACs; analysis and characterization of large-insert clones by
STS-content mapping, fingerprinting, and pulsed-field gel electrophoresis; creation of nested dele-
tion derivatives of YACs by fragmentation at repeat sequences or exons; and end sequence rescue.
Several procedures were used to manipulate sequences in YACs by homologous recombination to
introduce mammalian selectable markers or to engineer specific mutations into target sequences.
YAC DNA was prepared for transfer into cells in tissue culture or into the mouse germ line by lipo-
fection, spheroplast fusion, and pronuclear injection. Gene identification from large cloned segments
was accomplished by laboratory exercises in cDNA selection and exon trapping. Computer-based
sessions on accessing data from the World Wide Web and the use of a variety of databases in gene
searches were covered in class and by invited instructors. The practical component of the course
was supplemented with lectures by invited speakers who are prominent researchers utilizing many
of the procedures taught in the course. All participants presented their own research interests to
serve as the basis for structured discussions of how to apply current technologies to their specific
research projects.
PARTICIPANTS
Cicila, G., B.S., Ph.D., Medical College of Ohio, Toledo
De Gregorio, L., B.S., Istituto Nazionale Tumori, Milan, Italy
Furukawa, K., M.D., Ph.D., University of Kentucky, Lexington
Heresbach, D., M.D., Ph.D., North Shore Hospital,
Manhasset, New York
Lee, H.-G., B.S., Ph.D., Memorial Sloan-Kettering Institute,
New York
Maiwald, R., M.D., University of California, San Francisco
McKenzie, J., B.S., M.S., Peter Mac Callum Cancer Institute,
Victoria, Australia
McMahon, F., B.A., M.D., Johns Hopkins University,
Baltimore, Maryland
Mestroni, L., B.S., M.S., M.D., International Center for
Genetic Engineering & Biotechnology, Trieste, Italy
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Mills, D., B.S., M.S., Ph.D., Brown University/Rhode Island
Hospital, Providence
Nicholson, S., B.S., Imperial College School of Medicine at
St. Mary's, London, United Kingdom
Passos-Bueno, M.R., M.D., University of Sao Paulo, Brazil
Robert, M., B.S., M.S., Ph.D., John Innes Centre, Norwich,
United Kingdom
Romero, G., B.S., Ph.D., Philippine Rice Research Institute,
Munoz, Philippines
Sharp, J., B.S., Ph.D., University College London Medical
School, United Kingdom
White, R., B.S., Ph.D., The Children's Mercy Hospital,
Kansas City, Kansas
SEMINARS
Baxevanis, A., National Institutes of Health, Bethesda,
Maryland. Informatics in positional cloning.
Birren, B., Whitehead Institute, Cambridge, Massachusetts.
Physical mapping: BACs to the basics.
Church, D., University of Toronto, Ontario. Physical and tran-
scription mapping in the Cd du chat region.
Green, E., National Institutes of Health, Bethesda, Maryland.
Clone-based physical mapping.
Parimoo, S., Johnson & Johnson, Skilman, New Jersey.
Positional cloning of genes controlling hair follicle growth.
Reeves, R., Johns Hopkins University, Baltimore, Maryland.
Macromolecular Crystallography
Mapping the unmappable and cloning what's not there.
Roe, B., University of Oklahoma, Norman. Genome
sequencing: How, why, wherefore?
Silverman, G., Harvard Medical School, Cambridge. SCCA1
and SCCA2: A tale of two serpins.
Spencer, F., Johns Hopkins University, Baltimore, Maryland.
A tale of two topics: Chromosomes controlled and cross-
referenced.
Trask, B., University of Washington, Seattle. Cytogenetics in
genome analysis.
October 14-27
INSTRUCTORS
Furey, William, Ph.D., V.A. Medical Center, Pennsylvania
Gilliland, Gary, Ph.D., National Institute of Standards & Technologies, Maryland Texas
McPherson, Alexander, Ph.D., University of California, Riverside
Pflugrath, James, Ph.D., Molecular Structure Corporation, The Woodlands
ASSISTANTS
Vasquez, Gregory, National Institute of Standards & Technologies, Maryland
Crystallography and X-ray diffraction yield a wealth of structural information unobtainable through
other methods. This intensive laboratory/computational course focused on the major techniques
used to determine the three-dimensional structures of macromolecules. It was designed for sci-
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entists with a working knowledge of protein structure and function, but who were new to macromole-
cular crystallography. Topics that were covered included crystallization (proteins, nucleic acids, and
complexes), crystal characterization, X-ray sources and optics, crystal freezing, data collection,
data reduction, anomalous dispersion, multiple isomorphous replacement, phase determination, sol-
vent flattening, molecular replacement and averaging, electron density interpretation, structure
refinement, molecular graphics, molecular dynamics, and multidimensional NMR. Participants
learned through extensive hands-on experiments where they crystallized and determined a protein
structure, along with lectures and informal discussions on the theory behind the techniques.
PARTICIPANTS
Agianian, B., B.S., European Molecular Biology Laboratory,
Heidelberg, Germany
Bouvier, M., B.S., Ph.D., University of Connecticut, Storrs
Downing, AK., B.S., Ph.D., University of Oxford, United
Kingdom
Eklof-Spink, K., B.A., Stanford University, Stanford, California
Gaiser, 0., M.S., Max Delbruck Center, Berlin, Germany
Gampe, R., B.S., M.S., Glaxo Wellcome, Research Triangle
Park, North Carolina
Kapp ler, J., B.A., Ph.D., Howard Hughes Medical Institute,
Denver, Colorado
Li, J., B.S., University of Virginia, Charlottesville
SEMINARS
Brunger, A., Yale University, New Haven. Maximum
advances in refinement: Torsion-angle, simulated-anneal-
ing, cross validation, maximum likelihood.
Clore, M., National Institutes of Health, Bethesda, Maryland.
NMR structure determination of proteins and protein com-
plexes beyond 20 kD.
Davies, D., National Institutes of Health, Bethesda,
Maryland. Structure determinations of two enzymes that
utilize cofactors.
Fitzgerald, P., Merck Research Laboratories, Rahway, New
Jersey. Crystallographic studies in structure-based drug
design.
Fleming, P., Yale University, New Haven. Xenon: Binding to
proteins and use as a heavy atom derivative.
Gilliland, G., National Institute of Standards & Technology,
Gaithersburg, Maryland. Crystal structure of recombinant
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Locher, K., M.S., University of Basel, Switzerland
McGrath, W., B.S., Ph.D., Brookhaven National Laboratory,
Upton, New York
Mellman, D., B.S., Vanderbilt University, Nashville,
Tennessee
Nguyen, D., B.A., Johns Hopkins University, Baltimore,
Maryland
Nieves, R., B.S., University of Puerto Rico, San Juan
Sertchook, R., B.S., M.S., Ph.D., Hebrew University,
Jerusalem, Israel
Thoma, N., B.A., University of Cambridge, United Kingdom
Wiencek, J., B.S., Ph.D., University of Iowa, Iowa City
tetradeca- (3- fluorotyrosyl)- glutathione S-transferase.
Hendrickson, W., Columbia University, New York. Structural
biology of immune signaling through CD4 and Lck.
Joshua-Tor, L., Cold Spring Harbor Laboratory. The carboxyl
terminus of Ga16/bleomycin hydrolase acts as a molecular
ruler for proteolysis.
Sussman, J., Brookhaven National Laboratory, Upton, New
York. Weizmann Institute of Science, Rehovot, Israel.
Acetylcholinesterase in 3D: New mysteries revealed from
the crystal structure.
Sweet, R., Brookhaven National Laboratory, Upton, New
York. Laue diffraction and other methods as a tool for
study of dynamic effects in protein crystals.
Tronrud, D., University of Oregon, Eugene. Strange density.
Xu, R., Cold Spring Harbor Laboratory. Crystal structure of
the RNA-binding domain of human hnRNP Al.
Advanced In Situ Hybridization and Immunocytochemistry
October 14-27
INSTRUCTORS
Murray, John, Ph.D., University of Pennsylvania
Ochs, Robert, Ph.D., Scripps Research Institute
Ried, Thomas, Ph.D., National Institutes of Health
Schrock, Eve lin, Ph.D., National Institutes of Health
Spector, David, Ph.D., Cold Spring Harbor Laboratory
ASSISTANTS
Howard, Tamara, Cold Spring Harbor Laboratory
Quin lin, Margot, University of Pennsylvania
This course focused on specialized techniques in microscopy related to localizing DNA and RNA
sequences and proteins in cells for microscopic examination. The course emphasized the use of
the latest equipment and techniques in epifluorescence microscopy, confocal laser scanning
microscopy, electron microscopy, and digital image processing. The aim of the course was to
provide state-of-the-art technology and scientific expertise in the use of microscopic applications
to address basic questions in genome organization and cellular and molecular biology. The
course was designed for the molecular biologist who was in need of microscopic approaches
and for the cell biologist who was not familiar with the practical application of the advanced tech-
niques presented. Among the methods presented were the preparation of tagged nucleic acid
probes, fixation methods, detection of multiple DNA sequences in single nuclei or chromosome
spreads, comparative genomic hybridization, use of a variety of reporter molecules and nonanti-
body fluorescent tags, indirect antibody labeling and detection of multiple proteins in a single
cell. In addition, this year, a new section of the course emphasized the cellular localization of
RNA. In each method, several experimental protocols were presented allowing the students to
assess the relative merits of each and to relate them to their own research. Students were
encouraged to bring nucleic acid or antibody probes to the course which could be used in addi-
tion to those provided by the instructors. The laboratory portion of the course was supplemented
by invited lecturers who gave up-to-the-minute reports on current research using the techniques
being presented in the course.
PARTICIPANTS
Ahmad, S., D.V.M., M.S., Ph.D., University of California,
Davis
Averboukh, L., B.S., M.S., Ph.D., Ergo Science Corporation,
Charlestown, Massachusetts
Bell-Matesoi, D., M.D., Baylor Research Institute, Dallas,
Texas
Brink, A., B.S., University Hospital Vrije Universiteit,
Amsterdam, The Netherlands
Connolly, B., B.A., Ph.D., Merck Research Laboratories,
West Point, Pennsylvania
Hay-Schmidt, A., M.S., Ph.D., Royal Veterinary & Agricultural
University, Frederiksberg, Denmark
Inada, M., B.S., University of California, San Francisco
Katz, J., B.A., M.D., University of Pennsylvania, Philadelphia
Laub, F., B.S., Mount Sinai School of Medicine, New York
Levenson, C., B.A., Ph.D., Florida State University,
Tallahassee
Linney, E., B.S., M.S., Ph.D., Duke University Medical
Center, Durham, North Carolina
Lu, J., B.S., Ph.D., AMC Cancer Research Center, Denver,
Colorado
Maltzman, T, B.S., Ph.D., University of Colorado Health
Sciences Center, Denver
Pramatarova, A., B.S., M.S., McGill University, Montreal
General Hospital, Quebec, Canada
Radu, C., B.S., M.D., University of Texas Southwestern
Medical Center, Dallas
Skopicki, H., B.A., Ph.D., Columbia University College of
Physicians & Surgeons, New York
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SEMINARS
Deerinck, T., University of California, San Diego. Electron
microscopy as a tool in cell and molecular biology.
Garini, Y., Spectral Diagnostics, Carlesbad, California.
Spectral karyotyping.
Herman, B., University of North Carolina, Chapel Hill.
Fluorescence microscopy.
Huang, S., Northwestern University Medical School,
Chicago, Illinois. Localization of RNA.
Murray, J., University of Pennsylvania, Philadelphia. Basic
introduction to light microscopy and video
microscopy/Principles of confocal microscopy and decon-
volution techniques.
Piston, D., Vanderbilt University, Nashville, Tennessee.
Localization of proteins in living cells using GFP.
Mouse Behavorial Analysis
Ried, T., National Institutes of Health, Bethesda, Maryland.
Comparative genomic hybridization to detect amplifica-
tions and/or deletions in human cancers.
Salmon, T., University of North Carolina, Chapel Hill. High-
resolution multi-mode digital microscopy of microtubules
and mitosis.
Singer, R., Albert Einstein College of Medicine, Bronx, New
York. Cytoplasmic organization of mRNA.
Spector, D., Cold Spring Harbor Laboratory.
lmmunocytochemistry.
Waggoner, A., Amersham Life Sciences, Pittsburgh,
Pennsylvania. Development of fluorochromes and filters for
fluorescence microscopy.
November 4-17
INSTRUCTORS
Silva, Alcino, Ph.D., Cold Spring Harbor Laboratory
Gallagher, Michela, Ph.D., Johns Hopkins University
ASSISTANTS
Han, Jung-Soo, Johns Hopkins University
Kogan, Jeff, Cold Spring Harbor Laboratory
Pay lor, Richard, National Institutes of Mental Health
Smith, Dani, University of North Carolina
Wolfer, David, University of Zurich, Switzerland
This course provided a theoretical and experimental introduction to behavioral analysis in the
mouse, with a focus on learning and memory. It was especially designed for geneticists,
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lar biologists, pharmacologists, and electrophysiologists with a need for a hands-on introduc-
tion to behavioral analysis of the mouse. Additionally, the course covered the principles of using
mutant mice in behavioral studies, as well as the issues involved in integrating behavioral, neu-
roanatomical, neurophysiological, and molecular findings. Among the methods that were pre-
sented were the water maze, cued and contextual fear conditioning, natural/ethologically rele-
vant learning, open field behavior, the rotor-rod, and other activity tests. In addition, there were
demonstrations of several aspects of in vitro electrophysiology (fields and whole-cell recordings
of synaptic plasticity).
The speakers in the course included Howard Eichenbaum, Boston University; Larry Squire,
University of California, San Diego; Peter Holland, Duke University; Mathew L Shapiro, McGill
University; Roberto Malinow, Cold Spring Harbor Laboratory; Richard Thompson, University of
Southern California; Peter R. Rapp, Mt Sinai; Joseph Takahashi, Northwestern University;
Randal Reed, Johns Hopkins University School of Medicine; Michael Fanselow, University of
California, Los Angeles; P. Read Montague, Baylor College of Medicine.
PARTICIPANTS
Brandon, E., B.S., Ph.D., The Salk Institute, La Jolla,
California
Brown, G., B.S., Ph.D., Mount Sinai School of Medicine, New
York
Chen, J.-F., M.S., M.D., Ph.D., Harvard Medical School,
Charlestown
Hagan, J., B.S., Ph.D., SmithKline Beecham Pharmaceu-
ticals, Essex, United Kingdom
Hasan, M., B.A., Ph.D., Massachusetts Institute of
Technology, Cambridge
Isles, A., B.S., University of Cambridge, United Kingdom
Lau, D., B.A., New York University Medical Center, New York
Lin, Z., B.S. Ph.D., Cold Spring Harbor Laboratory
Magnusson, K., B.S., D.V.M., Ph.D., Colorado State
University, Fort Collins
Pittenger, C., B.S., M.S., Columbia University College of
Physicians & Surgeons, New York
Xu, B., B.S., Ph.D., University of California, San Francisco
Xu, W., B.S., Ph.D., Baylor College of Medicine, Houston,
Texas
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SEMINARS
Eichenbaum, H., Boston University, Massachusetts. Real life
and laboratory learning in humans and animals/Brain sys-
tems/Recognition memory.
Fanselow, M., University of California, Los Angeles. Fear
conditioning.
Fedorov, N., Cold Spring Harbor Laboratory. Measuring
EPSCS and EPSPS in hippocampal slices.
Frank land, P., Cold Spring Harbor Laboratory. The involve-
ment of the hippocampus on contex conditioning and
contex discrimination: Neuroanatomical and genetic evi-
dence.
Gal lager, M., Johns Hopkins University, Baltimore, Maryland.
The impact of aging on cognitive function: Rodent stud-
ies/Comparative approaches in the development of animal
models.
Giese, K., Cold Spring Harbor Laboratory. The involvement
of the aCaMKII in the plasticity of cells, circuits, and be-
havior.
Holland, P., Duke University, Durham, North Carolina.
Appetitive conditioning/Brain systems that mediate
Pavlovian conditioning.
Kogan, J., Cold Spring Harbor Laboratory. Memory studies
in CREB mutant mice.
Malinow, R., Cold Spring Harbor Laboratory. Mechanisms of
hippocampal synaptic plasticity.
Montague, P.R., Baylor College of Medicine, Houston, Texas.
The value of modeling brain function.
Nelson, R., Johns Hopkins University, Baltimore, Maryland.
Using converging methods to study nitric oxide synthase
in mice: Studies of aggression.
Rapp, P., Mt. Sinai School of Medicine, New York. Ad-
vanced stereological techniques for quantitative neu-
roanatomy.
Shapiro, M., McGill University, Montreal, Canada. Assessing
the performance of neural systems: Memory and long-term
potentiation/Assessing the performance of neural stems:
Recording neuron activity in behaving animals.
Silva, A., Cold Spring Harbor Laboratory. How to control
genetic background.
Takahashi, J., Northwestern University, Evanston, Illinois.
Genetics of circadian rhythms.
Thompson, R., University of California, Los Angeles.
Mutant mice in the analysis of cerebellar-dependent learn-
ing.
Phage Display of Combinatorial Antibody Libraries
November 4-17
INSTRUCTORS
Barbas, Carlos, Ph.D., Scripps Research Institute
Burton, Dennis, Ph.D., Scripps Research Institute
Silverman, Gregg, M.D., University of California, San Diego
CO-INSTRUCTOR
Siegel, Donald, M.D., Ph.D., University of Pennsylvania Medical Center
ASSISTANTS
Cary, Steven, University of California, San Diego
Fuller, Roberta, Scripps Research Institute
Recent advances in the generation and selection of antibodies from combinatorial libraries allow
the rapid production of antibodies from immune and nonimmune sources. This library/lecture
course focused on the construction of combinatorial antibody libraries expressed on the surface
of phage and selection of desired antibodies from the library. Students learned the theoretical
and practical aspects of constructing combinatorial libraries from immune and nonimmune
sources as well as the construction of synthetic antibody libraries. Antibodies were selected from
the library by panning. Production, purification, and characterization of Fab fragments expressed
in E. coli were also covered. The lecture series presented by a number of invited speakers
focused on PCR of immunoglobulin genes, the biology of filamentous phage and the utility of sur-
face expression libraries, expression of antibodies in E. coli and mammalian cells, antibody
structure and function, catalytic antibodies, the whole biology of antibody activity, and recent
results on the use of antibodies in therapy.
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PARTICIPANTS
Chung, J., M.D. Ph.D., Dongguk University College of
Medicine, Kyung-Ju, Korea
Flavell, D., B.S., Ph.D., University of South Hampton,
Hampshire, United Kingdom
Frank, H.-G., M.D. Ph.D., University of Aachen, Germany
Gomez Roig, A., B.S., MERCK Farma y Quimica, S.A.,
Barcelona, Spain
Greenfield, E., B.S., Ph.D., Dana Farber Cancer Institute,
Boston, Massachusetts
Hocking, D., B.S., CSL Ltd., Victoria, Australia
Kaushik, A., B.S., M.S., Ph.D., University of Guelph, Ontario,
Canada
Mantis, N., B.A., Ph.D., Harvard Medical School, Boston
SEMINARS
Barbas, C., The Scripps Research Institute, La Jolla,
California. Phage display of antibodies and zinc finger
protein.
Kelsoe, G., University of Maryland School of Medicine,
Baltimore. B-cell development: Phenotype, anatomy loca-
tion, and diversification of the antibody gene repertoire.
Lowman, H., Genetech, Inc., S. San Francisco, California.
Phage display of antibodies and other proteins.
Model, P., Rockefeller University, New York. Phage biology.
Nest ler, P., Cold Spring Harbor Laboratory. Encoded combi-
natorial libraries: Chemistry and beyond?
Pasqualini, R., La Jolla Cancer Research Institute,
California. In vivo panning.
Nord, K., M.S., Ph.D., Royal Institute of Technology,
Stockholm, Sweden
Schenk, J., B.S., Max Delbruck Center for Molecular
Medicine, Berlin, Germany
Selisko, B., B.S., Ph.D., National Autonomous University of
Mexico, Morelos
Tayapiwatana, C., B.S., M.S., Chiang Mai University, Chiang
Mai, Thailand
Wilkins, J., B.S., M.S., Ph.D., University of Manitoba, Canada
Xing, P.X., M.D., Ph.D., University of Melbourne, Victoria,
Australia
Zvi, A., M.S., Ph.D., Weizmann Institute of Science, Rehovot,
Israel
Sanz, I., University of Texas Health Science Center, San
Antonio. Generation and features of antibody diversity.
Scanlan, T., University of California, San Francisco, San
Francisco. Catalytic antibodies.
Scott, J., Simon Fraser University, Burnaby, British
Columbia, Canada. Phage display of peptides.
Siegel, D.L., University of Pennsylvania Medical Center,
Philadelphia. Cell surface selection of combinatorial Fab
libraries.
Silverman, G. University of California, San Diego. Repertoire
cloning of SLE autoantibodies.
Wilson, I., The Scripps Research Institute, La Jolla,
California. Structural biology of immune recognition.
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Molecular and Cell Biology of S. pombe and Other Yeasts
November 4-17
INSTRUCTORS
Chappell, Thomas, Ph.D., University College London, United Kingdom
Young, Paul, Ph.D., Queens University, Ontario, Canada
ASSISTANTS
Karagiannis, James, Queens University, Ontario, Canada
Gachet, Yannick, University College London, United Kingdom
Gregg, James, Oregon Graduate Institute of Science & Technology, Portland
Smith, Jennifer, University of Alberta, Canada
Fission yeast is often chosen as a model system for studies of cell and molecular biology. This
course was designed to introduce the basic genetic, molecular, and cell biological techniques nec-
essary for an investigator to adapt this system to their own laboratory/project. Topics included formal
genetics and tetrad dissection, cytology including fluorescent and immunological techniques, trans-
formation and gene replacement, plasmid recovery, and cell fractionation. Many of the experiments
exploited mutant strains affected in the cell cycle or cytoskeleton. Against this background, the
course introduced several other yeast systems of industrial or pathological interest. The Pichia sys-
tem was used for protein expression and Yarrowia for cell fractionation studies. In addition to the
laboratory component, invited speakers addressed various aspects of the biology of these systems.
PARTICIPANTS
Akoulitchev, A., B.S., M.S., Ph.D., New Jersey University of
Medicine & Dentistry, Piscataway, New Jersey
Ayoub, N., B.S., M.S., Hebrew University, Jerusalem, Israel
Blad, S., M.S., Institute for Molecular Cellular Biology,
Amsterdam, The Netherlands
Dove, S., B.S., Ph.D., University of Birmingham, United
Kingdom
Gauss, P., B.S., Ph.D., Western State College, Gunnison,
Colorado
Guevara-Lara, F., B.S., M.S., Unidad Irapuato, Irapuato,
Mexico
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Hanninen, A.-L., M.S., Ph.D., University of Helsinki, Finland
Hastings, C., B.S., M.S., Pioneer Hi-Bred International Inc.,
Johnston, Iowa
Kuznetsov, N., M.D., Ph.D., Marie Curie Research Institute,
Surrey, United Kingdom
Lechelt-Kunze, C., B.S., Bayer AG, Leverkusen, Germany
Novoa, I., B.S., New York University Medical Center, New
York
Raponi, M., B.S., University of South Wales, New South
Wales, Australia
Sterner, J., B.S., Eli Lilly & Company, Indianapolis, Indiana
SEMINARS
Chang, F., Columbia University, New York. Polarity in fission
yeast.
Chappell, T., University College London, United Kingdom.
Functional and genetics studies of Golgi enzymes in S.
pombe.
Cregg, J., Orgeon State Institute of Science & Technology,
Portland. Pichia expression.
Leatherwood, J., State University of New York, Stony Brook
Computational Genomics
Regulation of the cdc2 kinase.
McLeod, M., State University of New York, Brooklyn.
Regulation of meiosis in fission yeast.
Smith, J., University of Alberta, Canada. Peroxisomes in
Yarrowia.
Young, P., Queens University, Ontario, Canada. Sodium
transport in S. pombe.
November 6-11
INSTRUCTORS
Pearson, William, Ph.D., University of Virginia, Charlottesville
Smith, Randall, Ph.D., SmithKline Beecham Pharmaceuticals
The course presented a comprehensive overview of the theory and practice of computational meth-
ods for gene identification and characterization from DNA sequence data. The course focused on
approaches to extracting the maximum amount of information from protein and DNA sequence simi-
larity through sequence database searches, statistical analysis, and multiple sequence alignment.
Additional topics included gene recognition (exon/intron prediction), identifying signals in unaligned
sequences, and integration of genetic and sequence information in biological databases. The
course combined lectures with hands-on exercises; students were encouraged to pose challenging
sequence analysis problems using their own data. This year, the course made extensive use of local
World Wide Web pages to present problem sets and computing tools to solve them. The course was
taught using Unix servers and X-windows terminals; participants were expected to be comfortable
using the Unix operating system, the GCG sequence analysis package, and a Unix text editor (pro-
gramming knowledge was not required). The course was designed for biologists seeking advanced
training in biological sequence analysis, for computer core directors and staff for molecular biology
or genetics resources, and for scientists in other disciplines, such as computer science, who wish to
survey current research problems in biological sequence analysis.
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PARTICIPANTS
Bailey, W., B.A., B.S., Ph.D., Merck & Co., Inc., West Point,
Pennsylvania
Brown, S., B.S., Ph.D., New York University Medical Center,
New York
Cai, L., B.S., Ph.D., Children's Hospital, Boston,
Massachusetts
Cao, W., B.S. Ph.D., Cornell University Medical College,
New York
Duchateau-Nguyen, G., M.S., Ph.D., Universite Paris Sud,
Orsay, France
Gao, G.-J., B.S., Ph.D., University of Louisville, Kentucky
Gatewood, B., B.S., Ph.D., Johns Hopkins University,
Baltimore, Maryland
Greene, J., B.S., Ph.D., Human Genome Sciences, Inc.,
Rockville, Maryland
Hatzimanikatis, V., B.S., Ph.D., Dupont Company,
Wilmington, Delaware
Hinkle, G., B.A., Ph.D., University of Massachusetts, No.
SEMINARS
Eddy, S., Washington University School of Medicine, St.
Louis, Missouri. Blocks, motifs, domains, and other protein
databases/Multiple sequence comparison with hidden
Markov models.
Gish, W., Washington University, St. Louis, Missouri.
Statistics of sequence similarity scores/Searching databas-
es with BLAST and friends/NCBI tools for sequence analy-
sis.
Overbeek, R., Argonne National Laboratory, Argonne,
Illinois. Genomic databases and genome informatics/
Beyond gene sequences: Recognizing biological function
Dartmouth
Karnovsky, A., M.S., Ph.D., University of Colorado, Boulder
Leal, S., Ph.D., Rockefeller University, New York
Sanchez, R., B.S., Rockefeller University, New York
Schlink, G., B.A., Ph.D., Missouri Southern State College,
Joplin
Schmid, K., M.S., Ph.D., University of Munich, Munchen,
Germany
Simon, R., B.S., D.Sc., National Cancer Institute, Bethesda,
Maryland
Taylor, R., B.S., M.S., National Institutes of Health, Bethesda,
Maryland
Williams, S., B.A., Ph.D., Meharry Medical College,
Nashville, Tennessee
Yang, U.-C., B.S., Ph.D., National Yang-Ming University,
Taiwan, China
Zhu (Joe), X., B.S., Ph.D., SmithKline Beecham
Pharmaceuticals, King of Prussia, Pennsylvania
Pearson, W., University of Virginia, Charlottesville. Protein
evolution-biology/Practical issues in protein sequence
searching.
Retief, J., University of Virginia, Charlottesville. Introduction
to computer lab/GCG.
Smith, R., SmithKline Beecham Pharmaceuticals, King of
Prussia, Pennsylvania. Introduction to multiple sequence
comparison.
Stormo, G., University of Colorado, Boulder. Identifying sites
in unaligned sequences/New approaches to discovering
features in biological sequences.
The Laboratory would like to acknowledge the generosity of the following companies who loaned equipment and
reagents to the various courses:
ALA Scientific Instruments, Inc.
Amersham Corporation
Amresco
Atto Instruments
Axon Instruments
Bachem Biosciences
Beckman-BREA
Becton-Dickinson Labware
Bio-101
Bio-Rad
Boehringer Mannheim
Corporation
Burleigh Instruments, Inc.
Carl Zeiss, Inc.
CBS Scientific
Chroma Technology
Corporation
Codonics Inc.
Corning Costar Corporation
Diagnostic Instruments, Inc.
Drummond Scientific Company
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DuPont NEN
Dynal
E-Y Laboratories, Inc.
Eastman Kodak Company
Epicentre Technologies
Fisher Scientific
5 Prime - 3 Prime
FMC Corporation
Fotodyne
General Valve
Hamamatsu Photonic Systems
Hewlett Packard
Hoeffer Pharmacia
Invitrogen Corporation
Jackson Immunoresearch
Jouan, Inc.
Kopf Instruments
Leica, Inc.
LiCor, Inc.
Life Technologies, Inc.
MatTek Corporation
Medical Systems Corporation
Micro Video Instruments
MJ Research, Inc.
Modulation Optics, Inc.
Molecular Dynamics
Molecular Probes
Nalge Labware
Narishige International
USA, Inc.
NEN Life Science Products
New England Biolabs
Nikon
Olympus America Inc.
Operon Technologies Inc.
Optronics Engineering
Owl Scientific, Inc.
Packard Instruments
Perkin-Elmer
PerSeptive Biosystems
Pfanstiehl Laboratories, Inc.
Pharmacia Biotech, Inc.
Pierce
Princeton Separations
Promega Corporation
Qiagen Inc.
Robbins Scientific Corporation
Savant Instruments
Sherwood-Davis & Geck
Shimadzu
Sooner Scientific, Inc.
Sorenson
Stratagene
Sutter Instruments
Techne, Inc.
Technical Manufacturing Corp.
TMC
Tropix
Vector Laboratories
Vorhies Technologies, Inc.
VWR Scientific Products
Wallac, Inc.
SEMINARS
Invited Speaker Program
Each year, Cold Spring Harbor Laboratory invites speakers from outside the institution to present
their latest findings on a weekly basis. These seminars keep the CSHL staff current on the latest
developments and broaden their perspectives. Graduate students and postdoctoral fellows meet
with the seminar speakers for lunch immediately after the seminar, allowing an opportunity for the
exchange of ideas in an informal setting.
1997
January
Michael Greenberg, Harvard Medical School. Neurotrophin
and neurotransmitter regulation of gene expression and
neuronal adaptive responses. (Host: Holly Cline)
Richard Young, Whitehead Institute. Positive and negative
factors in gene expression. (Host: Winship Herr)
Walter Mangel, Brookhaven National Laboratory. Cofactors
(peptide and viral DNA) and structure (1.6 A resolution) of
the adenovirus proteinase. (Host: Xiaodong Cheng)
Jonathan Stamler, Duke University. Hemaglobin: A micro-
cosm of NO biology. (Host: Grisha Enikolopov)
February
Rudolf Jaenisch, Whitehead Institute. X-chromosome inacti-
vation. (Host: Tern Grodzicker)
Keith Burridge, University of North Carolina. RHO and focal
adhesions: Signaling and assembly. (Host: Nick Tonks)
Daniel Littman, Skirball Institute of Biomolecular Medicine.
New York University Medical Center. Chemokine receptors:
Roles in HIV entry and pathogenesis. (Host: Jacek
Skowronski)
March
Richard Assoian, University of Miami School of Medicine.
Cyclins and CDK inhibitors regulated by growth factors
and the extracellular matrix. (Host: Nick Tonks)
Richard Firtel, University of California, San Diego.
Regulatory pathways controlling morphogenesis and cell
fate decisions in Dictyostelium. (Host: Hong Ma)
James lhle, St. Jude's Children's Research Hospital,
Memphis. Signaling by the cytokine receptor superfamily.
(Host: Nick Tonks)
Aravinda Chakravarti, Case Western Reserve University.
Genetic dissection of a complex disease: Hirschprung dis-
ease. (Host: Tom Marr)
April
Ed Harlow, Massachusetts General Hospital. Closing the G,
gap. (Host: Lavina Faleiro)
Lorena Beese, Duke University Medical Center. DNA repli-
cation in a crystal: A high-resolution snapshot of a poly-
merase in action. (Host: Leemor Joshua-Tor)
Donald Ganem, University of California, San Francisco.
Human herpesvirus 8 and the biology of Kaposi's sarco-
ma. (Host: Nouria Hernandez)
Douglas Koshland, Carnegie Institute of Washington. The
five Cs of mitotic chromosomes: Cohesion, condensation,
centromeres, and cell cycle. (Host: David Spector)
October
Jeff Dangl, University of North Carolina, Chapel Hill,
Arabidopsis loci controlling cell death and disease resis-
tance. (Host: Rob Martienssen)
Walter Gehring, Biocenter, University of Basel.
Morphogenesis and evolution of eyes. (Host: Ueli
Grossniklaus)
Joan Steitz, Yale University. The cell nucleolus: An RNA
machine. (Host: Nouns Hernandez)
November
Larry Abbott, Brandeis University. Functional roles of synap-
tic depression in cortical processing. (Host: Rui-Ming Xu)
Judah Folkman, Children's Hospital, Boston. New directions
in angiogenesis research. (Host: Scott Lowe)
Leonard Guarente, Massachusetts Institute of Technology. A
molecular cause of aging. (Host: Bruce Stillman)
December
Michael Gaudy, Cornell University Medical College. Control
of neuronal cell fate decisions and neuronal cell signaling
by helix-loop-helix transcription factors in Drosophila and
mammals. (Host: Tim Tully)
William Weis. Stanford University. Structural analysis of the
Armadillo repeat region of p-catenin and its interactions
with cadherins. (Host: Leemor Joshua-Tor)
Carol Prives, Columbia University. Regulation of the p53
tumor suppressor protein. (Host: Tern Grodzicker)
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In-House Seminar Program
Cold Spring Harbor In-House Seminars were initiated to provide a semiformal avenue for communi-
cation between the various research groups at the Laboratory. They are particularly useful for
research personnel who have recently joined the Laboratory. The seminars also afford a necessary
opportunity for the graduate students and postgraduate staff to develop their skills in organizing,
presenting, and defending their research.
1997
January
Vivek Mittel (Hernandez Lab): Transcriptions a SNAP:
Communication between regulatory factors bound to an
unusual RNA porn' promoter.
Chun Liang (Stillman Lab): Control of DNA replication in the
budding yeast S. cerevisiae.
Nick Carpino: Chronic myelogenous leukemia and p62.
Ken La Montagne (Tonks Lab): PTPs, PTKs, and chronic
myelogenous leukemia.
February
Gregory Hannon: Toward genetics in animal cell.
Clifford Yen (Wig ler Lab): Genomic analysis of breast tumors
by RDA.
Yi Zhong: The Ras-NF1 complex regulated adenylyl cyclase
activity and its role in learning and memory.
El ly Nedivi (Visiting Scientist; Cline Lab): Differential cloning
of genes responsive to neuronal activity.
March
John lafrate (Skowronski Lab): Functional analysis of the HIV
nef gene.
Cyril Sanders (Stenlund Lab): Assembling the BPV-1 replica-
tion initiation complex.
Richard Freiman (Herr Lab): Virus/host cell interactions: Cell
cycle and transcriptional regulation by the VP16-associat-
ed protein HCF.
Dan Bush (Sabbatical Visitor; Martienssen Lab): Life without
a heart: Understanding plant sugar and amino acid trans-
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porters in the context of resource allocation and multicellu-
lar growth.
April
Tatsuya Hirano: Protein machines that build up chromo-
somes.
Michael Hengartner: Death and the hermaphrodite: The
hows and whys of programmed cell death in C. elegans.
Octrober
Viola Ellison (Stillman Lab): Characteriation of replication
factor C: A component of the eukaryotic DNA replication
machinery.
Howard Fearnhead (Lazebnik Lab): Is the enemy of my
enemy my friend? (and how to find him).
David Helfman: What I did on my sabbatical: Stable and
dynamic cytoskeletal assemblies.
Leemor Joshua -Tor: The carboxyl terminus of
Ga16/Bleomycin hydrolase: A molecularler in proteolysis.
November
Michael Murray (Krainer Lab): Role of a type-2C Ser/Thr pro-
tein phosphatase in pre-mRNA splicing.
Zack Mainen (Malinow Lab): Receptor recruitment during
LTP in GIuR2 knockout mice.
December
Jim DeZazzo (Tully Lab): Molecular genetics of the
Drosophila learning mutant nalyot.
Brandt Schneider (Futcher Lab): Divide or bust: Size matters
and the cell cycle.
UNDERGRADUATE RESEARCH
Program Director: Michael Hengartner
Program Assistant: Jane Reader
An important aspect of the summer program at the Laboratory is the participation of college
undergraduate students in active research projects under the supervision of full-time laboratory
staff members. The program was initiated in 1959. Since that year, 485 students have participat-
ed in the course, and many have gone on to productive careers in biological science.
The objectives of the program are to provide (1) a greater understanding of the fundamental
principles of biology; (2) an increased awareness of experimental approaches to science; (3) a
deeper understanding of the major issues in the fields of biochemistry, genetics, and molecular
and cellular biology; and (4) a personal acquaintance with research, research workers, and cen-
ters for study.
The following students, selected from more than 370 applicants, took part in the program.
Nizar Batada, Carleton University
Advisor: Peter Nest ler
Sponsor: Frederica von Stade Fund
Screening and detection of substrates of apoptotic protease,
CPP32.
Richard Benton, University of Cambridge
Advisor: Robert Martienssen
Sponsor: Emanuel An
Use of gene-trap and enhancer-trap systems to determine
pattern formation in the vegetative development of
Arabidopsis thaliana.
Scott A. Berkowitz, Yale University
Advisor: Yuri Lazebnik
Sponsor: Burroughs Wellcome Foundation
Searching for substrates of apoptotic proteases.
Jay Bikoff, Brown University
Advisor: Jerry Yin
Sponsor: Burroughs Wellcome Foundation
Regulation of the subcellular localization of the dOREB2
transcription factor.
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Joshua Busch, Emory University
Advisor: Hong Ma
Sponsor: Burroughs Wellcome Foundation
Immunological analysis of AGAMOUS.
Alice Chu, Drew University
Advisors: Shirley Pinto and Tim Tully
Sponsor: National Science Foundation
Alternate cDNA copies of Latheo, a gene implicated in
associative learning in Drosophila.
Andreas Demetriades, University College London
Advisor. Hollis Cline
Sponsors: Libby Internship; Jephson Educational Trust
Analysis of aberrant axon trajectories in homer-expressing
neurons.
Daniel Desrosiers, Saint Anselm College
Advisor: Jacek Skowronski
Sponsor: Garfield Fund
Deletion analysis of HIV-1 Nef
Yanfei Feng, Peking University
Advisors: Frances Hannan and Yi Zhong
Sponsors: Glass Foundation; Jephson Educational Trust
Yeast two-hybrid system screen for interactors of Drosophila
NF1 and Rutabaga adenylyl cyclase.
Andrew Fry, University of Glasgow, Scotland
Advisor: Linda Van Aelst
Sponsor: Shakespeare fund
Rac small GTPase and exchange factor TIAM1: An investi-
gation of T-cell adhesion.
Christina Grozinger, McGill University
Advisor: Winship Herr
Sponsor: Olney Foundation
Determination and characterization of the DNA-binding site
of the transcription factor LZIP.
Alberto Hazen, Harvard University
Advisor: Grigori Enikolopov
Sponsor: National Science Foundation
Transcription initiation in Drosophila nitric oxide synthase.
Kirstin Knox, Swarthmore College
Advisor: Scott Lowe
Sponsor: National Science Foundation
A genetic analysis of Ras-induced cell cycle arrest.
Robert J. Klein, Harvard University
Advisor: Michael Zhang
Sponsor: Burroughs Wellcome Fund
A computational description of the interaction between the
transcription factors E2F and Sp1.
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Carson Miller, The College of Wooster
Advisor: Ueli Grossniklaus
Sponsor: The Nationnal Science Foundation
Molecular and genetic analysis of an enhancer detector line
affecting megagametophyte development in Arabidopsis.
Andrew Miner, Duke University
Advisors: David Spector and Tom Misteli
Sponsor: Burroughs Wellcome Foundation
Biochemical characterization of pre-mRNA splicing factor
pools in vivo.
Geralda Parvilus, Tuskegee University
Advisor: Michael Hengartner
Sponsor: National Science Foundation
Temporal control of gene expression in the nervous system
of the nematode, C. elegans.
Nikos Reppas, Balliol College, Oxford University
Advisor: Bruce Stillman
Sponsor: Bliss Internship
The interaction of DNA polymerase a-primase with the ori-
gin recognition complex (ORC) in Saccharomyces cere-
visiae.
Joel Stern, Columbia University
Advisor: Alcino Silva
Sponsor: Burroughs Welcome Fund
The N-Ras heterozygous mutation rescues the spatial learn-
ing deficits caused by the NF1 heterozygous mutation.
Milos Tanurdzic, University of Novi Sad
Advisor: Erich Grotewold
Sponsor: Read Fellowship
Identification of additional factors interacting with regulators
of flavonoid biosynthesis.
Elizabeth Thomas, The Evergreen State College
Advisor: Adrian Krainer
Sponsor: National Science Foundation
Characterization of p54, a putative splicing factor.
Hung Tran, Columbia University
Advisor: Michael Wig ler
Sponsor: National Science Foundation
Characterization of the binding partners of the tumor sup-
pressor gene pTEN.
Keren Witkin, Wellesley College
Advisor: Rui-Ming Xu
Sponsor: National Science Foundation
Purification and preliminary crystallization studies of UNC-
69.
NATURE STUDY PROGRAM
The Nature Study Program gives elementary and secondary school students the opportunity to
acquire a greater knowledge and understanding of their environment. Through a series of spe-
cialized field courses, younger students can engage in introductory programs such as Nature
Bugs, Nature Detectives, and Nature Discovery, and older students can enroll in more advanced
programs such as Marine Biology and Nature Photography.
During the summer of 1997, a total of 383 students participated in 28 courses within the pro-
gram. The classes were held outdoors, weather permitting, at the West Side School. The
Laboratory has equipped and maintains classroom and laboratory facilities as well as a dark-
room at West Side School. This facility is used as a base for the students' exploration of the local
environment. Field classes are held on Laboratory grounds, St. John's Preserve, Fire Island
National Seashore, Caumsett State Park, the Cold Spring Harbor Fish Hatchery and Aquarium,
as well as other local preserves and sanctuaries.
In addition to the three, 2-week sessions, the Adventure Education course meets on two
Fridays for trips. The students go on a three-masted schooner to navigate and explore the waters
of Long Island Sound and on a 12-mile canoe trip on the Nissequogue River.
PROGRAM DIRECTOR
William M. Payoski, M.A., Adjunct Professor, Nassau Community College
REGISTRAR
Amy Stiso, Cold Spring Harbor Laboratory
INSTRUCTORS
Alison Forte, B.S., Marine Science, University of Rhode Island
Donna Pandaliano, M.S., Science Teacher, Valley Stream School District
Linda Payoski, M.S., Science Teacher, Uniondale School District
Marjorie Pizza, M.S., Science Teacher, Locust Valley School District
Brian Withers, Fine Arts Teacher, New York City School System
COURSES
Nature Bugs Pebble Pups Flora, Fauna, and Fun with
Nature Detectives Freshwater Life watercolors
Nature Discovery Seashore Life Nature Photography
Ecology Explorers Bird Study Adventure Education
Frogs, Flippers, and Marine Biology
Fins
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BANBURY CENTER
DIRECTOR'S REPORT
Banbury Center had a very busy 1997, with no fewer than 18 meetings in the course of the year.
In addition, the Center was used on a further 18 occasions for Laboratory meetings and by local
nonprofit organizations. The meetings program was as eclectic as usual, covering fundamental
research and topics of special interest in biotechnology as well as scientific education.
Participants
More than 570 participants came to the scientific meetings. The majority were of course drawn
from institutions in the United States, but the fact that 15% came from other countires under-
scores the international character of biomedical research and the high esteem in which Banbury
Center meetings are held. Most foreign visitors came from the United Kingdom (29), followed by
France (15) and Germany (9). The majority of participants from the United States came from the
Northeast, with New York, Massachusetts, and Maryland accounting for 26% of our visitors. The
second largest grouping came from California (12%). The Corporate Sponsors sent 42 scientists,
and 45 of the invited participants came from other companies.
Meetings on Genetics
Banbury Center has had a long-standing interest in genetics, originally dealing with the mute-
genic effects of environmental hazards. But, more recently, a sizable proportion of the Banbury
Center year has been devoted to human genetics, reflecting, in part, the success of the Human
Genome Project. Meeting topics have dealt with technical matters such as cloning genes or have
been devoted to specific disorders. We had examples of both meetings in 1997.
Duchenne muscular dystrophy (DMD) has the distinction of being one of the first genetic dis-
orders on which recombinant DNA techniques made a significant impact. The DMD gene was
cloned in 1986, and DNA-based diagnosis has played an important part in the lives of many
thousands of afflicted families. Unfortunately, progress has been slow in developing treatments
based on this molecular knowledge. The Up-regulation of Utrophin Gene Expression meeting
examined a new approach based on the finding that there is a fetal form of the protein defective
in DMD. This fetal gene is largely turned off in adults, but it may be possible to make it active
again. Experiments in mice have shown that this protein can replace defective dystrophin, and
the hope and expectation are that utrophin will be able to do the same in young males with DMD.
We brought human geneticists working on this approach together with scientists interested in
expression of muscle proteins and researchers who have been using this strategy successfully in
treating thalassemias.
We held also the third in a series of meetings on neurofibromatosis (NF). Banbury Center has
played a part in the NF story since the first meeting was held in 1990-an opportune moment for
the gene was cloned later that same year. Our 1997 meeting, The Pathogenesis of NF1 and NF2
Therapeutic Strategies, had the goal of examining the special clinical features of NF1 and NF2 in
the light of what is known of molecular changes in the genes. For example, cognitive dysfunction
is a common feature of these disorders but its basis is poorly understood. Here at Cold Spring
Harbor Laboratory, the groups of Alcino Silva and Yi Zhong are making important contributions
using NF1 mutant mice. In addition, there was much discussion of how knowledge of the bio-
chemical pathways involved in NF1 and NF2 might be exploited in devising therapies.
One of the attractions of doing scientific research is when unexpected connections are made
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Robertson house provides housing accommodations at Banbury Center.
in what had appeared to be unrelated fields. Such a connection had been made in research on
Parkinson's Disease in the summer of 1997 when it was found that Parkinson's Disease in one
family was associated with a mutation in the gene for a protein called synuclein. This same pro-
tein is known to be involved in birds learning and remembering their songs! So here is a highly
suggestive link between a protein and memory in two very different organisms, and our meeting,
Genetics of Parkinson's Disease, held in the fall, examined this new development. Although it
appears that this mutation is rare, it is hoped that the synuclein connection will provide clues as
to what goes wrong in this devastating disorder.
Research in Cancer
There were three meetings on cancer-related topics. The first of the year was The Biology of p53
and Its Implications for Diagnosis and Therapy. p53 was originally thought to be a gene involved
in making cancers, but further research showed that it suppresses cancer by being a key player
in controlling cell division. This workshop first reviewed what is currently known of the biology of
p53-how it exerts its effects in the cell and its interactions with other proteins. The workshop
then turned to the practical applications of our knowledge of p53, in particular the fact that differ-
ent mutations in p53 may lead to tumors with different properties. Thus, determining the type of
p53 mutation in a patient's tumor may have important implications for both diagnosis and treat-
ment.
The Biology of BRCA1 meeting had a similar purpose. The clonings of the BRCA1 gene in
1996 and of BRCA2 in 1997 were significant advances in research on breast cancer. However,
as in so many cases where disease genes have been cloned, the next steps have been prob-
lematic. The meeting reviewed the spectrum of mutations so far found in the BRCA1 and BRCA2
genes, as well as the mutations found in other tumor suppressor genes in breast cancer. The
participants then turned to the vexing question of the biological functions of the BRCA1 protein,
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an area of considerable controversy, but an understanding of which is essential for a rational
approach to devising therapies.
For many years, it has been hoped that an immunological attack on cancer would be possi-
ble. Cancer cells are different from the cells of the body and have different molecules on their
surface, molecules that the immune system might be expected to use to identify cancer cells to
be destroyed. Perhaps because overoptimistic hopes were not fulfilled, research on tumor
immunology has not been among the leading areas of cancer research. Nevertheless, very good
research continues in this area-research that deserves to be encouraged. The Alexander and
Margaret Stewart Trust has as its goal the development of less toxic therapies than those in cur-
rent use, and immunological therapies could provide these. The meeting Immunological Attacks
on Cancer brought together scientists working on a very broad range of topics; many of these
researchers had not met before for any extended period of time.
Genomics
Three meetings dealt with genetic studies at the level of complete genomes. The first-Finding
Genes: Computational Analysis of DNA Sequences-discussed highly technical issues relating
to what is becoming a critical problem. DNA sequence is being produced at an ever-increasing
rate, and computer analysis of the sequence is essential for trying to identify genes in the hun-
dreds of millions of bases. However, there is still considerable discussion as to which of the pre-
sent methods are best and what new developments are needed to improve the accuracy and
efficiency of the strategies and computer algorithms.
But all the computer-based gene detection in the world will count for very little unless experi-
mental biologists make use of the information for understanding how organisms function. This is
the so-called "post-genomics" world where genomics data will be used to design experiments.
An important intermediate step is to make use of all the biochemical, physiological, and cell
biology research that has been performed throughout this century. An amazing wealth of data
exists that must be assembled into a more coherent whole, using genetics as a framework. The
first steps are already being taken using the detailed knowledge of, for example, metabolic path-
ways in bacteria. These are not trivial tasks and Integrating Genetic, Biochemical, and Other
Data in the Post-Genomics Era examined the problems involved. Not least of these is devising
rational and consistent classifications of current knowledge. This is complicated further by the
very different forms data take in different fields.
One discipline that is likely to benefit is physiology, where the knowledge of genes and their
interactions should provide new insights into physiological processes. The American
Physiological Society funded a meeting at Banbury Center called Genomics to Physiology and
Beyond: How Do We Get There? Participants included geneticists who are producing genomic
data, scientists already using such data to examine interesting biological processes, and physi-
ologists who will be using genome data increasingly in planning their research.
Cell and Developmental Biology
Cells synthesize many tens of thousands of molecules, but for many of these-in particular, pro-
teins-synthesis is not the end of the story. There follows a series of changes in which various
groups, for example, sugars in glycosylation, are added to the proteins. These modifications are
essential for proper functioning of the proteins and pose problems for companies making human
proteins in bacteria that cannot make the necessary modifications. The Posttranslational Modifi-
cations meeting was not restricted to proteins but examined a wide variety of changes that cellu-
lar molecules undergo following synthesis.
A key element in the life of a cell is its interactions with its environment: the detection of mole-
cules in that environment, the conveyance of that information to the interior of the cell, and finally
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the development of an appropriate response. Signal transduction is of special interest to those
looking for therapeutic molecules to modify cell behavior. Signal Transduction in Endothelial Cells
examined the molecules, their receptors, and the pathways that are activated in this important
group of cells. A final discussion reviewed various models and mechanisms by which endothelial
cells integrate the many positive and negative signals that they receive.
Neuregulins and Neuregulin Receptors examined a particularly important group of molecules
involved in signal transduction. This family of proteins is large and their receptors are diverse,
and thus they are involved in many systems and not just, as their name implies, in neurons. They
have a role, for example, in signaling at synapses and the neuromuscular junction, in interactions
with glial cells, and in signaling in sensory systems.
Development was the theme of what was, perhaps, the most "basic" and intriguing of the
year's meetings. Animals are generally symmetrical during their early development and then
develop asymmetries, that is to say, handedness becomes apparent. Handedness and
Symmetry in Development brought to Banbury Center scientists whose expertise went from stud-
ies of molecular asymmetry, through embryology, to social studies of handedness in human
beings. There was extensive and speculative discussion of the genetics, mechanisms, and evo-
lutionary implications of this symmetry breaking during development.
Plant Molecular Biology
Banbury Center's plant meeting for 1997 dealt with Molecular and Genetic Approaches to
Transport in Plants, a topic of considerable economic and social importance. The geographical
distribution of plants is limited not only by climate, but also by the nature of the soil. The pres-
ence of metals such as aluminum and heavy metals and the nitrogen and phosphate content of
the soil restrict the areas in which plants can be grown. Recombinant DNA techniques have led
to the isolation of genes for the transporters that take up these elements and compounds. The
practical consequences of these studies are of great potential significance for increasing the
range of habitats in which a crop plant can be grown. We have been trying to promote plant mol-
ecular biology and genetics meetings, and the enthusiasm of both the participants and the mem-
bers of the Laboratory's Plant Corporate Associates Program for this meeting was very gratifying.
Lyme Disease
Lyme Disease is of special interest in our region and Banbury Center has held a series of meet-
ings on the topic since 1991. Research on Lyme Disease has changed dramatically since that
meeting, becoming increasingly molecular in its basis. This was reflected in the 1997 meeting,
entitled Molecular lmmunobiology of Lyme Disease, which covered the latest findings on topics
such as antigen expression, immune response, the importance of mixed infections, and progress
in developing a vaccine. We can expect the nature of Lyme Disease research to change even
more dramatically in the coming years, now that the complete genome sequence of the
spirochaete has been determined. I expect Banbury Center to continue its role of promoting this
research through further workshops.
Neuroscience
Banbury Center continues to hold meetings in the field of neuroscience, especially in topics relat-
ed to learning and memory, research areas of special interest to the Laboratory. The John A.
Hartford Foundation is interested in problems of learning and memory in human aging and has
made a substantial grant to the Laboratory for exploring how our research on learning and mem-
ory in Drosophila and mice relates to human beings. Banbury Center held a discussion work-
shop on Human Cognition and How It Fails as part of this program. The subjects covered were
extremely diverse, ranging from the development of learning and memory in infants through hip-
pocampal functioning and Alzheimer's Disease to models of memory formation.
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Science Education for Nonscientists
We were very pleased to join with the Federal Judicial Center in holding the second seminar on
The Art of Judging: Perspectives of Science. Some 30 Federal and State judges came to
Banbury Center to hear presentations on a wide variety of topics, ranging from the history of biol-
ogy through human genetics to viruses and plagues. A highlight of the meeting was a talk by
Leon Lederman, Nobel Laureate for Physics, on the very first moments after the Big Bang.
The J.P. Morgan/Cold Spring Harbor Laboratory Executives' Seminar
This was the 12th in this unique series of weekend seminars, intended to introduce areas of
novel biological research to the senior executives of pharmaceutical and biotechnology compa-
nies and financial institutions. Each seminar has seven scientists as speakers, chosen both for
the excellence of their research and for their ability to communicate with others. This year's semi-
nar was on Genetic Engineering-a particularly appropriate subject, it being 25 years since Stan
Cohen and Herb Boyer published their classic paper on cloning. We were very fortunate to have
Stan Cohen as the opening speaker. In addition, we moved to the latest form of cloning, when
Alan Colman of PPL Therapeutics told us about Dolly the Sheep. And in-between we fitted genet-
ic engineering of molecules, plants, and human beings.
Other Meetings
The Banbury Center is a facility of Cold Spring Harbor Laboratory and is used by scientists for
small discussion meetings on the Laboratory's research. For example, the DNA Tumor Virus
group used the Center for the annual review of their research. We also make the Center available
on a necessarily limited number of occasions for local nonprofit groups, including the Lloyd
Harbor Village Conservation Board and Cold Spring Harbor High School, and for Board meetings
of Holiday House and Huntington Hospital. The Lloyd Harbor Village Seminar series continued
successfully.
Funding
With each passing year, Banbury Center's debt to the Corporate Sponsors continues to grow.
The Program supports one third of Banbury Center meetings and provides us with the opportuni-
ty to have meetings that are both important for their relevance to biotechnology and pharmaceu-
tical research and at the forefront of "basic" research. This year, the Corporate Sponsor Program
funded the following meetings: Signal Transduction in Endothelial Cells; Finding Genes:
Computational Analysis of DNA Sequences; Integrating Genetic, Biochemical, and Other Data in
the Post-Genomics Era; Neuregulins and Neuregulin Receptors; Handedness and Symmetry in
Development; and Molecular and Genetic Approaches to Transport in Plants.
Funding from other companies is playing an increasing role in our activities. This year, for
example, Applied Microbiology, Inc. supported Posttranslational Modifications; OncorMed, Inc.
funded The Biology of p53 and Its Implications for Diagnosis and Therapy, and J.P. Morgan
again provided us with the means to do the Executives' Seminar Genetic Engineering.
We are particularly pleased that Foundations continue to find that Banbury Center meetings
make important contributions to their efforts. In 1997, four Foundations came here: the Oxnard
Foundation (Up-regulation of Utrophin Gene Expression); The Alexander and Margaret Stewart
Trust (Immunological Attacks on Cancer); The John A. Hartford Foundation (Human Cognition
and How It Fails); and the National Neurofibromatosis Foundation (The Pathogenesis of NF1 and
NF2: Therapeutic Strategies). The American Physiological Society was the primary supporter of
the Genomics to Physiology and Beyond: How Do We Get There?, and a contribution was made
to the meeting by the Burroughs-Wellcome Fund.
Federal funding is important, although the long lead times needed to make grant applications
274
conflict with Banbury Center's goal of holding meetings on current and controversial research.
Nevertheless, the National Cancer Institute was very helpful in contributing to both The Biology of
BRCA1 and Integrating Genetic, Biochemical, and Other Data in the Post-Genomics Era, while
the National Human Genome Research Institute and the National Institute for Neurological
Disorders and Stroke funded the meeting on the Genetics of Parkinson's Disease. Two
Institutes-the Centers for Disease Control and Prevention and the Federal Drug Administration-
were the primary funding agencies for Molecular Immunobiology of Lyme Disease. Federal fund-
ing, through the Federal Judicial Center, covered the costs of The Art of Judging: Perspectives of
Science.
Companies were also generous in providing supplemental funding, all of which contributed
significantly to the Center's program. These companies included Cambridge Neuroscience, Inc.
(Neuregulins and Neuregulin Receptors); CIBA-GEIGY, Ltd. (Genomics to Physiology and
Beyond: How Do We Get There?); Amgen, Inc. (The Biology of BRCA1); and Fort Dodge Animal
Health; Glaxo-Wellcome, Inc. and Pasteur Merieux Connaught (Molecular lmmunobiology of
Lyme Disease).
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MEETINGS
Up-regulation of Utrophin Gene Expression
February 7-9
FUNDED BY
Oxnard Foundation
ARRANGED BY
K.E. Davies, University of Oxford, United Kingdom
D. Weatherall, University of Oxford, United Kingdom
SESSION 1: DMD and Utrophin
Chairperson: K.E. Davies, University of Oxford, United Kingdom
K.E. Davies, University of Oxford, United Kingdom: J.M. Tinsley, University of Oxford, United Kingdom:
Background. Transgenic utrophin mdx mice.
M. Grady, Washington University School of Medicine, St. Discussion: Implications of this research.
Louis, Missouri: Double knockouts.
SESSION 2: Defining Promoters in Muscle Genes
Chairperson: P.W.J. Rigby, National Institute for Medical Research,
London, United Kingdom
B. Jasmin, University of Ottawa, Ontario, Canada: The P.W.J. Rigby, National Institute for Medical Research,
utrophin promoter. London, United Kingdom: Muscle genes.
S.D. Hauschka, University of Washington, Seattle: Muscle Discussion: What do we know about the properties of mus-
genes. cle promoters?
SESSION 3: Up-regulation Therapy
Chairperson: D. Weatherall, University of Oxford, United Kingdom
V.L. Funanage, Alfred I. DuPont Institute, Wilmington, Minneapolis: Embryonic globin gene activation in adult
Delaware: Up-regulation of utrophin: Effects of erythroid cells.
hemin. D. Weatherall, University of Oxford, United Kingdom: Clinical
D. Weatherall, University of Oxford, United Kingdom: The trials update.
hemoglobinopathies: Background. Discussion: What can up-regulation of the hemoglo-
G.D. Ginder, University of Minnesota Medical School, binopathies tell us?
SESSION 4: Strategies for Targeting Promoters
Chairperson: A.M. Bruskin, Oncogene Science, Inc., Uniondale, New York
C. Passananti, University of Rome, Italy: Targeting zipper Targeting gene transcription.
motifs. K. Giese, Chiron Corporation, Emeryville, California:
A.M. Bruskin, Oncogene Science, Inc., Uniondale, New Positive selection system to screen for modulators of tran-
York: Oncogene Science general strategies. scription.
P. Baeuerle, Tularik, Inc., South San Francisco, California: Discussion: Strategies to find new compounds.
SESSION 5: Other Possible Consequences of Up-regulation of Utrophin
Chairperson: L.M. Kunkel, Howard Hughes Medical Institute,
The Children's Hospital, Boston, Massachusetts
B. Jasmin, University of Ottawa, Ontario, Canada: The neu-
romuscular junction and transcriptional control-1.
K.P. Campbell, Howard Hughes Medical Institute, University
of Iowa College of Medicine, Iowa City: Reconstitution of
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the complex at the membrane.
J.S. Chamberlain, University of Michigan Medical School,
Ann Arbor: Toxicity of overexpression; levels of expression
needed; timing of delivery.
SESSION 6: Screening for Compounds Which May
Up-regulate Utrophin
Chairperson: G.D. Ginder, University of Minnesota
Medical School, Minneapolis
J. Haley, Oncogene Science, Inc., Uniondale, New York:
Oncogene Science assay.
G. Karpati, Montreal Neurological Institute & Hospital,
Canada: Studies of utrophin in culture.
Discussion: The best assay in muscle.
Summary and Discussion: Optimizing Strategies:
Screening and Testing
Chairperson: S.D. Hauschka, University of Washington,
Seattle
Genomics to Physiology and Beyond: How Do We Get There?
February 23-26
FUNDED BY
The American Physiological Society, with additional support from the Burroughs
Wellcome Fund and CIBA-GEIGY, Limited
ARRANGED BY
A.W. Cowley, Medical College of Wisconsin, Milwaukee
H.J. Jacob, Medical College of Wisconsin, Milwaukee
SESSION 1: Looking for Genes Involved in Interesting Processes
Chairperson: A.W. Cowley, Medical College of Wisconsin, Milwaukee
A.W. Cowley, Medical College of Wisconsin, Milwaukee, and human essential hypertension.
J.D. Watson, Cold Spring Harbor Laboratory: Opening L. Cardon, Sequana Therapeutics, Inc., La Jolla, California:
remarks-Goals and challenges. Positional cloning of genes involved in asthma.
D.R. Cox, Stanford University School of Medicine, California: G. Duyk, Millennium Pharmaceuticals, Inc., Cambridge,
The human genome. Massachusetts: Analysis of complex traits in a post-
M.J. Welsh, Howard Hughes Medical Institute, University of genome scan world: Real examples-Real solutions.
Iowa College of Medicine, Iowa City: Cystic fibrosis/ C.T. Caskey, The Merck Genomics Research Institute, Inc.,
CFTR. West Point, Pennsylvania: ESTs.
P. Corvol, INSERM, Paris, France: Predisposing genes to
SESSION 2: Comparative Genomics as a Key to Human Physiology
Chairperson: D.R. Cox, Stanford University School of Medicine, California
H.J. Jacob, Medical College of Wisconsin, Milwaukee: Is M.R. Riley, Marine Biological Laboratory, Woods Hole,
man a rat? Gene hunting for complex phenotypes. Massachusetts: Progress report on the sequences of E.
J.E. Womack, Texas A&M University, College Station: From coil and other prokaryotes.
the human genome to animal physiology. Breakout Groups: How to Find Genes of Interest to
M.C. Fishman, Massachusetts General Hospital-East, Physiologists?
Charlestown: Zebra fish as a model vertebrate.
SESSION 3: Determining Gene Function
Chairperson: M.J. Welsh, Howard Hughes Medical Institute, University of
Iowa College of Medicine, Iowa City
0. Smithies, University of North Carolina, Chapel Hill:
Knockout mice for elucidating gene function.
J.S. Takahashi, Northwestern University, Evanston, Illinois:
Using forward genetics in the mouse to study the function
of genes.
K.R. Chien, University of California, San Diego: Molecular
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analysis of complex cardiovascular phenotypes in geneti-
cally engineered mice.
R. Roberts, Baylor College of Medicine and Methodist
Hospital, Houston, Texas: Structure/function analysis of the
p-MHC gene and protein.
G.J. Nabel, Howard Hughes Medical Institute, University of
Michigan, Ann Arbor: Gene transfer in animal models and
human disease.
Discussion: Problems of Using Transgenic Techniques for Physiological
Studies
Chairperson: C.T. Caskey, The Merck Genomics Research Institute, Inc., West
Point, Pennsylvania
SESSION 4: Going Beyond Genomics
Chairperson: C.T. Caskey, The Merck Genomics Research Institute, Inc.,
West Point, Pennsylvania
A.R. Rut, SmithKline Beecham, King of Prussia, Pennsyl-
vania: Genomics and physiology.
M. Riley, Marine Biological Laboratory, Woods Hole,
Massachusetts: Integrating E. coli genomics and metabol-
ic pathways.
J.B. Bassingthwaighte, University of Washington, Seattle:
Formulating the cardiome project: A beginning for the
physiome project?
K.G. Hofbauer, Ciba-Geigy Ltd., Basel, Switzerland: A ratio-
nal approach to target identification, concept validation,
and patient selection.
General Discussion
Chairpersons: J.B. Bassingthwaighte, University of Washington,
Seattle; V.J. Dzau, Brigham & Women's Hospital, Boston,
Massachusetts
SESSION 5: Factors Affecting Implementation of Gene-based Approaches in
Physiology
Chairperson: A.W. Cowley, Medical College of Wisconsin, Milwaukee
A.W. Cowley, Medical College of Wisconsin, Milwaukee:
Introductory remarks.
C.T. Caskey, The Merck Genomics Research Institute, Inc.,
West Point, Pennsylvania: Industry.
D.R. Cox, Stanford University School of Medicine, California:
Genetics.
T. Unger, University of Kiel, Germany: Physiology.
V.J. Dzau, Brigham & Women's Hospital, Boston,
Massachusetts: Clinical.
S.C. Mockrin, National Heart, Lung, and Blood Institute,
National Institutes of Health, Bethesda, Maryland: NIH.
Discussion: How to Encourage Exploring Approaches in Physiology
Chairperson: J.A. Schafer, University of Alabama at Birmingham
C.T. Caskey, J. Witkowski, A. Cowley, D. Cox
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The Biology of p53 and Its Implications for Diagnosis and Therapy
March 5-8
FUNDED BY
OncorMed, Inc.
ARRANGED BY
A.J. Levine, Princeton University, New Jersey
S. Lowe, Cold Spring Harbor Laboratory
SESSION 1: Basic Biology of p53-What are the aspects of p53 biolo-
gy that may be relevant to the clinic?
Chairperson: S. Lowe, Cold Spring Harbor Laboratory
D.P. Lane, Dundee University, Scotland, United Kingdom:
Regulating p53 function through amino- and carboxy-ter-
minal domains.
T. Waldman, The Johns Hopkins Oncology Center,
Baltimore, Maryland: p21 checkpoint function and sensitiv-
ity to anticancer agents.
J. Wind le, University of Texas Health Science Center at San
Antonio: Effect of p53 on tumor properties and response to
chemotherapy in a transgenic mouse model.
A.J. Levine, Princeton University, New Jersey: The functions
of the MDM2 oncoprotein.
S.P. Linke, The Salk Institute for Biological Studies, San
Diego, California: p53-dependent cell cycle effects of y-
radiation and nucleotide antimetabolites.
SESSION 2: Complexities of p53 Biology-How might the complexities of
p53 biology confound simple analysis of clinical data? Are the biological
consequences of p53 mutation dependent on the type of p53 mutation?
Tissue type?
Chairperson: A.J. Levine, Princeton University, New Jersey
P.A. Hall, Ninewells Hospital and Medical School, Dundee, M. Oren, The Weizmann Institute of Science, Rehovot, Israel:
Scotland, United Kingdom: The heterogeneity of the p53 Anti-apoptotic gain of function of mutant p53.
response in mice. S. Lowe, Cold Spring Harbor Laboratory: Activation of p53 by
T.D. Tlsty, University of California, San Francisco: Loss of oncogenes.
genomic integrity in preneoplastic cells.
C. Prives, Columbia University, New York, New York:
Impact of p53 status on drug treatment of cells.
SESSION 3: Determining p53 Mutational Status-
What are the current strategies for identifying p53
mutations? Their limitations? Can we assess path-
ways rather than genes?
Chairperson: C. Cordon-Cardo, Memorial Sloan-
Kettering Cancer Center, New York, New York
M. Bywater, Cytometrics, Inc., Philadelphia, Pennsylvania.
B. Neri, Third Wave Technologies, Inc., Madison,
Wisconsin: The detection of p53 mutations using
cleavase fragment-length polymorphism (CFLP).
T. Soussi, Institut Curie, Paris, France: Serological analysis
of p53 alterations in human cancer.
D. Mack, Affymetrix, Inc., Santa Clara, California: Profiling
of cancer gene expression patterns and genotypic analy-
sis using high-density oligonucleotide arrays.
R. Iggo, Swiss Institute for Experimental Cancer Research,
Lausanne, Switzerland: Analysis of p53 tumor suppressor
gene function in yeast.
C. Prives, R. Iggo
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SESSION 4: p53 Mutations and Clinical Parameters-What are the clinical
implications of p53 mutations for cancer patients? How does this relate
to p53 biology? Should patients be tested for p53 mutations?
Chairperson: P.A. Hall, Ninewells Hospital and Medical School, Dundee,
Scotland, United Kingdom
R. Cote, University of Southern California School of
Medicine, Los Angeles: p53 and bladder cancer: Tu-
mor progression, response to therapy, and analytical meth-
ods.
C. Cordon-Cardo, Memorial Sloan-Kettering Cancer Center,
New York, New York: p53 as a biological determinant in
human solid tumors.
E. Newcomb, New York University Medical Center, New
York: p53 mutations and survival: Our experience with lym-
phoid, brain, and ovarian cancers.
R. Elledge, University of Texas Health Science Center at San
Antonio: Prognostic and predictive value of p53 in breast
cancer.
J.S. Kovach, City of Hope National Medical Center, Duarte,
California: Null and missense p53 mutations in primary
breast cancers are associated with adverse prognosis.
SESSION 5: Using p53 for Therapeutic Gain-How can p53, or knowl-
edge of p53 status, be used to improve cancer management? What
are the potential problems? What is needed from basic research to
overcome these problems?
Chairperson: D. Lane, Dundee University, Scotland, United Kingdom
D. Kim, Onyx Pharmaceuticals, Richmond, California: The
use of an E1B-55 kD gene-deleted adenovirus for the
treatment of p53-deficient tumors.
P. O'Connor, National Cancer Institute, Bethesda, Maryland:
Can molecular characterization aid drug discovery? A test
case with the p53 pathway in the NCI Anticancer Drug
Screen.
M. Rolfe, Mitotix Inc., Cambridge, Massachusetts: Small-
molecule inhibitors of p53 ubiquitination.
Posttranslational Modifications
M.I. Sherman, PharmaGenics, Inc., Allendale, New Jersey:
Strategic approaches to restoring lost p53 function.
D.P. Carbone, Vanderbilt University Cancer Center,
Nashville, Tennessee: Oncogene-targeted cellular
immunotherapy.
M. Harper, Introgen Therapeutics, Inc., Houston, Texas:
Strategies for p53 gene therapy in cancer: Molecular, bio-
logical, and clinical endpoints.
March 9-12
FUNDED BY
Applied Microbiology, Inc.
ARRANGED BY
S.L. Mowshowitz, Applied Microbiology, Inc., Tarrytown, New York
R. Pollack, Columbia University, New York, New York
SESSION 1
Chairperson: S.L. Mowshowitz, Applied Microbiology Inc., Terrytown, New York
H. Freeze, The Burham Institute, La Jolla, California: R.G.W. Anderson, University of Texas Southwestern Medical
Mannose and N-glycosylation: A minority report. Center, Dallas: Tyrosine kinase signal transduction from
B. Stillman, Cold Spring Harbor Laboratory: Histone acetyla- caveolae.
tion in chromatin assembly.
SESSION 2
Chairperson: B. Stillman, Cold Spring Harbor Laboratory
E.R. Stadtman, National Heart, Lung, and Blood Institute, by the HIV-1 capsid protein.
National Institutes of Health, Bethesda, Maryland: Reactive A.J. Franzusoff, University of Colorado Health Sciences
oxygen-mediated modification of proteins. Center, Denver: Intracellular trafficking pathways and HIV
W.I. Sundquist, University of Utah School of Medicine, Salt infectivity.
Lake City: Proteolytic processing and cyclophilin a binding
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F. Perlin, R. Morimoto
SESSION 3
Chairperson: S.L. Mowshowitz, Applied Microbiology, Inc., Tarrytown,
New York
F.B. Per ler, New England BioLabs, Inc., Beverly, Massa-
chusetts: Protein splicing.
M.-Q. Xu, New England BioLabs, Inc., Beverly, Massa-
chusetts: Mechanism of protein splicing and its applica-
tions.
S.B. Prusiner, University of California, San Francisco:
Conformational templating in the formation of the scrapie
prion protein.
D.J. Selkoe, Brigham and Women's Hospital/Harvard
Medical School, Boston, Massachusetts: Posttranslational
processing of the p-amyloid precursor protein and the
genesis of Alzheimer's disease.
M. Gasson, Institute of Food Research, Norwich, United
Kingdom.
J.N. Hansen, University of Maryland, College Park:
Formation, properties, and biological roles of the unusual
residues in nisin and subtilin.
R.I. Morimoto, Northwestern University, Evanston, Illinois:
Molecular chaperones in protein folding and protein
degradation.
T. Muir, Rockefeller University, New York, New York: Protein
synthesis via chemical ligation: New tools for probing pro-
tein structure and function.
NEUREGULINS AND NEUREGULIN RECEPTORS
March 16-19
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program, with additional
support from Cambridge NeuroScience, Inc.
ARRANGED BY
M.A. Marchionni, Cambridge NeuroScience, Inc., Massachusetts
G. Lemke, The Salk Institute for Biological Studies, San Diego, California
SESSION 1: Neuregulin Receptors and Signaling
Chairperson: G. Plowman, Sugen, Redwood City, California
Y. Yarden, National Institute of Child Health & Human
Development, Bethesda, Maryland: Signal diversification
by neuregulin receptors.
K.L. Carraway, Beth Israel Hospital, Boston, Massachusetts:
A ring-finger-containing protein that binds and clusters
ErbB receptors.
M.X. Sliwkowski, Genentech, Inc., South San Francisco,
California: Structure-function relationships of neuregulin
with its receptors.
D.F. Stern, Yale University School of Medicine, New Haven,
Connecticut: Hormonal regulation of the erbB receptor
family network.
D.L. Falls, Emory University, Atlanta, Georgia: Functions of
the neuregulin cytoplasmic domain.
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SESSION 2: Genetics of Neuregulins and Neuregulin Receptors
Chairperson: C. Ibanez, Karolinska Institute, Stockholm, Sweden
C. Birchmeier, Max-Delbrueck-Centrum, Berlin, Germany:
Genetic analysis of neuregulin and its receptors.
S.L. Erikson, Genentech, Inc., South San Francisco,
California: ErbB3 is essential for normal cardiac and cere-
bellar development: A comparison with NRG- and ErbB2-
deficient mice.
K.-F. Lee, The Salk Institute, La Jolla, California: Role of
neuregulin receptor erbB2 in mammalian development.
M. Gassmann, The Salk Institute, La Jolla, California: Neural
phenotypes in ErbB4 neuregulin receptor mutant embryos.
G. Lemke, The Salk Institute for Biological Studies, San
Diego, California: Neuregulin ablation by ribozymes.
SESSION 3: Neuregulins in Neuron/Glial Interactions
Chairperson: S. Scherer, University of Pennsylvania Medical Center,
Philadelphia
N. Ratner, University of Cincinnati College of Medicine,
Ohio: Modulation of Schwann cell proliferation through
alterations in Ras signaling and neuregulin production.
C.D. Stiles, Dana-Farber Cancer Institute, Boston,
Massachusetts: Activation of erbB2 during Wallerian
degeneration of sciatic nerve.
K.R. Jessen, University College London, United Kingdom:
Neuregulin signaling in early Schwann cell development.
J. Grinspan, Children's Hospital of Philadelphia, Pennsyl-
vania: Neuregulin as a survival factor for Schwann cells in
development peripheral nerve.
A. Mudge, University College London, United Kingdom:
Role of neuregulin in Schwann cell development.
J. Selzer, New York University Medical Center, New York:
Role of the neuregulins in the axonal-glial interactions of
myelination.
R.H. Miller, Case Western Reserve University, Cleveland,
Ohio: Role of neuregulins in the induction of oligodendro-
cyte precursors.
C.S. Raine, Albert Einstein College of Medicine, Bronx, New
York: Effect of neuregulins on autoimmune demyelination.
E. Anton, Yale University School of Medicine, New Haven,
Connecticut: GGf/neuregulin is a mediator of reciprocal
interactions between migrating neurons and radial glia in
the developing cerebral cortex.
G. Corfas, Harvard Medical School, Boston, Massachusetts:
Neuregulins in the developing cerebellum.
SESSION 4: Neuregulin Signaling at Synapses
Chairperson: A. Goodearl, Millennium Pharmaceuticals,
Inc., Cambridge, Massachusetts
W. Thompson, University of Texas, Austin: Neuregulins and
Schwann cells at the neuromuscular junction.
G.D. Fischbach, Harvard Medical School, Boston, Massachusetts:
Neuregulins at the neuromuscular junction.
S. Burden, New York University Medical Center, New York: NRG-
mediated signaling at neuromuscular synapses.
X. Yang, New York University Medical Center, New York: Regulation
of neuronal nAChR expression by neuregulins.
SESSION 5: Neuregulin Signaling in Sensory Systems and
New Ligands
Chairperson: C. Birchmeier, Max-Delbrueck-Centrum, Berlin,
Germany
J.T. Corwin, University of Virginia, Charlottesville: Neuregulins in the
sensory epithelia of the ear.
H. Chang, Stanford University School of Medicine, California:
Ligands for ErbB family receptors encoded by a newly character-
ized neuregulin-like gene.
C. Lai, The Scripps Research Institute, La Jolla, California: ErbB
receptor expression in the nervous system and neuregulin-2, a
novel neuregulin-like molecule.
M.A. Marchionni, Cambridge NeuroScience, Inc., Massachusetts:
Perspectives and summary.
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G. Lemke, S. Scherer
Finding Genes: Computational Analysis of DNA Sequences
March 23-26
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY
R. Gibbs, Baylor College of Medicine, Houston, Texas
P. Green, University of Washington, Seattle
J.-M. Claverie, CNRS, Marseille, France
SESSION 1: Overview
R.N. Waterston, Washington University, St. Louis, Missouri:
Challenges in genome sequencing interpretation.
J.-M. Claverie, CNRS, Marseille, France: Introductory talk on
SESSION 2: Computational Analysis
S. Karlin, Stanford University, California: Computational bias-
es in eukaryotic and prokaryotic genome sequences.
M. Borodovsky, Georgia Institute of Technology, Atlanta:
Statistical determinants of protein-coding regions in DNA
sequence.
M. Adams, The Institute for Genomic Research, Rockville,
Maryland: Use of constraints, consensus, and contradic-
SESSION 3: Signatures in DNA
S. Audic, CNRS, Marseille, France: Promoter detection in
mammalian DNA.
J.W. Fickett, SmithKline Beecham Pharmaceuticals, King of
Prussia, Pennsylvania: Eukaryotic promoter recognition:
Where do we stand?
M.O. Zhang, Cold Spring Harbor Laboratory: What do we
know about core promoters?
A. Smit, University of Washington, Seattle: Improving data-
base searches and gene prediction by identifying repeti-
practical methods for gene identification current concepts
and current problems.
tion in merging gene-prediction methods.
G.D. Stormo, University of Colorado, Boulder: New kinds of
information for DNA parsing.
A. Krogh, Technical University of Denmark, Lyngby: Hidden
Markov models for gene finding.
M. Gelfand, University of Southern California, Los Angeles:
Las Vegas algorithms for gene recognition.
tive and low-complexity DNA.
L. Hillier, Washington University, St. Louis, Missouri: Use and
interpretation of EST hits in gene prediction.
E.-C. Uberbacher, Oak Ridge National Laboratory,
Tennessee: Large-scale gene modeling with pattern
recognition and ESTs.
S. Banfi, Telethon Institute of Genetics & Medicine, Milan,
Italy: DRES: Drosophila-related expressed sequences.
SESSION 4: Comparisons of Computational and Experimental Gene Finding
A. Ansari-Lari, Baylor College of Medicine, Houston, Texas:
Large-scale sequencing in human chromosome 12p13:
Experimental and computational gene structure determina-
tion.
B.A. Roe, University of Oklahoma, Norman: Human and
bacterial genomic DNA sequence annotation.
SESSION 5: Gene Finding and Databases
W. Gish, Washington University, St. Louis, Missouri: Analysis
of human genomic sequence data at the GSC.
R. Durbin, Sanger Centre, Cambridge, United Kingdom:
Managing gene annotation for genomic sequencing pro-
jects.
R.A. Manning, Apo Com Inc., Oak Ridge, Tennessee:
Discovery tools for genomics.
E.M. Rubin, University of California, Berkeley: Computational
and biological results from the analysis of -700 kb of
genomic sequence from a megabase region at human
5q31.
Discussion: Testing computational models: Designing a
benchmark.
D. Haussler, University of California, Santa Cruz: Design of
the Genie Genefinder.
V. Solovyev, Amgen Inc., Thousand Oaks, California:
Sequence analysis by WWVV: From gene finding to struc-
ture prediction.
Summary: What Next?
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The Biology of BRCA1
April 2-4
FUNDED BY
National Cancer Institute, with additional support from Amgen Inc.
ARRANGED BY
M.-C. King, University of Washington, Seattle
D. Livingston, Dana-Farber Cancer Institute, Cambridge, Massachusetts
SESSION 1: Mutations in Breast Cancer
Chairperson: M.-C. King, University of Washington, Seattle
Opening discussion: Identifying the Key Questions.
Chairperson: E. Harlow, Massachusetts General Hospital Cancer
Center, Charlestown
A. Borg, University Hospital, Lund, Sweden: Biological and
genetic features of BRCA1 and BRCA2 tumors.
D. Haber, Massachusetts General Hospital Cancer Center,
Charlestown: Mutational analysis of BRCA1, BRCA2, and
ataxia telangiectasia in early onset breast cancer.
Discussion: Mutations in Breast Cancer.
A. Efstratiadis, Columbia University, New York, New York:
Phenotypes of BRCA1, BRCA2, BRCA1/BRCA2,
BRCA1/p53, and BRCA2 /p53nullizygous mouse embryos.
T. Mak, Ontario Cancer Institute, Toronto, Canada: BRCA1
and BRCA2 are required for embryonic cell proliferation.
SESSION 2: Biology of BRCA1
Chairperson: D. Livingston, Dana-Farber Cancer Institute, Cambridge,
Massachusetts
L.A. Chodosh, University of Pennsylvania School of
Medicine, Philadelphia: Role of BRCA1 in mammary
epithelial growth and differentiation.
P. Polakis, Onyx Pharmaceuticals, Richmond, California:
Response of the BRCA1 protein in cellular stress.
E. Solomon, UMDS-Guy's Hospital, London, United
Kingdom: Transcriptional regulation of BRCA1.
Discussion: Biology of BRCA1.
SESSION 3: BRCA1-Protein Interactions and Tumor Suppression I
Chairperson: D. Livingston, Dana-Farber Cancer Institute, Cambridge,
Massachusetts
R. Baer, University of Texas Southwestern Medical Center,
Dallas: Proteins that associate with the BRCA1 gene product.
F.J. Rauscher, The Wistar Institute, Philadelphia,
Pennsylvania: BAP-1, a novel enzyme that binds to the RING
finger of the BRCA1 gene product and exhibits properties of
a tumor suppressor.
11111111111.
Coffee break
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SESSION 4: BRCA1- Protein Interactions and Tumor Suppression
Chairperson: T. Mak, Ontario Cancer Institute, Toronto, Canada
C. Wilson, University of California, Los Angeles, School of
Medicine: Expression and subcellular localization of
BRCA1 and BRCA141 1 b.
D. Livingston, Dana-Farber Cancer Institute, Cambridge,
Massachusetts: Functional analysis of the BRCA1 gene
product.
J. Feunteun, Institut Gustave Roussy, Villejuif, France: Role
of BRCA1 in tumor suppression.
R. Jensen, Vanderbilt University School of Medicine,
Nashville, Tennessee: Mechanisms of tumor suppression
by BRCA1.
M.-C. King, University of Washington, Seattle: Possible
genetic mechanisms underlying the biology of BRCA1 in
sporadic tumors.
SESSION 5: BRCA1- Protein Interactions and Tumor Suppression III
Chairperson: E. Harlow, Massachusetts General Hospital Cancer
Center, Charlestown
J. Holt, Vanderbilt University School of Medicine, Nashville,
Tennessee: Tumor suppression by BRCA1.
S. Tavtigian, Myriad Genetics, Inc., Salt Lake City, Utah:
Predisposing mutations in BRCA1: Drawing connections
between protein-protein interactions and cancer risk.
SESSION 6: Discussion: What Don't We Know? Where Next?
Chairperson: E. Harlow, Massachusetts General Hospital Cancer Center,
Charlestown
Integrating Genetic, Biochemical, and Other Data in the
Postgenomics Era
April 6-9
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program, with additional support
from the National Cancer Institute
ARRANGED BY
M. Ashburner, University of Cambridge, United Kingdom
E. Harlow, Massachusetts General Hospital Cancer Center, Charlestown
P. Karp, SRI International, Menlo Park, California
SESSION 1
Chairperson: C. Sander, European Bioinformatics Institute,
Cambridge, United Kingdom
E. Harlow, Massachusetts General Hospital Cancer Center,
Charlestown: Opening remarks.
S. Letovsky, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Representation of gene function in
GDB.
M. Ashburner, University of Cambridge, United Kingdom:
On the representation of gene function in genetic data-
bases.
J.T. Eppig, The Jackson Laboratory, Bar Harbor, Maine:
De-fined vocabularies and functional/phenotypic classifi-
cations.
N. Maltsev, Argonne National Laboratory, Illinois:
Representation of function in the PUMA/WIT systems.
M. Kanehisa
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SESSION 2
Chairperson: M. Ashburner, University of Cambridge, United Kingdom
C. Sander, The European Bioinformatics Institute, Cam-
bridge, United Kingdom: Functional genome comparison.
A. Danchin, Institut Pasteur, Paris, France: Integration of
methodological knowledge and genetic knowledge.
P. Slonimski, Centre National de la Recherche Scientifique,
Gif-Sur-Yvette, France: Population genetics of genes within
genomes.
SESSION 3
Chairperson: A. Danchin, Institut Pasteur, Paris, France
M.L. Mavrovouniotis, Northwestern University, Evanston,
Illinois: Metabolic pathways.
P. Karp, SRI International, Menlo Park, California: A pathway
ontology is the key to computing with pathways.
R. Overbeek, Argonne National Laboratory, Illinois: WIT: A
SESSION 4
Chairperson: P. Karp, SRI International, Menlo Park, California
A. Zollner, Max-Planck-Institute for Biochemistry, Martinsried,
Germany: Functional categories of proteins (yeast
genome).
C. Ouzounis, The European Bioinformatics Institute,
S. Lewis, University of California, Berkeley: Issues in data
management for large-scale genomic analysis.
0. White, The Institute for Genomic Research, Rockville,
Maryland: Bacterial sequence annotation in high through-
put systems.
M. Fonstein, University of Chicago, Illinois
capsulatus genome project.
The Rhodobacter
system to support metabolic reconstruction.
E. Selkov, Argonne National Laboratory, Illinois: Genome
reconstruction: Methodology, status, and outlook.
M. Kanehisa, Kyoto University, Japan: From gene catalogs
to functional catalogs: The KEGG project.
Cambridge, United Kingdom: Representing and classify-
ing protein function.
M. Riley, Marine Biological Laboratory, Woods Hole, Massa-
chusetts: Functions of almost all E. coli gene products.
SESSION 5
Chairperson: L.T. Williams, Chiron Corporation, Emeryville, California
H. McAdams, Infernus, Stanford, California: What do we
have to know to model developmental decision points in
the cell?
J. Reinitz, Mount Sinai Medical School, New York, New York:
Circuitry from gene expression: Computational analysis of
segment determination in Drosophila.
S. Shaw, National Cancer Institute, National Institutes of
Health, Bethesda, Maryland: Strategies for efficiently har-
nessing the expertise of biologists in cumulative informa-
tion assembly: The PROW experiment.
J. Wagg, The Rockefeller University, New York, New York:
Computational tools for bridging the gap between molecu-
lar and integrative biology.
The Pathogenesis of NF1 and NF2: Therapeutic Strategies
July 14-17
FUNDED BY
The National Neurofibromatosis Foundation and The Wilson Foundation
ARRANGED BY
E. Casper, Memorial Sloan-Kettering Cancer Center, New York, New York
J. Gusella, Massachusetts General Hospital, Boston
D. Gutmann, Washington University School of Medicine, St. Louis, Missouri
B. Korf, Children's Hospital, Boston, Massachusetts
K. North, Royal Alexandra Hospital for Children, Parramatta, Australia
A. Rubenstein, Mt. Sinai School of Medicine, New York, New York
SESSION 1: Cognitive Function in NF1
Chairperson: K. North, Royal Alexandra Hospital for Children,
Parramatta, Australia
K. North, Royal Alexandra Hospital for Children, Parramatta, A. Bernards, Massachusetts General Hospital Cancer
Australia: Overview of cognitive deficit in NF1. Center, Charlestown: Genetic analysis of NF1 function in
P. Frankland, Cold Spring Harbor Laboratory: Molecular and Drosophila.
cellular mechanisms underlying the learning impairments Y. Zhong, Cold Spring Harbor Laboratory: Molecular basis
of NF1 mutant mice. of learning deficits in NF1 mutants.
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SESSION 2: Optic Glioma
Chairperson: D.H. Gutmann, Washington University School
St. Louis, Missouri
D.H. Gutmann, Washington University School of Medicine,
St. Louis, Missouri: Overview.
R. Listernick, Children's Memorial Hospital, Chicago, Illinois:
Clinical overview and natural history of pathway optic
glioma.
C.D. James, Mayo Foundation, Rochester, Minnesota:
Molecular genetics of astrocytomas.
A.J. Wong, Kimmel Cancer Institute, Philadelphia,
of Medicine,
Pennsylvania: Signal transduction in astrocytes and astro-
cytomas.
D.H. Gutmann, Washington University School of Medicine,
St. Louis, Missouri: Neurofibromin as a negative growth
regulator for astrocytes.
R.J. Packer, Children's National Medical Center, Washington,
D.C.: Chemotherapy and investigational drugs for optic
pathway gliomas.
SESSION 3: Neurofibroma
Chairperson: B.R. Korf, Children's Hospital, Boston, Massachusetts
B.R. Korf, Children's Hospital, Boston, Massachusetts: N. Ratner, University of Cincinnati College of Medicine,
Overview of neurofibromas in NF1. Ohio: Experimental systems.
D. Viskochil, University of Utah, Salt Lake City: Molecular T. Jacks, Massachusetts Institute of Technology, Cambridge:
genetics of neurofibroma. Mouse model.
J.B. Gibbs, Merck & Company, West Point, Pennsylvania: J.A. Epstein, University of Pennsylvania, Philadelphia:
Farnesyl transferase inhibitors. Cardiovascular defects in NF1-deficient mice.
F. Lieberman, Mt. Sinai Medical Center, New York, New York: L.F. Parada, University of Texas Southwestern Medical
Differentiation induction strategies for neuroectodermal Center, Dallas: Neurotrophin-independent survival of neu-
tumors. rons in the NF (-/-) mouse.
SESSION 4: Malignancy in NF1
Chairperson: E.S. Casper, Memorial Sloan-Kettering Cancer Center,
Denville, New Jersey
E.S. Casper, Memorial Sloan-Kettering Cancer Center,
Denville, New Jersey: Overview of malignancy in NF1.
A.I. Neugut, Columbia-Presbyterian Medical Center, New
York, New York: A critique of the association between neu-
rofibromatosis and sarcomas.
J. Woodruff, Memorial Sloan-Kettering Cancer Center, New
York, New York: Pathology of malignant peripheral nerve
SESSION 5: NF2
Chairperson: J.F. Gusella, Massachusetts General Hospital,
J.F. Gusella, Massachusetts General Hospital, Charlestown:
Overview.
V. Ramesh, Massachusetts General Hospital, Charlestown:
Cell biology of NF2 protein merlin.
R.G. Fehon, Duke University, Durham, North Carolina: Struc-
ture/function analysis of Drosophila merlin.
sheath tumors.
LH. Baker, University of Michigan Cancer Center, Ann Arbor:
The relationship of cafe au lait spots and sarcomas other
than neurofibrosarcoma.
K.M. Shannon, University of California, San Francisco:
Biologic and therapeutic studies in a murine model of
NF1-associated leukemia.
Charlestown
G. Thomas, Foundation Jean Dausset/CEPH, Paris, France:
Toward a mouse model for NF2.
M. Mac Collin, Massachusetts General Hospital, Charles-
town: Phenotype suppression using aminoglycoside antibi-
otics: A potential treatment for NF2.
Coffee break
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The Art of Judging: Perspectives of Science
October 14-17
FUNDED BY
The Federal Judicial Center, Judiciary Leadership Development Council,
and Cold Spring Harbor Laboratory
ARRANGED BY
J.A. Apple, The Federal Judicial Center, Washington, D.C.
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
D. Mick los, DNA Learning Center, Cold Spring Harbor
Laboratory: Cold Spring Harbor Laboratory and its place
in science.
SESSION 2
A.N.H. Creager, Princeton University, New Jersey: From
Darwin to Dolly: Developments in the biological sciences in
the 20th century.
D. Wilkinson, Princeton University, New Jersey: Life in an
inhospitable universe.
SESSION 3
M.D. Lemonick, Time Magazine, New York, New York: An
exploration of life.
J.A. Deddens, University'of Cincinnati, Ohio: Statistics and
SESSION 4
D. Wilkinson, Princeton University, New Jersey: Discussion
on new concepts of the universe.
SESSION 5
M. Gallo, Robert Wood Johnson Medical School,
Piscataway, New Jersey: Toxicology, the environment,
and risk assessment.
J.A. Witkowski, Banbury Center, Cold Spring Harbor
Laboratory: Human genetics: A look at the past.
SESSION 6
J.A.Witkowski, Banbury Center, Cold Spring Harbor
Laboratory: DNA and the Human Genome Project.
SESSION 7
R.M. Henig, Takoma Park, Maryland: Viruses and plagues:
The menace of the 21st century?
P. Reilly, Shriver Center of Mental Retardation, Waltham,
Massachusetts: Social implications of genetic research.
SESSION 8
L. Lederman, Fermi Laboratory, Chicago, Illinois: Great
issues in science; the challenge of the 21st century.
R. Henig, J. Apple, J. Witkowski, D. Boggs
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Immunological Attacks on Cancer
October 19-22
FUNDED BY
The Alexander and Margaret Stewart Trust
ARRANGED BY
B. Stillman, Cold Spring Harbor Laboratory
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: MHC and Antigen Processing
D.M. Pardoll, Johns Hopkins Oncology Center, Baltimore,
Maryland: Harnessing the cryptic universe of endogenous
antitumor T cells.
P.J. Lehner, Howard Hughes Medical Institute, Yale
University School of Medicine, New Haven, Connecticut: A
critical role for tapasin in the assembly of MHC class I
molecules.
L.L. Lanier, DNAX Research Institute, Palo Alto, California:
SESSION 2: Tumor Antigens
V.H. Engelhard, University of Virginia, Charlottesville:
Isolation and characterization of class -I- associated tumor
antigen peptides.
W. Zhou, The Johns Hopkins Oncology Center, Baltimore,
SESSION 3: Immune Regulation: Activation vs. Tolerance
H. Levitsky, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Peripheral tolerance to tumor anti-
gens.
G. Trinchieri, Wistar Institute, Philadelphia, Pennsylvania:
Interactions of innate and adaptive immunity in cancer
immunotherapy.
R.N. DuBois, Vanderbilt University Medical Center, Nashville,
Tennessee: Colorectal carcinogenesis and prevention:
Inhibitory receptors for MHC class I regulate immune
responses.
P.K. Srivastava, University of Connecticut School of
Medicine, Farmington: The case for uniqueness and pan-
valency.
R. Glas, Harvard Medical School, Boston, Massachusetts: A
nonproteasomal pathway for the generation of MHC class I
ligands in mouse tumor cells.
General Discussion: MHC and Antigen Processing
Maryland: Identifying tumor markers by looking at gene
expression.
S. Ladisch, Children's Research Institute, Washington, D.C.:
Shedding and immunosuppression by tumor ganglioside.
Underlying mechanisms. Immunomodulation by prosta-
glandins.
Gajewski, University of Chicago, Illinois: The role of cos-
timulation, cytokines, and Thl/Th2 differentiation in antitu-
mor immunity in vivo, and application for tumor antigen
immunization protocols in patients with melanoma.
J. Allison, University of California, Berkeley: The yin and yan
of T-cell activation.
B. Stillman, J. Allison
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SESSION 4: Immune Regulation: Activation vs. Tolerance II
C. Lieping, Mayo Clinic, Rochester, Minnesota: The role of T-
cell costimulators in the induction of tumor immunity
against tumor antigens.
O.J. Finn, University of Pittsburgh School of Medicine,
Pennsylvania: The importance of tumor-specific helper T
cells and examples of tolerance at the helper T-cell level in
case of tumor antigens that are also autoantigens.
Y. Hahn, University of Virginia Health Sciences Center,
SESSION 5: Vaccines
M.T. Lotze, University of Pittsburgh School of Medicine,
Philadelphia: Dendritic cells enhance effector mechanisms
in the immune response to cancer.
W.M. Kast, Loyola University of Chicago, Illinois: Vaccine
development against HPV-induced cervical cancer.
H. Kaufman, Albert Einstein College of Medicine, Bronx,
Charlottesville: Mechanism of immune evasion by tumori-
genic hepatitis C virus.
E. Gilboa, Duke University Medical Center, Durham, North
Carolina: Tumor RNA transfected dendritic cell vaccine:
Preclinical and clinical studies.
D.P. Carbone, Vanderbilt University Cancer Center,
Nashville, Tennessee: Mechanisms of dendritic cell dys-
function in cancer patients.
New York: Recombinant viral vaccines and adjuvants for
immunotherapy of human cancer.
R. Newman, IDEC Pharmaceuticals Corporation, San Diego,
California: Monoclonal antibodies: Evolution to mainstream
therapeutics.
J.P. Morgan & Co. Incorporated/Cold Spring Harbor Laboratory
Executive Conference on Genetic Engineering
October 24-26
ARRANGED BY
J.D. Watson, Cold Spring Harbor Laboratory
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
S. Cohen, Stanford University, California: Genetic engineering.
SESSION 2
J. Wells, Genentech, Inc., South San Francisco, California:
From bigger molecules to smaller ones.
S. Tilghman, Howard Hughes Medical Institute, Princeton
University, New Jersey: Exploring gene function in mice.
A. Colman, PPL Therapeutics plc, Edinburgh, Scotland,
United Kingdom: A tale of three sheep, Tracy, Dolly &
Polly: Implications for the biomedical uses of transgenic
livestock.
SESSION 3
S. Lowe, Cold Spring Harbor Laboratory: Oncogenes, tumor
suppressor genes, and chemosensitivity.
SESSION 4
K. Davies, University of Oxford, United Kingdom: Gene ther-
apy-genetic engineering in human beings.
R. Michelmore, University of California, Davis: The second
green revolution.
S. Fodor, Affymetrix, Inc., Santa Clara, California: Genes,
chips, and the human genome.
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P. Ringose, J. Witkowski, A. Colman, J. Watson
Molecular Immunobiology of Lyme Disease
November 2-5
FUNDED BY
Centers for Disease Control and Prevention, Food and Drug Administration,
Fort Dodge Animal Health, Glaxo Wellcome, Inc., Medlmmune, Inc., Pasteur
Merieux Connaught, and SmithKline Beecham Pharmaceuticals
ARRANGED BY
J.J. Dunn, Brookhaven National Laboratory, Upton, New York
S.E. Schutzer, UMDNJ-New Jersey Medical School, Newark
SESSION 1: Antigen Expression
Chairperson: M.T. Philipp, Tulane Regional Primate Research Center,
Covington, Louisiana
E. Fikrig, Yale University School of Medicine, New Haven,
Connecticut: Arthropod- and host-specific Borrelia gene
expression.
A. deSilva, Yale University School of Medicine, New Haven,
Connecticut: Borrelia gene expression and transmission
from ticks.
T.G. Schwan, Rocky Mountain Laboratories, NIAID, NIH,
Hamilton, Montana: Common themes in Borrelia proteins
SESSION 2: Diagnostics
Chairperson: B.J. Luft, State University of New York at Stony
. Ticehurst, ODE/CDRH/FDA, Rockville, Maryland: FDA
Public Health Advisory on assays for antibodies to B.
burgdorferi: Background/advice (2-step testing)/respons-
es/future.
M.E. Schriefer, DVBID, NCID, CDC, Ft. Collins, Colorado:
Diagnostic serology: Recommendations, performance,
future.
expressed in ticks.
S.E. Schutzer, UMDNJ-New Jersey Medical School, Newark:
In vivo expression of Borrelia antigens in cerebrospinal
fluid.
S.W. Barthold, University of California, Davis: Biologically rel-
evant antibody responses to B. burgdorferi antigens
expressed in vivo.
Brook
P.K. Coyle, State University of New York at Stony Brook:
Markers for neurological involvement.
A.E. Levin, Immunetics, Inc., Cambridge, Massachusetts:
Total automation of the two-step testing procedure for
Lyme antibodies: From esoteric procedure to routine clini-
cal lab test.
R.J. Dattwyler, State University of New York at Stony Brook
SESSION 3: Genetics
Chairperson: J.J. Dunn, Brookhaven National Laboratory, Upton,
New York
A.G. Barbour, University of California, Irvine: Analysis of
expression of OspA in bacterial and eukaryotic cells.
C.L. Lawson, Brookhaven National Laboratory, Upton, New
York: Structural analysis of B. burgdorferi outer surface
proteins A and B.
J. Radolf, University of Texas Southwestern Medical Center,
Dallas: Model systems for studying differential expression
of B. burgdorferi antigens.
P.A. Rosa, Rocky Mountain Laboratories, NIAID, NIH,
Hamilton, Montana: Gene activation by allelic exchange in
B. burgdorferi.
S. Bergstrom, Umea University, Sweden: OspH, a novel
chromosomally encoded outer-surface-exposed lipopro-
tein of Lyme disease Borrelia.
J. Dunn, P. Coyle
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SESSION 4: Immune Response
Chairperson: S.E. Schutzer, UMDNJ-New Jersey Medical School,
Newark
A.G. Steere, New England Medical Center, Boston,
Massachusetts: Phase III SmithKline Beecham Vaccine
Trial.
J.J. Weis, University of Utah School of Medicine, Salt Lake
City: The role of CD14 in signaling mediated by outer
membrane lipoprotiens of B. burgdorferi.
L.K. Bockenstedt, Yale University School of Medicine, New
Haven, Connecticut: T-cell regulation of murine Lyme
carditis.
M.T. Philipp, Tulane Regional Primate Research Center,
Covington, Louisiana: Is B. burgdorferi able to modulate
the inflammation it elicits?
J.L. Benach, State University of New York at Stony Brook:
Utilization of host proteases by Borrelia.
R.H. Jacobson, Cornell University, Ithaca, New York: Canine
cytokine responses to B. burgdorferi.
SESSION 5: Vaccines
Chairperson: W. Golde, State University of New York at Stony Brook
R.C. Huebner, Pasteur Merieux Connaught, Swiftwater,
Pennsylvania.
M. Hanson, Medlmmune, Inc., Gaithersburg, Maryland: B.
burgdorferi decorin binding protein A (DbpA) as a second
generation vaccine candidate.
J.N. Miller, University of California School of Medicine, Los
Angeles.
W. Zhong, Max-Planck-Institute fur Immunbiologie, Freiburg,
Germany: New strategies to vaccinate against Lyme dis-
ease.
SESSION 6: General Discussion
Chairperson: W. Golde, State University of New York at Stony Brook
SESSION 7: Mixed Infections
Chairperson: J.N. Miller, University of California School of Medicine,
Los Angeles
E. Hofmeister, Mayo Clinic, Rochester, Minnesota: Naturally
occurring coinfections in mammalian hosts.
E.M. Boller, State University of New York at Stony Brook:
Coinfection in ticks and
W. Golde, State University of New York at Stony Brook:
SESSION 8: Open Discussion
Chairperson: A.G. Barbour, University of California, Irvine
B.J.B. Johnson, Centers for Disease Control, Fort Collins,
Colorado
A.R. Marques, LCl/NIAID, Bethesda, Maryland
J. Soreth, U.S. Food and Drug Administration, Rockville,
Maryland
Multiple cases of human coinfection with three different
pathogens, Babesia, Ehrlichia, and Borrelia, transmitted by
Ixodes scapularis.
G.P. Wormser, Westchester County Center, Valhalla,
New York: HGE and Lyme disease coinfections.
Signal Transduction in Endothelial Cells
November 9-12
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY
D. Hanahan, University of California, San Francisco
F. McCormick, University of California, San Francisco
W. Risau, Max-Planck-Institut, Bad Nauheim, Germany
Introductory Remarks: D. Hanahan, University of California, San Francisco
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SESSION 1: The Big Picture: Endothelial Cell States and Their Regulators
Chairperson: J.M. Folkman, Children's Hospital, Boston, Massachusetts
W. Risau, Max-Planck-Institut, Bad Nauheim, Germany:
Overview of vasculogenesis, angiogenesis, and morpho-
genesis of endothelial cells for nonspecialists.
G.D. Yancopoulos, Regeneron Pharmaceuticals, Inc.,
Tarrytown, New York: Introduction to the major angiogene-
sis activators and their receptors (including FGFs, VEGFs,
HGF, IL-8, TGF-a, B61/Lerck1, and the angiopoeitins).
L. Holmgren, Karolinska Institute, Stockholm, Sweden:
Introduction to the major negative regulators of angiogene-
sis (including interferon, PF4, AGM1470, 16-kD prolactin,
angiostatin, and endostatin).
SESSION 2: Signal Transduction: Major Pathways, Latest Concepts
Chairperson: F. McCormick, University of California, San Francisco
M. Whitman, Harvard Medical School, Boston, Massa- signaling and overview of the jak/stat circuits.
chusetts: TGF-p signals. N. Tonks, Cold Spring Harbor Laboratory: Regulation by
N.C. Reich, State University of New York, Stony Brook: IFN phosphatases.
SESSION 3: Cell-Matrix and Cell-Cell Interactions
Chairperson: R.A. Weinberg, Whitehead Institute for Biomedical
Research, Cambridge, Massachusetts
D.A. Cheresh, The Scripps Research Institute, La Jolla,
California: Integrins controlling angiogenesis.
R.O. Hynes, Howard Hughes Medical Institute, Mass-
achusetts Institute of Technology, Cambridge:
Angiogenesis and vasculogenesis in a-v-null mice.
E. Dejana, Institute Mario Negri, Milan, Italy: Cadherins con-
trolling endothelial cell states.
SESSION 4: Endothelial Receptors
Chairperson: J. Rossant, Samuel Lunenfeld Research Institute,
Toronto, Canada
G.D. Yancopoulos, Regeneron Pharmaceuticals, Inc., W.A. Frazier, Washington University School of Medicine, St.
Tarrytown, New York: Inhibitory signals imparted by Louis, Missouri: TSP-1 and its receptors.
angiopoeitins. J. Liu, Massachusetts Institute of Technology, Cambridge:
C. Betsholtz, Goteborg University, Sweden: PDGF/PDGF-R The AGM1470 receptor.
control of pericytes.
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SESSION 5: Signaling Events in Endothelial Cells
Chairperson: W. Risau, Max-Planck-Institut, Bad Nauheim, Germany
E.F. Wagner, Research Institute of Molecular Pathology,
Vienna, Austria: src family kinases.
A. Zimmer, National Institute of Mental Health, National
Human Genome Research Institute, Bethesda, Maryland:
rafB signals in endothelial cells.
D. Falb, Millennium Pharmaceuticals Inc., Cambridge,
Massachusetts: Novel smads in endothelial cells.
R.I. Weiner, University of California, San Francisco: Signals
from the 16-kD prolactin receptor.
D. Linzer, Northwestern University, Evanston, Illinois:
Placental hormones sending angiogenic signals.
SESSION 6: General Discussion on the Integration of Positive and
Negative Signals in Endothelial Cells
Chairperson: D. Hanahan, University of California, San Francisco
M. Krasnow, Stanford University School of Medicine, mutants in zebrafish.
California: Genetic studies of signaling during branching Discussion: Mechanisms by which endothelial cells might
morphogenesis in the Drosophila tracheal network. integrate so many positive and negative signals; models
M.G. Fishman, Massachusetts General Hospital-East, and wild speculation.
Charlestown: Genetic screens for vascular patterning
Handedness and Symmetry in Development
November 16-19
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY
C. Tabin, Harvard Medical School, Boston, Massachusetts
L. Wolpert, University College London, United Kingdom
H.J. Yost, University of Utah, Salt Lake City
SESSION 1: Theories of Development of Asymmetry
Chairperson: H.J. Yost, University of Utah, Salt Lake City
L. Wolpert, University College London, United Kingdom:
Models for the generation of left/right asymmetry.
J. Frankel, University of Iowa, Iowa City: Hereditary hand-
edness in cell surface structural patterns of ciliates.
D.R. Mc Clay, Duke University, Durham, North Carolina:
Specification of symmetry in the sea urchin embryo.
SESSION 2: Human Behavioral Handedness I
Chairperson: H.J. Yost, University of Utah, Salt Lake City
I.C. McManus, University College London, United Kingdom:
Human handedness: Genetics, neurobiology, and evolu-
tion.
A.J.S. Klar, NCI-Frederick Cancer Research & Development
Center, Maryland: Tests of genetics and cultural models
for human handedness.
SESSION 3: Human Behavioral Handedness II
Chairperson: C. Tabin, Harvard Medical School, Boston,
Massachusetts
M.G. Corballis, University of Auckland, New Zealand:
Genetics and evolution of human handedness and cere-
bral asymmetry.
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SESSION 4: Heart Asymmetry
Chairperson: C. Tabin, Harvard Medical School, Boston,
Massachusettss
M.C. Fishman, Massachusetts General Hospital-East,
Charlestown: Genetic dissection of asymmetry in
zebrafish.
R.P. Harvey, Royal Melbourne Hospital, Victoria, Australia:
SESSION 5: Signals
Chairperson: L. Wolpert, University College London, United
H.J. Yost, University of Utah, Salt Lake City: The left-right
coordinator and the initiation of the left-right axis.
M. Mercola, Harvard Medical School, Boston, Massa-
chusetts: Role of Wnt-responsive signals.
C.V.E. Wright, Vanderbilt University School of Medicine,
Nashville, Tennessee: Xnr-1 and L-R determination in
Xenopus.
J. Cooke, National Institute for Medical Research, London,
Intrinsic control of heart asymmetry.
E.N. Olson, University of Texas Southwestern Medical
Center, Dallas: Regulation of heart handedness by hand
genes.
Kingdom
United Kingdom: The lateralized expression component of
the cSnR gene and its position in a putative cascade of L-
R information.
C. Tabin, Harvard Medical School, Boston, Massachusetts:
Transfer of left-right asymmetric positional information to
and from Hnesen's node in the chick embryo.
M. Levin, Harvard Medical School, Boston, Massachusetts:
Gap junctions and L-R asymmetry.
SESSION 6: Genetics I
Chairperson: E.J. Robertson, Harvard University, Cambridge,
Massachusetts
W.B. Wood, University of Colorado, Boulder: A gene affect-
ing initial establishment of handedness in C. elegans
embryos.
H. Hamada, Osaka University, Japan: The roles and tran-
scriptional regulation of lefty genes.
M. Brueckner, Yale University School of Medicine, New
Haven, Connecticut: L-R dynein: An axonemal dynein
SESSION 7: Genetics II
Chairperson: J. Burn, University of Newcastle, Newcastle upon
United Kingdom
B.M. Casey, Baylor College of Medicine, Houston, Texas:
Genetic aspects of situs inversus and other human L-R
axis malformations.
P.A. Overbeek, Baylor College of Medicine, Houston, Texas:
involved in L-R pattern formation in the mouse.
S.S. Potter, University of Cincinnati College of Medicine,
Ohio: Dyneins and L-R asymmetry in mice.
M.R. Kuehn, National Cancer Institute, Bethesda, Maryland:
Beyond iv and inv: Phenotypic and molecular analysis of
four additional mouse mutants with abnormal left/right
development.
Tyne,
YAC gene cure of the inv situs inversus mutation.
M. Penman Splitt, University of Newcastle, Newcastle upon
Tyne, United Kingdom: Human malformations associated
with disturbance of L-R asymmetry.
General Discussion
Chairperson: L. Wolpert, University College London, United Kingdom
Genetics of Parkinson's Disease
December 2-5
FUNDED BY
National Institute of Neurological Disorders & Stroke and National Human
Genome Research Institute
ARRANGED BY
Z.W. Hall, National Institute of Neurological Disorders & Stroke, Bethesda, Maryland
R.L. Nussbaum, National Human Genome Research Institute, Bethesda, Maryland
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SESSION 1: Synaptic Function and Biology of Synuclein I
Chairperson: Z.W. Hall, National Institute of Neurological Disorders &
Stroke, Bethesda, Maryland
Z.W. Hall, National Institute of Neurological Disorders &
Stroke, Bethesda, Maryland: Introduction.
T.C. Sudhof, University of Texas Southwestern Medical
Center, Dallas: Synaptic proteins, protein phosphorylation,
and the genetic analysis of synaptic functions.
P. DeCamilli, Yale University School of Medicine, New
Haven, Connecticut: Molecular mechanism in synaptic
vesicle endocytosis.
D.F. Clayton, University of Illinois at Urbana-Champaign:
Constraints on evolution and expression of synucleins:
Functional implications.
K. Nakaya, Showa University, Tokyo, Japan: The role of
phosphoneuroprotein 14 (p-synuclein) in neuronal forma-
tion and function.
J. George, University of Illinois at Urbana-Champaign: Lipid-
dependent changes in a-synuclein structure.
SESSION 2: Pathophysiology
Chairperson: M. Goedert, MRC Laboratory of Molecular Biology, Cambridge,
United Kingdom
M. Goedert, MRC Laboratory of Molecular Biology,
Cambridge, United Kingdom: Introduction.
M.G. Spillantini, University of Cambridge, United Kingdom:
a-synuclein in lewy bodies.
V.M.-Y. Lee, University of Pennsylvania, Philadelphia: a-
synuclein in lewy bodies in Parkinson's Disease and demen-
tia with lewy bodies.
A.L. Goldberg, Harvard Medical School, Boston, Massa-
chusetts: Functions of the ubiquitin proteasome pathway in
mammalian tissues in normal and diseased states.
SESSION 3: Genetics I
Chairperson: R.L. Nussbaum, National Human Genome Research Institute,
Bethesda, Maryland
R.L. Nussbaum, National Human Genome Research
Institute, Bethesda, Maryland: Genetic studies of
Parkinson's disease, an overview.
M.H. Polymeropoulos, National Center for Human Genome
Research, Bethesda, Maryland: Alpha synuclein and auto-
somal dominant Parkinson's disease.
Z.K. Wszolek, University of Nebraska Medical Center,
Omaha: Clinical assessment of Parkinson's disease and
parkinsonian-plus syndromes, genealogical investigations,
and longitudinal observations.
T. Gasser, University of Munich, Germany: Genetic linkage
and association studies Parkinson's disease: Evaluation of
candidate genes.
D.J. Selkoe, Brigham and Women's Hospital, Harvard Medi-
cal School, Boston, Massachusetts: Multiple genotypes
produce a common phenotype in Alzheimer's disease.
SESSION 4: Genetics II
Chairperson: R.L. Nussbaum, National Human Genome Research Institute,
Bethesda, Maryland
W. Scott, Duke University Medical Center, Durham, North
Carolina: Unraveling the complex etiology of Parkinson's
disease: Alzheimer's disease as a model.
R.H. Myers, Boston University School of Medicine,
Massachusetts: Contrasting the genetic component in
Parkinson's disease with that of Alzheimer's disease.
L. Ozelius, Massachusetts General Hospital, Charlestown:
Identification of a gene for early-onset dystonia.
SESSION 5: Models
Chairperson: D.L. Price, The Johns Hopkins University School of Medicine,
Baltimore, Maryland
J.Q. Trojanowski, University of Pennsylvania. Philadelphia: A.Y. Chiu, City of Hope Medical Center, Duarte, California:
NFH-LacZ transgenic mouse with lewy body-like inclu- Motor neurons are more vulnerable to injury in a trans-
sions show increased behavioral deficits following brain genic mouse model of familial amyotrophic lateral sclero-
trauma. sis.
D.L. Price, The Johns Hopkins University School of P.H. St. George-Hyslop, University of Toronto, Ontario,
Medicine, Baltimore, Maryland: Transgenic models of neu- Canada: Genetic models of human neurodegenerative dis-
rodegenerative disease. ease.
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Human Cognition and How It Fails
December 7-10
FUNDED BY
The John A. Hartford Foundation
ARRANGED BY
A. Baddeley, University of Bristol, United Kingdom
D.L. Price, Johns Hopkins University School of Medicine, Baltimore, Maryland
T. Tully, Cold Spring Harbor Laboratory
SESSION 1: Dynamics of Memory Formation
Chairperson: Y. Dudai, Weizmann Institute of Science, Rehovot,
A. Baddeley, University of Bristol, United Kingdom:
Working memory deficits in normal aging and Alzheimer's
disease.
C.K. Rovee-Collier, Rutgers University, Piscataway, New
Jersey: Dissociations in infant memory.
K. Thoroughman, Johns Hopkins University, Baltimore,
Maryland: Human motor memory processes.
Israel
Y. Dudai, Weizmann Institute of Science, Rehovot, Israel:
Dynamics of memory formation: The unique case of taste.
D.B. Willingham, University of Virginia, Charlottesville: A
neuropsychological theory of motor skill learning.
T.J. Carew, Yale University, New Haven, Connecticut:
Temporally and mechanistically distinct phases of constitu-
tive PKA activity in Aplysia sensory neurons.
SESSION 2: Structure of Memory Formation
Chairperson: J.P. Aggleton, University of Wales, Cardiff, United Kingdom
L.R. Squire, Veterans Administration Medical Center, San
Diego, California: Memory and the hippocampal formation.
M. Mishkin, National Institute of Mental Health, Bethesda,
Maryland: Hierarchical organization of cognitive memory.
J.P. Aggleton, University of Wales, Cardiff, United Kingdom:
Dissociating aspects of event memory.
P.S. Goldman-Rakic, Yale University School of Medicine,
New Haven, Connecticut: Domain-specific and receptor-
specific aspects of working memory.
A.P. Shimamura, University of California, Berkeley: Role of
the prefrontal cortex in human memory and cognition.
SESSION 3: Disruption/Enhancement of Memory Formation
Chairperson: E.R. Kandel, Columbia University, New York, New York
H.P. Davis, University of Colorado, Colorado Springs:
Changes in declarative memory, nondeclarative memory,
and frontal lobe functioning across the life span.
P.W. Landfield, University of Kentucky College of Medicine,
Lexington: Neurobiology of memory impairment with
aging: Implications for organization of memory.
Y. Stern, Sergievsky Center, Columbia University, New York:
Understanding individual differences in memory perfor-
mance in normal aging and Alzheimer's disease: Reserve
and compensation.
A.R. Mayes, University of Sheffield, United Kingdom: The
specific effects on memory of hippocampal lesions and
the amnesia syndrome.
T. Tully, Cold Spring Harbor Laboratory: Genes, memory,
and rest.
E.R. Kandel, Columbia University, New York, New York:
Memory suppressor genes in the hippocampus.
D. Price, K. Hsiao, R. Mayeux
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SESSION 4: Memory Dysfunction
Chairperson: Tim Tully, Cold Spring Harbor Laboratory
A. Silva, Cold Spring Harbor Laboratory: Gene targeting: A
tool to unravel mechanisms of learning and memory.
D.L. Price, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Animal models of aging and
Alzheimer's disease.
R. Mayeux, Columbia University, New York, New York:
Genetic epidemiology of Alzheimer's disease and related
disorders.
J. Gabrieli, Stanford University, California: Roles for pre-
frontal cortex in episodic memory.
M.S. Albert, Massachusetts General Hospital, Charlestown:
The boundary between aging and Alzheimer's disease.
SESSION 5: Memory Models
Chairperson: J.H. Byrne, University of Texas Medical School at Houston
K. Hsiao, University of Minnesota, Minneapolis: Behavioral J.H. Byrne, University of Texas Medical School at Houston:
deficits and electrophysiological abnormalities in trans- Insights into the neural mechanisms of operant condition-
genic mice overexpressing the Alzheimer amyloid precur- ing: The neglected form of associative learning.
sor protein. S. Dehaene, INSERM U-334, Orsay, France: A neuronal
A. Sailer, The Salk Institute for Biological Studies, La Jolla, model for the role of prefrontal cortex in evaluation and
California: Functional analysis of kainate receptors using planning.
gene targeting.
SESSION 6: Closing Discussion: What are the critical next experiments
for memory research?
Moderator: T.J. Carew, Yale University, New Haven, Connecticut
Molecular and Genetic Approaches to Transport in Plants
December 14-17
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY
J.I. Schroeder, University of California, San Diego, La Jolla
M.R. Sussman, University of Wisconsin, Madison
SESSION 1: Nitrogen Nutrition in Plants
Chairperson: A. Goffeau, University of Louvain, Belgium
W.-B. Frommer, Universitat TObingen, Germany: Molecular
biology of nitrogen uptate.
N. Crawford, University of California, San Diego, La Jolla:
Recent advances in nitrate uptake.
S.D. Tyerman, Flinders University of South Australia,
Adelaide: Ammonium exchange across symbiotic mem-
brane and aluminum-activated anion channel.
D.P.S. Verma, Ohio State University, Columbus: Regulation
of nitrogen assimilation in root nodules.
A.D.M. Glass, University of British Columbia, Vancouver,
Canada: Nitrogen absorption by plant roots: Regulation of
fluxes.
G. Coruzzi, New York University, New York: Arabidopsis
mutants define rate-limiting steps in nitrogen assimilation
into N-transport amino acids.
SESSION 2: Proton Pumps
Chairperson: J.I. Schroeder, University of California, San Diego, La Jolla
M.R. Sussman, University of Wisconsin, Madison: Proton
pumps and K+ channel knockouts.
A. Goffeau, University of Louvain, Belgium: Functional
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expression of plant membrane proteins in yeast.
C. Slayman, Yale University School of Medicine, New Haven,
Connecticut: H+ ATPases.
D. Hilgemann, C. Slayman, D. Sanders
SESSION 3: K+ Nutrition and Na+ Stress I
Chairperson: R.F. Gaber, Northwestern University, Evanston, Illinois
H.J. Bohnert, University of Arizona, Tucson: Potassium trans-
port and water uptake in relation to plant salinity tolerance.
E.J. Kim, University of California, San Diego, La Jolla:
Characterization of novel potassium transporters in plants.
D. Sanders, University of York, United Kingdom: Monovalent
cation transport: K+ nutrition and salinity tolerance.
SESSION 4: K+ Nutrition and Na+ Stress II
Chairperson: C. Slayman, Yale University School of Medicine, New Haven,
Connecticut
D. Hilgemann, University of Texas Southwestern Medical
School, Dallas: Study of membrane transports in giant
membrane patches.
J.-K. Zhu, University of Arizona, Tucson: Mutational analysis
SESSION 5: Sucrose, Glucose: Sensing and Transport I
Chairperson: G. Coruzzi, New York University, New York
Gaber, Northwestern University, Evanston, Illinois:
Glucose sensing and signaling in budding yeast.
J.-Y. Sheen, Massachusetts General Hospital, Boston: Sugar
SESSION 6: Sucrose, Glucose: Sensing and Transport II
Chairperson: W.-B. Frommer, Universitat TObingen, Germany
D.R. Bush, University of Illinois, Urbana: Sucrose and
amino acid transporters: Recent advances in defining
their structure and regulation.
of salt tolerance and osmotic signal transduction in
Arabidopsis thaliana.
E.P. Spalding, University of Wisconsin, Madison:
Electrophysiological analysis of K+ channel knockouts.
sensing and signaling in plants.
W. Tanner, University of Regensburg, Germany: Structure-
function analysis of hexose/H+-symporters.
SESSION 7: Micronutrients and Heavy Metal Transport
Chairperson: J.A.C. Smith, University of Oxford, United Kingdom
D.W. Ow, USDA-Plant Gene Expression Center, Albany,
California: Heavy metal transport and sequestration.
Stephan Clemens, University of California, San Diego: A
plant Ca" and heavy metal transporter.
M.L. Guerinot, Dartmouth College, Hanover, New
Hampshire: Characterization of a new family of metal
transport proteins.
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SESSION 8: Whole-plant Metal Transport and Tolerance
Chairperson: M.L. Guerinot, Dartmouth College, Hanover, New
Hampshire
J.A.C. Smith, University of Oxford, United Kingdom: Metal
transport and accumulation.
L. Herrera-Estrella, Centro de Investigaciones y Estudios
Avanzados, Guanajuato, Mexico: Genetically engineered
tolerance to aluminum toxicity.
J. Harper, The Scripps Research Institute, La Jolla,
California: Cadmium and calcium pumps.
SESSION 9: Phosphate and Root-Soil Interactions
Chairperson: A.D.M. Glass, University of British Columbia, Vancouver,
Canada
M. Harrison, The Samuel Roberts Noble Foundation, Inc.,
Ardmore, Oklahoma: Two phosphate transporters from M.
truncatula roots: Regulation of expression in response to
phosphate and to colonization by arbuscular mycorrhizal
fungi.
D. Shibata, Mitsui Plant Biotechnology Research Institute,
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Ibaraki, Japan: Overexpression of an Arabidopsis thaliana
high-affinity phosphate transporter gene in tobacco-cul-
tured cells enhances cell growth under phosphate-limited
conditions.
P. Doerner, The Salk Institute for Biological Studies, La Jolla,
California: Cell division control and nutrient availability.
DNA LEARNING CENTEF

DNA LEARNING CENTER
David A. Mick los
Judy Cumella Korabik
Mark V. Bloom
Scott Bronson
Michael Greenberg
Joan Alexander
Malissa Hewitt
Patricia Harrison
Andrew Morotti
John A. Kruper
Susan Lauter
Shirley Chan
As John Houseman once stated in a Smith-Barney ad, "We make our money
the hard way, we earn it." In our case, this means living primarily on the "soft"
money provided by gifts and grants. In this lifestyle, we come to value bene-
factors who appreciate one's work before it is well known and who provide
funding without the usual requirements for detailed reporting. Invariably, the
people who practice such "agape" giving become friends and mentors.
This summer, we mourned the death of one such special friend-Mary
Jeanne Harris. She was that rare woman one meets in life who can be consid-
ered in the same league as one's own mother. She was organized and knew
how to get things done. She had a certain can-do sensibility, which likely came
from a traditional Midwest upbringing. When something was not getting done,
she would jump in and do it herself.
Mary Jeanne and her husband Henry were the DNA Learning Center's
(DNALC's) first benefactors, and, in a real sense, we owe our careers to them.
In the fall of 1987, Mary Jeanne was on the trustee committee that was
involved with the Laboratory's new training program for high school teachers.
We were all fretting over taking an initial 6 months' lease of the old elementary
school building in Cold Spring Harbor to use as a base of operations for our
educational programs. Of course, we had no money for such an undertaking
and were not even sure in our hearts that it would really work. Everyone knew
the risk. Still, we needed $40,000 to move into the building. The weekend after
this had been discussed in committee, Mary Jeanne phoned Dave Mick los
from a golf outing in Texas to say that she and Henry would donate the first
$10,000 toward the initial lease. The DNA Learning Center opened the follow-
ing year.
On another occasion in 1989, Dave was struggling to find a little quiet time
to finish up a textbook he had been working on for several years with our col-
league Greg Freyer. In the fall, they were under fairly strict publication dead-
lines and just could not get the writing done in New York. Mary Jeanne sug-
gested a "mini-sabbatical" at Henry's family farm on Squam Lake in New
Hampshire. Of course, they agreed immediately and were captivated to find
themselves on the "Golden Pond" of movie fame. Between morning and after-
noon writing sessions, there was ample time for jogging amid the splendid fall
foliage, antiquing, and listening to otherworldly calls of the resident loons. It
was an incredibly productive week, during which the bulk of eight chapters
were drafted. DNA Science was published the following year.
In 1991, Mary Jeanne and Henry funded an architectural study and made
the lead gift toward construction of an addition to the DNA Learning Center.
That project has taken longer to percolate, but prospects now are very good
for construction to begin in 1998. It makes us terribly sad to think that Mary
Dave Mick los and Mary Jeanne
Harris (left), listen to Dr. James
Watson at the DNA Learning
Center's dedication ceremony in
September 1988.
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Jeanne will not see the fruition of this project, which will further secure our
unique place in American science education. Her death has made us feel more
vulnerable in many ways, and we worry that it may be a very long time, indeed,
before we find another friend of her stature.
Preparing for an Enlarged Facility
In May, we learned that the Dolan Family Foundation had provided a $1 million
grant in support of a 6000 square-foot Bio Media Addition to the DNALC. The
Dolan support adds to the lead grant of $50,000 from the Harris Trust and
$400,000 in tax-exempt funding from the Suffolk County Industrial Development
Corporation. Conceptual design was completed, with plans to begin construc-
tion late in 1998. We are currently seeking an additional $1.5 million to complete
construction and to purchase laboratory, computer, and video equipment.
Bio Media expresses our goal to explore the creative use of computer and
telecommunications technology in modern biology education. The focal points
on the main level will be an octagonal multimedia computer laboratory, and a
new exhibit gallery containing a Visible DNA Sequencing Laboratory. The
Bio Media Addition, and reconstruction of existing space, will create a suite of
three teaching laboratories and a student research laboratory, which will allow
students to move effortlessly between hands-on science and multimedia com-
puter experiences. A lunchroom and rest rooms are practical elements needed
to deal with our ever-increasing number of visitors. The upper level will feature
a video studio/production suite and multimedia conference room:Staff offices
will be located on the upper and lower levels, according to function.
The facilities in the Bio Media Addition will allow us to capitalize on $1.75
million in program grants received this year (described in following sections),
which will make the DNALC one of the largest Internet providers of multimedia
learning materials for biology education. By pairing high-level computation with
video production, we will be able to explore the "convergence" of CD/ROM,
video, broadcast, and cable media. Equipment for videoconferencing will pro-
vide leverage for the DNALC's unique instructional resources, including the
Laboratory's unparalleled pool of resident and visiting scientists. Distance
learning will allow us to provide seminars, laboratory training, and follow-up
support to many more schools than we can reach by traditional instructional
methods. A streaming audio/video server will allow us to incorporate videocon-
ference materials into our Internet site, along with content from commercial
broadcast and cable sources.
In addition to allowing us to capitalize on new opportunities, the Bio Media
Addition offers the only solution to very serious space limitations in our existing
facility. Although lab instruction was increased by over 30% in the 1997-1998
academic year, there is no possibility for any further increase in the existing
building. The DNALC staff has grown from 9 positions in 1996 to 15 positions in
1998-a 67% increase. The current staff offices, located in the basement, have
become so cramped that it is more and more difficult to maintain a high level of
morale and productivity. We do not have reasonable workspaces for several
additional staff we are currently recruiting to fulfill contractual obligations on
new grants.
The Bio Media expansion is in line with the current effort to develop com-
mercial biotechnology on Long Island. Since its inception in 1988, the DNALC
has helped develop the science-literate workforce and informed constituency
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needed to support a biotechnology industry. Because of the on-site and out-
reach programs of the DNALC, Long Island ranks alongside the San Francisco
Bay area as the world leader in advanced biotechnology education. The
DNALC remains the nation's largest single provider of biotechnology lab
instruction at the precollege level. The DNALC and teaching faculty it has
trained provide lab experiences to thousands of local students each year.
Students introduced to biotechnology in area schools are now pursuing
advanced degrees in science, doing basic biological research, and assuming
roles as opinion leaders in nonscience fields.
Creating the First On-line Genetics "Text"
In November, we received a 3-year grant of $820,000 from the Josiah Macy, Jr.
Foundation to develop an extensive Internet site for genetics education. The
first element to be developed will be DNA From the Beginning, an animated
"primer" to provide background information on classical genetics, DNA and
protein structure, the genetic code and protein synthesis, DNA mutations and
polymorphisms, and gene mapping and cloning. The primer will make exten-
sive use of multimedia animation, which can enliven unseen molecular events
and involve young people accustomed to video games. This component will be
the world's first on-line, animated genetics "text." The second element to be
developed, Gene Almanac, will be an animated "encyclopedia" of genetic
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disorders. The object will be to provide detailed information on diseases for
which causative or predisposing genes have been identified, including current
status of DNA diagnosis and treatments. Reviewed links will direct interested
users to research news, patient support groups, clinical trials, and gene/protein
sequences.
The Macy project was envisioned by CSHL President James Watson, who
for three decades has sought mechanisms to disseminate information on
genetics. Several of his works revolutionized science publishing: The Double
Helix (1968) was the first popular account of the process of scientific discovery,
as well as a critical and commercial success. Molecular Biology of the Gene
(1965) was the first college text in molecular genetics. Molecular Biology of the
Cell (1983) was the first "super-text" unifying cell and molecular biology. During
Dr. Watson's tenure, the CSHL Press has evolved into a major book and journal
publisher. Now, Dr. Watson sees the Internet as the next important channel
through which to broadly encourage genetic literacy.
It is especially appropriate that the Macy Foundation should support this
project. Lead support from the Macy Foundation in 1987 provided core staff
funding needed to expand laboratory programs to utilize the new DNALC facili-
ty, which opened in 1988. Now, a decade later, Macy funding will catalyze a
new program to effectively utilize facilities in the BioMedia Addition. Initial Macy
funding allowed us to demonstrate new laboratory methods in science educa-
tion; the next generation of funding will allow us to lead development of the
Internet as an effective tool in science education.
Creating a Multimedia Communications Group
For several years, we have been involved in the applications of computer tech-
nology in education. A key collaboration with John Kruper, at the
University of Chicago, allowed us to incorporate custom computer elements into
our program to popularize the educational use of human DNA fingerprinting.
With funding from the Howard Hughes Medical Institute, we worked with John's
computation group to develop an educational thermal cycler and Internet-
accessible database for Alu insertion polymorphisms. The receipt of large-scale
support from the Macy Foundation provided the impetus to create the multime-
dia communications group we have dreamed about for several years. Thus, we
were overjoyed when John arrived in November to head the new BioMedia
Group.
John has been a close collaborator since 1987, when he spent several
summers here as a graduate intern and based part of his doctoral thesis on
our longitudinal survey of Vector Workshop participants. We first tried to recruit
John in 1991, but our offer was bettered by the University of Chicago, where he
stayed until 1996 as Director of Academic Computing for the Biological
Sciences Division. While at Chicago, he oversaw the development of a pur-
pose-built computer center, a server system for faculty and students, and over
$4 million in grant-funded projects. As Director of Educational Computing at
Allegheny College (1996-1997), he wrote and began to implement a strategic
plan for a campus-wide shift to modern distributed computing.
Also arriving in November was Shirley Chan, who will be the content
expert and primary author of DNA From the Beginning and Gene Almanac.
Shirley had just received her doctorate from the Department of Molecular and
Medical Genetics at the University of Toronto, where she worked in the labora-
tory of Joseph Culotti. Her thesis research on the cloning of the unc-40 gene in
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C. elegans was published in the journal Cell. Despite this early success in
research, Shirley desired a position that combined science with her avocation
of creative writing. The fact that she developed a demonstration Internet site on
genetics education was evidence to us of her intent. Appropriately enough, we
located Shirley through an advertisement on the Internet.
This nucleus team is rounded out by Creative Director Susan Lauter, who
has been with the DNALC since its inception. Over the years, Susan has
become a world-class computer animator and scientific illustrator. Sue joined
the Laboratory in 1985 as an undergraduate photography intern in the public
affairs and development office. She joined the full-time staff after receiving her
bachelor's degree in fine arts from The Cooper Union. Sue is among the first
generation of computer designers, now working almost exclusively in digital
media. She computer-rendered over 200 pieces of artwork for the textbooks
DNA Science (1990) and Laboratory DNA Science (1995) and has developed
numerous interactive computer tutorials. She led development of the DNALC's
Internet site and the early deployment of on-line Shockwave animations in 1996.
Moving Biology Education into the Genome Era
During the past several years, we have worked to develop an accurate analog
of human genome research that allows students to learn about science in the
same way as do modern scientists. We advocate that students experimentally
determine their own DNA polymorphisms ("fingerprints"), then use Internet
computer resources to analyze and share results. This approach received con-
siderable support in 1997.
At the beginning of the year, we received a 3-year grant of $335,000 from
the Department of Energy (DOE) for a nationwide training program, The Science
and Issues of Human DNA Polymorphisms. This 3-day workshop introduces
high school biology faculty to a laboratory-based unit on human DNA polymor-
phisms, which provides a uniquely personal perspective on the science and
Ethical, Legal and Social Implications (ELSI) of the Human Genome Project. By
targeting motivated biology faculty who currently perform student laboratories
with viral and bacterial DNA, this program offers a cost-effective means to bring
high school biology education up to the minute with genomic biology.
Between October and December, we instructed the first of 12 workshops
nationwide at Mt. Sinai School of Medicine (New York), Boston University
School of Medicine (Massachusetts), and Canada College (California). Each
workshop mixed theoretical, laboratory, and computer work with practical and
ethical implications. Program participants learned simplified lab techniques for
amplifying two types of chromosomal polymorphisms-an A/u insertion and a
VNTR (D1S80). These polymorphisms illustrate the use of DNA variations in
disease diagnosis, forensic biology, and identity testing and provide a starting
point for discussion of the uses and potential abuses of genetic technology.
At mid-year, we received a $600,000 grant from the National Science
Foundation (NSF) for a 3-year program to develop and disseminate advanced
technology units on genomic biology. This project is funded by the Advanced
Technological Education (ATE) Program, which focuses on improving technical
education in high schools and 2-year colleges. Operating under a direct con-
gressional mandate, the ATE program aims to ensure U.S. competitiveness in
emerging technologies of the 21st century.
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The ATE Project made a strong start with a workshop held at Cold Spring
Harbor on June 23-28 to bring together DNALC staff with staff from project
partners at the Center for Occupational Research and Development (CORD, of
Waco, Texas) and members of a national Editorial Advisory Board:
Lesli Adler, Thomas S. Wooton High School, Rockville, MD
Clint Brown, Thomas S. Wooton High School, Rockville, MD
Ginny Brown, Winston Churchill High School, Potomac, MD
Dee Dee Glassett, Merced College, Merced, CA
John LaPolla, Stuyvesant High School, New York, NY
Robert McKown, James Madison University, Harrisonburg, VA
Jean McLain, Wilson Technological Center, Dix Hills, NY
Kum Kum Prabhakar, Nassau Community College, Garden City, NY
Judy Price, Montgomery County Public Schools, MD
Gary Sarinsky, Kingsborough Community College, Brooklyn, NY
Janet Shagam, TVI Community College, Albuquerque, NM
Jerry Watkins, Central Islip High School, Central Islip, NY
The project team reviewed prototype lab materials to be included in the
technology that represents a continuum of modern methods of gene identifica-
tion and analysis. The units stress fundamental themes of evolutionary similarity
and individual variation in genetic information. Comparative genomics and evo-
lutionary biology are illustrated by computer manipulations of gene databases,
including on-line projects using student-generated data, as well as data from
DNA/protein databases. The high school unit focuses on length polymorphisms
in human DNA and human population genetics, and articulates with CORD's
nationally used curriculum Applications in Biology/CheMistry (ABC). The col-
lege unit analyzes human sequence polymorphisms in mitochondrial DNA, as
well as polymorphisms in plants. One experiment examines how CSHL
researchers use the Ds transposon (discovered by Barbara McClintock) to
"tag" genes in the model plant Arabidopsis. Another shows the molecular basis
of Mendel's wrinkled seed trait in peas. Following a year of development and
testing, the Genomic Biology units will be introduced to 216 faculty at training
institutes held at eight sites nationwide.
The project will be guided by a national mail survey that will reach a pur-
posive sample of 12,000 high school biology teachers-equal to about one
fourth of all such faculty in the U.S. This survey should give us the first careful
measure of the number of high school students who participate in hands-on
DNA labs. These students are the logical targets for Genomic Biology units.
Improving PCR for the Classroom
With support from DOE and NSF, we made significant biochemical modifica-
tions that will make it much easier for teachers to bring human PCR into high
school and college classrooms.
We optimized the DNA extraction protocol from hair follicles, thus removing
the potential objection to using cheek scrapings or saliva as a cell source for
human DNA typing. For several years, we have advocated isolation of DNA
from buccal cells obtained by saline mouthwash and Chelex extraction as the
most reproducible method for isolating human template DNA for PCR amplifi-
cation. Other educational groups advocate the use of buccal cells obtained by
cheek scraping. Although noninvasive, both methods have the disadvantage of
being perceived as "body fluids" potentially harboring pathogens; some school
districts prohibit the use of buccal cells in student experiments. Overall, hair
preps are about 10% less effective than mouthwash. Many people believe
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the root to be a good source of DNA, but we have found that reproducible DNA
recovery is, in fact, most highly correlated with the presence of a sheath. This
structure is a bundle of several thousand squamous cells, which surround the
hair shaft above (and usually separate from) the root. Brief incubation with pro-
teinase K, followed by boiling with Chelex, disrupts the sheath membrane,
releasing small groups of squamous cells that are readily lysed by boiling. Both
sheath cells and hair shaft have mitochondria, making hair an ideal source of
DNA for sequencing the mitochondrial control region.
We optimized PCR reaction conditions for Pharmacia "Ready-to-Go-
Beads," which incorporate Taq polymerase in a dried bead. Each bead comes
in its own reaction tube and is stable at room temperature. Use of Ready-to-Go
Beads simplifies set up of PCRs, ensures reagent consistency, and reduces
contamination. Primers and DNA template (from buccal or hair cells) are simply
added to the beads. As another time saver, we incorporate the loading dye
cresol red into the primer mix. This has no effect on PCR amplification and
saves the step of adding loading dye prior to loading samples in an agarose
gel.
We have synthesized new primers that amplify Alu alleles of approximately
500 by and 800 bp, as compared to the 100- and 400-bp alleles we have ampli-
fied in the past. These larger alleles stain reproducibly with methylene blue (as
well as with ethidium bromide). The larger alleles can be resolved in a lower per-
centage agarose gel (1.2% vs. 2.0%), reducing cost and staining time.
Our several-year effort to develop and disseminate an inexpensive DNA
thermal cycler culminated in February with receipt of a license from PE Applied
Biosystems to distribute the Biogenerator as an "authorized thermal cycler for
PCR." This is, to our knowledge, the first thermal cycler specifically licensed for
educational use. Although the Biogenerator is clearly a "Rube Goldberg" appa-
ratus, it gives results comparable to commercial machines, and its open design
allows students to better understand the process of thermal cycling. In antici-
pation of scaling up to the first production run of 100 machines, in October, we
invested in a custom-printed circuit board for the key analog-digital controller.
By year's end, we had sold 43 Biogenerators, through the DNALC Internet site
and to distributor Carolina Biological Supply Company.
Sequencing Mitochondria! DNA
In collaboration with staff at the CSHL Arabidopsis Genome Sequencing Center,
run by Dick McCombie, we developed reliable methods for generating mitchon-
drial (mt) DNA sequences from cheek and hair cells. Sequencing the variable
"control region" proved an immense hit at a June workshop for members of the
advisory board of our NSF Advanced Technological Education program. This
technology proved readily reproducible at teacher workshops presented by
Dave Mick los in Great Britain during the month of September. Two-day work-
shops were conducted at the University of Edinburgh, the University of Newcas-
tle, and the Sanger Center at Hinxton Hall. Dave also gave a special lecture,
"Cloning the DNA Classroom" at the London headquarters of the Wellcome Trust,
which was the primary sponsor of the "tour." The enthusiastic response to
mtDNA sequencing abroad encouraged us to immediately introduce this new
technology at teacher-training workshops conducted under our DOE grant.
Although several educational groups have programs in student DNA
sequencing, these focus on hand-sequencing of unknown sequences.
Conversely, our program focuses on the student's own DNA sequence,
devoped from colorimetric sequencing, as an entree to modern bioinformatics.
John Kruper speaks to
Editorial Advisory Board at
June workshop.
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In this example, the on-line
sequence analysis tutorial
was used to compare
modern human mitochon-
drial DNA sequence with
Neanderthal DNA.
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We advocate a system where an initial PCR amplification and dye labeling
reactions are done in class (a several-hour commitment). Then, the ready-to-
sequence DNAs are sent to regional centers for sequencing. Under our new
NSF program, we are developing a model Sequencing Service, which will
develop student sequences and post the results via Internet.
Experience gained in generating mtDNA sequence for more than 125
teachers at the Wellcome Trust and DOE workshops has demonstrated the fea-
sibility of the Sequencing Service. We can obtain clean sequence from about
80% of buccal and hair samples; we are testing reagent modifications that can
potentially put us within our projected total cost of $3.00 per sequence.
Although we are currently using an Applied Biosystems 377 sequencer in the
Arabidopsis Genome Sequencing Center, our objective is to obtain a
sequencer for the DNALC site. We envision a functioning, mini-sequencing
lab-enclosed by picture windows-as a permanent exhibit in the new gallery
of the Bio Media Addition.
In the fall, we published our first sequence analysis tutorial on DNALC's
web site (http://darwin.cshi.org/SequenceAnalysisExercise/index1.html). This
exercise is designed to allow students and teachers to use their own mtDNA
sequences to explore on-line genome resources, to test theories of human evo-
lution, and to "solve" cases in forensic biology. In the exercise, site users
choose a sequence from a database of mtDNA sequence submitted by teach-
ers and students. The chosen sequence is then used as a query in a BLAST
search to identify similar sequences in the Genome Project's primary repository,
Genbank. After determining that the chosen sequence is from the control region
of mtDNA, students then perform a CLUSTAL analysis to localize this area with-
in the entire mitochondrial genome (16,569 bp).
Students then apply these bioinformatics tools to perform three compar-
isons that use mitochondrial sequence variations as a "molecular clock" to
determine whether Neanderthal hominids were our direct ancestors:
How similar are the mtDNA sequences of different modern humans?
How similar are modern human sequences to Neanderthal sequences?
How similar are modern human sequences to chimpanzee sequences?
The tutorial uses current Frames and Java Script technologies to present
an inquiry-based exercise that "wraps" difficult to use genome resources within
an easy to use contextual guide. The sequence analysis tutorial quickly
became the second most popular destination on the DNALC's Internet site,
demonstrating the success of this novel approach.
Local Programs Expand Greatly
As shown in the table below, student and teacher participation in DNALC pro-
grams topped 27,000 in 1997, an increase of nearly 5,000 over 1996. Most
importantly, lab instruction for local students increased by 31%. Virtually all of
this growth came from the middle school program, Genetics as a Model for
Whole Learning (GMWL). The majority of the increase came from in-school
instruction, which can be scheduled independent of lab use at the DNALC.
Additional lab field trips to the DNALC were made possible by redeveloping
the computer laboratory into a genetics laboratory for middle school students.
The low lab tables are well scaled for younger children, and the lab was further
equipped with a projection microscope. The existence of a dedicated middle
school laboratory allowed us to schedule "block" visits during which a single
district completes all its lab field trips over several consecutive days. It also
30 additional high school classes per year.
Despite this significant increase in capacity, demand for labs was so keen that
all available lab dates for the 1997-1998 academic year were essentially filled
in May. Thus, any further increase in on-site instruction will have to await new
laboratory space in the BioMedia Addition.
The GMWL program expanded to reach 8440 students from 40 elementary
and middle schools from 13 school districts in New York City, Nassau County,
and Suffolk County (see following table). This was a 72% increase over 1996
participation. Thirty-eight percent of program participants were minority stu-
dents: 25% Black, 6% Hispanic, 7% Asian/Pacific Islander, and 1% Native
American.
GMWL offers each school district a unique program based on its individual
needs. The program encompasses three components: teacher training, in-
1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 Total
Student labs (on-site) 2,031 3,753 3,758 4,248 4,624 3,422 3,961 4,682 6,088 7,105 43,672
Student labs (off-site) 291 435 1,305 1,434 2,328 5,045 7,665 18,503
Teacher labs 58 278 270 234 270 254 302 379 302 392 2,739
Student workshops 32 13 24 176 234 351 361 503 437 402 2,533
Teacher workshops _AK 285 _IL.4 333 441 243 171 j:LQ 183 245 2,827
Lab subtotal 2,617 4,329 4,366 5,282 6,004 5,581 6,235 7,993 12,023 15,809 70,239
Student lectures 553 449 660 600 1,000 734 575 520 575 407 6,073
Exhibit/LI discovery 3,231 2,547 2,964 1,480 848 6,416 9,943 10,366 10,122 11,150 59,067
Total 6,401 7,325 7,990 7,362 7,852 12,731 16,753 18,879 22,720 27,366 135,379
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school instruction, and field trips to the DNALC. Typically, DNALC staff work with
district science coordinators to create a sequential program that targets at least
two grade levels. Prior to in-school instruction, a teacher training session is held
to expose classroom teachers to the various labs their students will perform. A
DNALC middle school instructor visits each class several times to perform a
core of hands-on labs designed to increase genetic literacy while enhancing
critical and creative thinking. This core experience is then supplemented with
follow-up activities that classroom teachers design with the assistance of
DNALC staff. Most schools include a field trip to the DNALC as the culmination
of the GMWL unit. This field trip includes an instructional tour of the Story of a
Gene Exhibit and a hands-on laboratory.
Tricia Harrison instructs a
DNA extraction experi-
ment to middle-school
students in the former
BioMedia Computer Lab.
Making Inroads into New York City
Our ongoing studies of instructional innovation have documented that about
175,000 hands-on DNA experiments are performed annually in American high
schools. However, this has been largely a suburban movement, effectively
excluding the vast majority of students in urban settings. Likewise, younger chil-
dren in city schools are much less likely to receive the benefits of hands-on
learning stipulated by the National Science Education Standards. Sadly, this is
true of the New York City schools in our own backyard.
Within the last year, however, we have forged important partnerships that
will provide opportunities in modern genetics education to large numbers of
minority and disadvantaged students in New York City public schools. A collab-
oration with Community School District 29 in southeast Queens is a model for
the large-scale implementation of the GMWL program, and a collaboration with
the Gateway to Higher Education Program has provided a means to reach large
numbers of high school students.
Located immediately to the north of Kennedy Airport, District 29 serves
25,000 students in grades K-8, of whom 95% are minorities, 67% are eligible
for lunch assistance, and 31% have limited English proficiency. By working
closely with Superintendent Celestine Miller, Director of Funded Programs Ellen
Schlesinger, and Supervisor of Science Diane Ehrlich, we have developed a
program for systemic change that maximizes involvement at all levels in the dis-
trict. Parents and school board members participated in three workshops, giv-
ing them a chance to do some of the same activities done by the students.
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Faculty participated in 25 hours of after-school and Saturday workshops
designed to increase their command of multidisciplinary lab instruction.
Administrators, school board members, and faculty also participated in a
recognition dinner at Cold Spring Harbor Laboratory.
In 1997, we doubled the number of District 29 students involved in the
GMWL program. DNALC staff presented 29 days of in-school instruction,
reaching 90 sixth grade classes. Students performed four labs in school: con-
structing cell models, observing cells under compound microscopes, con-
structing DNA models, and extracting DNA from bacteria. A fifth lab-observ-
ing fruit fly mutations under stereo microscopes-was conducted during field
trips to the DNALC. We further expanded the program by piloting a follow-up
chemistry program for seventh graders. The chemistry lab sequence includes
experiments on molecular modeling, enzyme structure and function, practical
enzymology, and bioreactors.
Mort Slater, of Mount Sinai School of Medicine, has been our guide into city
high schools. Mort runs the Gateway to Higher Education Program, a 4-year pro-
gram that prepares minority and low-income students to graduate from high
school and to make a smooth transition into university science programs. The pro-
gram involves 2000 students in seven high schools representing all five boroughs
of New York City. In the past year, we have begun to effectively merge the
DNALC's content expertise in hands-on lab instruction with Gateway's expertise in
school change.
Tangible evidence of this unique instruction/infrastructure partnership was
the opening in the spring of a dedicated DNA laboratory in Brooklyn Technical
High School. Mort found about $20,000 to purchase research-quality elec-
trophoresis and cell culture equipment, refrigerator/freezer, autoclave, and ice
maker. With Mort's deft guidance, the project miraculously sidestepped the
notoriously slow New York City bureaucracy and was finished in several
months. Support for the project was as surprising as it was heartwarming:
Learning-disabled students fabricated lab benches from discarded lunchroom
tables; custodians arranged to paint the room in noninstitutional colors; and
central administration approved the installation of heavy-duty air conditioners
so that the lab can effectively be used for summer courses.
The Brooklyn Tech laboratory found immediate use in the spring semester,
serving 306 students in Advanced Placement (AP) biology and genetics class-
es. During the summer, the laboratory was the site of two workshops spon-
sored by the Greenwall Foundation, which were attended by 40 teachers from
throughout New York City. Two student workshops drew 33 students, of whom
82% were minorities. In the fall, the DNA Laboratory was a key stop in a tour of
Gateway schools by Luther Williams, head of the Directorate for Education and
Human Resources at the National Science Foundation.
Mort Slater, director of the
Gateway to Higher Education
Program. Photo by Janis Lewin.
Gateway
High School NYC Borough Enrollment
Poverty
level*
Demographics (%)
Asian Hispanic White Black Other
Stuyvesant Manhattan 3100 31% 47 3.9 44.8 4.7
Jamaica Queens 2600 35% 17 14 60 9
John F Kennedy Bronx 5000 73% 5 71 5 17
Port Richmond Staten Island 2000 22% 5 16 58 21
Brooklyn Tech Brooklyn 4500 30% 32 14 16 37
"Poverty levels determined from Lunch Eligible Program (LEP) statistics.
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Acclaim for the lab was so great that the Board of Education approved
$175,000 to equip additional DNA laboratories in each of the five boroughs.
Each of the DNA laboratories will also be wired for Internet communication, so
these schools will be able to fully participate in both the experimental and on-
line aspects of our genomic biology curriculum. When fully operational, with
integrated experimental and computation, the DNA laboratories in New York
City will have no peer in illustrating the modern synthesis of science and tech-
nology. As shown by the demographics for five participating schools, the DNA
laboratories will serve populations that are truly representative of urban
America (see table above).
Getting Out Word on Marfan Syndrome
As a complement to the GMWL program, we took on a key collaboration with
the National Marfan Foundation (NMF). Our task was to develop a teacher's
guide to complement How Do Your Genes Fit?, an award-winning video on
Marfan syndrome for middle-school students. To expand the video's useful-
ness, we used Marfan syndrome as a means to introduce general concepts of
cell biology, DNA structure/function, and genetics. The teacher's guide incorpo-
rates three laboratories from the GMWL curriculum: baggie cell model of a
fibroblast, DNA extraction, and Punnett square statistics.
The guide is currently undergoing final editing and review by NMF staff
and is scheduled for publication in the near future. The guide will be distrib-
uted nationally along with 700 free copies of the video, with additional copies
provided at cost. The first major distribution will take place at the annual meet-
ing of the National Science Teachers' Association, to be held in April in Las
Vegas.
We believe that this project provides a particularly important outlet for our
curriculum expertise. Perhaps more than any other genetic disorder, it is critical
to get the word out about Marfan syndrome to young people and their parents.
Only within the last several years have physicians and geneticists realized that
there are a large number of related disorders caused by defects in the Marfan
gene, which produces the structural protein fibrillin. Outward physical effects
tend to be subtle, so all of these disorders are difficult to diagnose. Experts
believe that tens of thousands of young people have undiagnosed Marfan syn-
drome or related fibrillin disorders and need to be evaluated by a physician.
All fibrillin disorders weaken connective tissue, which provides strength
and resiliency to muscle and bone. The weakening of the wall of the aorta, the
major artery carrying blood from the heart, is the only life-threatening risk of
undiagnosed Marfan syndrome. Over time, the connective tissue in the aorta
weakens and the high pressure of blood pumped out of the heart causes the
aorta wall to bubble out and burst-an aneurysm. There have been several
publicized cases of apparently healthy athletes who died of aneurysms during
exercise, and who later proved to have undiagnosed Marfan syndrome. We
feel that our guide can help raise awareness of this "ticking time bomb" and
encourage the early diagnosis of the disorder. With early intervention, blood
pressure can be regulated to minimize damage to the aorta, and affected chil-
dren can limit strenuous exercise.
Corporate Advisory Board
The Corporate Advisory Board (CAB) provides a crucial link to local business-
es that serve the same population base as the DNALC. Represented on the
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Chairman
John J. Leahy, Grant Thornton
Vice Chairman
Gary E. Frashier, OSI Pharmaceuticals, Inc.
Members
Michael Aboff, Aboff's Inc.
Andrew D. Ackerman, Chase Manhattan Bank
Rocco S. Barrese, Esq., Dilworth & Barrese
Howard M. Blankman, Blankman Cunningham Group, LLC
Jane S. Block, Pall Corporation
Thomas J. Calabrese
Edward A. Chernoff, Motors & Armatures, Inc.
Paul Czeladnicki, Rivkin, Radler & Kremer
Robert E. Diller, Brinkmann Instruments
Candido Fuentes, M.D.
Arthur D. Herman, Herman Development Corp.
Richard Kalenka, Price Waterhouse LLP
John Kean, Kean Development Co.
Laurie J. Landeau, V.M.D.
Ralf Lange, Luitpold Pharmaceuticals, Inc.
Lilo Leeds, CMP Publications
James Mattutat, Omnicare, Inc.
Patricia Petersen, Daniel Gale Agency
William Porter, U.S. Trust Company
William Roche, Republic New York Securities Corp.
Wendy Vander Poel Russell, CSHL Trustee
Horst Saalbach, Festo Corporation
Peter G. Schiff, Northwood Ventures LLC
Charles R. Schueler, Cablevision
James Shaw, Newsday
Paul A. Vermylen, Jr., Meenan Oil Company, L.P.
Lawrence J. Waldman, KPMG Peat Marwick LLP
Raymond A. Walters, Ph.D., CSH Central School District
board are companies of all kinds-from family-owned to multinational and from
biotechnology to banking. A major goal of the board is to raise awareness of
the DNALC among opinion leaders on Long Island and to involve others in our
work.
To support this goal, two hands-on workshops were held at the DNALC for
CAB members, family, and friends. All of the 48 participants produced their
own DNA fingerprints, illustrating the uses of DNA typing in court cases. To
show appreciation for the CAB's achievements, CSHL Director Bruce Stillman
hosted a dinner party at Airs lie for CAB members and other DNALC donors on
May 4. The evening began on the main campus with a briefing by Mike Wig ler
on breast cancer and continued with lab tours by Jerry Yin and Dick
McCombie.
Under the leadership of Jack Leahy, the CAB raised $181,361 in support
of the DNALC, a 13% increase over 1996. Key to this huge success was the
fouth annual golf tournament, held on June 18 at Piping Rock Club. Under the
chairmanship of Horst Saalbach, the tournament drew 156 players and netted
$97,714. J.P. Morgan was the major corporate sponsor; other corporate spon-
sors were Cablevision, Chase Manhattan Bank, Festo Corporation, Luitpold
Pharmaceuticals, and Price Waterhouse.
Staff and Interns
Melissa Hewitt took over the management of the rapidly growing middle school
programs after the departure of Jane Conigliaro and Diane Jedlicka in March.
We are much indebted to Malissa for rising to the task under difficult circum-
stances and ensuring the continued quality of the GMWL program. Her com-
plex position involves liaision with superintendents, principals, and faculty at 13
different school districts, and coordinating in-school and on-site instruction,
conducting teacher training, and managing four other staff members. Patricia
Harrison joined the middle school staff as a laboratory instructor in January
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New staff to the DNALC in
1997 (top left to lower
right): John Kruper, Shirley
Chan, Patricia Harrison,
and Scott Bronson,
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and ably assisted Malissa in managing the GMWL program. Tricia has a bach-
elor's degree in elementary education from the University of Scranton and is
currently a Masters candidate in special education and reading at Long Island
University. In the fall, middle school instructor Andrew Morotti began to divide
his time between teaching at the DNALC and working in a half-time position as
a lab tech with CSHL Scientist Jerry Yin.
Scott Bronson joined the full-time DNALC staff as laboratory instructor, and
in the summer assumed responsibility for managing the teaching and prep
labs, as well as the student intern program. Scott brings to the staff expertise in
current research methods in molecular biology. He formerly worked for 3 years
as a technician in the laboratory of CSHL scientist Jacek Skowronski, where he
investigated the role of the nef protein in HIV pathogenesis. Scott holds bache-
lor's degrees in molecular and marine biology, and he is currently pursuing a
master's degree in science education.
The laboratory and computational staff was ably assisted by a number of
veteran interns: Trevor Carlson (Central Islip High School), Gerry DeGregoris
(Chaminade High School), Karin Glaizer (Port ledge School), Mera Goldman
(Walt Whitman High School), Hana Mizuno (Cold Spring Harbor High School),
Rachael Neumann (Syosset High School), Trevor Sammis (Huntington High
School), and Jermel Watkins (New York Institute of Technology). Stacey Trotter
(Cornell University) and Salley Ann Gibney (Johns Hopkins University) returned
during the summer to assist with the student and faculty workshops. In August,
we bid farewell to Dan Gibson (Cold Spring Harbor High School) who began
his freshman year at Lehigh University. Newcomers Michele Hollander (Jericho
High School) and Jennifer Kirschenbaum (Jericho High School) joined the staff
in fall.
Amy Cross, a valuable and popular member of our administrative team,
left her position as program assistant in August to teach first- through third-
grade science at Friends Academy. Her sunny disposition and office support
have been greatly missed. Staff Associate Jerry Watkins, of Central Islip High
School, once again dedicated several weeks of his summer break to instruct-
ing student workshops hosted at the American Museum of Natural History in
Manhattan. Joining him as lab assistants were his sons Jermel (a veteran
DNALC lab intern) and Justin.
Workshops, Meetings, and Collaborations
January 7
January 9
January 10
January 14
January 16
January 30-31
February 6-7
February 11
February 16-17
February 22
February 28
March 4-5
March 11
March 12
March 13
March 28
April 4
April 4-6
April 8
April 11-12
April 14
April 15
April 18-20
April 23
April 29
May 1
May 9
May 9-11
May 20
May 29
June 16
June 23-28
June 30-July 3
July 7-11
July 7-16
July 10-14
July 14-18
July 14-22
July 19
July 21-25
July 28-August 1
August 4-8
August 11-15
August 14-22
Laboratory for Women in Science and Engineering Program, SUNY Stony Brook, DNALC
Presentation to McClintock Book Club, Hofstra University, Hempstead, New York
Community School District 29 Meeting, Rosedale, New York
Site visit by Betty Faber, Liberty Science Center, Jersey City, New Jersey
Science for the 21. Century, Seminar given at Chicago Academy of Science, Illinois
Workshop, Brooklyn Technical High School, Brooklyn, New York
National Science Foundation Grant Review, Washington, D.C.
Laboratory for Women in Science and Engineering Program, SUNY Stony Brook, DNALC
American Association for the Advancement of Science Meeting, Seattle, Washington
Laboratory for Corporate Advisory Board, DNALC
Site visit by Alan Thaw, Brooklyn Technical High School, Brooklyn, New York
Site visit by Andrea Thompson, Newsday
Howard Hughes Medical Institute Grant Review, Bethesda, Maryland
Site visit by Jinx Perullo and John LaPolla, Stuyvesant High School, New York, New York
Site visit by Bonnie Kaiser, Rockefeller University, New York, New York
Laboratory for parents of students in Community School District 29, Queens, New York
Site visit by Monica Volkmann, Miles Gordon, and Nancy Hechinger, American Museum
of Natural History, New York, New York
Site visit by Rob Kelly, Computer Associates, Islandia, New York
National Science Foundation Workshop, Human Genome Diversity-Student Allele Database,
University of Chicago, Illinois
Great Moments in DNA Science Honors Students Seminar, CSHL
National Science Foundation Follow-up Workshop, University of Alaska, Fairbanks
Applications of Recombinant DNA Seminar, Westpoint, New York
Great Moments in DNA Science Honors Students Seminar, CSHL
National Science Foundation Workshop, Human Genome Diversity-Student Allele Database,
Foothill College, Los Altos Hills, California
National Institute of Social Sciences Meeting, Harvard Club, New York, New York
Great Moments in DNA Science Honors Students Seminar, CSHL
Site visit by Diane Ehrlich and Ellen Schlesinger, Community School District 29, Queens,
New York
Site visit by June Osborn, Macy Foundation, New York, New York, and David Luke,
Chairman of CSHL Board of Trustees
National Science Foundation Workshop, Human Genome Diversity-Student Allele Database,
Washington University, St. Louis, Missouri
Brinkmann Instruments Meeting, Westbury, New York
Creating Futures, Seminar at C.W. Post/Long Island University, New York
Site visit by Cablevision, filming Oceanside #8 Middle School
Editorial Advisory Board Workshop, DNALC
World of Enzymes Workshop, DNALC
Fun With DNA Workshop, IS59, Queens, New York
DNA Science Workshop, DNALC
DNA Science Minority Teacher Training Workshop, Brooklyn Technical High School, New York
Advanced DNA Science Minority Workshop, Central Islip, New York
Center for Image Processing Meeting, Rochester, Minnesota
Fun With DNA Minority Teacher Training Workshop, Brooklyn Technical High School, New York
Introduction to Computer Design Workshop, DNALC
Advanced DNA Science Workshop, DNALC
Site visit by Phil Talbot, Skyline High School, Salt Lake City, Utah
Fun With DNA Minority Workshop, IS 59, Queens, New York
DNA Science Minority Workshop, Brooklyn Technical High School, New York
Fun With DNA Workshop, DNALC
DNA Science Workshop, DNALC
DNA Science Minority Workshop, Brooklyn Technical High School, Brooklyn, New York
DNA Science Minority Workshop, American Museum of Natural History, New York, New York
Fun With DNA Workshop, DNALC
DNA Science Minority Workshop, American Museum of Natural History, New York, New York
Advanced DNA Science Workshop, Delbruck Laboratory, CSHL
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August 18-22 Fun With DNA, Port ledge School, Locust Valley, New York
DNA Science Workshop, DNALC
DNA Science Minority Workshop, American Museum of Natural History, New York, New York
Introduction to Computer Design, DNALC
August 21 Site visit by Mark Schoofs, Village Voice
August 25-29 Fun With DNA Workshop, DNALC
DNA Science Workshop, Delbruck Laboratory, CSHL
September 10-11 The Wellcome Trust Workshop, Science and Issues of Human DNA Polymorphisms, University of
Edinburgh, Scotland
September 12-13 The Wellcome Trust Workshop, Science and Issues of Human DNA Polymorphisms,
Newcastle-On-Tyne, Great Britain
September 16 Site visit by Lalita Khosla, Metro News
September 17 Cloning the DNA Classroom, Seminar presented at The Wellcome Trust, London,
Great Britain
September 19-20 The Wellcome Trust Workshop, Science and Issues of Human DNA Polymorphisms,
Cambridge, Great Britain
October 9 Site visit by Dr. Mort Slater, Gateway to Highway Education
October 14 Cold Spring Harbor Laboratory and It's Place in Science, seminar presented at
Banbury Center, CSHL
October 18 Laboratory for Corporate Advisory Board, DNALC
October 24-26 Department of Energy Workshop, The Science & Issues of Human DNA Polymorphisms, Mt. Sinai
School of Medicine, New York, New York
November 8-10 Department of Energy Workshop, The Science & Issues of Human DNA Polymorphisms, City Lab,
Boston University School of Medicine, Massachusetts
November 11-13 Department of Energy Meeting, Santa Fe, New Mexico
November 14-16 Department of Energy Workshop, The Science & Issues of Human DNA Polymorphisms,
Canada College, Redwood City, California
November 21-23 National Science Foundation Advanced Technological Education Meeting, Washington, D.C.
December 5-7 Department of Energy Workshop, The Science & Issues of Human DNA Polymorphisms,
Morehouse College, Atlanta, Georgia
December 11 National Institutes of Health ELSI Grant Review
December 18 Site visit by Rockefeller University, New York
Sites of Major Faculty Workshops 1985-1997
Key: High School College Middle School
ALABAMA University of Alabama, Tuscaloosa 1987-1990
ALASKA University of Alaska, Fairbanks 1996
ARIZONA Tuba City High School 1988
ARKANSAS Henderson State University, Arkadelphia 1992
CALIFORNIA Foothill College, Los Altos Hills 1997
University of California, Davis 1986
San Francisco State University 1991
University of California, Northridge 1993
Canada College, Redwood City 1997
COLORADO Colorado College, Colorado Springs 1994
United States Air Force Academy, Colorado Springs 1995
CONNECTICUT Choate Rosemary Hall, Wallingford 1987
DISTRICT OF COLUMBIA Howard University 1992, 1996
FLORIDA North Miami Beach Senior High School 1991
University of Western Florida, Pensacola 1991
Armwood Senior High School, Tampa 1991
GEORGIA Fernbank Science Center, Atlanta 1989
Morehouse College, Atlanta 1991, 1996
Morehouse College, Atlanta 1997
HAWAII Kamehameha Secondary School, Honolulu 1990
ILLINOIS Argonne National Laboratory 1986,1987
University of Chicago 1992
University of Chicago 1997
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INDIANA Butler University, Indianapolis 1987
IDAHO University of Idaho, Moscow 1994
IOWA Drake University, Des Moines 1987
KANSAS University of Kansas, Lawrence 1995
KENTUCKY Murray State University 1988
University of Kentucky, Lexington 1992
Western Kentucky University, Bowling Green 1992
LOUISIANA Jefferson Parish Public Schools, Harvey 1990
John McDonogh High School, New Orleans 1993
MAINE Bates College, Lewiston 1995
MARYLAND Annapolis Senior High School 1989
Frederick Cancer Research Center, Frederick 1995
McDonogh School, Baltimore 1988
Montgomery County Public Schools 1990-1992
St. John's College, Annapolis 1991
MASSACHUSETTS Beverly High School 1986
City Lab, Boston University School of Medicine 1997
Dover-Sherborn High School, Dover 1989
Randolph High School 1988
Winsor School, Boston 1987
Boston University 1994, 1996
MICHIGAN Athens High School, Troy 1989
MISSISSIPPI Mississippi School for Math & Science, Columbus 1990, 1991
MISSOURI Washington University, St. Louis 1989
Washington University, St. Louis 1997
NEW HAMPSHIRE St. Paul's School, Concord 1986, 1987
NEVADA University of Nevada, Reno 1992
NEW YORK Albany High School 1987
Bronx High School of Science 1987
Columbia University, New York 1993
Cold Spring Harbor High School 1985, 1987
DeWitt Middle School, Ithaca 1991, 1993
DNA Learning Center 1988-1995
DNA Learning Center 1990, 1992, 1995
DNA Learning Center 1990-1992
Fostertown School, Newburgh 1991
Huntington High School 1986
Irvington High School 1986
Junior High School 263, Brooklyn 1991
Lindenhurst Junior High School 1991
Mt. Sinai School of Medicine, New York 1997
Orchard Park Junior High School 1991
Plainview-Old Bethpage Middle School 1991
State University of New York, Purchase 1989
State University of New York, Stony Brook 1987-1990
Titusville Middle School, Poughkeepsie 1991, 1993
Wheatley School, Old Westbury 1985
US Military Academy, West Point 1996
NORTH CAROLINA North Carolina School of Science, Durham 1987
OHIO Case Western Reserve University, Cleveland 1990
Cleveland Clinic 1987
North Westerville High School 1990
OKLAHOMA School of Science and Mathematics, Oklahoma City 1994
PENNSYLVANIA Duquesne University, Pittsburgh 1988
Germantown Academy 1988
SOUTH CAROLINA Medical University of South Carolina, Charleston 1988
University of South Carolina, Columbia 1988
TEXAS J.J. Pearce High School, Richardson 1990
Langham Creek High School, Houston 1991
Taft High School, San Antonio 1991
Trinity University, San Antonio 1994
UTAH University of Utah, Salt Lake City 1993
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VERMONT University of Vermont, Burlington 1989
VIRGINIA Eastern Mennonite University, Harrisonburg 1996
James Madison University, Harrisonburg 1997
Jefferson School of Science, Alexandria 1987
Mathematics and Science Center, Richmond 1990
WASHINGTON University of Washington, Seattle 1993
WEST VIRGINIA Bethany College 1989
WISCONSIN Marquette University, Milwaukee 1986, 1987
University of Wisconsin, Madison 1988, 1989
WYOMING University of Wyoming, Laramie 1991
AUSTRALIA Walter and Eliza Hall Institute and University of Melbourne 1996
CANADA Red River Community College, Winnipeg, Manitoba 1989
ITALY International Institute of Genetics and Biophysics, Naples 1996
PANAMA University of Panama, Panama City 1994
PUERTO RICO University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Rio Piedras 1993
University of Puerto Rico, Rio Piedras 1994
RUSSIA Shemyakin Institute of Bioorganic Chemistry, Moscow 1991
SWEDEN Kristineberg Marine Research Station, Fiskebackskil 1995
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1997 PUBLICATIONS
Laboratory Manuals
Fly Pushing: The Theory and Practice of Drosophila
Genetics
Ralph J. Greenspan
Analyzing DNA: A Laboratory Manual
Genome Analysis, Volume 1
Bruce Birren, Eric D. Green, Sue Klapholz, Richard M.
Myers, and Jane Roskams (eds.)
Discovering Neurons: The Experimental Basis of
Neuroscience
Carol Ann Paul, Barbara Beltz, and Joanne Berger-Sweeney
Methods in Yeast Genetics: A Cold Spring Harbor
Laboratory Course Manual, 1997 Edition
Alison Adams, Daniel E. Gottschling, Chris A. Kaiser, and
Tim Stearns
Cells: A Laboratory Manual
David L. Spector, Robert Goldman, and Leslie Leinwand
(eds.)
CSHL Monograph Series
Oxidative Stress and the Molecular Biology of Antioxidant
Defenses
John G. Scandalios (ed.)
C. elegans //
Donald L. Riddle, Thomas Blumenthal, Barbara J. Meyer,
and James R. Priess (eds.)
Cell Cycle and Cell Biology
The Molecular and Cellular Biology of the Yeast
Saccharomyces, Volume 3
John R. Pringle, James R. Broach, and Elizabeth W. Jones
(eds.)
RNA Structure and Function
Robert W. Simons and Marianne Grumberg-Manago (eds.)
General Books
Vaccines 97: Molecular Approaches to the Control of
Infectious Diseases
Fred Brown, Dennis Burton, Peter Doherty, John Mekalanos,
and Erling Norrby (eds.)
Mutants of Maize
M. Gerald Neuffer, Edward H. Coe, and Susan R. Wessler
Function and Dysfunction in the Nervous System
Cold Spring Harbor Symposia on Quantitative Biology LXI
Correcting the Blueprint of Life: An Historical Account of the
Discovery of DNA Repair Mechanisms
Errol C. Friedberg
Toward the 21st Century: Incorporating Genetics into
Primary Health Care
Nancy Touchette, Neil A. Holtzman, Jessica G. Davis, and
Suzanne Feetham
Retroviruses
John M. Coffin, Stephen H. Hughes, and Harold E. Varmus
(eds.)
Murderous Science: Elimination by Scientific Selection of
Jews, Gypsies, and Others in Germany 1933-1945
Benno Muller-Hill
Cancer Surveys Series
Vol. 29: Checkpoint Controls and Cancer
M.B. Kastan (ed.)
Vol. 30: Lymphoma
A.G. Wotherspoon (ed.)
Journals
Genes & Development (Volume 11, 24 issues)
T. Grodzicker and N. Hastie (eds.)
Genome Research (Volume 7, 12 issues)
L. Goodman, M. Boguski, A. Chakravarti, R. Gibbs,
E. Green, and R. Myers (eds.)
Learning & Memory (Volume 4, 6 issues)
J.H. Byrne (ed.)
Slides
The Art of Retroviruses
A Companion Slide Set from Retroviruses
J.M. Coffin, S.H. Hughes, and H.E. Varmus (eds.)
Other
CSHL Annual Report 1996
Banbury Center Annual Report 1996
Administration and Financial Annual Report 1996
COLD SPRING HARBOR LABORATORY PRESS
For Cold Spring Harbor Laboratory Press, 1997 was a year of extensive change. Significant
improvement was made in organizational efficiency, technical competence, and financial perfor-
mance. A two-stage administrative restructuring reduced staff costs and produced a more coor-
dinated, responsive organization. Production methods were radically overhauled to permit
greater flexibility in design and illustration, and output in varying formats. Books were printed
with faster schedules, more competitive pricing, and higher quality. Eighteen new books were
published, twice the 1996 total, and several were exceptional, even by the customary high stan-
dards of our program. Journal subscriptions and advertising pages increased and two titles were
published on-line for the first time. Revenues increased by 9% to $5.24 million and produced a
satisfactory operating excess.
Book Program
The book program maintained its strategic focus on techniques manuals and monographs, with
more modest objectives in the history of science. The complete list of 1997 titles is printed oppo-
site, but space permits specific mention of only some of the 18 books published.
Among the laboratory manuals published this year were Genome Analysis: Analyzing DNA,
the first of a series on genomics edited by Eric D. Green, Bruce Birren, Sue Klapholz, Richard M.
Myers, and Philip Hieter, the updated Methods in Yeast Genetics by Alison Adams, Dan
Gottschling, Chris Kaiser, and Tim Stearns, and most notably Cells, edited by David Spector,
Robert Goldman, and Leslie Leinwand. This impressive three-volume manual is beautifully illus-
trated with outstanding color photomicrographs. It was a complex project involving more than
130 contributions, and determined administration and vigorous editing were needed to achieve
the necessary completeness and coherence. Since its release at the American Society for Cell
Biology meeting, the book has been greeted with sustained enthusiasm. It may well rival our
classic publications Molecular Cloning and Antibodies, collections of techniques that, even a
decade after publication, are regarded as essential to their fields.
Two manuals were published with clearly educational goals. Ralph Greenspan's Fly Pushing
responded to the long-felt need for a simple introduction to the theory and practice of Drosophila
genetics. Discovering Neurons, by Carol Ann Paul, Barbara Beltz, and Joanne Berger-Sweeney,
is a unique collection of techniques for college teachers introducing juniors and seniors to practi-
cal neurobiology.
A very warm response has greeted Retroviruses, the new monograph edited by John Coffin,
Stephen Hughes, and Harold Varmus. A generous review in Nature hailed it as "the new testa-
ment" for investigators in the field. A descendant of two celebrated books on tumor viruses pub-
lished by the Laboratory in the 1970s, this handsome volume has the look, feel, and intention of
a textbook, with fine illustrations that are also available in slide form. As elders of the retrovirus
research community, the editors proved able to coax particularly thoughtful contributions from
distinguished investigators in this field and then boldly reshaped the material to fit their ambitious
vision of the book. Their aim was not only to assist professional virologists, but also to convince
physicians treating AIDS and its consequences that the biology of HIV needs to be understood
in the context of its retroviral cousins. They have created an important and lasting contribution to
the literature.
Additions to the Cold Spring Harbor Monograph series included C. elegans //, edited by Don
Riddle, Thomas Blumenthal, Barbara Meyer, and James Priess, the core reference work for the
expanding community of scientists studying this nematode. Our trilogy on the biology of the
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yeast Saccharomyces was completed with the long-awaited appearance of the volume Cell
Cycle and Cell Biology, edited by John Pringle, James Broach, and Elizabeth Jones.
Our growing history list was graced by an expanded edition of Murderous Science, Benno
Willer-Hill's compelling account of eugenics in Nazi Germany, and Correcting the Blueprint of
Life, Errol Friedberg's widely praised history of the study of DNA repair.
We were also delighted to publish after several years' preparation the lavishly illustrated refer-
ence work Mutants of Maize by Gerald Neuffer, Edward Coe, and Susan Wessler. Generous grant
support for the production of this book was gratefully received from corn seed companies, espe-
cially Pioneer Hi-Bred. The collective effort of authors, developmental editors, and supporters
was rewarded when the book was honored by the American Association of Publishers as one of
the Books of the Year in biology.
Journal Publishing
All three journals, Genes & Development, Genome Research, and Learning & Memory, were
offered more and better manuscripts for publication, and the number of pages published by
each rose substantially. Content diversified with the addition of short papers and regular reviews
to Genes & Development and a commentary section Inside/Outlook to Genome Research.
Editorial administration was strengthened with the appointment of Laurie Goodman as Editor of
Genome Research and Managing Editor of Learning & Memory, and Kim Gavin as Assistant
Editor of Genes & Development.
In September, Nicholas Hastie, European Editor of Genes & Development since 1990, was
succeeded by the distinguished developmental biologist Davor Solter, from the Max-Planck
Institute of Immunobiology in Freiburg, Germany. Nick deserves our thanks and gratitude for his
dedicated service to the journal through a period of mounting responsibilities as Director of the
MRC Human Genetics Unit in Edinburgh.
The measured influence of our journals continued to grow in 1997, an important matter as
libraries worldwide strive to rationalize the use of shrinking resources for print publications. The
impact factor of Genes & Development, calculated by the Institute for Scientific Information,
increased to 18.81 in 1997, maintaining its ranking in the top ten of all primary research journals.
Editor Terri Grodzicker, her colleagues in the European editorial office, and the board of advisors
continue to place an insistent demand on quality, even as the journal has broadened into new
areas of molecular and cell biology.
With the March 1 issue, the journal celebrated its tenth anniversary. These days, many journal
launches occur by binary fission, as newcomers bud from established entities. Ten years ago,
Genes & Development was a bold initiative from a publisher new to journals, in partnership with
a society rooted in population genetics, not molecular biology. All those who shared the vision of
what was possible a decade ago, and have contributed to the journal's current success, deserve
a feeling of quiet satisfaction with the outcome.
Genome Research acquired an impact factor for the first time, based solely on citations to the
first four issues of the journal in 1995. The editorial team of Laurie Goodman and scientists Mark
Boguski, Aravinda Chakravarti, Richard Gibbs, Eric Green, and Richard Myers is intent on raising
the quality of the journal and expanding its scope beyond mapping and sequencing into biology.
Learning & Memory, with the widely respected neurobiologist Jack Byrne now well estab-
lished as editor, continued to advance in all respects and was accepted by a number of impor-
tant bibliographic resources, including the prominent Current Contents Life Sciences database.
In September, the full text of issues of Genes & Development and Genome Research was
published on the World Wide Web, in collaboration with the HighWire Press, a division of
Stanford University Library. Access was free to all until the end of 1997, when it became part of
the 1998 subscription package.
The value of these on-line editions to users is high. A keyword-based search permits recovery
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of all articles on a given subject from the journal database. In addition, links can be made from
papers in our journals to other articles, either via Med line abstracts or to the full text if they are
available on-line. However, among the many misunderstood issues in the exciting new world of
on-line publishing is the cost of its development. The economics of this publishing model are
certainly different from those of print publication, but when done properly, on-line publishing is
not inexpensive, and, like many publishers, we found it necessary to pass on some of the addi-
tional cost to subscribers.
Meanwhile, the print circulation of both Genes & Development and Genome Research rose by
a gratifying 6% in 1997, notable in an era of generally flat or falling journal sales. The subscrip-
tion base of Learning & Memory changed more modestly but will be boosted in the future by a
regular production schedule made possible by increased manuscript submission. Successful
special issues were published on mushroom bodies and gene knockouts. With the help of
Laboratory Trustee William Murray, a generous grant from the Oliver S. and Jennie R. Donaldson
Charitable Trust was obtained to support the growth of this journal and will likely be used to fund
the journal's on-line publication in 1998.
Advertising sales for the two larger journals increased by a remarkable 48% over the previous
year, in response to more vigorous, focused, and creative sales activities.
Marketing and Distribution
Marketing activities in 1997 relied on the trusted strategies of direct mail, meeting exhibits, and
journal advertising but also for the first time incorporated some on-line advertising. The direct
mail program centered on a widely distributed catalog entitled Genes, Cells, and Proteins, a fall
New Book Titles newsletter, and a variety of title-specific brochures. These were attractively
redesigned and produced on the Mac/Quark page composition platform, with consequent bene-
fits in speed of production, cost savings, and flexibility.
The Press had exhibits at the seven major scientific society meetings this year and at several
smaller, more topic-focused conferences. These appearances introduce the Press to young sci-
entists and to potential authors and others with ideas to share. The thriving Cold Spring Harbor
meetings and courses offer similar promotional opportunities to display our books and journals in
the campus bookstore. Many positive reviews in major journals, a consistently updated Press
website, and electronic advertisements on other websites also helped increase the visibility of
our publications.
Our own website-at 3 years old, now ancient in web terms-has a growing role in our mar-
keting activities. The on-line catalog is definitive since our complete print catalog was discontin-
ued, and it is linked with detailed announcements of new books and journal issues, sample
chapters from forthcoming titles, and the opportunity to purchase books electronically. On-line
journal access has increased traffic at the site and book sales have steadily increased. The next
step is a major revision of the site to improve its design and ease of use and to introduce new
technologies to fulfill its potential as a dynamic sales tool.
Web-based information and the opportunity to communicate by E-mail is particularly appreci-
ated by customers outside the United States, who represent a high percentage of on-line pur-
chasers and inquirers. However, we maintain valuable relationships with agents who represent us
in several international markets, and the Frankfurt Book Fair this year was an important opportu-
nity to confer with them and scout for candidates to open up new regions.
In the Fulfillment Department, events were dominated by the decision to decommission our
10-year old minicomputer-based sales management system and convert to a new client-server
platform running Windows NT software and a new proprietary package for order fulfillment.
Installation of the new system, begun in October for first quarter 1998 completion, will offer
unprecedented operational power and flexibility together with major improvements in the analysis
of sales, costs, and customers.
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New Projects
During the year, 11 major new publishing projects were placed under contract, and at year's end,
more than 20 others were in discussion. In the second half of the year, responsibility for acquisi-
tion of new projects was diversified in order to strengthen this vital component of the publishing
process. The new acquisition team brought in Judy Cuddihy and Kaaren Janssen, both experi-
enced editors widely acquainted with science and scientists. Their ideas, contacts, and energy
will be invaluable in building our program to a new level of productivity.
Staff Changes
The year's reorganization of the publishing staff resulted in the formation of a Production
Department charged with print and electronic production of books and journals, and a Book
Editorial Development Department responsible for the timely extraction and appropriate prepara-
tion of publishable manuscripts from authors. New scheduling, transition, and reporting proce-
dures were instituted to coordinate the work of these two vital units and ensure that accurate, up-
to-date information on progress reaches all other parts of the publishing enterprise.
The staff members of the Press as of December 1997 are listed elsewhere in this volume. Our
thanks are extended to each one of them for their commitment, dedication, and participation in
this challenging year of change. It is a pleasure to note that those directly responsible for the
creation of our publications are now appropriately acknowledged on the mastheads of journals
and the title verso pages of books.
Special mention must be made of the members of the new management team: Denise Weiss,
whose appointment this year as Production Manager for books and journals was the catalyst for
much technological innovation and staff education; Jan Argentine, who as Editorial Development
Manager maintained the coordination of book publishing; Nancy Hodson, our Business Manager
who carried forward our exhausting computer conversion; Ingrid Benirschke, Marketing Manager,
and Guy Keyes, Fulfillment Manager, whose dedication to their responsibilities was essential to
the implementation of change; Laurie Goodman, a talented editor with energy and flair that will
serve the entire publishing program well; and Marcie Ebenstein, our newly appointed Journal
Advertising Manager, whose skills are tapping unexploited revenue potential from this source.
We welcomed several other new members of staff: Chris Bianco, Production Editor; Cynthia
Weidman, Marketing Assistant; Peggy Calicchia, Editorial Secretary; and Joanne Thomas,
Fulfillment Assistant. We bade farewell to Nancy Ford, Managing Editor of the Press, whose
retirement was noted in last year's Annual Report, at a January luncheon honoring her 24 years'
service to the Laboratory and her key role in establishing the publishing program. Another
crowded luncheon, in August, marked Barbara Terry's retirement after 15 years of devoted ser-
vice to our book and journal purchasers in the Fulfillment Department. Doris Lawrence, Editorial
Secretary, also left us, for a college career. And we celebrated with Judy Cuddihy her transition
from the position of Managing Editor, in which she had played a pivotal role in journal publishing
since 1987, to a new life high in the mountains of New Mexico where, thanks to the marvels of
telecommuting, she continues to be invaluable in the development of several important forthcom-
ing books and the acquisition of future projects.
This is an extraordinary time in the communications industry. Corporate consolidation has
reduced the number of publishers in science to a handful of powerful commercial companies
and a small but influential group of learned societies. Cold Spring Harbor Laboratory Press is
unusual in this environment-tiny in financial terms compared with our commercial colleagues,
lacking the societies' security of member dollars, but respected for the distinction of our book list
and the excellence of our journals. Our mission is to contribute to the Laboratory's economy, not
drain from it, a distinction that became clear in interactions with other participants in the
High Wire Press on-line publishing initiative.
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The rush to on-line publication has been swift but the consequences are still uncertain. So far,
only a minority of journal subscribers are making use of the electronic subscription, but this may
reflect technical unreadiness among libraries and subscription agents rather than readers' lack
of interest. It seems highly likely that, soon, all journals will have to be on-line, to be noticed at all.
And what about books? Is there still a role for the first-class technical monograph in science, or
is it only really useful as a database with links to other on-line resources? Like most publishers,
we are watching this evolving marketplace with enormous fascination and experimenting to see
what is technically and financially feasible. But as means of distribution and access change, one
constant remains: the value of quality. In this respect, the goal of publishing at Cold Spring
Harbor is what it has always been: to provide the best, in a medium of choice. In 1997, much
was done to secure that position.
John Ft. Inglis
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FINANCIAL STATEMENTS
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
December 31, 1997
With comparative amounts as of December 31, 1996
Assets: 1997 1996
Cash and cash equivalents $ 16,542,395 12,959,798
Investments 140,573,553 123,682,720
Accounts receivable:
Publications 829,653 489,932
Other 158,235 191,162
Grants receivable 3,038,893 2,251,645
Contributions receivable 1,707,605 3,518,165
Publications inventory 1,991,707 1,426,118
Prepaid expenses and other assets 1,377,264 1,308,461
Investment in employee residences 2,269,345 2,370,943
Land, buildings, and equipment:
Land and land improvements 9,980,071 9,037,008
Buildings 66,519,640 60,467,671
Furniture, fixtures, and equipment 4,950,130 4,310,386
Laboratory equipment 12,655,257 11,721,056
Library books and periodicals 365,630 365,630
Construction in progress 626,728 1,103,850
95,097,456 87,005,601
Less accumulated depreciation and amortization (30,500,090) (27,354,072)
Land, buildings, and equipment, net 64,597,366 59,651,529
Total assets $ 233,086,016 207,850,473
Liabilities and Net Assets:
Liabilities:
Accounts payable and accrued expenses $ 2,599,761 1,470,007
Notes payable 645,839 864,961
Bonds payable 30,000,000 30,000,000
Deferred revenue 5,554,037 5,715,510
Total liabilities 39,799,637 38,050,478
Net assets:
Unrestricted
General operating 5,760,936 6,030,181
Designated by Board for:
Research programs 1,150,000 1,150,000
Capital expenditures 3,709,145 5,753,947
Endowment 70,713,010 63,334,506
Net investment in plant 33,951,527 28,786,568
Total unrestricted 115,284,618 105,055,202
Temporarily restricted 4,723,413 1,269,123
Permanently restricted 74,278,348 63,475,670
Total net assets 194,286,379 169,799,995
Total liabilities and net assets $ 233,086,016 207,850,473
330
CONSOLIDATED STATEMENT OF ACTIVITIES
Year Ended December 31, 1997
With comparative totals for the year ended December 31, 1996
Unrestricted
Temporarily
Restricted
Permanently
Restricted
1997
Total
1996
Total
Revenue, gains, and other support:
Public support (contributions and
nongovernment grant awards) $ 9,012,034 4,663,412 335,498 14,010,944 14,355,769
Government grant awards 15,392,415 15,392,415 13,756,042
Indirect cost allowances 10,000,564 10,000,564 9,817,300
Other revenue:
Program fees 2,117,904 2,117,904 1,948,793
Rental income 389,658 389,658 443,934
Publications sales 5,237,814 5,237,814 4,804,744
Dining services 2,172,196 2,172,196 2,080,803
Rooms and apartments 1,712,294 1,712,294 1,639,324
Royalty and licensing fees 679,082 679,082 464,652
Net appreciation in fair
value of investments 6,716,633 10,467,180 17,183,813 9,146,939
Investment income
(interest and dividends) 5,677,213 5,677,213 6,258,338
Miscellaneous 167,324 167,324 109,733
Total other revenue 24,870,118 10,467,180 35,337,298 26,897,260
Net assets released from restrictions:
Expiration of time restrictions 1,209,122 (1,209,122) -
Total revenue, gains, and other support 60,484,253 3,454,290 10,802,678 74,741,221 64,826,371
Expenses:
Research 27,715,449 27,715,449 25,258,285
Summer programs
(meetings and courses) 6,848,437 - 6,848,437 7,022,511
Publications 5,400,006 - 5,400,006 5,104,457
Banbury Center conferences 953,562 953,562 795,244
DNA Learning Center programs 627,763 627,763 604,605
General and administrative 6,091,915 6,091,915 5,694,590
Dining services 2,617,705 2,617,705 2,487,117
Total expenses 50,254,837 50,254,837 46,966,809
Increase in net assets before
cumulative effect of change
in accounting principle 10,229,416 3,454,290 10,802,678 24,486,384 17,859,562
Cumulative effect of change in
accounting for investments 12,671,355
Increase in net assets 10,229,416 3,454,290 10,802,678 24,486,384 30,530,917
Net assets at beginning of year 105,055,202 1,269,123 63,475,670 169,799,995 139,269,078
Net assets at end of year $ 115,284,618 4,723,413 74,278,348 194,286,379 169,799,995
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CONSOLIDATED STATEMENT OF CASH FLOWS
Year ended December 31, 1997
With comparative amounts for the year ended December 31, 1996
1997 1996
Cash flows from operating activities:
Increase in net assets $ 24,486,384 30,530,917
Adjustments to reconcile increase in net assets to net
cash provided by operating activities:
Cumulative effect of change in accounting principle (12,671,355)
Depreciation and amortization 3,370,584 2,988,112
Net appreciation in fair value of investments (17,183,813) (9,146,939)
Contributions restricted for long-term investment (4,998,910) (4,716,321)
Changes in assets and liabilities
(Increase) decrease in accounts receivables (306,794) 278,633
(Increase) decrease in grants receivable (787,248) 777,102
Decrease (increase) in contributions receivable 1,810,560 (3,018,165)
Increase in publications inventory (565,589) (31,398)
(Increase) decrease in prepaid expenses and other assets (68,803) 769,773
Increase in accounts payable and accrued expenses 1,129,754 520,928
(Decrease) increase in deferred revenue (161,473) 363,841
Net cash provided by operating activities 6,724,652 6,645,128
Cash flows from investing activities:
Capital expenditures (8,316,421) (4,628,242)
Proceeds from sales and maturities of investments 100,940,803 162,766,609
Purchases of investments (100,647,823) (169,651,705)
Net change in investments in employee residences 101,598 (545,302)
Net cash used in investing activities (7,921,843) (12,058,640)
Cash flows from financing activities:
Permanently restricted contributions 335,498 3,537,198
Contributions restricted for investment in land, buildings, and equipment 4,663,412 1,179,123
Repayment of notes payable (570,122) (352,559)
Issuance of notes payable 351,000 550,000
Net cash provided by financing activities 4,779,788 4,913,762
Net increase (decrease) in cash and cash equivalents 3,582,597 (499,750)
Cash and cash equivalents at beginning of year 12,959,798 13,459,548
Cash and cash equivalents at end of year $ 16,542,395 12,959,798
Supplemental disclosures:
Interest paid $ 1,239,341 1,277,376
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COMPARATIVE OPERATING HISTORY 1993-1997
(Dollars in Thousands)
1993 1994 1995 1996 1997
Income:
Main Lab:
Grants and contracts $ 18,136 19,293 19,653 20,879 22,743
Indirect cost reimbursement 8,383 8,460 8,881 9,704 9,910
Other 6,049 6,808 7,461 7,859 8,472
CSHL Press 4,319 4,390 5,119 4,805 5,238
Banbury Center 1,281 1,569 1,732 1,214 1,495
DNA Learning Center 796 824 954 754 875
Total income 38,964 41,344 43,800 45,215 48,733
Expenses:
Main Lab:
Research and training 18,136 19,293 19,653 20,879 22,743
Operation and maintenance of plant 4,777 5,141 5,266 5,446 5,274
General and administrative 2,785 2,909 3,329 3,438 3,625
Other 4,385 4,847 4,959 5,367 5,759
CSHL Press 4,134 4,309 5,079 5,032 5,320
Banbury Center 1,226 1,498 1,643 1,225 1,437
DNA Learning Center 768 798 958 781 887
Total expenses, excluding depreciation 36,211 38,795 40,887 42,168 45,045
Excess before depreciation and
release of designated funds 2,753 2,549 2,913 3,047 3,688
Depreciation (2,522) (2,668) (2,821) (2,988) (3,371)
Release of funds designated (1) 200
Net operating excess $ 231 81 92 59 317
The above amounts are presented on a combined basis for all funds for which Cold Spring Harbor Laboratory prepares operating budgets.
(1) Funds designated to underwrite future direct and indirect expenses of the neuroscience and other research programs.
COLD SPRING HARBOR LABORATORY
SOURCES OF REVENUE
YEAR ENDED DECEMBER 31, 1997
Auxiliary Activities 19.4
Corporate Contributions and Grants 4.5
Interest and Miscellaneous 1.4
....--Royalty and Licensing Fees 4.2
Federal Grants 4t.2 %
Foundation and Private
Contributions and Grants 19.3
Endowments and Board
Designated Funds 10.0
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FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory, Banbury Center, and the DNA Learning Center receive a substan-
tial portion of their funding through grants from the Federal Government and through grants, capi-
tal gifts, and annual contributions from private foundations, corporations, and individuals. The fol-
lowing section summarizes funding that occurred during 1997.
GRANTS January 1, 1997-December 31, 1997
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator Duration of Grant 1997 Funding*
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Program Projects Dr. Herr 1/92-12/01 $ 3,941,478
Dr. Marr 6/95-5/98 958,072
Dr. Stillman 8/90-7/00 2,701,460
Dr. Tully 5/96-4/99 698,729
Research Support Dr. Arndt/Dr. Tonks 1/95-12/98 135,200
Dr. Beach 5/94-2/99 315,935
Dr. Beach 8/95-5/00 264,618
Dr. Cline 12/95-11/98 281,273
Dr. Enikolopov 9/94-8/98 220,491
Dr. Futcher 4/93-3/01 266,020
Dr. Futcher 1/91-12/99 168,445
Dr. Greider 8/91-7/01 285,689
Dr. Greider 12/94-11/97 96,899
Dr. Helfman 4/94-3/98 247,050
Dr. Helfman 8/93-5/98 309,655
Dr. Hengartner 5/95-4/00 233,236
Dr. Hernandez 7/87-6/00 147,108
Dr. Herr 8/96-7/00 206,305
Dr. Hirano 5/96-4/00 206,660
Dr. Joshua-Tor 8/96-7/99 225,062
Dr. Krainer 7/94-6/98 349,086
Dr. Malinow 5/95-4/00 265,474
Dr. Malinow 4/95-2/98 266,785
Dr. Nedivi 7/97-6/02 108,241
Dr. Skowronski 12/93-11/97 296,587
Dr. Spector 4/95-3/99 327,844
Dr. Silva 7/95-6/00 260,301
Dr. Stillman 7/91-5/00 502,212
Dr. Tonks 8/91-3/01 476,957
Dr. Tonks 5/97-4/01 277,933 *
Dr. Tully 4/94-3/02 382,106
Dr. Tully 8/96-6/00 277,309
Dr. Tully 5/97-4/99 84,500 *
Dr. Van Aelst 12/97-11/01 348,875 *
Dr. Wig ler 7/95-4/99 1,937,881
Dr. Xu 12/97-11/02 325,184
Dr. Yin 9/96-8/99 264,784
Dr. Zhang 9/97-8/00 372,815
Dr. Zhong 2/96-1/00 240,754New Grants Awarded in 1997
*Includes Direct and Indirect Cost
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Grantor Program/Principal Investigator Duration of Grant 1997 Funding*
Fellowships Dr. Dickinson 11/97-6/00 14,806 *
Dr. Dubnau 7/96-6/99 24,420
Dr.Huang 8/97-7/02 69,762 *
Dr. Kogan 1/97-12/98 23,700 *
Dr. Le 2/96-1/99 16,143
Dr. Yang 9/97-8/98 25,420
Training Support Training in Cancer Cell Biology
and Tumor Virology
7/94-2/99 171,686
Course Support Advanced Bacterial Genetics 5/93-4/98 60,852
Cancer Research Center Workshops 4/92-3/98 260,570
Neurobiology Short-term Training 5/82-4/01 143,585
CSHL Analysis of Large DNA Molecules 4/91-3/01 52,727
Computational Genomics for 1991-1998 40,478
Molecular Biologists
Advanced In Situ Hybridization
and Immunocytochemistry
1992-1998 62,845
Automated Genome Sequencing 4/95-3/98 73,962
Molecular Biology and Development
of Xenopus laevis
4/96-3/99 10,000
Meeting Support Genome Mapping and Sequencing 4/90-3/99 32,354
Tyrosine Phosphorylation and Cell Signaling 4/97-3/98 5,000'
Cell and Molecular Biology of Aplysia 4/97-3/98 10,000 *
Regulation of Liver Gene Expression
in Health and Disease
5/97-4/98 14,000 *
62nd Symposium: Pattern Formation
during Development
6/97-5/98 8,000 *
Eukaryotic DNA Replication 7/97-6/98 5,000 *
Programmed Cell Death 7/97-6/98 19,273
Microbial Pathogenesis and Host 8/97-7/98 5,000 *
Defense
Mechanisms of Eukaryotic 7/97-7/98 7,000 *
Transcription
Neurobiology of Drosophila 7/97-6/98 15,000 *
Eukaryotic mRNA Processing 8/97-8/98 6,000 *
NATIONAL SCIENCE FOUNDATION
Cooperative Agreement Drs. Martienssen/McCombie 9/96-8/99 1,430,000
Research Support Dr. Cline 9/96-8/99 100,000
Dr. Grossniklaus 8/97-7/00 120,000 *
Dr. Grotewold 2/97-4/98 5,000'
Dr. Grotewold 9/97-9/00 90,000
Drs. Martienssen/McCombie 8/97-7/98 228,000 *
Dr. Peunova 9/95-8/98 101,125
Training Support Undergraduate Research Program 6/91-5/98 50,000
Course Support Arabidopsis Molecular Genetics 6/94-5/00 60,000
Early Development of Xenopus Laevis 9/96-8/98 14,682
Meeting Support Tyrosine Phosphorylation and Cell Signaling 3/97-2/98 6,000 *
Cell and Molecular Biology of 3/97-2/98 11,017
Aplysia and Related Invertebrates
Mechanism of Eukaryotic Transcription 7/97-6.98 3,000
Eukaryotic DNA Replication 7/97-6/98 3,000
New Grants Awarded in 1997
*Includes Direct and Indirect Cost
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Grantor Program/Principal Investigator Duration of Grant 1997 Funding+
Eukaryotic mRNA Processing 8/97-7/98 3,000'
Neurobiology of Drosophila 8/97-7/98 13,795 *
Equipment Multiple Column Peptide Synthesizer
for Combinatorial Chemistry
9/97-8/98 85,000 *
A Rotating Anode X-ray Generator for 3/97-2/98 84,140 a
Biological Macro-Molecular Crystallography
DEPARTMENT OF ENERGY
Research Support Dr. Martienssen 8/91-2/98 96,000
Course Support Macromolecular Crystallography 9/93-12/97 15,000
UNITED STATES DEPARTMENT OF AGRICULTURE
Research Support Drs. Ma/McCombie 9/96-8/98 48,574
Drs. McCombie/Martienssen 6/95-6/98 78,654
Drs. McCombie/Martienssen 9/97-8/00 123,186'
Dr. Martienssen 9/97-8/00 67,888 *
UNITED STATES DEPARTMENT OF ARMY
Research Support Dr, Futcher 6/94-6/99 218,997
Dr. Futcher 7/97-6/00 97,180 a
Dr. Hannon 9/96-8/00 150,000
Dr. Hengartner 7/97-6/00 95,490 *
Dr. Wig ler 7/94-8/99 200,000
Fellowship Support Dr. Liu 12/96-11/99 41,783
J. Polyakova 7/97 6/00 20,000 a
Dr, Schneider 8/97-7/00 41,000 a
Dr. Sherlock 7/97-6/00 41,000 *
Meeting Support Microbial Pathogenesis and 9/97-8/98 4,500 *
Host Defense
NONFEDERAL GRANTS
Research Support
American Cancer Society Dr. Wig ler, Professorship 1986-2012 50,000
Dr. Wig ler, Supply Allowance 1986-1998 10,000
Amplicon Corporation Dr. Wig ler 6/94-10/97 192,736
Arnold and Mabel Beckman Dr. Joshua-Tor 7/96-6/98 100,000
Foundation
Calbiochem-Novabiochem Dr. Krainer 2/96-1/98 40,000
Foundation
Council for Tobacco Research Dr. Futcher 1/97-12/99 65,000 *
Dr. Skowronski 7/97-6/00 75,000'
Dr. Tonks 1/95-12/97 93,000
Charles A. Dana Foundation Dr. Marr 1/96-6/97 36,000
Oliver S. and Jennie R.
Donaldson Charitable Trust Dr. Hengartner 7/96-6/98 62,500
New Grants Awarded in 1997
'Includes Direct and Indirect Cost
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Grantor Program/Principal Investigator Duration of Grant 1997 Funding*
Irving A. Hansen Memorial Dr. Tonks 8/95-7/98 10,000
Foundation
Lita Annenberg Hazen Dr. Svoboda 12/96-11/97 200,000
Foundation
The John A. Hartford Dr. Tully 1/97-12/99 269,082 *
Foundation
Helicon Therapeutics Drs. Tully/Yin 9/97-8/00 975,000 *
Helen Hoffritz Foundation Dr. Cline 12/96-11/98 25,000
ISIS Pharmaceuticals Dr. Spector 6/93-6/97 15,000 *
Esther A. and Joseph Dr. Enikolopov 7/94-6/98 40,000
Klingenstein Fund, Inc.
Charles Henry Leach II Dr. Enikolopov 1/97-12/97 25,000
Foundation
1 in 9: L.I. Breast Cancer Dr. Wig ler 1997 146,565
Action Coalition
Long Beach Breast Cancer Dr. Wig ler 1997 1,000 *
Coalition
G. Harold and Leila Mathers Dr. Malinow 1/95-12/97 278,975
Charitable Foundation
The McKnight Endowment Dr. Silva 7/95-6/98 50,000
Fund for Neuroscience Dr. Yin 7/96-6/99 50,000
Mellam Family Foundation Dr. Tonks 12/96-11/00 50,000
Merck Genome Research Dr. Zhang 11/97-10/99 100,000 *
Institute
NIH/Sloan Kettering Dr. Wig ler 9/95-8/98 330,498
Subcontract Drs. TonksNan Aelst 8/97-5/01 434,681 *
NIH/Nanoprobes, Inc Dr. Spector 9/96-8/98 31,508
Subcontracts Dr. Spector 9/96-8/98 31,444
Dr. Spector 9/97-2/98 12,727 *
NIH/University of Pennsylvania Dr. Yin 10/97-9/01 102,760 *
Subcontract
N.A.T.O. Dr. Nest ler 1/96-12/98 7,049 *
Otsuka American Dr. Zhang 6/97-6/98 30,000 *
Pharmaceutical, Inc.
Perkin Fund Dr. Silva 6/97-5/99 25,000 *
Pew Charitable Trust Dr. Hannon 7/97-6/01 50,000 *
Dr. Hirano 7/96-6/00 50,000
Dr. Lazebnik 7/95-6/99 50,000
Dr. Zhong 7/94-6/98 50,000
Pioneer Hi-Bred International Dr. Grossniklaus 10/97-9/99 35,000 *
Lauri Strauss Leukemia Dr. Tonks 12/97-11/98 15,000 *
Foundation, Felix Schnyder
Memorial Fund
Tularik, Inc. Dr. Wig ler 10/97-10/03 604,402 *
Volkswagen Foundation Dr. Silva 7/96-6/99 26,652
Equipment Support
The Louis Berkowitz Family Equipment 12/97-11/98 26,000 *
Foundation, Inc.
E.S. Moore Foundation Equipment 1997 10,000
Fellowships
Rita Allen Foundation Dr. Hengartner 9/94-8/99 30,000
American Cancer Society Dr. Ellison 7/95-6/98 28,000
Dr. Kass-Eisler 11/96-10/99 26,000
American Heart Association Dr. Berthier 7/96-6/98 30,000
Argentinian Research Council Dr. Rabinowicz 2/96-1/98 18,900
Fellowship
*New Grants Awarded in 1997
*Includes Direct and Indirect Cost
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Grantor Program/Principal Investigator Duration of Grant 1997 Funding'
Burroughs Wellcome Fund Dr. Mainen 9/97-8/99 55,000 *
Cancer Research Fund of the Dr. Liang 9/94-8/97 34,000
Damon Runyon-Walter
Winchell Foundation
CSHL Association Fellowships 4/95-9/98 165,152
Demerec Kaufmann Hollaender Dr. Grossniklaus 7/97-6/98 5,574 *
Fellowship
European Molecular Biology Dr. Chong 3/97-10/97 16,753 *
Organization Dr. Gartner 6/97-3/99 29,097'
Fundacion Ramon Areces Dr. Mendez 10/96-9/97 18,000
Joseph G. Goldring Fellowship 1997 50,000 *
Foundation
Human Frontier Science Dr. Cartegni 10/97-9/99 36,400 *
Program Dr. Chong 11/97-10/99 5,900 *
Dr. Curtis 6/97-6/99 38,700 *
Dr. Mendez 10/97-9/99 8,850 *
Dr. Poncer 4/97-3/99 28,550 *
Dr. Soengas 6/97-5/99 35,400 *
Japan Society for Promotion
of Science
Dr. Shibahara 4/97-3/99 40,000 *
Sidney Kimmel Foundation Dr. Lowe 7/97-6/99 100,000
Dr. Van Aelst 7/97-6/99 100,000 *
New Zealand Crop and Research Dr. Bicknell 1/97-6/97 9,000 *
New Zealand Foundation for Dr. Packer 12/97-11/99 38,554'
Research Science and Technology
Max Kade Foundation, Inc. Dr. Gartner 2/97-1/98 10,100
Leukemia Society of America, Inc. Dr. Blasco 7/96-3/97 7,830
Dr. Kimura 7/97-6/00 36,700 *
Dr. Tansey 7/96-6/99 33,480
Dr. Weinreich 7/97-6/00 36,700
Ministerio de Educacion y Dr. Losado 10/96-9/98 18,000
Cultura, Spain
Neurofibromatosis Foundation Dr. Hannan 6/97-6/98 35,000
Andrew Seligson Memorial Dr. Fearnhead 1/97-12/98 35,000 *
Fellowship
The V Foundation Dr. Van Aelst 8/97-7/99 50,000 *
Helen Hay Whitney Dr. Sun 1/97-12/99 27,000 *
Foundation
The Wellcome Trust Dr. Connolly 6/97-5/98 7,850 *
Dr. Sanders 1/96-12/97 11,700
Dr. Zaman 8/96-7/98 20,253
Henry Wendt Fellowship Support 1997 50,000 *
Training Support
Emanuel Ax Fund CSHL Summer Undergraduate Program 1997 5,385 *
Burroughs Wellcome Fund CSHL Summer Undergraduate Program 1997 43,984 *
Cornelius N. Bliss Memorial
Fund CSHL Summer Undergraduate Program 1997 8,000 *
Dorcas Cummings CSHL Summer Undergraduate Program 1997 5,440 *
Garfield Fellowship CSHL Summer Undergraduate Program 1997 7,550 *
H. Bentley Glass CSHL Summer Undergraduate Program 1997 2,692 *
Howard Hughes Medical Graduate Student Support 1994-1997 20,000
Institute
Jephson Educational CSHL Summer Undergraduate Program 1997 7,500 *
Libby Fellowship CSHL Summer Undergraduate Program 1997 3,771 *
Olney Fellowship CSHL Summer Undergraduate Program 1997 5,531 *
Joan R. Read Fund CSHL Summer Undergraduate Program 1997 4,342 *
W.M. Shakespeare Fellowship CSHL Summer Undergraduate Program 1997 5,131 *
Von Stade Fellowship CSHL Summer Undergraduate Program 1997 5,119'
'New Grants Awarded in 1997
includes Direct and Indirect Cost
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Grantor Program/Principal Investigator Duration of Grant 1997 Funding'
Course Support
Athena Neurosciences, Inc. Neurological Diseases Course 1/97-12/97 500 *
Grass Foundation Scholarships 5/94-4/98 15,000
Howard Hughes Medical Advanced Neurobiology Courses 1991-1999 275,000
Institute
Esther A. and Joseph Advanced Neurobiology Courses 5/94-4/98 60,000
Klingenstein Fund, Inc.
Meeting Support
Ariad Pharmaceuticals, Inc. Mechanisms of Eukaryotic Transcription 1997 500 *
Canji, Inc. Vector Targeting Strategies for Therapeutic 1997 1,000 *
- Gene Delivery
Council for Tobacco Research Regulation of Liver Gene Expression
in Health Disease
1997 1,500 *
Cystic Fibrosis Foundation Vector Targeting Strategies for Therapeutic 1997 5,000 *
Gene Delivery
DEKALB Genetics Corporation The Arabidopsis Genome: From Sequence
to Function
1997 1,000 *
Dupont Merck Pharmaceutical Regulation of Liver Gene Expression
in Health Disease
1997 2,000 *
Gen Medicine, Inc. Vector Targeting Strategies for Therapeutic 1997 2,000 *
Gene Delivery
Genzyme Vector Targeting Strategies for Therapeutic 1997 2,500 *
Gene Delivery
Glaxo Wellcome Inc. Vector Targeting Strategies for Therapeutic 1997 500 *
Gene Delivery
Invitrogen Corporation Mechanisms of Eukaryotic Transcription 1997 1,000 *
Intraimmune Therapies, Inc. Vector Targeting Strategies for Therapeutic 1997 1,000 *
Gene Delivery
JIC Innovation The Arabidopsis Genome: From Sequence
to Function
1997 1,563 *
Key Gene N.V. The Arabidopsis Genome: From Sequence
to Function
1997 1,500 *
March of Dimes Regulation of Liver Gene Expression
in Health Disease
1997 5,000 *
Microbiological Associates, Inc. Vector Targeting Strategies for Therapeutic 1997 1,000 *
Gene Delivery
Monsanto Company The Arabidopsis Genome: From Sequence
to Function
1997 5,000 *
E.I. DuPont De Nemours Differential Display and Related Techniques
and Company for Gene Discovery 1997 2,000 *
Novartis Crop Protection, Inc. The Arabidopsis Genome: From Sequence
to Function
1997 1,000 *
Pfizer, Inc. Regulation of Liver Gene Expression
in Health Disease
1997 1,000 *
Prolinx, Inc. Vector Targeting Strategies for Therapeutic 1997 1,000 *
Gene Delivery
Stanford University/Morrison Human Evolution 1997 9,135 *
Institute
Targeted Genetics Corp. Vector Targeting Strategies for Therapeutic 1997 2,000*
Gene Delivery
Therexsys Limited Vector Targeting Strategies for Therapeutic 1997 5,000 *
Gene Delivery
Tularik Inc. Mechanisms of Eukaryotic Transcription 1997 1,000 *
Upstate Biotechnology, Inc. Tyrosine Phosphorylation 1997 1,000 *
Virus Research Institute, Inc. Vector Targeting Strategies for Therapeutic 1997 2,000
Gene Delivery
Wyeth-Ayerst Laboratorie Vector Targeting Strategies for Therapeutic 1997 3,000
Gene Delivery
New Grants Awarded in 1997
*Includes Direct and Indirect Cost
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BANBURY CENTER
Grantor Program/Principal Investigator Duration of Grant 1997 Funding'
FEDERAL SUPPORT
CDC Centers for Disease
Control and Prevention Lyme Disease Workshop: In Vivo 1997 10,000 *
Expression and Recognition of Antigenes
of Borelia burgdorferi
FDA Food and Drug Administration Molecular Immunobiology of Lyme 1997 15,000 *
Disease Workshop
The Federal Judicial Center The Art of Judging Workshop 1997 18,122 *
Judiciary Leadership
Developmental Council
NINDS National Institute of Genetics of Parkinson's Disease 1997 27,849
Neurological Disorders
and Stroke
NONFEDERAL SUPPORT
Meeting Support
Albert B. Sabin Vaccine Case Studies in Vaccine Development 1996 27,243
Foundation, Inc.
Albert B. Sabin Vaccine Sabin HIV 1996 14,987
Foundation, Inc.
Alexander and Margaret Stewart Trust Immunological Attacks on Cancer 1997 28,760 *
American Physiological Society Genomics to Physiology and Beyond 1997 34,146 *
Amgen, Inc. Breast Cancer 1997 5,000
Applied Microbiology, Inc. (AMBI) Posttranslational Modifications 1997 17,007 *
Cambridge Neuroscience, Inc. Neuregulins and Neuregulin Receptors 1997 3,000 *
Fort Dodge Animal Hospital Lyme Disease 1997 1,000 *
Glaxo Wellcome Inc. Lyme Disease 1997 5,000 *
John A. Hartford Foundation Human Cognition 1997 33,000 *
Medlmmune, Inc. Lyme Disease 1997 2,000 *
The National Neurofibromatosis Neurofibromatosis 1997 30,189 *
Foundation, Inc.
OncorMed, Inc. p53 1997 28,278 *
Pasteur Merieux Connaught Lyme Disease 1997 5,000 *
SmithKline Beecham Pharmaceuticals Lyme Disease 1997 5,000 *
The Wilson Foundation Neurofibromatosis 1997 6,813 *
SPECIAL PROJECT SUPPORT
Oxnard Foundation Utrophin Project 11/96-10/99 40,000
ADDITIONAL SUPPORT FOR THE UTROPHIN PROJECT
Barbara Bancroft
Bernard F. and Alva B. Gimbel
Mr. and Mrs. William T. Lai
Mr. and Mrs. Paul G. Pennoyer, Jr.
Martha P. Thomas
'New Grants Awarded in 1997
'Includes Direct and Indirect Cost
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Mr. and Mrs. Andrew M. Blum
Mr. and Mrs. Thomas S. Gimbel
Valerie Louthan Designs, Inc.
Gertrude Colletti Perucca
Kevin and Gloria Daigh
Anne D. Glenn
OBX, Inc.
Robin and Enrique Senior Philanthropic
Fund of the Jewish Communal Fund
DNA LEARNING CENTER
Grantor Program/Principal Investigator Duration of Grant 1997 Funding+
FEDERAL GRANTS
NATIONAL SCIENCE FOUNDATION A Two-part Program to Develop and 4/93-6/97 10,435
Support a Nationwide Corps of Human
and Molecular Genetics Resource Teachers
at the Secondary Level, David Mick los
A Novel Mechanism for Introducing 4/95-4/98 89,556
Human Genome Research in Freshman
Biology Classes, Mark Bloom
A Partnership to Develop Advanced 8/97-7/00 49,954 *
Technology Units on Genomic Biology
DEPARTMENT OF ENERGY The Science and Issues of Human DNA 1/97-1/00 67,755
Polymorphisms: An ELSI Training
Program for High School Biology
Teachers
NONFEDERAL GRANTS
Genentech, Inc Story of a Gene Exhibit 4/95-4/97 722
Hearst Foundation Genetics as a Model for Whole Learning 1/97-12/97 50,000 *
Howard Hughes Medical Institute Precollege Science Education Initiative
for Biomedical Research Institutions
7/94-8/99 35,738
Josiah Macy, Jr. Foundation Gene Almanac 10/97-9/00 57,555 *
The following schools each awarded a grant for the Genetics as a Model for Whole Learning Program:
China Town School District 1 5,040 Jericho Union Free School District 4,700
Community School District 29 26,700 Lawrence Union Free School District 10,000
East Meadow Union Free School District 2,450 Locust Valley Central School District 7,160
Elwood Union Free School District 3,425 Plainview-Old Bethpage Central School District 1,175
Green Vale School 2,375 South Huntington Union Free School District 10,400
Half Hollow Hills Central School District 2,750 Syosset Central School District 14,700
The following schools each awarded a grant for Curriculum Study of 1,100:
Commack Union Free School District
East Meadow Union Free School District
Elwood Union Free School District
Garden City Union Free School District
Great Neck Union Free School District
Half Hollow Hills Central School District
Harborfields Central School District
Herricks Union Free School District
Island Trees Union Free School District
Jericho Union Free School District
Lawrence Union Free School District
Locust Valley Central School District
of 1,500:
Long Beach School District
of 2,000:
East Woods School
Friends Academy
Green Vale School
Oceanside Union Free School District
`New Grants Awarded in 1997
*Includes Direct and Indirect Cost
Massapequa Union Free School District
North Shore Central School District
Oyster Bay-East Norwich Central School District
Plainedge Union Free School District
Plainview-Old Bethpage Central School District
Port ledge School
Port Washington Union Free School District
Ramaz School
Roslyn Union Free School District
Sachem Central School District
West Hempstead Union Free School District
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We wish to express the genuine gratitude of the trustees, administration, and most espe-
cially the scientists of Cold Spring Harbor Laboratory for the generous financial support of
those persons, corporations, and foundations whose names appear on the following
pages of the annual report.
Richard L. Cosnotti, Chief Development Officer
Cold Spring Harbor Laboratory is a nonprofit research and educational institution char-
tered by the University of the State of New York. Less than half (44.1%) of our annual sup-
port is derived from Federal grants and contracts, and thus we rely heavily on support
from the private sector: foundations, corporations, and individuals. Contributions from the
private sector are tax exempt under the provisions of Section 501(c)(3) of the Internal
Revenue Code. In addition, the Laboratory is designated a "public charity" and therefore
is enabled to receive funds resulting from the termination of "private foundations."
METHODS OF CONTRIBUTING TO COLD SPRING HARBOR LABORATORY
Gifts of money can be made directly to Cold Spring Harbor Laboratory.
Securities: You can generally deduct the full amount of the gift on your income tax return,
and, of course, you need pay no capital gains tax on the stock's appreciation.
We recommend any of the following methods:
(1) Have your broker sell the stock and remit the proceeds to Cold Spring
Harbor Laboratory.
(2) Deliver the stock certificates to your broker with instructions to open an ac-
count for Cold Spring Harbor Laboratory and hold the securities in that ac-
count pending instructions from Cold Spring Harbor Laboratory.
(3) Send the unendorsed stock certificates directly to the Laboratory: Comptroller, Cold
Spring Harbor Laboratory, One Bungtown Road, Post Office Box 100, Cold Spring
Harbor, New York 11724. In a separate envelope, send an executed stock power.
Pooled Income Funds: Combine gifts from a number of donors in a pool for attractive
investment and tax purposes.
Appreciated real estate or personal property: Sizable tax benefits can result from such
donations; the Laboratory can use some in its program and can sell others.
Life insurance and charitable remainder trusts can be structured to suit the donor's
specific desires as to extent, timing, and tax needs.
Bequests: Most wills probably need to be updated. Designating Cold Spring Harbor
Laboratory as beneficiary ensures that a bequest will be utilized as specified.
Conversion of private foundation to "public" status on termination: This may be
done by creating a separate fund within Cold Spring Harbor Laboratory whereby the
assets of the private foundation are accounted for as a separate fund and used for the
purposes specified by the donor. Alternatively, the private foundation can be established
as a supporting organization of Cold Spring Harbor Laboratory.
For additional information, please contact the Chief Development Officer, Cold Spring Harbor
Laboratory, One Bungtown Road, Post Office Box 100, Cold Spring Harbor, NY 11724, or call 516-
367 -8840.
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CAPITAL AND PROGRAM CONTRIBUTIONS
January 1, 1997-December 31, 1997
Contributions of $5,000 and above, exclusive of Annual Fund
In 1997, the Laboratory received significant support in the form of capital and program contribu-
tions from individuals, foundations, and corporations.
Rita Allen Foundation, Inc.
Arrow Electronics
Banbury Fund
Louis Berkowitz Family Foundation, Inc.
Burroughs Wellcome Fund
Carnegie Institution of Washington
Oliver S. & Jenny R. Donaldson Charitable Trust
Robert L. Garland
Bernard F. and Alva B. Gimbel Foundation
Goldring Family Foundation
The Grass Foundation
Irving A. Hansen Memorial Foundation
Lita Annenberg Hazen Foundation
Helicon Therapeutics Inc.
Helen Hoffritz Foundation
Howard Hughes Medical Institute
Max Kade Foundation, Inc.
W.M. Keck Foundation
Sidney Kimmel Foundation for Cancer Research
The Esther A. and Joseph Klingenstein Fund, Inc.
David H. Koch Charitable Foundation
Charles Henry Leach II Foundation
Mary D. Lindsay
Josiah Macy, Jr. Foundation
Total $ 10,063,021
Marks Family Foundation
The Maxfield Foundation
Leonard Marx
The Merck Genome Research Institute
Edward S. Moore Foundation
National Neurofibromatosis Foundation, Inc.
1 in 9: The Long Island Breast Cancer Action
Coalition
Oxnard Foundation
The Perkin Fund
Pew Charitable Trust
Pioneer Hi-Bred International, Inc.
William and Maude Pritchard Charitable Trust
Mark Ptashne
John R. Reese
Mr. and Mrs. Alan Seligson
Robin and Enrique Senior Philanthropic Fund of the
Jewish Communal Fund
St. Giles Foundation
Alexander and Margaret Stewart Trust
Laurie S. Strauss Leukemia Foundation
The V Foundation
Henry Wendt
Helen Hay Whitney Foundation
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CHILD CARE CENTER CAPITAL CAMPAIGN
January 1, 1997-December 31, 1997
Contributions of 1,000 and above, exclusive of Annual Fund
The child care center capital campaign is on-going. This list reflects only gifts received in 1997.
David and Pamela Banker
Centerbrook
The Chase Manhattan Foundation
R. H. Cushman
Theodore N. Danforth
Mr. and Mrs. Daniel P. Davison
Dextra Baldwin McGonagle
Foundation, Inc.
Charley Dickey and Sheila
Wyckoff-Dickey
Mr. and Mrs. William T. Dunn, Jr.
Mr. and Mrs. James A. Eisenman
Mrs. Oliver R. Grace
John A. Hartford Foundation, Inc.
Mr. and Mrs. Henry U. Harris, Jr.
Mrs. Horace Havemeyer, Jr.
Huy ler C. Held
Dorothy H. Hirshon
Nancy Hopkins
Frederic B. Ingraham
Kean Development Company
The Krasnoff Family
Laurie J. Landeau, VMD
Total $ 245,628
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Lilo and Gerard Leeds,
CMP Media, Inc.
George Lindsay, Jr. and
Nancy Metz
John and Mary Lindsay
Peter Lindsay and
Mary-Kate Murphy
Stephen W. Lindsay
Long Island Community
Foundation
The Henry Luce Foundation, Inc.
Mr. and Mrs. William R. Miller
Edith D. Moore
Barbara S. Mosbacher
North Country Garden Club
William E. Murray and The Samuel
Freeman Charitable Trust
Carol R. Noyes
Oncogene Science, Inc.
Playground Environments
Don and Carole Procida
Dr. Mark Ptashne
Mr. and Mrs. Thomas L. Pulling
Louise Lindsay Read and
Curtis Read
The Roslyn Savings Foundation
Wendy Vander Poel Russell
Donna and Phillip Satow
Julia C. Schieffelin
Mrs. John A. Scrymgeour
Dr. Michael Smith
Mr. and Mrs. James F. Stebbins
J. Patricia M. Swenson
In memory of Mimi Coleman
Thompson
The Tilles Family
Mrs. Ernest T. Turner
Mrs. Bruce S. Wagner in memory
of William F. Russell
Mr. and Mrs. Colton P. Wagner
Mrs. Henry G. Walter, Jr.
Mr. and Mrs. H. G. Wellington in
memory of Mrs. J. Harvey
Humpstone
Dr. and Mrs. Michael Wigler
Zebra Media Productions
ANNUAL CONTRIBUTIONS
Corporate Sponsor Program
The Cold Spring Harbor Laboratory Corporate Sponsor Program continues to make a very substantial contribu-
tion to the meetings programs in Grace Auditorium on the main campus and at Banbury Center. This funding
enables us to bring specially invited speakers to the meetings, to help underwrite the expenses of young scien-
tists attending meetings, and to ensure that the meetings at Banbury Center are on cutting-edge research. More
than 6000 scientists attended meetings at Cold Spring Harbor Laboratory and Banbury Center in 1997. Full
details of these meetings are found elsewhere in this Annual Report.
The members of the Program receive special privileges in acknowledgment of their contributions. We waive
all on-site fees for eight representatives of each company at our meetings. Three of these scientists may attend
meetings at Banbury Center, where attendance is otherwise only by invitation of the organizers. Corporate
Sponsors receive gratis copies of Cold Spring Harbor Laboratory Press publications including the journals
Genes & Development, Learning & Memory, and Genome Research. Special meetings held in Grace Auditorium
in the Spring and Fall are also available to Corporate Sponsor Program members.
In addition, we acknowledge our Sponsors in all relevant publications, including the books of abstracts given
to every participant. The names of the sponsoring companies are listed on the poster describing the meetings.
This is mailed to approximately 17,000 scientists throughout the world. There were 36 members of the Program
in 1997, including virtually all of the pharmaceutical companies and major players in biotechnology. This num-
ber is a tribute both to the scientific acumen and generosity of the member companies and to the quality of the
Program. However, continuing mergers in the pharmaceutical and biotechnology worlds are reducing the pool
of potential members, and each year it becomes ever more important that members renew. The following com-
panies participated in the Program in 1997:
COLD SPRING HARBOR LABORATORY CORPORATE SPONSORS
Alafi Capital Company
Amgen Inc.
BASF Bioresearch Corporation
Becton Dickinson and Company
Boehringer Mannheim
Corporation
Bristol-Myers Squibb Company
Chiron Corporation
Chugai Research Institute for
Molecular Medicine, Inc.
Diagnostic Products Corporation
The Du Pont Merck
Pharmaceutical Company
COLD SPRING HARBOR LABORATORY
PLANT CORPORATE ASSOCIATES
American Cyanamid Company
Kirin Brewery Co., Ltd.
Monsanto Company
Total $ 792,000
Forest Laboratories, Inc. The Perkin-Elmer Corporation,
Genentech, Inc. Applied Biosystems Division
Glaxo Wellcome Inc. Pfizer Inc.
Hoechst Marion Roussel Pharmacia & Upjohn, Inc.
Hoffmann-La Roche Inc. Research Genetics, Inc.
Johnson & Johnson Schering-Plough Corporation
Kyowa Hakko Kogyo Co., Ltd. SmithKline Beecham
Life Technologies, Inc. Pharmaceuticals
Eli Lilly and Company Wyeth-Ayerst Research
Merck & Co., Inc. Zeneca Group PLC
Novartis Pharma Research
OSI Pharmaceuticals, Inc.
Pall Corporation
Pioneer Hi-Bred International, Inc.
Westvaco Corporation
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DNALC Corporate Advisory Board Annual Fund
An important objective of the Corporate Advisory Board of the DNA Learning Center is to provide a
sustainable level of annual funding for the Learning Center's programs and to increase visibility in the
local business community. As a means of reaching this objective, the Board conducts an Annual
Fund and an Annual Golf Tournament with proceeds benefiting the DNA Learning Center.
Chairman: John J. Leahy, Grant Thornton, LLP
Vice Chairman: Gary E. Frashier, OSI Pharmaceuticals, Inc
Michael Aboff, Aboff's Inc.
Andrew D. Ackerman, Chase Manhattan
Bank
Rocco S. Barrese, Esq., Dilworth &
Barrese
Howard M. Blankman, Blackman
Cunningham Group, LLC
Jane S. Block, Pall Corporation
Thomas J. Calabrese
Edward A. Chernoff, Motors & Armatures,
Inc.
Paul Czeladnicki, Rivkin, Radler &
Kremer
ANNUAL FUND CONTRIBUTORS
CORPORATE BENEFACTORS
Contributions of $10.000 or more
Luitpold Pharmaceuticals, Inc
Edward A. Chernoff, Motors & Armatures,
Inc.
CORPORATE PATRONS
Contributions of $5,000 or more
Laurie J. Landeau, V.M.D.
Pall Corporation
Price Waterhouse LLP
CORPORATE ASSOCIATES
Contributions of $2,500 or more
Brinkmann Instruments, Inc.
Chase Manhattan Bank
KPMG Peat Marwick LLP
Louis & Virginia Clemente Foundation,
Inc.
Meenan Oil Co., LP
Newsday
OSI Pharmaceuticals, Inc.
Pittway Corporation Charitable
Foundation
MATCHING GIFT CONTRIBUTORS
Robert E. Diller, Brinkmann Instruments
Candido Fuentes, M.D.
Arthur D. Herman, Herman Development
Corp.
Richard Kalenka, Price Waterhouse LLP
John Kean, Kean Development Company
Laurie J. Landeau, V.M.D.
Ralf Lange, Luitpold Pharmaceuticals,
Inc.
Lilo Leeds, CMP Publications
James E. Mattutat, Omnicare, Inc.
Patricia Petersen, Daniel Gale Agency
William Porter, U.S. Trust Company
CORPORATE MEMBERS
Contributions of 01.000 or more
Aboff's Inc.
Adchem Corporation
G. Morgan Browne
Daniel Gale Real Estate Companies
Dilworth & Barrese
Festo Corporation
Gerard and Lilo Leeds
Harweb Foundation
Henry Schein Inc.
Herman Development Corp.
Omnicare, Inc.
Rivkin, Radler & Kremer
William D. Roche
The Schiff Foundation
FRIENDS OF THE DNALC
Contributions of $50 or more
Efren B. Abella, Esq.
John & Carole Aksak
Berger's Wholesale Meats
Mr. and Mrs. Martin Bernard
Mr. and Mrs. George Bourne
Rosemary Bourne
Carl Zeiss, Inc.
GIFT IN HONOR CONTRIBUTORS
Republic National Bank of New York Pam and Marty Bernard in honor of
The Chase Manhattan Foundation Edward A. Chernoff
Total
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$83,647
William Roche, Republic New York
Securities Corp.
Wendy Vander Poel Russell, CSHL
Honorary Trustee
Horst Seelbach, Festo Corporation
Peter G. Schiff, Northwood Ventures LLC
Charles R. Schueler, Cablevision
James Shaw, Newsday
Paul A. Vermylen, Jr., Meenan Oil
Company, L.P.
Lawrence J. Waldman, KPMG Peat
Marwick LLP
Raymond A. Walters, Ph.D., CSH Central
School District
Thomas and Marilyn Chengot
Mr. and Mrs. William Chin
Cohen & Company, LLC
James and Lenore Conenello
Mr. and Mrs. Gerald R. Davino
Dr. and Mrs. Fred Glasser
Robert & Cynthia Hoey
Laura L. Hundt
Lackmann Food Service
Mr. and Mrs. John J. Leahy
James E. Mattutat
Kevin & Jeanne O'Donnell
Mr. George A. Roche
Mrs. Wendy Vander Poel Russell
Drs. Jerry & Sabiha Soriano
State Bank of Long Island
Judith and Bernard Stebel
The Tumminio Family
Raymond Walters, Ph.D.
Windemere Development Corp.
W.T. Hickey Corp.
OTHER CONTRIBUTORS
Gerard Jr. and Ann DeGregoris
Ms. Elaine Ronnenburger
Lydia T. Smith
FOURTH ANNUAL GOLF TOURNAMENT SPONSORS
Major Tournament Sponsor
J.P. Morgan & Co. Inc.
Corporate Sponsors
Cablevision
Chase Manhattan Bank
Festo Corporation
Luitpold Pharmaceuticals,
Inc.
Price Waterhouse LLP
Cocktail Party and Buffet
Sponsor
Hoffmann & Baron, LLP
Auction Prize
Lufthansa
Hole-In-One Prize
Badge Agency Inc.
Refreshment Sponsor
The Americana at Manhasset
Putting Green Sponsor
Centerbrook Architects
Gold Sponsors
Badge Agency Inc.
Barnes & Noble Bookstores
Brinkmann Instruments, Inc.
Cortel Business Systems,
Inc.
Daniel Gale Real Estate
Dilworth & Barrese
Ernst & Young LLP
Farrell, Fritz, Caemmerer,
Cleary, Barnosky &
Armentano
Ferran Brothers, Inc.
Great Eastern Printing
Company, Inc.
Hoffmann & Baron, LLP
Kean Development Company
KPMG Peat Marwick LLP
Meltzer, Lippe, Goldstein,
Wolf & Schlissel, P.C.
Motors & Armatures, Inc.
Northwood Ventures LLC
Total
OSI Pharmaceuticals, Inc.
Rivkin, Radler & Kremer
U.S. Trust Company
Silver Sponsors
Herman Development Corp.
J&H Marsh & McLennan
Holmes Protection
Newsday
The Hartford
Village Green Service Center
Bronze Sponsors
Aboff's Inc.
Gilbert Tweed Associates,
Inc.
Commemorative Journal
Sponsors
The Albicocco Family
Berger's Wholesale Meats
Bogardt & Co.
Clinical Communications Inc.
Corporate Property Investors
D.M. Garlick, Inc.
Drew Pallas & Associates,
Inc.
Fisher Scientific
Dr. & Mrs. Candido E.
Fuentes
Gerard Klauer Mattison &
Co., Inc.
Huntington Business
Products Centre
I. Janvey & Sons, Inc.
Jeff's Seafood
Mr. and Mrs. Jeffrey S. Jurick
Lawrence & Lawrence
Lewisy Fuel Oil
Nastech
New York Biotechnology
Assn., Inc.
Nortech Laboratories Inc.
Pharmacia Biotech Inc.
Stimpson Co. Inc.Sunrise
Medical Laboratories, Inc.
Sunrise Medical Laboratories
Inc.
$ 97,714
To-Jo Provisions-Boar's Head
V.I. Technologies, Inc.
Vittorio Auto Body
Weitz & Luxenberg
Tee/Green Sponsors
A. D. Herman Construction
Co., Inc.
Alliant Foodservice
Burt Building Materials Corp.
Dvirka & Bartilucci,
Consulting Engineers
Blankman Cunningham
Group LLC
Raffle Prizes
Aboff's Inc.
Alarm Tech Security Systems
Angelina's Ristorante
Arizona Beverage
Audio Command Systems
Bank of Smithtown
Barney's Restaurant
Bissell Nursery Corp.
Mr. Art Brings
Canterbury Ales, Huntington
Capriccio Restaurant
Clare Rose
Cobblestone Country Club,
Florida
Coca-Cola Bottling Company
Coco's Water Café
Ecco Environmental Control
Company
Enterprise Rent-A-Car
Mr. Clark Gil lies
Global Direct Mail Corp.
Harborview Automotive
Huntington Business
Products Centre
The Inn on the Harbor
Kean Development
Company, Inc.
L&L Camera, Inc.
Main Street Nursery
Motors & Armatures, Inc.
National Arts Club Dining
Room
Vincent & Laurie Nesi
Total DNA Learning Center Annual Fund $ 181,361
O.C. Tanner
Oyster Bay Frame Shop
Piccolo Restaurant
Price Waterhouse LLP
Riverhead Building Supply
Corp.
Rivkin Radler & Kremer
Scarsella's Florist
Sempre Vivo lo
Spinnaker Travel
Sunderland of Scotland
Trattoria Grasso
Trios
Ultimate Class Limo
Village Green Service Center
Winebow, Inc., Ltd.
Zip Limousine
Other Contributors
A Partymaker
Abbott Laboratories
Callan, Regenstreich, Koster
& Brady
CompuMail Business
Services
Hofheimer, Gartlir & Gross,
Esqs.
Bumble Ingham-The Worth
Collection
J&M Bakery Products
Mr. Robert Marcus
Margolin & Margolin, Esqs.
Margolin, Winer & Evens
Mr. Elihu Mod lin
Mrs. William F. Russell
Mr. James Spingarn
Stirling Creek Associates
The Country Printer
Tony's Fish & Seafood Corp.
Uniflex
Beverage Donations
Arizona Beverage
The Lion Brewery
Gift Bags
Badge Agency, Inc.
The Hartford
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Cold Spring Harbor Laboratory Association (CSHLA)
Officers
Mr. John P. Cleary, President
Mrs. James M. Large, Vice President
Mrs. Robert G. Merrill, Secretary/Treasurer
Directors
Mrs. Joseph S. Augusciak
W. Dillaway Ayres, Jr.
Nicholas Bartilucci
Mrs. Harry A. Brooks
Mrs. Thomas J. Calabrese
Mrs. Harry G. Charlston
David C. Clark
David H. Deming
John S. Grace
Mary Jeanne Harris
Antoine C. Kemper, Jr.
E. Coe Kerr
Mrs. George N. Lindsay
Mrs. Vincent Nesi
Gerald D. Olin
Gilbert R. Ott, Jr.
Phillip M. Satow
Mrs. Thomas A. Saunders III
Mrs. Peter G. Schiff
Mrs. Douglas S. Soref
James L. Spingarn
Mrs. James F Stebbins
President's Report
It was a year of continued growth in the support activities of the Association, aimed at furthering the mission of
Cold Spring Harbor Laboratory. The activities of the members were many and varied, manifesting a broad
range of interests in serving this community.
On February 2, 1997 our year commenced with the annual meeting of the CSHL Association. The guest
speaker was Philip R. Reilly, M.D., who spoke to us about "Genetics, Ethics, and You." The lecture was thought-
provoking, leaving most of us with thoughts about various issues that face us as the science of genetics
increasingly affects our daily lives. Dr. Reilly discussed topics including the future of genetic testing and the
impact of genetic information on health and life insurance and employment. The lecture raised important ques-
tions that must be addressed in this increasingly scientific world.
Five directors stepped down after having served the Association generously and unselfishly. They are Joyce
Green, Laurie Genovese, Dr. Alan M. Kisner, Robert L. Marcus, and Edward F McCann II. At our February meet-
ing, new directors were elected. They are W. Dillaway Ayres, Jr., Mary Jeanne Harris, Gilbert R. Ott, Jr., and
Cynthia Stebbins. The Association was deeply saddened by the passing of Mary Jeanne Harris on August 19,
1997. Mary Jeanne served the Laboratory in many capacities including Trustee of the Laboratory, Director of the
Association for a number of terms, and as a volunteer in helping young scientists adjust upon arrival at the
Laboratory. Her unselfish enthusiasm, support, and contributions will be truly missed.
On June 1, Dr. Sean Carroll of the University of Wisconsin addressed the Association and friends at the
annual CSHLA Dorcas Cummings Memorial Lecture during the CSHL Symposium. Dr. Carroll's talk was entitled
"Embryos and Ancestors: The formation and evolution of animal body patterns." His in-depth discussion of the
similarities in development between various species was a concept that few of us had previously considered.
Following the lecture, dinner parties were hosted by members of the Association for scientists and friends of the
Laboratory. The hosts and hostesses entertained diverse groups of neighbors, visiting scientists, and the Lab's
own scientists on a lovely evening. The Association wishes to express its special thanks to each:
Mr. and Mrs. W. Dillaway Ayres, Jr.
Mr. and Mrs. Henry Babcock, Jr.
Ms. Mary Lenore Blair
Mr. and Mrs. Robert Walton
Mr. and Mrs. G. Morgan Browne
Mr. and Mrs. Harry Charlston
Mr. and Mrs. David Clark
Mr. and Mrs. John Cleary
Mr. and Mrs. John Grace
Mr. and Mrs. Henry Harris, Jr.
Mr. and Mrs. David Luke
Mr. and Mrs. Robert O'Connor
Mr. and Mrs. John Phelan
Mr. and Mrs. Whitney Pidot
Mr. and Mrs. Douglas Soref
Mr. and Mrs. John Stevenson
Mr. and Mrs. Daniel Tenney
In the fall, the Association commenced its major annual giving campaign, As a result of the tireless efforts of
many of our directors and members of the Association, in excess of $654,000 was raised from 682 members.
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CSHLA Volunteer Reception
Franny Elder, John Cleary, Duncan Elder
West Side School Science Night
Winship Herr speaks to students and parents.
The directors are pleased with this outcome as it represents an increase in the number of con-
tributors and surpasses our goal. Additionally, it is the intention of the directors to continue to
develop new friends and enhance the level of contributions in furtherance of the effort to support
the Laboratory's mission. The funds raised in the annual giving campaign are earmarked for the
support of young scientists who are, for the most part, recent graduates of doctoral programs
throughout the world. Their arrival at the Laboratory campus is an exciting time for them, as
indeed it is for the Laboratory.
As alluded to above, the activities of the Association and its members cover a diverse range
of interests and activities that include not only support of the Lab, but also dissemination of infor-
mation to the public. On April 2, Dr. Mary-Claire King, Professor in the Division of Medical
Genetics at the University of Washington, delivered a public lecture entitled "Breast Cancer
Update." Dr. King was responsible for identifying BRCA1, the first known breast cancer gene,
and she is well known for her outspoken advocacy of increased research on breast cancer.
Another timely and important topic to many of us is Lyme disease. Long Island has traditional-
ly been an area in which Lyme disease is a constant threat to the health and well being of its res-
idents. On November 2, a panel discussion, "Lyme Disease: Research and Clinical Update," was
held in Grace Auditorium. The evening was moderated by Steven E. Schutzer, M.D. and John
Dunne, Ph.D. and addressed the status of current research and the prognosis for conquering the
disease. The speakers were Patricia K. Coyle, M.D. and Raymond Dattwyler, M.D.
In another area of interest, Barbara Conolly, a Long Island naturalist and resident of the com-
munity, gave a tour of the Laboratory on May 18 to individuals interested in flora and fauna. Her
program, "Bird and Flower Walk," highlighted much of the natural beauty located on the
Laboratory grounds and was both well attended and well received with great interest and enthu-
siasm from the participants.
On the music front, an outstanding concert, open to all members of the Association, was held
on June 13. The performance featured world renowned pianist Misha Dichter. This concert was
like many that the Laboratory supports each year usually free of charge and open to the public.
In addition to the above-mentioned activities, the Laboratory, with the participation of
Association members, conducted several school tours, permitting students to observe
Laboratory scientists at work. This exposure is vital to enhancing children's understanding of the
manner in which science is done at the Laboratory and other scientific institutions. The intention
is to interest children in science at a young age in the hope of cultivating a continuing interest in
science.
Another program warranting special attention is the Next Generation Initiative (NGI). This effort
was conceived and implemented by younger members of the community and its activities have
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been well received. This year's NGI lecture was held on January 10, 1998 in Grace Auditorium.
Dr. Bruce Stillman, Director of Cold Spring Harbor Laboratory, introduced Dr. Nicholas Tonks, a
principal investigator at the Lab, who spoke on "Drug Targets for Cancer and Diabetes." Dr.
Tonks has discovered an entirely new class of enzymes which have been implicated in cancer,
diabetes, and other diseases. He is now striving to determine the function of these enzymes.
Many thanks go to Lola and John Grace, who hosted a dinner party for all attendees following
the lecture. Special thanks also go to the members of the committee who organized the evening,
including Tony Kemper, Mary Alice Kolodner, Calvert Saunders, Cathy Soref, Laura Swiggett, and
of course, Lola and John Grace.
I am stepping down as president of the Association, and at this time I wish to state that it has
been a particular privilege and pleasure for me to serve the Association and the Laboratory. I
know that the Association and the Laboratory will continue to grow and prosper, and contribute
to the furtherance of science in the years to come. I would like at this time to thank Laurie Nesi,
Gerry Olin, Holly Brooks, and Maureen Augusciak, who have retired as Directors this year. Each
of them, in many different and varying ways, gave unstintingly of their time and effort in furthering
the work of the Association and the Laboratory. The Association is very grateful to them for their
support. Special thanks also go to Jean Houghton who served as our Staff Director and also to
the other members of the Laboratory's Development Office who supported the day-to-day activi-
ties of the Association.
February 1998 John P. Cleary
Members of the Cold Spring Harbor Laboratory Association
ANGELS'
Mr. and Mrs. John P. Cleary
Mrs. John L. Davenport
Mr. Robert B. Gardner, Jr.
Mrs. George N. Lindsay
Mr. and Mrs. David L. Luke III
Mr. Leonard Marx
Mr. and Mrs. Thomas J. McGrath
Mrs. Cynthia R. Mead
Dr. and Mrs. Walter C. Meier
Mr. Arthur C. Merrill
Mr. and Mrs. Robert G. Merrill
Mr. and Mrs. William R. Miller
Mr. and Mrs. Douglas P. Morris
Mr. and Mrs. Edward L. Palmer
The Dorothy Schiff Foundation
The Samuel M. Soref & Helene K.
Soref Foundation
Mary G. Turner Charitable Unitrust
BENEFACTORS
Mr. and Mrs. Roger L. Bahnik
Mr. and Mrs. Harry A. Brooks
Mr. and Mrs. G. Morgan Browne
Mr. and Mrs. Peter B. Cannel!
The Wilfred P. Cohen Foundation,
Inc.
Mr. and Mrs. David H. Deming
Mrs. Robin T. Hadley
Mr. Henry U. Harris, Jr
Mr. Alexander M. Luke
Mr. and Mrs. Robert L. Marcus
Mr. and Mrs. Charles E. Murcott
Mr. and Mrs. Gerald D. Olin
Dr. and Mrs. David B. Pall
Joyce and John Phelan
Mr. and Mrs. Phillip M. Satow
Mr. and Mrs. Philip R. von Stade
Mr. and Mrs. Douglas A. Warner III
Dr. and Mrs. James D. Watson
Wellington Foundation
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PATRONS
The Ada Howe Kent Foundation
The Alex J. Weinstein Foundation,
Inc.
Mr. and Mrs. W. Dillaway Ayres, Jr.
Rod and Cheryl Brayman
Centerbrook Architects
Craigmyle Foundation
Mr. and Mrs. Norris Darrell, Jr.
Mr. Robert O. Fehr
Mr. and Mrs. Edward E. Fessenden
Mr. and Mrs. Edward H. Gerry
Mr. and Mrs. John S. Grace
Mr. and Mrs. Barclay Jones
Mr. and Mrs. Townsend J. Knight
Mr. and Mrs. James M. Large, Jr.
Mrs. Henry Lewis III
Mr. and Mrs. Robert V. Lindsay
The Nussdorf Family of Duality King
Dist., Inc.
Mrs. Jessie E. Phillips
Mrs. H. Irving Pratt
Mr, and Mrs. John R. Reese
Mr. and Mrs. Peter G. Schiff
Mr. and Mrs. James L Spingarn
Mr. and Mrs. James F. Stebbins
ASSOCIATES
Abby and George O'Neill Trust
Mr. Warren S. Adams II
Robert F. and Betty J. Albertson
Ms. Dorothy T. Baldwin
Mr. and Mrs. William W. Bancroft
Mr. and Mrs. Thomas M. Bancroft, Jr.
Mr. and Mrs. David L Banker
Mr. and Mrs. Nicholas J. Bartilucci
Mr. and Mrs. Edmund Bartlett
Elizabeth and Rodney Berens
Allen and Jane Boorstein
David Botstein and Renee Fitts
Lester E. Brion
Vincent and Joan Carosella
Charlotte Palmer Phillips Foundation,
Inc.
Mr. and Mrs. Harry Charlston
Mr. and Mrs. Thomas H. Choate
Mr. and Mrs. David C. Clark
Mrs. Robert L. Clarkson, Jr.
Mr. James W. Cleary
Mr. and Mrs. John H. Coleman
Mr. and Mrs. Peter 0. Crisp
Mr. and Mrs. Arthur M. Crocker
Mr. and Mrs. Roderick H.Cushman
Mr. and Mrs. George W. Cutting, Jr.
Mr. Charles B. Delafield
Mr. and Mrs. Nelson Doubleday
Mr. and Mrs. James A. Eisenman
Mr. and Mrs. Duncan Elder
Mr. and Mrs. Johnston L. Evans
Mr. and Mrs. William Everdell
Mr. and Mrs. Stephen C. Eyre
The Fay J. Linder Foundation
Dr. Robert and Marjorie Feeney
Mr. and Mrs. Leonard Feinstein
Fidelity Investments Charitable Gift
Fund
Mr. and Mrs. Stephen D. Fuller
E.M. Geddes, Jr.
The General William Mayer Fdn.
Mr. and Mrs. Elbridge T. Gerry, Jr.
Mr. and Mrs. Gordon S. Hargraves
Mr. Lindsay C. Harkness III
Mr. Albert P. Hildebrandt
Mr. and Mrs. Hans D. Holterbosch
Mr. David L. Hopkins, Jr.
Mr. and Mrs. Waldo Hutchins III
Mr. Frederick B. Ingraham
The John & Katherine Naudin
Foundation
Mr. Jeffrey Keller and Ms. Dolores
Fredrich
Mr. and Mrs. John Klingenstein
Mr. and Mrs. Gordon E. Lamb
Mr. and Mrs. Edward M. Lamont
Mrs. Lois A. Lenahan
Leo Model Foundation, Inc
Mr. Eugene Levitt
Dr. Robert V Lewis
Mr. and Mrs. Robert D. Lindsay
Mrs. Vladimir S. Littauer
Mr. and Mrs. Luke D. Lynch, Jr.
Mr. and Mrs. John Macaskill
Dr. Thomas Maniatis
Ms. Diana McIlvaine
Mr. and Mrs. Franklin C. McRoberts
Mr. and Mrs. Clarence F Michalis
Mr. and Mrs. Keith M. Moffat
Mr. and Mrs. Francis W. Murray III
Mr. and Mrs. William J. Nammack
Mr. and Mrs. Vincent R. Nesi
Mr. and Mrs. Adams H. Nickerson
Mrs. Carol R. Noyes
Mr. and Mrs. Michael S. O'Brien
Dr. Adrienne O'Brien and Dr. David
G. Salten
Mr. and Mrs. Walter H. Page
Dr. and Mrs. Philip F. Palmedo
Mr. and Mrs. William Parsons, Jr.
Mr. and Mrs. Christopher Pascucci
Mr. and Mrs. Whitney D. Pidot
Ellen and Martin Pollak
Mr. and Mrs. Richardson Pratt, Jr.
Mr. and Mrs. Curtis S. Read
Frances S. Reese
Ms. Augusta Reese
Mrs. Victoria Reese-Kennedy
Mr. and Mrs. Richardson Pratt, Jr.
Mr. and Mrs. William S. Robertson
Mr. and Mrs. Arthur M. Rogers, Jr.
Mr. and Mrs. J. Wright Rumbough,
Jr.
Mrs. Wendy Russell
Mr. and Mrs. Steven M. Schlussel
Mr. and Mrs. Enrique S. Senior
Mr and Mrs. Owen T. Smith
Mr. and Mrs. Peter 0. Solbert
Dr. and Mrs. Bruce Stillman
Mrs. Martin Victor
Mr. and Mrs. Bradford A. Warner
Mrs. William W. Wilson
FRIENDS.
Albrecht, Viggiano, Zureck &
Company, P.C.
Mrs. Jules W. Aubry
Henry and Erica Babcock
Mr. and Mrs. Rynn Berry
Mr. John C. Bierwirth
Dr. William Bloom
Mr. and Mrs. William Braden
Harry A. Brooks
Mr. and Mrs. Thomas J. Calabrese,
Jr.
Mr. and Mrs. Samuel R. Callaway
Dr. Eleanor Chernick
Dr. and Mrs. Bayard D. Clarkson
Mr. and Mrs. Robert E. Cooper
Mr. and Mrs. Curtis Cushman
Mr. Richard S. Davis
Daniel P. Davison
Mr. and Mrs. Guy de Chazal
Mr. and Mrs. William Tucker Dean
Mr. E. Richard Droesch
Dr. Lester Dubnick
Duplex Electrical Supply Corporation
Ms. Julie C. Eichenberger
Mr. Martin Elias
Dr. and Mrs. Jerry Ellstein
Mr. and Mrs. Joel M. Fairman
Mr. and Mrs. Harold L. Fates
Mr. and Mrs. Robert A. Gay
Joseph L. Goldstein
Dr. and Mrs. Charles Goodwin
Mr. and Mrs. Austen T. Gray, Jr.
Dr. and Mrs. Maurice Green
Mr. and Mrs. Norman Gross
Dr. and Mrs. Gary Gussin
Mr. and Mrs. Harold W. Hawkey
Mrs. Gayle Heller
Mr. and Mrs. Landon Hilliard III
Hubbinette-Cowell Associates, Inc.
Mr. and Mrs. John Juda, Jr.
Mrs. Gilbert W. Kahn
Mr. and Mrs. Antoine C. Kemper, Jr.
Mr. and Mrs. Peter D. Klein
Barbara B. Knowles
Nancy B. Leeds
Mr. and Mrs. Thomas Leon
Mr. and Mrs. Stephen M. Lessing
George Lindsay, Jr and Nancy Metz
Henry Luce III
Mr. and Mrs. Norton W. Mailman
Mr. and Mrs. William H. Mathers
Virginia E. Maurer, M.D.
C. Richard McDaniel
Mr. and Mrs. Robert M. McLane
Dr. and Mrs. Jeffrey H. Miller
Mr. and Mrs. George G. Montgomery
Mr. and Mrs. John P. Morgan II
Mr. and Mrs. Peter O'Neill
Mr. and Mrs. Innis O'Rourke, Jr.
Mrs. John H. Page
Mr. Charles Papa lcure
Mr. and Mrs. Nicholas B.
Paumgarten
Mr. and Mrs. Richard Pechter
Mr. and Mrs. Sterling Pile, Jr.
Mr. and Mrs. James J. Pirtle, Jr.
Dr. and Mrs. Richard M. Powers
Mr. and Mrs. Richard F. Powers
Mr. and Mrs. Richard I. Purnell
Mr. and Mrs. Richard Rubinstein
Mr. and Mrs. Henry E. Salzhauer
Mr. Ernest Scalamandre
Dr. and Mrs. Walter Shropshire, Jr.
Mr. and Mrs. Craig S. Sim
Mr. and Mrs. Howard Simpson
Dr. Maxine F. Singer
Mr. and Mrs. Herbert L Smith III
Mrs. Howard S. Spingarn
Mr. and Mrs. Erwin P. Staller
Drs. Joan and Thomas Steitz
Mr. and Mrs. B. Albert Stern, Jr.
Mrs. Richard Storrs
Mrs. Jane S. Sykes
Jill and Stuart Tane
Mrs. David S. Taylor
Mr. and Mrs. Daniel G. Tenney, Jr.
Mrs. Edward Townsend
Mr. and Mrs. James P. Townsend
Mr. and Mrs. Bronson Trevor, Jr.
Mr. and Mrs. Stanley S. Trotman, Jr.
Dr. Hwei-Gene H. Wang
Mr. and Mrs. George M. Wheatley III
Mr. and Mrs. Douglas Williams
Dr. and Mrs. Philip D. Wilson, Jr.
Mr. and Mrs. Frederick C. Witsell, Jr.
Mr. and Mrs. Ronald Wurtzburger
Dr. Charles Yanofsky
Mr. and Mrs. Irwin Young
BASIC MEMBERSHIP...
Mr. and Mrs. Thomas H. Ackerman
Mr. and Mrs. Alan M. Ades
Mr. and Mrs. M. Farrag Ahmed
Mr. and Mrs. James W. Allen
Mr. and Mrs. Charles 0. Ames
Drs. Harold and Shirley Andersen
Ms. Jean E. Andersen
Carl W. And Mary E. Anderson
Mr. and Mrs. J. Bryan Anthony
Mr. and Mrs. S. Reed Anthony
Christine R. Appel
Jens and Marion Bakke
Dr. and Mrs. Henry H. Bard
Mrs. Dudley R. Barr
Dr. and Mrs. Neil Barton
Dr. and Mrs. Neil J. Battinelli
Fred and Ilse Baum
Mrs. Sherburn M. Becker III
Robert and Elena Benson
Mr. Anthony J. Berejka and Mrs.
Maureen K. Berejka
Mr. John Berejka and Dr. Diane
Moriarty
Dr. Barbara Bergman
Dr. and Mrs. Arthur M. Bernhang
Mr. and Mrs. Ashok Bhavnani
Mr. and Mrs. Nicholas Biddle, Jr.
Mrs. William Binnian
Ms. June B. Birge
Mary Lenore Blair
Mr. and Mrs. Peter H. Blohm
Mr. and Mrs. Stuart Blumner
Lilias K. Bostwick
Mr. and Mrs. Barnett W. Bronfman
Ms. Miranda Brooks and Mr. Ward
Meyer
Mr. and Mrs. Barry Brumberg
Mrs. Walter Brunauer
The Buffalo News
Mr. Peter A. Bullock
Dr. Charles Buntschuh
Mrs. Frances W. Bush-Brown
Mr. and Mrs. Michael C. Cammarota
Mr. and Mrs. Ward C. Campbell
Ms. Madeline S. Carver
Mr. and Mrs. Arthur Cerrone
Mr. and Mrs. Gilbert W. Chapman, Jr.
Dr. and Mrs. Donald E. Chiarello
Mr. and Mrs. William H. Chisholm
Mr. and Mrs. Robert Citrino
Maurice J. Cohn and Milton S. Cohn
Ms. Maryda S. Colowick
Mrs. Alan L Corey
Mr. Richard L. Cosnotti and
Rev. Sharon Bledsoe
Reverend Mano Costa
Mr. W.C. Coulbourn
Ms. Katya Davey
Mr. Lawrence E. Davidow
Dr. E. William Davis, Jr.
Mr. and Mrs. Raymond de Clairville
Mr. and Mrs. Edward F DelFoe
Mr. and Mrs. John N. Deming
Mr. and Mrs. Andrew DeNatale
Dentaco Corporation
Carolyn C. Dilworth
Dr. and Mrs. David Dines
Mr. and Mrs. Joseph T. Donohue
Dr. and Mrs. Thomas J. Dowling, Jr.
Mr. and Mrs. Anthony D. Duke, Jr.
Mr. and Mrs. Don Durgin
Mrs. William S. Eakins
Dr. and Mrs. James D. Ebert
Mr. and Mrs. John E. Eckelberry
Dr. Phyllis B. Edelheit and Mr. David
Edelheit
Mr. and Mrs. Richard H. Emmert
Dr. and Mrs. N. Dennis Eryou
Mrs. James M. Estabrook
Mrs. Raymond Z. Fahs
Mrs. Frances Fennebresque
James C. and Jeanne F. Ferrer
Dr. and Mrs. Neil Fidel
Dr. and Mrs. Noah Finkel
Mr. Herbert S. Fitzgibbon II
Mr. and Mrs. William Floyd-Jones
Mr. and Mrs. Paul B. Forchelli
Mr. and Mrs. J.J. Frey
Charles R. Gabalis
Mr. and Mrs. Richard Gachot
Mr. and Mrs. John W. Galston
Mr. and Mrs. John Gambling
Bernard Gartlir
Mr. and Mrs. John W. Gates
Mr. and Mrs. William C. Gay, Jr.
Dr. and Mrs. Martin Gellert
Mr. Roger Gerber
Henry and Nancy Gerry
Dr. and Mrs. Lewis A. Goldfinger
Mrs. Elliot H. Goodwin
Mr. George Gorelick
Mr. and Mrs. Michael M. Gottsegen
Mrs. Austen T. Gray
Dr. and Mrs. Raymond B. Griffiths
Susan Gunduz, M.D., F.A.A.P.
Mrs. Hamilton Hadden
Mr. and Mrs. Edward Haleman
Mrs. Beverly F. Hanson
Dr. and Mrs. Matthew N. Harris
Dr. and Mrs. Chester Hartenstein
Stuart. Hartmeyer
Robin Heim
Mrs. W. Peter Henderson
Mr. Anthony S. Hendrick
Mr. and Mrs. Robert V. Henning
Mr. Larry Hertz
Mr. and Mrs. Arno Herzog
Mrs. Charles L. Hewitt
Mr. and Mrs. Charles A. Hickmann
Mrs. Albert L. Hoffman
Mr. and Mrs. Charles R. Holcomb
Mr. Irving Holtzman
Mrs. Bruce D. Hooton
Mr. and Mrs. James Hoover
Mr. and Mrs. George J. Hossfeld, Jr.
Mr. Donald E. Houghton
Mr. and Mrs. George H. Howard III
Mr. and Mrs. George H. Howard
Dr. and Mrs. Shiu-Lok Hu
Mr. and Mrs. Charles J. Hubbard
Mr. and Mrs. Philip G. Hull
Mrs. Beatrice W. Ingham
Mr. and Mrs. Herbert S. Ingham
Dr. and Mrs. John Inglis
Mrs. David Ingraham
Mrs. Sarah Ingraham
Mr. Thomas lovino
Mr. and Mrs. Charles J. Irwin
Mr. and Mrs. Fred A. Irwin
Mrs. Martha T. Jackson
Mr. and Mrs. Valdemar F. Jacobsen
Ruth B. Jordan
Dr. and Mrs. Richard S. Joseph
Mr. and Mrs. Howard L. Kane
Ms. Bonnie Kansler
Mr. and Mrs. Morris I. Karpen
Yoshiro Kawano, Ph.D.
Mr. and Mrs. Spencer Kellogg II
Thomas J. and Joan T. Kelly
Mr. Arnold E. Keppler
Doris Ketcham
Dr. Stanley Kitzis
Mr. and Mrs. David M. Knott
Mrs. Anne R. Knowlton
Angela Koenig
Dr. and Mrs. Fred Kornblueh
Mr. and Mrs. Edward W. Kozlik
Mr. and Mrs. Jerry Kuliga
Mrs. Mitsuko Kurahara
Mr. Bruno L. Larvoi
Ms. Betty D. Lasek
Sue Lathrop
Mrs. Leslie S. Learned
Ms. Lorraine Patton Lee
Mr. and Mrs. Anthony V. Leness
Mr. and Mrs. Michael Lesko
Mrs. Elizabeth A. Lindsay
Dr. and Mrs. Lawrence J. Lippert
Mr. and Mrs. David Lippman
Dr. Irene Llovera and Mr. Candido
Llovera
Mr. and Mrs. Marten Loewengart
Mr. and Mrs. Alan J. Long
Mrs. W.Z. Lotowycz
Mr. and Mrs. James R. Lowell III
Joseph and Antoinette Ludden
Mr. and Mrs. Richard H. MacDougall
Mr. and Mrs. John W. MacKay
Mr. Wilfred G. Mackey
Mrs. Henry R. Macy
Ms. Mary Louise Magee
Mr. and Mrs. Scott Marcus
Mildred Marmur
Mr. and Mrs. John Maroney
Mr. and Mrs. Ronald C. Martello
Ms. Pamela J. Mathews
Mr. and Mrs. William B. Matteson
Drs. Egon and Marcia Mayer
Mr. and Mrs. Gregory Mc Mahon
Ms. Alison McCall
Mrs. Winifred M. Jolly and Mr.
Malcom S. McClintock
Mrs. Martha McDuffie
Mr. and Mrs. Angus P. McIntyre
Winifred W. Megear
Mr. and Mrs. Arthur C. Merrill, Jr
Ms. Dianne L. Parker and Mr. James
Metcalfe
Ms. Lisa Meyer
Mr. and Mrs. George S. Meyer
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Mr. and Mrs. William A. Milanese, Jr.
Mr. and Mrs. Shepard Milians
Mr. and Mrs. John R. Miller III
Mr. William H. Miller
Ms. Mary M. Misiorek
Mr. and Mrs. Jesse Mittleman
Mr. and Mrs. Elihu Mod lin
Mary and John Morrison
Charles and Jane Morton
Mr. & Mrs. Brent M. Mowery Jr.
Mr. and Mrs. Gardner M. Mundy
Mrs. Alfred E. Munier
Dr. and Mrs. Stephen H. Munroe
Mr. and Mrs. Yale Murov
Mr. and Mrs. Thomson C. Murray
Mr. and Mrs. Rem V. Myers
Dr. and Mrs. Larry Nathanso
Dr. Peter and Marcy. Neumann
Dr. and Mrs. Benny Ng
Dr. Junichi Nikawa
North Country Garden Club
Mr. and Mrs. David C. Noyes, Jr.
Mr. and Mrs. Frank J. Olt, Jr.
Mrs. Martha M. Osterhus
Mr and Mrs. Michael Paloian
Mr. and Mrs. Samuel D. Parkinson
Mr and Mrs. Joseph M. Parriott
Mr. and Mrs. Scott L. Paterson
Mr. and Mrs. Paul G. Pennoyer, Jr.
Harry and Marjorie Phillips
Ms. Julie Emery and Mr. Sebastian
Piccione
Robert and Helen Pilkington
Mr and Mrs. Graham L. Platt
Honorable and Mrs. Thomas C. Platt
Mr. and Mrs. Grant A. Porter
Mr. and Mrs. Edward E. Post
Ms. M. Wynona Powers
Dr. and Mrs. R. Scott Powers
Dr. and Mrs. Alan E. Prestia
Angels, $10,000 or more
*. Benefactors, $5,000 or more
Patrons, $2,500 or more
Mr. and Mrs. Millard B. Prisant
Mr. and Mrs. Preston V. Pumphrey
Dr. and Mrs. Edward Raskin
Mr. Daren A. Rathkopf
Mr. and Mrs. Mark Rechler
Mr. Geraldyn L. Redmond
Mr. Arthur G. Reid
Mr. Cornelius J. Reid, Jr.
Mrs. Ewing W. Reilley
Mr. and Mrs. Charles J. Reina
Dr. and Mrs. Robert M. Reiss
Mr. and Mrs. Jay Remsen
Dr. and Mrs. Michael Repice
Mr. Edward F. Ribaudo
Mr. and Mrs. Harold Van B. Richard
Mr. and Mrs. Bernard Richards
Dr. Frederic M. Richards
Mr. and Mrs. Joseph Rizza, Jr.
Dr. and Mrs. Francis J. Roberts
Mr. and Mrs. Douglas Robinson
Dr. and Mrs. James N. Romanelli
Mr. and Mrs. Robert A. Rubin
Mr. and Mrs. Leon A. Rushmore, Jr.
Mr. and Mrs. Jay E. Russ
Ms. Charlene A. Russert
Mrs. Robert M. Salant
Mrs. Anita H. Salembier
Mr. and Mr. Martin B. Salzman
Mrs. Patricia P. Sands
Dr. Kay H. Sato
Ms. Phyllis Satz
Dr. Walter Schaffner
Mr. and Mrs. Tancred V Schiavoni
Dr. Ronald Schmeltzer and
Dr. Alyson Andres
Jane R. Schreuder
James W. Schubauer
Raymond G. Schuville
Mr. and Mrs. Steven S.
Schwa.reich
Associates, $1,000 or more
no Friends, $300 or more
o+ Basic Membership, $50 or more
OTHER CONTRIBUTORS TO THE CSHL ASSOCIATION
Mrs. George F. Bird
Ms. Melissa Brooks and Robert
Zakarian
Dr. and Mrs. Salvatore Caravella
Mr. and Mrs. Robert Coe
Dr. & Mrs. Peter F Cohn
Mr. and Mrs. Gerard DeGregoris, Jr.
Dr. Kathleen M. Doyle
Mrs. Edith Drucker
Mr. and Mrs. Leonard K. Du Brul
Mr. and Mrs. A.A. Forman
Mr. and Mrs. Robert Hutchings
Dr. Morton Kissen
Rev. and Mrs. T. Carleton Lee
Mr. David R. Schwarz
Mrs. Dorothy Scott
Mr. and Mrs. Alfred Seaman
Ms. Elizabeth A. Sell
Frederick E. and Jane Seymour
Mr. and Mrs. Daniel S. Shapiro
Mr. and Mrs. Marvin J. Sharfin
Mr. and Mrs. Paul C. Sheeline
Dr. and Mrs. Edward M. Shepard
Mr. Edward Shads
Mr. Robert N. Shwa. and Mrs.
Susan J. Greenberg
Mr and Mrs. Constantine Sidamon-
Eristoff
Mr. and Mrs. Richard Simon, Jr.
Mr. and Mrs. William C. Simpson
Mrs. James C. Skiff
Mr. Richard Slade
Mrs. Suzanne Slocum
Mr. and Mrs. William S. Smoot
Mr. and Mrs. James Sommermeyer
Mr. and Mrs. John Specce
Spinnaker Travel Ltd.
Dr. and Mrs. David Stacy, Jr.
Dr. Franklin W. Stahl
Mrs. Robert H. Staniford, Jr.
Mr. and Mrs. Lawrence Starr
Stat Design, Inc.
Mr. and Mrs. Thomas Staudt
Judith and Bernard Stebel
Donata and Walter Stern
Mr. and Mrs. Jeffrey T. Stevenson
Mr. and Mrs. John C. Stevenson
Mr. and Mrs. James Stewart
Mr. and Mrs. William M. Stiger
Mrs. J.S. Stout
Sid and Carol Strickland
Mr. James D. Taliaferro
Dr. Frances Taylor
Mrs. Anne M. Thomas
Mr. and Mrs. Kenneth MacDonald
Richard and Judith Opsahl
Ms. Elaine Ronneburger
Ms. Diana Russell
Dr. Claire A. Ryan
Dr. Franz Schager-Eckartsau
Mr. and Mrs. John D. Simpson
Mr. and Mrs. Edward M. Thomas
Mr. and Mrs. Evan W. Thomas II
Mr. George M. Thomas
Mr. William D. Thompson
Three Harbors Garden Club
Mr. and Mrs. George H. Tilghman
Mr. Stanford W. Ting
Mr. and Mrs. Warren I. Titus, Jr.
Mr. and Mrs. George I. Toumanoff
Mr. and Mrs. David B. Townsend
Mr. and Mrs. Bronson Trevor
Mr. and Mrs. Robert C. Troxler
Mr. and Mrs. Cornelius M. Ulman
Mr. and Mrs. Stephen Van R. Ulman
Mr. Michael D. Unger
Dr. and Mrs. Thornton A. Vandersall
Mr. and Mrs. Thomas R.
Vandeventer
Mr. and Mrs. Stephen Vesce
Mr. and Mrs. Niklaus Vetsch
Mr. and Mrs. Joseph C. Viviani
Mr. and Mrs. Donald Vogel
Dr. and Mrs. Ernest Vomero
Mr. and Mrs. Eugene D.
Wadsworth
Mr. and Mrs. Colton P. Wagner
Jocelyn G. Walker
Mr. and Mrs. Robert P. Walton
Mr. and Mrs. William Watman
Mr. and Mrs. Stephen Wafters
Mr. and Mrs. Richard K. Webel
Mrs. Bradford G. Weekes
Richard and Janina Weghorn
Mrs. L.B. Wehle, Jr.
Mrs. John C. Wilmerding
Mr. and Mrs. Steven M. Woghin
Mr. and Mrs. Warren D. Wylie
Drs. Moshe and Josette Yaniv
Ms. Joan C. Zulch
Dr. Garland Stern
Dr. Janey S. Symington
Drs. Robert and Ruth Waldbaum
Mrs. Mary Louise R. Wallendort
Mr. Edward C. Whitcraft
Mrs. Lorraine S. Wicks
CSHLA CORPORATE MATCHING AND FOUNDATION CONTRIBUTIONS AND OTHER DIRECT GIFTS
The Arthur & Barbara Crocker
Charitable Trust
The Bado Foundation
Banbury Fund
The Belmont Foundation
The Bradford and Nancy H. Warner
Fund
The Bristol-Myers Squibb Company
Mr. and Mrs. John P. Campbell
The Chase Manhattan Foundation
Citibank
Computer Associates
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Corning Inc., Foundation
Mr. Paul A. Cowell, Jr.
Dean Witter Reynolds, Inc.
The Fluor Foundation
General Electric Foundation
GreenPoint Bank
The Greenvale School
The Jewish Communal Fund
The John A. Hartford Foundation,
Inc.
Johnson & Johnson
JP Morgan and Company, Inc.
The Long Island Community
Foundation
Lubrizol
The Miller Family Foundation
The New York Community Trust
Norwood Foundation, Inc.
Oppenheimer Funds, Inc.
Pentara Foundation, Inc.
Phelps Dodge Foundation
Pfizer, Inc.
Mr. and Mrs. John Pflug
The Richard Foundation
Reuter's America, Inc.
The Schiff Foundation
The Scudder Charitable Foundation
Mr. and Mrs. Sedgwick Snedeker
Mr. and Mrs. Douglas Soref
The Stebbins Fund, Inc.
The Times Mirror Foundation
Union Pacific Corporation
Unity Foundation
Mr. Charles H. Wellington
CSHLA Annual Fund
CSHLA Membership (640) and Other Support
Angels, Benefactors, Patrons, Associates $ 573,192.76
Friends and Basic Members $ 69,930.45
Other $635.00
Total $ 643,758
MEMORIAL AND GIFT IN HONOR CONTRIBUTORS
Robert and Selena Barron
Mrs. Nancy H. Biddle
Mr. and Mrs. Harry A. Brooks
The Burke Rehabilitation Hospital, Inc.
Mr. and Mrs. Charles L. Capito, Jr.
Mr. and Mrs. John P. Cleary
Dr. Joseph J. Colasanti
Mr. and Mrs. John H. Coleman
Jane and Judith Collum
Mr. and Mrs. Robert E. Cooper
Loretta M. Cronin
Ms. Marie P. Cummings
Mrs. Vincent De Roulet
Mr. and Mrs. Robert B. Deans, Jr.
Mr. and Mrs. William T. Dunn, Jr.
Mrs. Frances Fennebresque
Mr. and Mrs. William R. Fitz
Mr. and Mrs. Raymond French
Mr. and Mrs. Irwin Frish
Glasser & Haims, P.C.
Mr. and Mrs. Allen A. Goldring
Mr. and Mrs. John S. Grace
Mrs. Selma A. Greenbaum
J.C. D. Hadden
Ca lista and Henry Harder
Mr. and Mrs. Gordon S. Hargraves
Richard Harte
IN MEMORY OF
Clarence E. Ball
Nina M. Galston
Mary Jeanne Harris
Alfred D. Hershey
Gertrude Hornstein
Christopher Kohler
Mr. and Mrs. Thomas M. Hearn
Ms. Gila Hellman
Lucile P. Herbert
The Hovey Family
The James Barry-Robinson Home
for Boys
Mrs. Jane D. Kersey
Mrs. Albert Key
Mr. and Mrs. Jordan E. Krown
Ms. Evelyn Lehman
Mr. and Mrs. John H. Leib
Muriel and Rob Logan
Edmund C. Lynch
Lynn Dental Associates
Mr. and Mrs. Leonard F. Marshall, Jr.
Mr. and Mrs. William L. Matheson
Mrs. William P. McBride
Mr. and Mrs. William J. McKinnon, Jr.
Mr. and Mrs. Robert M. McLane
Mrs. Bayard H. Megear
Mr. and Mrs. Robert G. Merrill
Mr. and Mrs. Gordon Mills
Mr. and Mrs. Frederick H. Morgan
Emil Mosbacher, Jr.
Mr. & Mrs. Brent M. Mowery, Jr.
Mrs. George Murnane, Jr.
Mr. and Mrs. Francis W. Murray III
Edward Lawrence
Bruce Littman
Daniel Mandel
William F. Russell
Angela Wall
Marie M. Yeager
Mr. Gerald I. White
Whitehall Foundation, Inc.
The Wilfred P. Cohen Foundation, Inc.
The William Ewing Foundation
W.P. Carey & Co., Inc.
Norfolk Collegiate School
Colleen B. O'Brien
Mr. and Mrs. Edward L. Palmer
The Peter 0. Crisp Fund
Mr. and Mrs. Howard Phipps, Jr.
Mr. and Mrs. John G. Pieper
Mr. and Mrs. Sterling Pile, Jr.
Mrs. Barbara Powers
Mrs. Wendy Russell
Mr. and Mrs. Norman Schulman
Richard W. Sesnewicz
Mr. and Mrs. Edward H. Starr
Philip Steers
Mr. and Mrs. Robert L. Stott, Jr.
Dorothy and Alfred Szczesny
Mr. and Mrs. Stuart Tane
Mrs. David S. Taylor
William D. Van Dyke III
Mr. and Mrs. Lawrence B. Van Ingen
Mrs. Beverly S. VanderPoel
Mrs. Martin Victor
Mr. and Mrs. Charles A. von
Stackelberg
Mr. and Mrs. Henry G. Walter, Jr.
Mrs. David E. Warden
Katherine C. Willis
Mrs. Eunice J. Winslow
IN HONOR OF
Leonard Asher
Susan Cooper
Bernard Gartlir
George J. Joseph
Memorials and In Honor Totals $ 10,910
Jemina J. Schilling
Abe Shulman
Mort Siegler
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President's Council
The President's Council supports our program of Cold Spring Harbor Fellows, a position created in
1986. Cold Spring Harbor Fellows are exceptionally talented, young scientists who already show
the capacity for high level, independent research while in pursuit of their doctoral degrees.
CONTRIBUTORS
Abraham Appel
Peter Bloom
James Conneen
Michel David-Weill
Leo A. Guthart
Charles E. Harris
Walter B. Kissenger
Donald A. Pels
George B. Rathmann
Hubert J. P. Schoemaker
James H. Simons
Sigi Ziering
Total $ 235,000
Undergraduate Research Program/Partners for the Future
The Undergraduate Research Program introduces college students to the skills they need to
become research scientists. Approximately 20 participants work under the guidance of staff scien-
tists for 10 weeks each summer on projects of mutual interest. The Partners for the Future Program
teaches the principles and methods of basic scientific research to six Long Island high school
seniors, who work with a scientist 10 hours per week after school, from October through March.
CONTRIBUTORS ENDOWMENTS
Cornelius N. Bliss Memorial Fund
Cablevision Systems Corp.
Dorcas Cummings Memorial Lecture
Reverend Linda P. Hancock
Jephson Educational Trust
Reuter's America Inc.
Joan P. Tilney
Total
Total All Annual Funds
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Burroughs Wellcome Fund
Emanuel Ax Fund
Garfield Fellowship
H. Bentley Glass Fellowship
Libby Fellowship
Olney Fund
Joan Redmond Read Fund
William Shakespeare Fellowship
Frederica von Stade Fund
$ 121,907
$ 356,907
LABORATORY STAFF
James D. Watson, President
Bruce W. Stillman, Director
Winship Herr, Asst. Director
G. Morgan Browne, Administrative Director
John P. Maroney, Asst. Administrative Director
William D. Keen, Comptroller
FACULTY
Investigators
David Beach
Carol Greider*
David Helfman
Nouria Hernandez*
Adrian Krainer
Roberto Malinow
Robert Martienssen
David Spector
Nicholas Tonks
Timothy Tully
Michael Wig ler
Associate Investigators
Xiaodong Cheng*
Hollis Cline
Grigori Enikolopov
Bruce Futcher
Ryuji Kobayashi
Hong Ma
Richard McCombie
Alcino Silva
Jacek Skowronski
Arne Stenlund
Yi Zhong
Assistant Investigators
Ulrich Grossniklaus
Erich Grotewold
Gregory Hannon
Michael Hengartner
Tatsuva Hirano
David Jackson
Leemor Joshua-Tor
Yuri Lazebnik
Scott Lowe
Peter H. Nest ler
Andrew Neuwald
Karel Svoboda
William Tansey
Linda Van Aelst
Rui Ming Xu
Chi-Ping (Jerry) Yin
Michael Zhang
Research Investigators
Joseph Colasanti*
Nei lay Dedhia
Masaaki Hamaguchi
Robert Lucito
Akila Mayeda
El ly Nedivi
Natalia Peunova
Andrew Reiner
Shou Waga
Clifford Yen
Adjunct Investigator
Tom Marr
Adjunct Associate
Investigator
Scott Powers
Adjunct Assistant
Investigator
Craig Ogata
Visiting Scientists
Jiaxin An
Eli Hatchwell
Ming Huang
Nobuhiro Kashige
Marjana Maletic-Savatic
Tatyana Michurina
Mariko Nakamura
Vladimir Scheinker
Zuoping Xie
Senior Fellow
Douglas Conklin
Postdoctoral Fellows
Marcia Belvin
Anton Bennett
Christine Berthier
Benjamin Bottner
Mary Byrne
Isabel Cantallops
*Funding provided by Howard Hughes Medical Institute
'Departed in 1997
Terri I. Grodzicker, Asst. Director for Academic
Affairs
Jan A. Witkowski, Director of Banbury Center
David A. Mick los, Director of DNA Learning Center
John R. Inglis, Executive Director of CSHL Press
David J. Stewart, Director of Meetings and Courses
Luca Cartegni
James Chong
Mark Curtis
Pedro De Campos-Lima
Robert Del Vecchio
Serge Desnoyers
James Dezazzo
Jeffrey Dickinson
Dennis Dong
Joseph Donovan
Andrea Doseff
Eric Drier
Joshua Dubnau
Nicholas Edgington
Ype Elgersma
Viola Ellison
Jose Esteban
Howard Fearnhead
Nikolai Federov
Francisco Ferrezuelo
Paul Frank land
Fei Gao
Anton Gartner
Andrew Garton
Karl Giese
Cameron Gray
Michael Greenberg
Hui-Fu Guo
Michael Gutch
Frances Hannan
Mariko Hayashi
Yasunori Hayashi
Ronald (Bill) Henry
Craig Hinkley
Sangeet Honey
Junjiro Horiuchi
Ilya loschikhes
Alyson Kass-Eisler
Catherine Kidner
Keiji Kimura
Jeffrey Kogan
Peter Krasnov
Chun Liang
Wen-Chuan (Athena) Lin
Zhixin Lin
Dehua Liu
Hong-Xiang Liu
Ruiping Liu
Yi Liu
Martin Lock
Ana Losada
Zachary Mainen
Mireya Marin
Juan Mendez
Thomas Misteli
Vivek Mittal*
Michael Murray
Michael Myers
Naoki Nakaya
Pol O'Fearghail
Michael Packer
Laurence Parnell
Shannon Pendergrast
Jean-Christophe Poncer
Pablo Rabinowicz
Indrani Rajan
Baskar Ramamurthy
Michael Regulski
Minoru Saito
Cyril Sanders
Brandt Schneider
Lidia Serina
Gavin Sherlock
Keiichi Shibahara
Kaetrin Simpson
Maria Soengas
Mona Spector
Yuri Stasiv
Peiqing Sun
Jack Tabaska
Anne Vaahtokari
Daan van Aalten
Daniel Vaughn
Alain Verreault
Jean-Philippe Vielle-
Caizada
Jonathan Wallach
Jing (Jenny) Wang
Yalin Wang
Yung-Chih (Judy) Wang
Michael Weinreich
Nicholas Wright
Shouzhen Xia
Ming Yang
Shahid Zaman
Shaohui Zhang
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Xuemei Zhao
Jianlong (Jim) Zhou
Dong-Jing Zou
Graduate Students
Robert Babb
Kenneth Chang
Degui (Charlie) Chen
Grace Chen
Pin (Adele) Chen
Jeffrey Christensen
Yi Chieh (Nancy) Du
Lavina Faleiro
Ethan Ford
Richard Freiman
Eric Gillitzer
Tina Gumienny
Daniel Hoeppner
John lafrate
Tracy Kuhlman
Kenneth La Montagne
Arlinda Lee
Qiong Liu
Michele Mc Donough
Troy Messick
John Mignone
Stuart Milstein
Paul Mintz
James Moore
Debra Morrison
Shirley Pinto
Julia Polyakova
Alex Rai
Patrick Reilly
Jose Rodriguez'
Peter Rubinelli
Ahmed Samatar
Andrew Samuelson
Laura Schramm
Meenakshi Selvakumar
Setareh Sepehri
Andrew (Mark) Settles
Songhai Shi
Michael Stebbins
Javor Stolarov
Tomasz (Tomek) Swigut
Marcela Tello-Ruiz
Suzanne Tharin
Tzu-Ling Tseng
Hua Tu
Thomas Tubon
Thomas Volpe
Rachel Wallace-Brodeur
Joseph West
Herman Wijnen
Qiang We
Xiaohong (Helena) Yang
Lee Zou
Howard Hughes Medical
Institute Employees
Support Staff
Beicong Ma
Carol Sekunda
Yu ling Sun
Roderick Thomas
Research Associates
Carmelita Bautista
Lisa Manche
Linda Rodgers
Lab Facility Managers
Maria Coronesi
Diane Esposito
Thomas Malone
Timothy Mulligan
Spencer Tep lin
Regina Whitaker
Laboratory Manager
Martha Daddario
Technical Programmers
Steven Cozza
David Cuddihy
John Healy
Ryutaro Iwasaki
Moira Mallison
Jacqueline Salit
Adam Tracy
Secretaries
Sadie Arana
Patricia Bird
ldee Mallardi
Carol Marcincuk
Barbara Matusik
Lorraine Mc Inerny
Jane Reader
Judith Smith
Madeline Wisnewski
Research Assistants
Oliver Bowes
Keith Wu
Laboratory Technicians
Caroline Alexander
Susan Allan
Dorca Almanzar
Deborah Aufiero
Kimberly Bronson
Barry Burbach
Eileen Cahill
Chuan-Min Chen
Xiocun (Joan) Chen
Jodi Coblentz
Alison Coluccio
Jill Daniell
Nancy Dawkins-Pisani
Melissa de la Bastide
Ping Dong
Minetta Elgersma
Margaret Falkowski
Tristan Gill
Lidia Gnoj
Scott Gossweiler
Tina Gottesman
Jill Grossman
Kristina Habermann
Ying Han
Meredith Hannon
Michiko Hirano
Tamara Howard
Yi Hu
Emily Huang
Kimberly Ivarson
Santosh John
Rachel Jones
Manpreet Katari
James Keller
Aaron Laskey
Martine Lessard
Hui Li
Lin Luo
Mila McCurrach
Robert McGuirk
Jeremy Medal le
Andrew Morotti
Joshua Nagel
Aigoul Nourjanova
Peter O'Brien
Elizabeth O'Connor
Ronnie Packer
Nora Poppito
Maryam Rahimzadeh
Michael Riggs
Julie Rosenbaum
Simone Salghetti
Joseph Salvatore
Kristin Schutz
Rosemarie Sherlock
Nadim Shohdy
Joseph Simorowski
Patrick Smith
Jennifer Troge
Vickie (Hui-Qi) Tu
Klara Velinzon
Miho Waga
Kimberly Wanat
Jessica Waskewich
Patricia Wendel
Jeanne Wiggins
Priscilla Wu
Lin-Ying Xie
Cristina Yordan
Zhuang Yuan
Ying Zhang
Hong Zhou
Media Makers/
Laboratory Aides
Esteban Araya
June Blanchford
Patricia Brady
Jack Brodsky
Florinda Chaves
Rodney Chisum
Janice Douglas
Salvador Henriquez
Robin Kirchner
Christine Maurel
Vincent Meschan
Yvette Redler
Rulan Shen
Margaret Wallace
Eugene Chris Williams
Xiu-Xia Zhang
DEPARTMENTS
Art
Michael Ockler
James Duffy
Irwin Mend linger
Philip Renna
Information Services
Gerald Latter
James Bense
John Healy
Patrick Monardo
Robert Pace
William Palafox
Barbara Peters
Salvatore Serafino
John Uhl
Lee Wilbur
CSHL Press
Acquisition
Elizabeth Powers
Books: Editorial
Janet Argentine
Mary Cozza
Judith Cuddihy
Maryliz Dickerson
*Funding provided by Howard
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Hughes Medical Institute
Joan Ebert
Kaaren Janssen
Inez Sialiano
Journals: Editorial
Laurie Goodman
Margaret Calicchia
Kimberly Gavin
Valerie Pakaluk
Production
Denise Weiss
Patricia Barker
Christopher Bianco
Dorothy Brown
Nadine Dumser
Elaine Gaveglia
Cynthia Grimm
Kristin Kraus
Laura Mintz
Susan Schaefer
FulfillmenUDistribution
Guy Keyes
Kathleen Cirone
Gabriella Horvath
Jacqueline Matura
Walter McKenna
Sharon Story
Joanne Thomas
Finance
Nancy Hodson
Marketing
Ingrid Benirschke
Cynthia Weidman
Advertising Sales
Marcie Ebenstein
Public Affairs
Margot Bennett
Marlene Emmons
Wendy Goldstein
Lynn Hardin
Development
Richard Cosnotti
Sherrie Hammond
Gordon Hargraves
Jean Houghton
Laura Hundt
Julie Sutherland
Cathie Wardell
Library
Margaret Henderson
Paula Abisognio
Clare Bunce
Laura Hyman
Leigh Johnson
Wanda Stolen
Claudia Zago
Accounting
Jennifer Blovsky
Guy Cozza
Mary Ellen Goldstein
Elizabeth Janow
Patricia Maroney
Alison McDermott
Carlos Mendez
Mary Ann Miceli
Elizabeth Panagot
Amy Stiso
Patricia Urena
Noreen Vance
Barbara Wang
Grants
Susan Schultz
Sharon Bense
Wendy Crowley
Maureen Davies
Carol DuPree
Patricia Kurfess
William Mahoney
Dee McKeon
Human Resources
Cheryl Sinclair
Marjorie Berko
Jan Eisenman
Kim Gronachan
Barbara Purcell
Merilyn Simkins
Rita Wienclaw
Food Service
James Hope
Kevin Adler
Jaime Bonilla
Francis Bowdren
Guiditta Carino
William Carmona
Michael Corral
Joan Doxey
Julie Ehrlich
Karen Farrell
Alec Firestone
Robert Gilman
Barbara Gordon
Jennifer Gordon
'Funding provided by Howard Hughes Medical Institute
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Oscar Lastra
Renee Le Strange
Maureen Morrow
Ronald Padden
Jorge Ramirez
Victor Ramones
Mauricio Rodriguez
Cathy Van Deurs
Leslie Wenzel
Keith Wieczorek
Meetings/Courses
Edward Campodonico
William Dickerson
Donna Dykeman
Michael Glaessgen
James Koziol
Michela McBride
Andrew Mendelsohn
Andrea Newell
James (Herb) Parsons
Mary Smith
Margaret Stellabotte
Andrea Stephenson
Diane Tighe
Nancy Weeks
Purchasing
Philip Lembo
Margaret Brock
Carol Brower
Lorraine Byers
Susan De Angelo
Bruce Fahlbusch
Patricia Hinton-Stenko
Edith Kappenberg
Susan Rose
Leonard Sposato
Central Administration
Maureen Berejka
Barry Braunstein
Carol Dempster
Delia King
Roberta Salant
Banbury Center
Katya Davey
Eleanor Sidorenko
Beatrice To liver
DNA Learning Center
Joan Alexander
Mark Bloom
Scott Bronson
Shirley Chan
Judy Cumella-Korabik
Michael Greenberg
Patricia Harrison
Melissa Hewitt
Barbara Hull
John Kruper
Susan Lauter
Andrew Morotti
Facilities
Arthur Brings
Christopher Hubert
Jack Richards
Peter Stahl
Leslie Allen
Margaret Chellis
Marlene Rubino
Katherine Ruffolo
Frank Russo
Charles Schneider
Carpentry and Painting
Peter Schwind
Edwin Bennett
Michael Demers
John Meyer
Joseph Pirnak
Wilson Ramones
Peter Rohde
Benjamin Veneable
Harry Wozniak
Custodial/Housekeeping
Steven Tang
Elizabeth Botti
Dessie Carter
Ming-Kai Chan
Stephen Gay
Jose Hernandez
Joaquin Herrera
Patricia Mc Adams
Susanne Mac Pherson
Dora Merlino
Guido Mosquera
Mary Muno
Wayne Pay
Ronald Romani
Claudia Schmid
Danuta Slodkowska
William Suescun
Jaroslaw Swidzinski
Yew Teo
David Williams
Electrical
Louis Jagoda
Jeffrey Goldblum
Environmental Health
and Safety
Randal Jones
Bill Kearney
John Pisciotta
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Equipment Design
Fabrication and Repair
Cliff Sutkevich
Robert Eifert
George Newell
James Robey
Grounds
Daniel Miller
Paul Draser
Joseph Ellis
Lawrence Giordano
Edward Haab
Christopher McEvoy
John Nolan
Mark Petro
Andrew Sauer
Stanley Schwarz
Dariusz Slodkowski
Harris Research
Support Facility
Lisa Bianco
Charlene De Poto
Jennifer Fauvell
Halina Swidzinski
Ryszard Swidzinski
Mechanical Services
Russell Allen
Greg Beal
William Bishop
Robert Collins
Lane Smith
Keith Spooner
Security
Robert Gensel
Frank Carberry
Randy Wilfong
Shipping and Receiving
Christopher Oravitz
Daniel Jusino
Joseph Marcello
Curtis Williams
Research Staff Depar-
tures during 1997
Faculty
Xiaodong Cheng
Joseph Colesanti
Carol Greider
*Funding provided by Howard Hughes Medical Institute
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Visiting Scientists
Ross Bicknell
Daniel Bush"
Liam Dolan-
Ai-Ping Dong
Konstantin Galactionov
Satoshi Kida
Boris Kuzin
Roberta Maestro
Postdoctoral Fellows
Maria Blasco
Gert Bolwig
Stephen Brand
Stephen Buck
Javier Caceres
Amancio Carnero
Gerhard Cullmann
Kang Dai
James Edwards
Hua-Ying Fan
Kimberly Gavin
Weimin Gong
Derek Gordon
Bing Guo
Masumi Hidaka
David Horowitz
John Horton
Hai Huang
Sui Huang
Masayoshi lizuka
Arthur Johnson
Christopher Jones
Thillai Koothan
Siyuan Le
Yu Liu
Muhammad Lodhi
Peter Lorenz
Salim Mamajiwalla
Caroline Mirzayan
Margaret O'Gara
Bong-Kyeong Oh
Michael D. Rudd
Manuel Serrano
Patricia Springer
Tony Tiganis
Qizhi Wang
Gang Yi Wu
Xujia Zhang
Graduate Students
Nicholas Carpino
Chong (Chris) Huang
Benjamin Lee
Jian Sheng
Aneil Shirke


